
<html lang="en"     class="pb-page"  data-request-id="1fcc669f-a427-44b9-8163-78a8789a79b6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.5b00497;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends" /></meta><meta name="dc.Creator" content="Peng  Zhan" /></meta><meta name="dc.Creator" content="Christophe  Pannecouque" /></meta><meta name="dc.Creator" content="Erik  De Clercq" /></meta><meta name="dc.Creator" content="Xinyong  Liu" /></meta><meta name="dc.Description" content="The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains,..." /></meta><meta name="Description" content="The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains,..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 5, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00497" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00497" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00497" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00497" /></link>
        
    
    

<title>Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00497" /></meta><meta property="og:title" content="Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0035.jpeg" /></meta><meta property="og:description" content="The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains, poor bioavailability, and cumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and additional therapeutic agents with novel action modes or targets. From this perspective, we first review current strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature. We highlight the development of phosphate ester-based prodrugs as a means to improve the aqueous solubility of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance. Finally, we discuss future directions for research, including opportunities for exploitation of novel antiretroviral targets, and the strategy of activation of latent HIV reservoirs as a means to eradicate the virus." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00497"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00497">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00497&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00497&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00497&amp;href=/doi/10.1021/acs.jmedchem.5b00497" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2849-2878</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b01201" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peng++Zhan">Peng Zhan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Pannecouque">Christophe Pannecouque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erik++De+Clercq">Erik De Clercq</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinyong++Liu">Xinyong Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012, Jinan, Shandong, P. R. China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium</span></div><div class="corresp-info"><strong>*</strong>E.D.C.: e-mail, <a href="/cdn-cgi/l/email-protection#1277607b793c7677717e7760716352607775733c79677e776764777c3c73713c7077"><span class="__cf_email__" data-cfemail="cda8bfa4a6e3a9a8aea1a8bfaebc8dbfa8aaace3a6b8a1a8b8bba8a3e3acaee3afa8">[email protected]</span></a>; phone, 3216337367.</div><div class="corresp-info"><strong>*</strong>X.L.: e-mail, <a href="/cdn-cgi/l/email-protection#91e9f8ffe8fefff6fdd1e2f5e4bff4f5e4bff2ff"><span class="__cf_email__" data-cfemail="98e0f1f6e1f7f6fff4d8ebfcedb6fdfcedb6fbf6">[email protected]</span></a>; phone, 086-531-88380270, 88382005.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00497&amp;href=/doi/10.1021%2Facs.jmedchem.5b00497" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2849–2878</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 28, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 March 2015</li><li><span class="item_label"><b>Published</b> online</span>5 November 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00497" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00497</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2849%26pageCount%3D30%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPeng%2BZhan%252C%2BChristophe%2BPannecouque%252C%2BErik%2BDe%2BClercq%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D7%26contentID%3Dacs.jmedchem.5b00497%26title%3DAnti-HIV%2BDrug%2BDiscovery%2Band%2BDevelopment%253A%2BCurrent%2BInnovations%2Band%2BFuture%2BTrends%26numPages%3D30%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2878%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00497"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7053</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">170</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00497" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Peng&quot;,&quot;last_name&quot;:&quot;Zhan&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Pannecouque&quot;},{&quot;first_name&quot;:&quot;Erik&quot;,&quot;last_name&quot;:&quot;De Clercq&quot;},{&quot;first_name&quot;:&quot;Xinyong&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;2849-2878&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00497&quot;},&quot;abstract&quot;:&quot;The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains, poor bioavailability, and cumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and additional therapeutic agents with novel action modes or targets. From this perspective, we first review current strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature. We highlight the development of phosphate ester-based prodrugs as a means to improve the aqueous solubility of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance. Finally, we discuss future directions for research, including opportunities for exploitation of novel antiretroviral targets, and the strategy of activation of latent HIV reservoirs as a means to eradicate the viru&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00497&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00497" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00497&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00497" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00497&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00497" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00497&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00497&amp;href=/doi/10.1021/acs.jmedchem.5b00497" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00497" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00497" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00497%26sid%3Dliteratum%253Aachs%26pmid%3D26509831%26genre%3Darticle%26aulast%3DZhan%26date%3D2016%26atitle%3DAnti-HIV%2BDrug%2BDiscovery%2Band%2BDevelopment%253A%2BCurrent%2BInnovations%2Band%2BFuture%2BTrends%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D2849%26epage%3D2878%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0035.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains, poor bioavailability, and cumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and additional therapeutic agents with novel action modes or targets. From this perspective, we first review current strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature. We highlight the development of phosphate ester-based prodrugs as a means to improve the aqueous solubility of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance. Finally, we discuss future directions for research, including opportunities for exploitation of novel antiretroviral targets, and the strategy of activation of latent HIV reservoirs as a means to eradicate the virus.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human immunodeficiency virus type 1 (HIV-1) is the main causative agent of acquired immunodeficiency syndrome (AIDS), which remains a serious public health problem throughout the world. At present, about 30 drugs in five main classes have been approved for the treatment of HIV/AIDS. These drugs target different steps of the viral life cycle: (i) viral entry (e.g., co-receptor antagonists and fusion inhibitors); (ii) reverse transcription (reverse transcriptase (RT) inhibitors); (iii) integration (integrase (IN) inhibitors); and (iv) viral maturation (protease (PR) inhibitors).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Powerful combinatorial antiretroviral therapy (cART, a combination of anti-HIV drugs targeting different steps in the life cycle of the virus) has had considerable success in controlling HIV infection. However, there are still two key issues: first, the emergence of extensively cross-resistant strains of HIV-1 (partly because of poor compliance), and second, the adverse effects (poor tolerability, drug–drug interactions, toxicities) of long-term use of these drug regimens, leading to poor patient compliance (namely, failure of patients to adhere to the drug regimen).<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2-6)</a> Thus, there is an urgent need for new anti-HIV drug candidates with increased potency, novel targets, improved pharmacokinetic properties, and reduced side effects.</div><div class="NLM_p last">The traditional approach of random screening and subsequent optimization of lead compounds by systematic organic synthesis is highly resource- and time-consuming. Thus, more efficient and faster strategies that shorten and facilitate the discovery process would be extremely beneficial. Indeed, the discovery of anti-HIV agents is moving on from trial-and-error approaches to sophisticated methodologies. In recent years, several strategies have been employed to discover novel anti-HIV agents with novel scaffolds and better resistance profiles, including fragment-based screening, privileged fragment-based reconstruction, dynamic ligation screening (DLS)-based drug discovery, rapid diversity-oriented synthesis combined with in situ screening, and hierarchical multiple-filter database searching. In this article, we present a critical survey of current structural modification strategies in the medicinal chemistry of anti-HIV agents, with the aid of selected examples from the recent literature. We also highlight a new strategy for improving drug efficacy and mitigating solubility-limited bioavailability by using phosphate ester-based prodrugs, and a novel structure-based drug design methodology to reduce drug susceptibility to resistance mutations, based on the substrate envelope hypothesis. Finally, we present an overview of structure biology-based exploration of novel targets in the HIV-1 replication cycle, as well as an alternative strategy, which has been described as the “shock-and-kill” (or “kick-and-kill”) strategy, based on the idea of activating the latent viral reservoirs in order to completely eradicate the virus.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 New Medicinal Chemistry Strategies for Lead Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Orthodox drug discovery has usually relied on screening a significant number of druglike molecules to find lead compounds that act at a putative target. Although high-throughput screening (HTS) and experimental screening of in-house chemical libraries have been successful in finding many “original hits”, leading ultimately to clinically useful drugs, the approach suffers from substantial drawbacks, including extremely low hit rates, many false positives, and the need for laborious lead modification, as the initial hit is often far from optimal for binding to the target.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> In contrast, innovations such as fragment-based drug design (FBDD), DLS methodology, high-speed diversity-oriented synthesis combined with in situ screening, and hierarchical multiple-filter database searching have enabled rapid and efficient progress in anti-HIV drug discovery.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Fragment-Based Screening</h3><div class="NLM_p">Fragment-based screening (FBS) by means of biophysical techniques, such as X-ray crystallography, NMR spectroscopy, or surface plasmon resonance (SPR), is quickly becoming a valuable technique for identifying new fragment hits and new target sites for drug discovery.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> It has been utilized in the development of novel antiretroviral agents bearing unprecedented scaffolds for several well-validated targets, such as HIV PR, RT, and IN, which are pivotal in HIV replication but mutate rapidly, leading to significant drug resistance.</div><div class="NLM_p">In 2013, the fragment indole-6-carboxylic acid (<b>1</b>, 1F1) was identified as a ligand binding to the flap site of HIV PR in a fragment-based screen. 3-Indolepropionic acid (<b>2</b>, 1F1-N) was then identified by means of computational docking (AutoDock) and a nucleation crystallization inhibition assay. It was demonstrated by X-ray crystallography and measurements of conformational stabilization and direct site occupancy that compounds <b>1</b> and <b>2</b> occupy an external site on PR both in the solid state and in solution.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It is well-known that fragments are poor binders with only partial occupancy, resulting in weak, difficult-to-fit electron density. The employment of a brominated fragment library overcomes this difficulty, as bromine can be located accurately through anomalous scattering. Consequently, in 2014, the same research group reported crystallographic fragment-based discovery of two more novel hits, 3-bromo-2,6-dimethoxybenzoic acid (<b>3</b>, Br6) (in the flap site) and 1-bromo-2-naphthoic acid (<b>4</b>, Br27) (in the exosite) from a brominated fragment library targeting HIV PR.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> It was indicated that fragment binding at the flap site favors a closed conformation of PR (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Allosteric regulation of PR activity was suggested to be a potential approach to overcome the development of drug-resistance. These findings expanded the range of fragments available for development of higher-affinity allosteric inhibitors.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> We envision that future research will focus on elaborating these fragments into larger molecules that potently inhibit PR.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of small molecules at novel sites of HIV PR. Protein Data Bank codes are the following: for <b>1</b> in the outside/top of the flap, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJ8">4EJ8</a>; for <b>2</b> in the outside/top of flap, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJK">4EJK</a>; for <b>3</b> in the flap site, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4Q">4K4Q</a>; for <b>4</b> in the exosite, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4R">4K4R</a>.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, Deng et al. utilized the combination of AutoDock calculations with recently developed free energy methods (binding energy analysis method (BEDAM) and the standard double decoupling method (DDM)) to screen fragments targeting the allosteric site on the flap of HIV PR.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">In 2014, compounds <b>5</b> and <b>6a</b> were identified as small-molecular-weight fragments targeting dynamic pockets of HIV-1 PR by means of structure-based computational screening, and further derivatization afforded <b>6b</b>,<b>c</b>, <b>7</b>, and <b>8a</b>,<b>b</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Among them, <b>6c</b>, <b>7</b>, and <b>8a</b>,<b>b</b> are potential allosteric inhibitors (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). These compound pairs have high SAR information content and exhibit activity cliffs, exemplifying situations where small structural changes lead to significant differences in potency.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of fragments <b>5</b> and <b>6a</b> targeting dynamic pockets of HIV-1 PR by virtual screening and the results of further derivatization to afford <b>6b</b>,<b>c</b>, <b>7</b>, and <b>8a</b>,<b>b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HIV-1 RT is another central target for antiretroviral therapy. RT undergoes conformational changes during HIV replication, and its intrinsic flexibility provides potential allosteric sites for inhibition. In 2011, a novel scaffold bromoindanone <b>9</b> was identified as an inhibitor of wild-type (WT) and drug-resistant HIV-1 RT by screening a library of 1040 fragments. It exhibits submillimolar <i>K</i><sub>d</sub> and IC<sub>50</sub> values against WT and three drug-resistant variants (K103N, Y181C, and L100I).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Bauman et al. successfully utilized X-ray crystallography-based fragment screening to detect novel allosteric sites of HIV-1 RT that can be pursued for further drug design. Concretely, a total of 775 fragments were divided into 143 cocktails, and crystals of RT complexed with the non-nucleoside RT inhibitor (NNRTI) <b>14</b> (TMC278) were soaked in these cocktails. Finally, fragments binding to three druggable sites (a site adjacent to NNRTI, the Knuckles site, and the incoming nucleotide binding site) were found to show RT-inhibitory activity, opening up opportunities for discovery of new anti-AIDS drugs.<a onclick="showRef(event, 'cit19a cit19b'); return false;" href="javascript:void(0);" class="ref cit19a cit19b">(19a, 19b)</a> An analysis of their binding modes based on X-ray crystallography data provided structural insights into the ligand-binding site in RT, and this should also be useful for the design of more active RT inhibitors (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a–e).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Structures of new RT ligands <b>9</b>–<b>13</b> and the NNRTI <b>14</b> and (b–e) the results of crystallography of RT complexed with TMC278 and the corresponding ligands: (b) fragment <b>10</b> at the site adjacent to NNRTI (exemplified by TMC278) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFB">4KFB</a>); (c, d) fragments <b>11</b>,<b>12</b> near the Knuckles site (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IG3">4IG3</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IFY">4IFY</a>); (e) fragment <b>13</b> at the incoming dNTP binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ICL">4ICL</a>). (f) HIV-1 RT binders identified by STD NMR and functional assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Very recently, La et al. employed a combination of saturation-transfer difference (STD) NMR and in vitro inhibition assays to screen a fragment library for HIV-1 RT binders with novel scaffolds. Eventually, three molecules <b>15</b>–<b>17</b> were found to potently inhibit not only HIV-1 RT but also clinically relevant drug-resistant mutants (K103N, Y181C, or G190A).<a onclick="showRef(event, 'cit19c'); return false;" href="javascript:void(0);" class="ref cit19c">(19c)</a> Notably, oxime <b>16</b> and <i>p</i>-hydroxyaniline <b>17</b> competitively inhibit HIV-1 RT with respect to the DNA template/primer (T/P) or the dNTP substrate and are thus mechanistically distinct from clinically used HIV-1 RT inhibitors (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>f).<a onclick="showRef(event, 'cit19c'); return false;" href="javascript:void(0);" class="ref cit19c">(19c)</a></div><div class="NLM_p">Moreover, fragment-based screening has also resulted in the discovery of novel binders and binding sites in IN and gp41 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a> Superposition of the crystal structures of IN with fragments <b>18</b> (KM00835) and <b>19</b> (SB00942) led to discovery of the benzodioxole <b>20</b>. Fragment <b>20</b> bound at novel site in IN, and the crystal structure of this complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AO2">3AO2</a>) was employed by Wielens and his co-workers to design elaborated second-generation inhibitors that bind with higher affinity and good ligand efficiency.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Meanwhile, a fragment-based screening employing NMR and SPR was successfully employed to probe interactions of various fragments with IN. A novel pocket in IN was defined by crystallography as a valid target site for rational design of allosteric IN inhibitors. Then, X-ray crystallographic data (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZT3">3ZT3</a>) was used to guide the elaboration/linking of fragment <b>21</b>, which show high ligand efficiency (IC<sub>50</sub> = 295 μM), eventually leading to a more active molecule <b>22</b> (IC<sub>50</sub> = 5 μM).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> A similar structure <b>23</b> was identified as a novel binder of the lens epithelium-derived growth factor/p75 (LEDGF/p75) binding site of the HIV catalytic core domain through fragment-based screening and structure-based drug design (SBDD). It inhibited HIV infection in a cell-based assay with an EC<sub>50</sub> of 29 μM. Examination of the crystallographic structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZSO">3ZSO</a>) afforded further insights into the ligand-binding modes in IN and should provide a basis for the discovery of more active IN inhibitors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Fragment-based screening and hit identification: (a) benzodioxole-based IN binder <b>20</b>; (b) LEDGF/p75 inhibitors <b>22</b> and <b>23</b>; (c) thioenylaminopyrazole fragment <b>24</b> (gp41 binder).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Drug development targeting the HIV-1 envelope glycoprotein gp41 fusion intermediate has been hindered by challenges inherent in the complexity of the underlying protein–protein interactions (PPIs). Using a specifically designed assay and a limited focused NMR screening of a 500-member fragment library (purchased from Chembridge), Chu and Gochin discovered thioenylaminopyrazole fragments (exemplified by <b>24</b>, <i>K</i><sub>d</sub> (dissociation constant) of ∼500 μM) binding to a relatively shallow subpocket (at the C-terminal) adjacent to the deep hydrophobic site on the NHR coiled coil.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Shape-based similarity searching identified additional phenylazole fragments in this library, revealing structural features required for activity and enriching the hit rate over serendipitous screening. These subpocket-binding fragments may exhibit cooperative binding when linked with hydrophobic pocket ligands.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In addition, new antagonists that bind to known pockets within CCR5 have also been uncovered by fragment screening, and a fragment-based screening system to target the TAR-Tat interaction was reported.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">These examples show that fragment-based screening can be complementary to existing structure-based virtual screening approaches for identification of novel druggable sites and hits. It should be noted that different assay formats have their own advantages and disadvantages and are sensitive to the experimental conditions and assay design. For example, fragment screening by STD NMR allows the chemical authenticity of fragments to be established at the time of screening. But NMR screening was considerably prolonged and hindered by practical complications such as selection of fragments for clustering to avoid NMR signal overlap and issues of low solubility. On the other hand, SPR allows relatively straightforward measurement of binding affinity. Thus, a combination of complementary, orthogonal biophysical techniques is often employed to screen fragment libraries and validate hits.<a onclick="showRef(event, 'cit19c ref25'); return false;" href="javascript:void(0);" class="ref cit19c ref25">(19c, 25)</a></div><div class="NLM_p last">Of course, fragment-based screening methods cannot identify the optimum molecule for synthesis, and the choice of the best-suited fragment hit for further optimization, as well as elimination of chemically infeasible structures among the detected hits, is crucial for success. Fragments were selected to contain at least one aromatic group and some polar functionality. The most common approach is to apply multiple filters to remove molecules that do not meet all of the property parameters (such as small size, hydrophilic nature, and excellent ligand efficiency). In general, the so-called “rule of three” (molecular weight of <300, number of hydrogen bond acceptors of ≤3, number of hydrogen bond donors of ≤3, ClogP of ≤3, number of rotatable bonds of ≤3, and polar surface area of ≤60) is suggested to be useful for fragment selection.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.2 Privileged Fragment-Based Reconstruction Approach</h3><div class="NLM_p">A deconstruction–-reconstruction strategy utilizing privileged fragments of existing ligands (known as “privileged structure”-guided scaffold refining) has been reported.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> For example, compounds bearing the 8-hydroxyquinoline skeleton exhibit many kinds of biological activities, suggesting that this scaffold might be a privileged motif with great potential in drug discovery.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">In 2013, two 8-hydroxyquinolines <b>25</b> and <b>26</b> were identified as inhibitors of the HIV-1 IN-LEDGF/p75 via a privileged fragment-based reconstruction approach followed by diverse modifications (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>); these compounds inhibited viral replication (EC<sub>50</sub>) in MT-4 cells at the low micromolar level.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The potential of targeting PPIs for antiviral therapeutic intervention has so far been largely untapped; this successful example demonstrated that PPIs can be modulated by druglike small molecules. Thus, the fragment-based reconstruction approach in combination with molecular docking may save time and minimize the cost of synthesis and bioassays. This methodology should be potentially applicable for efficient construction of diverse compound collections of privileged structures for drug discovery or for modification of existing compounds.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Flowchart of discovery of <b>25</b> and <b>26</b> as inhibitors of HIV-1 IN-LEDGF/p75 interaction via the privileged fragment-based reconstruction approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.3 Dynamic Ligation Screening (DLS)</h3><div class="NLM_p">Combinatorial chemistry is a powerful approach to rapidly obtain large numbers of potentially bioactive compounds. In the past decade, new combinatorial concepts and methodologies based upon the FBDD approach have been proposed for the generation of molecular screening libraries. In particular, dynamic ligation screening (DLS) has been developed for dynamic, target-guided synthesis (TGS) of active compounds from a pool of small-molecular reactive fragments under thermodynamic control.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div><div class="NLM_p">In situ click chemistry employing Huisgen azide–alkyne cycloaddition (AAC) has been extensively applied in DLS for efficient construction of diverse molecule collections.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> In recent years, this approach has been evaluated for high-speed synthesis and screening of nonpeptidic inhibitors of HIV-1 PR (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Taking advantage of the presence of HIV PR, the azide <b>27</b> (IC<sub>50</sub> = 4.2 μM) was incubated with synthetically available alkynes (<b>28a</b>–<b>e</b>, IC<sub>50</sub> > 100 μM).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The best fragments from each binding site of PR should react preferentially because of their spatial proximity to afford the corresponding dimeric binder displaying synergistic inhibition. Screening of the triazole library is very simple because triazole formation is easily detected by mass spectrometry (MS). Finally, 1,2,3-triazole <b>29</b> (IC<sub>50</sub> = 6 nM, <i>K</i><sub>i</sub> = 1.7 nM) was picked up selectively by PR and was found to be a potent inhibitor of the WT and drug-resistant strains at the nanomolar level. This approach avoids labor-intensive organic synthesis, isolation, and purification and is considered as an efficient tool for drug discovery.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery of a potent HIV-1 PR inhibitor by DLS employing AAC. When the reaction components simultaneously bind to the target, the rate of the usually slow cycloaddition significantly increases. Though the azide and the alkyne themselves are likely to be weak binders, the triazole is a much stronger ligand, as it is accessing to two binding sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The potential of DLS is certainly significant in the early stages of medicinal chemistry projects. For targets featuring ill-defined binding sites that cannot be addressed easily by SBDD, DLS represents a particularly elegant alternative. However, protein-templated DLS has several shortcomings. For example, in most cases, the libraries employed remain of moderate size. In larger and more complex libraries, false negatives are usually ascribed to multiple and sometimes interdependent reasons, which can be tackled through multidisciplinary approaches (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> The application of novel click or clicklike reactions is likely to offer additional opportunities to improve this methodology for accessing a wider range of anti-HIV drug targets.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Major Reasons for False Negatives in the DLS Strategy and Corresponding Solutions<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">major reasons for false negatives</th><th class="colsep0 rowsep0" align="center">possible solutions</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Long equilibration times (from hours to days or weeks, at 37 °C) that are not tolerated by particularly unstable proteins.</td><td class="colsep0 rowsep0" align="left">The Cu(I)-doped protein technique has enabled selective assembly of triazole products in detectable amounts.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Inadequate detection limits of analytical methods</td><td class="colsep0 rowsep0" align="left">(1) Different analytical techniques are available to detect any traces of a templated product, including the traditional HPLC method, MS coupling using the selected ion monitoring mode (SIM), and the MS–MS fragmentation pattern (especially if multiple molecules with the same molecular weight may be encountered). (2) Indirect detection with fluorometric activity in situ assays using the enzymatic mixture. (3) X-ray crystallography can afford convincing evidence regarding the stereodiscrimination and regiochemistry of the reaction.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Low binding affinity of reaction fragments</td><td class="colsep0 rowsep0" align="left">It is possible to covalently link one of the two fragments to generate an artificial anchor for accelerating the reaction.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Poisoning of the biocatalyst due to the templated products themselves</td><td class="colsep0 rowsep0" align="left">Mutant proteins can be designed specifically to improve the dissociation rate of the protein–binder complex, thus facilitating multiple turns of biocatalysis.</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.4 Rapid Diversity-Oriented Synthesis and in Situ Screening</h3><div class="NLM_p">In current drug discovery programs, parallel high-throughput synthesis can be an effective method to exploit the chemical space and to rapidly probe structure–activity relationships (SARs). However, a key challenge is the availability and application of high-throughput chemical reactions that enable rapid synthesis, purification, and screening of diverse chemical libraries from privileged fragments. In recent years, diversity-oriented high-speed synthesis of potent HIV-1 PR inhibitors has been achieved with Cu(I)-catalyzed azide–alkyne 1,3-dipolar cycloaddition (CuAAC) click chemistry in microtiter plates<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> and with in situ aminocarbonylation reaction.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> This methodology usually requires synthetically available building blocks (i.e., diversely substituted azides and alkynes) or organic reactions (exemplified by CuAAC or aminocarbonylation). For CuAAC-based diversity-oriented high-speed library generation, diversely substituted azides and alkynes were subjected to CuAAC reaction in microtiter plates (solution-phase) to provide densely functionalized Huisgen’s 1,2,3-triazoles. The products can be assayed directly in situ without separation. On the basis of these preliminary protein inhibition data, the most potent library members were individually resynthesized on a larger scale for further biological screening and complete characterization. If necessary, further modifications including functionalization of the triazoles at the 5-position, or replacement of the triazole with a range of alternative linkers, can be performed.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> This methodology, integrating high-throughput synthesis and screening, afforded highly active and bioavailable nonpeptidic HIV-1 PR inhibitors (e.g., <b>29</b>, <b>30</b>, and <b>31</b>, with <i>K</i><sub>i</sub> values as low as 1.7, 4, and 8 nM, respectively; <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) from two independent focused libraries.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> In general, a wide range of substituents can be readily installed by means of CuAAC, and the method has high functional group tolerance, as demonstrated by the prepared 1,2,3-triazole library. In addition, the commercial availability of diverse azide building blocks and improvements in the synthesis of the alkyne precursors have made this protocol suitable for rapid preparation of huge, diverse compound collections. Nevertheless, there is still a potential issue with false positives and negatives. Specifically, copper will be present in the samples after evaporation. To rule out possible undesirable effects in in situ screening, it will be important to examine the influence of diverse copper salts at the highest expected concentration. The introduction of new copper-free click chemistry, such as strain-promoted azide–alkyne cycloaddition, should circumvent this problem.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Principle of the triazole-forming reaction to generate a library of HIV PR inhibitors, coupled with high-throughput screening (compounds <b>29</b>, <b>30</b>) and further modifications (compound <b>31</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, DLS and rapid diversity-oriented lead generation are completely different, but as the Chinese proverb says, they allow us <i>to achieve the same ultimate goal by different routes</i>, as exemplified by the discovery of compound <b>29</b>. DLS may be more useful as a pharmacological tool to pick up ligands with the best match from a focused pool of small fragments, whereas diversity-oriented synthesis and screening may be more useful as a novel HTS protocol for rapid drug discovery from large-scale compound collections.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.5 Hierarchical Virtual Screening</h3><div class="NLM_p">Hierarchical multiple-filter database searching is an economical and rapid approach that has had considerable success in numerous drug discovery campaigns. It can take advantage of available ligands and structural information to discover hits that are synthetically accessible or have favorable ADME or physicochemical properties and to reduce candidates from a large compound collection to a number small enough for experimental testing by applying multiple sequential virtual screening filters (such as Lipinski’s rule of five).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Hierarchical virtual screening has become an important tool for lead discovery directed at specific anti-HIV targets.</div><div class="NLM_p">Two efficient approaches using hierarchical database screenings to seek novel NNRTIs were described several years ago.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> Nevertheless, it seems that there has not yet been any successful case of NNRTI drug discovery in which the hierarchical approach has been the major contributor. Even so, virtual screening methodology is likely to remain the focus of much interest.</div><div class="NLM_p">A shift of binding energy contributions from highly mutable residues to more conserved residues is considered to be crucial to get improved drug resistance profiles for anti-HIV agents. On the basis of this hypothesis, a virtual screening protocol was devised including construction of combinatorial library (by modifying the two functional groups of <b>32</b> (lopinavir, LPV)), docking, rescoring of the docking results by MM/GBSA, and reranking based on the binding energy distribution (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>a). Finally, 18 candidate molecules were picked up by means of this protocol for bioassay. Inhibitory activity measurements (IC<sub>50</sub>) and drug resistance predictions successfully uncovered two molecules (<b>33</b> and <b>34</b>) with HIV PR inhibitory potency, antiviral efficacy, and improved drug resistance profile against a set of HIV mutants (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>b).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery of HIV PR inhibitors via a hierarchical computational strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An optimized computational search method, sequentially utilizing support vector machine (SVM), shape similarity, pharmacophore modeling, and molecular docking, was applied to screen the National Cancer Institute database (NCI), which contains 260 000 molecules (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>c). Finally, compound <b>35</b> (NSC111887) was obtained, with an IC<sub>50</sub> value of 62 μM against HIV-1 PR.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Very recently, to identify potential CXCR4 antagonists, Das et al. carried out a hierarchical multistage virtual screening of a library containing about 604 000 molecules. First, compounds that were too flexible (>20 rotatable bonds) or did not lie within the desired molecular weight range (between 350 and 750 Da) were eliminated. Subsequent computational screening employed the shape of <b>36</b> (IT1t), a reported CXCR4 antagonist, as a reference and adopted various algorithms, including three-dimensional shape similarity (molecules with Tanimoto coefficients of at least 0.7 were retained), isomer generation, and docking into a CXCR4 crystal structure (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Sixteen compounds were selected for bioassays on the basis of their high shape similarity to IT1t, and their putative binding modes including hydrogen bond interactions with at least two critical residues (Asp97 and Glu288, which are important for fusion elicited by HIV-1 envelope glycoprotein). Three molecules with piperidinylethanamine scaffolds demonstrated potency and were resynthesized. Compound <b>37</b> (CX6) displayed significant potency against cell–cell fusion (IC<sub>50</sub> = 1.9 μM for fusion elicited by X4 HIV-1NL 4-3 glycoprotein), inhibition of Ca<sup>2+</sup>-flux binding (IC<sub>50</sub> = 92 nM, assayed with stromal cell-derived factor 1α (SDF-1α)), and anti-X4 HIV-1 activity (EC<sub>50</sub> = 1.5 μM).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Flow diagram of discovery of piperidinylethanamine-base CXCR4 antagonist <b>37</b> via a hierarchical multiple-filter database searching protocol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, virtual screening approaches have played a significant role in the search for small-molecular inhibitors of PPIs and in changing the notion of nondruggability of PPIs.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Several examples of virtual screening studies associated with PPIs have been disclosed, including HIV-1 IN-LEDGF/p75 <a onclick="showRef(event, 'ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50 ref51">(48-51)</a> and HIV Nef-SH3.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Christ et al. reported an example of the application of LBSB-hierarchical virtual screening for the discovery of inhibitors of the HIV-1 IN-LEDGF/p75 interaction.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> They successively employed pharmacophore-based screening, docking, and pharmacophore postfiltering to provide 25 diverse compounds for experimental verification. Medicinal chemistry optimization of initial hits resulted in the discovery of molecules showing inhibitory activity at low μM concentrations. Betzi et al. used a druglike filter, molecular docking, and a pharmacophoric filter to obtain inhibitors targeting HIV Nef-SH3 interaction with μM potency.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p last">Because hierarchical virtual screening requires simultaneous consideration of many filters, including biological activities and druglike properties, it involves subjective elements. For example, in situations where candidates are abundant, it would be appropriate to apply more filters. But where the cost of a missed opportunity is expensive, as is usually the case in drug discovery, the risk of incorrectly neglecting favorable molecules may be too great. Therefore, filters and a validation set should be treated with caution and compromises must be made.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">3 Medicinal Chemistry Strategies in the Scaffold Evolution of HIV Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The frequent onset of resistance to approved anti-HIV drugs necessitates a continuing search for novel antiretroviral drugs and alternative drug design strategies. In this section, we will describe some successful case studies to illustrate the current state of the art in structural evolution (optimization) of HIV inhibitors by exploiting novel medicinal chemistry strategies to increase potency, to improve drug resistance profiles, to address pharmacokinetic issues, or even to acquire intellectual property rights.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.1 Rationally Designed Multitarget-Directed Ligands (MTDLs)</h3><div class="NLM_p">In recent years, the design of a single drug molecule that is able to simultaneously and specifically interact with multiple biological targets, namely, multitarget-directed ligands (MTDLs), has proven to be a promising anti-HIV drug discovery approach to improve drug resistance profile and patient compliance (poor compliance is a key reason for development of extensive cross-resistance).<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> In particular, knowledge-based pharmacophore combination, namely, the rational construction of fused and highly merged MTDLs with minimal structural change in the scaffold of HIV-1 NNRTIs, has been a fruitful approach to acquire IN inhibitors (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>).<a onclick="showRef(event, 'ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58 ref59">(55-59)</a></div><div class="NLM_p">The key to rational design of MTDLs via a knowledge-based pharmacophore combination approach is to identify a tolerant domain in the target. Crystallographic investigations demonstrated that some NNRTI platforms contain structural groups located in the solvent-exposed area controlled by the Pro236 loop of the NNRTI binding pocket (NNIBP); this area is not directly related to RT binding, and some chemical variation could be tolerated there. For example, the phenyl moiety at the N-1 site of the 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivative <b>38</b> is amenable to structural alteration. IN binding requires at least a hydrophobic benzyl group and a metal(II) ion chelating motif (as exemplified by <b>39</b>). Thus, this tolerant position in NNRTIs can be utilized to introduce a relatively hydrophilic IN chelating functionality, thereby generating a bifunctional scaffold.<a onclick="showRef(event, 'cit60a cit60b cit60c cit60d cit60e cit60f'); return false;" href="javascript:void(0);" class="ref cit60a cit60b cit60c cit60d cit60e cit60f">(60a-60f)</a></div><div class="NLM_p">On the basis of the pharmacophoric profiles and SARs of existing molecules, several series of scaffolds capable of inhibiting both RT and IN were established via incorporation of an IN-inhibitory pharmacophore at this tolerant site of established NNRTIs (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). Remarkably, the obtained molecules <b>40a</b>,<b>b</b> display robust anti-HIV activities in the nanomolar concentration range, highlighting the effectiveness of the MTDLs approach.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery of fused or highly merged RT/IN dual inhibitors based on the combination of RT inhibitor <b>38</b> with IN inhibitor <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, in an extension of this research, 3-hydroxypyrimidine-2,4-dione (exemplified by <b>41a</b>–<b>c</b>) featuring an <i>N</i>-OH moiety was rationally derived from the HEPT skeleton as a novel molecular platform for RT/IN dual inhibition. The evolved scaffold includes a minimal 3-N hydroxylation in the pyrimidine core of HEPTs to give a chelating triad motif along with the existing benzyl moiety, meeting the basic structural requirements for IN binding. The newly introduced OH could potentially generate H-bonds with a consecutive lysine motif (Lys101-Lys104) in the NNIBP.<a onclick="showRef(event, 'ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59">(57-59)</a> Thus, SAR investigations led to a detailed understanding of the optimal requirements for inhibition of RT and IN and laid the foundation for a novel class of anti-HIV agents. Furthermore, the low molecular weight of highly merged inhibitors is beneficial for the design of dual-acting ligands with more “druglike” properties. These concepts (fused or highly merged dual inhibitors) could be powerful tools for developing novel antiviral drugs to treat HIV infection.</div><div class="NLM_p last">In addition, focused or random optimization of parent compounds is another important approach to generate MTDLs with multiple anti-HIV activities.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> Although compounds may already possess multiple potencies, structural decoration is required to balance or increase the activities.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.2 Bisubstrate (Heterobivalent) Ligands</h3><div class="NLM_p">Bisubstrate (bivalent) inhibitors comprise two conjugated fragments, each targeted to a binding site in a multisubstrate protein. The main advantage of bisubstrate inhibitors is their ability to form more contacts with the target, providing substantially increased affinity and selectivity, when compared with traditional single active site-targeted inhibitors. This is also an attractive approach for the discovery of novel anti-HIV agents.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">The close proximity (10–15 Å) of the NRTI and NNRTI binding sites in RT and the crosstalk between these sites offer the opportunity for creating a single molecular “bifunctional” (chimeric) inhibitor that targets both sites simultaneously. In 2013, Anderson’s group<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> used molecular modeling to guide focused chemical syntheses of heterobivalent ligands having nucleoside (d4T) and NNRTI (TMC derivative <b>42</b>) moieties tethered via a flexible polyethylene glycol (PEG) linker. <b>43</b> (the triphosphate of d4T-4PEG-TMC conjugate), a representative compound of this series, maintains the potency of the original pharmacophores at both targets, being recognized as a substrate by RT and incorporated into double-stranded DNA in a base-specific manner.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In addition, compound <b>43</b> demonstrated low nanomolar inhibition of RT polymerase inhibition in vitro, being 4300-fold and 4.3-fold more potent than d4T and <b>42</b>, respectively; this result represents a proof-of-concept of this methodology for antiviral drug discovery.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The same group also reported the preparation and biochemical assay of another bifunctional RT inhibitor <b>44</b> (d4T-6PEG-TIBO conjugate) utilizing d4T and a TIBO derivative linked by a PEG linker (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). However, its effectiveness was limited.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Even so, this strategy should be applicable to other proteins with multiple binding sites. Moreover, these heterobivalent systems could also be utilized as pharmacological probes, for example, to estimate the distance between binding sites and the spatial distribution of binding sites.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Schematic representation of heterobivalent HIV-1 RT ligands consisting of NRTI and NNRTI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.3 Antibody-Recruiting Molecules Targeting HIV</h3><div class="NLM_p">Antibody-recruiting molecules (ARMs) are bifunctional compounds that mediate the generation of ternary complexes between disease-causing agents (such as proteins, viruses, or cells) and antibodies. ARM-induced antibody opsonization causes immune-mediated destruction of the target. In general, ARMs contain three structural domains: an antibody-binding terminus (ABT), a target-binding terminus (TBT), and a chemical linker. Modifications in the TBT domain and linker domain have resulted in the discovery of ARMs targeting bacteria, viruses, and cancer cells.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">In the initial step of HIV entry into host cells, the viral envelope protein gp120 interacts with CD4 glycoprotein expressed on the surface of human immune cells. It is the primary target for antibody-mediated viral neutralization. Recently, Spiegel developed a series of ARMs that targets HIV gp120. These bifunctional ARMs are designed to bind simultaneously to HIV gp120 and anti-dinitrophenyl (anti-DNP) antibodies. Anti-DNP antibodies are present endogenously in the human bloodstream in high concentrations. By linking these two components together, ARMs (exemplified by <b>46</b>, derived from the previously described compound <b>45</b> (BMS-378806)) could mediate the generation of a ternary complex, resulting in inhibition of virus entry as well as antibody-mediated immune clearance of envelope glycoprotein (Env)-expressing cells (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>).<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Antibody-recruiting small molecules <b>46</b> and <b>48</b> that target HIV gp120 and the mechanism of action of chemically programmed antibodies <b>49</b> and <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, structure-based, computationally driven optimization of ARMs targeting HIV gp120 resulted in an optimized derivative <b>48</b> (derived from <b>47)</b>, which was almost 1000-fold more active than compound <b>46</b> in gp120-binding and antiviral assays in MT-2 cells. It was also active against multiple laboratory and clinical HIV pseudotypes (clades A, B, and C).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">In 2013, Sato et al. described the design and application of two <i>N</i>-acyl-β-lactam derivatives <b>49</b> and <b>50</b> (derived from <b>45</b>) as chemically programmed antibodies to program the binding activity of aldolase antibody 38C2 and to inhibit the interaction between HIV-1 gp120 and T-cells based on the use of mAb 38C2, an aldolase antibody formed by reactive immunization with a 1,3-diketone hapten (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). This seems to be a promising new approach for advancing AIDS therapy.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p last">Certainly, the design of ARMs is a sophisticated game, requiring thoughtful selection and combination of drugs, linker, and antibody. As demonstrated by the above studies (exemplified by the discovery of <b>48</b>), molecular modeling seems to be an indispensable tool to identify suitable linkage sites and structures in the design of ARMs and chemically programmed antibodies so that downstream chemical efforts can be well focused.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">3.4 Multiobjective Optimization: Ligand Efficiency (LE), Ligand-Lipophilicity Efficiency (LLE), and Other Parameters</h3><div class="NLM_p">In the discovery of novel pharmaceutical agents, it is clear that multiple parameters should be optimized in parallel to find the best balance of potency and safety. Much recent work has focused on approaches to aid the simultaneous optimization of multiple parameters required for a successful drug, aiming to identify molecules with the highest possibilities of downstream success at an early stage of drug discovery.<a onclick="showRef(event, 'ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref70 ref71 ref72">(70-72)</a> These methodologies have been described in various ways, such as multiobjective (-parameter or -dimensional) optimization or multicriteria decision-making (for convenience, herein we will refer to all such methods as multiobjective optimization). At present, ligand efficiency (LE) and ligand-lipophilicity efficiency (LLE) are considered to be important indicators of “druglikeness”, reflecting the ligand’s potency and physicochemical profile (see legend of <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). Optimizing molecules has generally been based on their binding affinity and pharmacokinetic profile,<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73, 74)</a> but consideration of LLE is helpful for the improvement of bioactivity and metabolic stability. For instance, compounds that are relatively lipophilic generally suffered metabolic instability in human liver microsomes. Consequently, with aim to increase efficacy and improve metabolic stability, it is often necessary to improve the LLE value.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Discovery of NNRTI candidate lersivirine via scaffold refining and LE/LLE-guided optimization. HLM = human liver microsomes. LE (binding energy per heavy atom, kcal mol<sup>–1</sup>) = −1.4 log(RT IC<sub>50</sub>)/number of heavy atoms. LLE = −log(RT IC<sub>50</sub>) – clog P. RT IC<sub>50</sub> = <i>K</i><sub>i</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Traditionally, structure optimizations of anti-HIV agents that lead to the improvement of one property, e.g., potency, often have a negative effect on other key properties, e.g., lipophilicity. Currently, the structure modification of anti-HIV agents is not solely affinity-driven, but instead LE/LLE values are generally employed to guide elaboration of the scaffold and substituent groups. For example, scaffold refinement of the abandoned NNRTI drug candidate <b>51</b> (capravirine) resulted in the discovery of pyrazole as a suitable heterocyclic scaffold for improved NNRTIs.<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> Structure-based optimization with emphasis on LLE has led to the discovery of several novel chemotypes, which show robust antiviral potency, notably reduced clearance, and increased half-life (<i>T</i><sub>1/2</sub>) (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>).<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> In particular, <b>52b</b> (UK-453061, lersivirine) was selected for clinical trials on the basis of its potent and wide-spectrum antiviral activity against a broad panel of clinically relevant RT mutations, as well as its safety and its favorable pharmacokinetic properties.<a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79-81)</a> As anticipated, <b>52b</b> was designed to be less lipophilic than <b>51</b>, and it has greatly improved metabolic stability (<i>T</i><sub>1/2</sub> = 73 min).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Moreover, LE and LLE have also been employed as filters (variables) in NNRTIs hit discovery via an in silico (virtual screening) approach<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a> and in the structure optimizations of HIV-1 IN inhibitors and attachment inhibitors (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>).<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a> Notably, the impact of substitution on ligand efficiency was taken into account in the modifications of naphthyridinone HIV-1 IN strand-transfer inhibitors, which ultimately led to the discovery of naphthyridinone-based clinical candidate <b>53</b> (GSK-364735).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> In addition, optimization of the early lead molecule <b>54</b> with heteroaryl substitution at the C7 position guided by LE and/or LLE considerations afforded 1,2,4-oxadiazole analogue <b>55</b>, which exhibits picomolar-level inhibition, as well as improved clearance and half-life characteristics and higher oral bioavailability in rats.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Discovery of HIV-1 IN strand-transfer inhibitor <b>53</b> and indole-based attachment inhibitor <b>55</b> by means of LE/LLE-guided optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Overcoming hERG affinity in the discovery of the CCR5 antagonist <b>56</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibition of the voltage-dependent ion channel encoded by human ether-a-go-go-related gene (hERG) may result in acquired long QT syndrome, which is a critical adverse effect of noncardiovasular therapeutic drugs. Thus, rejecting potential hERG channel blockers early in the drug discovery process will lower the risk of cardiotoxicity-related side effects in the later, more costly development phase.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p">The discovery of <b>56</b> (maraviroc) provides a case history of the problems facing all practicing medicinal chemists in attempting multiparameter optimization of the original hit <b>57</b> (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>).<a onclick="showRef(event, 'ref87 ref88 ref89 ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref89 ref90 ref91 ref92">(87-92)</a> Notably, the focus on cardiovascular safety (hERG liability) and pharmacokinetic properties from a very early stage in this project was critical for ultimate success. In general, there appeared to be correlation between hERG inhibition and physiochemical properties such as lipophilicity or p<i>K</i><sub>a</sub>. Therefore, unwanted hERG interactions could be abolished by altering the substitution patterns and/or orientation of the aromatic rings or by moderating the basicity/steric environment of the central nitrogen in the molecules. Besides, computational techniques also provide useful and feasible approaches to evaluate the hERG liability for large-scale compound collections.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> We envision the possibility that medicinal chemists could widely apply these strategies in early stages of drug discovery to eliminate hERG affinity associated with the desired molecules while retaining activity at the primary target.</div><div class="NLM_p">Moreover, it has been suggested that ligand–receptor residence time (the reciprocal of the dissociation rate constant <i>k</i><sub>off</sub>), a useful binding kinetics parameters for the lifetime of the ligand–receptor complex, can be employed as a predictor of drug potency and safety.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a> Darunavir (structure displayed in <a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>), a clinically used HIV-1 PR inhibitor, is differentiated from its structural analogues by having an extremely long inhibitor-enzyme residence time. It was demonstrated that the binding kinetics of darunavir to HIV-1 PR well explain the potent antiviral activity and high genetic barrier to the development of resistance.<a onclick="showRef(event, 'ref96 ref97 ref98 ref99 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref96 ref97 ref98 ref99 ref100 ref101">(96-101)</a> In addition, a study of the molecular mechanism of binding of maraviroc indicated that its long residence time in the human CCR5 receptor is critical to its clinical success.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">The emergence of new techniques will greatly increase the utility of multiobjective optimization. For instance, the SPR technique allows both effective screening of molecules and more detailed mechanistic and kinetic analysis of specific interactions.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_p last">To sum up, multiobjective optimization strategies were introduced into anti-HIV drug discovery about a decade ago and have steadily gained acceptance. Incorporation of suitable optimization parameters can decrease the attrition rate in later stages of drug development. We envision that further improvements in multiobjective optimization techniques contribute substantially to anti-HIV drug development, especially directed toward newer anti-HIV drug targets.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">3.5 Structure-Guided (Crystallographic Overlay-Based) Molecular Hybridization</h3><div class="NLM_p">Molecular hybridization is considered to be a very robust strategy for identification of bioactive compounds through combination of essential pharmacophore elements from diverse bioactive fragments to generate a novel hybrid entity endowed with significantly improved affinity and efficacy, compared to the parent compounds.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The reported crystal structures of several important proteins in the HIV-l life cycle revealed critical factors determining the binding affinity of their ligands, providing a rational basis for structure-based drug design and valuable clues to ways of optimizing the scaffold and improving drug potency.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Novel indazole NNRTIs <b>69a</b>,<b>b</b> using crystallographic overlay-based molecular hybridization. Crystallographic overlay of the published RT cocrystal structures of <b>51</b> (green) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKO">1FKO</a>) and <b>68</b> (pink) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EP4">1EP4</a>) (other residues removed for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Crystallographic structure of <b>69a</b> (pink) in the NNRTI binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JLE">2JLE</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2009, a novel class of indazoles with potency against both WT and key HIV-1 mutants was efficiently generated by employing crystallographic overlay-based molecular hybridization of the previously reported NNRTIs <b>51</b> (capravirine) and <b>68</b> (efavirenz) (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>). In particular, compounds <b>69a</b>,<b>b</b> displayed robust antiviral potency with satisfactory metabolic stability.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Moreover, the crystal structure of the complex with <b>69a</b> afforded structural insights into the inhibitory activity. As shown in <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>, compound <b>69a</b> shows edge-to-face π-interactions with the highly conserved Trp229, and the indazole NH participates in a hydrogen bond with the main chain of Lys101.</div><div class="NLM_p last">This case provides a proof-of-concept for the utility of structure-guided molecular hybridization in the discovery of novel molecules from substructures of pre-existing inhibitors that bind a common target. Given the increasingly availability of high-resolution X-ray cocrystal structures, the success rate of this strategy should be superior to that of more conventional de novo design methodologies. Such a crystallographic overlay-based molecular hybridization approach, taking full advantage of structural biology information, should become increasingly valuable.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">3.6 Conformational Restriction</h3><div class="NLM_p">Proteins are inherently dynamic and conformationally heterogeneous, existing as an ensemble of differently populated conformers in equilibrium. However, certain conformations may be playing key roles in biofunctions, including catalytic activity and molecular recognition. Cumulative evidence strongly supports the idea that conformational restriction (rigidity) of a flexible molecule to match the pharmacological target conformation is effective for drug discovery because it minimizes the entropic loss on ligand binding, resulting in increased affinity and increased isoform selectivity, as well as enhanced drug metabolic stability.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div><div class="NLM_p"><b>70</b> (L-870810) was an early IN inhibitor that entered clinical trials.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Because of its rotatable amide bond, there is a dynamic equilibrium between two rotational isomers of <b>70</b>: conformational states A and B (<a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>). State B was postulated to be the bioactive form for metal chelation (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>). The rotational energy barrier for conversion from A to B is approximately 5 kcal/mol. Consequently, it may be feasible to design molecules that specifically target a certain conformational state of IN and “lock” IN into an inactive form.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Two rotational isomers of the IN inhibitor <b>70</b> arise from rotation around the amide bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Crystal structure of the prototype foamy virus (PFV) intasome (a homologous protein of HIV IN) complexed with <b>70</b> (pale) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYF">3OYF</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To prepay the conformational penalty in binding to IN, conformationally restricted platforms have been proposed. For example, tricyclic molecules <b>72</b>–<b>74</b> were synthesized to lock the metal coordination motif in the lead molecule <b>71</b> into the necessary coplanar orientation for effective metal binding. As expected, conformational rigidity resulted in increased inhibitory potency toward HIV and IN, compared with that of <b>71</b> (<a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>).<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Design of conformationally restricted HIV IN inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compared with the <i>N</i>-methyl hydroxamate <b>75</b>, the LLE value of the rigid rotamer <i>N</i>-hydroxydihydronaphthyridinone <b>76a</b> was dramatically increased.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Another derivative <b>76b</b> (PF-4776548) was disclosed as a promising candidate with high activity and a high barrier to resistance (<a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>).<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> This research supports the value of conformational restriction as a strategy to generate novel IN inhibitors with improved potency and druglike profile.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">3.7 Dismantling the Rigid Polycyclic Nucleus of Prototypes (Ring-Opening)</h3><div class="NLM_p">It is well-known that an interesting option for further development of small-molecular drugs containing fused cyclic systems is to synthesize ring-opened analogues or to delete some of the rings. These derivatives often display potency similar to that of the parent analogues and have improved pharmacokinetic properties. Indeed, inhibitors incorporating conformational flexibility and positional adaptability can minimize the entropic penalty of binding and accommodating to mutated residues.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>, the new-generation NNRTIs 1-[2-(diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole (<b>78</b>), <b>80</b>, and <b>82</b>–<b>84</b> may be envisaged as “open models” of their parent compounds, since they retain the pharmacophoric elements and conformation of the classical NNRTIs necessary for efficient RT inhibition.<a onclick="showRef(event, 'ref113 ref114 ref115 ref116 ref117 ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref113 ref114 ref115 ref116 ref117 ref118 ref119">(113-119)</a> These ring-opened derivatives seem to be promising starting points for further investigation.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0022.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Development of (a) 1-[2-(diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazoles (DAMNIs) (exemplified by <b>78</b>),<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> (b) phenethylthiazolylthioureas (PETTs) (exemplified by <b>80</b>),<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> (c) 2,3-diaryl-1,3-thiazolidin-4-one (exemplified by <b>82</b>),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> 1,3-dihydro-2<i>H</i>-benzimidazol-2-one (exemplified by <b>84</b>),<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> and 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)benzimidazole (exemplified by <b>83</b>)<a onclick="showRef(event, 'ref117 ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref117 ref118 ref119">(117-119)</a> by dismantling parts of the rigid tricyclic scaffold of prototype leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">4 Novel Medicinal Chemistry Strategy for Improving the Aqueous Solubility of HIV Inhibitors: Phosphate Ester-Based Prodrug Approach</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34620" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34620" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Physiochemical properties, especially aqueous solubility, are a major factor determining the ultimate success or failure of drug candidates.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> The design of water-soluble prodrugs is therefore expected to be an effective strategy in drug development. Recent examples from the literature illustrate the utility of phosphate ester introduction as a new strategy for improving drug efficacy and mitigating solubility-limited bioavailability of anti-HIV drug candidates.<a onclick="showRef(event, 'ref121 ref122 ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref121 ref122 ref123 ref124">(121-124)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0023.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Illustration of the phosphooxymethyl prodrug approach (top, hydrolysis of <b>85</b> via an unstable intermediate <b>86</b> to liberate <b>87</b>) and some examples of derivatization to obtain prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>, the phosphate ester prodrug <b>85</b> displays much greater water solubility (12 mg/mL) than the parent compound <b>87</b> (0.0002 mg/mL). This approach has been further validated by the development of phosphooxymethyl-based prodrugs <b>89</b> (BMS-663749) and <b>91</b> (BMS-663068) as HIV-1 attachment inhibitors, which are converted to the bioactive parent drugs <b>88</b> and <b>90</b> in vivo, respectively.<a onclick="showRef(event, 'ref122 ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref122 ref123 ref124">(122-124)</a> Oxymethylphosphate (OMP) and oxyethylphosphate (OEP) prodrugs of HIV PR inhibitors <b>92</b> (lopinavir) and <b>32</b>, exemplified by <b>93</b>–<b>96</b>, also provided significantly increased aqueous solubility, high cleavage rates, and high plasma levels of their prototypes after oral administration to rats and dogs.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><div class="NLM_p last">In this prodrug approach, release of the parent compounds involves a two-step process. Hydrolytic dephosphorylation by alkaline phosphatase (primarily located in the brush border membranes of small intestinal epithelium) affords the hydroxymethyl intermediate <b>86</b>, which is inherently unstable, spontaneously decomposing into formaldehyde and the parent compound <b>87</b> in the vicinity of the membrane, thus enabling favorable absorption (<a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>).<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121, 122)</a> This seems to be a flexible strategy for improving exposure and addressing solubility limited absorption of anti-HIV agents.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">5 Substrate Envelope Hypothesis: Novel Structure-Based Drug Design Methodology To Reduce Drug Susceptibility to Resistance Mutations</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Drug resistance is a principal concern in drug design targeting rapidly evolving proteins, such as HIV-1 PR. Crystal structure analyses of HIV-1 PR complexed with its peptide substrates suggested that the specificity for substrates depends on matching a defined shape (envelope) within the binding pocket. This shape is termed the “substrate envelope”. Consequently, to obtain broad binding selectivity against a protein target and its mutants, a useful strategy has been to discover inhibitors that remain within the substrate envelope, since these should be less likely to induce resistance mutants than those that extend the envelope. This idea can be designated as the “substrate envelope hypothesis” (<a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>).<a onclick="showRef(event, 'ref126 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128">(126-128)</a></div><div class="NLM_p">As illustrated in <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>, in the WT drug target, an envelope-violating inhibitor (a) occupies more of the binding site and forms more contacts than a substrate (d). But such an envelope-violating molecule may bind only weakly to mutated proteins (mutants I and II) that differ from the WT target, either being forced away from the binding site via removal of a stabilizing interaction (consequently decreasing the binding affinity) (b, pentagram) or protruding further into the binding pocket and suffering a potential steric clash (c, polygon). On the contrary, the substrate does not show decreased affinity, as it does not contact the mutated residue (e and f). Therefore, if the inhibitor is designed to solely form interactions mimicking those of the substrate with invariant residues, HIV mutation would probably have little impact on the binding affinity.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0024.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Schematic diagram illustrating the substrate envelope hypothesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0025.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Discovery of novel HIV-1 PR inhibitors <b>97</b> and <b>98</b> based on the substrate envelope hypothesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In fact, successful next-generation drug candidates tend to exploit more interactions with the substrate. For instance, in recent years, a general strategy of combining computational structure-based design with substrate-envelope constraints has been utilized to develop subnanomolar HIV-1 PR inhibitors active toward a panel of patient-derived multidrug-resistant (MDR) viruses; these inhibitors offer reduced structural complexity and good cost-effectiveness (<a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>).<a onclick="showRef(event, 'ref129 ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref129 ref130 ref131">(129-131)</a> Notably, the potency of <b>97</b> (darunavir, TMC114) against MDR PR variants is likely due to a combination of its extremely high affinity and its close fit within the substrate envelope.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><div class="NLM_p">In 2012, a new series of HIV-1 PR inhibitors was designed using this combined strategy. Some derivatives exhibit antiviral inhibition at nanomolar level against clinically derived viruses from HIV-1 clades A, B, and C and two MDR mutants. Crystal structure analysis of representive compound <b>98</b> disclosed that the carbonyl groups in the newly introduced P2 moieties promote extensive H-bond interactions with the conserved Asp-29 residue of PR, which may be responsible for the impressive activities against MDR PR mutants and antiviral activities in cellular assays.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div><div class="NLM_p">In 2013, the effectiveness of substrate-envelope hypothesis-guided drug design was further validated by the synthesis of designed pairs of compounds (envelope-respecting/-violating inhibitors, which are very similar to one another).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><div class="NLM_p">It is noteworthy that the NRTI drugs zidovudine (AZT, structure not displayed) and lamivudine (3TC, structure not displayed) protrude beyond the corresponding elements of normal nucleotides (the consensus substrate envelope), creating an opportunity for HIV-1 RT to develop resistance. Hence, it might be beneficial to focus on the relationship between their structures and that of normal dNTPs and to design future NRTIs lying within the substrate envelope. Indeed, the substrate envelope hypothesis has already been applied in the discovery of nucleotide tenofovir.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Tenofovir might elude drug resistance through locating itself within the substrate envelope, but it might still be vulnerable to excision and to resistance involving loss of key interactions. Further efforts to discover new NRTIs should also take fully into account the insight that if the ligand fits within the substrate envelope, certain interactions with the protein (especially the backbone atoms) may be lost, potentially decreasing its binding affinity.</div><div class="NLM_p last">The substrate envelope hypothesis has also been applied to inhibitors of NS3/4A protease, a primary drug target for the hepatitis C virus (HCV).<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(135, 136)</a> Application of this hypothesis may revolutionize future drug design.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">6 New Insights into the Clinically Validated Antiretroviral Targets and Burgeoning Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In spite of the availability of nearly 30 licensed anti-HIV drugs, the rapid emergence of MDR mutations requires the development of new, safe, and effective antiviral agents targeting alternative mechanisms or new binding sites on traditional targets or newly emerging targets.<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137, 138)</a></div><div class="NLM_p">In theory, drugs that can target new sites should have different resistance profiles to existing drugs and would complement the current anti-HIV drugs used in cART. For the clinically validated HIV targets (RT, IN, PR, and CCR5), there is still great scope for further development of novel inhibitors with distinct mechanisms of action, such as RNase H inhibitors,<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> nucleotide-competing RT inhibitors (NcRTIs),<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> noncatalytic site (allosteric) IN inhibitors,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> and PR dimerization inhibitors.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> From the HIV therapy point of view, an allosteric inhibitor could restore the potency of an active site inhibitor against multidrug-resistant mutants, so combined therapy with an active site inhibitor and an allosteric inhibitor may be available as a new anti-HIV strategy to overcome drug resistance. Recently, a high-resolution crystal structure of human CCR5 bound to the approved drug <b>56</b> (<a class="ref internalNav" href="#fig25" aria-label="Figure 25">Figure 25</a>) revealed a ligand-binding pocket that is distinct from the putative major binding sites for chemokines and HIV gp120, affording an unprecedented insight into the mechanism of allosteric modulation of chemokine signaling and viral entry.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> This structure may suggest potential new avenues for modifications of <b>56</b> that could further inhibit bioactivity of CCR5.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> In addition, a subpocket on the N-trimer of HIV-1 gp41 was identified, with implications for the development of anti-HIV entry inhibitors.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0026.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structure of <b>56</b> (pink carbons) complexed with CCR5 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS">4MBS</a>). (a) Key residues (blue carbons, in stick representation) in the CCR5 binding pocket involved in the interaction with <b>56</b>. A water molecule is displayed as a red sphere. (b) Schematic representation of interactions between CCR5 and <b>56</b> for surface presentation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Besides targeting an unconventional binding site, another rational design strategy to combat drug resistance has been to maximize highly conserved site interactions, especially to enhance extensive H-bond interactions with main-chain atoms.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> This strategy has been extensively employed to seek a variety of scaffolds for NNRTIs, HIV-1 PR inhibitors, and gp41 inhibitors.<a onclick="showRef(event, 'ref144 ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref146">(144-146)</a></div><div class="NLM_p">In addition, other targets have been functionally and structurally characterized as potentially interesting and druggable alternatives because they are crucial for key steps of viral replication, such as protein–protein and protein–nucleic acid interactions,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> DNA G-quadruplex formation,<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> protein conformational transitions,<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> the dimerization initiation site (DIS) of the HIV-1 genomic RNA,<a onclick="showRef(event, 'ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref150 ref151">(150, 151)</a> HIV-1 matrix protein,<a onclick="showRef(event, 'ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref152 ref153">(152, 153)</a> HIV-1 capsid,<a onclick="showRef(event, 'ref154 ref155 ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref154 ref155 ref156 ref157">(154-157)</a> nuclear import of preintegration complex,<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Rev- mediated viral RNA biogenesis (compound <b>99</b> (ABX464) is a first-in-class anti-HIV drug candidate in phase II clinical trial, <a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>),<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> HIV assembly and release,<a onclick="showRef(event, 'ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref160 ref161">(160, 161)</a> retroviral nucleocapsid zinc fingers,<a onclick="showRef(event, 'ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref162 ref163">(162, 163)</a> and many host antiviral restriction factors (such as Vif-dependent degradation of human APOBEC3G and mTORC-1/2).<a onclick="showRef(event, 'ref164 ref165 ref166 ref167 ref168'); return false;" href="javascript:void(0);" class="ref ref164 ref165 ref166 ref167 ref168">(164-168)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0027.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure of <b>99</b>, targeting Rev-mediated viral RNA biogenesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HIV requires host cellular factors for successful completion of its replication cycle. Host factors mutate less frequently than do viral proteins. They are very attractive targets, as fewer mutations mean a lower possibility of drug resistance. However, discovery of host antiviral factors-targeting compounds as HIV-1-selective inhibitors has always been problematic. Very recently, motivated by the key role of CXCR4 as an HIV entry co-receptor,<a onclick="showRef(event, 'ref169 ref170'); return false;" href="javascript:void(0);" class="ref ref169 ref170">(169, 170)</a> Wu et al. reported a de novo function-oriented hit-to-lead effort for discovery of HIV-1-selective, subnanomolar purine-based CXCR4-specific antagonists with a broad therapeutic window (<a class="ref internalNav" href="#fig27" aria-label="Figure 27">Figure 27</a>).<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Interestingly, compound <b>103</b> (EC<sub>50</sub> = 0.5 nM against HIV-1 entry into host cells; IC<sub>50</sub> = 16.4 nM for inhibition of radioligand SDF-1α binding to CXCR4) exhibited a 130-fold improvement in anti-HIV potency compared to the approved CXCR4 antagonist, <b>104</b> (AMD3100, Plerixafor, <a class="ref internalNav" href="#fig28" aria-label="Figure 28">Figure 28</a>), though both molecules showed similar activity in mobilizing CXCR4(+)/CD34(+) stem cells at a high concentration. This investigation provides insight into the discovery of antiviral agents without major interference with SDF-1α function. It was rationalized that <b>102</b> complementarily interacted with key CXCR4 amino acids important for binding to the gp120 V3 loop and the subsequent HIV-1 entry process. Generally, this study offers tantalizing insights into the feasibility of designing antagonists that selectively target critical residues in host factors governing viral replication.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0028.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Function-oriented development of CXCR4 antagonists as selective HIV-1 entry inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0029.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Structure of the approved CXCR4 antagonist <b>104</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0030.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Conversion workflow of <b>105</b>–<b>106</b> (a partial CD4 agonist) to a full CD4 antagonist <b>107</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As another example, it was generally concluded that structural transformation on the oxalamide motif (region II) of <b>105</b> (NBD-556, a full CD4-agonist) was detrimental to binding and anti-HIV activity, which was considered to be intolerant of optimization previously.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Very recently, through systematic structure-based modifications of the critical region II, synthesis, and functional and biophysical assays, Debnath et al. disclosed the successful conversion of <b>105</b> through <b>106</b> (NBD-09027, a partial CD4-agonist) to <b>107</b> (NBD-11021) as a full CD4-antagonist with broad spectrum anti-HIV-1 activity (IC<sub>50</sub> as low as 270 nM, for neutralization activity against a panel of HIV-1 Env pseudoviruses) (<a class="ref internalNav" href="#fig29" aria-label="Figure 29">Figure 29</a>). To our knowledge, this study unprecedentedly shows that optimization of the oxalamide motif is feasible and may be crucial to improving anti-HIV activity of this class of entry inhibitors.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div><div class="NLM_p last">In summary, the availability of an enormous volume of structural biology information,<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> revealing mechanisms of actions and resistance at the molecular and atomic levels and distinctive binding modes of inhibitors, will facilitate structure-based rational drug design and diminish the likelihood that drug resistance will develop.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">7 Activation of Latent HIV Reservoirs: “Kick and Kill” Strategy</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Current cART provides potent suppression of HIV-1 replication and can maintain patients with undetectable viremia for a long time. However, cART does not eliminate latent viral reservoirs within cells so that HIV-infected individuals are not cured, and persistent infection is still a significant challenge.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></div><div class="NLM_p">Consequently, several therapeutic strategies are being evaluated to eliminate these viral reservoirs. One of these strategies, termed “kick (shock)-and-kill” strategy,<a onclick="showRef(event, 'ref176 ref177 ref178 ref179'); return false;" href="javascript:void(0);" class="ref ref176 ref177 ref178 ref179">(176-179)</a> is to employ small-molecular compounds that stimulate viral replication (activate viral reservoirs), potentially allowing these reservoirs to be eliminated in conjunction with current cART.<a onclick="showRef(event, 'ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref180 ref181">(180, 181)</a></div><div class="NLM_p">Recent studies have shown that histone deacetylase (HDAC) inhibitors (such as <b>108</b> (vorinostat/SAHA), <b>109</b> (entinostat), <b>110</b> (NCH51), <b>111</b> (M344), <b>112</b> (MC1239), and <b>113</b> (ITF2357)) can reactivate latent HIV in some patients, providing evidence that the shock-and-kill strategy may be feasible (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>a).<a onclick="showRef(event, 'ref182 ref183 ref184'); return false;" href="javascript:void(0);" class="ref ref182 ref183 ref184">(182-184)</a> The mechanisms involved in the reactivation of latent HIV-1 by HDAC inhibitors have been identified (<a class="ref internalNav" href="#fig30" aria-label="Figure 30">Figure 30</a>b).<a onclick="showRef(event, 'ref185 ref186'); return false;" href="javascript:void(0);" class="ref ref185 ref186">(185, 186)</a> In the latent state, HDACs block HIV-1 expression by catalyzing deacetylation of histone tails and keeping the chromatin in a compacted form. Suppression of HDACs by HDAC inhibitors facilites histone acetylation by histone acetyl transferases (HATs), resulting in relaxation of the chromatin and initiation of transcription. Though HDAC inhibitors have demonstrated promise in invoking latency in humans, it will take many years to move from these initial findings to clinical application. One obstacle to repositioning HDAC inhibitors for therapy of HIV infection lies in intellectual property issues surrounding the original HDAC inhibitors. The number of drug analogues is far more than that of approved drugs, making “repositioning drug analogues (privileged structures)” a feasible way to find new leads for eliminating the latent HIV reservoir.<a onclick="showRef(event, 'ref27 ref187'); return false;" href="javascript:void(0);" class="ref ref27 ref187">(27, 187)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0031.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Disruption of HIV latency by HDAC inhibitors:<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> (a) structures of representative HDAC inhibitors; (b) mechanisms involved in the reactivation of latent HIV-1 by HDAC inhibitors. LTR: long-terminal repeat.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HIV latency is multifactorial, and thus, additional approaches are required for the eradication of HIV infection. Consequently, other potential targets, such as IκB proteins,<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> lysine-specific demethylase 1 (LSD1),<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> protein kinase C,<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> P-TEFb,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> and various unidentified factors,<a onclick="showRef(event, 'ref192 ref193'); return false;" href="javascript:void(0);" class="ref ref192 ref193">(192, 193)</a> have been recently studied. However, most of the mechanisms of action remain enigmatic. Various model systems, both in primary cells and in animal models, are beginning to be validated.<a onclick="showRef(event, 'ref194 ref195'); return false;" href="javascript:void(0);" class="ref ref194 ref195">(194, 195)</a> Clearly, targeting of individual factors is not enough to eliminate latent virus, and so a combination of compounds that can reactivate HIV via diverse mechanisms will be needed.<a onclick="showRef(event, 'ref196 ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref196 ref197 ref198">(196-198)</a></div><div class="NLM_p">Rational design of agents to target HIV latency is not available at present, as better understanding of the molecular control of HIV-1 transcription is still deficient. Another obstacle to rational design for therapy lies in the requirement that the desired molecule should motivate viral reactivation without inducing global T cell activation. Improving the applicability of new models in investigating HIV-1 latency should be helpful for further research.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a></div><div class="NLM_p last">Eventually, antilatency drugs should be used in parallel with other interventions, such as antiviral immune responses (immune augmentation strategies), antiretroviral drugs, or cytopathic effects, to eradicate persistent HIV infection.<a onclick="showRef(event, 'ref200 ref201 ref202'); return false;" href="javascript:void(0);" class="ref ref200 ref201 ref202">(200-202)</a></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">8 Pre-Exposure Prophylaxis and Topical Microbicides</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pre-exposure prophylaxis and topical microbicides have been regarded as essential approaches in the prevention of sexual transmission of HIV.<a onclick="showRef(event, 'ref203 ref204 ref205'); return false;" href="javascript:void(0);" class="ref ref203 ref204 ref205">(203-205)</a> Especially, many membrane-permeable, tight-binding NNRTIs could inactivate cell-free and cell-based HIV-1 in semen without metabolic activation.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Consequently, some NNRTIs are being investigated as experimental microbicides (<a class="ref internalNav" href="#fig31" aria-label="Figure 31">Figure 31</a>), including <b>114</b> (dapivirine, TMC120),<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a><b>115</b> (UAMC01398),<a onclick="showRef(event, 'ref207 ref208'); return false;" href="javascript:void(0);" class="ref ref207 ref208">(207, 208)</a><b>116</b> (MC1220),<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a><b>117</b> (YML220),<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a><b>118</b> (UC781),<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a><b>119</b> (HI-443),<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a><b>120</b> (MIV-150),<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> and dithiocarbamate–thiourea hybrid (<b>121)</b>.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> Notably, <b>114</b> formulated as a vaginal ring has entered two phase III efficacy and safety studies.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> Recently, a diaryltriazine derivative <b>115</b> demonstrated a superior safety profile, favorable in vitro potency against dapivirine-resistant strains, and favorable biopharmaceutical profiles, thus warranting further investigation as a promising microbicide candidate.<a onclick="showRef(event, 'ref207 ref208'); return false;" href="javascript:void(0);" class="ref ref207 ref208">(207, 208)</a> Equally important, a microbicide must be potent against multiple HIV-1 mutations. Thus, combining agents with multiple mechanisms of action may improve microbicide efficiency.<a onclick="showRef(event, 'ref216 ref217 ref218'); return false;" href="javascript:void(0);" class="ref ref216 ref217 ref218">(216-218)</a></div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0032.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Representative NNRTIs as HIV microbicides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">9 Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">There is a continuing demand for novel HIV-1 inhibitors due to the emergence of drug-resistant strains, as well as poor pharmacokinetic profiles and the cumulative toxicities of drugs currently used in cART. Tremendous progress in bioinformatics, structural biology, and understanding of the HIV life cycle over the past 2 decades has facilitated the rapid discovery of potent inhibitors for therapeutically established anti-HIV targets. But the discovery of new first-in-class drugs for the treatment of HIV infection is an expensive and lengthy process. Even an ideal follow-on anti-HIV drug (namely, a new antiretroviral for a known target) should meet rigorous requirements: (i) improved activity against WT and resistant virus; (ii) favorable oral bioavailability and metabolic stability; (iii) minimal side effects and good safety profile; (iv) lack of drug–drug interactions (ability to interact beneficially with other drugs); and (v) ease of preparation and formulation.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> Nevertheless, innovative medicinal chemistry methodologies, emerging techniques, and new concepts have been developed to address both drug resistance and poor aqueous solubility and also to promote the identification and optimization of leads with high potential for generating new antiviral therapeutic drugs. As Confucius said, “Consider the past, and you shall know the future”, and this gives us hope that the well-filled toolbox of contemporary medicinal chemists will indeed lead to the timely discovery of improved HIV inhibitors.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">10 Discussion and Prospects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this review, we have briefly described the various methodologies and tactics that have been used to discover novel drug entities, to improve drug resistance profiles and solubility, and to promote eradication of latent HIV reservoirs (<a class="ref internalNav" href="#fig32" aria-label="Figure 32">Figure 32</a>).</div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0033.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Schematic illustration of key issues in anti-HIV therapy and innovative medicinal chemistry methodologies and approaches available for anti-HIV drug discovery and development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In recent years, fragment-based methodologies for lead discovery, such as fragment-based screening and reconstruction approaches, have gained increasing momentum in the pharmaceutical industry and in academia as complementary approaches to HTS. It is widely recognized that the challenge in the fragment evolution approach is to transform binders with low affinity into potent leads while maintaining high potency and reasonable druglike properties. In the future, the combination of fragment-based optimization with visualization of binding profiles by means of crystallographic studies is likely to be particularly effective in creating highly efficient inhibitors.</div><div class="NLM_p">New concepts and methodologies of combinatorial chemistry, including DLS and rapid diversity-oriented synthesis and in situ screening, have been proposed for the design and synthesis of structurally diverse or focused libraries.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> We wish to stress that design of molecular libraries for screening should take into account the need to obtain an appropriate balance of many diverse properties. In such solution-phase approaches, it is also important to minimize the usage of additional reagents that might adversely influence the subsequent in situ bioassays. This is important because the absence of a purification procedure in library assembly employing CuAAC reaction has allowed medicinal chemists to exploit the relevant chemical space around a candidate scaffold in a swift and efficient manner. However, despite the popularity of diversity-oriented synthesis via this widely used click chemistry, there is still a lack of highly concise and convergent synthesis strategies that give access to alkyne/azide-containing fragments as key building blocks for click chemistry.</div><div class="NLM_p">The hierarchical multiple-filter database searching strategy, which combines many cheminformatic tools, is a fascinating approach to identify new anti-HIV leads with a high probability of achieving the required properties profile. However, it should be emphasized that issues such as the inaccuracy of scoring functions for estimating target–ligand binding free energy, the difficulty of considering target flexibility in docking, and the high false-positive rate still represent major challenges to current multiple-filters strategy. Besides, the uncertainties in in silico predictions mean that a computer software cannot discover a final candidate with complete confidence that it will gain all of the required druglike properties. Consequently, further optimization via chemically tractable synthesis is inevitable. Therefore, it is desirable to apply a synthetic accessibility score as a filter to remove molecules that would be hard to synthesize.</div><div class="NLM_p">A relatively new strategy in the scaffold evolution of HIV inhibitors is the development of MTDLs. The advantages of integrated MTDLs (also referred to as merged or fused designed multiple ligands or twin ligands) over linked MTDLs include reduction of molecular weight, clogP, and topological polar surface area, which are all key aspects of “druglike” profiles. It is broadly acknowledged that combining a desirable balanced bioactivity with a “druglike” profile is a pivotal aspect of successful drug discovery. Therefore, the design of integrated MTDLs seems a very promising strategy for the discovery of new anti-HIV drugs.</div><div class="NLM_p">Bisubstrate (heterobivalent) ligands can interact simultaneously at two orthosteric binding sites of a heterodimer, potentially providing higher affinity, improved selectivity, and modified physiological response, with the possibility of enhanced administration compliance in patients. At present such compounds are useful as pharmacological probes, but their use as drugs is restricted by their relatively large molecular size.</div><div class="NLM_p">ARMs have the potential to interfere with HIV replication through multiple complementary mechanisms, viz., inhibition of virus entry and antibody-mediated immune clearance of Env-expressing cells. To design novel potent ARMs, conjugation strategies of bisubstrate (heterobivalent) ligands are available. This conjugation approach consists of two phases. The first is selection of an appropriate template molecule and identification of a suitable position for introducing a linker. The next is chemical optimization of promising inhibitors.</div><div class="NLM_p">A high quality drug must have a good balance of potency against its therapeutic target(s) with physicochemical properties, ADME properties, and safety. Multiparameter optimization approaches can guide the simultaneous optimization of multiple properties to find molecules with the highest success rate in downstream step. The application of efficiency indices (LE and LLE) has already proved highly effective to rapidly identify and improve the quality of molecules with anti-HIV potency and to rationally design derivatives with highly optimized chemical entities. In general, LE could be used as a decision-making parameter during the early stage of hit identification to maximize bioactivity versus molecular mass, whereas LLE could be adopted during the later stage of optimization to balance bioactivity and lipophilicity. In addition, the story of the discovery of CCR5 antagonist maraviroc as a drug for HIV treatment demonstrated that avoiding cardiac liability related to inhibition of hERG is key for successful antiviral drug discovery and development. As is well-known, drugs in vivo are situated in an open environment, in which their microenvironment and concentrations are continually variable. Aside from parameters of drug binding affinity, in recent years, the kinetics of drug binding (<i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> of the drug–target interaction) and drug residence time have been increasingly recognized as vital parameters for therapeutic efficacy of anti-HIV drugs, such as HIV PR inhibitors and CCR5 antagonist maraviroc. Drugs with prolonged on-target residence times generally display superior efficacy, but so far, general strategies for optimizing drug–target residence time are lacking. It seems clear that integration of different ligand-binding assays (<i>K</i><sub>d</sub>, IC<sub>50</sub>, <i>k</i><sub>off</sub>) will be important to enhance the efficiency of anti-HIV drug discovery and development.<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a></div><div class="NLM_p">Targeting of noncatalytic cysteines with reversible covalent inhibitors may serve as a broadly applicable approach that promotes “residence time by design”, i.e., the capacity of modulating and improving the duration of target engagement in vivo.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a> The methodology could be generalizable to anti-HIV drug targets that contain such cysteine residues, such as Y181C mutated RT.</div><div class="NLM_p">From a medicinal chemistry point of view, crystallographic overlay-based molecular hybridization, conformational restriction, and ring-opening, three commonly used rational scaffold-hopping approaches, require the availability of structural biology information about the chemical space around the antiviral biotargets of interest so that the essential determinants of binding affinity and the tolerant region for scaffold hybridization, fusion, or opening can be identified. For instance, in general, one of the benefits of conformationally restricted molecules is their ability to reduce conformational entropy by constraining themselves in conformations that can selectively bind to their target. However, for easily mutated targets, the relative flexibility of ring-opened compounds might allow them to adapt to a mutated drug pocket more readily, as compared to the rigid fused-ring structure.</div><div class="NLM_p">Decreasing the dosing frequency of anti-HIV therapies has been found to have a significant impact on improving patient adherence, which represents an important goal within antiretroviral drug discovery. Given that low aqueous solubility remains a primary issue in antiviral drug discovery, the development of structural analogues with improved solubility is highly desirable. The use of phosphate ester-based prodrugs is an important new approach to overcome solubility-limited bioavailability of anti-HIV agents. Besides, to overcome absorption-limiting physicochemical properties, other innovative prodrug strategies (such as the acetal carbonate prodrug) were recently applied in the structural optimization of HIV-1 integrase inhibitors (including <b>122</b> (raltegravir) and 2-pyridinone <b>123</b> (MK-0536), <a class="ref internalNav" href="#fig33" aria-label="Figure 33">Figure 33</a>), which led to the identification of new drug candidates (exemplified by acetal carbonate prodrugs <b>124</b> and <b>125</b>) with favorable antiviral efficacy, suitable physicochemical and preclinical pharmacokinetic profiles, and less frequent administration (to support a once-daily dosage).<a onclick="showRef(event, 'ref222 ref223'); return false;" href="javascript:void(0);" class="ref ref222 ref223">(222, 223)</a></div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0034.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures of HIV-1 integrase inhibitors <b>122</b> and <b>123</b> and their acetal carbonate prodrugs <b>124</b> and <b>125</b> (also an acetal carbonate–phosphate double prodrug).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From a strategic point of view, the substrate–envelope hypothesis is a useful structure-based drug design methodology to reduce drug susceptibility to resistance mutations. While the means to achieve wide selectivity toward potential drug-resistance mutations depends on the system of interest, the idea of trying to mimic the static and dynamic molecular recognition features of the natural substrate (especially its shape and flexibility) is a powerful idea when dealing with proteins that are prone to resistance mutations.</div><div class="NLM_p">As the availability of high-resolution structures of viral particles is rapidly increasing, one of the most exciting fields of HIV research is the search for agents directed at novel targets, including new sites and/or alternative mechanisms interacting with the traditional targets.</div><div class="NLM_p">Due to the presence of latent viral reservoirs, another key issue is to develop new agents that induce activation of latent HIV reservoirs and to evaluate their use in combination with established agents, aiming to completely eradicate HIV from infected individuals. This approach is challenging and has been unsuccessful thus far. Although HDAC inhibitors are promising, an in-depth understanding of key mechanisms of HDAC isoforms in latency and feasible tools to translate these knowledge into practice are urgently needed. Moreover, a major concern with this strategy is that compounds should induce latent viruses without increasing the susceptibility of uninfected cells to HIV.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Generally, as HIV latency and the persistence of infection are multifactorial, the thorough eradication of HIV infection may require a variety of approaches.</div><div class="NLM_p last">Overall, the multidisciplinary coordination of methodologies from the usual approaches and the emerging alternatives will prompte anti-HIV drug discovery and development in the future.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00497" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erik De Clercq</span> - <span class="hlFld-Affiliation affiliation">Rega Institute
for Medical Research, Katholieke Universiteit
Leuven, Minderbroedersstraat
10, B-3000 Leuven, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#204552494b0e4445434c4552435160524547410e4b554c455556454e0e41430e4245"><span class="__cf_email__" data-cfemail="7c190e15175218191f10190e1f0d3c0e191b1d5217091019090a1912521d1f521e19">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinyong Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Key
Laboratory of Chemical Biology (Ministry of Education), School of
Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012, Jinan, Shandong, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2b5342455244454c476b584f5e054e4f5e054845"><span class="__cf_email__" data-cfemail="d2aabbbcabbdbcb5be92a1b6a7fcb7b6a7fcb1bc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peng Zhan</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Key
Laboratory of Chemical Biology (Ministry of Education), School of
Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012, Jinan, Shandong, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Pannecouque</span> - <span class="hlFld-Affiliation affiliation">Rega Institute
for Medical Research, Katholieke Universiteit
Leuven, Minderbroedersstraat
10, B-3000 Leuven, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Peng Zhan</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=BIO-d5264e2355-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Peng Zhan</b> obtained his B.S. degree from Shandong University, China, in 2005. Then he earned his M.S. and Ph.D degrees in Medicinal Chemistry from Shandong University in 2008 and 2010, respectively. He subsequently joined the research group of Professor Xinyong Liu as a Lecturer (2010–2012). From 2012 to 2014, he worked as a Postdoctoral Fellow funded by JSPS (Japan Society for the Promotion of Science) in the Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan. He is now working as an Associate Professor in the laboratory of Professor Xinyong Liu. His research interests involve the discovery of novel antiviral, anticancer, and neurodegenerative disease-related agents based on rational drug design and combinatorial chemistry approaches.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Christophe Pannecouque</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=BIO-d5264e2360-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Christophe Pannecouque</b> studied pharmaceutical sciences and obtained a Ph.D. in Medicinal Chemistry at the Rega Institute for Medical Research of the Katholieke Universiteit Leuven in 1990 and 1995, respectively. In 1995 he joined the group of Professor Erik De Clercq as a postdoctoral fellow. An Associate Professor since 2003, he teaches courses in cell biology and biochemistry at the Faculty of Pharmaceutical Sciences of the Katholieke Universiteit Leuven, Belgium. In the field of virological research, he has unraveled the mode of action of several classes of new products with anti-HIV activity. The last years of his research focused more on cellular targets interfering with HIV replication and research in the domain of the regulation of the (cyto)pathogenicity of the virus.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Erik De Clercq</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=BIO-d5264e2365-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Erik De Clercq</b> has M.D. and Ph.D. degrees and has taught courses in cell biology, biochemistry, and microbiology at Katholieke Universiteit Leuven (and Kortrijk) Medical School, Belgium, where he was Chairman of the Department of Microbiology and Immunology until September 2006. He is currently Emeritus Professor of Katholieke Universiteit Leuven, Member of the Belgian (Flemish) Royal Academy of Medicine and the Academia Europaea, and Fellow of the American Association for the Advancement of Science. In 2008, he was elected European Inventor of the Year (Lifetime Achievement Award), and in 2010 he, together with Dr. A. S. Fauci, was Laureate of the Dr. Paul Janssen Award for Biomedical Research. He is the (co)inventor of a number of antiviral drugs (valaciclovir, brivudin, cidofovir, adefovir, and tenofovir).</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Xinyong Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=BIO-d5264e2370-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xinyong Liu</b> received his B.S. and M.S. degrees from School of Pharmaceutical Sciences, Shandong University, China, in 1984 and in 1991, respectively. From 1997 to 1999 he worked at Instituto de Quimica Medica (CSIC) in Spain as a senior visiting scholar. He obtained his Ph.D. from Shandong University in 2004. He is currently a Full Professor of the Institute of Medicinal Chemistry, Shandong University. His research interests include rational drug design and synthesis and antiviral evaluation of a variety of molecules that interact with specific enzymes and receptors in the viral life cycle (HIV, HBV, HCV, and FluV). Other ongoing programs include the molecular modification and structure–activity relationships study of some natural products to treat cardiovascular diseases, and drug delivery research using PEGylated small-molecular agents.</p></figure></div><div class="ack" id="ACK-d5264e2375-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge financial support from the National Natural Science Foundation of China (NSFC Grants 81573347, 81102320, 81273354), Key Project of NSFC for International Cooperation (Grant 81420108027), Research Fund for the Doctoral Program of Higher Education of China (Grants 20110131130005, 20110131120037), The Science and Technology Development Project of Shandong Province (Grant 2014GSF118012), and the China Postdoctoral Science Foundation funded special project (Grant 2012T50584). All figures showing binding modes were generated using PyMol (<a href="http://www.pymol.org" class="extLink">www.pymol.org</a>).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> Abbreviations Used</h2><tr><td class="NLM_term">AAC</td><td class="NLM_def"><p class="first last">azide–alkyne cycloaddition</p></td></tr><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immunodeficiency syndrome</p></td></tr><tr><td class="NLM_term">ARM</td><td class="NLM_def"><p class="first last">antibody-recruiting molecule</p></td></tr><tr><td class="NLM_term">BEAM</td><td class="NLM_def"><p class="first last">binding energy analysis method</p></td></tr><tr><td class="NLM_term">cART</td><td class="NLM_def"><p class="first last">combinatorial antiretroviral therapy</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">Cu(I)-catalyzed azide–alkyne 1,3-dipolar cycloaddition</p></td></tr><tr><td class="NLM_term">DDM</td><td class="NLM_def"><p class="first last">double decoupling method</p></td></tr><tr><td class="NLM_term">DLS</td><td class="NLM_def"><p class="first last">dynamic ligation screening</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug design</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fragment-based screening</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">histone acetyl transferase</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HEPT</td><td class="NLM_def"><p class="first last">1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IN</td><td class="NLM_def"><p class="first last">integrase</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LEDGF/p75</td><td class="NLM_def"><p class="first last">lens epithelium-derived growth factor/p75</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">ligand-lipophilicity efficiency</p></td></tr><tr><td class="NLM_term">LSD1</td><td class="NLM_def"><p class="first last">lysine-specific demethylase 1</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug-resistant</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multitarget-directed ligand</p></td></tr><tr><td class="NLM_term">NcRTI</td><td class="NLM_def"><p class="first last">nucleotide-competing reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">NNIBP</td><td class="NLM_def"><p class="first last">non-nucleoside reverse transcriptase inhibitor binding pocket</p></td></tr><tr><td class="NLM_term">NRTI</td><td class="NLM_def"><p class="first last">nucleoside reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">NNRTI</td><td class="NLM_def"><p class="first last">non-nucleoside reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">protease</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">reverse transcriptase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">SDF-1α</td><td class="NLM_def"><p class="first last">stromal-derived factor 1α</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">SVM</td><td class="NLM_def"><p class="first last">support vector machine</p></td></tr><tr><td class="NLM_term">STD</td><td class="NLM_def"><p class="first last">saturation-transfer difference</p></td></tr><tr><td class="NLM_term">TGS</td><td class="NLM_def"><p class="first last">target-guided synthesis</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 223 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Menéndez-Arias, L.</span><span> </span><span class="NLM_article-title">Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23403210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Cjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2013&pages=93-120&author=L.+Men%C3%A9ndez-Arias&title=Molecular+basis+of+human+immunodeficiency+virus+type+1+drug+resistance%3A+overview+and+recent+developments&doi=10.1016%2Fj.antiviral.2013.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments</span></div><div class="casAuthors">Menendez-Arias, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-120</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The introduction of potent combination therapies in the mid-90s had a tremendous effect on AIDS mortality.  However, drug resistance has been a major factor contributing to antiretroviral therapy failure.  Currently, there are 26 drugs approved for treating human immunodeficiency virus (HIV) infections, although some of them are no longer prescribed.  Most of the available antiretroviral drugs target HIV genome replication (i.e. reverse transcriptase inhibitors) and viral maturation (i.e. viral protease inhibitors).  Other drugs in clin. use include a viral coreceptor antagonist (maraviroc), a fusion inhibitor (enfuvirtide) and two viral integrase inhibitors (raltegravir and elvitegravir).  Elvitegravir and the nonnucleoside reverse transcriptase inhibitor rilpivirine have been the most recent addns. to the antiretroviral drug armamentarium.  An overview of the mol. mechanisms involved in antiretroviral drug resistance and the role of drug resistance-assocd. mutations was previously presented (Menendez-Arias, L., 2010. Mol. basis of human immunodeficiency virus drug resistance: an update. Antiviral Res. 85, 210-231).  This article provides now an updated review that covers currently approved drugs, new exptl. agents (e.g. neutralizing antibodies) and selected drugs in preclin. or early clin. development (e.g. exptl. integrase inhibitors).  Special attention is dedicated to recent research on resistance to reverse transcriptase and integrase inhibitors.  In addn., recently discovered interactions between HIV and host proteins and novel strategies to block HIV assembly or viral entry emerge as promising alternatives for the development of effective antiretroviral treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvrS_xWc_nfrVg90H21EOLACvtfcHk0lgATUJ5oZo_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Cjs74%253D&md5=4d2d4cecae563206aab0c7fe23d19011</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DMen%25C3%25A9ndez-Arias%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520drug%2520resistance%253A%2520overview%2520and%2520recent%2520developments%26jtitle%3DAntiviral%2520Res.%26date%3D2013%26volume%3D98%26spage%3D93%26epage%3D120%26doi%3D10.1016%2Fj.antiviral.2013.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ghosh, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chawla, S.</span><span> </span><span class="NLM_article-title">Recent advances in antiretroviral drugs</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1517/14656566.2010.509345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F14656566.2010.509345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20698725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKqurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=31-46&author=R.+K.+Ghoshauthor=S.+M.+Ghoshauthor=S.+Chawla&title=Recent+advances+in+antiretroviral+drugs&doi=10.1517%2F14656566.2010.509345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in antiretroviral drugs</span></div><div class="casAuthors">Ghosh, Raktim Kumar; Ghosh, Samhati Mondal; Chawla, Shalini</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-46</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Acquired immunodeficiency syndrome (AIDS) is one of the leading causes of death worldwide.  Although the combination therapies of highly active antiretroviral therapy (HAART) have significantly contributed to virol. suppression, improved immune function and quality of life, issues such as tolerability, drug-drug interactions and cross-resistance amongst members of a particular drug class still pose a significant barrier to long-term successful treatment.  There is a const. need for newer anti HIV drugs with increased potency and improved pharmacokinetic properties either in the existing classes or drugs from new classes that target several new steps in HIV replication cycle.  Areas covered in this review: The authors have discussed newer antiretroviral drugs belonging to second-generation nucleoside analog reverse transcriptase inhibitors (amdoxovir, elvucitabine, apricitabine, racivir), non-nucleoside analog reverse transcriptase inhibitors (etravirine, rilpivirine), protease inhibitors (darunavir, tipranavir) as well as emerging new classes, i.e., fusion inhibitors (enfuvirtide, sifuvirtide), CCR5 inhibitors (maraviroc, vicriviroc, PRO 140, PRO 542), CD4-receptor inhibitors (ibalizumab), integrase inhibitors (raltegravir, elvitegravir, GSK-1349572), maturation inhibitors (bevirimat), cobicistat (pharmacoenhancer), lens epithelium-derived growth factor inhibitors and capsid assembly inhibitors.  What the reader will gain: The reader will gain an understanding of the mechanism of action, mechanism of resistance, stages of development and important clin. trials related to the newer antiretroviral drugs and future potential of these drugs.  Take home message: The initial clin. trial data of these newer drugs are very encouraging for the long-term successful control of HIV in both treatment-naive and treatment-experienced patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-A8fskGp2WrVg90H21EOLACvtfcHk0lgATUJ5oZo_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKqurjO&md5=3bc4b28ebf919cbe449f3f94c28d7c7a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14656566.2010.509345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2010.509345%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DR.%2BK.%26aulast%3DGhosh%26aufirst%3DS.%2BM.%26aulast%3DChawla%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520antiretroviral%2520drugs%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26spage%3D31%26epage%3D46%26doi%3D10.1517%2F14656566.2010.509345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumpacker, C.</span><span> </span><span class="NLM_article-title">Eradication of HIV and cure of AIDS, now and how?</span> <span class="citation_source-journal">Front Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="refDoi"> DOI: 10.3389/fimmu.2013.00337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3389%2Ffimmu.2013.00337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24151495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2cfltlClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=337&author=J.+Zhangauthor=C.+Crumpacker&title=Eradication+of+HIV+and+cure+of+AIDS%2C+now+and+how%3F&doi=10.3389%2Ffimmu.2013.00337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Eradication of HIV and Cure of AIDS, Now and How?</span></div><div class="casAuthors">Zhang Jielin; Crumpacker Clyde</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">337</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">Recent studies have highlighted the importance of eradication of human immunodeficiency virus (HIV) and cure of acquired immunodeficiency syndrome (AIDS).  However, a pivotal point that the patient immunity controls HIV reactivation after highly active anti-retroviral therapy [HAART or combination anti-retroviral therapy (cART)] remains less well addressed.  In spite of the fact that both innate and adaptive immunities are indispensable and numerous cells participate in the anti-HIV immunity, memory CD4 T-cells are indisputably the key cells organizing all immune actions against HIV while being the targets of HIV.  Here we present a view and multidisciplinary approaches to HIV/AIDS eradication and cure.  We aim at memory CD4 T-cells, utilizing the stem cell properties of these cells to reprogram an anti-HIV memory repertoire to eliminate the viral reservoir, toward achieving an AIDS-free world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0LHjcR5VvfMkU0YCbOU3EfW6udTcc2ea_sa3q2Fbek7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfltlClsw%253D%253D&md5=d1124b8ac1a5dbc4923c0dde52a77e00</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2013.00337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2013.00337%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCrumpacker%26aufirst%3DC.%26atitle%3DEradication%2520of%2520HIV%2520and%2520cure%2520of%2520AIDS%252C%2520now%2520and%2520how%253F%26jtitle%3DFront%2520Immunol.%26date%3D2013%26volume%3D4%26spage%3D337%26doi%3D10.3389%2Ffimmu.2013.00337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Antiretroviral drugs</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1016/j.coph.2010.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.coph.2010.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20471318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygurbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=507-515&author=E.+De+Clercq&title=Antiretroviral+drugs&doi=10.1016%2Fj.coph.2010.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antiretroviral drugs</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-515</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In Oct. 2010, it will be exactly 25 years ago that the first antiretroviral drug, AZT (zidovudine, 3'-azido-2',3'-dideoxythymidine), was described.  It was the first of 25 antiretroviral drugs that in the past 25 years have been formally licensed for clin. use.  These antiretroviral drugs fall into seven categories nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FIs), co-receptor inhibitors (CRIs) and integrase inhibitors (INIs).  The INIs (i.e. raltegravir) represent the most recent advance in the search for effective and selective anti-HIV agents.  Combination of several anti-HIV drugs [often referred to as highly active antiretroviral therapy (HAART)] has drastically altered AIDS from an almost uniformly fatal disease to a chronic manageable one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCPVCVhWJFaLVg90H21EOLACvtfcHk0lgr2cydXZIWHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygurbP&md5=420f862f94677ac5d961f4462a4d4797</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DAntiretroviral%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D507%26epage%3D515%26doi%3D10.1016%2Fj.coph.2010.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS)</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1016/B978-0-12-405880-4.00009-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FB978-0-12-405880-4.00009-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23886005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=317-358&author=E.+De+Clercq&title=The+nucleoside+reverse+transcriptase+inhibitors%2C+nonnucleoside+reverse+transcriptase+inhibitors%2C+and+protease+inhibitors+in+the+treatment+of+HIV+infections+%28AIDS%29&doi=10.1016%2FB978-0-12-405880-4.00009-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS)</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">Antiviral Agents</span>),
    <span class="NLM_cas:pages">317-358</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to either of the following three classes: nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).  At present, there are 7 NRTIs, 5 NNRTIs, and 10 PIs approved for clin. use.  They are discussed from the following viewpoints: (i) chem. formulas; (ii) mechanism of action; (iii) drug combinations; (iv) clin. aspects; (v) preexposure prophylaxis; (vi) prevention of mother-to-child transmission; (vii) their use in children; (viii) toxicity; (ix) adherence (compliance); (x) resistance; (xi) new NRTIs, NNRTIs, or PIs in (pre)clin. development; and (xii) the prospects for a "cure" of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1maBDcG5yerVg90H21EOLACvtfcHk0lgr2cydXZIWHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kku7jP&md5=aff6298471b1d27934035206151f75c5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-405880-4.00009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-405880-4.00009-3%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520nucleoside%2520reverse%2520transcriptase%2520inhibitors%252C%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitors%252C%2520and%2520protease%2520inhibitors%2520in%2520the%2520treatment%2520of%2520HIV%2520infections%2520%2528AIDS%2529%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2013%26volume%3D67%26spage%3D317%26epage%3D358%26doi%3D10.1016%2FB978-0-12-405880-4.00009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Dancing with chemical formulae of antivirals: a personal account</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bcp.2013.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23876344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=711-725&author=E.+De+Clercq&title=Dancing+with+chemical+formulae+of+antivirals%3A+a+personal+account&doi=10.1016%2Fj.bcp.2013.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Dancing with chemical formulae of antivirals: A personal account</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">711-725</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A chem. structure is a joy forever, and this is how I perceived the chem. structures of a no. of antiviral compds. with which I have been personally acquainted over the past 3 decades: (1) amino acid esters of acyclovir (i.e. valaciclovir); (2) 5-substituted 2'-deoxyuridines (i.e. brivudin); (3) 2',3'-dideoxynucleoside analogs (i.e. stavudine); (4) acyclic nucleoside phosphonates (ANPs) (i.e. cidofovir, adefovir); (5) tenofovir disoproxil fumarate (TDF) and drug combinations therewith; (6) tenofovir alafenamide (TAF, GS-7340), a new phosphonoamidate prodrug of tenofovir; (7) pro-prodrugs of PMEG (i.e. GS-9191 and GS-9219); (8) new ANPs: O-DAPy and 5-aza-C phosphonates; (9) non-nucleoside reverse transcriptase inhibitors (NNRTIs): HEPT and TIBO derivs.; and (10) bicyclam derivs. (i.e. AMD3100).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPuHJzFVMivrVg90H21EOLACvtfcHk0liWnztpLPfmtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emt77I&md5=db37a140f4d8443380b6e5d378d962d5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DDancing%2520with%2520chemical%2520formulae%2520of%2520antivirals%253A%2520a%2520personal%2520account%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D711%26epage%3D725%26doi%3D10.1016%2Fj.bcp.2013.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Dancing with chemical formulae of antivirals: A panoramic view (Part 2)</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bcp.2013.09.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=1397-1410&author=E.+De+Clercq&title=Dancing+with+chemical+formulae+of+antivirals%3A+A+panoramic+view+%28Part+2%29&doi=10.1016%2Fj.bcp.2013.09.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DDancing%2520with%2520chemical%2520formulae%2520of%2520antivirals%253A%2520A%2520panoramic%2520view%2520%2528Part%25202%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D1397%26epage%3D1410%26doi%3D10.1016%2Fj.bcp.2013.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kim, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, J. C.</span><span> </span><span class="NLM_article-title">Identification of a novel type of small molecule inhibitor against HIV-1</span> <span class="citation_source-journal">BMB Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.5483/BMBRep.2015.48.2.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.5483%2FBMBRep.2015.48.2.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25413304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=121-126&author=B.+S.+Kimauthor=J.+A.+Parkauthor=M.+J.+Kimauthor=S.+H.+Kimauthor=K.+L.+Yuauthor=J.+C.+You&title=Identification+of+a+novel+type+of+small+molecule+inhibitor+against+HIV-1&doi=10.5483%2FBMBRep.2015.48.2.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel type of small molecule inhibitor against HIV-1</span></div><div class="casAuthors">Kim, Byung Soo; Park, Jung Ae; Kim, Min-Jung; Kim, Seon Hee; Yu, Kyung Lee; You, Ji Chang</div><div class="citationInfo"><span class="NLM_cas:title">BMB Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-126</span>CODEN:
                <span class="NLM_cas:coden">BRMEC2</span>;
        ISSN:<span class="NLM_cas:issn">1976-670X</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Here we report a new chem. inhibitor against HIV-1 with a novel structure and mode of action.  The inhibitor, designated as A1836, inhibited HIV-1 replication and virus prodn. with a 50% inhibitory concn. (IC50) of 2.0 μM in an MT-4 cell-based and cytopathic protection antiviral assay, while its 50% cytotoxic concn. (CC50) was much higher than 50 μM.  Examn. of the effect of A1836 on in vitro HIV-1 reverse transcriptase (RT) and integrase showed that neither were mol. targets of A1836.  The characterization and re-infection assay of the HIV-1 virions generated in the presence of A1836 showed that the synthesis of early RT products in the cells infected with the virions was inhibited dose-dependently, due in part to abnormal protein formation within the virions, thus resulting in an impaired infectivity.  These results suggest that A1836 might be a novel candidate for the development of a new type of HIV-1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Rr6_7JYh9rVg90H21EOLACvtfcHk0liWnztpLPfmtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsrzL&md5=8f1d00396d450ad95a40eaf65c7fae5c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2015.48.2.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2015.48.2.239%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DYu%26aufirst%3DK.%2BL.%26aulast%3DYou%26aufirst%3DJ.%2BC.%26atitle%3DIdentification%2520of%2520a%2520novel%2520type%2520of%2520small%2520molecule%2520inhibitor%2520against%2520HIV-1%26jtitle%3DBMB%2520Rep.%26date%3D2015%26volume%3D48%26spage%3D121%26epage%3D126%26doi%3D10.5483%2FBMBRep.2015.48.2.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kim, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cechetto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boese, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenistein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brondani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, P.</span><span> </span><span class="NLM_article-title">Identification of a novel sulfonamide non-nucleoside reverse transcriptase inhibitor by a phenotypic HIV-1 full replication assay</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68767</span><span class="refDoi"> DOI: 10.1371/journal.pone.0068767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0068767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68767&author=T.+H.+Kimauthor=Y.+Koauthor=T.+Christopheauthor=J.+Cechettoauthor=J.+Kimauthor=K.+A.+Kimauthor=A.+S.+Boeseauthor=J.+M.+Garciaauthor=D.+Fenisteinauthor=M.+K.+Juauthor=J.+Kimauthor=S.+J.+Hanauthor=H.+J.+Kwonauthor=V.+Brondaniauthor=P.+Sommer&title=Identification+of+a+novel+sulfonamide+non-nucleoside+reverse+transcriptase+inhibitor+by+a+phenotypic+HIV-1+full+replication+assay&doi=10.1371%2Fjournal.pone.0068767"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068767%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.%2BH.%26aulast%3DKo%26aufirst%3DY.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DCechetto%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%2BA.%26aulast%3DBoese%26aufirst%3DA.%2BS.%26aulast%3DGarcia%26aufirst%3DJ.%2BM.%26aulast%3DFenistein%26aufirst%3DD.%26aulast%3DJu%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%2BJ.%26aulast%3DKwon%26aufirst%3DH.%2BJ.%26aulast%3DBrondani%26aufirst%3DV.%26aulast%3DSommer%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520a%2520novel%2520sulfonamide%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitor%2520by%2520a%2520phenotypic%2520HIV-1%2520full%2520replication%2520assay%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68767%26doi%3D10.1371%2Fjournal.pone.0068767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span> </span><span class="NLM_article-title">Combining biophysical screening and X-ray crystallography for fragment-based drug discovery</span> <span class="citation_source-journal">Top. Curr. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1007/128_2011_225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2F128_2011_225" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=115-143&author=M.+Hennigauthor=A.+Rufauthor=W.+Huber&title=Combining+biophysical+screening+and+X-ray+crystallography+for+fragment-based+drug+discovery&doi=10.1007%2F128_2011_225"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F128_2011_225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2011_225%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DHuber%26aufirst%3DW.%26atitle%3DCombining%2520biophysical%2520screening%2520and%2520X-ray%2520crystallography%2520for%2520fragment-based%2520drug%2520discovery%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2011%26volume%3D317%26spage%3D115%26epage%3D143%26doi%3D10.1007%2F128_2011_225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Scott, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abell, C.</span><span> </span><span class="NLM_article-title">Fragment-based approaches in drug discovery and chemical biology</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4990</span><span class="NLM_x">–</span> <span class="NLM_lpage">5003</span><span class="refDoi"> DOI: 10.1021/bi3005126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3005126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4990-5003&author=D.+E.+Scottauthor=A.+G.+Coyneauthor=S.+A.+Hudsonauthor=C.+Abell&title=Fragment-based+approaches+in+drug+discovery+and+chemical+biology&doi=10.1021%2Fbi3005126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Scott, Duncan E.; Coyne, Anthony G.; Hudson, Sean A.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4990-5003</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based approaches to finding novel small mols. that bind to proteins are now firmly established in drug discovery and chem. biol.  Initially developed primarily in a few centers in the biotech and pharma industry, this methodol. has now been adopted widely in both the pharmaceutical industry and academia.  After the initial success with kinase targets, the versatility of this approach has now expanded to a broad range of different protein classes.  Herein we describe recent fragment-based approaches to a wide range of target types, including Hsp90, β-secretase, and allosteric sites in human immunodeficiency virus protease and fanesyl pyrophosphate synthase.  The role of fragment-based approaches in an academic research environment is also examd. with an emphasis on neglected diseases such as tuberculosis.  The development of a fragment library, the fragment screening process, and the subsequent fragment hit elaboration will be discussed using examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2ry6mWC83bVg90H21EOLACvtfcHk0ljMaciy8AbNgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D&md5=39a6f0f741e711fd572e24c95142f55d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi3005126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3005126%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DHudson%26aufirst%3DS.%2BA.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-based%2520approaches%2520in%2520drug%2520discovery%2520and%2520chemical%2520biology%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D4990%26epage%3D5003%26doi%3D10.1021%2Fbi3005126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Krimm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praly, J. P.</span><span> </span><span class="NLM_article-title">Binding evaluation of fragment-based scaffolds for probing allosteric enzymes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1287</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span><span class="refDoi"> DOI: 10.1021/jm201439b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201439b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1287-1295&author=I.+Krimmauthor=J.+M.+Lancelinauthor=J.+P.+Praly&title=Binding+evaluation+of+fragment-based+scaffolds+for+probing+allosteric+enzymes&doi=10.1021%2Fjm201439b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm201439b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201439b%26sid%3Dliteratum%253Aachs%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DLancelin%26aufirst%3DJ.%2BM.%26aulast%3DPraly%26aufirst%3DJ.%2BP.%26atitle%3DBinding%2520evaluation%2520of%2520fragment-based%2520scaffolds%2520for%2520probing%2520allosteric%2520enzymes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1287%26epage%3D1295%26doi%3D10.1021%2Fjm201439b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baksh, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Happer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perryman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torbett, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Small molecule regulation of protein conformation by binding in the Flap of HIV protease</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span><span class="refDoi"> DOI: 10.1021/cb300611p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300611p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1223-1231&author=T.+Tiefenbrunnauthor=S.+Forliauthor=M.+M.+Bakshauthor=M.+W.+Changauthor=M.+Happerauthor=Y.+C.+Linauthor=A.+L.+Perrymanauthor=J.+K.+Rheeauthor=B.+E.+Torbettauthor=A.+J.+Olsonauthor=J.+H.+Elderauthor=M.+G.+Finnauthor=C.+D.+Stout&title=Small+molecule+regulation+of+protein+conformation+by+binding+in+the+Flap+of+HIV+protease&doi=10.1021%2Fcb300611p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcb300611p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300611p%26sid%3Dliteratum%253Aachs%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DBaksh%26aufirst%3DM.%2BM.%26aulast%3DChang%26aufirst%3DM.%2BW.%26aulast%3DHapper%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DPerryman%26aufirst%3DA.%2BL.%26aulast%3DRhee%26aufirst%3DJ.%2BK.%26aulast%3DTorbett%26aufirst%3DB.%2BE.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DSmall%2520molecule%2520regulation%2520of%2520protein%2520conformation%2520by%2520binding%2520in%2520the%2520Flap%2520of%2520HIV%2520protease%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1223%26epage%3D1231%26doi%3D10.1021%2Fcb300611p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Happer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Crystallographic fragment-based drug discovery: use of a brominated fragment library targeting HIV protease</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1111/cbdd.12227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fcbdd.12227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23998903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=141-148&author=T.+Tiefenbrunnauthor=S.+Forliauthor=M.+Happerauthor=A.+Gonzalezauthor=Y.+Tsaiauthor=M.+Soltisauthor=J.+H.+Elderauthor=A.+J.+Olsonauthor=C.+D.+Stout&title=Crystallographic+fragment-based+drug+discovery%3A+use+of+a+brominated+fragment+library+targeting+HIV+protease&doi=10.1111%2Fcbdd.12227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease</span></div><div class="casAuthors">Tiefenbrunn, Theresa; Forli, Stefano; Happer, Meaghan; Gonzalez, Ana; Tsai, Yingssu; Soltis, Michael; Elder, John H.; Olson, Arthur J.; Stout, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A library of 68 brominated fragments was screened against a new crystal form of inhibited HIV-1 protease in order to probe surface sites in soaking expts.  Often, fragments are weak binders with partial occupancy, resulting in weak, difficult-to-fit electron d.  The use of a brominated fragment library addresses this challenge, as bromine can be located unequivocally via anomalous scattering.  Data collection was carried out in an automated fashion using AutoDrug at SSRL.  Novel hits were identified in the known surface sites: 3-bromo-2,6-dimethoxybenzoic acid (Br6) in the flap site and 1-bromo-2-naphthoic acid (Br27) in the exosite, expanding the chem. of known fragments for development of higher affinity potential allosteric inhibitors.  At the same time, mapping the binding sites of a no. of weaker binding Br-fragments provides further insight into the nature of these surface pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhTrhnhMsliLVg90H21EOLACvtfcHk0lhwH20Xg1-How"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFymsg%253D%253D&md5=1fc5fec8c0511d4b288795ccc407cf3e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12227%26sid%3Dliteratum%253Aachs%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHapper%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DTsai%26aufirst%3DY.%26aulast%3DSoltis%26aufirst%3DM.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DCrystallographic%2520fragment-based%2520drug%2520discovery%253A%2520use%2520of%2520a%2520brominated%2520fragment%2520library%2520targeting%2520HIV%2520protease%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D83%26spage%3D141%26epage%3D148%26doi%3D10.1111%2Fcbdd.12227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Deng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perryman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span> </span><span class="NLM_article-title">Distinguishing Binders from false positives by free energy calculations: fragment screening against the flap site of HIV protease</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1021/jp506376z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp506376z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVykur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2015&pages=976-988&author=N.+Dengauthor=S.+Forliauthor=P.+Heauthor=A.+Perrymanauthor=L.+Wickstromauthor=R.+S.+Vijayanauthor=T.+Tiefenbrunnauthor=D.+Stoutauthor=E.+Gallicchioauthor=A.+J.+Olsonauthor=R.+M.+Levy&title=Distinguishing+Binders+from+false+positives+by+free+energy+calculations%3A+fragment+screening+against+the+flap+site+of+HIV+protease&doi=10.1021%2Fjp506376z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease</span></div><div class="casAuthors">Deng, Nanjie; Forli, Stefano; He, Peng; Perryman, Alex; Wickstrom, Lauren; Vijayan, R. S. K.; Tiefenbrunn, Theresa; Stout, David; Gallicchio, Emilio; Olson, Arthur J.; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">976-988</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. docking is a powerful tool used in drug discovery and structural biol. for predicting the structures of ligand-receptor complexes.  However, the accuracy of docking calcns. can be limited by factors such as the neglect of protein reorganization in the scoring function; as a result, ligand screening can produce a high rate of false pos. hits.  Although abs. binding free energy methods still have difficulty in accurately rank-ordering binders, we believe that they can be fruitfully employed to distinguish binders from nonbinders and reduce the false pos. rate.  Here we study a set of ligands that dock favorably to a newly discovered, potentially allosteric site on the flap of HIV-1 protease.  Fragment binding to this site stabilizes a closed form of protease, which could be exploited for the design of allosteric inhibitors.  Twenty-three top-ranked protein-ligand complexes from AutoDock were subject to the free energy screening using two methods, the recently developed binding energy anal. method (BEDAM) and the std. double decoupling method (DDM).  Free energy calcns. correctly identified most of the false positives (≥83%) and recovered all the confirmed binders.  The results show a gap averaging ≥3.7 kcal/mol, sepg. the binders and the false positives.  We present a formula that breaks the binding free energy down into contributions from the receptor conformational macrostates, which provides insights into the roles of different binding modes.  Our binding free energy component anal. further suggests that improving the treatment for the desolvation penalty assocd. with the unfulfilled polar groups could reduce the rate of false pos. hits in docking.  The current study demonstrates that the combination of docking with free energy methods can be very useful for more accurate ligand screening against valuable drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRSRY59SZJ8LVg90H21EOLACvtfcHk0lhwH20Xg1-How"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVykur3L&md5=f359ec844a65149cb1aba2451d46ddeb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjp506376z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp506376z%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DPerryman%26aufirst%3DA.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DVijayan%26aufirst%3DR.%2BS.%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DStout%26aufirst%3DD.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DDistinguishing%2520Binders%2520from%2520false%2520positives%2520by%2520free%2520energy%2520calculations%253A%2520fragment%2520screening%2520against%2520the%2520flap%2520site%2520of%2520HIV%2520protease%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2015%26volume%3D119%26spage%3D976%26epage%3D988%26doi%3D10.1021%2Fjp506376z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kunze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todoroff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geppert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreuder, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baringhaus, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, G.</span><span> </span><span class="NLM_article-title">Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span><span class="refDoi"> DOI: 10.1021/ci400712h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400712h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisV2gsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=987-991&author=J.+Kunzeauthor=N.+Todoroffauthor=P.+Schneiderauthor=T.+Rodriguesauthor=T.+Geppertauthor=F.+Reisenauthor=H.+Schreuderauthor=J.+Saasauthor=G.+Hesslerauthor=K.+H.+Baringhausauthor=G.+Schneider&title=Targeting+dynamic+pockets+of+HIV-1+protease+by+structure-based+computational+screening+for+allosteric+inhibitors&doi=10.1021%2Fci400712h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Dynamic Pockets of HIV-1 Protease by Structure-Based Computational Screening for Allosteric Inhibitors</span></div><div class="casAuthors">Kunze, Jens; Todoroff, Nickolay; Schneider, Petra; Rodrigues, Tiago; Geppert, Tim; Reisen, Felix; Schreuder, Herman; Saas, Joachim; Hessler, Gerhard; Baringhaus, Karl-Heinz; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">987-991</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present the discovery of low mol. wt. inhibitors of human immunodeficiency virus 1 (HIV-1) protease subtype B that were identified by structure-based virtual screening as ligands of an allosteric surface cavity.  For pocket identification and prioritization, we performed a mol. dynamics simulation and obsd. several flexible, partially transient surface cavities.  For one of these presumable ligand-binding pockets that are located in the so-called "hinge region" of the identical protease chains, we computed a receptor-derived pharmacophore model, with which we retrieved fragment-like inhibitors from a screening compd. pool.  The most potent hit inhibited protease activity in vitro in a noncompetitive mode of action.  Although attempts failed to crystallize this ligand bound to the enzyme, the study provides proof-of-concept for identifying innovative tool compds. for chem. biol. by addressing flexible protein models with receptor pocket-derived pharmacophore screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUMUEo8-6gbVg90H21EOLACvtfcHk0lj2dKdRFm__2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisV2gsbk%253D&md5=6239b51f01499776c9a6ef60d82b6648</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fci400712h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400712h%26sid%3Dliteratum%253Aachs%26aulast%3DKunze%26aufirst%3DJ.%26aulast%3DTodoroff%26aufirst%3DN.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DGeppert%26aufirst%3DT.%26aulast%3DReisen%26aufirst%3DF.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DSaas%26aufirst%3DJ.%26aulast%3DHessler%26aufirst%3DG.%26aulast%3DBaringhaus%26aufirst%3DK.%2BH.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DTargeting%2520dynamic%2520pockets%2520of%2520HIV-1%2520protease%2520by%2520structure-based%2520computational%2520screening%2520for%2520allosteric%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D987%26epage%3D991%26doi%3D10.1021%2Fci400712h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Dimova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikamp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3345</span><span class="refDoi"> DOI: 10.1021/jm400147j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400147j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFSqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3339-3345&author=D.+Dimovaauthor=K.+Heikampauthor=D.+Stumpfeauthor=J.+Bajorath&title=Do+medicinal+chemists+learn+from+activity+cliffs%3F+A+systematic+evaluation+of+cliff+progression+in+evolving+compound+data+sets&doi=10.1021%2Fjm400147j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Do Medicinal Chemists Learn from Activity Cliffs? A Systematic Evaluation of Cliff Progression in Evolving Compound Data Sets</span></div><div class="casAuthors">Dimova, Dilyana; Heikamp, Kathrin; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3339-3345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity cliffs are defined as pairs of structurally similar compds. with a significant difference in potency.  These compd. pairs have high SAR information content because they represent small structural changes leading to large potency alterations.  Accordingly, activity cliffs are of prime interest for SAR exploration and compd. optimization.  It is currently unknown to what extent activity cliff information is utilized in practical medicinal chem.  Therefore, we have assembled 56 compd. data sets that evolved over time and searched for analogs of activity cliff-forming compds. with further increased potency.  For ∼75% of all activity cliffs, there was no evidence for further chem. exploration.  For ∼25% of all cliffs, potency progression was detected.  In total, for ∼15% of all activity cliffs, pos. cliff progression was obsd. that often involved multiple analogs.  Given these findings, chem. unexplored activity cliffs should provide significant opportunities for further study in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhIU8CUIW4FLVg90H21EOLACvtfcHk0lj2dKdRFm__2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFSqtLs%253D&md5=78fa4942501fdddc6f77db79fbfdfcac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm400147j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400147j%26sid%3Dliteratum%253Aachs%26aulast%3DDimova%26aufirst%3DD.%26aulast%3DHeikamp%26aufirst%3DK.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DDo%2520medicinal%2520chemists%2520learn%2520from%2520activity%2520cliffs%253F%2520A%2520systematic%2520evaluation%2520of%2520cliff%2520progression%2520in%2520evolving%2520compound%2520data%2520sets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3339%26epage%3D3345%26doi%3D10.1021%2Fjm400147j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dimova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Activity cliff clusters as a source of structure-activity relationship information</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1517/17460441.2015.1019861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2015.1019861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=441-447&author=D.+Dimovaauthor=D.+Stumpfeauthor=Y.+Huauthor=J.+Bajorath&title=Activity+cliff+clusters+as+a+source+of+structure-activity+relationship+information&doi=10.1517%2F17460441.2015.1019861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1019861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1019861%26sid%3Dliteratum%253Aachs%26aulast%3DDimova%26aufirst%3DD.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DActivity%2520cliff%2520clusters%2520as%2520a%2520source%2520of%2520structure-activity%2520relationship%2520information%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D441%26epage%3D447%26doi%3D10.1517%2F17460441.2015.1019861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Geitmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elinder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Identification of a novel scaffold for allosteric inhibition of wild type and drug resistant HIV-1 reverse transcriptase by fragment library screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span><span class="refDoi"> DOI: 10.1021/jm1010513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1010513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=699-708&author=M.+Geitmannauthor=M.+Elinderauthor=C.+Seegerauthor=P.+Brandtauthor=I.+J.+de+Eschauthor=U.+H.+Danielson&title=Identification+of+a+novel+scaffold+for+allosteric+inhibition+of+wild+type+and+drug+resistant+HIV-1+reverse+transcriptase+by+fragment+library+screening&doi=10.1021%2Fjm1010513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm1010513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010513%26sid%3Dliteratum%253Aachs%26aulast%3DGeitmann%26aufirst%3DM.%26aulast%3DElinder%26aufirst%3DM.%26aulast%3DSeeger%26aufirst%3DC.%26aulast%3DBrandt%26aufirst%3DP.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DIdentification%2520of%2520a%2520novel%2520scaffold%2520for%2520allosteric%2520inhibition%2520of%2520wild%2520type%2520and%2520drug%2520resistant%2520HIV-1%2520reverse%2520transcriptase%2520by%2520fragment%2520library%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D699%26epage%3D708%26doi%3D10.1021%2Fjm1010513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Fragment screening and HIV therapeutics</span> <span class="citation_source-journal">Top. Curr. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1007/128_2011_232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2F128_2011_232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=181-200&author=J.+D.+Baumanauthor=D.+Patelauthor=E.+Arnold&title=Fragment+screening+and+HIV+therapeutics&doi=10.1007%2F128_2011_232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1007%2F128_2011_232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2011_232%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DFragment%2520screening%2520and%2520HIV%2520therapeutics%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2011%26volume%3D317%26spage%3D181%26epage%3D200%26doi%3D10.1007%2F128_2011_232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromer, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shatkin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2738</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span><span class="refDoi"> DOI: 10.1021/jm301271j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301271j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2738-2746&author=J.+D.+Baumanauthor=D.+Patelauthor=C.+Dhariaauthor=M.+W.+Fromerauthor=S.+Ahmedauthor=Y.+Frenkelauthor=R.+S.+Vijayanauthor=J.+T.+Eckauthor=W.+C.+Hoauthor=K.+Dasauthor=A.+J.+Shatkinauthor=E.+Arnold&title=Detecting+allosteric+sites+of+HIV-1+reverse+transcriptase+by+X-ray+crystallographic+fragment+screening&doi=10.1021%2Fjm301271j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening</span></div><div class="casAuthors">Bauman, Joseph D.; Patel, Disha; Dharia, Chhaya; Fromer, Marc W.; Ahmed, Sameer; Frenkel, Yulia; Vijayan, R. S. K.; Eck, J. Thomas; Ho, William C.; Das, Kalyan; Shatkin, Aaron J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2738-2746</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV-1 reverse transcriptase (RT) undergoes a series of conformational changes during viral replication and is a central target for antiretroviral therapy.  The intrinsic flexibility of RT can provide novel allosteric sites for inhibition.  Crystals of RT that diffract X-rays to better than 2 Å resoln. facilitated the probing of RT for new druggable sites using fragment screening by X-ray crystallog.  A total of 775 fragments were grouped into 143 cocktails, which were soaked into crystals of RT in complex with the non-nucleoside drug rilpivirine (TMC278).  Seven new sites were discovered, including the Incoming Nucleotide Binding, Knuckles, NNRTI Adjacent, and 399 sites, located in the polymerase region of RT, and the 428, RNase H Primer Grip Adjacent, and 507 sites, located in the RNase H region.  Three of these sites (Knuckles, NNRTI Adjacent, and Incoming Nucleotide Binding) are inhibitory and provide opportunities for discovery of new anti-AIDS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXzUWRf_7PLVg90H21EOLACvtfcHk0lhVpfjy_DBtbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrs%253D&md5=73cbd7d266cea42eac4b1cd9a06d0279</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm301271j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301271j%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DDharia%26aufirst%3DC.%26aulast%3DFromer%26aufirst%3DM.%2BW.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DFrenkel%26aufirst%3DY.%26aulast%3DVijayan%26aufirst%3DR.%2BS.%26aulast%3DEck%26aufirst%3DJ.%2BT.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DShatkin%26aufirst%3DA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DDetecting%2520allosteric%2520sites%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520X-ray%2520crystallographic%2520fragment%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2738%26epage%3D2746%26doi%3D10.1021%2Fjm301271j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">La, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinetti, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyssen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluis-Cremer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachedjian, G.</span><span> </span><span class="NLM_article-title">Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">6979</span><span class="NLM_x">–</span> <span class="NLM_lpage">6984</span><span class="refDoi"> DOI: 10.1073/pnas.1423900112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1423900112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26038551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVKrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=6979-6984&author=J.+Laauthor=C.+F.+Lathamauthor=R.+N.+Tinettiauthor=A.+Johnsonauthor=D.+Tyssenauthor=K.+D.+Huberauthor=N.+Sluis-Cremerauthor=J.+S.+Simpsonauthor=S.+J.+Headeyauthor=D.+K.+Chalmersauthor=G.+Tachedjian&title=Identification+of+mechanistically+distinct+inhibitors+of+HIV-1+reverse+transcriptase+through+fragment+screening&doi=10.1073%2Fpnas.1423900112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening</span></div><div class="casAuthors">La, Jennifer; Latham, Catherine F.; Tinetti, Ricky N.; Johnson, Adam; Tyssen, David; Huber, Kelly D.; Sluis-Cremer, Nicolas; Simpson, Jamie S.; Headey, Stephen J.; Chalmers, David K.; Tachedjian, Gilda</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6979-6984</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fragment-based screening methods can be used to discover novel active site or allosteric inhibitors for therapeutic intervention.  Using satn. transfer difference (STD) NMR and in vitro activity assays, we have identified fragment-sized inhibitors of HIV-1 reverse transcriptase (RT) with distinct chem. scaffolds and mechanisms compared to nonnucleoside RT inhibitors (NNRTIs) and nucleoside/nucleotide RT inhibitors (NRTIs).  Three compds. were found to inhibit RNA- and DNA-dependent DNA polymerase activity of HIV-1 RT in the micromolar range while retaining potency against RT variants carrying one of three major NNRTI resistance mutations: K103N, Y181C, or G190A.  These compds. also inhibit Moloney murine leukemia virus RT but not the Klenow fragment of Escherichia coli DNA polymerase I.  Steady-state kinetic analyses demonstrate that one of these fragments is a competitive inhibitor of HIV-1 RT with respect to deoxyribonucleoside triphosphate (dNTP) substrate, whereas a second compd. is a competitive inhibitor of RT polymerase activity with respect to the DNA template/primer (T/P), and consequently also inhibits RNase H activity.  The dNTP competing RT inhibitor retains activity against the NRTI-resistant mutants K65R and M184V, demonstrating a drug resistance profile distinct from the nucleotide competing RT inhibitors indolopyridone-1 (INDOPY-1) and 4-dimethylamino-6-vinylpyrimidine-1 (DAVP-1).  In antiviral assays, the T/P competing compd. inhibits HIV-1 replication at a step consistent with an RT inhibitor.  Screening of addnl. structurally related compds. to the three fragments led to the discovery of mols. with improved potency against HIV-1 RT.  These fragment inhibitors represent previously unidentified scaffolds for development of novel drugs for HIV-1 prevention or treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L7MqNPmod7Vg90H21EOLACvtfcHk0lhVpfjy_DBtbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVKrtb8%253D&md5=302b6938dde7584167248eec03d3d7b6</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1423900112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1423900112%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DJ.%26aulast%3DLatham%26aufirst%3DC.%2BF.%26aulast%3DTinetti%26aufirst%3DR.%2BN.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DTyssen%26aufirst%3DD.%26aulast%3DHuber%26aufirst%3DK.%2BD.%26aulast%3DSluis-Cremer%26aufirst%3DN.%26aulast%3DSimpson%26aufirst%3DJ.%2BS.%26aulast%3DHeadey%26aufirst%3DS.%2BJ.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DTachedjian%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520mechanistically%2520distinct%2520inhibitors%2520of%2520HIV-1%2520reverse%2520transcriptase%2520through%2520fragment%2520screening%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D6979%26epage%3D6984%26doi%3D10.1073%2Fpnas.1423900112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wielens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlon, M. J.</span><span> </span><span class="NLM_article-title">Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1002/cmdc.201000483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.201000483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=258-261&author=J.+Wielensauthor=S.+J.+Headeyauthor=J.+J.+Deadmanauthor=D.+I.+Rhodesauthor=G.+T.+Leauthor=M.+W.+Parkerauthor=D.+K.+Chalmersauthor=M.+J.+Scanlon&title=Fragment-based+design+of+ligands+targeting+a+novel+site+on+the+integrase+enzyme+of+human+immunodeficiency+virus+1&doi=10.1002%2Fcmdc.201000483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000483%26sid%3Dliteratum%253Aachs%26aulast%3DWielens%26aufirst%3DJ.%26aulast%3DHeadey%26aufirst%3DS.%2BJ.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26atitle%3DFragment-based%2520design%2520of%2520ligands%2520targeting%2520a%2520novel%2520site%2520on%2520the%2520integrase%2520enzyme%2520of%2520human%2520immunodeficiency%2520virus%25201%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D258%26epage%3D261%26doi%3D10.1002%2Fcmdc.201000483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandegraaff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeevarajah, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winfield, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thienthong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</span> <span class="citation_source-journal">Antivir. Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.3851/IMP1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3851%2FIMP1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21602613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2mtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=155-168&author=D.+I.+Rhodesauthor=T.+S.+Peatauthor=N.+Vandegraaffauthor=D.+Jeevarajahauthor=G.+Leauthor=E.+D.+Jonesauthor=J.+A.+Smithauthor=J.+A.+Coatesauthor=L.+J.+Winfieldauthor=N.+Thienthongauthor=J.+Newmanauthor=D.+Lucentauthor=J.+H.+Ryanauthor=G.+P.+Savageauthor=C.+L.+Francisauthor=J.+J.+Deadman&title=Structural+basis+for+a+new+mechanism+of+inhibition+of+HIV-1+integrase+identified+by+fragment+screening+and+structure-based+design&doi=10.3851%2FIMP1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</span></div><div class="casAuthors">Rhodes, David I.; Peat, Thomas S.; Vandegraaff, Nick; Jeevarajah, Dharshini; Le, Giang; Jones, Eric D.; Smith, Jessica A.; Coates, Jonathan A. V.; Winfield, Lisa J.; Thienthong, Neeranat; Newman, Janet; Lucent, Del; Ryan, John H.; Savage, G. Paul; Francis, Craig L.; Deadman, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    
            (<span class="NLM_cas:orgname">International Medical Press, Ltd.</span>)
        </div><div class="casAbstract">Background: HIV-1 integrase is a clin. validated therapeutic target for the treatment of HIV-1 infection, with one approved therapeutic currently on the market.  This enzyme represents an attractive target for the development of new inhibitors to HIV-1 that are effective against the current resistance mutations.  Methods: A fragment-based screening method employing surface plasmon resonance and NMR was initially used to detect interactions between integrase and fragments.  The binding sites of the fragments were elucidated by crystallog. and the structural information used to design and synthesize improved ligands.  Results: The location of binding of fragments to the catalytic core of integrase was found to be in a previously undescribed binding site, adjacent to the mobile loop.  Enzyme assays confirmed that formation of enzyme-fragment complexes inhibits the catalytic activity of integrase and the structural data was utilized to further develop these fragments into more potent novel enzyme inhibitors.  Conclusions: The authors have defined a new site in integrase as a valid region for the structure-based design of allosteric integrase inhibitors.  Using a structure-based design process the authors have improved the activity of the initial fragments 45-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIC4puV2Mqt7Vg90H21EOLACvtfcHk0ljhEJUD4EnmCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2mtLc%253D&md5=236dfc80ddb1930185f1c5ede9d1b66d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3851%2FIMP1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP1716%26sid%3Dliteratum%253Aachs%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DVandegraaff%26aufirst%3DN.%26aulast%3DJeevarajah%26aufirst%3DD.%26aulast%3DLe%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DE.%2BD.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DCoates%26aufirst%3DJ.%2BA.%26aulast%3DWinfield%26aufirst%3DL.%2BJ.%26aulast%3DThienthong%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DLucent%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DJ.%2BH.%26aulast%3DSavage%26aufirst%3DG.%2BP.%26aulast%3DFrancis%26aufirst%3DC.%2BL.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520a%2520new%2520mechanism%2520of%2520inhibition%2520of%2520HIV-1%2520integrase%2520identified%2520by%2520fragment%2520screening%2520and%2520structure-based%2520design%26jtitle%3DAntivir.%2520Chem.%2520Chemother.%26date%3D2011%26volume%3D21%26spage%3D155%26epage%3D168%26doi%3D10.3851%2FIMP1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Peat, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandegraaff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thienthong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of the LEDGF site of human immunodeficiency virus integrase identified by fragment screening and structure based design</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e40147</span><span class="refDoi"> DOI: 10.1371/journal.pone.0040147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0040147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e40147&author=T.+S.+Peatauthor=D.+I.+Rhodesauthor=N.+Vandegraaffauthor=G.+Leauthor=J.+A.+Smithauthor=L.+J.+Clarkauthor=E.+D.+Jonesauthor=J.+A.+Coatesauthor=N.+Thienthongauthor=J.+Newmanauthor=O.+Dolezalauthor=R.+Mulderauthor=J.+H.+Ryanauthor=G.+P.+Savageauthor=C.+L.+Francisauthor=J.+J.+Deadman&title=Small+molecule+inhibitors+of+the+LEDGF+site+of+human+immunodeficiency+virus+integrase+identified+by+fragment+screening+and+structure+based+design&doi=10.1371%2Fjournal.pone.0040147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0040147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0040147%26sid%3Dliteratum%253Aachs%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DVandegraaff%26aufirst%3DN.%26aulast%3DLe%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DClark%26aufirst%3DL.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BD.%26aulast%3DCoates%26aufirst%3DJ.%2BA.%26aulast%3DThienthong%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DO.%26aulast%3DMulder%26aufirst%3DR.%26aulast%3DRyan%26aufirst%3DJ.%2BH.%26aulast%3DSavage%26aufirst%3DG.%2BP.%26aulast%3DFrancis%26aufirst%3DC.%2BL.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520the%2520LEDGF%2520site%2520of%2520human%2520immunodeficiency%2520virus%2520integrase%2520identified%2520by%2520fragment%2520screening%2520and%2520structure%2520based%2520design%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De40147%26doi%3D10.1371%2Fjournal.pone.0040147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gochin, M.</span><span> </span><span class="NLM_article-title">Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5114</span><span class="NLM_x">–</span> <span class="NLM_lpage">5118</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2013.07.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5114-5118&author=S.+Chuauthor=M.+Gochin&title=Identification+of+fragments+targeting+an+alternative+pocket+on+HIV-1+gp41+by+NMR+screening+and+similarity+searching&doi=10.1016%2Fj.bmcl.2013.07.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DS.%26aulast%3DGochin%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520fragments%2520targeting%2520an%2520alternative%2520pocket%2520on%2520HIV-1%2520gp41%2520by%2520NMR%2520screening%2520and%2520similarity%2520searching%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5114%26epage%3D5118%26doi%3D10.1016%2Fj.bmcl.2013.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Towards novel therapeutics for HIV through fragment-based screening and drug design</span> <span class="citation_source-journal">Prog. Biophys. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.pbiomolbio.2014.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.pbiomolbio.2014.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25455312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSlsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2014&pages=124-140&author=T.+Tiefenbrunnauthor=C.+D.+Stout&title=Towards+novel+therapeutics+for+HIV+through+fragment-based+screening+and+drug+design&doi=10.1016%2Fj.pbiomolbio.2014.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Towards novel therapeutics for HIV through fragment-based screening and drug design</span></div><div class="casAuthors">Tiefenbrunn, Theresa; Stout, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">124-140</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fragment-based drug discovery has been applied with varying levels of success to a no. of proteins involved in the HIV (Human Immunodeficiency Virus) life cycle.  Fragment-based approaches have led to the discovery of novel binding sites within protease, reverse transcriptase, integrase, and gp41.  Novel compds. that bind to known pockets within CCR5 have also been identified via fragment screening, and a fragment-based approach to target the TAR-Tat interaction was explored.  In the context of HIV-1 reverse transcriptase (RT), fragment-based approaches have yielded fragment hits with mid-μM activity in an in vitro activity assay, as well as fragment hits that are active against drug-resistant variants of RT.  Fragment-based drug discovery is a powerful method to elucidate novel binding sites within proteins, and the method has had significant success in the context of HIV proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHcrmdqaWPFrVg90H21EOLACvtfcHk0lgl86fCxv7OUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSlsr7L&md5=464daa30e33cf3ce924069e998aa1cd4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2014.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2014.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DTowards%2520novel%2520therapeutics%2520for%2520HIV%2520through%2520fragment-based%2520screening%2520and%2520drug%2520design%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D116%26spage%3D124%26epage%3D140%26doi%3D10.1016%2Fj.pbiomolbio.2014.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wielens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlon, M. J.</span><span> </span><span class="NLM_article-title">Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1177/1087057112465979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1177%2F1087057112465979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23139382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC3s7itFGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=147-159&author=J.+Wielensauthor=S.+J.+Headeyauthor=D.+I.+Rhodesauthor=R.+J.+Mulderauthor=O.+Dolezalauthor=J.+J.+Deadmanauthor=J.+Newmanauthor=D.+K.+Chalmersauthor=M.+W.+Parkerauthor=T.+S.+Peatauthor=M.+J.+Scanlon&title=Parallel+screening+of+low+molecular+weight+fragment+libraries%3A+do+differences+in+methodology+affect+hit+identification%3F&doi=10.1177%2F1087057112465979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</span></div><div class="casAuthors">Wielens Jerome; Headey Stephen J; Rhodes David I; Mulder Roger J; Dolezal Olan; Deadman John J; Newman Janet; Chalmers David K; Parker Michael W; Peat Thomas S; Scanlon Martin J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fragment screening is becoming widely accepted as a technique to identify hit compounds for the development of novel lead compounds.  In neighboring laboratories, we have recently, and independently, performed a fragment screening campaign on the HIV-1 integrase core domain (IN) using similar commercially purchased fragment libraries.  The two campaigns used different screening methods for the preliminary identification of fragment hits; one used saturation transfer difference nuclear magnetic resonance spectroscopy (STD-NMR), and the other used surface plasmon resonance (SPR) spectroscopy.  Both initial screens were followed by X-ray crystallography.  Using the STD-NMR/X-ray approach, 15 IN/fragment complexes were identified, whereas the SPR/X-ray approach found 6 complexes.  In this article, we compare the approaches that were taken by each group and the results obtained, and we look at what factors could potentially influence the final results.  We find that despite using different approaches with little overlap of initial hits, both approaches identified binding sites on IN that provided a basis for fragment-based lead discovery and further lead development.  Comparison of hits identified in the two studies highlights a key role for both the conditions under which fragment binding is measured and the criteria selected to classify hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaYsG71Pu6x669lAbTj9rGfW6udTcc2eYumyaKQtbpK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7itFGluw%253D%253D&md5=9061e308aecbffc35d50a29b5b682283</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F1087057112465979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112465979%26sid%3Dliteratum%253Aachs%26aulast%3DWielens%26aufirst%3DJ.%26aulast%3DHeadey%26aufirst%3DS.%2BJ.%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DMulder%26aufirst%3DR.%2BJ.%26aulast%3DDolezal%26aufirst%3DO.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26atitle%3DParallel%2520screening%2520of%2520low%2520molecular%2520weight%2520fragment%2520libraries%253A%2520do%2520differences%2520in%2520methodology%2520affect%2520hit%2520identification%253F%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2013%26volume%3D18%26spage%3D147%26epage%3D159%26doi%3D10.1177%2F1087057112465979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">A “rule of three” for fragment-based lead discovery?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%E2%80%9Crule+of+three%E2%80%9D+for+fragment-based+lead+discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2eYumyaKQtbpK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%25E2%2580%259Crule%2520of%2520three%25E2%2580%259D%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">“Old friends in new guise”: exploiting privileged structures for scaffold re-evolution/refining</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.2174/1386207317666140122101631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F1386207317666140122101631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24446784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOgsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=536-553&author=Y.+Songauthor=W.+Chenauthor=D.+Kangauthor=Q.+Zhangauthor=P.+Zhanauthor=X.+Liu&title=%E2%80%9COld+friends+in+new+guise%E2%80%9D%3A+exploiting+privileged+structures+for+scaffold+re-evolution%2Frefining&doi=10.2174%2F1386207317666140122101631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">"Old Friends in New Guise": Exploiting Privileged Structures for Scaffold Re-Evolution/Refining</span></div><div class="casAuthors">Song, Yu'ning; Chen, Wenmin; Kang, Dongwei; Zhang, Qingzhu; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">536-553</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The attempts to increase novel drug productivity through creative discovery technologies have fallen short of producing the satisfactory results.  For these reasons, evolved from the concept of drug repositioning, "privileged structure"-guided scaffold re-evolution/refining is a primary strategy to identify structurally novel chemotypes by modifying the central core structure and the side-chain of the existing active compds., or to exploit undescribed bioactivites by making full use of readily derivatized motifs with well-established synthetic protocols.  Herein, we review the basic tricks of exploiting privileged structures for scaffold re-evolution/refining.  The power of this strategy is exemplified in the discovery of other new therapeutic applications by refining privileged structures in anti-viral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUo4fL_STkjrVg90H21EOLACvtfcHk0lj-5J5VkLwcLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOgsLvF&md5=4353d66dbd43353caefcd150938f94cd</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.2174%2F1386207317666140122101631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207317666140122101631%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3D%25E2%2580%259COld%2520friends%2520in%2520new%2520guise%25E2%2580%259D%253A%2520exploiting%2520privileged%2520structures%2520for%2520scaffold%2520re-evolution%252Frefining%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2014%26volume%3D17%26spage%3D536%26epage%3D553%26doi%3D10.2174%2F1386207317666140122101631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Repurposing of HDAC inhibitors toward anti-hepatitis C virus drug discovery: teaching an old dog new tricks</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span><span class="refDoi"> DOI: 10.4155/fmc.15.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4155%2Ffmc.15.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26230876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1367-1371&author=F.+Zhaoauthor=N.+Liuauthor=P.+Zhanauthor=X.+Liu&title=Repurposing+of+HDAC+inhibitors+toward+anti-hepatitis+C+virus+drug+discovery%3A+teaching+an+old+dog+new+tricks&doi=10.4155%2Ffmc.15.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing of HDAC inhibitors toward anti-hepatitis C virus drug discovery: teaching an old dog new tricks</span></div><div class="casAuthors">Zhao, Fabao; Liu, Na; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1367-1371</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc7dMC-jpz_rVg90H21EOLACvtfcHk0lj-5J5VkLwcLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvO&md5=817927f51219a6e23073d4b26e6c1ac0</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.76%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRepurposing%2520of%2520HDAC%2520inhibitors%2520toward%2520anti-hepatitis%2520C%2520virus%2520drug%2520discovery%253A%2520teaching%2520an%2520old%2520dog%2520new%2520tricks%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1367%26epage%3D1371%26doi%3D10.4155%2Ffmc.15.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2014.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25263697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=105-113&author=H.+Chenauthor=X.+Zhouauthor=A.+Wangauthor=Y.+Zhengauthor=Y.+Gaoauthor=J.+Zhou&title=Evolutions+in+fragment-based+drug+design%3A+the+deconstruction-reconstruction+approach&doi=10.1016%2Fj.drudis.2014.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span></div><div class="casAuthors">Chen, Haijun; Zhou, Xiaobin; Wang, Ailan; Zheng, Yunquan; Gao, Yu; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of mol. recognition and protein-ligand interactions have facilitated rapid development of potent and selective ligands for therapeutically relevant targets.  Over the past two decades, a variety of useful approaches and emerging techniques have been developed to promote the identification and optimization of leads that have high potential for generating new therapeutic agents.  Intriguingly, the innovation of a fragment-based drug design (FBDD) approach has enabled rapid and efficient progress in drug discovery.  In this crit. review, we focus on the construction of fragment libraries and the advantages and disadvantages of various fragment-based screening (FBS) for constructing such libraries.  We also highlight the deconstruction-reconstruction strategy by utilizing privileged fragments of reported ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWzbA5c5707Vg90H21EOLACvtfcHk0lj-5J5VkLwcLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO&md5=13ce52517b336a860136ac3eb4151b16</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEvolutions%2520in%2520fragment-based%2520drug%2520design%253A%2520the%2520deconstruction-reconstruction%2520approach%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D105%26epage%3D113%26doi%3D10.1016%2Fj.drudis.2014.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">8-Hydroxyquinoline: a privileged structure with broad-ranging pharmacological potentials</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1039/C4MD00284A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4MD00284A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=61-74&author=Y.+Songauthor=H.+Xuauthor=W.+Chenauthor=P.+Zhanauthor=X.+Liu&title=8-Hydroxyquinoline%3A+a+privileged+structure+with+broad-ranging+pharmacological+potentials&doi=10.1039%2FC4MD00284A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC4MD00284A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00284A%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3D8-Hydroxyquinoline%253A%2520a%2520privileged%2520structure%2520with%2520broad-ranging%2520pharmacological%2520potentials%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D61%26epage%3D74%26doi%3D10.1039%2FC4MD00284A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Serrao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2322</span><span class="refDoi"> DOI: 10.1021/jm301632e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301632e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2311-2322&author=E.+Serraoauthor=B.+Debnathauthor=H.+Otakeauthor=Y.+Kuangauthor=F.+Christauthor=Z.+Debyserauthor=N.+Neamati&title=Fragment-based+discovery+of+8-hydroxyquinoline+inhibitors+of+the+HIV-1+integrase-lens+epithelium-derived+growth+factor%2Fp75+%28IN-LEDGF%2Fp75%29+interaction&doi=10.1021%2Fjm301632e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm301632e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301632e%26sid%3Dliteratum%253Aachs%26aulast%3DSerrao%26aufirst%3DE.%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DOtake%26aufirst%3DH.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DFragment-based%2520discovery%2520of%25208-hydroxyquinoline%2520inhibitors%2520of%2520the%2520HIV-1%2520integrase-lens%2520epithelium-derived%2520growth%2520factor%252Fp75%2520%2528IN-LEDGF%252Fp75%2529%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2311%26epage%3D2322%26doi%3D10.1021%2Fjm301632e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mondal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, A. K.</span><span> </span><span class="NLM_article-title">Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2455</span><span class="NLM_x">–</span> <span class="NLM_lpage">2488</span><span class="refDoi"> DOI: 10.1039/C4CS00493K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4CS00493K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25706945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFCjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=2455-2488&author=M.+Mondalauthor=A.+K.+Hirsch&title=Dynamic+combinatorial+chemistry%3A+a+tool+to+facilitate+the+identification+of+inhibitors+for+protein+targets&doi=10.1039%2FC4CS00493K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets</span></div><div class="casAuthors">Mondal, Milon; Hirsch, Anna K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2455-2488</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dynamic combinatorial chem. (DCC) has emerged as a powerful strategy to identify ligands for biol. targets given that it enables the target to direct the synthesis and amplification of its strongest binder(s) from the library of interconverting compds.  Since the first report of DCC applied to the discovery of binders for a protein, this elegant tool has been employed on a range of protein targets at various stages of medicinal-chem. projects.  A series of suitable, reversible reactions that are biocompatible have been established and the portfolio of anal. techniques is growing.  Despite progress, in most cases, the libraries employed remain of moderate size.  We present here the most recent advances in the field of DCC applied to protein targets, paying particular attention to the exptl. conditions and anal. methods chosen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaA7XHQ6x8xrVg90H21EOLACvtfcHk0ljv3nHSHgIwGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFCjsbk%253D&md5=78c0c6047db102c978432fb92397c68a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FC4CS00493K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00493K%26sid%3Dliteratum%253Aachs%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%26atitle%3DDynamic%2520combinatorial%2520chemistry%253A%2520a%2520tool%2520to%2520facilitate%2520the%2520identification%2520of%2520inhibitors%2520for%2520protein%2520targets%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D2455%26epage%3D2488%26doi%3D10.1039%2FC4CS00493K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Oueis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P. Y.</span><span> </span><span class="NLM_article-title">New insights into the kinetic target-guided synthesis of protein ligands</span> <span class="citation_source-journal">Chem. Commun. (Cambridge, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">12158</span><span class="NLM_x">–</span> <span class="NLM_lpage">12169</span><span class="refDoi"> DOI: 10.1039/C5CC04183J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC5CC04183J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26144842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWgtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=12158-12169&author=E.+Oueisauthor=C.+Sabotauthor=P.+Y.+Renard&title=New+insights+into+the+kinetic+target-guided+synthesis+of+protein+ligands&doi=10.1039%2FC5CC04183J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the kinetic target-guided synthesis of protein ligands</span></div><div class="casAuthors">Oueis, Emilia; Sabot, Cyrille; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">12158-12169</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The kinetic target-guided synthesis (KTGS) strategy is an unconventional discovery approach that takes advantage of the presence of the biol. target itself in order to irreversibly assemble the best inhibitors from an array of building blocks.  This strategy has grown over the last two decades notably after the introduction of the in situ click chem. concept by Sharpless and colleagues in the early 2000s based on the use of the Huisgen cycloaddn. between terminal alkynes and azides.  KTGS is a captivating area of research offering an unprecedented and powerful strategy to probe the macromol. complexity and dynamics of biol. targets.  After a brief introduction listing all chem. ligation reactions reported to date in KTGS, this review focuses on the last five years' progress to expand the repertoire of the click or "click-like" tool box targeting proteins, as well as to overcome limitations arising in particular from false negatives, i.e. potent ligands that are not formed, or formed in undetectable trace amts.  Furthermore, we wish to analyze the new twists and novelties described in some of these applications in order to better understand the conditions that govern this strategy and the extent to which it can be developed and generalized for a more efficient process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3mdKSqL3JKLVg90H21EOLACvtfcHk0lhDS2VaVSgPuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWgtbbE&md5=76af69545c88c006feb0fe7a544b3805</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC5CC04183J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC04183J%26sid%3Dliteratum%253Aachs%26aulast%3DOueis%26aufirst%3DE.%26aulast%3DSabot%26aufirst%3DC.%26aulast%3DRenard%26aufirst%3DP.%2BY.%26atitle%3DNew%2520insights%2520into%2520the%2520kinetic%2520target-guided%2520synthesis%2520of%2520protein%2520ligands%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2015%26volume%3D51%26spage%3D12158%26epage%3D12169%26doi%3D10.1039%2FC5CC04183J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetsch, R.</span><span> </span><span class="NLM_article-title">Kinetic target-guided synthesis</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1039/b904092g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2Fb904092g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20309488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1316-24&author=X.+Huauthor=R.+Manetsch&title=Kinetic+target-guided+synthesis&doi=10.1039%2Fb904092g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic target-guided synthesis</span></div><div class="casAuthors">Hu, Xiangdong; Manetsch, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1316-1324</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In the last decade, various target-guided synthesis (TGS) approaches have been developed in which a target protein is actively engaged in the assembly of its own bidentate ligand from a pool of smaller reactive fragments.  Although TGS is relatively less explored, it demonstrates great promise to streamline drug discovery by combining screening and synthesis into a single step.  In this review, the authors focus on the class of kinetic TGS approaches which utilize irreversible reactions to combine two reactive fragments into the inhibitory compd.  These kinetic TGS applications have been successful due to the unique combination of the slow nature of the chem. reaction combining the two fragments into a single mol. and the use of reactive fragments displaying good affinities toward one of the binding sites.  So far, kinetic TGS and esp. in situ click chem., a kinetic TGS variant using the 1,3-dipolar cycloaddn. of azides and alkynes, have led to the identification of highly potent inhibitors.  This tutorial review focuses on kinetic TGS approaches aside from those employing the 1,3-dipolar cycloaddn. of azides and alkynes, and discusses the features and advantages of these TGS approaches in detail.  The successes of in silt click chem. dramatically changed kinetic TGS approaches.  Predicted and developed more than 30 years ago, early kinetic TGS approaches suffered from serious limitations, making lead discovery projects impossible.  Logically, biol. targets will favor certain reactions over the others; thus research should continue to focus on the development of bioorthogonal reactions and their use in kinetic TGS approaches.  Although significant progress has been achieved over the last decade, kinetic TGS is still relatively less explored and hence represents an interesting area rich in research opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5y6kP6omeuLVg90H21EOLACvtfcHk0lhDS2VaVSgPuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggu70%253D&md5=97936395184abe8dc367c3b6a4829193</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fb904092g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb904092g%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DManetsch%26aufirst%3DR.%26atitle%3DKinetic%2520target-guided%2520synthesis%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D1316%26epage%3D24%26doi%3D10.1039%2Fb904092g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Thirumurugan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matosiuk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jozwiak, K.</span><span> </span><span class="NLM_article-title">Click chemistry for drug development and diverse chemical-biology applications</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">4905</span><span class="NLM_x">–</span> <span class="NLM_lpage">4979</span><span class="refDoi"> DOI: 10.1021/cr200409f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200409f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslahtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=4905-4979&author=P.+Thirumuruganauthor=D.+Matosiukauthor=K.+Jozwiak&title=Click+chemistry+for+drug+development+and+diverse+chemical-biology+applications&doi=10.1021%2Fcr200409f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Click Chemistry for Drug Development and Diverse Chemical-Biology Applications</span></div><div class="casAuthors">Thirumurugan, Prakasam; Matosiuk, Dariusz; Jozwiak, Krzysztof</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4905-4979</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 303 refs. on application of lick chem. reactions in chem., biochem., and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnNgMztlQYCLVg90H21EOLACvtfcHk0lgL4VZD6PfTNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslahtLY%253D&md5=d9c664c199b63c7d556c60fe9cd1507d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr200409f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200409f%26sid%3Dliteratum%253Aachs%26aulast%3DThirumurugan%26aufirst%3DP.%26aulast%3DMatosiuk%26aufirst%3DD.%26aulast%3DJozwiak%26aufirst%3DK.%26atitle%3DClick%2520chemistry%2520for%2520drug%2520development%2520and%2520diverse%2520chemical-biology%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D4905%26epage%3D4979%26doi%3D10.1021%2Fcr200409f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Whiting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muldoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 protease by using in situ click chemistry</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1435</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span><span class="refDoi"> DOI: 10.1002/anie.200502161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fanie.200502161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28XitF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=1435-1439&author=M.+Whitingauthor=J.+Muldoonauthor=Y.+C.+Linauthor=S.+M.+Silvermanauthor=W.+Lindstromauthor=A.+J.+Olsonauthor=H.+C.+Kolbauthor=M.+G.+Finnauthor=K.+B.+Sharplessauthor=J.+H.+Elderauthor=V.+V.+Fokin&title=Inhibitors+of+HIV-1+protease+by+using+in+situ+click+chemistry&doi=10.1002%2Fanie.200502161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 protease by using in situ click chemistry</span></div><div class="casAuthors">Whiting, Matthew; Muldoon, John; Lin, Ying-Chuan; Silverman, Steven M.; Lindstrom, William; Olson, Arthur J.; Kolb, Hartmuth C.; Finn, M. G.; Sharpless, K. Barry; Elder, John H.; Fokin, Valery V.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1435-1439</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Twice poor equals potent: HIV-1 Protease assembles its own potent inhibitor through formation of the triazole linkage from azide- and alkyne-contg. fragments that are themselves poor binders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxygIXDTyVz7Vg90H21EOLACvtfcHk0lgL4VZD6PfTNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitF2qtLg%253D&md5=d575780546dbc314eb9df85bc2459539</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fanie.200502161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200502161%26sid%3Dliteratum%253Aachs%26aulast%3DWhiting%26aufirst%3DM.%26aulast%3DMuldoon%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DSilverman%26aufirst%3DS.%2BM.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease%2520by%2520using%2520in%2520situ%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D1435%26epage%3D1439%26doi%3D10.1002%2Fanie.200502161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutsuga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">An unexpected example of protein-templated click chemistry</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6817</span><span class="NLM_x">–</span> <span class="NLM_lpage">6820</span><span class="refDoi"> DOI: 10.1002/anie.201002205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fanie.201002205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6817-6820&author=T.+Suzukiauthor=Y.+Otaauthor=Y.+Kasuyaauthor=M.+Mutsugaauthor=Y.+Kawamuraauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+G.+Finnauthor=N.+Miyata&title=An+unexpected+example+of+protein-templated+click+chemistry&doi=10.1002%2Fanie.201002205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An Unexpected Example of Protein-Templated Click Chemistry</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Kasuya, Yuki; Mutsuga, Motoh; Kawamura, Yoko; Tsumoto, Hiroki; Nakagawa, Hidehiko; Finn, M. G.; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6817-6820, S6817/1-S6817/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors have established that a Cu(I) complex of HDAC8 (human recombinant histone deacetylase) accelerates a selective azide-alkyne cycloaddn. (AAC) between an azide and an alkyne, thereby forming a triazole deriv. with greater inhibitory power towards the enzyme than either of the reactants alone.  In this case, the unwavering regioselectivity of the CuAAC process overrides the tendency of the Cu-free in situ click reaction to form the more potent (syn-isomer, 1,5-triazolyl) of the two triazole isomers.  Thus, regiospecific formation of triazole adducts from alkyne I and azide II in presence of HDAC8 gave rise to a significant peak in HPLC corresponding to anti-isomer (1,4-triazolyl) adduct III along with a smaller peak being the syn-isomer (1,5-triazolyl) adduct IV.  To examine whether Cu(I) is required for the cycloaddn., AAC was conducted using I and II in presence of HDAC8 and bathocuproine disulfonic acid [BCDSA; a Cu(I)-specific chelator and inhibitor of the CuAAC reaction].  The results showed that BCDSA inhibited the triazole formation.  In addn., Zn(OAc)2 was added to the mixt. of reactants I and II along with HDAC8 to displace Cu from the protein.  This treatment completely suppressed the formation of anti-isomer III, whereas in soln., Zn(II) had no effect on the CuAAC reaction.  In summary, the authors regard this study as an important precedent in the search for highly active protein catalysts of the CuAAC reaction, as well as an interesting and potentially useful example of in situ inhibitor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5wSD48iQp7Vg90H21EOLACvtfcHk0liyOpTmoWlofg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK&md5=f6e6a2b9aa0a51df9a9828c8a4c1f92c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fanie.201002205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201002205%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520unexpected%2520example%2520of%2520protein-templated%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6817%26epage%3D6820%26doi%3D10.1002%2Fanie.201002205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Brik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muldoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. H.</span><span> </span><span class="NLM_article-title">Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1002/cbic.200300724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcbic.200300724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=14613121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFajt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=1246-1248&author=A.+Brikauthor=J.+Muldoonauthor=Y.+C.+Linauthor=J.+H.+Elderauthor=D.+S.+Goodsellauthor=A.+J.+Olsonauthor=V.+V.+Fokinauthor=K.+B.+Sharplessauthor=C.+H.+Wong&title=Rapid+diversity-oriented+synthesis+in+microtiter+plates+for+in+situ+screening+of+HIV+protease+inhibitors&doi=10.1002%2Fcbic.200300724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors</span></div><div class="casAuthors">Brik, Ashraf; Muldoon, John; Lin, Ying-chuan; Elder, John H.; Goodsell, David S.; Olson, Arthur J.; Fokin, Valery V.; Sharpless, K. Barry; Wong, Chi-huey</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1246-1248</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The azide cores I and II were prepd. and converted to libraries of triazoles for in situ screening for HIV protease inhibitor activity by cycloaddn. with acetylenes.  The triazoles III and IV had IC50 for inhibition of HIV protease of 6±0.5 and 13±0.5 nM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9NCHXJLlkrVg90H21EOLACvtfcHk0liyOpTmoWlofg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFajt7k%253D&md5=1f0285eb738c69c6b70132f373e80092</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200300724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200300724%26sid%3Dliteratum%253Aachs%26aulast%3DBrik%26aufirst%3DA.%26aulast%3DMuldoon%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DRapid%2520diversity-oriented%2520synthesis%2520in%2520microtiter%2520plates%2520for%2520in%2520situ%2520screening%2520of%2520HIV%2520protease%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2003%26volume%3D4%26spage%3D1246%26epage%3D1248%26doi%3D10.1002%2Fcbic.200300724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Whiting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripp, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span> </span><span class="NLM_article-title">Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7697</span><span class="NLM_x">–</span> <span class="NLM_lpage">7710</span><span class="refDoi"> DOI: 10.1021/jm060754+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060754%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GjsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7697-7710&author=M.+Whitingauthor=J.+C.+Trippauthor=Y.+C.+Linauthor=W.+Lindstromauthor=A.+J.+Olsonauthor=J.+H.+Elderauthor=K.+B.+Sharplessauthor=V.+V.+Fokin&title=Rapid+discovery+and+structure-activity+profiling+of+novel+inhibitors+of+human+immunodeficiency+virus+type+1+protease+enabled+by+the+copper%28I%29-catalyzed+synthesis+of+1%2C2%2C3-triazoles+and+their+further+functionalization&doi=10.1021%2Fjm060754%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery and Structure-Activity Profiling of Novel Inhibitors of Human Immunodeficiency Virus Type 1 Protease Enabled by the Copper(I)-Catalyzed Synthesis of 1,2,3-Triazoles and Their Further Functionalization</span></div><div class="casAuthors">Whiting, Matthew; Tripp, Jonathan C.; Lin, Ying-Chuan; Lindstrom, William; Olson, Arthur J.; Elder, John H.; Sharpless, K. Barry; Fokin, Valery V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7697-7710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building from the results of a computational screen of a range of triazole-contg. compds. for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed.  The copper(I)-catalyzed azide-alkyne cycloaddn. (CuAAC), which provides ready access to 1,4-disubstituted-1,2,3-triazoles, was used to unite a focused library of azide-contg. fragments with a diverse array of functionalized alkyne-contg. building blocks.  In combination with direct screening of the crude reaction products, this method led to the rapid identification of a lead structure and readily enabled optimization of both azide and alkyne fragments.  Replacement of the triazole with a range of alternative linkers led to greatly reduced protease inhibition; however, further functionalization of the triazoles at the 5-position gave a series of compds. with increased activity, exhibiting Ki values as low as 8 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxP4sXbJdAZbVg90H21EOLACvtfcHk0liyOpTmoWlofg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GjsbjL&md5=252fb639055fb8e55a1e1a0eb0842853</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm060754%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060754%252B%26sid%3Dliteratum%253Aachs%26aulast%3DWhiting%26aufirst%3DM.%26aulast%3DTripp%26aufirst%3DJ.%2BC.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26atitle%3DRapid%2520discovery%2520and%2520structure-activity%2520profiling%2520of%2520novel%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520enabled%2520by%2520the%2520copper%2528I%2529-catalyzed%2520synthesis%2520of%25201%252C2%252C3-triazoles%2520and%2520their%2520further%2520functionalization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7697%26epage%3D7710%26doi%3D10.1021%2Fjm060754%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wannberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larhed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span><span class="refDoi"> DOI: 10.1021/cc050016r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc050016r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFWhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=611-617&author=J.+Wannbergauthor=N.+F.+Kaiserauthor=L.+Vrangauthor=B.+Samuelssonauthor=M.+Larhedauthor=A.+Hallberg&title=High-speed+synthesis+of+potent+C2-symmetric+HIV-1+protease+inhibitors+by+in-situ+aminocarbonylations&doi=10.1021%2Fcc050016r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">High-Speed Synthesis of Potent C2-Symmetric HIV-1 Protease Inhibitors by In-Situ Aminocarbonylations</span></div><div class="casAuthors">Wannberg, Johan; Kaiser, Nils-Fredrik K.; Vrang, Lotta; Samuelsson, Bertil; Larhed, Mats; Hallberg, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel series of C2-sym. HIV-1 protease inhibitors were synthesized by microwave-promoted, palladium-catalyzed amino carbonylation of the o-iodo- and m-bromo benzyloxy P1/P1' substituted core structures.  Molybdenum hexacarbonyl was used as a convenient solid source of carbon monoxide in these transformations.  After the initial high-speed library generation, biol. testing identified highly active HIV-1 protease inhibitors.  Selected ortho- and meta-decorated inhibitors were subsequently re-synthesized on a larger scale and re-tested for their affinity toward HIV-1 protease, showing micro-molar to low nanomolar inhibition.  The discovery of highly active inhibitors contg. large Ph amide ortho substituents in the P1/P1' positions indicates that larger groups than previously believed are tolerated in this part of the S1/S1' pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjaH7YrpIcYLVg90H21EOLACvtfcHk0liOwGJWJyQxbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFWhur0%253D&md5=a418a85404c8f477bf739475ffb51eb5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcc050016r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc050016r%26sid%3Dliteratum%253Aachs%26aulast%3DWannberg%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DN.%2BF.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DHigh-speed%2520synthesis%2520of%2520potent%2520C2-symmetric%2520HIV-1%2520protease%2520inhibitors%2520by%2520in-situ%2520aminocarbonylations%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2005%26volume%3D7%26spage%3D611%26epage%3D617%26doi%3D10.1021%2Fcc050016r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Strategies for the discovery of target-specific or isoform-selective modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7611</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVans7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7611-7633&author=P.+Zhanauthor=Y.+Itohauthor=T.+Suzukiauthor=X.+Liu&title=Strategies+for+the+discovery+of+target-specific+or+isoform-selective+modulators&doi=10.1021%2Facs.jmedchem.5b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators</span></div><div class="casAuthors">Zhan, Peng; Itoh, Yukihiro; Suzuki, Takayoshi; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7611-7633</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Currently, the creation of class- and isoform-selective modulators of biol. important targets is a particularly challenging problem because different isoforms within a protein family often show striking similarity in spatial quaternary structure, esp. at the catalytic sites or binding pockets.  Therefore, an understanding of both the precise three-dimensional structure of the target protein and the mechanisms of action of modulators is important for developing more effective and selective agents.  In this Perspective, the authors discuss currently available rational design strategies for obtaining class- and isoform-selective inhibitors and the authors illustrate these strategies with the aid of specific examples from the recent literature.  The strategies covered include: (1) target-derived (-dependent) de novo drug discovery methodologies, and (2) follow-on derivatization approaches from initially identified active mols. (hit-to-lead and lead-to-candidate efforts).  The authors also comment on prospects for further development and integration of strategies to achieve target-specific or isoform-selective inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9nLY2BYFSobVg90H21EOLACvtfcHk0liOwGJWJyQxbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVans7rK&md5=2fdffce4f0c8c57a266468dcb8a901ae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00229%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DStrategies%2520for%2520the%2520discovery%2520of%2520target-specific%2520or%2520isoform-selective%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7611%26epage%3D7633%26doi%3D10.1021%2Facs.jmedchem.5b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span> </span><span class="NLM_article-title">Hierarchical virtual screening approaches in small molecule drug discovery</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2014.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ymeth.2014.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25072167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12mt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=26-37&author=A.+Kumarauthor=K.+Y.+Zhang&title=Hierarchical+virtual+screening+approaches+in+small+molecule+drug+discovery&doi=10.1016%2Fj.ymeth.2014.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchical virtual screening approaches in small molecule drug discovery</span></div><div class="casAuthors">Kumar, Ashutosh; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-37</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Virtual screening has played a significant role in the discovery of small mol. inhibitors of therapeutic targets in last two decades.  Various ligand and structure-based virtual screening approaches are employed to identify small mol. ligands for proteins of interest.  These approaches are often combined in either hierarchical or parallel manner to take advantage of the strength and avoid the limitations assocd. with individual methods.  Hierarchical combination of ligand and structure-based virtual screening approaches has received noteworthy success in numerous drug discovery campaigns.  In hierarchical virtual screening, several filters using ligand and structure-based approaches are sequentially applied to reduce a large screening library to a no. small enough for exptl. testing.  In this review, we focus on different hierarchical virtual screening strategies and their application in the discovery of small mol. modulators of important drug targets.  Several virtual screening studies are discussed to demonstrate the successful application of hierarchical virtual screening in small mol. drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5IS_ELjp3rVg90H21EOLACvtfcHk0liOwGJWJyQxbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12mt7bO&md5=37afd198e391774598a72214a377fd05</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2014.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2014.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26atitle%3DHierarchical%2520virtual%2520screening%2520approaches%2520in%2520small%2520molecule%2520drug%2520discovery%26jtitle%3DMethods%26date%3D2015%26volume%3D71%26spage%3D26%26epage%3D37%26doi%3D10.1016%2Fj.ymeth.2014.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">–</span> <span class="NLM_lpage">2444</span><span class="refDoi"> DOI: 10.1021/jm049606e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049606e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2432-2444&author=J.+Wangauthor=X.+Kangauthor=I.+D.+Kuntzauthor=P.+A.+Kollman&title=Hierarchical+database+screenings+for+HIV-1+reverse+transcriptase+using+a+pharmacophore+model%2C+rigid+docking%2C+solvation+docking%2C+and+MM-PB%2FSA&doi=10.1021%2Fjm049606e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM-PB/SA</span></div><div class="casAuthors">Wang, Junmei; Kang, Xinshan; Kuntz, Irwin D.; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2432-2444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work, an efficient strategy was presented to search drug leads for human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) using hierarchical database screenings, which included a pharmacophore model, multiple-conformation rigid docking, solvation docking, and mol. mechanics-Poisson-Boltzmann/surface area (MM-PB/SA) sequentially.  Encouraging results were achieved in searching a refined available chem. directory (ACD) database: the enrichment factor after the first three filters was estd. to be 25-fold; the hit rate for all the four filters was predicted to be 41% in a control test using 37 known HIV-1 non-nucleoside reverse transcriptase inhibitors; 10 out of 30 promising solvation-docking hits had MM-PB/SA binding free energies better than -6.8 kcal/mol and the best one, HIT15, had -17.0 kcal/mol.  In conclusion, the hierarchical multiple-filter database searching strategy is an attractive strategy in drug lead exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWs2lXBbUFbbVg90H21EOLACvtfcHk0liOwGJWJyQxbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsF2isb8%253D&md5=6a0dfb0307674ba5f2caa91b78fbe509</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm049606e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049606e%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DX.%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHierarchical%2520database%2520screenings%2520for%2520HIV-1%2520reverse%2520transcriptase%2520using%2520a%2520pharmacophore%2520model%252C%2520rigid%2520docking%252C%2520solvation%2520docking%252C%2520and%2520MM-PB%252FSA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2432%26epage%3D2444%26doi%3D10.1021%2Fjm049606e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Leitão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andricopulo, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, C. A.</span><span> </span><span class="NLM_article-title">In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1412</span><span class="NLM_x">–</span> <span class="NLM_lpage">1422</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2007.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2007.08.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1412-1422&author=A.+Leit%C3%A3oauthor=A.+D.+Andricopuloauthor=C.+A.+Montanari&title=In+silico+screening+of+HIV-1+non-nucleoside+reverse+transcriptase+and+protease+inhibitors&doi=10.1016%2Fj.ejmech.2007.08.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DAndricopulo%26aufirst%3DA.%2BD.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DIn%2520silico%2520screening%2520of%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520and%2520protease%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1412%26epage%3D1422%26doi%3D10.1016%2Fj.ejmech.2007.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Using hierarchical virtual screening to combat drug resistance of the HIV-1 protease</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1400</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.1021/acs.jcim.5b00056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1aksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1400-1412&author=N.+Liauthor=R.+I.+Ainsworthauthor=B.+Dingauthor=T.+Houauthor=W.+Wang&title=Using+hierarchical+virtual+screening+to+combat+drug+resistance+of+the+HIV-1+protease&doi=10.1021%2Facs.jcim.5b00056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease</span></div><div class="casAuthors">Li, Nan; Ainsworth, Richard I.; Ding, Bo; Hou, Tingjun; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1400-1412</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV) protease inhibitors (PIs) are important components of highly active anti-retroviral therapy (HAART) that block the catalytic site of HIV protease, thus preventing maturation of the HIV virion.  However, with two decades of PI prescriptions in clin. practice, drug-resistant HIV mutants have now been found for all of the PI drugs.  Therefore, the continuous development of new PI drugs is crucial both to combat the existing drug-resistant HIV strains and to provide treatments for future patients.  Here we purpose an HIV PI drug design strategy to select candidate PIs with binding energy distributions dominated by interactions with conserved protease residues in both wild-type and various drug-resistant mutants.  On the basis of this strategy, we have constructed a virtual screening pipeline including combinatorial library construction, combinatorial docking, MM/GBSA-based rescoring, and reranking on the basis of the binding energy distribution.  We have tested our strategy on lopinavir by modifying its two functional groups.  From an initial 751 689 candidate mols., 18 candidate inhibitors were selected using the pipeline for exptl. validation.  IC50 measurements and drug resistance predictions successfully identified two ligands with both HIV protease inhibitor activity and an improved drug resistance profile on 2382 HIV mutants.  This study provides a proof of concept for the integration of MM/GBSA energy anal. and drug resistance information at the stage of virtual screening and sheds light on future HIV drug design and the use of virtual screening to combat drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHHiHtaG7NVLVg90H21EOLACvtfcHk0lj7jICElX_jUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1aksLs%253D&md5=088bbeb88cf6971bcca3b666d71d7e30</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00056%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DAinsworth%26aufirst%3DR.%2BI.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DUsing%2520hierarchical%2520virtual%2520screening%2520to%2520combat%2520drug%2520resistance%2520of%2520the%2520HIV-1%2520protease%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D1400%26epage%3D1412%26doi%3D10.1021%2Facs.jcim.5b00056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Multistage virtual screening and identification of novel HIV-1 protease inhibitors by integrating SVM, shape, pharmacophore and docking methods</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2015.06.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=409-418&author=Y.+Weiauthor=J.+Liauthor=Z.+Chenauthor=F.+Wangauthor=W.+Huangauthor=Z.+Hongauthor=J.+Lin&title=Multistage+virtual+screening+and+identification+of+novel+HIV-1+protease+inhibitors+by+integrating+SVM%2C+shape%2C+pharmacophore+and+docking+methods&doi=10.1016%2Fj.ejmech.2015.06.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DMultistage%2520virtual%2520screening%2520and%2520identification%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520by%2520integrating%2520SVM%252C%2520shape%252C%2520pharmacophore%2520and%2520docking%2520methods%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D409%26epage%3D418%26doi%3D10.1016%2Fj.ejmech.2015.06.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavande, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, H.</span><span> </span><span class="NLM_article-title">Insights into the mechanism of inhibition of CXCR4: identification of piperidinylethanamine analogs as anti-HIV-1 inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span><span class="refDoi"> DOI: 10.1128/AAC.04654-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.04654-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1895-1904&author=D.+Dasauthor=K.+Maedaauthor=Y.+Hayashiauthor=N.+Gavandeauthor=D.+V.+Desaiauthor=S.+B.+Changauthor=A.+K.+Ghoshauthor=H.+Mitsuya&title=Insights+into+the+mechanism+of+inhibition+of+CXCR4%3A+identification+of+piperidinylethanamine+analogs+as+anti-HIV-1+inhibitors&doi=10.1128%2FAAC.04654-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FAAC.04654-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04654-14%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DD.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DGavande%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DD.%2BV.%26aulast%3DChang%26aufirst%3DS.%2BB.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DInsights%2520into%2520the%2520mechanism%2520of%2520inhibition%2520of%2520CXCR4%253A%2520identification%2520of%2520piperidinylethanamine%2520analogs%2520as%2520anti-HIV-1%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D1895%26epage%3D1904%26doi%3D10.1128%2FAAC.04654-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Targeting protein-protein interactions: a promising avenue of anti-HIV drug discovery</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3393</span><span class="NLM_x">–</span> <span class="NLM_lpage">3409</span><span class="refDoi"> DOI: 10.2174/092986710793176357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986710793176357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20712566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cms7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3393-3409&author=P.+Zhanauthor=W.+Liauthor=H.+Chenauthor=X.+Liu&title=Targeting+protein-protein+interactions%3A+a+promising+avenue+of+anti-HIV+drug+discovery&doi=10.2174%2F092986710793176357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein-protein interactions: a promising avenue of anti-HIV drug discovery</span></div><div class="casAuthors">Zhan, Peng; Li, Wenjun; Chen, Hongfei; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3393-3409</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, the no. of useful chem. biol. information of protein-protein interactions in the HIV life cycle and related inhibitors, is growing rapidly, which makes protein-protein interactions a new investigative area for antiviral drug intervention.  This review will summarize recent work in this field, mainly focusing on the utilization of small mols. targeted against a variety of protein-protein interactions that have great therapeutic feasibility for HIV infection, and lastly outline some other important protein-protein interactions with a potential to advance into novel anti-HIV drug targets in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVauv4e2ym_bVg90H21EOLACvtfcHk0lj7jICElX_jUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cms7fL&md5=ea38fcd5e399a420bbcc011780c41d1c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F092986710793176357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710793176357%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DTargeting%2520protein-protein%2520interactions%253A%2520a%2520promising%2520avenue%2520of%2520anti-HIV%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3393%26epage%3D3409%26doi%3D10.2174%2F092986710793176357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desimmie, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardiot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Remoortel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelkov, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaltin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span> </span><span class="NLM_article-title">Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span><span class="refDoi"> DOI: 10.1038/nchembio.370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchembio.370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20473303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFaltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=442-448&author=F.+Christauthor=A.+Voetauthor=A.+Marchandauthor=S.+Nicoletauthor=B.+A.+Desimmieauthor=D.+Marchandauthor=D.+Bardiotauthor=N.+J.+Van+der+Vekenauthor=B.+Van+Remoortelauthor=S.+V.+Strelkovauthor=M.+De+Maeyerauthor=P.+Chaltinauthor=Z.+Debyser&title=Rational+design+of+small-molecule+inhibitors+of+the+LEDGF%2Fp75-integrase+interaction+and+HIV+replication&doi=10.1038%2Fnchembio.370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication</span></div><div class="casAuthors">Christ, Frauke; Voet, Arnout; Marchand, Arnaud; Nicolet, Stefan; Desimmie, Belete A.; Marchand, Damien; Bardiot, Dorothee; Van der Veken, Nam Joo; Van Remoortel, Barbara; Strelkov, Sergei V.; De Maeyer, Marc; Chaltin, Patrick; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">442-448</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lens epithelium-derived growth factor (LEDGF/p75) is a cellular cofactor of HIV-1 integrase that promotes viral integration by tethering the preintegration complex to the chromatin.  By virtue of its crucial role in the early steps of HIV replication, the interaction between LEDGF/p75 and integrase represents an attractive target for antiviral therapy.  We have rationally designed a series of 2-(quinolin-3-yl)acetic acid derivs. (LEDGINs) that act as potent inhibitors of the LEDGF/p75-integrase interaction and HIV-1 replication at submicromolar concn. by blocking the integration step.  A 1.84-Å resoln. crystal structure corroborates the binding of the inhibitor in the LEDGF/p75-binding pocket of integrase.  Together with the lack of cross-resistance with two clin. integrase inhibitors, these findings define the 2-(quinolin-3-yl)acetic acid derivs. as the first genuine allosteric HIV-1 integrase inhibitors.  Our work demonstrates the feasibility of rational design of small mols. inhibiting the protein-protein interaction between a viral protein and a cellular host factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRSR1oWvr1XrVg90H21EOLACvtfcHk0lh83MSIQl_g3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFaltr4%253D&md5=2f77b35a182fbee6d7b49da563e3447f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.370%26sid%3Dliteratum%253Aachs%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DVoet%26aufirst%3DA.%26aulast%3DMarchand%26aufirst%3DA.%26aulast%3DNicolet%26aufirst%3DS.%26aulast%3DDesimmie%26aufirst%3DB.%2BA.%26aulast%3DMarchand%26aufirst%3DD.%26aulast%3DBardiot%26aufirst%3DD.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DN.%2BJ.%26aulast%3DVan%2BRemoortel%26aufirst%3DB.%26aulast%3DStrelkov%26aufirst%3DS.%2BV.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DChaltin%26aufirst%3DP.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DRational%2520design%2520of%2520small-molecule%2520inhibitors%2520of%2520the%2520LEDGF%252Fp75-integrase%2520interaction%2520and%2520HIV%2520replication%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D442%26epage%3D448%26doi%3D10.1038%2Fnchembio.370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morreale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitto, R.</span><span> </span><span class="NLM_article-title">New scaffolds of natural origin as integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2013.07.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=405-411&author=L.+De+Lucaauthor=F.+Morrealeauthor=F.+Christauthor=Z.+Debyserauthor=S.+Ferroauthor=R.+Gitto&title=New+scaffolds+of+natural+origin+as+integrase-LEDGF%2Fp75+interaction+inhibitors%3A+virtual+screening+and+activity+assays&doi=10.1016%2Fj.ejmech.2013.07.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DMorreale%26aufirst%3DF.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DGitto%26aufirst%3DR.%26atitle%3DNew%2520scaffolds%2520of%2520natural%2520origin%2520as%2520integrase-LEDGF%252Fp75%2520interaction%2520inhibitors%253A%2520virtual%2520screening%2520and%2520activity%2520assays%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D68%26spage%3D405%26epage%3D411%26doi%3D10.1016%2Fj.ejmech.2013.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iraci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span> </span><span class="NLM_article-title">Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1316</span><span class="refDoi"> DOI: 10.1002/cmdc.200900070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.200900070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1311-1316&author=L.+De+Lucaauthor=M.+L.+Barrecaauthor=S.+Ferroauthor=F.+Christauthor=N.+Iraciauthor=R.+Gittoauthor=A.+M.+Monforteauthor=Z.+Debyserauthor=A.+Chimirri&title=Pharmacophore-based+discovery+of+small-molecule+inhibitors+of+protein-protein+interactions+between+HIV-1+integrase+and+cellular+cofactor+LEDGF%2Fp75&doi=10.1002%2Fcmdc.200900070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900070%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DIraci%26aufirst%3DN.%26aulast%3DGitto%26aufirst%3DR.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DChimirri%26aufirst%3DA.%26atitle%3DPharmacophore-based%2520discovery%2520of%2520small-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%2520between%2520HIV-1%2520integrase%2520and%2520cellular%2520cofactor%2520LEDGF%252Fp75%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1311%26epage%3D1316%26doi%3D10.1002%2Fcmdc.200900070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10108</span><span class="NLM_x">–</span> <span class="NLM_lpage">10117</span><span class="refDoi"> DOI: 10.1021/jm301226a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301226a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10108-10117&author=G.+Huauthor=X.+Liauthor=X.+Zhangauthor=Y.+Liauthor=L.+Maauthor=L.+M.+Yangauthor=G.+Liuauthor=W.+Liauthor=J.+Huangauthor=X.+Shenauthor=L.+Huauthor=Y.+T.+Zhengauthor=Y.+Tang&title=Discovery+of+inhibitors+to+block+interactions+of+HIV-1+integrase+with+human+LEDGF%2Fp75+via+structure-based+virtual+screening+and+bioassays&doi=10.1021%2Fjm301226a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm301226a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301226a%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520inhibitors%2520to%2520block%2520interactions%2520of%2520HIV-1%2520integrase%2520with%2520human%2520LEDGF%252Fp75%2520via%2520structure-based%2520virtual%2520screening%2520and%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10108%26epage%3D10117%26doi%3D10.1021%2Fjm301226a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Restouin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arold, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrot, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerlesquin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collette, Y.</span><span> </span><span class="NLM_article-title">Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">19256</span><span class="NLM_x">–</span> <span class="NLM_lpage">19261</span><span class="refDoi"> DOI: 10.1073/pnas.0707130104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.0707130104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=18042718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19256-19261&author=S.+Betziauthor=A.+Restouinauthor=S.+Opiauthor=S.+T.+Aroldauthor=I.+Parrotauthor=F.+Guerlesquinauthor=X.+Morelliauthor=Y.+Collette&title=Protein+protein+interaction+inhibition+%282P2I%29+combining+high+throughput+and+virtual+screening%3A+Application+to+the+HIV-1+Nef+protein&doi=10.1073%2Fpnas.0707130104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-protein interaction inhibition (2P2I) combining high throughput and virtual screening: application to the HIV-1 nef protein</span></div><div class="casAuthors">Betzi, Stephane; Restouin, Audrey; Opi, Sandrine; Arold, Stefan T.; Parrot, Isabelle; Guerlesquin, Francoise; Morelli, Xavier; Collette, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19256-19261</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein-protein recognition is the cornerstone of multiple cellular and pathol. functions.  Therefore, protein-protein interaction inhibition (2P2I) is endowed with great therapeutic potential despite the initial belief that 2P2I was refractory to small-mol. intervention.  Improved knowledge of complex mol. binding surfaces has recently stimulated renewed interest for 2P2I, esp. after identification of "hot spots" and first inhibitory compds.  However, the combination of target complexity and lack of starting compd. has thwarted exptl. results and created intellectual barriers.  Here we combined virtual and exptl. screening when no previously known inhibitors can be used as starting point in a structure-based research program that targets an SH3 binding surface of the HIV type I Nef protein.  High-throughput docking and application of a pharmacophoric filter on one hand and search for analogy on the other hand identified drug-like compds. that were further confirmed to bind Nef in the micromolar range (isothermal titrn. calorimetry), to target the Nef SH3 binding surface (NMR expts.), and to efficiently compete for Nef-SH3 interactions (cell-based assay, GST pull-down).  Initial identification of these compds. by virtual screening was validated by screening of the very same library of compds. in the cell-based assay, demonstrating that a significant enrichment factor was attained by the in silico screening.  To our knowledge, our results identify the first set of drug-like compds. that functionally target the HIV-1 Nef SH3 binding surface and provide the basis for a powerful discovery process that should help to speed up 2P2I strategies and open avenues for new class of antiviral mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm0hLpNUw_G7Vg90H21EOLACvtfcHk0lhcQQax1xlAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVKqsA%253D%253D&md5=1c8a22ad645fd87ba9a7affaa3e0f6f4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0707130104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0707130104%26sid%3Dliteratum%253Aachs%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DRestouin%26aufirst%3DA.%26aulast%3DOpi%26aufirst%3DS.%26aulast%3DArold%26aufirst%3DS.%2BT.%26aulast%3DParrot%26aufirst%3DI.%26aulast%3DGuerlesquin%26aufirst%3DF.%26aulast%3DMorelli%26aufirst%3DX.%26aulast%3DCollette%26aufirst%3DY.%26atitle%3DProtein%2520protein%2520interaction%2520inhibition%2520%25282P2I%2529%2520combining%2520high%2520throughput%2520and%2520virtual%2520screening%253A%2520Application%2520to%2520the%2520HIV-1%2520Nef%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19256%26epage%3D19261%26doi%3D10.1073%2Fpnas.0707130104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Rationally designed multitarget anti-HIV agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1743</span><span class="NLM_x">–</span> <span class="NLM_lpage">1758</span><span class="refDoi"> DOI: 10.2174/0929867311320130011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F0929867311320130011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23410170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1743-1758&author=P.+Zhanauthor=X.+Liu&title=Rationally+designed+multitarget+anti-HIV+agents&doi=10.2174%2F0929867311320130011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally designed multitarget anti-HIV agents</span></div><div class="casAuthors">Zhan, P.; Liu, X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1743-1758</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multitarget-directed ligands (MTDLs), an emerging and appealing drug discovery strategy, utilizing a single chem. entity to inhibit multitargets, was confirmed to be effective in reducing the likelihood of drug resistance, diminishing problems of dosing complexity, drug-drug interactions and toxicities, as well as improving patient compliance.  The exploration of MTDL strategy should be valuable in anti-HIV drug discovery.  In this article, current knowledge and strategies for the rational design of the multitarget and selective anti-HIV agents are described and a no. of illustrative examples are given.  Moreover, the challenges, limitations and outlook of such novel drug design strategies are also presented, with a goal to highlight the representative paradigms in the rational design of MTDLs, and to help medicinal chemists discover the next generation of multitarget anti-HIV agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNRXcarV8VEbVg90H21EOLACvtfcHk0lhcQQax1xlAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jurw%253D&md5=b553b36a0107949cf8813b342aaeda1e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F0929867311320130011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320130011%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRationally%2520designed%2520multitarget%2520anti-HIV%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1743%26epage%3D1758%26doi%3D10.2174%2F0929867311320130011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Designed multiple ligands: an emerging anti-HIV drug discovery paradigm</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span><span class="refDoi"> DOI: 10.2174/138161209788453266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161209788453266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19519431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFCgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1893-1917&author=P.+Zhanauthor=X.+Liu&title=Designed+multiple+ligands%3A+an+emerging+anti-HIV+drug+discovery+paradigm&doi=10.2174%2F138161209788453266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Designed multiple ligands: an emerging anti-HIV drug discovery paradigm</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1893-1917</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently, the effect of AIDS single-target chemotherapy is severely compromised by the quick emergence of resistant HIV strains.  Highly active antiretroviral therapy (HAART) combines HIV reverse transcriptase inhibitors with protease inhibitors or integrase inhibitors, and successfully suppresses HIV viral load to an undetectable level, dramatically improving the life quality of AIDS patients.  However, the benefits of this approach are often compromised by poor patient compliance.  Recently, there has been a move toward multicomponent drugs whereby two or more agents are coformulated in a single tablet to make dosing regimes simpler and thereby to improve patient compliance, but there are significant risks involved in the development of multicomponent drugs.  Designed multiple ligands (DMLs) therapy as an emerging anti-HIV drug discovery paradigm, using a single entity to inhibit multitargets could yield improved patient compliance, thus reducing the likelihood of drug resistance.  The exploration of such multifunctional ligands has proven valuable for anti-HIV leads discovery.  However, presently many multifunctional scaffolds were first discovered by serendipity or screening; rational design by combining existing monofunctional scaffolds remains an enormous challenge.  A key issue in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  This review of literature examples introduce numerous attractive lead compds., capable of interfering with different stages of HIV infection and AIDS pathogenesis, which reveals trends and insights that might provide valuable clues for novel anti-HIV drug design and help medicinal chemists discover the next generation of multiple ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAXjh7m9EEnbVg90H21EOLACvtfcHk0lhcQQax1xlAHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFCgtro%253D&md5=7d3bba631dac7febeaf5e17af81cae6b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F138161209788453266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209788453266%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDesigned%2520multiple%2520ligands%253A%2520an%2520emerging%2520anti-HIV%2520drug%2520discovery%2520paradigm%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D1893%26epage%3D1917%26doi%3D10.2174%2F138161209788453266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span> </span><span class="NLM_article-title">Rationally designed dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3416</span><span class="NLM_x">–</span> <span class="NLM_lpage">3419</span><span class="refDoi"> DOI: 10.1021/jm070512p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070512p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3416-3419&author=Z.+Wangauthor=E.+M.+Bennettauthor=D.+J.+Wilsonauthor=C.+Salomonauthor=R.+Vince&title=Rationally+designed+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1021%2Fjm070512p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase</span></div><div class="casAuthors">Wang, Zhengqiang; Bennett, Eric M.; Wilson, Daniel J.; Salomon, Christine; Vince, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3416-3419</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bifunctional inhibitors were designed and synthesized based on 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) non-nucleoside reverse transcriptase (RT) inhibitors and diketoacid (DKA) integrase (IN) inhibitors.  Biochem. studies revealed activity against RT and IN at low nanomolar and low micromolar concns., resp.  Exceptionally low IC50 values from a cell-based assay were achieved along with remarkably high therapeutic indexes.  Compd. I was identified as the best compd. of the series (IC50: 24 nM against RT, 4.4 μM against IN, and 10 nM against HIV-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKQ5ZDoIQqLVg90H21EOLACvtfcHk0lja48MjK_Modg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D&md5=021d763f7f62919cc1fe9d010ab56e60</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm070512p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070512p%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DSalomon%26aufirst%3DC.%26aulast%3DVince%26aufirst%3DR.%26atitle%3DRationally%2520designed%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3416%26epage%3D3419%26doi%3D10.1021%2Fjm070512p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span> </span><span class="NLM_article-title">Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4202</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmc.2010.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20576573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntV2rtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4202-4211&author=Z.+Wangauthor=J.+Tangauthor=C.+E.+Salomonauthor=C.+D.+Dreisauthor=R.+Vince&title=Pharmacophore+and+structure-activity+relationships+of+integrase+inhibition+within+a+dual+inhibitor+scaffold+of+HIV+reverse+transcriptase+and+integrase&doi=10.1016%2Fj.bmc.2010.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase</span></div><div class="casAuthors">Wang, Zhengqiang; Tang, Jing; Salomon, Christine E.; Dreis, Christine D.; Vince, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4202-4211</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rational design of dually active inhibitors against human immunodeficiency virus (HIV) reverse transcriptase (RT) and integrase (IN) has proved viable with 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) type of non-nucleoside RT inhibitors (NNRTIs).  To establish the pharmacophore and study the structure-activity relationships (SAR) of integrase inhibition within a previously disclosed RT/IN dual inhibitor scaffold, new analogs featuring substitution at different sites of the HEPT ring were designed and synthesized.  These studies have revealed an IN inhibition pharmacophore that is merged with the known RT pharmacophore through a shared C-6 benzyl group.  Further SAR also demonstrated that optimal IN inhibition within our dual inhibitor scaffold requires a regiospecific (N-1) diketoacid (DKA)-carrying pendant with a certain length.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhRvNGIpI8pbVg90H21EOLACvtfcHk0lja48MjK_Modg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntV2rtb4%253D&md5=603652ca80d40b34489c6d6f1fa28dd6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DSalomon%26aufirst%3DC.%2BE.%26aulast%3DDreis%26aufirst%3DC.%2BD.%26aulast%3DVince%26aufirst%3DR.%26atitle%3DPharmacophore%2520and%2520structure-activity%2520relationships%2520of%2520integrase%2520inhibition%2520within%2520a%2520dual%2520inhibitor%2520scaffold%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4202%26epage%3D4211%26doi%3D10.1016%2Fj.bmc.2010.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">N-3 hydroxylation of pyrimidine-2,4-diones yields dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1021/ml1002162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlalurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=63-67&author=J.+Tangauthor=K.+Maddaliauthor=C.+D.+Dreisauthor=Y.+Y.+Shamauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=N-3+hydroxylation+of+pyrimidine-2%2C4-diones+yields+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1021%2Fml1002162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase</span></div><div class="casAuthors">Tang, Jing; Maddali, Kasthuraiah; Dreis, Christine D.; Sham, Yuk Y.; Vince, Robert; Pommier, Yves; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-67</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new mol. scaffold featuring an N-hydroxyimide functionality and capable of inhibiting both reverse transcriptase (RT) and integrase (IN) of human immunodeficiency virus (HIV) was rationally designed based on 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) non-nucleoside RT inhibitors (NNRTIs).  The design involves a minimal 3-N hydroxylation of the pyrimidine ring of HEPT compd. to yield a chelating triad which, along with the existing benzyl group, appeared to satisfy major structural requirements for IN binding.  In the mean time, this chem. modification did not severely compromise the compd.'s ability to inhibit RT.  A preliminary structure-activity relationship (SAR) study reveals that this N-3 OH is essential for IN inhibition and that the benzyl group on N-1 side chain is more important for IN binding than the one on C-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqONtaoARK-6bVg90H21EOLACvtfcHk0lja48MjK_Modg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlalurzP&md5=8b20b2ac50ef44513cdcfe51664790ca</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml1002162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002162%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DDreis%26aufirst%3DC.%2BD.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DN-3%2520hydroxylation%2520of%2520pyrimidine-2%252C4-diones%2520yields%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D63%26epage%3D67%26doi%3D10.1021%2Fml1002162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2282</span><span class="NLM_x">–</span> <span class="NLM_lpage">2292</span><span class="refDoi"> DOI: 10.1021/jm1014378</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1014378" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisl2qu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2282-2292&author=J.+Tangauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Y.+Shamauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=3-Hydroxypyrimidine-2%2C4-diones+as+an+inhibitor+scaffold+of+HIV+integrase&doi=10.1021%2Fjm1014378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase</span></div><div class="casAuthors">Tang, Jing; Maddali, Kasthuraiah; Sham, Yuk Y.; Vince, Robert; Pommier, Yves; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2282-2292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Integrase (IN) represents a clin. validated target for the development of antivirals against human immunodeficiency virus (HIV).  Inhibitors with a novel structure core are essential for combating resistance assocd. with known IN inhibitors (INIs).  We have previously disclosed a novel dual inhibitor scaffold of HIV IN and reverse transcriptase (RT).  Here we report the complete structure-activity relationship (SAR), mol. modeling, and resistance profile of this inhibitor type on IN inhibition.  These studies support an antiviral mechanism of dual inhibition against both IN and RT and validate 3-hydroxypyrimidine-2,4-diones as an IN inhibitor scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxF_3fkEp67Vg90H21EOLACvtfcHk0lja48MjK_Modg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisl2qu7Y%253D&md5=8b53b8997bd2623f3f17851dce6c2ed0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm1014378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014378%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D3-Hydroxypyrimidine-2%252C4-diones%2520as%2520an%2520inhibitor%2520scaffold%2520of%2520HIV%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2282%26epage%3D2292%26doi%3D10.1021%2Fjm1014378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2400</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2011.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21392991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12ku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2400-2402&author=J.+Tangauthor=K.+Maddaliauthor=C.+D.+Dreisauthor=Y.+Y.+Shamauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=6-Benzoyl-3-hydroxypyrimidine-2%2C4-diones+as+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1016%2Fj.bmcl.2011.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase</span></div><div class="casAuthors">Tang, Jing; Maddali, Kasthuraiah; Dreis, Christine D.; Sham, Yuk Y.; Vince, Robert; Pommier, Yves; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2400-2402</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-3-Hydroxylation of pyrimidine-2,4-diones was recently found to yield inhibitors of both HIV-1 reverse transcriptase (RT) and integrase (IN).  An extended series of analogs featuring a benzoyl group at the C-6 position of the pyrimidine ring was synthesized.  Through biochem. studies it was found that these new analogs are dually active against both RT and IN in low micromolar range.  Antiviral assays confirmed that these new inhibitors are active against HIV-1 in cell culture at nanomolar to low micromolar range, further validating 3-hydroxypyrimidine-2,4-diones as a viable scaffold for antiviral development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsIm-OLOGzF7Vg90H21EOLACvtfcHk0ligPLIUm_PLpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12ku7w%253D&md5=bcbbf988ce7835a8c6fcdf43241dc24e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DDreis%26aufirst%3DC.%2BD.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D6-Benzoyl-3-hydroxypyrimidine-2%252C4-diones%2520as%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2400%26epage%3D2402%26doi%3D10.1016%2Fj.bmcl.2011.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009–2013 update</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.2174/09298673113206660298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F09298673113206660298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24164196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=329-355&author=Y.+Songauthor=Z.+Fangauthor=P.+Zhanauthor=X.+Liu&title=Recent+advances+in+the+discovery+and+development+of+novel+HIV-1+NNRTI+platforms+%28Part+II%29%3A+2009%E2%80%932013+update&doi=10.2174%2F09298673113206660298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms (Part II): 2009-2013 Update</span></div><div class="casAuthors">Song, Yu-ning; Fang, Zengjun; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-355</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The long-term usage of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) eventually leads to rapid emergence of drug-resistant viruses and severe side effect.  Therefore, it is imperative to seek the addnl. NNRTIs with potent and broad spectrum anti-mutant activities, and excellent pharmacokinetic profiles.  The discovery of etravirine, rilpivirine and other successful examples has influenced the NNRTIs design strategy profoundly.  Sustained efforts in this area have led to the identification of many promising NNRTIs hits, leads and candidates for the last few years.  Hence, this review aims to highlight recent prominent advances in this field as well as contributions from our lab. toward the discovery of novel potent NNRTIs from 2009 to 2013 (by May).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zOLPDI7Lg7Vg90H21EOLACvtfcHk0ligPLIUm_PLpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOisb4%253D&md5=10535ebea845f8acaff293bc414216f1</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.2174%2F09298673113206660298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113206660298%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520HIV-1%2520NNRTI%2520platforms%2520%2528Part%2520II%2529%253A%25202009%25E2%2580%25932013%2520update%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D329%26epage%3D355%26doi%3D10.2174%2F09298673113206660298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit60b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006–2008 update</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2876</span><span class="NLM_x">–</span> <span class="NLM_lpage">2889</span><span class="refDoi"> DOI: 10.2174/092986709788803231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986709788803231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19689270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2876-2889&author=P.+Zhanauthor=X.+Liuauthor=Z.+Li&title=Recent+advances+in+the+discovery+and+development+of+novel+HIV-1+NNRTI+platforms%3A+2006%E2%80%932008+update&doi=10.2174%2F092986709788803231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60bR"><div class="casContent"><span class="casTitleNuber">60b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong; Li, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2876-2889</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently, the long-term usage of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV/AIDS patients eventually leads to the development of drug resistance and severe side effect.  Therefore, it is imperative to look for the novel NNRTIs with potent and broad spectrum anti-mutant activity that are also safe and have excellent pharmacokinetic profiles.  In this article, newly emerging NNRTIs scaffolds in recent three years, together with the underlying strategies for developing new generation HIV-1 NNRTIs with improved resilience to current drug resistant mutants, are reviewed and analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFdlFyWSotibVg90H21EOLACvtfcHk0ligPLIUm_PLpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLw%253D&md5=378adc5bb5cb7bf9345ae9ef2a7f5d09</span></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=10.2174%2F092986709788803231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803231%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520HIV-1%2520NNRTI%2520platforms%253A%25202006%25E2%2580%25932008%2520update%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2876%26epage%3D2889%26doi%3D10.2174%2F092986709788803231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit60c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">E1</span><span class="NLM_x">–</span> <span class="NLM_lpage">E72</span><span class="refDoi"> DOI: 10.1002/med.20241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fmed.20241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21523792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=E1-E72&issue=Suppl.+1&author=P.+Zhanauthor=X.+Chenauthor=D.+Liauthor=Z.+Fangauthor=E.+De+Clercqauthor=X.+Liu&title=HIV-1+NNRTIs%3A+structural+diversity%2C+pharmacophore+similarity%2C+and+implications+for+drug+design&doi=10.1002%2Fmed.20241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60cR"><div class="casContent"><span class="casTitleNuber">60c</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design</span></div><div class="casAuthors">Zhan, Peng; Chen, Xuwang; Li, Dongyue; Fang, Zengjun; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">E1-E72</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nonnucleoside reverse transcriptase inhibitors (NNRTIs) nowadays represent very potent and most promising anti-AIDS agents that specifically target the HIV-1 reverse transcriptase (RT).  However, the effectiveness of NNRTI drugs can be hampered by rapid emergence of drug-resistant viruses and severe side effects upon long-term use.  Therefore, there is an urgent need to develop novel, highly potent NNRTIs with broad spectrum antiviral activity and improved pharmacokinetic properties, and more efficient strategies that facilitate and shorten the drug discovery process would be extremely beneficial.  Fortunately, the structural diversity of NNRTIs provided a wide space for novel lead discovery, and the pharmacophore similarity of NNRTIs gave valuable hints for lead discovery and optimization.  More importantly, with the continued efforts in the development of computational tools and increased crystallog. information on RT/NNRTI complexes, structure-based approaches using a combination of traditional medicinal chem., structural biol., and computational chem. are being used increasingly in the design of NNRTIs.  First, this review covers two decades of research and development for various NNRTI families based on their chem. scaffolds, and then describes the structural similarity of NNRTIs.  We have attempted to assemble a comprehensive overview of the general approaches in NNRTI lead discovery and optimization reported in the literature during the last decade.  The successful applications of medicinal chem. strategies, crystallog., and computational tools for designing novel NNRTIs are highlighted.  Future directions for research are also outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7jjFerOFrbVg90H21EOLACvtfcHk0lhFez3xqJf0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWmsbo%253D&md5=08cc3f8e0815f70ee052ccda81d75dfb</span></div><a href="/servlet/linkout?suffix=cit60c&amp;dbid=16384&amp;doi=10.1002%2Fmed.20241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20241%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DHIV-1%2520NNRTIs%253A%2520structural%2520diversity%252C%2520pharmacophore%2520similarity%252C%2520and%2520implications%2520for%2520drug%2520design%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26issue%3DSuppl.%25201%26spage%3DE1%26epage%3DE72%26doi%3D10.1002%2Fmed.20241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit60d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1517/13543776.2011.568481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F13543776.2011.568481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21457080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFantrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=717-796&author=P.+Zhanauthor=X.+Liu&title=Novel+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors%3A+a+patent+review+%282005+-+2010%29&doi=10.1517%2F13543776.2011.568481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60dR"><div class="casContent"><span class="casTitleNuber">60d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 -- 2010)</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">717-796</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Non-nucleoside reverse transcriptase inhibitors (NNRTIs) form the backbone of antiretroviral treatment for many HIV-infected individuals.  The unique antiviral activity, high specificity and low toxicity assocd. with this class of agents make them a frequent choice for first-line therapy.  However, the effectiveness of NNRTI drugs can be hampered by the rapid emergence of drug-resistant viruses, poor pharmacokinetic (PK) properties and severe side effects in long-term usage.  Therefore, there is an urgent need to develop novel NNRTIs without such limitations.  An anal. of this vast group of already existing inhibitors should constitute the basis of the effort toward the development of more potent, promising drugs or candidates.Areas covered: The present review provides an overview of NNRTI research from 2005 to 2010, and highlights some important medicinal chem. principles and strategies in the development of NNRTIs.Expert opinion: An in-depth anal. of the common binding configuration and structural features of NNRTIs, as well as the underlying clues to the follow-on''-based chem. evolution efforts (including the key medicinal chem. principles and strategies: bioisosteric replacement, mol. hybridization, scaffold hopping, prodrug, etc.) has greatly accelerated the optimization of the pharmacodynamic (PD) and PK profiles.  There is still a good deal of opportunity to discover new highly potent NNRTIs or novel scaffolds with unconventional mechanisms for reverse transcriptase (RT) inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYU8akFVz6W7Vg90H21EOLACvtfcHk0lhFez3xqJf0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFantrc%253D&md5=a6b5c62bd7d1183413c380397bc610c1</span></div><a href="/servlet/linkout?suffix=cit60d&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.568481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.568481%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DNovel%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282005%2520-%25202010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D717%26epage%3D796%26doi%3D10.1517%2F13543776.2011.568481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit60e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Design strategies of novel NNRTIs to overcome drug resistance</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3903</span><span class="NLM_x">–</span> <span class="NLM_lpage">3917</span><span class="refDoi"> DOI: 10.2174/092986709789178019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986709789178019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19747133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=3903-3917&author=P.+Zhanauthor=X.+Liuauthor=Z.+Liauthor=C.+Pannecouqueauthor=E.+De+Clercq&title=Design+strategies+of+novel+NNRTIs+to+overcome+drug+resistance&doi=10.2174%2F092986709789178019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60eR"><div class="casContent"><span class="casTitleNuber">60e</span><div class="casTitle"><span class="NLM_cas:atitle">Design strategies of novel NNRTIs to overcome drug resistance</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong; Li, Zhenyu; Pannecouque, Christophe; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3903-3917</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are very potent and most promising anti-AIDS drugs that specifically inhibit HIV-1 reverse transcriptase (RT).  However, to a great extent, the efficacy of NNRTI drugs is impaired by rapid emergence of drug-resistance mutations.  Fortunately, detailed anal. of a wide range of crystal structures of HIV-1 RT/NNRTI complexes together with data on drug resistance mutations has identified factors important for design of inhibitors and resilience to mutations, such as, exhibiting conformational flexibility and positional adaptability of NNRTIs, forming extensive main chain hydrogen bonding, targeting highly conserved residues in HIV-1 RT and possessing unconventional mechanisms for NNRTI-mediated inhibition of RT.  Besides, the plasticity of NNRTIs binding pocket (NNIBP) also provides a broad space for the discovery of new generations of NNRTIs.  For instance, the composite binding pocket, integrating all available crystal structure information about the NNRTI binding site of HIV RT, was demonstrated to be an effective tool to better understand the flexible nature of the binding pocket and to identify specific inhibitors.  The RT/solvent interface proved to be an attractive site for incorporating a moiety to improve water soly. and pharmacokinetics or introducing a second pharmacophore to construct multifunctional ligand.  Totally, the characterization of NNRTIs and NNIBP may help in the design of more effective drugs that are potent toward wild type and drug-resistant strains of RT.  In this paper we attempt to translate the general knowledge gained from a large no. of related literature into a set of medicinal chem. strategies to improve the drug resistance profile of NNRTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfBY0F4M_eN7Vg90H21EOLACvtfcHk0lhFez3xqJf0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCktbvM&md5=4834066bfce8ae018df14be7e84d5a90</span></div><a href="/servlet/linkout?suffix=cit60e&amp;dbid=16384&amp;doi=10.2174%2F092986709789178019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709789178019%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DDesign%2520strategies%2520of%2520novel%2520NNRTIs%2520to%2520overcome%2520drug%2520resistance%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D3903%26epage%3D3917%26doi%3D10.2174%2F092986709789178019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit60f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 - 2014)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1517/13543776.2014.964685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F13543776.2014.964685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25313716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1199-1227&author=X.+Liauthor=L.+Zhangauthor=Y.+Tianauthor=Y.+Songauthor=P.+Zhanauthor=X.+Liu&title=Novel+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors%3A+a+patent+review+%282011+-+2014%29&doi=10.1517%2F13543776.2014.964685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60fR"><div class="casContent"><span class="casTitleNuber">60f</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 - 2014)</span></div><div class="casAuthors">Li, Xiao; Zhang, Lingzi; Tian, Ye; Song, Yu'ning; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1199-1227</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: There is a continuous need for next-generation non-nucleoside RT inhibitors (NNRTIs) with different resistance profiles, improved safety, excellent tolerability, and favorable physicochem. properties.  Areas covered: In this review we intend to narrate a general and cutting-edge overview of current state of NNRTI patents during the 2011 - 2014 (June) period and future perspectives.  Particular focus is placed on the highlighting of some emerging medicinal chem. principles and insights in the discovery and development of NNRTIs.  Expert opinion: The development of effective NNRTIs is moving on from trial-and-error approaches to sophisticated subconscious strategies.  Several newly emerging structure-based virtual screening methodologies (such as Monte Carlo free energy perturbation calcns.) or new drug design insights, such as taking full use of the specific noncovalent reverse transcriptase/NNRTIs interactions, stereochem. diversity-oriented conformational restriction, novel strategies to enhance soly. and early absorption, distribution, metab., excretion, and toxicity (ADMET) assessment, will continue to evolve to complement the classical NNRTIs discovery approaches (structure-based core-refining and substituents-decorating).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovB7ip_ksH-7Vg90H21EOLACvtfcHk0ljGOrcgE2KFsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgur%252FP&md5=52fbb7a65dd285055d8450f5e0cc7cd7</span></div><a href="/servlet/linkout?suffix=cit60f&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.964685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.964685%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DNovel%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282011%2520-%25202014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1199%26epage%3D1227%26doi%3D10.1517%2F13543776.2014.964685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Vernekar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kankanala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1021/jm501132s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501132s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=651-664&author=S.+K.+Vernekarauthor=Z.+Liuauthor=E.+Nagyauthor=L.+Millerauthor=K.+A.+Kirbyauthor=D.+J.+Wilsonauthor=J.+Kankanalaauthor=S.+G.+Sarafianosauthor=M.+A.+Parniakauthor=Z.+Wang&title=Design%2C+synthesis%2C+biochemical%2C+and+antiviral+evaluations+of+C6+benzyl+and+C6+biarylmethyl+substituted+2-hydroxylisoquinoline-1%2C3-diones%3A+dual+inhibition+against+HIV+reverse+transcriptase-associated+RNase+H+and+polymerase+with+antiviral+activities&doi=10.1021%2Fjm501132s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities</span></div><div class="casAuthors">Vernekar, Sanjeev Kumar V.; Liu, Zheng; Nagy, Eva; Miller, Lena; Kirby, Karen A.; Wilson, Daniel J.; Kankanala, Jayakanth; Sarafianos, Stefan G.; Parniak, Michael A.; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reverse transcriptase (RT) assocd. RNase H (RNase H) remains the only virally encoded enzymic function not targeted by current chemotherapy against human immunodeficiency virus (HIV).  Although numerous chemotypes have been reported to inhibit HIV RNase H biochem., few show significant antiviral activity against HIV.  We report herein the design, synthesis, and biol. evaluations of a novel variant of 2-hydroxyisoquinoline-1,3-dione (HID) scaffold featuring a crucial C-6 benzyl or biarylmethyl moiety, e. g., I.  The synthesis involved a recently reported metal-free direct benzylation between tosylhydrazone and boronic acid, which allowed the generation of structural diversity for the hydrophobic arom. region.  Biochem. studies showed that the C-6 benzyl and biarylmethyl HID analogs, previously unknown chemotypes, consistently inhibited HIV RT-assocd. RNase H and polymerase with IC50s in low to submicromolar range.  The obsd. dual inhibitory activity remained uncompromised against RT mutants resistant to non-nucleoside RT inhibitors (NNRTIs), suggesting the involvement of binding site(s) other than the NNRTI binding pocket.  Intriguingly, these same compds. inhibited the polymerase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Escherichia coli RNase H.  Addnl. biochem. testing revealed a substantially reduced level of inhibition against HIV integrase.  Mol. docking corroborates favorable binding of these analogs to the active site of HIV RNase H.  Finally, a no. of these analogs also demonstrated antiviral activity at low micromolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeenALml-35bVg90H21EOLACvtfcHk0ljGOrcgE2KFsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO&md5=a4574233b65a5a0efd3634a2011fc94f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm501132s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501132s%26sid%3Dliteratum%253Aachs%26aulast%3DVernekar%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DKankanala%26aufirst%3DJ.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%252C%2520biochemical%252C%2520and%2520antiviral%2520evaluations%2520of%2520C6%2520benzyl%2520and%2520C6%2520biarylmethyl%2520substituted%25202-hydroxylisoquinoline-1%252C3-diones%253A%2520dual%2520inhibition%2520against%2520HIV%2520reverse%2520transcriptase-associated%2520RNase%2520H%2520and%2520polymerase%2520with%2520antiviral%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D651%26epage%3D664%26doi%3D10.1021%2Fjm501132s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pescatori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Métifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masoaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzucoli Crucitti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madia, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccoliti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scipione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leva, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grice, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">N-Substituted quinolinonyl diketo acid derivatives as HIV integrase strand transfer inhibitors and their activity against RNase H function of reverse transcriptase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4610</span><span class="NLM_x">–</span> <span class="NLM_lpage">4623</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00159</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00159" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXot1Sqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4610-4623&author=L.+Pescatoriauthor=M.+M%C3%A9tifiotauthor=S.+Chungauthor=T.+Masoakaauthor=G.+Cuzzucoli+Crucittiauthor=A.+Messoreauthor=G.+Pupoauthor=V.+N.+Madiaauthor=F.+Saccolitiauthor=L.+Scipioneauthor=S.+Tortorellaauthor=F.+S.+Di+Levaauthor=S.+Cosconatiauthor=L.+Marinelliauthor=E.+Novellinoauthor=S.+F.+Le+Griceauthor=Y.+Pommierauthor=C.+Marchandauthor=R.+Costiauthor=R.+Di+Santo&title=N-Substituted+quinolinonyl+diketo+acid+derivatives+as+HIV+integrase+strand+transfer+inhibitors+and+their+activity+against+RNase+H+function+of+reverse+transcriptase&doi=10.1021%2Facs.jmedchem.5b00159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62aR"><div class="casContent"><span class="casTitleNuber">62a</span><div class="casTitle"><span class="NLM_cas:atitle">N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase</span></div><div class="casAuthors">Pescatori, Luca; Metifiot, Mathieu; Chung, Suhman; Masoaka, Takashi; Cuzzucoli Crucitti, Giuliana; Messore, Antonella; Pupo, Giovanni; Madia, Valentina Noemi; Saccoliti, Francesco; Scipione, Luigi; Tortorella, Silvano; Di Leva, Francesco Saverio; Cosconati, Sandro; Marinelli, Luciana; Novellino, Ettore; Le Grice, Stuart F. J.; Pommier, Yves; Marchand, Christophe; Costi, Roberta; Di Santo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4610-4623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Aralkyl)oxoquinolinyl hydroxyoxobutenoates I [R = ArCH2, Ph(CH2)4; R1 = H, Cl; R2 = H, Cl; R3 = H, Et; Ar = Ph, 2-FC6H4, 2-MeOC6H4, 3-FC6H4, 3-MeOC6H4, 4-ClC6H4, 4-HOC6H4, 4-MeOC6H4, 4-O2NC6H4, 2,4-F2C6H3, 2,5-F2C6H3, 2,6-F2C6H3, 3,4-F2C6H3, 3,5-F2C6H3, 2,4-Cl2C6H3, 2,6-Cl2C6H3, 2,4-Me2C6H3, 3,5-Me2C6H3, 3-Cl-2-FC6H3, 3-Cl-4-FC6H3, 4-pyridinyl, 2-naphthyl, 2-quinolinyl] were prepd. as HIV-1 integrase inhibitors selective for inhibition of strand transfer over 3'-processing and RNase H activities; their inhibition of HIV-1 integrase and their inhibition of HIV-1 and toxicity to human cells were detd.  In vitro, the most potent compd. was I (R = 2,4-F2C6H3CH2; R1 = R2 = R3 = H) (IC50 = 10 nM), while the most active compds. against HIV-infected cells were ester derivs. I (R = 2,4-F2C6H3CH2, 2,6-F2C6H3CH2; R1 = R2 = H; R3 = Et).  In general, the activity of I against RNase H was negligible, with only a few compds. active at concns. higher than 10 μM.  The binding mode of I (R = 2,4-F2C6H3CH2; R1 = R2 = R3 = H) within the integrase catalytic core domain (CCD) is described as well as its binding mode within the RNase H catalytic site to rationalize its selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkRG7fbljvyLVg90H21EOLACvtfcHk0ljGOrcgE2KFsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXot1Sqs78%253D&md5=c539fa70d35ac98be4f8e6b0d813a722</span></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00159%26sid%3Dliteratum%253Aachs%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DM%25C3%25A9tifiot%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DMasoaka%26aufirst%3DT.%26aulast%3DCuzzucoli%2BCrucitti%26aufirst%3DG.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DPupo%26aufirst%3DG.%26aulast%3DMadia%26aufirst%3DV.%2BN.%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLe%2BGrice%26aufirst%3DS.%2BF.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DN-Substituted%2520quinolinonyl%2520diketo%2520acid%2520derivatives%2520as%2520HIV%2520integrase%2520strand%2520transfer%2520inhibitors%2520and%2520their%2520activity%2520against%2520RNase%2520H%2520function%2520of%2520reverse%2520transcriptase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4610%26epage%3D4623%26doi%3D10.1021%2Facs.jmedchem.5b00159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cuzzucoli Crucitti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Métifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madia, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccoliti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scipione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadeddu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1928</span><span class="refDoi"> DOI: 10.1021/jm501799k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501799k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1915-1928&author=G.+Cuzzucoli+Crucittiauthor=M.+M%C3%A9tifiotauthor=L.+Pescatoriauthor=A.+Messoreauthor=V.+N.+Madiaauthor=G.+Pupoauthor=F.+Saccolitiauthor=L.+Scipioneauthor=S.+Tortorellaauthor=F.+Espositoauthor=A.+Coronaauthor=M.+Cadedduauthor=C.+Marchandauthor=Y.+Pommierauthor=E.+Tramontanoauthor=R.+Costiauthor=R.+Di+Santo&title=Structure-activity+relationship+of+pyrrolyl+diketo+acid+derivatives+as+dual+inhibitors+of+HIV-1+integrase+and+reverse+transcriptase+ribonuclease+H+domain&doi=10.1021%2Fjm501799k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=10.1021%2Fjm501799k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501799k%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzucoli%2BCrucitti%26aufirst%3DG.%26aulast%3DM%25C3%25A9tifiot%26aufirst%3DM.%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DMadia%26aufirst%3DV.%2BN.%26aulast%3DPupo%26aufirst%3DG.%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DCorona%26aufirst%3DA.%26aulast%3DCadeddu%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DTramontano%26aufirst%3DE.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520of%2520pyrrolyl%2520diketo%2520acid%2520derivatives%2520as%2520dual%2520inhibitors%2520of%2520HIV-1%2520integrase%2520and%2520reverse%2520transcriptase%2520ribonuclease%2520H%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1915%26epage%3D1928%26doi%3D10.1021%2Fjm501799k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.2174/092986713805076649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986713805076649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23116144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=815-832&author=Y.+Songauthor=P.+Zhanauthor=X.+Liauthor=D.+Raiauthor=E.+De+Clercqauthor=X.+Liu&title=Multivalent+agents%3A+a+novel+concept+and+preliminary+practice+in+anti-HIV+drug+discovery&doi=10.2174%2F092986713805076649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span></div><div class="casAuthors">Song, Yu-ning; Zhan, Peng; Li, Xiao; Rai, Diwakar; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">815-832</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The term multivalency (polyvalency) in the biol. science is defined as the simultaneous binding of multiple ligands to one receptor (or multiple receptors to one ligand).  The possibility of gaining potency and selectivity was significantly increased through the use of multivalent ligand as a homo- or hetero-dimer, thus multivalent ligands provided a more attractive strategy to design novel anti-HIV agents with therapeutic applications.  Moreover, similar to phenomenon of multivalency, an alternative strategy is called the "mixed sites inhibitor", viz. a single mol. that possesses enough chem. space to maximize interactions with its complementary binding pocket, or to bind simultaneously in more than one regions in a target.  Actually, the addn. of a third heterocyclic nucleus to the parent compd. resulted in "mixed sites" anti-HIV agents with broad spectrum of activities against the mutant HIV-1 strains.  Based on current representative examples, the present article provided a brief review on the rationale for the design of different classes of multivalency anti-HIV agents and also discussed the advantages over their monomeric counterparts, providing a novel paradigm to facilitate the development of anti-HIV/AIDS therapeutic agents in treatment of HIV infected community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeQQtvZeCCbVg90H21EOLACvtfcHk0ljH5sGS7diWTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D&md5=118fe3f5df6cced753c2e27fdcf77112</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F092986713805076649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986713805076649%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRai%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DMultivalent%2520agents%253A%2520a%2520novel%2520concept%2520and%2520preliminary%2520practice%2520in%2520anti-HIV%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D815%26epage%3D832%26doi%3D10.2174%2F092986713805076649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Bailey, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyidogan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Caro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span> </span><span class="NLM_article-title">Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3959</span><span class="NLM_x">–</span> <span class="NLM_lpage">3968</span><span class="refDoi"> DOI: 10.1021/jm400160s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400160s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3959-3968&author=C.+M.+Baileyauthor=T.+J.+Sullivanauthor=P.+Iyidoganauthor=J.+Tirado-Rivesauthor=R.+Chungauthor=J.+Ruiz-Caroauthor=E.+Mohamedauthor=W.+L.+Jorgensenauthor=R.+Hunterauthor=K.+S.+Anderson&title=Bifunctional+inhibition+of+human+immunodeficiency+virus+type+1+reverse+transcriptase%3A+mechanism+and+proof-of-concept+as+a+novel+therapeutic+design+strategy&doi=10.1021%2Fjm400160s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy</span></div><div class="casAuthors">Bailey, Christopher M.; Sullivan, Todd J.; Iyidogan, Pinar; Tirado-Rives, Julian; Chung, Raymond; Ruiz-Caro, Juliana; Mohamed, Ebrahim; Jorgensen, William L.; Hunter, Roger; Anderson, Karen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3959-3968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is a major target for currently approved anti-HIV drugs.  These drugs are divided into two classes: nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs).  This study illustrates the synthesis and biochem. evaluation of a novel bifunctional RT inhibitor utilizing d4T (NRTI) and a TMC-deriv. (a diarylpyrimidine NNRTI) linked via a poly(ethylene glycol) (PEG) linker.  HIV-1 RT successfully incorporates the triphosphate of d4T-4PEG-TMC bifunctional inhibitor in a base-specific manner.  Moreover, this inhibitor demonstrates low nanomolar potency that has 4.3-fold and 4300-fold enhancement of polymn. inhibition in vitro relative to the parent TMC-deriv. and d4T, resp.  This study serves as a proof-of-concept for the development and optimization of bifunctional RT inhibitors as potent inhibitors of HIV-1 viral replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruGVBT61MtubVg90H21EOLACvtfcHk0ljH5sGS7diWTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWitr8%253D&md5=47a61d684ef88a76a90e3aae9b40b93e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm400160s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400160s%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DC.%2BM.%26aulast%3DSullivan%26aufirst%3DT.%2BJ.%26aulast%3DIyidogan%26aufirst%3DP.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DRuiz-Caro%26aufirst%3DJ.%26aulast%3DMohamed%26aufirst%3DE.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26atitle%3DBifunctional%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%253A%2520mechanism%2520and%2520proof-of-concept%2520as%2520a%2520novel%2520therapeutic%2520design%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3959%26epage%3D3968%26doi%3D10.1021%2Fjm400160s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Piao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basavapathruni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyidogan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutschman, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span> </span><span class="NLM_article-title">Bifunctional inhibition of HIV-1 reverse transcriptase: a first step in designing a bifunctional triphosphate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1518</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.12.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1511-1518&author=D.+Piaoauthor=A.+Basavapathruniauthor=P.+Iyidoganauthor=G.+Daiauthor=W.+Hinzauthor=A.+S.+Rayauthor=E.+Murakamiauthor=J.+Y.+Fengauthor=F.+Youauthor=G.+E.+Dutschmanauthor=D.+J.+Austinauthor=K.+A.+Parkerauthor=K.+S.+Anderson&title=Bifunctional+inhibition+of+HIV-1+reverse+transcriptase%3A+a+first+step+in+designing+a+bifunctional+triphosphate&doi=10.1016%2Fj.bmcl.2012.12.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPiao%26aufirst%3DD.%26aulast%3DBasavapathruni%26aufirst%3DA.%26aulast%3DIyidogan%26aufirst%3DP.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DHinz%26aufirst%3DW.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DYou%26aufirst%3DF.%26aulast%3DDutschman%26aufirst%3DG.%2BE.%26aulast%3DAustin%26aufirst%3DD.%2BJ.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26atitle%3DBifunctional%2520inhibition%2520of%2520HIV-1%2520reverse%2520transcriptase%253A%2520a%2520first%2520step%2520in%2520designing%2520a%2520bifunctional%2520triphosphate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1511%26epage%3D1518%26doi%3D10.1016%2Fj.bmcl.2012.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Adair, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, K. A.</span><span> </span><span class="NLM_article-title">Antibody-drug conjugates - a perfect synergy</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1517/14712598.2012.693473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F14712598.2012.693473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22650648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wls73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1191-1206&author=J.+R.+Adairauthor=P.+W.+Howardauthor=J.+A.+Hartleyauthor=D.+G.+Williamsauthor=K.+A.+Chester&title=Antibody-drug+conjugates+-+a+perfect+synergy&doi=10.1517%2F14712598.2012.693473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-drug conjugates - a perfect synergy</span></div><div class="casAuthors">Adair, John R.; Howard, Philip W.; Hartley, John A.; Williams, David G.; Chester, Kerry A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1191-1206</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: There is a great unmet need for effective new treatments in cancer, which continues to be a major cause of death.  Antibody-drug conjugates (ADCs) are emerging, after a long gestation, as a class of biopharmaceuticals with the potential to address this need by directing highly potent cytotoxic drugs to their point of action.  There is increasing interest in ADCs by major pharmaceutical companies and a growing pipeline of candidates for clin. use.  This review summarises progress with development of this new class of drugs.Areas covered: The authors describe sep. the antibody and drug elements of ADCs and then examine the technol. and consequences of linkage.  The work is presented in the light of recent developments in the design, using clin. examples where possible.Expert opinion: Since their emergence as independent drugs, antibodies and chemotherapy are being brought together in effective synergy.  The conjunction is timely: many of the tech. challenges in prepg. antibodies have been addressed; potent new drugs are available and linker technol. is advancing apace.  ADCs however are not just a sum of their individual parts.  The current challenge is in understanding the holistic nature of this exciting class of drugs that promise a new avenue for cancer treatment.  Target selection, the interaction of ADC with tumor and off-tumor targets and the internalisation of ADCs, are crit. to the effective maturation of ADC technol.  Ongoing recent developments in attachment sites and linker chem. can provide fine-tuning of drug loading, elements of ADC PK and off-target ADC toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY30NZYFPh-rVg90H21EOLACvtfcHk0liREwCVUU1A8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wls73P&md5=e3604ba9b52c917335b4c5568e54057c</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1517%2F14712598.2012.693473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2012.693473%26sid%3Dliteratum%253Aachs%26aulast%3DAdair%26aufirst%3DJ.%2BR.%26aulast%3DHoward%26aufirst%3DP.%2BW.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BG.%26aulast%3DChester%26aufirst%3DK.%2BA.%26atitle%3DAntibody-drug%2520conjugates%2520-%2520a%2520perfect%2520synergy%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2012%26volume%3D12%26spage%3D1191%26epage%3D1206%26doi%3D10.1517%2F14712598.2012.693473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Parker, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domaoal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, D. A.</span><span> </span><span class="NLM_article-title">An antibody-recruiting small molecule that targets HIV gp120</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">16392</span><span class="NLM_x">–</span> <span class="NLM_lpage">16394</span><span class="refDoi"> DOI: 10.1021/ja9057647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9057647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1yjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=16392-16394&author=C.+G.+Parkerauthor=R.+A.+Domaoalauthor=K.+S.+Andersonauthor=D.+A.+Spiegel&title=An+antibody-recruiting+small+molecule+that+targets+HIV+gp120&doi=10.1021%2Fja9057647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">An Antibody-Recruiting Small Molecule That Targets HIV gp120</span></div><div class="casAuthors">Parker, Christopher G.; Domaoal, Robert A.; Anderson, Karen S.; Spiegel, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16392-16394</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV/AIDS is a global pandemic for which new treatment strategies are desperately needed.  The authors have designed a novel small mol.I [X = (CH2CH2O)5, Y = = (CH2CH2O)3], designated as ARM-H, that has the potential to interfere with HIV survival through two mechanisms: (1) by recruiting antibodies to gp120-expressing virus particles and infected human cells, thus enhancing their uptake and destruction by the human immune system, and (2) by binding the viral glycoprotein gp120, inhibiting its interaction with the human protein CD4 and preventing virus entry.  Here the authors demonstrate that ARM-H I is capable of simultaneously binding gp120, a component of the Env surface viral glycoprotein (found on the surface of both HIV and virus-infected cells) and anti-2,4-dinitrophenyl antibodies (already present in the human bloodstream).  The ternary complex formed between the antibody, ARM-H I, and gp120 is immunol. active and leads to the complement-mediated destruction of Env-expressing cells.  Furthermore, ARM-H prevents virus entry into human T-cells and should therefore be capable of inhibiting virus replication through two mutually reinforcing mechanisms (inhibition of virus entry and antibody-mediated killing).  These studies demonstrate the viable anti-HIV activity of antibody-recruiting small mols. and have the potential to initiate novel paradigms in HIV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb1oDLtlzoG7Vg90H21EOLACvtfcHk0liREwCVUU1A8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1yjtLvN&md5=1c8913f7b4ac456ac7ccf2138f29fe0a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja9057647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9057647%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DDomaoal%26aufirst%3DR.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26aulast%3DSpiegel%26aufirst%3DD.%2BA.%26atitle%3DAn%2520antibody-recruiting%2520small%2520molecule%2520that%2520targets%2520HIV%2520gp120%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D16392%26epage%3D16394%26doi%3D10.1021%2Fja9057647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Parker, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglass, E. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jawanda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spasov, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domaoal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, D. A.</span><span> </span><span class="NLM_article-title">Illuminating HIV gp120-ligand recognition through computationally-driven optimization of antibody-recruiting molecules</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2317</span><span class="refDoi"> DOI: 10.1039/c4sc00484a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2Fc4sc00484a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25379167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFSqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2311-2317&author=C.+G.+Parkerauthor=M.+K.+Dahlgrenauthor=R.+N.+Taoauthor=D.+T.+Liauthor=E.+F.+Douglassauthor=T.+Shodaauthor=N.+Jawandaauthor=K.+A.+Spasovauthor=S.+Leeauthor=N.+Zhouauthor=R.+A.+Domaoalauthor=R.+E.+Suttonauthor=K.+S.+Andersonauthor=W.+L.+Jorgensenauthor=M.+Krystalauthor=D.+A.+Spiegel&title=Illuminating+HIV+gp120-ligand+recognition+through+computationally-driven+optimization+of+antibody-recruiting+molecules&doi=10.1039%2Fc4sc00484a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating HIV gp120-ligand recognition through computationally-driven optimization of antibody-recruiting molecules</span></div><div class="casAuthors">Parker, Christopher G.; Dahlgren, Markus K.; Tao, Ran N.; Li, Don T.; Douglass, Eugene F.; Shoda, Takuji; Jawanda, Navneet; Spasov, Krasimir A.; Lee, Sangil; Zhou, Nannan; Domaoal, Robert A.; Sutton, Richard E.; Anderson, Karen S.; Krystal, Mark; Jorgensen, William L.; Spiegel, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2311-2317</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Here we report on the structure-based optimization of antibody-recruiting mols. targeting HIV gp120 (ARM-H).  These studies have leveraged a combination of medicinal chem., biochem. and cellular assay anal., and computation.  Our findings have afforded an optimized analog of ARM-H, which is ∼1000 fold more potent in gp120-binding and MT-2 antiviral assays than our previously reported deriv.  Furthermore, computational anal., taken together with exptl. data, provides evidence that azaindole- and indole-based attachment inhibitors bind gp120 at an accessory hydrophobic pocket beneath the CD4-binding site and can also adopt multiple distinct binding modes in interacting with gp120.  These results are likely to prove enabling in the development of novel HIV attachment inhibitors, and more broadly, they suggest novel applications for ARMs as probes of conformationally flexible systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1hVkLLcqd7Vg90H21EOLACvtfcHk0liREwCVUU1A8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFSqs7s%253D&md5=9ecc41d0ae77c6f0a5804d3b74127687</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2Fc4sc00484a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4sc00484a%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DTao%26aufirst%3DR.%2BN.%26aulast%3DLi%26aufirst%3DD.%2BT.%26aulast%3DDouglass%26aufirst%3DE.%2BF.%26aulast%3DShoda%26aufirst%3DT.%26aulast%3DJawanda%26aufirst%3DN.%26aulast%3DSpasov%26aufirst%3DK.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DDomaoal%26aufirst%3DR.%2BA.%26aulast%3DSutton%26aufirst%3DR.%2BE.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DKrystal%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DD.%2BA.%26atitle%3DIlluminating%2520HIV%2520gp120-ligand%2520recognition%2520through%2520computationally-driven%2520optimization%2520of%2520antibody-recruiting%2520molecules%26jtitle%3DChem.%2520Sci.%26date%3D2014%26volume%3D5%26spage%3D2311%26epage%3D2317%26doi%3D10.1039%2Fc4sc00484a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inokuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsubo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbas, C. F.,  3rd</span><span> </span><span class="NLM_article-title">Chemically programmed antibodies as hiv-1 attachment inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1021/ml400097z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400097z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=460-465&author=S.+Satoauthor=T.+Inokumaauthor=N.+Otsuboauthor=D.+R.+Burtonauthor=C.+F.+Barbas&title=Chemically+programmed+antibodies+as+hiv-1+attachment+inhibitors&doi=10.1021%2Fml400097z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fml400097z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400097z%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DInokuma%26aufirst%3DT.%26aulast%3DOtsubo%26aufirst%3DN.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DChemically%2520programmed%2520antibodies%2520as%2520hiv-1%2520attachment%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D460%26epage%3D465%26doi%3D10.1021%2Fml400097z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Segall, M. D.</span><span> </span><span class="NLM_article-title">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span><span class="refDoi"> DOI: 10.2174/138161212799436430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161212799436430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22316157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1292-1310&author=M.+D.+Segall&title=Multi-parameter+optimization%3A+identifying+high+quality+compounds+with+a+balance+of+properties&doi=10.2174%2F138161212799436430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span></div><div class="casAuthors">Segall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1292-1310</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful, efficacious and safe drug must have a balance of properties, including potency against its intended target, appropriate absorption, distribution, metab., and elimination (ADME) properties and an acceptable safety profile.  Achieving this balance of, often conflicting, requirements is a major challenge in drug discovery.  Approaches to simultaneously optimizing many factors in a design are broadly described under the term "multi-parameter optimization" (MPO).  In this review, we will describe how MPO can be applied to efficiently design and select high quality compds. and describe the range of methods that have been employed in drug discovery, including; simple "rules of thumb" such as Lipinski's rule; desirability functions; Pareto optimization; and probabilistic approaches that take into consideration the uncertainty in all drug discovery data due to predictive error and exptl. variability.  We will explore how these methods have been applied to predicted and exptl. data to reduce attrition and improve the productivity of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPFOVyg2ehWbVg90H21EOLACvtfcHk0lhB9-40XRsY-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D&md5=43f90ad751fd2c0bc47715f465ef31b3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.2174%2F138161212799436430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436430%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26atitle%3DMulti-parameter%2520optimization%253A%2520identifying%2520high%2520quality%2520compounds%2520with%2520a%2520balance%2520of%2520properties%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1292%26epage%3D1310%26doi%3D10.2174%2F138161212799436430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Nicolaou, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span> </span><span class="NLM_article-title">Multi-objective optimization methods in drug design</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e427</span><span class="NLM_x">–</span> <span class="NLM_lpage">e435</span><span class="refDoi"> DOI: 10.1016/j.ddtec.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ddtec.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24050140" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=e427-e435&author=C.+A.+Nicolaouauthor=N.+Brown&title=Multi-objective+optimization+methods+in+drug+design&doi=10.1016%2Fj.ddtec.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DC.%2BA.%26aulast%3DBrown%26aufirst%3DN.%26atitle%3DMulti-objective%2520optimization%2520methods%2520in%2520drug%2520design%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2013%26volume%3D10%26spage%3De427%26epage%3De435%26doi%3D10.1016%2Fj.ddtec.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Nicolaou, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kannas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loizidou, E.</span><span> </span><span class="NLM_article-title">Multi-objective optimization methods in de novo drug design</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.2174/138955712802762284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138955712802762284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22420573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=979-987&author=C.+A.+Nicolaouauthor=C.+Kannasauthor=E.+Loizidou&title=Multi-objective+optimization+methods+in+de+novo+drug+design&doi=10.2174%2F138955712802762284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-objective optimization methods in De novo drug design</span></div><div class="casAuthors">Nicolaou, C. A.; Kannas, C.; Loizidou, E.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">979-987</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  De-novo drug design (DND) is a complex procedure, requiring the satisfaction of many pharmaceutically important objectives.  Several computational methodologies employing various optimization approaches have been developed to search for satisfactory solns. to this multi-objective problem varying from composite methods, which transform the problem to a single objective one to Pareto methods searching for numerous solns. compromising the objectives.  In this review we initially focus on the DND problem and the challenges it poses to computational methods, followed by an examn. of the reported methodologies and specific applications.  Emphasis is placed on the multiobjective nature of the problem, related considerations and the solns. proposed by the drug discovery community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHVpLH0SRre7Vg90H21EOLACvtfcHk0lhB9-40XRsY-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWku7fK&md5=428931bacd115a2db249699f6f3889fc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F138955712802762284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955712802762284%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DC.%2BA.%26aulast%3DKannas%26aufirst%3DC.%26aulast%3DLoizidou%26aufirst%3DE.%26atitle%3DMulti-objective%2520optimization%2520methods%2520in%2520de%2520novo%2520drug%2520design%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D979%26epage%3D987%26doi%3D10.2174%2F138955712802762284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYwyXoRuhBNJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perišić, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. E.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20727982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KqurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=804-811&author=C.+Abad-Zapateroauthor=O.+Peri%C5%A1i%C4%87author=J.+Wassauthor=A.+P.+Bentoauthor=J.+Overingtonauthor=B.+Al-Lazikaniauthor=M.+E.+Johnson&title=Ligand+efficiency+indices+for+an+effective+mapping+of+chemico-biological+space%3A+the+concept+of+an+atlas-like+representation&doi=10.1016%2Fj.drudis.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation</span></div><div class="casAuthors">Abad-Zapatero, Cele; Perisic, Ognjen; Wass, John; Bento, A. Patricia; Overington, John; Al-Lazikani, Bissan; Johnson, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">804-811</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  We propose a numerical framework that permits an effective atlas-like representation of chemico-biol. space based on a series of Cartesian planes mapping the ligands with the corresponding targets connected by an affinity parameter (K i or related).  The numerical framework is derived from the concept of ligand efficiency indexes, which provide a natural coordinate system combining the potency toward the target (biol. space) with the physicochem. properties of the ligand (chem. space).  This framework facilitates navigation in the multidimensional drug discovery space using map-like representations based on pairs of combined variables related to the efficiency of the ligands per Dalton (mol. wt. or no. of non-hydrogen atoms) and per unit of polar surface area (or no. of polar atoms).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM4D5FkxdfoLVg90H21EOLACvtfcHk0lhlV_n6kKS4VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KqurrJ&md5=8ccee251c53513905dbd13c93a4ec1ed</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPeri%25C5%25A1i%25C4%2587%26aufirst%3DO.%26aulast%3DWass%26aufirst%3DJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DM.%2BE.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520an%2520effective%2520mapping%2520of%2520chemico-biological%2520space%253A%2520the%2520concept%2520of%2520an%2520atlas-like%2520representation%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D804%26epage%3D811%26doi%3D10.1016%2Fj.drudis.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhlV_n6kKS4VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lhlV_n6kKS4VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 1: design and initial optimisation of a novel template</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5599</span><span class="NLM_x">–</span> <span class="NLM_lpage">5602</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.08.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5599-5602&author=C.+E.+Mowbrayauthor=C.+Burtauthor=R.+Corbauauthor=M.+Perrosauthor=I.+Tranauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+1%3A+design+and+initial+optimisation+of+a+novel+template&doi=10.1016%2Fj.bmcl.2009.08.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25201%253A%2520design%2520and%2520initial%2520optimisation%2520of%2520a%2520novel%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5599%26epage%3D5602%26doi%3D10.1016%2Fj.bmcl.2009.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 3: optimisation of physicochemical properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5603</span><span class="NLM_x">–</span> <span class="NLM_lpage">5606</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.08.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19717303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5603-5606&author=C.+E.+Mowbrayauthor=R.+Corbauauthor=M.+Hawesauthor=L.+H.+Jonesauthor=J.+E.+Millsauthor=M.+Perrosauthor=M.+D.+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+3%3A+optimisation+of+physicochemical+properties&doi=10.1016%2Fj.bmcl.2009.08.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole NNRTIs 3: Optimisation of physicochemical properties</span></div><div class="casAuthors">Mowbray, Charles E.; Corbau, Romuald; Hawes, Michael; Jones, Lyn H.; Mills, James E.; Perros, Manos; Selby, Matthew D.; Stupple, Paul A.; Webster, Rob; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5603-5606</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our efforts to reduce overall lipophilicity and increase ligand-lipophilicity efficiency (LLE) by modification of the 3- and 5-substituents of pyrazole I, a novel non-nucleoside HIV reverse transcriptase inhibitor (NNRTI) prototype were unsuccessful.  In contrast replacement of the substituted benzyl group with corresponding phenylthio or phenoxy groups resulted in marked improvements in potency, ligand efficiency (LE) and LLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoctiZUAaZLMrVg90H21EOLACvtfcHk0lj_IlFlwPCjEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E&md5=f25509e8183b985daae551f052c3e3e7</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.043%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25203%253A%2520optimisation%2520of%2520physicochemical%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5603%26epage%3D5606%26doi%3D10.1016%2Fj.bmcl.2009.08.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinton, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5857</span><span class="NLM_x">–</span> <span class="NLM_lpage">5860</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.08.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5857-5860&author=C.+E.+Mowbrayauthor=C.+Burtauthor=R.+Corbauauthor=S.+Gaytonauthor=M.+Hawesauthor=M.+Perrosauthor=I.+Tranauthor=D.+A.+Priceauthor=F.+J.+Quintonauthor=M.+D.+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+4%3A+selection+of+UK-453%2C061+%28lersivirine%29+as+a+development+candidate&doi=10.1016%2Fj.bmcl.2009.08.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.080%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DGayton%26aufirst%3DS.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DQuinton%26aufirst%3DF.%2BJ.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25204%253A%2520selection%2520of%2520UK-453%252C061%2520%2528lersivirine%2529%2520as%2520a%2520development%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5857%26epage%3D5860%26doi%3D10.1016%2Fj.bmcl.2009.08.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Fätkenheuer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plettenburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. M.</span><span> </span><span class="NLM_article-title">Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2122</span><span class="refDoi"> DOI: 10.1097/QAD.0b013e32832fef5b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAD.0b013e32832fef5b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=2115-2122&author=G.+F%C3%A4tkenheuerauthor=S.+Staszewskiauthor=A.+Plettenburgauthor=F.+Hackmanauthor=G.+Laytonauthor=L.+McFadyenauthor=J.+Davisauthor=T.+M.+Jenkins&title=Activity%2C+pharmacokinetics+and+safety+of+lersivirine+%28UK-453%2C061%29%2C+a+next-generation+nonnucleoside+reverse+transcriptase+inhibitor%2C+during+7-day+monotherapy+in+HIV-1-infected+patients&doi=10.1097%2FQAD.0b013e32832fef5b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1097%2FQAD.0b013e32832fef5b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0b013e32832fef5b%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25A4tkenheuer%26aufirst%3DG.%26aulast%3DStaszewski%26aufirst%3DS.%26aulast%3DPlettenburg%26aufirst%3DA.%26aulast%3DHackman%26aufirst%3DF.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DMcFadyen%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DJenkins%26aufirst%3DT.%2BM.%26atitle%3DActivity%252C%2520pharmacokinetics%2520and%2520safety%2520of%2520lersivirine%2520%2528UK-453%252C061%2529%252C%2520a%2520next-generation%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitor%252C%2520during%25207-day%2520monotherapy%2520in%2520HIV-1-infected%2520patients%26jtitle%3DAIDS%26date%3D2009%26volume%3D23%26spage%3D2115%26epage%3D2122%26doi%3D10.1097%2FQAD.0b013e32832fef5b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishburn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowbray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Burchnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringrose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knöchel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span> </span><span class="NLM_article-title">Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4463</span><span class="refDoi"> DOI: 10.1128/AAC.01455-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.01455-09" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4451-4463&author=R.+Corbauauthor=J.+Moriauthor=C.+Phillipsauthor=L.+Fishburnauthor=A.+Martinauthor=C.+Mowbrayauthor=W.+Pantonauthor=C.+Smith-Burchnellauthor=A.+Thornberryauthor=H.+Ringroseauthor=T.+Kn%C3%B6chelauthor=S.+Irvingauthor=M.+Westbyauthor=A.+Woodauthor=M.+Perros&title=Lersivirine%2C+a+nonnucleoside+reverse+transcriptase+inhibitor+with+activity+against+drug-resistant+human+immunodeficiency+virus+type+1&doi=10.1128%2FAAC.01455-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1128%2FAAC.01455-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01455-09%26sid%3Dliteratum%253Aachs%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DFishburn%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DMowbray%26aufirst%3DC.%26aulast%3DPanton%26aufirst%3DW.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DThornberry%26aufirst%3DA.%26aulast%3DRingrose%26aufirst%3DH.%26aulast%3DKn%25C3%25B6chel%26aufirst%3DT.%26aulast%3DIrving%26aufirst%3DS.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DLersivirine%252C%2520a%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitor%2520with%2520activity%2520against%2520drug-resistant%2520human%2520immunodeficiency%2520virus%2520type%25201%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4451%26epage%3D4463%26doi%3D10.1128%2FAAC.01455-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">García-Sosa, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takkis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, U.</span><span> </span><span class="NLM_article-title">Combined approach using ligand efficiency, cross-docking, and antitarget hits for wild-type and drug-resistant Y181C HIV-1 reverse transcriptase</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2595</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span><span class="refDoi"> DOI: 10.1021/ci200203h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200203h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2595-2611&author=A.+T.+Garc%C3%ADa-Sosaauthor=S.+Sildauthor=K.+Takkisauthor=U.+Maran&title=Combined+approach+using+ligand+efficiency%2C+cross-docking%2C+and+antitarget+hits+for+wild-type+and+drug-resistant+Y181C+HIV-1+reverse+transcriptase&doi=10.1021%2Fci200203h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase</span></div><div class="casAuthors">Garcia-Sosa, Alfonso T.; Sild, Sulev; Takkis, Kalev; Maran, Uko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2595-2611</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New hits against HIV-1 wild-type and Y181C drug-resistant reverse transcriptases were predicted taking into account the possibility of some of the known metab. interactions.  In silico hits against a set of antitargets (i.e., proteins or nucleic acids that are off-targets from the desired pharmaceutical target objective) are used to predict a simple, visual measure of possible interactions for the ligands, which helps to introduce early safety considerations into the design of compds. before lead optimization.  This combined approach consists of consensus docking and scoring: cross-docking to a group of wild-type and drug-resistant mutant proteins, ligand efficiency (also called binding efficiency) indexes as new ranking measures, pre- and postdocking filters, a set of antitargets and estn., and minimization of at. clashes.  Diverse, small-mol. compds. with new chem. (such as a triazine core with arom. side chains) as well as known drugs for different applications (oxazepam, chlorthalidone) were highly ranked to the targets having binding interactions and functional group spatial arrangements similar to those of known inhibitors, while being moderate to low binders to the antitargets.  The results are discussed on the basis of their relevance to medicinal and computational chem.  Optimization of ligands to targets and off-targets or antitargets is foreseen to be crit. for compds. directed at several simultaneous sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNNU7H0dMB5bVg90H21EOLACvtfcHk0lhJvNd4iH52Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7%252FO&md5=29c705ababd0d3280b64206136a8ccc9</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fci200203h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200203h%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Sosa%26aufirst%3DA.%2BT.%26aulast%3DSild%26aufirst%3DS.%26aulast%3DTakkis%26aufirst%3DK.%26aulast%3DMaran%26aufirst%3DU.%26atitle%3DCombined%2520approach%2520using%2520ligand%2520efficiency%252C%2520cross-docking%252C%2520and%2520antitarget%2520hits%2520for%2520wild-type%2520and%2520drug-resistant%2520Y181C%2520HIV-1%2520reverse%2520transcriptase%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2595%26epage%3D2611%26doi%3D10.1021%2Fci200203h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Bustanji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Masri, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qasem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Bakri, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taha, M. O.</span><span> </span><span class="NLM_article-title">In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2009.00852.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fj.1747-0285.2009.00852.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19703027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=258-265&author=Y.+Bustanjiauthor=I.+M.+Al-Masriauthor=A.+Qasemauthor=A.+G.+Al-Bakriauthor=M.+O.+Taha&title=In+silico+screening+for+non-nucleoside+HIV-1+reverse+transcriptase+inhibitors+using+physicochemical+filters+and+high-throughput+docking+followed+by+in+vitro+evaluation&doi=10.1111%2Fj.1747-0285.2009.00852.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation</span></div><div class="casAuthors">Bustanji, Yasser; Al-Masri, Ihab M.; Qasem, Ahmad; Al-Bakri, Amal G.; Taha, Mutasem Omar</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-265</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Reverse transcriptase, being the pivot in human immunodeficiency virus replication, is one of the most attractive targets for the development of new antiretroviral agents.  A virtual screening workflow based on a combination of physicochem. filters with high-throughput rigid mol. docking was applied to discover novel efficient lead scaffolds for human immunodeficiency virus type 1 reverse transcriptase inhibition.  In the protocol, different filters were employed to enrich the lead-likeness and improve the ligands efficiency of the filtered compds.  Out of the 238,819 compds. included in the National Cancer Institute database, 500 virtual screening hits were retrieved employing FILTER and FRED (mol. docking engine) softwares.  Four compds. from the 20 highest ranking scored hits tested pos. in human immunodeficiency virus type 1 reverse transcriptase using non-radioactive colorimetric assay method.  These results demonstrate that the virtual screening protocol is able to enrich novel scaffolds for human immunodeficiency virus type 1 reverse transcriptase inhibition that could be useful for drug development in the area of acquired immune-deficiency syndrome treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9SiartewbzLVg90H21EOLACvtfcHk0lhJvNd4iH52Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7bI&md5=d1e6d2371f5ac357073625f5621fd721</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00852.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00852.x%26sid%3Dliteratum%253Aachs%26aulast%3DBustanji%26aufirst%3DY.%26aulast%3DAl-Masri%26aufirst%3DI.%2BM.%26aulast%3DQasem%26aufirst%3DA.%26aulast%3DAl-Bakri%26aufirst%3DA.%2BG.%26aulast%3DTaha%26aufirst%3DM.%2BO.%26atitle%3DIn%2520silico%2520screening%2520for%2520non-nucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors%2520using%2520physicochemical%2520filters%2520and%2520high-throughput%2520docking%2520followed%2520by%2520in%2520vitro%2520evaluation%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D258%26epage%3D265%26doi%3D10.1111%2Fj.1747-0285.2009.00852.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boros, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koble, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.11.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=422-425&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=E.+E.+Borosauthor=J.+B.+Thompsonauthor=C.+S.+Kobleauthor=E.+P.+Garveyauthor=S.+A.+Fosterauthor=J.+L.+Jeffreyauthor=T.+Fujiwara&title=Naphthyridinone+%28NTD%29+integrase+inhibitors%3A+N1+protio+and+methyl+combination+substituent+effects+with+C3+amide+groups&doi=10.1016%2Fj.bmcl.2012.11.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.071%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DNaphthyridinone%2520%2528NTD%2529%2520integrase%2520inhibitors%253A%2520N1%2520protio%2520and%2520methyl%2520combination%2520substituent%2520effects%2520with%2520C3%2520amide%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D422%26epage%3D425%26doi%3D10.1016%2Fj.bmcl.2012.11.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Yeung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trehan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadjura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santone, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 attachment. Part 8: the effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.10.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.10.117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=203-208&author=K.+S.+Yeungauthor=Z.+Qiuauthor=Z.+Yinauthor=A.+Trehanauthor=H.+Fangauthor=B.+Pearceauthor=Z.+Yangauthor=L.+Zadjuraauthor=C.+J.+D%E2%80%99Arienzoauthor=K.+Riccardiauthor=P.+Y.+Shiauthor=T.+P.+Spicerauthor=Y.+F.+Gongauthor=M.+R.+Browningauthor=S.+Hanselauthor=K.+Santoneauthor=J.+Barkerauthor=T.+Coulterauthor=P.+F.+Linauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Inhibitors+of+HIV-1+attachment.+Part+8%3A+the+effect+of+C7-heteroaryl+substitution+on+the+potency%2C+and+in+vitro+and+in+vivo+profiles+of+indole-based+inhibitors&doi=10.1016%2Fj.bmcl.2012.10.117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.10.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.10.117%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DTrehan%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DPearce%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZadjura%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DRiccardi%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DP.%2BY.%26aulast%3DSpicer%26aufirst%3DT.%2BP.%26aulast%3DGong%26aufirst%3DY.%2BF.%26aulast%3DBrowning%26aufirst%3DM.%2BR.%26aulast%3DHansel%26aufirst%3DS.%26aulast%3DSantone%26aufirst%3DK.%26aulast%3DBarker%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DP.%2BF.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DInhibitors%2520of%2520HIV-1%2520attachment.%2520Part%25208%253A%2520the%2520effect%2520of%2520C7-heteroaryl%2520substitution%2520on%2520the%2520potency%252C%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520profiles%2520of%2520indole-based%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D203%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2012.10.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Narayana Moorthy, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. A.</span><span> </span><span class="NLM_article-title">Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.2174/138945013804806460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138945013804806460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23061466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FkslGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=102-113&author=N.+S.+Narayana+Moorthyauthor=M.+J.+Ramosauthor=P.+A.+Fernandes&title=Human+ether-a-go-go-related+gene+channel+blockers+and+its+structural+analysis+for+drug+design&doi=10.2174%2F138945013804806460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design</span></div><div class="casAuthors">Narayana Moorthy Narayana S Hari; Ramos Maria J; Fernandes Pedro A</div><div class="citationInfo"><span class="NLM_cas:title">Current drug targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The human ether-a-go-go-related gene (hERG) is a K+ channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death.  In this present review, we have focused the physicochemical properties responsible for the hERG blocking activity of structurally different compounds.  The reported research works showed that the hydrophobicity on the van der Waals (vdW) surface of the molecules (aroused from the aromatic ring) necessary for the hERG blocking activity along with topological and electronic properties.  The quinolizidine alkaloids (natural products) such as oxymatrine, sophoridine, sophocarpine and matrine carry the common molecular structure of O=C=N-C-C-C-N that possessed positive ionotropic effect and hERG blocking activity.  Acehytisine hydrochloride (previously named Guangfu base A) was isolated from the root of Aconitum coreanum (Levl.), is an anti-arrhythmic drug in phase IV clinical trial.  The isoquinoline alkaloid, neferine (Nef) induces a concentration-dependent decrease in current amplitude (IC50 of 7.419 MM).  Most of these natural product compounds contain non-flexible aromatic structures but have significant activity due to the presence of optimum hydrophobicity.  Recent research works revealed that Eag and hERG channels are expressed by a variety of cancer cell lines and tissues.  The Eag channel showed an oncogenic potential while hERG channels are associated with more aggressive tumors and have a role in mediating invasion.  This review concluded that the consideration of physicochemical properties necessary for the hERG blocking activity will guide to develop novel drugs with less cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9xQpaoQZPkRgd2Wuil24tfW6udTcc2eYfHBMxFui2Drntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FkslGhuw%253D%253D&md5=a1e8607483efd5dd60f068ca51f35f0e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2174%2F138945013804806460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945013804806460%26sid%3Dliteratum%253Aachs%26aulast%3DNarayana%2BMoorthy%26aufirst%3DN.%2BS.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26atitle%3DHuman%2520ether-a-go-go-related%2520gene%2520channel%2520blockers%2520and%2520its%2520structural%2520analysis%2520for%2520drug%2520design%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2013%26volume%3D14%26spage%3D102%26epage%3D113%26doi%3D10.2174%2F138945013804806460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leishman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIV</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span><span class="refDoi"> DOI: 10.2174/156802608785700007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F156802608785700007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=18782009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1140-1151&author=D.+A.+Priceauthor=D.+Armourauthor=M.+de+Grootauthor=D.+Leishmanauthor=C.+Napierauthor=M.+Perrosauthor=B.+L.+Stammenauthor=A.+Wood&title=Overcoming+hERG+affinity+in+the+discovery+of+maraviroc%3B+a+CCR5+antagonist+for+the+treatment+of+HIV&doi=10.2174%2F156802608785700007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIV</span></div><div class="casAuthors">Price, David A.; Armour, Duncan; de Groot, Marcel; Leishman, Derek; Napier, Carolyn; Perros, Manos; Stammen, Blanda L.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1140-1151</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Avoiding cardiac liability assocd. with blockade of hERG (human ether a go-go) is key for successful drug discovery and development.  This paper describes the work undertaken in the discovery of a potent CCR5 antagonist, maraviroc 34, for the treatment of HIV.  In particular the use of a pharmacophore model of the hERG channel and a high throughput binding assay for the hERG channel are described that were crit. to elucidate SAR to overcome hERG liabilities.  The key SAR involves the introduction of polar substituents into regions of the mol. where it is postulated to undergo hydrophobic interactions with the ion channel.  Within the CCR5 project there appeared to be no strong correlation between hERG affinity and physiochem. parameters such as pKa or lipophilicity.  It is believed that chemists could apply these same strategies early in drug discovery to remove hERG interactions assocd. with lead compds. while retaining potency at the primary target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxIPJP8rohLLVg90H21EOLACvtfcHk0lgd5iV_e8PC_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrnN&md5=7bcb98bc1409d6d73a8a28a5caebfe8c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.2174%2F156802608785700007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700007%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DLeishman%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOvercoming%2520hERG%2520affinity%2520in%2520the%2520discovery%2520of%2520maraviroc%253B%2520a%2520CCR5%2520antagonist%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1140%26epage%3D1151%26doi%3D10.2174%2F156802608785700007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leishman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4633</span><span class="NLM_x">–</span> <span class="NLM_lpage">4637</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2006.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=16782336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4633-4637&author=D.+A.+Priceauthor=D.+Armourauthor=M.+de+Grootauthor=D.+Leishmanauthor=C.+Napierauthor=M.+Perrosauthor=B.+L.+Stammenauthor=A.+Wood&title=Overcoming+HERG+affinity+in+the+discovery+of+the+CCR5+antagonist+maraviroc&doi=10.1016%2Fj.bmcl.2006.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc</span></div><div class="casAuthors">Price, David A.; Armour, Duncan; De Groot, Marcel; Leishman, Derek; Napier, Carolyn; Perros, Manos; Stammen, Blanda L.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4633-4637</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of maraviroc (I) is described with particular ref. to the generation of high selectivity over affinity for the HERG potassium channel.  This was achieved through the use of a high throughput binding assay for the HERG channel that is known to show an excellent correlation with functional effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6P6g23qVq_LVg90H21EOLACvtfcHk0lhji62w99l_zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlurw%253D&md5=a77b63c145102df315c3931fd3814b64</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DLeishman%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOvercoming%2520HERG%2520affinity%2520in%2520the%2520discovery%2520of%2520the%2520CCR5%2520antagonist%2520maraviroc%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4633%26epage%3D4637%26doi%3D10.1016%2Fj.bmcl.2006.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Dorr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macartney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Burchnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span> </span><span class="NLM_article-title">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4732</span><span class="refDoi"> DOI: 10.1128/AAC.49.11.4721-4732.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.49.11.4721-4732.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=16251317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4721-4732&author=P.+Dorrauthor=M.+Westbyauthor=S.+Dobbsauthor=P.+Griffinauthor=B.+Irvineauthor=M.+Macartneyauthor=J.+Moriauthor=G.+Rickettauthor=C.+Smith-Burchnellauthor=C.+Napierauthor=R.+Websterauthor=D.+Armourauthor=D.+Priceauthor=B.+Stammenauthor=A.+Woodauthor=M.+Perros&title=Maraviroc+%28UK-427%2C857%29%2C+a+potent%2C+orally+bioavailable%2C+and+selective+small-molecule+inhibitor+of+chemokine+receptor+CCR5+with+broad-spectrum+anti-human+immunodeficiency+virus+type+1+activity&doi=10.1128%2FAAC.49.11.4721-4732.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span></div><div class="casAuthors">Dorr, Patrick; Westby, Mike; Dobbs, Susan; Griffin, Paul; Irvine, Becky; Macartney, Malcolm; Mori, Julie; Rickett, Graham; Smith-Burchnell, Caroline; Napier, Carolyn; Webster, Rob; Armour, Duncan; Price, David; Stammen, Blanda; Wood, Anthony; Perros, Manos</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4721-4732</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent antihuman immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacol. properties.  Maraviroc is the product of a medicinal chem. effort initiated following identification of an imidazopyridine CCR5 ligand from a high-throughput screen of the Pfizer compd. file.  Maraviroc demonstrated potent antiviral activity against all CCR5-tropic HIV-1 viruses tested, including 43 primary isolates from various clades and diverse geog. origin (geometric mean 90% inhibitory concn. of 2.0 nM).  Maraviroc was active against 200 clin. derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.  There was little difference in the sensitivity of the 200 viruses to maraviroc, as illustrated by the biol. cutoff in this assay (= geometric mean plus two std. deviations [SD] of 1.7-fold).  The mechanism of action of maraviroc was established using cell-based assays, where it blocked binding of viral envelope, gp120, to CCR5 to prevent the membrane fusion events necessary for viral entry.  Maraviroc did not affect CCR5 cell surface levels or assocd. intracellular signaling, confirming it as a functional antagonist of CCR5.  Maraviroc has no detectable in vitro cytotoxicity and is highly selective for CCR5, as confirmed against a wide range of receptors and enzymes, including the hERG ion channel (50% inhibitory concn., > 10 μM), indicating potential for an excellent clin. safety profile.  Studies in preclin. in vitro and in vivo models predicted maraviroc to have human pharmacokinetics consistent with once- or twice-daily dosing following oral administration.  Clin. trials are ongoing to further investigate the potential of using maraviroc for the treatment of HIV-1 infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN0Z8KdsHODrVg90H21EOLACvtfcHk0lhji62w99l_zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM&md5=561aea68490f7c6d3ec0f65676450155</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.11.4721-4732.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.11.4721-4732.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DP.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DDobbs%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DIrvine%26aufirst%3DB.%26aulast%3DMacartney%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DRickett%26aufirst%3DG.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DStammen%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DMaraviroc%2520%2528UK-427%252C857%2529%252C%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520chemokine%2520receptor%2520CCR5%2520with%2520broad-spectrum%2520anti-human%2520immunodeficiency%2520virus%2520type%25201%2520activity%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4721%26epage%3D4732%26doi%3D10.1128%2FAAC.49.11.4721-4732.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.2174/138161212798919084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161212798919084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22236118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVehsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=100-112&author=W.+Chenauthor=P.+Zhanauthor=E.+De+Clercqauthor=X.+Liu&title=Recent+progress+in+small+molecule+CCR5+antagonists+as+potential+HIV-1+entry+inhibitors&doi=10.2174%2F138161212798919084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors</span></div><div class="casAuthors">Chen, Wenwen; Zhan, Peng; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-112</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently the long-term usage of traditional anti-HIV drugs, such as nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), eventually leads to the emergence of drug resistance and severe side effects.  Thus it is imperative to design and develop more promising HIV-1 inhibitors to overcome these drawbacks.  Fortunately, with the identification of some fascinating targets in the entry process of viral life cycle, HIV-1 entry inhibitors (EIs) with low cytotoxicity and mild side effects turned out as novel and effective anti-HIV agents.  Esp., of these potent EIs, small mol. CCR5 antagonist maraviroc was approved by US FDA in 2007, which significantly increased the therapeutic options for the clin. treatment of HIV-infected patients.  Subsequently, as promising anti-HIV drug candidates, kinds of small mol. CCR5 antagonists have been synthesized and evaluated in clin. trials.  In this article, current progress in the development of novel small mol. CCR5 antagonists will be reviewed on the basis of their chem. structures with a special attention to their discovery stories.  Simultaneously, binding mode anal. based on mol. modeling studies will also be introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_kc6j05FgPrVg90H21EOLACvtfcHk0lhji62w99l_zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVehsbo%253D&md5=d1256ed12bc6b05137dbae48a5bb71fc</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.2174%2F138161212798919084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212798919084%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520small%2520molecule%2520CCR5%2520antagonists%2520as%2520potential%2520HIV-1%2520entry%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D100%26epage%3D112%26doi%3D10.2174%2F138161212798919084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Veljkovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucicevic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glisic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veljkovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span> </span><span class="NLM_article-title">Preclinical discovery and development of maraviroc for the treatment of HIV</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1517/17460441.2015.1041497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2015.1041497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=671-684&author=N.+Veljkovicauthor=J.+Vucicevicauthor=S.+Tassiniauthor=S.+Glisicauthor=V.+Veljkovicauthor=M.+Radi&title=Preclinical+discovery+and+development+of+maraviroc+for+the+treatment+of+HIV&doi=10.1517%2F17460441.2015.1041497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1041497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1041497%26sid%3Dliteratum%253Aachs%26aulast%3DVeljkovic%26aufirst%3DN.%26aulast%3DVucicevic%26aufirst%3DJ.%26aulast%3DTassini%26aufirst%3DS.%26aulast%3DGlisic%26aufirst%3DS.%26aulast%3DVeljkovic%26aufirst%3DV.%26aulast%3DRadi%26aufirst%3DM.%26atitle%3DPreclinical%2520discovery%2520and%2520development%2520of%2520maraviroc%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D671%26epage%3D684%26doi%3D10.1517%2F17460441.2015.1041497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Van Der Ryst, E.</span><span> </span><span class="NLM_article-title">Maraviroc—A CCR5 antagonist for the treatment of HIV-1 infection</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="refDoi"> DOI: 10.3389/fimmu.2015.00277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3389%2Ffimmu.2015.00277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26097475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2MblvVartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=277&author=E.+Van+Der+Ryst&title=Maraviroc%E2%80%94A+CCR5+antagonist+for+the+treatment+of+HIV-1+infection&doi=10.3389%2Ffimmu.2015.00277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc - A CCR5 Antagonist for the Treatment of HIV-1 Infection</span></div><div class="casAuthors">Van Der Ryst Elna</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">277</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_r26tYzfmojW1zwg2yUK5fW6udTcc2easDWjOXNDnO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblvVartQ%253D%253D&md5=cc5d64b64bf4836c4a7e85f06996f7e2</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00277%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BRyst%26aufirst%3DE.%26atitle%3DMaraviroc%25E2%2580%2594A%2520CCR5%2520antagonist%2520for%2520the%2520treatment%2520of%2520HIV-1%2520infection%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D277%26doi%3D10.3389%2Ffimmu.2015.00277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span> </span><span class="NLM_article-title">Recent developments in computational prediction of HERG blockage</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span><span class="refDoi"> DOI: 10.2174/15680266113139990036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F15680266113139990036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23675938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wntr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1317-1326&author=S.+Wangauthor=Y.+Liauthor=L.+Xuauthor=D.+Liauthor=T.+Hou&title=Recent+developments+in+computational+prediction+of+HERG+blockage&doi=10.2174%2F15680266113139990036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Developments in Computational Prediction of hERG Blockage</span></div><div class="casAuthors">Wang, Sichao; Li, Youyong; Xu, Lei; Li, Dan; Hou, Tingjun</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1317-1326</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The blockage of the voltage dependent ion channel encoded by human ether-a-go-go related gene (hERG) may lead to drug-induced QT interval prolongation, which is a crit. side-effect of non-cardiovascular therapeutic agents.  Therefore, identification of potential hERG channel blockers at the early stage of drug discovery process will decrease the risk of cardiotoxicity-related attritions in the later and more expensive development stage.  Computational approaches provide economic and efficient ways to evaluate the hERG liability for large-scale compd. libraries.  In this review, the structure of the hERG channel is briefly outlined first.  Then, the latest developments in the computational predictions of hERG channel blockers and the theor. studies on modeling hERG-blocker interactions are summarized.  Finally, the challenges of developing reliable prediction models of hERG blockers, as well as the strategies for surmounting these challenges, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQUN7vGQ4e7Vg90H21EOLACvtfcHk0lixnuu1nHkL3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wntr7M&md5=e73ab899e6a0556bcfd18191063bcd61</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990036%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DT.%26atitle%3DRecent%2520developments%2520in%2520computational%2520prediction%2520of%2520HERG%2520blockage%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1317%26epage%3D1326%26doi%3D10.2174%2F15680266113139990036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Applying thermodynamic profiling in lead finding and optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1038/nrd4486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnrd4486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25614222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVemtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=95-110&author=G.+Klebe&title=Applying+thermodynamic+profiling+in+lead+finding+and+optimization&doi=10.1038%2Fnrd4486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Applying thermodynamic profiling in lead finding and optimization</span></div><div class="casAuthors">Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-110</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. drug discovery involves the optimization of various physicochem. properties of a ligand, particularly its binding affinity for its target receptor (or receptors).  In recent years, there has been growing interest in using thermodn. profiling of ligand-receptor interactions in order to select and optimize those ligands that might be most likely to become drug candidates with desirable physicochem. properties.  The thermodn. of binding is influenced by multiple factors, including hydrogen bonding and hydrophobic interactions, desolvation, residual mobility, dynamics and the local water structure.  This article discusses key issues in understanding the effects of these factors and applying this knowledge in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtHj7SsL6rrVg90H21EOLACvtfcHk0lixnuu1nHkL3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVemtr4%253D&md5=c2e12760623de81335ce252cb804c602</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnrd4486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4486%26sid%3Dliteratum%253Aachs%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DApplying%2520thermodynamic%2520profiling%2520in%2520lead%2520finding%2520and%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D95%26epage%3D110%26doi%3D10.1038%2Fnrd4486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Cusack, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoemann, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marjanovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span> </span><span class="NLM_article-title">Design strategies to address kinetics of drug binding and residence time</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2019</span><span class="NLM_x">–</span> <span class="NLM_lpage">2027</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2015.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25782745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2019-2027&author=K.+P.+Cusackauthor=Y.+Wangauthor=M.+Z.+Hoemannauthor=J.+Marjanovicauthor=R.+G.+Heymauthor=A.+Vasudevan&title=Design+strategies+to+address+kinetics+of+drug+binding+and+residence+time&doi=10.1016%2Fj.bmcl.2015.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Design strategies to address kinetics of drug binding and residence time</span></div><div class="casAuthors">Cusack, Kevin P.; Wang, Ying; Hoemann, Michael Z.; Marjanovic, Jasmina; Heym, Roland G.; Vasudevan, Anil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2019-2027</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The kinetics of drug binding and drug residence time are recognized to be important in the clin. effectiveness of drug candidates.  In most cases a long residence time of the drug-target complex results in an extended duration of pharmacodynamic activity, even when systemic concns. of drug have been notably reduced through elimination routes.  Hence, if selective for target, long residence times can increase the duration of drug efficacy in vivo and can significantly diminish the potential for off-target-mediated toxicities.  Furthermore, a compd. with a slower dissocn. rate may allow a reduced dosing schedule relative to a compd. with a rapid dissocn. rate.  Factors contributing to long residence time that could be useful to medicinal chemists in the prospective design of compds. with long residence times will be discussed in this perspective.  Particular emphasis will be on case studies highlighting how kinetics can be measured, modulated based on supporting structure kinetic relationships and whether these effects are translatable into man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru6nmUGLHP_rVg90H21EOLACvtfcHk0lhxvD7YNhvF0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCjsLg%253D&md5=c3735de36094915768dbecc7472917d4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DCusack%26aufirst%3DK.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHoemann%26aufirst%3DM.%2BZ.%26aulast%3DMarjanovic%26aufirst%3DJ.%26aulast%3DHeym%26aufirst%3DR.%2BG.%26aulast%3DVasudevan%26aufirst%3DA.%26atitle%3DDesign%2520strategies%2520to%2520address%2520kinetics%2520of%2520drug%2520binding%2520and%2520residence%2520time%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2019%26epage%3D2027%26doi%3D10.1016%2Fj.bmcl.2015.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hämäläinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlén, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Relationships between structure and interaction kinetics for HIV-1 protease inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5430</span><span class="NLM_x">–</span> <span class="NLM_lpage">5439</span><span class="refDoi"> DOI: 10.1021/jm0208370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0208370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFSru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5430-5439&author=P.+O.+Markgrenauthor=W.+Schaalauthor=M.+H%C3%A4m%C3%A4l%C3%A4inenauthor=A.+Karl%C3%A9nauthor=A.+Hallbergauthor=B.+Samuelssonauthor=U.+H.+Danielson&title=Relationships+between+structure+and+interaction+kinetics+for+HIV-1+protease+inhibitors&doi=10.1021%2Fjm0208370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between Structure and Interaction Kinetics for HIV-1 Protease Inhibitors</span></div><div class="casAuthors">Markgren, Per-Olof; Schaal, Wesley; Haemaelaeinen, Markku; Karlen, Anders; Hallberg, Anders; Samuelsson, Bertil; Danielson, U. Helena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5430-5439</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interaction between HIV-1 protease and 58 structurally diverse transition-state analog inhibitors has been analyzed by a surface plasmon resonance based biosensor.  Assocn. and dissocn. rate consts. and affinities were detd. and displayed as kon-koff-KD maps.  It was shown that different classes of inhibitors fall into distinct clusters in these maps.  Significant changes in assocn. and dissocn. rates were found as a result of modifying the P1/P1' or P2/P2' side chains of a linear lead compd.  Similarly, cyclic urea and cyclic sulfamide inhibitors displayed different kinetic features and the affinities of both classes of cyclic compds. were limited by fast dissocn. rates.  These results confirm that assocn. and dissocn. rates are important features of drug-target interactions and indicate that optimization of inhibitor efficacy may be guided by aiming for high assocn. and low dissocn. rates rather than high affinity alone.  The present approach thus provides a new tool for structure-interaction kinetic anal. and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-IpythylbjrVg90H21EOLACvtfcHk0lhxvD7YNhvF0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFSru7w%253D&md5=11099efcbe75d675ecf31f3b80166862</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm0208370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208370%26sid%3Dliteratum%253Aachs%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DSchaal%26aufirst%3DW.%26aulast%3DH%25C3%25A4m%25C3%25A4l%25C3%25A4inen%26aufirst%3DM.%26aulast%3DKarl%25C3%25A9n%26aufirst%3DA.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DRelationships%2520between%2520structure%2520and%2520interaction%2520kinetics%2520for%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5430%26epage%3D5439%26doi%3D10.1021%2Fjm0208370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Shuman, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Improved structure-activity relationship analysis of HIV-1 protease inhibitors using interaction kinetic data</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5953</span><span class="NLM_x">–</span> <span class="NLM_lpage">5961</span><span class="refDoi"> DOI: 10.1021/jm0499110</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0499110" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5953-5961&author=C.+F.+Shumanauthor=L.+Vrangauthor=U.+H.+Danielson&title=Improved+structure-activity+relationship+analysis+of+HIV-1+protease+inhibitors+using+interaction+kinetic+data&doi=10.1021%2Fjm0499110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm0499110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0499110%26sid%3Dliteratum%253Aachs%26aulast%3DShuman%26aufirst%3DC.%2BF.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DImproved%2520structure-activity%2520relationship%2520analysis%2520of%2520HIV-1%2520protease%2520inhibitors%2520using%2520interaction%2520kinetic%2520data%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5953%26epage%3D5961%26doi%3D10.1021%2Fjm0499110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Dierynck, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keuleers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersmissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertogs, K.</span><span> </span><span class="NLM_article-title">Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">13845</span><span class="NLM_x">–</span> <span class="NLM_lpage">13851</span><span class="refDoi"> DOI: 10.1128/JVI.01184-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.01184-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17928344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsValsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=13845-13851&author=I.+Dierynckauthor=M.+De+Witauthor=E.+Gustinauthor=I.+Keuleersauthor=J.+Vandersmissenauthor=S.+Hallenbergerauthor=K.+Hertogs&title=Binding+kinetics+of+darunavir+to+human+immunodeficiency+virus+type+1+protease+explain+the+potent+antiviral+activity+and+high+genetic+barrier&doi=10.1128%2FJVI.01184-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier</span></div><div class="casAuthors">Dierynck, Inge; De Wit, Mieke; Gustin, Emmanuel; Keuleers, Inge; Vandersmissen, Johan; Hallenberger, Sabine; Hertogs, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13845-13851</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The high incidence of cross-resistance between human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) limits their sequential use.  This necessitates the development of PIs with a high genetic barrier and a broad spectrum of activity against PI-resistant HIV, such as tipranavir and darunavir (TMC114).  We performed a surface plasmon resonance-based kinetic study to investigate the impact of PI resistance-assocd. mutations on the protease binding of five PIs used clin.: amprenavir, atazanavir, darunavir, lopinavir, and tipranavir.  With wild-type protease, the binding affinity of darunavir was more than 100-fold higher than with the other PIs, due to a very slow dissocn. rate.  Consequently, the dissociative half-life of darunavir was much higher (>240 h) than that of the other PIs, including darunavir's structural analog amprenavir.  The influence of protease mutations on the binding kinetics was tested with five multidrug-resistant (MDR) proteases derived from clin. isolates harboring 10 to 14 PI resistance-assocd. mutations with a decreased susceptibility to various PIs.  In general, all PIs bound to the MDR proteases with lower binding affinities, caused mainly by a faster dissocn. rate.  For amprenavir, atazanavir, lopinavir, and tipranavir, the decrease in affinity with MDR proteases resulted in reduced antiviral activity.  For darunavir, however, a nearly 1000-fold decrease in binding affinity did not translate into a weaker antiviral activity; a further decrease in affinity was required for the reduced antiviral effect.  These observations provide a mechanistic explanation for darunavir's potent antiviral activity and high genetic barrier to the development of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCX6QtrwFLLVg90H21EOLACvtfcHk0lhxvD7YNhvF0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsValsbbF&md5=9a75941452df1d51d8aab351be05600f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1128%2FJVI.01184-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01184-07%26sid%3Dliteratum%253Aachs%26aulast%3DDierynck%26aufirst%3DI.%26aulast%3DDe%2BWit%26aufirst%3DM.%26aulast%3DGustin%26aufirst%3DE.%26aulast%3DKeuleers%26aufirst%3DI.%26aulast%3DVandersmissen%26aufirst%3DJ.%26aulast%3DHallenberger%26aufirst%3DS.%26aulast%3DHertogs%26aufirst%3DK.%26atitle%3DBinding%2520kinetics%2520of%2520darunavir%2520to%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520explain%2520the%2520potent%2520antiviral%2520activity%2520and%2520high%2520genetic%2520barrier%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D13845%26epage%3D13851%26doi%3D10.1128%2FJVI.01184-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">King, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabu-Jeyabalan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalivaika, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Béthune, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">12012</span><span class="NLM_x">–</span> <span class="NLM_lpage">12021</span><span class="refDoi"> DOI: 10.1128/JVI.78.21.12012-12021.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.78.21.12012-12021.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=15479840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=12012-12021&author=N.+M.+Kingauthor=M.+Prabu-Jeyabalanauthor=E.+A.+Nalivaikaauthor=P.+Wigerinckauthor=M.+P.+de+B%C3%A9thuneauthor=C.+A.+Schiffer&title=Structural+and+thermodynamic+basis+for+the+binding+of+TMC114%2C+a+next-generation+human+immunodeficiency+virus+type+1+protease+inhibitor&doi=10.1128%2FJVI.78.21.12012-12021.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor</span></div><div class="casAuthors">King, Nancy M.; Prabu-Jeyabalan, Moses; Nalivaika, Ellen A.; Wigerinck, Piet; de Bethune, Marie-Pierre; Schiffer, Celia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12012-12021</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">TMC114, a newly designed human immunodeficiency virus type 1 (HIV-1) protease inhibitor, is extremely potent against both wild-type (wt.) and multidrug-resistant (MDR) viruses in vitro as well as in vivo.  Although chem. similar to amprenavir (APV), the potency of TMC114 is substantially greater.  To examine the basis for this potency, we solved crystal structures of TMC114 complexed with wt. HIV-1 protease and TMC114 and APV complexed with an MDR (L63P, V82T, and I84V) protease variant.  In addn., we detd. the corresponding binding thermodn. by isothermal titrn. calorimetry.  TMC114 binds approx. 2 orders of magnitude more tightly to the wt. enzyme (Kd = 4.5×10-12 M) than APV (Kd = 3.9×10-10 M).  Our x-ray data (resoln. ranging from 2.2 to 1.2 Å) reveal strong interactions between the bis-tetrahydrofuranyl urethane moiety of TMC114 and main-chain atoms of D29 and D30.  These interactions appear largely responsible for TMC114's very favorable binding enthalpy to the wt. protease (-12.1 kcal/mol).  However, TMC114 binding to the MDR HIV-1 protease is reduced by a factor of 13.3, whereas the APV binding const. is reduced only by a factor of 5.1.  However, even with the redn. in binding affinity to the MDR HIV protease, TMC114 still binds with an affinity that is more than 1.5 orders of magnitude tighter than the first-generation inhibitors.  Both APV and TMC114 fit predominantly within the substrate envelope, a property that may be assocd. with decreased susceptibility to drug-resistant mutations relative to that of first-generation inhibitors.  Overall, TMC114's potency against MDR viruses is likely a combination of its extremely high affinity and close fit within the substrate envelope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRCtpDBSgPLVg90H21EOLACvtfcHk0lhGJpQt9m3S5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKlsbw%253D&md5=dbe410a8b7dc6a5078c312e90f24a538</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1128%2FJVI.78.21.12012-12021.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.78.21.12012-12021.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DN.%2BM.%26aulast%3DPrabu-Jeyabalan%26aufirst%3DM.%26aulast%3DNalivaika%26aufirst%3DE.%2BA.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3Dde%2BB%25C3%25A9thune%26aufirst%3DM.%2BP.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DStructural%2520and%2520thermodynamic%2520basis%2520for%2520the%2520binding%2520of%2520TMC114%252C%2520a%2520next-generation%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%26jtitle%3DJ.%2520Virol.%26date%3D2004%26volume%3D78%26spage%3D12012%26epage%3D12021%26doi%3D10.1128%2FJVI.78.21.12012-12021.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2012.01417.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fj.1747-0285.2012.01417.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22621379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2iur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=440-454&author=D.+Liauthor=M.+S.+Liuauthor=B.+Jiauthor=K.+C.+Hwangauthor=Y.+Huang&title=Identifying+the+molecular+mechanics+and+binding+dynamics+characteristics+of+potent+inhibitors+to+HIV-1+protease&doi=10.1111%2Fj.1747-0285.2012.01417.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease inhibitors</span></div><div class="casAuthors">Li, Dechang; Liu, Ming S.; Ji, Baohua; Hwang, Keh-Chih; Huang, Yonggang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-454</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 protease (HIV-1 PR) is one of the primary inhibition targets for chemotherapy of AIDS because of its crit. role in the replication cycle of the HIV.  In this work, a combinatory coarse-grained and atomistic simulation method was developed for dissecting mol. mechanisms and binding process of inhibitors to the active site of HIV-1 PR, in which 35 typical inhibitors were tried.  We found that the mol. size and stiffness of the inhibitors and the binding energy between the inhibitors and PR play important roles in regulating the binding process.  Comparatively, the smaller and more flexible inhibitors have larger binding energy and higher binding rates; they even bind into PR without opening the flaps.  In contrast, the larger and stiffer inhibitors have lower binding energy and lower binding rate, and their binding is subjected to the opening and gating of the PR flaps.  Furthermore, the components of binding free energy were quantified and analyzed by their dependence on the mol. size, structures, and hydrogen bond networks of inhibitors.  Our results also deduce significant dynamics descriptors for detg. the quant. structure and property relation in potent drug ligands for HIV-1 PR inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohtrnMySv_K7Vg90H21EOLACvtfcHk0lhGJpQt9m3S5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2iur7F&md5=bbbe7942fd7d9a06e4872a6cf8f93e6e</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2012.01417.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2012.01417.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DK.%2BC.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DIdentifying%2520the%2520molecular%2520mechanics%2520and%2520binding%2520dynamics%2520characteristics%2520of%2520potent%2520inhibitors%2520to%2520HIV-1%2520protease%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D440%26epage%3D454%26doi%3D10.1111%2Fj.1747-0285.2012.01417.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Geitmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2367</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span><span class="refDoi"> DOI: 10.1021/jm0504048</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2367-2374&author=M.+Geitmannauthor=T.+Ungeauthor=U.+H.+Danielson&title=Biosensor-based+kinetic+characterization+of+the+interaction+between+HIV-1+reverse+transcriptase+and+non-nucleoside+inhibitors&doi=10.1021%2Fjm0504048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm0504048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504048%26sid%3Dliteratum%253Aachs%26aulast%3DGeitmann%26aufirst%3DM.%26aulast%3DUnge%26aufirst%3DT.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DBiosensor-based%2520kinetic%2520characterization%2520of%2520the%2520interaction%2520between%2520HIV-1%2520reverse%2520transcriptase%2520and%2520non-nucleoside%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2367%26epage%3D2374%26doi%3D10.1021%2Fjm0504048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beavis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deval, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dioszegi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravendran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankuratri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vauquelin, G.</span><span> </span><span class="NLM_article-title">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3364</span><span class="NLM_x">–</span> <span class="NLM_lpage">3375</span><span class="refDoi"> DOI: 10.1111/bph.12683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fbph.12683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24628038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3364-3375&author=D.+C.+Swinneyauthor=P.+Beavisauthor=K.+T.+Chuangauthor=Y.+Zhengauthor=I.+Leeauthor=P.+Geeauthor=J.+Devalauthor=D.+M.+Rotsteinauthor=M.+Dioszegiauthor=P.+Ravendranauthor=J.+Zhangauthor=S.+Sankuratriauthor=R.+Kondruauthor=G.+Vauquelin&title=A+study+of+the+molecular+mechanism+of+binding+kinetics+and+long+residence+times+of+human+CCR5+receptor+small+molecule+allosteric+ligands&doi=10.1111%2Fbph.12683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span></div><div class="casAuthors">Swinney, David C.; Beavis, Paul; Chuang, Kai-Ting; Zheng, Yue; Lee, Ina; Gee, Peter; Deval, Jerome; Rotstein, David M.; Dioszegi, Marianna; Ravendran, Palani; Zhang, Jun; Sankuratri, Surya; Kondru, Rama; Vauquelin, Georges</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3364-3375</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The human CCR5 receptor is a co-receptor for HIV-1 infection and a target for anti-viral therapy.  A greater understanding of the binding kinetics of small mol. allosteric ligand interactions with CCR5 will lead to a better understanding of the binding process and may help discover new mols. that avoid resistance.  Exptl. Approach : Using [3H] maraviroc as a radioligand, a no. of different binding protocols were employed in conjunction with simulations to det. rate consts., kinetic mechanism and mutant kinetic fingerprints for wild-type and mutant human CCR5 with maraviroc, aplaviroc and vicriviroc.  Key Results : Kinetic characterization of maraviroc binding to the wild-type CCR5 was consistent with a two-step kinetic mechanism that involved an initial receptor-ligand complex (RA), which transitioned to a more stable complex, R'A, with at least a 13-fold increase in affinity.  The dissocn. rate from R'A, k-2, was 1.2 × 10-3 min-1.  The maraviroc time-dependent transition was influenced by F85L, W86A, Y108A, I198A and Y251A mutations of CCR5.  Conclusions and Implications : The interaction between maraviroc and CCR5 proceeded according to a multi-step kinetic mechanism, whereby initial mass action binding and later reorganizations of the initial maraviroc-receptor complex lead to a complex with longer residence time.  Site-directed mutagenesis identified a kinetic fingerprint of residues that affected the binding kinetics, leading to the conclusion that allosteric ligand binding to CCR5 involved the rearrangement of the binding site in a manner specific to each allosteric ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ko1PQQH-V7Vg90H21EOLACvtfcHk0lhGJpQt9m3S5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK&md5=400071d4fb6418a133752ddcd95a0d9c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fbph.12683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12683%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DBeavis%26aufirst%3DP.%26aulast%3DChuang%26aufirst%3DK.%2BT.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DRotstein%26aufirst%3DD.%2BM.%26aulast%3DDioszegi%26aufirst%3DM.%26aulast%3DRavendran%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DVauquelin%26aufirst%3DG.%26atitle%3DA%2520study%2520of%2520the%2520molecular%2520mechanism%2520of%2520binding%2520kinetics%2520and%2520long%2520residence%2520times%2520of%2520human%2520CCR5%2520receptor%2520small%2520molecule%2520allosteric%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3364%26epage%3D3375%26doi%3D10.1111%2Fbph.12683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Cimitan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Early absorption and distribution analysis of antitumor and anti-AIDS drugs: lipid membrane and plasma protein interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3536</span><span class="NLM_x">–</span> <span class="NLM_lpage">3546</span><span class="refDoi"> DOI: 10.1021/jm049343o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049343o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3536-3546&author=S.+Cimitanauthor=M.+T.+Lindgrenauthor=C.+Bertucciauthor=U.+H.+Danielson&title=Early+absorption+and+distribution+analysis+of+antitumor+and+anti-AIDS+drugs%3A+lipid+membrane+and+plasma+protein+interactions&doi=10.1021%2Fjm049343o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Early Absorption and Distribution Analysis of Antitumor and Anti-AIDS Drugs: Lipid Membrane and Plasma Protein Interactions</span></div><div class="casAuthors">Cimitan, Samanta; Lindgren, Maria T.; Bertucci, Carlo; Danielson, U. Helena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3536-3546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interactions of a set of compds. of potential importance for anticancer and AIDS chemotherapy with lipid membranes and plasma proteins were studied with a surface plasmon resonance (SPR) based optical biosensor, giving valuable information on the absorption and distribution of the compds.  The technique allowed both effective screening of compds. and more detailed kinetic and mechanistic anal. of specific interactions.  The interaction with two different types of lipid membranes could be reliably measured at a drug concn. as low as 20 μM, allowing anal. of poorly sol. compds.  Distribution was evaluated by investigation of the interactions with two human plasma proteins, human serum albumin (HSA) and α1-acid glycoprotein (AGP).  Two apparent binding sites were clearly defined for HSA: one with rapid and one with slow assocn. and dissocn. rates.  The sites appear to differ in accessibility and recognition characteristics rather than in their capacities to form strong complexes with drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnw84D06UeLVg90H21EOLACvtfcHk0lhsKjK21UB_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWnt7k%253D&md5=4cd97d0bf7a351b607f5b9fae49aa6fc</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm049343o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049343o%26sid%3Dliteratum%253Aachs%26aulast%3DCimitan%26aufirst%3DS.%26aulast%3DLindgren%26aufirst%3DM.%2BT.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DEarly%2520absorption%2520and%2520distribution%2520analysis%2520of%2520antitumor%2520and%2520anti-AIDS%2520drugs%253A%2520lipid%2520membrane%2520and%2520plasma%2520protein%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3536%26epage%3D3546%26doi%3D10.1021%2Fjm049343o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent advances in the structure-based rational design of TNKSIs</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2783</span><span class="NLM_x">–</span> <span class="NLM_lpage">2799</span><span class="refDoi"> DOI: 10.1039/C4MB00385C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4MB00385C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25211064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2783-2799&author=P.+Zhanauthor=Y.+Songauthor=Y.+Itohauthor=T.+Suzukiauthor=X.+Liu&title=Recent+advances+in+the+structure-based+rational+design+of+TNKSIs&doi=10.1039%2FC4MB00385C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the structure-based rational design of TNKSIs</span></div><div class="casAuthors">Zhan, Peng; Song, Yu'ning; Itoh, Yukihiro; Suzuki, Takayoshi; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2783-2799</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Human tankyrases 1 and 2 (TNKS1/2) are attractive pharmacol. biotargets, esp. for the treatment of specific types of cancer.  This article provides a fairly comprehensive overview of the structural biol. of the TNKS-inhibitor complex and the current medicinal chem. strategies being used in the structure-based rational design of tankyrase-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKsymkDwCMxLVg90H21EOLACvtfcHk0lhsKjK21UB_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP&md5=ff91450e15ffa81a39ef5667f300d77b</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1039%2FC4MB00385C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00385C%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520advances%2520in%2520the%2520structure-based%2520rational%2520design%2520of%2520TNKSIs%26jtitle%3DMol.%2520BioSyst.%26date%3D2014%26volume%3D10%26spage%3D2783%26epage%3D2799%26doi%3D10.1039%2FC4MB00385C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knöchel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringrose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span> </span><span class="NLM_article-title">Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1223</span><span class="refDoi"> DOI: 10.1021/jm801322h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801322h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1219-1223&author=L.+H.+Jonesauthor=G.+Allanauthor=O.+Barbaauthor=C.+Burtauthor=R.+Corbauauthor=T.+Dupontauthor=T.+Kn%C3%B6chelauthor=S.+Irvingauthor=D.+S.+Middletonauthor=C.+E.+Mowbrayauthor=M.+Perrosauthor=H.+Ringroseauthor=N.+A.+Swainauthor=R.+Websterauthor=M.+Westbyauthor=C.+Phillips&title=Novel+indazole+non-nucleoside+reverse+transcriptase+inhibitors+using+molecular+hybridization+based+on+crystallographic+overlays&doi=10.1021%2Fjm801322h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Indazole Non-Nucleoside Reverse Transcriptase Inhibitors Using Molecular Hybridization Based on Crystallographic Overlays</span></div><div class="casAuthors">Jones, Lyn H.; Allan, Gill; Barba, Oscar; Burt, Catherine; Corbau, Romuald; Dupont, Thomas; Knochel, Thorsten; Irving, Steve; Middleton, Donald S.; Mowbray, Charles E.; Perros, Manos; Ringrose, Heather; Swain, Nigel A.; Webster, Robert; Westby, Mike; Phillips, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1219-1223</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major problem assocd. with non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV is their lack of resilience to mutations in the reverse transcriptase (RT) enzyme.  Using structural overlays of the known inhibitors efavirenz and capravirine complexed in RT as a starting point, and structure-based drug design techniques, we have created a novel series of indazole NNRTIs that possess excellent metabolic stability and mutant resilience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWWogFxi8kLVg90H21EOLACvtfcHk0lhsKjK21UB_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oitrc%253D&md5=6dc8758049f0c1a33b1ce3ba9a1513a0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm801322h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801322h%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DAllan%26aufirst%3DG.%26aulast%3DBarba%26aufirst%3DO.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DDupont%26aufirst%3DT.%26aulast%3DKn%25C3%25B6chel%26aufirst%3DT.%26aulast%3DIrving%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DRingrose%26aufirst%3DH.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DC.%26atitle%3DNovel%2520indazole%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520using%2520molecular%2520hybridization%2520based%2520on%2520crystallographic%2520overlays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1219%26epage%3D1223%26doi%3D10.1021%2Fjm801322h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2014.09.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=52-62&author=Z.+Liuauthor=W.+Chenauthor=P.+Zhanauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=X.+Liu&title=Design%2C+synthesis+and+anti-HIV+evaluation+of+novel+diarylnicotinamide+derivatives+%28DANAs%29+targeting+the+entrance+channel+of+the+NNRTI+binding+pocket+through+structure-guided+molecular+hybridization&doi=10.1016%2Fj.ejmech.2014.09.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.054%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%2520and%2520anti-HIV%2520evaluation%2520of%2520novel%2520diarylnicotinamide%2520derivatives%2520%2528DANAs%2529%2520targeting%2520the%2520entrance%2520channel%2520of%2520the%2520NNRTI%2520binding%2520pocket%2520through%2520structure-guided%2520molecular%2520hybridization%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.ejmech.2014.09.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit106b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmc.2014.01.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1863-72&author=W.+Chenauthor=P.+Zhanauthor=D.+Raiauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=J.+Balzariniauthor=Z.+Zhouauthor=H.+Liuauthor=X.+Liu&title=Discovery+of+2-pyridone+derivatives+as+potent+HIV-1+NNRTIs+using+molecular+hybridization+based+on+crystallographic+overlays&doi=10.1016%2Fj.bmc.2014.01.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.054%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DRai%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25202-pyridone%2520derivatives%2520as%2520potent%2520HIV-1%2520NNRTIs%2520using%2520molecular%2520hybridization%2520based%2520on%2520crystallographic%2520overlays%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1863%26epage%3D72%26doi%3D10.1016%2Fj.bmc.2014.01.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Conformational restriction: an effective tactic in “follow-on”-based drug discovery</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span><span class="refDoi"> DOI: 10.4155/fmc.14.50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4155%2Ffmc.14.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24962281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=885-901&author=Z.+Fangauthor=Y.+Songauthor=P.+Zhanauthor=Q.+Zhangauthor=X.+Liu&title=Conformational+restriction%3A+an+effective+tactic+in+%E2%80%9Cfollow-on%E2%80%9D-based+drug+discovery&doi=10.4155%2Ffmc.14.50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational restriction: an effective tactic in 'follow-on'-based drug discovery</span></div><div class="casAuthors">Fang, Zengjun; Song, Yu'ning; Zhan, Peng; Zhang, Qingzhu; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">885-901</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The conformational restriction (rigidification) of a flexible ligand has often been a commonly used strategy in drug design, as it can minimize the entropic loss assocd. with the ligand adopting a preferred conformation for binding, which leads to enhanced potency for a given physiol. target, improved selectivity for isoforms and reduced the possibility of drug metab.  Therefore, the application of conformational restriction strategy is a core aspect of drug discovery and development that is widely practiced by medicinal chemists either deliberately or subliminally.  The present review will highlight current representative examples and a brief overview on the rational design of conformationally restricted agents as well as discuss its advantages over the flexible counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoupMomfg9J_bVg90H21EOLACvtfcHk0lig--5Pd8GGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE&md5=dcf5fa6cead84c77b3603c7e0800f49b</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.50%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DConformational%2520restriction%253A%2520an%2520effective%2520tactic%2520in%2520%25E2%2580%259Cfollow-on%25E2%2580%259D-based%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D885%26epage%3D901%26doi%3D10.4155%2Ffmc.14.50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Egbertson, M. S.</span><span> </span><span class="NLM_article-title">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at Merck West Point and Merck Rome (IRBM)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span><span class="refDoi"> DOI: 10.2174/156802607781212248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F156802607781212248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17627556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1251-1272&author=M.+S.+Egbertson&title=HIV+integrase+inhibitors%3A+from+diketoacids+to+heterocyclic+templates%3A+a+history+of+HIV+integrase+medicinal+chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29&doi=10.2174%2F156802607781212248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at merck west point and merck rome (IRBM)</span></div><div class="casAuthors">Egbertson, Melissa S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1251-1272</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Replication of the human immunodeficiency virus (HIV) is dependent upon the enzyme HIV integrase (IN), one of three essential enzymes encoded in the viral genome.  HIV-1 IN catalyzes the insertion of the proviral DNA into the host genome (strand transfer).  HIV-1 IN therefore presents an attractive chemotherapeutic target for the treatment of HIV infection and AIDS that could provide patients and physicians with an addnl. option for treatment.  Assays were developed to identify inhibitors of IN strand transfer.  Diketoacid lead compds. were explored and developed into a variety of heterocyclic templates that are potent inhibitors of integrase strand transfer with suitable medicinal chem. properties for treating HIV infection and AIDS.  The 1,6-naphthyridine L-870810 (Antiviral activity in cells IC95 NHS = 102 nM, n = 237), was shown to be efficacious in reducing viral RNA by 1.7 log units after doses of 400mg BID to HIV infected patients.  Optimization of phys. properties led to L-900564, an inhibitor of HIV IN that has excellent cell potency in the presence of protein (Antiviral activity in cells IC95 NHS = 16 nM, n = 15), excellent activity against mutants raised to HIV integrase inhibitors, and a very good pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnZK4Ww16-rVg90H21EOLACvtfcHk0lig--5Pd8GGtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN&md5=63978cc76f8e9036b73f0932d0470585</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.2174%2F156802607781212248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212248%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26atitle%3DHIV%2520integrase%2520inhibitors%253A%2520from%2520diketoacids%2520to%2520heterocyclic%2520templates%253A%2520a%2520history%2520of%2520HIV%2520integrase%2520medicinal%2520chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1251%26epage%3D1272%26doi%3D10.2174%2F156802607781212248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Fardis, M.; Jin, H.; Chen, X.; Tsiang, M.; Chen, J.; Kim, C.; Wright, M.</span><span> </span><span class="NLM_article-title">Conformationally constrained tricyclic HIV integrase inhibitors</span>. In  <span class="citation_source-book">HIV-1 Integrase: Mechanism and Inhibitor Design</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Neamati, N.</span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Chapter 16.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2F9781118015377.ch16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Fardis&author=H.+Jin&author=X.+Chen&author=M.+Tsiang&author=J.+Chen&author=C.+Kim&author=M.+Wrightauthor=N.+Neamati&title=HIV-1+Integrase%3A+Mechanism+and+Inhibitor+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1002%2F9781118015377.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118015377.ch16%26sid%3Dliteratum%253Aachs%26aulast%3DFardis%26aufirst%3DM.%26atitle%3DConformationally%2520constrained%2520tricyclic%2520HIV%2520integrase%2520inhibitors%26btitle%3DHIV-1%2520Integrase%253A%2520Mechanism%2520and%2520Inhibitor%2520Design%26aulast%3DNeamati%26aufirst%3DN.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delisle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flahive, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3393</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span><span class="refDoi"> DOI: 10.1021/jm200208d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200208d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3393-3417&author=T.+W.+Johnsonauthor=S.+P.+Tanisauthor=S.+L.+Butlerauthor=D.+Dalvieauthor=D.+M.+Delisleauthor=K.+R.+Dressauthor=E.+J.+Flahiveauthor=Q.+Huauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=W.+Liuauthor=G.+A.+McClellanauthor=Q.+Pengauthor=M.+B.+Pleweauthor=P.+F.+Richardsonauthor=G.+L.+Smithauthor=J.+Solowiejauthor=K.+T.+Tranauthor=H.+Wangauthor=X.+Yuauthor=J.+Zhangauthor=H.+Zhu&title=Design+and+synthesis+of+novel+N-hydroxy-dihydronaphthyridinones+as+potent+and+orally+bioavailable+HIV-1+integrase+inhibitors&doi=10.1021%2Fjm200208d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm200208d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200208d%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDelisle%26aufirst%3DD.%2BM.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DFlahive%26aufirst%3DE.%2BJ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcClellan%26aufirst%3DG.%2BA.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520N-hydroxy-dihydronaphthyridinones%2520as%2520potent%2520and%2520orally%2520bioavailable%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3393%26epage%3D3417%26doi%3D10.1021%2Fjm200208d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stead, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bru, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisselle, R. A.</span><span> </span><span class="NLM_article-title">Discovery of an HIV integrase inhibitor with an excellent resistance profile</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span><span class="refDoi"> DOI: 10.1039/c3md00014a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2Fc3md00014a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=709-719&author=D.+C.+Prydeauthor=R.+Websterauthor=S.+L.+Butlerauthor=E.+J.+Murrayauthor=K.+Whitbyauthor=C.+Pickfordauthor=M.+Westbyauthor=M.+J.+Palmerauthor=D.+J.+Bullauthor=H.+Vuongauthor=D.+C.+Blakemoreauthor=D.+Steadauthor=C.+Ashcroftauthor=I.+Gardnerauthor=C.+Bruauthor=W.+Y.+Cheungauthor=I.+O.+Robertsauthor=J.+Mortoneauthor=R.+A.+Bisselle&title=Discovery+of+an+HIV+integrase+inhibitor+with+an+excellent+resistance+profile&doi=10.1039%2Fc3md00014a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1039%2Fc3md00014a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00014a%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DMurray%26aufirst%3DE.%2BJ.%26aulast%3DWhitby%26aufirst%3DK.%26aulast%3DPickford%26aufirst%3DC.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DBull%26aufirst%3DD.%2BJ.%26aulast%3DVuong%26aufirst%3DH.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DStead%26aufirst%3DD.%26aulast%3DAshcroft%26aufirst%3DC.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DBru%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DW.%2BY.%26aulast%3DRoberts%26aufirst%3DI.%2BO.%26aulast%3DMortone%26aufirst%3DJ.%26aulast%3DBisselle%26aufirst%3DR.%2BA.%26atitle%3DDiscovery%2520of%2520an%2520HIV%2520integrase%2520inhibitor%2520with%2520an%2520excellent%2520resistance%2520profile%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D709%26epage%3D719%26doi%3D10.1039%2Fc3md00014a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Anderson, A. C.</span><span> </span><span class="NLM_article-title">Winning the arms race by improving drug discovery against mutating targets</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1021/cb200394t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200394t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=278-288&author=A.+C.+Anderson&title=Winning+the+arms+race+by+improving+drug+discovery+against+mutating+targets&doi=10.1021%2Fcb200394t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fcb200394t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200394t%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DWinning%2520the%2520arms%2520race%2520by%2520improving%2520drug%2520discovery%2520against%2520mutating%2520targets%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D278%26epage%3D288%26doi%3D10.1021%2Fcb200394t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Silvestri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marceddu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, P.</span><span> </span><span class="NLM_article-title">1-[2-(Diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole: a potent lead for the design of novel NNRTIs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1016/S0960-894X(99)00664-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS0960-894X%2899%2900664-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=253-256&author=R.+Silvestriauthor=M.+Articoauthor=S.+Massaauthor=T.+Marcedduauthor=F.+De+Montisauthor=P.+La+Colla&title=1-%5B2-%28Diphenylmethoxy%29ethyl%5D-2-methyl-5-nitroimidazole%3A+a+potent+lead+for+the+design+of+novel+NNRTIs&doi=10.1016%2FS0960-894X%2899%2900664-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900664-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900664-2%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DMarceddu%26aufirst%3DT.%26aulast%3DDe%2BMontis%26aufirst%3DF.%26aulast%3DLa%2BColla%26aufirst%3DP.%26atitle%3D1-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-2-methyl-5-nitroimidazole%253A%2520a%2520potent%2520lead%2520for%2520the%2520design%2520of%2520novel%2520NNRTIs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D253%26epage%3D256%26doi%3D10.1016%2FS0960-894X%2899%2900664-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Ahgren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeter, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaskunas, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasher, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J. R. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muesing, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noreen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paget, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkowitz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pranc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rippy, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahlberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ternansky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasileff, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. X.</span><span> </span><span class="NLM_article-title">The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span><span class="refDoi"> DOI: 10.1128/AAC.39.6.1329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.39.6.1329" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=1329-1335&author=C.+Ahgrenauthor=K.+Backroauthor=F.+W.+Bellauthor=A.+S.+Cantrellauthor=M.+Clemensauthor=J.+M.+Colacinoauthor=J.+B.+Deeterauthor=J.+A.+Engelhardtauthor=M.+Hogbergauthor=S.+R.+Jaskunasauthor=N.+G.+Johanssonauthor=C.+L.+Jordanauthor=J.+S.+Kasherauthor=M.+D.+Kinnickauthor=P.+Lindauthor=C.+Lopezauthor=J.+R.+J.+M.+Morinauthor=M.+A.+Muesingauthor=R.+Noreenauthor=B.+Obergauthor=C.+J.+Pagetauthor=J.+A.+Palkowitzauthor=C.+A.+Parrishauthor=P.+Prancauthor=M.+K.+Rippyauthor=C.+Rydergardauthor=C.+Sahlbergauthor=S.+Swansonauthor=R.+J.+Ternanskyauthor=T.+Ungeauthor=R.+T.+Vasileffauthor=L.+Vrangauthor=S.+J.+Westauthor=H.+Zhangauthor=X.+X.+Zhou&title=The+PETT+series%2C+a+new+class+of+potent+nonnucleoside+inhibitors+of+human+immunodeficiency+virus+type+1+reverse+transcriptase&doi=10.1128%2FAAC.39.6.1329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1128%2FAAC.39.6.1329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.39.6.1329%26sid%3Dliteratum%253Aachs%26aulast%3DAhgren%26aufirst%3DC.%26aulast%3DBackro%26aufirst%3DK.%26aulast%3DBell%26aufirst%3DF.%2BW.%26aulast%3DCantrell%26aufirst%3DA.%2BS.%26aulast%3DClemens%26aufirst%3DM.%26aulast%3DColacino%26aufirst%3DJ.%2BM.%26aulast%3DDeeter%26aufirst%3DJ.%2BB.%26aulast%3DEngelhardt%26aufirst%3DJ.%2BA.%26aulast%3DHogberg%26aufirst%3DM.%26aulast%3DJaskunas%26aufirst%3DS.%2BR.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DJordan%26aufirst%3DC.%2BL.%26aulast%3DKasher%26aufirst%3DJ.%2BS.%26aulast%3DKinnick%26aufirst%3DM.%2BD.%26aulast%3DLind%26aufirst%3DP.%26aulast%3DLopez%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DJ.%2BR.%2BJ.%2BM.%26aulast%3DMuesing%26aufirst%3DM.%2BA.%26aulast%3DNoreen%26aufirst%3DR.%26aulast%3DOberg%26aufirst%3DB.%26aulast%3DPaget%26aufirst%3DC.%2BJ.%26aulast%3DPalkowitz%26aufirst%3DJ.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DPranc%26aufirst%3DP.%26aulast%3DRippy%26aufirst%3DM.%2BK.%26aulast%3DRydergard%26aufirst%3DC.%26aulast%3DSahlberg%26aufirst%3DC.%26aulast%3DSwanson%26aufirst%3DS.%26aulast%3DTernansky%26aufirst%3DR.%2BJ.%26aulast%3DUnge%26aufirst%3DT.%26aulast%3DVasileff%26aufirst%3DR.%2BT.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%2BX.%26atitle%3DThe%2520PETT%2520series%252C%2520a%2520new%2520class%2520of%2520potent%2520nonnucleoside%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D1329%26epage%3D1335%26doi%3D10.1128%2FAAC.39.6.1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappalà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span> </span><span class="NLM_article-title">Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1796</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00304-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS0960-894X%2801%2900304-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1793-1796&author=M.+L.+Barrecaauthor=A.+Chimirriauthor=L.+De+Lucaauthor=A.+M.+Monforteauthor=P.+Monforteauthor=A.+Raoauthor=M.+Zappal%C3%A0author=J.+Balzariniauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=M.+Witvrouw&title=Discovery+of+2%2C3-diaryl-1%2C3-thiazolidin-4-ones+as+potent+anti-HIV-1+agents&doi=10.1016%2FS0960-894X%2801%2900304-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900304-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900304-3%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DChimirri%26aufirst%3DA.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DMonforte%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DZappal%25C3%25A0%26aufirst%3DM.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DWitvrouw%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25202%252C3-diaryl-1%252C3-thiazolidin-4-ones%2520as%2520potent%2520anti-HIV-1%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1793%26epage%3D1796%26doi%3D10.1016%2FS0960-894X%2801%2900304-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappalà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, P.</span><span> </span><span class="NLM_article-title">Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3433</span><span class="NLM_x">–</span> <span class="NLM_lpage">3437</span><span class="refDoi"> DOI: 10.1021/jm049279a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049279a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3433-3437&author=M.+L.+Barrecaauthor=A.+Raoauthor=L.+De+Lucaauthor=M.+Zappal%C3%A0author=A.+M.+Monforteauthor=G.+Magaauthor=C.+Pannecouqueauthor=J.+Balzariniauthor=E.+De+Clercqauthor=A.+Chimirriauthor=P.+Monforte&title=Computational+strategies+in+discovering+novel+non-nucleoside+inhibitors+of+HIV-1+RT&doi=10.1021%2Fjm049279a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fjm049279a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049279a%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DZappal%25C3%25A0%26aufirst%3DM.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DMaga%26aufirst%3DG.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DChimirri%26aufirst%3DA.%26aulast%3DMonforte%26aufirst%3DP.%26atitle%3DComputational%2520strategies%2520in%2520discovering%2520novel%2520non-nucleoside%2520inhibitors%2520of%2520HIV-1%2520RT%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3433%26epage%3D3437%26doi%3D10.1021%2Fjm049279a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Kroeger Smith, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hose, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipchock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnsworth, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michejda, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. H.,  Jr.</span><span> </span><span class="NLM_article-title">Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span><span class="refDoi"> DOI: 10.1021/jm020271f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020271f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1940-1947&author=M.+B.+Kroeger+Smithauthor=B.+M.+Hoseauthor=A.+Hawkinsauthor=J.+Lipchockauthor=D.+W.+Farnsworthauthor=R.+C.+Rizzoauthor=J.+Tirado-Rivesauthor=E.+Arnoldauthor=W.+Zhangauthor=S.+H.+Hughesauthor=W.+L.+Jorgensenauthor=C.+J.+Michejdaauthor=R.+H.+Smith&title=Molecular+modeling+calculations+of+HIV-1+reverse+transcriptase+nonnucleoside+inhibitors%3A+correlation+of+binding+energy+with+biological+activity+for+novel+2-aryl-substituted+benzimidazole+analogues&doi=10.1021%2Fjm020271f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm020271f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020271f%26sid%3Dliteratum%253Aachs%26aulast%3DKroeger%2BSmith%26aufirst%3DM.%2BB.%26aulast%3DHose%26aufirst%3DB.%2BM.%26aulast%3DHawkins%26aufirst%3DA.%26aulast%3DLipchock%26aufirst%3DJ.%26aulast%3DFarnsworth%26aufirst%3DD.%2BW.%26aulast%3DRizzo%26aufirst%3DR.%2BC.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%2BH.%26atitle%3DMolecular%2520modeling%2520calculations%2520of%2520HIV-1%2520reverse%2520transcriptase%2520nonnucleoside%2520inhibitors%253A%2520correlation%2520of%2520binding%2520energy%2520with%2520biological%2520activity%2520for%2520novel%25202-aryl-substituted%2520benzimidazole%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1940%26epage%3D1947%26doi%3D10.1021%2Fjm020271f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Morningstar, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnsworth, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckheit, R. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julias, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michejda, C. J.</span><span> </span><span class="NLM_article-title">Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4003</span><span class="NLM_x">–</span> <span class="NLM_lpage">4015</span><span class="refDoi"> DOI: 10.1021/jm060103d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060103d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot12ht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4003-4015&author=M.+L.+Morningstarauthor=T.+Rothauthor=D.+W.+Farnsworthauthor=M.+K.+Smithauthor=K.+Watsonauthor=R.+W.+Buckheitauthor=K.+Dasauthor=W.+Zhangauthor=E.+Arnoldauthor=J.+G.+Juliasauthor=S.+H.+Hughesauthor=C.+J.+Michejda&title=Synthesis%2C+biological+activity%2C+and+crystal+structure+of+potent+nonnucleoside+inhibitors+of+HIV-1+reverse+transcriptase+that+retain+activity+against+mutant+forms+of+the+enzyme&doi=10.1021%2Fjm060103d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Activity, and Crystal Structure of Potent Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase That Retain Activity against Mutant Forms of the Enzyme</span></div><div class="casAuthors">Morningstar, Marshall L.; Roth, Thomas; Farnsworth, David W.; Smith, Marilyn Kroeger; Watson, Karen; Buckheit, Robert W., Jr.; Das, Kalyan; Zhang, Wanyi; Arnold, Eddy; Julias, John G.; Hughes, Stephen H.; Michejda, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4003-4015</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an ongoing effort to develop novel and potent nonnucleoside HIV-1 reverse transcriptase (RT) inhibitors that are effective against the wild type (WT) virus and clin. obsd. mutants, 1,2-bis-substituted benzimidazoles were synthesized and tested.  Optimization of the N1 and C2 positions of benzimidazole led to the development of 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-4-methylbenzimidazole (I) (IC50 = 0.2 μM, EC50 = 0.44 μM, and TC50 ≥ 100 against WT).  This paper describes how substitution on the benzimidazole ring profoundly affects activity.  Substituents at the benzimidazole C4 dramatically enhanced potency, while at C5 or C6 substituents were generally detrimental or neutral to activity, resp.  A 7-Me analog did not inhibit HIV-1 RT.  Detn. of the crystal structure of I bound to RT provided the basis for accurate modeling of addnl. analogs, which were synthesized and tested.  Several derivs. were nanomolar inhibitors of wild-type virus and were effective against clin. relevant HIV-1 mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYm2PeluuHVrVg90H21EOLACvtfcHk0ljtr5KV1JNcnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot12ht7s%253D&md5=6798e7613857ba5bf97845e6aeaa5bc5</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm060103d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060103d%26sid%3Dliteratum%253Aachs%26aulast%3DMorningstar%26aufirst%3DM.%2BL.%26aulast%3DRoth%26aufirst%3DT.%26aulast%3DFarnsworth%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DM.%2BK.%26aulast%3DWatson%26aufirst%3DK.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DJulias%26aufirst%3DJ.%2BG.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520activity%252C%2520and%2520crystal%2520structure%2520of%2520potent%2520nonnucleoside%2520inhibitors%2520of%2520HIV-1%2520reverse%2520transcriptase%2520that%2520retain%2520activity%2520against%2520mutant%2520forms%2520of%2520the%2520enzyme%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4003%26epage%3D4015%26doi%3D10.1021%2Fjm060103d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Michejda, C. J.; Morningstar, M.; Roth, T.</span><span> </span><span class="NLM_article-title">Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase</span>. WO1998037072 A1,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=C.+J.+Michejda&author=M.+Morningstar&author=T.+Roth&title=Substituted+benzimidazoles+as+non-nucleoside+inhibitors+of+reverse+transcriptase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DSubstituted%2520benzimidazoles%2520as%2520non-nucleoside%2520inhibitors%2520of%2520reverse%2520transcriptase%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Walker, M. A.</span><span> </span><span class="NLM_article-title">Novel tactics for designing water-soluble molecules in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span><span class="refDoi"> DOI: 10.1517/17460441.2014.960839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2014.960839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25226793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2ltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1421-1433&author=M.+A.+Walker&title=Novel+tactics+for+designing+water-soluble+molecules+in+drug+discovery&doi=10.1517%2F17460441.2014.960839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Novel tactics for designing water-soluble molecules in drug discovery</span></div><div class="casAuthors">Walker, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1421-1433</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Physiochem. drug properties, such as aq. soly. are considered to be a major factor in detg. the ultimate success or failure of exptl. agents.  Soly. is important because it dets. the max. dose which can be taken up.  As the size and hydrophobicity of drug candidates has increased over the years, poor soly. has become a more prevalent issue.  Recent examples from the literature show that an improved understanding of the relationship between mol. structure and soly. allows this issue to be approached using rational design.  Areas covered: This review provides selected examples from the recent drug discovery literature that demonstrate various tactics, which have been applied successfully towards improving drug soly.  The examples that were selected demonstrate the underlying principles behind aq. soly., such as hydrophobicity and cryst. stability.  Expert opinion: From a strategic point of view, improving the soly. of a compd. should be straightforward because it can be accomplished by simply reducing hydrophobicity or cryst. stability.  However, the structural elements and phys. properties which control soly. also influence potency, pharmacokinetics and toxicity.  Furthermore, there are practical aspects such as the quantity and quality of soly.-related data, which hamper the development of structure-soly. relationships.  Given that poor aq. soly. remains a primary issue in drug discovery, there is a continuous need for novel methods to overcome it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcCkPIepQBjLVg90H21EOLACvtfcHk0ljtr5KV1JNcnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2ltbfO&md5=373cda72cecfa7b5077ed1551a6d1dd9</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1517%2F17460441.2014.960839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2014.960839%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520tactics%2520for%2520designing%2520water-soluble%2520molecules%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D1421%26epage%3D1433%26doi%3D10.1517%2F17460441.2014.960839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Jolly, S. M.; Anthony, N.; Gomez, R.; Dubost, D. C.; Woodward, R. G.</span><span> </span><span class="NLM_article-title">Prodrugs of an HIV reverse transcriptase inhibitor</span>. WO2011126969 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+M.+Jolly&author=N.+Anthony&author=R.+Gomez&author=D.+C.+Dubost&author=R.+G.+Woodward&title=Prodrugs+of+an+HIV+reverse+transcriptase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJolly%26aufirst%3DS.%2BM.%26atitle%3DProdrugs%2520of%2520an%2520HIV%2520reverse%2520transcriptase%2520inhibitor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Timmins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1288</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2014.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1288-1293&author=P.+Timminsauthor=J.+Brownauthor=N.+A.+Meanwellauthor=G.+J.+Hannaauthor=L.+Zhuauthor=J.+F.+Kadow&title=Enabled+clinical+use+of+an+HIV-1+attachment+inhibitor+through+drug+delivery&doi=10.1016%2Fj.drudis.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHanna%26aufirst%3DG.%2BJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DEnabled%2520clinical%2520use%2520of%2520an%2520HIV-1%2520attachment%2520inhibitor%2520through%2520drug%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1288%26epage%3D1293%26doi%3D10.1016%2Fj.drudis.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Leahy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, S. K.</span><span> </span><span class="NLM_article-title">Preparation of phosphonooxymethyl prodrugs of HIV-1 attachment inhibitors</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span><span class="refDoi"> DOI: 10.1021/op400225q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op400225q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=1440-1444&author=D.+K.+Leahyauthor=S.+K.+Pack&title=Preparation+of+phosphonooxymethyl+prodrugs+of+HIV-1+attachment+inhibitors&doi=10.1021%2Fop400225q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fop400225q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop400225q%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DD.%2BK.%26aulast%3DPack%26aufirst%3DS.%2BK.%26atitle%3DPreparation%2520of%2520phosphonooxymethyl%2520prodrugs%2520of%2520HIV-1%2520attachment%2520inhibitors%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2013%26volume%3D17%26spage%3D1440%26epage%3D1444%26doi%3D10.1021%2Fop400225q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D.</span><span> </span><span class="NLM_article-title">Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2048</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span><span class="refDoi"> DOI: 10.1021/jm201218m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201218m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2048-2056&author=J.+F.+Kadowauthor=Y.+Uedaauthor=N.+A.+Meanwellauthor=T.+P.+Connollyauthor=T.+Wangauthor=C.+P.+Chenauthor=K.+S.+Yeungauthor=J.+Zhuauthor=J.+A.+Benderauthor=Z.+Yangauthor=D.+Parkerauthor=P.+F.+Linauthor=R.+J.+Colonnoauthor=M.+Mathewauthor=D.+Morganauthor=M.+Zhengauthor=C.+Chienauthor=D.+Grasela&title=Inhibitors+of+human+immunodeficiency+virus+type+1+%28HIV-1%29+attachment+6.+Preclinical+and+human+pharmacokinetic+profiling+of+BMS-663749%2C+a+phosphonooxymethyl+prodrug+of+the+HIV-1+attachment+inhibitor+2-%284-benzoyl-1-piperazinyl%29-1-%284%2C7-dimethoxy-1H-pyrrolo%5B2%2C3-c%5Dpyridin-3-yl%29-2-oxoethanone+%28BMS-488043%29&doi=10.1021%2Fjm201218m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm201218m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201218m%26sid%3Dliteratum%253Aachs%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DConnolly%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%2BP.%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DP.%2BF.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DMathew%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DGrasela%26aufirst%3DD.%26atitle%3DInhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520attachment%25206.%2520Preclinical%2520and%2520human%2520pharmacokinetic%2520profiling%2520of%2520BMS-663749%252C%2520a%2520phosphonooxymethyl%2520prodrug%2520of%2520the%2520HIV-1%2520attachment%2520inhibitor%25202-%25284-benzoyl-1-piperazinyl%2529-1-%25284%252C7-dimethoxy-1H-pyrrolo%255B2%252C3-c%255Dpyridin-3-yl%2529-2-oxoethanone%2520%2528BMS-488043%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2048%26epage%3D2056%26doi%3D10.1021%2Fjm201218m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">DeGoey, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grampovnik, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flosi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span> </span><span class="NLM_article-title">Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2970</span><span class="refDoi"> DOI: 10.1021/jm900080g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900080g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2964-2970&author=D.+A.+DeGoeyauthor=D.+J.+Grampovnikauthor=W.+J.+Flosiauthor=K.+C.+Marshauthor=X.+C.+Wangauthor=L.+L.+Kleinauthor=K.+F.+McDanielauthor=Y.+Liuauthor=M.+A.+Longauthor=W.+M.+Katiauthor=A.+Mollaauthor=D.+J.+Kempf&title=Water-soluble+prodrugs+of+the+human+immunodeficiency+virus+protease+inhibitors+lopinavir+and+ritonavir&doi=10.1021%2Fjm900080g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Water-Soluble Prodrugs of the Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir</span></div><div class="casAuthors">DeGoey, David A.; Grampovnik, David J.; Flosi, William J.; Marsh, Kennan C.; Wang, Xiu C.; Klein, Larry L.; McDaniel, Keith F.; Liu, Yaya; Long, Michelle A.; Kati, Warren M.; Molla, Akhteruzzaman; Kempf, Dale J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2964-2970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We studied the synthesis, cleavage rates, and oral administration of prodrugs of the HIV protease inhibitors (PIs) lopinavir and ritonavir.  Phosphate esters attached directly to the central hydroxyl groups of these PIs did not demonstrate enzyme-mediated cleavage in vitro and did not provide measurable plasma levels of the parent drugs in vivo.  However, oxymethylphosphate (OMP) and oxyethylphosphate (OEP) prodrugs provided improved rates of cleavage, high levels of aq. soly., and high plasma levels of the parent drugs when dosed orally in rats and dogs.  Dosing unformulated capsules contg. the solid prodrugs led to plasma levels equiv. to those obsd. for dosing formulated solns. of the parent drugs.  A direct synthetic process for the prepn. of OMP and OEP prodrugs was developed, and the improved synthetic method may be applicable to the prepn. of analogous sol. prodrugs of other drug classes with limited soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeiB07ekQMJ7Vg90H21EOLACvtfcHk0ljnrBoYLl5I_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D&md5=6e64ddfeabd5725929cac142bdfe782d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm900080g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900080g%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DGrampovnik%26aufirst%3DD.%2BJ.%26aulast%3DFlosi%26aufirst%3DW.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DKlein%26aufirst%3DL.%2BL.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%2BA.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26atitle%3DWater-soluble%2520prodrugs%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520protease%2520inhibitors%2520lopinavir%2520and%2520ritonavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2964%26epage%3D2970%26doi%3D10.1021%2Fjm900080g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Logsdon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickrey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proteasa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepke, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terlecky, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wawrzak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merigan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, L. C.</span><span> </span><span class="NLM_article-title">Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">3123</span><span class="NLM_x">–</span> <span class="NLM_lpage">3132</span><span class="refDoi"> DOI: 10.1128/JVI.78.6.3123-3132.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.78.6.3123-3132.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=14990731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlSnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=3123-3132&author=B.+C.+Logsdonauthor=J.+F.+Vickreyauthor=P.+Martinauthor=G.+Proteasaauthor=J.+I.+Koepkeauthor=S.+R.+Terleckyauthor=Z.+Wawrzakauthor=M.+A.+Wintersauthor=T.+C.+Meriganauthor=L.+C.+Kovari&title=Crystal+structures+of+a+multidrug-resistant+human+immunodeficiency+virus+type+1+protease+reveal+an+expanded+active-site+cavity&doi=10.1128%2FJVI.78.6.3123-3132.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity</span></div><div class="casAuthors">Logsdon, Bradley C.; Vickrey, John F.; Martin, Philip; Proteasa, Gheorghe; Koepke, Jay I.; Terlecky, Stanley R.; Wawrzak, Zdzislaw; Winters, Mark A.; Merigan, Thomas C.; Kovari, Ladislau C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3123-3132</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The goal of this study was to use X-ray crystallog. to investigate the structural basis of resistance to human immunodeficiency virus type 1 (HIV-1) protease inhibitors.  We overexpressed, purified, and crystd. a multidrug-resistant (MDR) HIV-1 protease enzyme derived from a patient failing on several protease inhibitor-contg. regimens.  This HIV-1 variant contained codon mutations at positions 10, 36, 46, 54, 63, 71, 82, 84, and 90 that confer drug resistance to protease inhibitors.  The 1.8-angstrom (Å) crystal structure of this MDR patient isolate reveals an expanded active-site cavity.  The active-site expansion includes position 82 and 84 mutations due to the alterations in the amino acid side chains from longer to shorter (e.g., V82A and I84V).  The MDR isolate 769 protease "flaps" stay open wider, and the difference in the flap tip distances in the MDR 769 variant is 12 Å.  The MDR 769 protease crystal complexes with lopinavir and DMP450 reveal completely different binding modes.  The network of interactions between the ligands and the MDR 769 protease is completely different from that seen with the wild-type protease-ligand complexes.  The water mol.-forming hydrogen bonds bridging between the two flaps and either the substrate or the peptide-based inhibitor are lacking in the MDR 769 clin. isolate.  The S1, S1', S3, and S3' pockets show expansion and conformational change.  Surface plasmon resonance measurements with the MDR 769 protease indicate higher koff rates, resulting in a change of binding affinity.  Surface plasmon resonance measurements provide kon and koff data (Kd = koff/kon) to measure binding of the multidrug-resistant protease to various ligands.  This MDR 769 protease represents a new antiviral target, presenting the possibility of designing novel inhibitors with activity against the open and expanded protease forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryLkwNDos2YrVg90H21EOLACvtfcHk0ljHeW-wW0McRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlSnu78%253D&md5=cd6270a3d879c2e0965ee0013f7e8e5b</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1128%2FJVI.78.6.3123-3132.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.78.6.3123-3132.2004%26sid%3Dliteratum%253Aachs%26aulast%3DLogsdon%26aufirst%3DB.%2BC.%26aulast%3DVickrey%26aufirst%3DJ.%2BF.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DProteasa%26aufirst%3DG.%26aulast%3DKoepke%26aufirst%3DJ.%2BI.%26aulast%3DTerlecky%26aufirst%3DS.%2BR.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DWinters%26aufirst%3DM.%2BA.%26aulast%3DMerigan%26aufirst%3DT.%2BC.%26aulast%3DKovari%26aufirst%3DL.%2BC.%26atitle%3DCrystal%2520structures%2520of%2520a%2520multidrug-resistant%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520reveal%2520an%2520expanded%2520active-site%2520cavity%26jtitle%3DJ.%2520Virol.%26date%3D2004%26volume%3D78%26spage%3D3123%26epage%3D3132%26doi%3D10.1128%2FJVI.78.6.3123-3132.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Prabu-Jeyabalan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalivaika, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilek-Snyder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">–</span> <span class="NLM_lpage">1521</span><span class="refDoi"> DOI: 10.1128/AAC.50.4.1518-1521.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.50.4.1518-1521.2006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1518-1521&author=M.+Prabu-Jeyabalanauthor=N.+M.+Kingauthor=E.+A.+Nalivaikaauthor=G.+Heilek-Snyderauthor=N.+Cammackauthor=C.+A.+Schiffer&title=Substrate+envelope+and+drug+resistance%3A+crystal+structure+of+RO1+in+complex+with+wild-type+human+immunodeficiency+virus+type+1+protease&doi=10.1128%2FAAC.50.4.1518-1521.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.4.1518-1521.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.4.1518-1521.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPrabu-Jeyabalan%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DN.%2BM.%26aulast%3DNalivaika%26aufirst%3DE.%2BA.%26aulast%3DHeilek-Snyder%26aufirst%3DG.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DSubstrate%2520envelope%2520and%2520drug%2520resistance%253A%2520crystal%2520structure%2520of%2520RO1%2520in%2520complex%2520with%2520wild-type%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1518%26epage%3D1521%26doi%3D10.1128%2FAAC.50.4.1518-1521.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anjum, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">6099</span><span class="NLM_x">–</span> <span class="NLM_lpage">6113</span><span class="refDoi"> DOI: 10.1021/ja076558p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja076558p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Klsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=6099-6113&author=M.+D.+Altmanauthor=A.+Aliauthor=G.+S.+Reddyauthor=M.+N.+Nalamauthor=S.+G.+Anjumauthor=H.+Caoauthor=S.+Chellappanauthor=V.+Kairysauthor=M.+X.+Fernandesauthor=M.+K.+Gilsonauthor=C.+A.+Schifferauthor=T.+M.+Ranaauthor=B.+Tidor&title=HIV-1+protease+inhibitors+from+inverse+design+in+the+substrate+envelope+exhibit+subnanomolar+binding+to+drug-resistant+variants&doi=10.1021%2Fja076558p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants</span></div><div class="casAuthors">Altman, Michael D.; Ali, Akbar; Reddy, G. S. Kiran Kumar; Nalam, Madhavi N. L.; Anjum, Saima Ghafoor; Cao, Hong; Chellappan, Sripriya; Kairys, Visvaldas; Fernandes, Miguel X.; Gilson, Michael K.; Schiffer, Celia A.; Rana, Tariq M.; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6099-6113</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The acquisition of drug-resistant mutations by infectious pathogens remains a pressing health concern, and the development of strategies to combat this threat is a priority.  Here the authors have applied a general strategy, inverse design using the substrate envelope, to develop inhibitors of HIV-1 protease.  Structure-based computation was used to design inhibitors predicted to stay within a consensus substrate vol. in the binding site.  Two rounds of design, synthesis, exptl. testing, and structural anal. were carried out, resulting in a total of 51 compds.  Improvements in design methodol. led to a roughly 1000-fold affinity enhancement to a wild-type protease for the best binders, from a Ki of 30-50 nM in round one to below 100 pM in round two.  Crystal structures of a subset of complexes revealed a binding mode similar to each design that respected the substrate envelope in nearly all cases.  All four best binders from round one exhibited broad specificity against a clin. relevant panel of drug-resistant HIV-1 protease variants, losing no more than 6-13-fold affinity relative to wild type.  Testing a subset of second-round compds. against the panel of resistant variants revealed three classes of inhibitors: robust binders (max. affinity loss of 14-16-fold), moderate binders (35-80-fold), and susceptible binders (greater than 100-fold).  Although for esp. high-affinity inhibitors addnl. factors may also be important, overall, these results suggest that designing inhibitors using the substrate envelope may be a useful strategy in the development of therapeutics with low susceptibility to resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyQ3p-W7ytzbVg90H21EOLACvtfcHk0ljHeW-wW0McRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Klsr4%253D&md5=24700edba306ef3fd764c813c4adde7f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fja076558p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja076558p%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DG.%2BS.%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DAnjum%26aufirst%3DS.%2BG.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DChellappan%26aufirst%3DS.%26aulast%3DKairys%26aufirst%3DV.%26aulast%3DFernandes%26aufirst%3DM.%2BX.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DHIV-1%2520protease%2520inhibitors%2520from%2520inverse%2520design%2520in%2520the%2520substrate%2520envelope%2520exhibit%2520subnanomolar%2520binding%2520to%2520drug-resistant%2520variants%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D6099%26epage%3D6113%26doi%3D10.1021%2Fja076558p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1097/COH.0b013e3283136cee</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FCOH.0b013e3283136cee" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19373036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ot1Kksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=642-646&author=M.+N.+Nalamauthor=C.+A.+Schiffer&title=New+approaches+to+HIV+protease+inhibitor+drug+design+II%3A+testing+the+substrate+envelope+hypothesis+to+avoid+drug+resistance+and+discover+robust+inhibitors&doi=10.1097%2FCOH.0b013e3283136cee"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors</span></div><div class="casAuthors">Nalam Madhavi N L; Schiffer Celia A</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in HIV and AIDS</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">642-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Drug resistance results when the balance between the binding of inhibitors and the turnover of substrates is perturbed in favor of the substrates.  Resistance is quite widespread to the HIV-1 protease inhibitors permitting the protease to process its 10 different substrates.  This processing of the substrates permits the virus HIV-1 to mature and become infectious.  The design of HIV-1 protease inhibitors that closely fit within the substrate-binding region is proposed to be a strategy to avoid drug resistance.  RECENT FINDINGS:  Cocrystal structures of HIV-1 protease with its substrates define an overlapping substrate-binding region or substrate envelope.  Novel HIV-1 protease inhibitors that were designed to fit within this substrate envelope were found to retain high binding affinity and have a flat binding profile against a panel of drug-resistant HIV-1 proteases.  SUMMARY:  The avoidance of drug resistance needs to be considered in the initial design of inhibitors to quickly evolving targets such as HIV-1 protease.  Using a detailed knowledge of substrate binding appears to be a promising strategy for achieving this goal to obtain robust HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHjlj55d1hQJw7prLlxLOzfW6udTcc2eZrrgBEO8pBYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ot1Kksw%253D%253D&md5=e2a26e14ec6852789724650080db65f6</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e3283136cee&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e3283136cee%26sid%3Dliteratum%253Aachs%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DNew%2520approaches%2520to%2520HIV%2520protease%2520inhibitor%2520drug%2520design%2520II%253A%2520testing%2520the%2520substrate%2520envelope%2520hypothesis%2520to%2520avoid%2520drug%2520resistance%2520and%2520discover%2520robust%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2008%26volume%3D3%26spage%3D642%26epage%3D646%26doi%3D10.1097%2FCOH.0b013e3283136cee" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">5368</span><span class="NLM_x">–</span> <span class="NLM_lpage">5378</span><span class="refDoi"> DOI: 10.1128/JVI.02531-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.02531-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20237088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVWgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=5368-5378&author=M.+N.+Nalamauthor=A.+Aliauthor=M.+D.+Altmanauthor=G.+S.+Reddyauthor=S.+Chellappanauthor=V.+Kairysauthor=A.+Ozenauthor=H.+Caoauthor=M.+K.+Gilsonauthor=B.+Tidorauthor=T.+M.+Ranaauthor=C.+A.+Schiffer&title=Evaluating+the+substrate-envelope+hypothesis%3A+structural+analysis+of+novel+HIV-1+protease+inhibitors+designed+to+be+robust+against+drug+resistance&doi=10.1128%2FJVI.02531-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance</span></div><div class="casAuthors">Nalam, Madhavi N. L.; Ali, Akbar; Altman, Michael D.; Reddy, G. S. Kiran Kumar; Chellappan, Sripriya; Kairys, Visvaldas; Ozen, Aysegul; Cao, Hong; Gilson, Michael K.; Tidor, Bruce; Rana, Tariq M.; Schiffer, Celia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5368-5378</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Drug resistance mutations in HIV-1 protease selectively alter inhibitor binding without significantly affecting substrate recognition and cleavage.  This alteration in mol. recognition led us to develop the substrate-envelope hypothesis which predicts that HIV-1 protease inhibitors that fit within the overlapping consensus vol. of the substrates are less likely to be susceptible to drug-resistant mutations, as a mutation impacting such inhibitors would simultaneously impact the processing of substrates.  To evaluate this hypothesis, over 130 HIV-1 protease inhibitors were designed and synthesized using three different approaches with and without substrate-envelope constraints.  A subset of 16 representative inhibitors with binding affinities to wild-type protease ranging from 58 nM to 0.8 pM was chosen for crystallog. anal.  The inhibitor-protease complexes revealed that tightly binding inhibitors (at the picomolar level of affinity) appear to "lock" into the protease active site by forming hydrogen bonds to particular active-site residues.  Both this hydrogen bonding pattern and subtle variations in protein-ligand van der Waals interactions distinguish nanomolar from picomolar inhibitors.  In general, inhibitors that fit within the substrate envelope, regardless of whether they are picomolar or nanomolar, have flatter profiles with respect to drug-resistant protease variants than inhibitors that protrude beyond the substrate envelope; this provides a strong rationale for incorporating substrate-envelope constraints into structure-based design strategies to develop new HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1FdWkZ1EQDLVg90H21EOLACvtfcHk0ljitaLemX2i4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVWgtrc%253D&md5=09e55d24a9ff7382cefd2fccc5206ada</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1128%2FJVI.02531-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02531-09%26sid%3Dliteratum%253Aachs%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DReddy%26aufirst%3DG.%2BS.%26aulast%3DChellappan%26aufirst%3DS.%26aulast%3DKairys%26aufirst%3DV.%26aulast%3DOzen%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DEvaluating%2520the%2520substrate-envelope%2520hypothesis%253A%2520structural%2520analysis%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520designed%2520to%2520be%2520robust%2520against%2520drug%2520resistance%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D5368%26epage%3D5378%26doi%3D10.1128%2FJVI.02531-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunzelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, L. C.</span><span> </span><span class="NLM_article-title">Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease</span> <span class="citation_source-journal">Protein J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1007/s10930-011-9316-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2Fs10930-011-9316-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21394574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=173-183&author=Z.+Liuauthor=Y.+Wangauthor=J.+Brunzelleauthor=I.+A.+Kovariauthor=L.+C.+Kovari&title=Nine+crystal+structures+determine+the+substrate+envelope+of+the+MDR+HIV-1+protease&doi=10.1007%2Fs10930-011-9316-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Nine Crystal Structures Determine the Substrate Envelope of the MDR HIV-1 Protease</span></div><div class="casAuthors">Liu, Zhigang; Wang, Yong; Brunzelle, Joseph; Kovari, Iulia A.; Kovari, Ladislau C.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-183</span>CODEN:
                <span class="NLM_cas:coden">PJROAH</span>;
        ISSN:<span class="NLM_cas:issn">1572-3887</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Under drug selection pressure, emerging mutations render HIV-1 protease drug resistant, leading to the therapy failure in anti-HIV treatment.  It is known that nine substrate cleavage site peptides bind to wild type (WT) HIV-1 protease in a conserved pattern.  However, how the multidrug-resistant (MDR) HIV-1 protease binds to the substrate cleavage site peptides is yet to be detd.  MDR769 HIV-1 protease (resistant mutations at residues 10, 36, 46, 54, 62, 63, 71, 82, 84, and 90) was selected for present study to understand the binding to its natural substrates.  MDR769 HIV-1 protease was co-crystd. with nine substrate cleavage site hepta-peptides.  Crystallog. studies show that MDR769 HIV-1 protease has an expanded substrate envelope with wide open flaps.  Furthermore, ligand binding energy calcns. indicate weaker binding in MDR769 HIV-1 protease-substrate complexes.  These results help in designing the next generation of HIV-1 protease inhibitors by targeting the MDR HIV-1 protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrktms43A2Ug7Vg90H21EOLACvtfcHk0ljitaLemX2i4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2jsrk%253D&md5=719994f70a7b6b38458d5e444a06f46a</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs10930-011-9316-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10930-011-9316-2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBrunzelle%26aufirst%3DJ.%26aulast%3DKovari%26aufirst%3DI.%2BA.%26aulast%3DKovari%26aufirst%3DL.%2BC.%26atitle%3DNine%2520crystal%2520structures%2520determine%2520the%2520substrate%2520envelope%2520of%2520the%2520MDR%2520HIV-1%2520protease%26jtitle%3DProtein%2520J.%26date%3D2011%26volume%3D30%26spage%3D173%26epage%3D183%26doi%3D10.1007%2Fs10930-011-9316-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Parai, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huggins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6328</span><span class="NLM_x">–</span> <span class="NLM_lpage">6341</span><span class="refDoi"> DOI: 10.1021/jm300238h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300238h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6328-6341&author=M.+K.+Paraiauthor=D.+J.+Hugginsauthor=H.+Caoauthor=M.+N.+Nalamauthor=A.+Aliauthor=C.+A.+Schifferauthor=B.+Tidorauthor=T.+M.+Rana&title=Design%2C+synthesis%2C+and+biological+and+structural+evaluations+of+novel+HIV-1+protease+inhibitors+to+combat+drug+resistance&doi=10.1021%2Fjm300238h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm300238h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300238h%26sid%3Dliteratum%253Aachs%26aulast%3DParai%26aufirst%3DM.%2BK.%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DRana%26aufirst%3DT.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520and%2520structural%2520evaluations%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520to%2520combat%2520drug%2520resistance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6328%26epage%3D6341%26doi%3D10.1021%2Fjm300238h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">Testing the substrate-envelope hypothesis with designed pairs of compounds</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2441</span><span class="refDoi"> DOI: 10.1021/cb400468c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400468c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yiur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2433-2441&author=Y.+Shenauthor=M.+D.+Altmanauthor=A.+Aliauthor=M.+N.+Nalamauthor=H.+Caoauthor=T.+M.+Ranaauthor=C.+A.+Schifferauthor=B.+Tidor&title=Testing+the+substrate-envelope+hypothesis+with+designed+pairs+of+compounds&doi=10.1021%2Fcb400468c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Testing the substrate-envelope hypothesis with designed pairs of compounds</span></div><div class="casAuthors">Shen, Yang; Altman, Michael D.; Ali, Akbar; Nalam, Madhavi N. L.; Cao, Hong; Rana, Tariq M.; Schiffer, Celia A.; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2433-2441</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acquired resistance to therapeutic agents is a significant barrier to the development of clin. effective treatments for diseases in which evolution occurs on clin. time scales, frequently arising from target mutations.  We previously reported a general strategy to design effective inhibitors for rapidly mutating enzyme targets, which we demonstrated for HIV-1 protease inhibition.  Specifically, we developed a computational inverse design procedure with the added constraint that designed inhibitors bind entirely inside the substrate envelope, a consensus vol. occupied by natural substrates.  The rationale for the substrate-envelope constraint is that it prevents designed inhibitors from making interactions beyond those required by substrates and thus limits the availability of mutations tolerated by substrates but not by designed inhibitors.  The strategy resulted in subnanomolar inhibitors that bind robustly across a clin. derived panel of drug-resistant variants.  To further test the substrate-envelope hypothesis, here we have designed, synthesized, and assayed derivs. of our original compds. that are larger and extend outside the substrate envelope.  Our designs resulted in pairs of compds. that are very similar to one another, but one respects and one violates the substrate envelope.  The envelope-respecting inhibitor demonstrates robust binding across a panel of drug-resistant protease variants, whereas the envelope-violating one binds tightly to wild type but loses affinity to at least one variant.  This study provides strong support for the substrate-envelope hypothesis as a design strategy for inhibitors that reduce susceptibility to resistance mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxEZ752OIVobVg90H21EOLACvtfcHk0liECHhDbeYPFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yiur%252FE&md5=8febc495df52db0dd9463e25a2f5284d</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fcb400468c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400468c%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DTesting%2520the%2520substrate-envelope%2520hypothesis%2520with%2520designed%2520pairs%2520of%2520compounds%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2433%26epage%3D2441%26doi%3D10.1021%2Fcb400468c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Tuske, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeger, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerina, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1038/nsmb760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnsmb760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=15107837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=469-474&author=S.+Tuskeauthor=S.+G.+Sarafianosauthor=A.+D.+Clarkauthor=J.+Dingauthor=L.+K.+Naegerauthor=K.+L.+Whiteauthor=M.+D.+Millerauthor=C.+S.+Gibbsauthor=P.+L.+Boyerauthor=P.+Clarkauthor=G.+Wangauthor=B.+L.+Gaffneyauthor=R.+A.+Jonesauthor=D.+M.+Jerinaauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structures+of+HIV-1+RT-DNA+complexes+before+and+after+incorporation+of+the+anti-AIDS+drug+tenofovir&doi=10.1038%2Fnsmb760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir</span></div><div class="casAuthors">Tuske, Steve; Sarafianos, Stefan G.; Clark, Arthur D.; Ding, Jianping; Naeger, Lisa K.; White, Kirsten L.; Miller, Michael D.; Gibbs, Craig S.; Boyer, Paul L.; Clark, Patrick; Wang, Gang; Gaffney, Barbara L.; Jones, Roger A.; Jerina, Donald M.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">469-474</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tenofovir, also known as PMPA, R-9-2-(phosphonomethoxypropyl)adenine, is a nucleotide reverse transcriptase (RT) inhibitor.  We have detd. the crystal structures of two related complexes of HIV-1 RT with template primer and tenofovir: (i) a ternary complex at a resoln. of 3.0 Å of RT crosslinked to a dideoxy-terminated DNA with tenofovir-diphosphate bound as the incoming substrate; and (ii) a RT-DNA complex at a resoln. of 3.1 Å with tenofovir at the 3' primer terminus.  The tenofovir nucleotide in the tenofovir-terminated structure seems to adopt multiple conformations.  Some nucleoside reverse transcriptase inhibitors, including 3TC and AZT, have elements ('handles') that project beyond the corresponding elements on normal dNTPs (the 'substrate envelope').  HIV-1 RT resistance mechanisms to AZT and 3TC take advantage of these handles; tenofovir's structure lacks handles that could protrude through the substrate envelope to cause resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi1ei68A2R6bVg90H21EOLACvtfcHk0liECHhDbeYPFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsL8%253D&md5=da428445f0276f07fd66dbde46732fbf</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fnsmb760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb760%26sid%3Dliteratum%253Aachs%26aulast%3DTuske%26aufirst%3DS.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DNaeger%26aufirst%3DL.%2BK.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DGibbs%26aufirst%3DC.%2BS.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DGaffney%26aufirst%3DB.%2BL.%26aulast%3DJones%26aufirst%3DR.%2BA.%26aulast%3DJerina%26aufirst%3DD.%2BM.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructures%2520of%2520HIV-1%2520RT-DNA%2520complexes%2520before%2520and%2520after%2520incorporation%2520of%2520the%2520anti-AIDS%2520drug%2520tenofovir%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D469%26epage%3D474%26doi%3D10.1038%2Fnsmb760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Xue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span> </span><span class="NLM_article-title">Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span><span class="refDoi"> DOI: 10.1021/ci400060j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400060j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=621-633&author=W.+Xueauthor=Y.+Banauthor=H.+Liuauthor=X.+Yao&title=Computational+study+on+the+drug+resistance+mechanism+against+HCV+NS3%2F4A+protease+inhibitors+vaniprevir+and+MK-5172+by+the+combination+use+of+molecular+dynamics+simulation%2C+residue+interaction+network%2C+and+substrate+envelope+analysis&doi=10.1021%2Fci400060j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Study on the Drug Resistance Mechanism against HCV NS3/4A Protease Inhibitors Vaniprevir and MK-5172 by the Combination Use of Molecular Dynamics Simulation, Residue Interaction Network, and Substrate Envelope Analysis</span></div><div class="casAuthors">Xue, Weiwei; Ban, Yihe; Liu, Huanxiang; Yao, Xiaojun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">621-633</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) NS3/4A protease is an important and attractive target for anti-HCV drug development and discovery.  Vaniprevir (phase III clin. trials) and MK-5172 (phase II clin. trials) are two potent antiviral compds. that target NS3/4A protease.  However, the emergence of resistance to these two inhibitors reduced the effectiveness of vaniprevir and MK-5172 against viral replication.  Among the drug resistance mutations, three single-site mutations at residues Arg155, Ala156, and Asp168 in NS3/4A protease are esp. important due to their resistance to nearly all inhibitors in clin. development.  A detailed understanding of drug resistance mechanism to vaniprevir and MK-5172 is therefore very crucial for the design of novel potent agents targeting viral variants.  In this work, mol. dynamics (MD) simulation, binding free energy calcn., free energy decompn., residue interaction network (RIN), and substrate envelope anal. were used to study the detailed drug resistance mechanism of the three mutants R155K, A156T, and D168A to vaniprevir and MK-5172.  MD simulation was used to investigate the binding mode for these two inhibitors to wild-type and resistant mutants of HCV NS3/4A protease.  Binding free energy calcn. and free energy decompn. anal. reveal that drug resistance mutations reduced the interactions between the active site residues and substituent in the P2 to P4 linker of vaniprevir and MK-5172.  Furthermore, RIN and substrate envelope anal. indicate that the studied mutations of the residues are located outside the substrate (4B5A) binding site and selectively decrease the affinity of inhibitors but not the activity of the enzyme and consequently help NS3/4A protease escape from the effect of the inhibitors without influencing the affinity of substrate binding.  These findings can provide useful information for understanding the drug resistance mechanism against vaniprevir and MK-5172.  The results can also provide some potential clues for further design of novel inhibitors that are less susceptible to drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpue_rx5rWDtrVg90H21EOLACvtfcHk0liECHhDbeYPFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOjsrg%253D&md5=34a5874ce873bf38334d21fad486dbaf</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fci400060j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400060j%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DW.%26aulast%3DBan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DX.%26atitle%3DComputational%2520study%2520on%2520the%2520drug%2520resistance%2520mechanism%2520against%2520HCV%2520NS3%252F4A%2520protease%2520inhibitors%2520vaniprevir%2520and%2520MK-5172%2520by%2520the%2520combination%2520use%2520of%2520molecular%2520dynamics%2520simulation%252C%2520residue%2520interaction%2520network%252C%2520and%2520substrate%2520envelope%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D621%26epage%3D633%26doi%3D10.1021%2Fci400060j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Ozen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Improving the resistance profile of hepatitis C NS3/4A inhibitors: dynamic substrate envelope guided design</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5693</span><span class="NLM_x">–</span> <span class="NLM_lpage">5705</span><span class="refDoi"> DOI: 10.1021/ct400603p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct400603p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1amt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=5693-5705&author=A.+Ozenauthor=W.+Shermanauthor=C.+A.+Schiffer&title=Improving+the+resistance+profile+of+hepatitis+C+NS3%2F4A+inhibitors%3A+dynamic+substrate+envelope+guided+design&doi=10.1021%2Fct400603p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Resistance Profile of Hepatitis C NS3/4A Inhibitors: Dynamic Substrate Envelope Guided Design</span></div><div class="casAuthors">Ozen, Aysegul; Sherman, Woody; Schiffer, Celia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5693-5705</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug resistance is a principal concern in the treatment of quickly evolving diseases.  The viral protease NS3/4A is a primary drug target for the hepatitis C virus (HCV) and is known to evolve resistance mutations in response to drug therapy.  At the mol. level, drug resistance reflects a subtle change in the balance of mol. recognition by NS3/4A; the drug resistant protease variants are no longer effectively inhibited by the competitive active site inhibitors but can still process the natural substrates with enough efficiency for viral survival.  In previous works, the authors have developed the "substrate envelope" hypothesis, which posits that inhibitors should be less susceptible to drug resistance if they better mimic the natural substrate mol. recognition features.  The authors perform mol. dynamics simulations on four native substrates bound to NS3/4A and discover a clearly conserved dynamic substrate envelope.  The authors show that the most severe drug resistance mutations in NS3/4A occur at residues that are outside the substrate envelope.  Comparative anal. of three NS3/4A inhibitors reveals structural and dynamic characteristics of inhibitors that could lead to resistance.  The authors also suggest inhibitor modifications to improve resistance profiles based on the dynamic substrate envelope.  This study provides a general framework for guiding the development of novel inhibitors that will be more robust against resistance by mimicking the static and dynamic binding characteristics of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk2uHtoexId7Vg90H21EOLACvtfcHk0ljttSutUGLQnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1amt7%252FF&md5=91c75667e5fc91c1c07d59c71e995283</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fct400603p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct400603p%26sid%3Dliteratum%253Aachs%26aulast%3DOzen%26aufirst%3DA.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DImproving%2520the%2520resistance%2520profile%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520inhibitors%253A%2520dynamic%2520substrate%2520envelope%2520guided%2520design%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2013%26volume%3D9%26spage%3D5693%26epage%3D5705%26doi%3D10.1021%2Fct400603p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Hartman, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckheit, R. W.,  Jr.</span><span> </span><span class="NLM_article-title">The continuing evolution of HIV-1 therapy: identification and development of novel antiretroviral agents targeting viral and cellular targets</span> <span class="citation_source-journal">Mol. Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">401965</span><span class="refDoi"> DOI: 10.1155/2012/401965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1155%2F2012%2F401965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22848825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC38fpslymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=401965&author=T.+L.+Hartmanauthor=R.+W.+Buckheit&title=The+continuing+evolution+of+HIV-1+therapy%3A+identification+and+development+of+novel+antiretroviral+agents+targeting+viral+and+cellular+targets&doi=10.1155%2F2012%2F401965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets</span></div><div class="casAuthors">Hartman Tracy L; Buckheit Robert W Jr</div><div class="citationInfo"><span class="NLM_cas:title">Molecular biology international</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401965</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the past three decades, over thirty-five anti-HIV-1 therapies have been developed for use in humans and the progression from monotherapeutic treatment regimens to today's highly active combination antiretroviral therapies has had a dramatic impact on disease progression in HIV-1-infected individuals.  In spite of the success of AIDS therapies and the existence of inhibitors of HIV-1 reverse transcriptase, protease, entry and fusion, and integrase, HIV-1 therapies still have a variety of problems which require continued development efforts to improve efficacy and reduce toxicity, while making drugs that can be used throughout both the developed and developing world, in pediatric populations, and in pregnant women.  Highly active antiretroviral therapies (HAARTs) have significantly delayed the progression to AIDS, and in the developed world HIV-1-infected individuals might be expected to live normal life spans while on lifelong therapies.  However, the difficult treatment regimens, the presence of class-specific drug toxicities, and the emergence of drug-resistant virus isolates highlight the fact that improvements in our therapeutic regimens and the identification of new and novel viral and cellular targets for therapy are still necessary.  Antiretroviral therapeutic strategies and targets continue to be explored, and the development of increasingly potent molecules within existing classes of drugs and the development of novel strategies are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHnpGf4gD5z5ZoeNcnHOQ9fW6udTcc2eaZVLFNykVypLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fpslymtA%253D%253D&md5=888be26cabfda3660f263881932fae3b</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1155%2F2012%2F401965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F401965%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DT.%2BL.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26atitle%3DThe%2520continuing%2520evolution%2520of%2520HIV-1%2520therapy%253A%2520identification%2520and%2520development%2520of%2520novel%2520antiretroviral%2520agents%2520targeting%2520viral%2520and%2520cellular%2520targets%26jtitle%3DMol.%2520Biol.%2520Int.%26date%3D2012%26volume%3D2012%26spage%3D401965%26doi%3D10.1155%2F2012%2F401965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Kang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">“Old Dogs with New Tricks”: exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1998</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span><span class="refDoi"> DOI: 10.1039/C4MB00147H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4MB00147H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24841339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2qtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1998-2022&author=D.+Kangauthor=Y.+Songauthor=W.+Chenauthor=P.+Zhanauthor=X.+Liu&title=%E2%80%9COld+Dogs+with+New+Tricks%E2%80%9D%3A+exploiting+alternative+mechanisms+of+action+and+new+drug+design+strategies+for+clinically+validated+HIV+targets&doi=10.1039%2FC4MB00147H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">"Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets</span></div><div class="casAuthors">Kang, Dongwei; Song, Yu'ning; Chen, Wenmin; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1998-2022</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  HIV-1 reverse transcriptase, protease and integrase have been recognized as clin. validated but still underexploited targets for antiretroviral treatment.  Although a large no. of inhibitors have been used in clin. trials, the rapid emergence of multiple drug-resistant strains requires the identification of not only novel classes of antiretroviral drugs that act via the unprecedented mechanism of action but also innovative drug discovery strategies towards these three important targets.  This review summarizes and discusses current endeavours towards the discovery and development of novel inhibitors with alternative mechanisms of action, and also provides examples illustrating new methodologies in medicinal chem. that contribute to the identification of novel antiretroviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojDxKGIeu30LVg90H21EOLACvtfcHk0ljttSutUGLQnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2qtLnM&md5=aa42a7ee57c401cbade15a54737b21a8</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1039%2FC4MB00147H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00147H%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3D%25E2%2580%259COld%2520Dogs%2520with%2520New%2520Tricks%25E2%2580%259D%253A%2520exploiting%2520alternative%2520mechanisms%2520of%2520action%2520and%2520new%2520drug%2520design%2520strategies%2520for%2520clinically%2520validated%2520HIV%2520targets%26jtitle%3DMol.%2520BioSyst.%26date%3D2014%26volume%3D10%26spage%3D1998%26epage%3D2022%26doi%3D10.1039%2FC4MB00147H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Cao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent progress in the research of small molecule HIV-1 RNase H inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span><span class="refDoi"> DOI: 10.2174/0929867321666140120121158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F0929867321666140120121158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24438523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1956-1967&author=L.+Caoauthor=W.+Songauthor=E.+De+Clercqauthor=P.+Zhanauthor=X.+Liu&title=Recent+progress+in+the+research+of+small+molecule+HIV-1+RNase+H+inhibitors&doi=10.2174%2F0929867321666140120121158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors</span></div><div class="casAuthors">Cao, Lili; Song, Weiguo; De Clercq, Erik; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reverse transcription of human immunodeficiency virus type 1 (HIV-1) is a crucial step in the life cycle initiated by the viral-coded reverse transcriptase (RT), functioning as RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) and the RNase H (RNase H).  The RNase H functions to degrade the RNA strand of the RNA:DNA heteroduplex, which makes it an attractive target for rational anti-HIV-1 drug design and development.  Although development of drugs targeting the DNA polymerase have been highly successful, the discovery of drugable inhibitors of HIV RNase H is still in its infancy and none of RNase H inhibitors has reached the clin. development stage currently.  This review describes the recent progress in the HIV-1 RNase H inhibitors, focusing on their chem. feature, mechanism and the structure-activity relationship (SAR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1aiiPIvi0xLVg90H21EOLACvtfcHk0ljttSutUGLQnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D&md5=b304a792478d2ffcbe8d85405c74f0c1</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140120121158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140120121158%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520the%2520research%2520of%2520small%2520molecule%2520HIV-1%2520RNase%2520H%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1956%26epage%3D1967%26doi%3D10.2174%2F0929867321666140120121158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Maga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ennifar, E.</span><span> </span><span class="NLM_article-title">HIV-1 RT inhibitors with a novel mechanism of action: NNRTIs that compete with the nucleotide substrate</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span><span class="refDoi"> DOI: 10.3390/v2040880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3390%2Fv2040880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21994659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Oitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=880-899&author=G.+Magaauthor=M.+Radiauthor=M.+A.+Gerardauthor=M.+Bottaauthor=E.+Ennifar&title=HIV-1+RT+inhibitors+with+a+novel+mechanism+of+action%3A+NNRTIs+that+compete+with+the+nucleotide+substrate&doi=10.3390%2Fv2040880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 RT inhibitors with a novel mechanism of action: NNRTIs that compete with the nucleotide substrate</span></div><div class="casAuthors">Maga, Giovanni; Radi, Marco; Gerard, Marie-Aline; Botta, Maurizio; Ennifar, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">880-899</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided into two classes: (i) nucleoside analog RT inhibitors (NRTIs), which compete with natural nucleoside substrates and act as terminators of proviral DNA synthesis, and (ii) non-nucleoside RT inhibitors (NNRTIs), which bind to a hydrophobic pocket close to the RT active site.  In spite of the efficiency of NRTIs and NNRTIs, the rapid emergence of multidrug-resistant mutations requires the development of new RT inhibitors with an alternative mechanism of action.  Recently, several studies reported the discovery of novel non-nucleoside inhibitors with a distinct mechanism of action.  Unlike classical NNRTIs, they compete with the nucleotide substrate, thus forming a new class of RT inhibitors: nucleotide-competing RT inhibitors (NcRTIs).  In this review, we discuss current progress in the understanding of the peculiar behavior of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraGrAxfc35n7Vg90H21EOLACvtfcHk0liXTAUUyOmE4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Oitbw%253D&md5=52fdf085818b9e8c3d2807df8d1ae9d9</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.3390%2Fv2040880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv2040880%26sid%3Dliteratum%253Aachs%26aulast%3DMaga%26aufirst%3DG.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DGerard%26aufirst%3DM.%2BA.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DEnnifar%26aufirst%3DE.%26atitle%3DHIV-1%2520RT%2520inhibitors%2520with%2520a%2520novel%2520mechanism%2520of%2520action%253A%2520NNRTIs%2520that%2520compete%2520with%2520the%2520nucleotide%2520substrate%26jtitle%3DViruses%26date%3D2010%26volume%3D2%26spage%3D880%26epage%3D899%26doi%3D10.3390%2Fv2040880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Tan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span><span class="refDoi"> DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-HIV+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0liXTAUUyOmE4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-HIV%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Qiu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span> </span><span class="NLM_article-title">Identification and characterization of a subpocket on the N-trimer of HIV-1 gp41: implication for viral entry and drug target</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span><span class="refDoi"> DOI: 10.1097/QAD.0000000000000683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAD.0000000000000683" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1015-1024&author=Z.+Qiuauthor=H.+Chongauthor=X.+Yaoauthor=Y.+Suauthor=S.+Cuiauthor=Y.+He&title=Identification+and+characterization+of+a+subpocket+on+the+N-trimer+of+HIV-1+gp41%3A+implication+for+viral+entry+and+drug+target&doi=10.1097%2FQAD.0000000000000683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1097%2FQAD.0000000000000683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0000000000000683%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DChong%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520subpocket%2520on%2520the%2520N-trimer%2520of%2520HIV-1%2520gp41%253A%2520implication%2520for%2520viral%2520entry%2520and%2520drug%2520target%26jtitle%3DAIDS%26date%3D2015%26volume%3D29%26spage%3D1015%26epage%3D1024%26doi%3D10.1097%2FQAD.0000000000000683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Muzammil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelmer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">5144</span><span class="NLM_x">–</span> <span class="NLM_lpage">5154</span><span class="refDoi"> DOI: 10.1128/JVI.02706-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.02706-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17360759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1GrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=5144-5154&author=S.+Muzammilauthor=A.+A.+Armstrongauthor=L.+W.+Kangauthor=A.+Jakalianauthor=P.+R.+Bonneauauthor=V.+Schmelmerauthor=L.+M.+Amzelauthor=E.+Freire&title=Unique+thermodynamic+response+of+tipranavir+to+human+immunodeficiency+virus+type+1+protease+drug+resistance+mutations&doi=10.1128%2FJVI.02706-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations</span></div><div class="casAuthors">Muzammil, S.; Armstrong, A. A.; Kang, L. W.; Jakalian, A.; Bonneau, P. R.; Schmelmer, V.; Amzel, L. M.; Freire, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5144-5154</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Drug resistance is a major problem affecting the clin. efficacy of antiretroviral agents, including protease inhibitors, in the treatment of infection with human immunodeficiency virus type 1 (HIV-1)/AIDS.  Consequently, the elucidation of the mechanisms by which HIV-1 protease inhibitors maintain antiviral activity in the presence of mutations is crit. to the development of superior inhibitors.  Tipranavir, a nonpeptidic HIV-1 protease inhibitor, has been recently approved for the treatment of HIV infection.  Tipranavir inhibits wild-type protease with high potency (Ki = 19 pM) and demonstrates durable efficacy in the treatment of patients infected with HIV-1 strains contg. multiple common mutations assocd. with resistance.  The high potency of tipranavir results from a very large favorable entropy change (-TΔS = -14.6 kcal/mol) combined with a favorable, albeit small, enthalpy change (ΔH = -0.7 kcal/mol, 25°).  Characterization of tipranavir binding to wild-type protease, active site mutants I50V and V82F/I84V, the multidrug-resistant mutant L10I/L33I/M46I/I54V/L63I/V82A/I84V/L90M, and the tipranavir in vitro-selected mutant I13V/V32L/L33F/K45I/V82L/I84V was performed by isothermal titrn. calorimetry and crystallog.  Thermodynamically, the good response of tipranavir arises from a unique behavior: it compensates for entropic losses by actual enthalpic gains or by sustaining minimal enthalpic losses when facing the mutants.  The net result is a small loss in binding affinity.  Structurally, tipranavir establishes a very strong hydrogen bond network with invariant regions of the protease, which is maintained with the mutants, including catalytic Asp25 and the backbone of Asp29, Asp30, Gly48 and Ile50.  Moreover, tipranavir forms hydrogen bonds directly to Ile50, while all other inhibitors do so by being mediated by a water mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKelAppM3mbrVg90H21EOLACvtfcHk0lir6UjEH_Z7_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1GrsLY%253D&md5=57b7379d383b8f5948100bbf0d9b7eb1</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1128%2FJVI.02706-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02706-06%26sid%3Dliteratum%253Aachs%26aulast%3DMuzammil%26aufirst%3DS.%26aulast%3DArmstrong%26aufirst%3DA.%2BA.%26aulast%3DKang%26aufirst%3DL.%2BW.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DBonneau%26aufirst%3DP.%2BR.%26aulast%3DSchmelmer%26aufirst%3DV.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DUnique%2520thermodynamic%2520response%2520of%2520tipranavir%2520to%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520drug%2520resistance%2520mutations%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D5144%26epage%3D5154%26doi%3D10.1128%2FJVI.02706-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, D. K.</span><span> </span><span class="NLM_article-title">Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">14316</span><span class="NLM_x">–</span> <span class="NLM_lpage">14320</span><span class="refDoi"> DOI: 10.1074/jbc.275.19.14316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.275.19.14316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10799511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjt1Cns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=14316-14320&author=J.+Renauthor=C.+Nicholsauthor=L.+E.+Birdauthor=T.+Fujiwaraauthor=H.+Sugimotoauthor=D.+I.+Stuartauthor=D.+K.+Stammers&title=Binding+of+the+second+generation+non-nucleoside+inhibitor+S-1153+to+HIV-1+reverse+transcriptase+involves+extensive+main+chain+hydrogen+bonding&doi=10.1074%2Fjbc.275.19.14316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding</span></div><div class="casAuthors">Ren, Jingshan; Nichols, Charles; Bird, Louise E.; Fujiwara, Tamio; Sugimoto, Hirohiko; Stuart, David I.; Stammers, David K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">14316-14320</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">S-1153 (AG1549) is perhaps the most promising nonnucleoside inhibitor of HIV-1 reverse transcriptase currently under development as a potential anti-AIDS drug, because it has a favorable profile of resilience to many drug resistance mutations.  We have detd. the crystal structure of S-1153 in a complex with HIV-1 reverse transcriptase.  The complex possesses some novel features, including an extensive network of hydrogen bonds involving the main chain of residues 101, 103, and 236 of the p66 reverse transcriptase subunit.  Such interactions are unlikely to be disrupted by side chain mutations.  The reverse transcriptase/S-1153 complex suggests different ways in which resilience to mutations in the non-nucleoside inhibitors of reverse transcriptase binding site can be achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr72giIIu1rVg90H21EOLACvtfcHk0lir6UjEH_Z7_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjt1Cns70%253D&md5=0b643e074b66456de58f65679f298d2a</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.19.14316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.19.14316%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DNichols%26aufirst%3DC.%26aulast%3DBird%26aufirst%3DL.%2BE.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DStammers%26aufirst%3DD.%2BK.%26atitle%3DBinding%2520of%2520the%2520second%2520generation%2520non-nucleoside%2520inhibitor%2520S-1153%2520to%2520HIV-1%2520reverse%2520transcriptase%2520involves%2520extensive%2520main%2520chain%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D14316%26epage%3D14320%26doi%3D10.1074%2Fjbc.275.19.14316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osswald, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agniswamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, H.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Potent HIV-1 Protease Inhibitors with Modified P1-Biphenyl Ligands: Synthesis, Biological Evaluation, and Enzyme-Inhibitor X-ray Structural Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5334</span><span class="NLM_x">–</span> <span class="NLM_lpage">5343</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5334-5343&author=A.+K.+Ghoshauthor=X.+Yuauthor=H.+L.+Osswaldauthor=J.+Agniswamyauthor=Y.+F.+Wangauthor=M.+Amanoauthor=I.+T.+Weberauthor=H.+Mitsuya&title=Structure-Based+Design+of+Potent+HIV-1+Protease+Inhibitors+with+Modified+P1-Biphenyl+Ligands%3A+Synthesis%2C+Biological+Evaluation%2C+and+Enzyme-Inhibitor+X-ray+Structural+Studies&doi=10.1021%2Facs.jmedchem.5b00676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00676%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26aulast%3DAgniswamy%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DStructure-Based%2520Design%2520of%2520Potent%2520HIV-1%2520Protease%2520Inhibitors%2520with%2520Modified%2520P1-Biphenyl%2520Ligands%253A%2520Synthesis%252C%2520Biological%2520Evaluation%252C%2520and%2520Enzyme-Inhibitor%2520X-ray%2520Structural%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5334%26epage%3D5343%26doi%3D10.1021%2Facs.jmedchem.5b00676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span> </span><span class="NLM_article-title">ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1838</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bbamem.2013.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24388952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslOmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=1296-1305&author=F.+Yuauthor=L.+Luauthor=Q.+Liuauthor=X.+Yuauthor=L.+Wangauthor=E.+Heauthor=P.+Zouauthor=L.+Duauthor=R.+W.+Sandersauthor=S.+Liuauthor=S.+Jiang&title=ADS-J1+inhibits+HIV-1+infection+and+membrane+fusion+by+targeting+the+highly+conserved+pocket+in+the+gp41+NHR-trimer&doi=10.1016%2Fj.bbamem.2013.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer</span></div><div class="casAuthors">Yu, Fei; Lu, Lu; Liu, Qi; Yu, Xiaowen; Wang, Lili; He, Elaine; Zou, Peng; Du, Lanying; Sanders, Rogier W.; Liu, Shuwen; Jiang, Shibo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1296-1305</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We previously identified a potent small-mol. human immunodeficiency virus type 1 (HIV-1) fusion inhibitor, termed ADS-J1, and hypothesized that it mainly targeted the hydrophobic pocket in the gp41 N-terminal heptad repeat (NHR) trimer.  However, this hypothesis has been challenged by the fact that ADS-J1 cannot induce drug-resistance mutation in the gp41 pocket region.  Therefore, we show herein that HIV-1 mutants resistant to T2635, a peptide derived from the gp41 C-terminal heptad repeat (CHR) region with pocket-binding domain (PBD), were also resistant to ADS-J1.  We also show that pseudoviruses with mutations at positions 64 and 67 in the gp41 pocket region were highly resistant to ADS-J1 and C34, another CHR-peptide with PBD, but relatively sensitive to T20, a CHR-peptide without PBD.  ADS-J1 could effectively bind to N36Fd, a mimic of the gp41 NHR-trimer with pocket exposed, and block binding of C34 to N36Fd trimer to form six-helix bundle (6-HB).  However, ADS-J1 was less effective in binding to N36Fd trimer with mutations in the gp41 pocket region, such as N36(Q64A)Fd, N36(Q64L)Fd, N36(A67G)Fd, N36(A67S)Fd, and N36(Q66R)Fd, as well as less effective in blocking 6-HB formation between C34 and these mutant N36Fd trimers.  These results confirm that ADS-J1 mainly targets the pocket region in the HIV-1 gp41 NHR trimer and suggest that it could be used as a lead for developing small-mol. HIV fusion inhibitors and as a mol. probe for studying the mechanisms of gp41-mediated membrane fusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm_XbLY-vlIrVg90H21EOLACvtfcHk0lir6UjEH_Z7_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslOmur0%253D&md5=addc5f2cf75d2c4ecd780bfe5cc966f7</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DE.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26atitle%3DADS-J1%2520inhibits%2520HIV-1%2520infection%2520and%2520membrane%2520fusion%2520by%2520targeting%2520the%2520highly%2520conserved%2520pocket%2520in%2520the%2520gp41%2520NHR-trimer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D1296%26epage%3D1305%26doi%3D10.1016%2Fj.bbamem.2013.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapy</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3713</span><span class="NLM_x">–</span> <span class="NLM_lpage">3728</span><span class="refDoi"> DOI: 10.2174/138161211798220972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161211798220972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21875413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3713-3728&author=M.+Moriauthor=F.+Manettiauthor=M.+Botta&title=Targeting+protein-protein+and+protein-nucleic+acid+interactions+for+anti-HIV+therapy&doi=10.2174%2F138161211798220972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapy</span></div><div class="casAuthors">Mori, Mattia; Manetti, Fabrizio; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">3713-3728</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Protein-protein and protein-nucleic acid interactions are involved in many regulatory cellular pathways, playing a key role in cell growth and proliferation, as well as in the progression and development of various diseases such as infectious diseases.  Esp. in the anti-AIDS research, protein-protein and protein-nucleic acid complexes are being considered as promising targets for pharmaceutical interventions aimed at overcoming the drug resistance obsd. for most of the classic enzyme inhibitors.  Consequently, more and more protein-protein and protein-nucleic acid interaction inhibitors have being identified and developed as candidate agents for antiretroviral therapy.  Here, we review the state of the art in the discovery and development of protein-protein and protein-nucleic acid interaction inhibitors that block the main steps of the HIV-1 replication cycle, giving a medicinal chem.-oriented view of strategies for inhibiting these regulatory interactions that are involved in the entry process, in the dimerization of reverse transcriptase and protease enzymes, and in the activity of the nucleocapsid protein by means of small mol. potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hDghABbo8LVg90H21EOLACvtfcHk0li4a4l90fN6vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVGluw%253D%253D&md5=b12d5bc2ae23ed9a6f2272df65eb12c3</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F138161211798220972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211798220972%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DM.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DTargeting%2520protein-protein%2520and%2520protein-nucleic%2520acid%2520interactions%2520for%2520anti-HIV%2520therapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D3713%26epage%3D3728%26doi%3D10.2174%2F138161211798220972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Amrane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedrat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vialet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreola, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergny, J. L.</span><span> </span><span class="NLM_article-title">Topology of a DNA G-quadruplex structure formed in the HIV-1 promoter: a potential target for anti-HIV drug development</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">5249</span><span class="NLM_x">–</span> <span class="NLM_lpage">5252</span><span class="refDoi"> DOI: 10.1021/ja501500c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja501500c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=5249-5252&author=S.+Amraneauthor=A.+Kerkourauthor=A.+Bedratauthor=B.+Vialetauthor=M.+L.+Andreolaauthor=J.+L.+Mergny&title=Topology+of+a+DNA+G-quadruplex+structure+formed+in+the+HIV-1+promoter%3A+a+potential+target+for+anti-HIV+drug+development&doi=10.1021%2Fja501500c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fja501500c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja501500c%26sid%3Dliteratum%253Aachs%26aulast%3DAmrane%26aufirst%3DS.%26aulast%3DKerkour%26aufirst%3DA.%26aulast%3DBedrat%26aufirst%3DA.%26aulast%3DVialet%26aufirst%3DB.%26aulast%3DAndreola%26aufirst%3DM.%2BL.%26aulast%3DMergny%26aufirst%3DJ.%2BL.%26atitle%3DTopology%2520of%2520a%2520DNA%2520G-quadruplex%2520structure%2520formed%2520in%2520the%2520HIV-1%2520promoter%253A%2520a%2520potential%2520target%2520for%2520anti-HIV%2520drug%2520development%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D5249%26epage%3D5252%26doi%3D10.1021%2Fja501500c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Herschhorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J. G.</span><span> </span><span class="NLM_article-title">A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1038/nchembio.1623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchembio.1623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25174000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVCrtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=845-852&author=A.+Herschhornauthor=C.+Guauthor=N.+Espyauthor=J.+Richardauthor=A.+Finziauthor=J.+G.+Sodroski&title=A+broad+HIV-1+inhibitor+blocks+envelope+glycoprotein+transitions+critical+for+entry&doi=10.1038%2Fnchembio.1623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry</span></div><div class="casAuthors">Herschhorn, Alon; Gu, Christopher; Espy, Nicole; Richard, Jonathan; Finzi, Andres; Sodroski, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Binding to the primary receptor, CD4, triggers conformational changes in the metastable HIV-1 envelope glycoprotein (Env) trimer ((gp120-gp41)3) that are important for virus entry into host cells.  These changes include an 'opening' of the trimer, creation of a binding site for the CCR5 co-receptor and formation and/or exposure of a gp41 coiled coil.  Here we identify a new compd., 18A (1), that specifically inhibits the entry of a wide range of HIV-1 isolates. 18A does not interfere with CD4 or CCR5 binding, but it inhibits the CD4-induced disruption of quaternary structures at the trimer apex and the exposure of the gp41 HR1 coiled coil.  Anal. of HIV-1 variants with increased or reduced sensitivity to 18A suggests that the inhibitor can distinguish distinct conformational states of gp120 in the unliganded Env trimer.  The broad-range activity and obsd. hypersensitivity of resistant mutants to antibody neutralization support further investigation of 18A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdMNhL1zmpCrVg90H21EOLACvtfcHk0li4a4l90fN6vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVCrtb7K&md5=4760afdc82c060b2cf1d7607f412b58c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1623%26sid%3Dliteratum%253Aachs%26aulast%3DHerschhorn%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DEspy%26aufirst%3DN.%26aulast%3DRichard%26aufirst%3DJ.%26aulast%3DFinzi%26aufirst%3DA.%26aulast%3DSodroski%26aufirst%3DJ.%2BG.%26atitle%3DA%2520broad%2520HIV-1%2520inhibitor%2520blocks%2520envelope%2520glycoprotein%2520transitions%2520critical%2520for%2520entry%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D845%26epage%3D852%26doi%3D10.1038%2Fnchembio.1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Ennifar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslam, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, F. L.</span><span> </span><span class="NLM_article-title">Structure-guided discovery of a novel aminoglycoside conjugate targeting HIV-1 RNA viral genome</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2509</span><span class="NLM_x">–</span> <span class="NLM_lpage">2517</span><span class="refDoi"> DOI: 10.1021/cb400498n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400498n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2509-2517&author=E.+Ennifarauthor=M.+W.+Aslamauthor=P.+Strasserauthor=G.+Hoffmannauthor=P.+Dumasauthor=F.+L.+van+Delft&title=Structure-guided+discovery+of+a+novel+aminoglycoside+conjugate+targeting+HIV-1+RNA+viral+genome&doi=10.1021%2Fcb400498n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fcb400498n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400498n%26sid%3Dliteratum%253Aachs%26aulast%3DEnnifar%26aufirst%3DE.%26aulast%3DAslam%26aufirst%3DM.%2BW.%26aulast%3DStrasser%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DG.%26aulast%3DDumas%26aufirst%3DP.%26aulast%3Dvan%2BDelft%26aufirst%3DF.%2BL.%26atitle%3DStructure-guided%2520discovery%2520of%2520a%2520novel%2520aminoglycoside%2520conjugate%2520targeting%2520HIV-1%2520RNA%2520viral%2520genome%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2509%26epage%3D2517%26doi%3D10.1021%2Fcb400498n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Tam, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tor, Y.</span><span> </span><span class="NLM_article-title">Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">3257</span><span class="NLM_x">–</span> <span class="NLM_lpage">3266</span><span class="refDoi"> DOI: 10.1021/ja0675797</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0675797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=3257-3266&author=V.+K.+Tamauthor=D.+Kwongauthor=Y.+Tor&title=Fluorescent+HIV-1+Dimerization+Initiation+Site%3A+design%2C+properties%2C+and+use+for+ligand+discovery&doi=10.1021%2Fja0675797"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fja0675797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0675797%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DV.%2BK.%26aulast%3DKwong%26aufirst%3DD.%26aulast%3DTor%26aufirst%3DY.%26atitle%3DFluorescent%2520HIV-1%2520Dimerization%2520Initiation%2520Site%253A%2520design%252C%2520properties%252C%2520and%2520use%2520for%2520ligand%2520discovery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D3257%26epage%3D3266%26doi%3D10.1021%2Fja0675797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Zentner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciunas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinnik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedichev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-García, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocklin, S.</span><span> </span><span class="NLM_article-title">Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix protein</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1002/cmdc.201200577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.201200577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23361947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=426-432&author=I.+Zentnerauthor=L.+J.+Sierraauthor=A.+K.+Fraserauthor=L.+Maciunasauthor=M.+K.+Mankowskiauthor=A.+Vinnikauthor=P.+Fedichevauthor=R.+G.+Ptakauthor=J.+Mart%C3%ADn-Garc%C3%ADaauthor=S.+Cocklin&title=Identification+of+a+small-molecule+inhibitor+of+HIV-1+assembly+that+targets+the+phosphatidylinositol+%284%2C5%29-bisphosphate+binding+site+of+the+HIV-1+matrix+protein&doi=10.1002%2Fcmdc.201200577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Small-Molecule Inhibitor of HIV-1 Assembly that Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein</span></div><div class="casAuthors">Zentner, Isaac; Sierra, Luz-Jeannette; Fraser, Ayesha K.; Maciunas, Lina; Mankowski, Marie K.; Vinnik, Andrei; Fedichev, Peter; Ptak, Roger G.; Martin-Garcia, Julio; Cocklin, Simon</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">426-432</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The development of drug resistance remains a crit. problem for current HIV-1 antiviral therapies, creating a need for new inhibitors of HIV-1 replication.  We previously reported on a novel anti-HIV-1 compd., N2-(phenoxyacetyl)-N-[4-(1-piperidinylcarbonyl)benzyl]glycinamide (14), that binds to the highly conserved phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) binding pocket of the HIV-1 matrix (MA) protein.  In this study, we re-evaluate the hits from the virtual screen used to identify compd. 14 and test them directly in an HIV-1 replication assay using primary human peripheral blood mononuclear cells.  This study resulted in the identification of three new compds. with antiviral activity; 2-(4-{[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl})-1-piperazinyl)-N-(4-methylphenyl)acetamide (7), 3-(2-ethoxyphenyl)-5-[[4-(4-nitrophenyl)piperazin-1-yl]methyl]-1,2,4-oxadiazole (17), and N-[4-ethoxy-3-(1-piperidinylsulfonyl)phenyl]-2-(imidazo[2,1-b][1,3]thiazol-6-yl)acetamide (18), with compd. 7 being the most potent of these hits.  Mechanistic studies on 7 demonstrated that it directly interacts with and functions through HIV-1 MA.  In accordance with our drug target, compd. 7 competes with PI(4,5)P2 for MA binding and, as a result, diminishes the prodn. of new virus.  Mutation of residues within the PI(4,5)P2 binding site of MA decreased the antiviral effect of compd. 7.  Addnl., compd. 7 displays a broadly neutralizing anti-HIV activity, with IC50 values of 7.5-15.6 μM for the group M isolates tested.  Taken together, these results point towards a novel chem. probe that can be used to more closely study the biol. role of MA and could, through further optimization, lead to a new class of anti-HIV-1 therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr11-gHfqPpe7Vg90H21EOLACvtfcHk0liOwx2Tp3Rchw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGiurY%253D&md5=19c5f1741bbf8c4bd87716021fa20e19</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200577%26sid%3Dliteratum%253Aachs%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSierra%26aufirst%3DL.%2BJ.%26aulast%3DFraser%26aufirst%3DA.%2BK.%26aulast%3DMaciunas%26aufirst%3DL.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DVinnik%26aufirst%3DA.%26aulast%3DFedichev%26aufirst%3DP.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DMart%25C3%25ADn-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DCocklin%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520small-molecule%2520inhibitor%2520of%2520HIV-1%2520assembly%2520that%2520targets%2520the%2520phosphatidylinositol%2520%25284%252C5%2529-bisphosphate%2520binding%2520site%2520of%2520the%2520HIV-1%2520matrix%2520protein%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D426%26epage%3D432%26doi%3D10.1002%2Fcmdc.201200577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Zentner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciunas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinnik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedichev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-García, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocklin, S.</span><span> </span><span class="NLM_article-title">Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.11.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1132-1135&author=I.+Zentnerauthor=L.+J.+Sierraauthor=L.+Maciunasauthor=A.+Vinnikauthor=P.+Fedichevauthor=M.+K.+Mankowskiauthor=R.+G.+Ptakauthor=J.+Mart%C3%ADn-Garc%C3%ADaauthor=S.+Cocklin&title=Discovery+of+a+small-molecule+antiviral+targeting+the+HIV-1+matrix+protein&doi=10.1016%2Fj.bmcl.2012.11.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSierra%26aufirst%3DL.%2BJ.%26aulast%3DMaciunas%26aufirst%3DL.%26aulast%3DVinnik%26aufirst%3DA.%26aulast%3DFedichev%26aufirst%3DP.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DMart%25C3%25ADn-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DCocklin%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520small-molecule%2520antiviral%2520targeting%2520the%2520HIV-1%2520matrix%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1132%26epage%3D1135%26doi%3D10.1016%2Fj.bmcl.2012.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maître, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacoste, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenfant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, S. W.</span><span> </span><span class="NLM_article-title">Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1021/cb400075f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400075f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1074-1082&author=N.+Goudreauauthor=C.+T.+Lemkeauthor=A.+M.+Faucherauthor=C.+Grand-Ma%C3%AEtreauthor=S.+Gouletauthor=J.+E.+Lacosteauthor=J.+Rancourtauthor=E.+Malenfantauthor=J.+F.+Mercierauthor=S.+Titoloauthor=S.+W.+Mason&title=Novel+inhibitor+binding+site+discovery+on+HIV-1+capsid+N-terminal+domain+by+NMR+and+X-ray+crystallography&doi=10.1021%2Fcb400075f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fcb400075f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400075f%26sid%3Dliteratum%253Aachs%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DGrand-Ma%25C3%25AEtre%26aufirst%3DC.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DLacoste%26aufirst%3DJ.%2BE.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DMalenfant%26aufirst%3DE.%26aulast%3DMercier%26aufirst%3DJ.%2BF.%26aulast%3DTitolo%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DS.%2BW.%26atitle%3DNovel%2520inhibitor%2520binding%2520site%2520discovery%2520on%2520HIV-1%2520capsid%2520N-terminal%2520domain%2520by%2520NMR%2520and%2520X-ray%2520crystallography%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1074%26epage%3D1082%26doi%3D10.1021%2Fcb400075f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Dewan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahasenan, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musier-Forsyth, K.</span><span> </span><span class="NLM_article-title">Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.1021/cb200450w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200450w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=761-769&author=V.+Dewanauthor=T.+Liuauthor=K.+M.+Chenauthor=Z.+Qianauthor=Y.+Xiaoauthor=L.+Kleimanauthor=K.+V.+Mahasenanauthor=C.+Liauthor=H.+Matsuoauthor=D.+Peiauthor=K.+Musier-Forsyth&title=Cyclic+peptide+inhibitors+of+HIV-1+capsid-human+lysyl-tRNA+synthetase+interaction&doi=10.1021%2Fcb200450w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fcb200450w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200450w%26sid%3Dliteratum%253Aachs%26aulast%3DDewan%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DK.%2BM.%26aulast%3DQian%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKleiman%26aufirst%3DL.%26aulast%3DMahasenan%26aufirst%3DK.%2BV.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMatsuo%26aufirst%3DH.%26aulast%3DPei%26aufirst%3DD.%26aulast%3DMusier-Forsyth%26aufirst%3DK.%26atitle%3DCyclic%2520peptide%2520inhibitors%2520of%2520HIV-1%2520capsid-human%2520lysyl-tRNA%2520synthetase%2520interaction%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D761%26epage%3D769%26doi%3D10.1021%2Fcb200450w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Kortagere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schön, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princiotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passic, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-García, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">8472</span><span class="NLM_x">–</span> <span class="NLM_lpage">8481</span><span class="refDoi"> DOI: 10.1128/JVI.05006-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.05006-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22647699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2jtLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=8472-8481&author=S.+Kortagereauthor=N.+Madaniauthor=M.+K.+Mankowskiauthor=A.+Sch%C3%B6nauthor=I.+Zentnerauthor=G.+Swaminathanauthor=A.+Princiottoauthor=K.+Anthonyauthor=A.+Ozaauthor=L.+J.+Sierraauthor=S.+R.+Passicauthor=X.+Wangauthor=D.+M.+Jonesauthor=E.+Stavaleauthor=F.+C.+Krebsauthor=J.+Mart%C3%ADn-Garc%C3%ADaauthor=E.+Freireauthor=R.+G.+Ptakauthor=J.+Sodroskiauthor=S.+Cocklinauthor=A.+B.+Smith&title=Inhibiting+early-stage+events+in+HIV-1+replication+by+small-molecule+targeting+of+the+HIV-1+capsid&doi=10.1128%2FJVI.05006-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid</span></div><div class="casAuthors">Kortagere, Sandhya; Madani, Navid; Mankowski, Marie K.; Schon, Arne; Zentner, Isaac; Swaminathan, Gokul; Princiotto, Amy; Anthony, Kevin; Oza, Apara; Sierra, Luz-Jeannette; Passic, Shendra R.; Wang, Xiaozhao; Jones, David M.; Stavale, Eric; Krebs, Fred C.; Martin-Garcia, Julio; Freire, Ernesto; Ptak, Roger G.; Sodroski, Joseph; Cocklin, Simon; Smith, Amos B., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8472-8481</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 capsid (CA) protein plays essential roles in both early and late stages of virl replication and has emerged as a novel drug target.  We report hybrid structure-based virtual screening to identify small mols. with the potential to interact with the N-terminal domain (NTD) of HIV-1 CA and disrupt early, preintegration steps of the HIV-1 replication cycle.  The small mol. 4,4'-[dibenzo[b,d]furan-2,8-diylbis(5-phenyl-1H-imidazole-4,2-diyl)]dibenzoic acid (CK026), which had anti-HIV-1 activity in single- and multiple-round infections but failed to inhibit viral replication in peripheral blood mononuclear cells (PBMCs), was identified.  Three analogs of CK026 with reduced size and better drug-like properties were synthesized and assessed.  Compd. I-XW-053 (4-(4,5-diphenyl-1H-imidazol-2-yl)benzoic acid) retained all of the antiviral activity of the parental compd. and inhibited the replication of a diverse panel of primary HIV-1 isolates in PBMCs, while displaying no appreciable cytotoxicity.  This antiviral activity was specific to HIV-1, as I-XW-053 displayed no effect on the replication of SIV or against a panel of nonretroviruses.  Direct interaction of I-XW-053 was quantified with wild-type and mutant CA protein using surface plasmon resonance and isothermal titrn. calorimetry.  Mutation of Ile37 and Arg173, which are required for interaction with compd. I-XW-053, crippled the virus at an early, preintegration step.  Using quant. PCR, we demonstrated that treatment with I-XW-053 inhibited HIV-1 reverse transcription in multiple cell types, indirectly pointing to dysfunction in the uncoating process.  In summary, we have identified a CA-specific compd. that targets and inhibits a novel region in the NTD-NTD interface, affects uncoating, and possesses broad-spectrum anti-HIV-1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Tdf1mUZ85bVg90H21EOLACvtfcHk0lhX7kcbyArjtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2jtLzE&md5=324cf8cda7a0aa6e07b5b8e529c91aaf</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1128%2FJVI.05006-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05006-11%26sid%3Dliteratum%253Aachs%26aulast%3DKortagere%26aufirst%3DS.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSch%25C3%25B6n%26aufirst%3DA.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSwaminathan%26aufirst%3DG.%26aulast%3DPrinciotto%26aufirst%3DA.%26aulast%3DAnthony%26aufirst%3DK.%26aulast%3DOza%26aufirst%3DA.%26aulast%3DSierra%26aufirst%3DL.%2BJ.%26aulast%3DPassic%26aufirst%3DS.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DStavale%26aufirst%3DE.%26aulast%3DKrebs%26aufirst%3DF.%2BC.%26aulast%3DMart%25C3%25ADn-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DCocklin%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DInhibiting%2520early-stage%2520events%2520in%2520HIV-1%2520replication%2520by%2520small-molecule%2520targeting%2520of%2520the%2520HIV-1%2520capsid%26jtitle%3DJ.%2520Virol.%26date%3D2012%26volume%3D86%26spage%3D8472%26epage%3D8481%26doi%3D10.1128%2FJVI.05006-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadrozny, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedzicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pornillos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganser-Pornillos, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Griffero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, M.</span><span> </span><span class="NLM_article-title">Structural basis of HIV-1 capsid recognition by PF74 and CPSF6</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">18625</span><span class="NLM_x">–</span> <span class="NLM_lpage">18630</span><span class="refDoi"> DOI: 10.1073/pnas.1419945112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1419945112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25518861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrt7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=18625-18630&author=A.+Bhattacharyaauthor=S.+L.+Alamauthor=T.+Frickeauthor=K.+Zadroznyauthor=J.+Sedzickiauthor=A.+B.+Taylorauthor=B.+Demelerauthor=O.+Pornillosauthor=B.+K.+Ganser-Pornillosauthor=F.+Diaz-Grifferoauthor=D.+N.+Ivanovauthor=M.+Yeager&title=Structural+basis+of+HIV-1+capsid+recognition+by+PF74+and+CPSF6&doi=10.1073%2Fpnas.1419945112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV-1 capsid recognition by PF74 and CPSF6</span></div><div class="casAuthors">Bhattacharya, Akash; Alam, Steven L.; Fricke, Thomas; Zadrozny, Kaneil; Sedzicki, Jaroslaw; Taylor, Alexander B.; Demeler, Borries; Pornillos, Owen; Ganser-Pornillos, Barbie K.; Diaz-Griffero, Felipe; Ivanov, Dmitri N.; Yeager, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">18625-18630</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Upon infection of susceptible cells by HIV-1, the conical capsid formed by ∼250 hexamers and 12 pentamers of the CA protein is delivered to the cytoplasm.  The capsid shields the RNA genome and proteins required for reverse transcription.  In addn., the surface of the capsid mediates numerous host-virus interactions, which either promote infection or enable viral restriction by innate immune responses.  In the intact capsid, there is an intermol. interface between the N-terminal domain (NTD) of one subunit and the C-terminal domain (CTD) of the adjacent subunit within the same hexameric ring.  The NTD-CTD interface is crit. for capsid assembly, both as an architectural element of the CA hexamer and pentamer and as a mechanistic element for generating lattice curvature.  Here we report biochem. expts. showing that PF-3450074 (PF74), a drug that inhibits HIV-1 infection, as well as host proteins cleavage and polyadenylation specific factor 6 (CPSF6) and nucleoporin 153 kDa (NUP153), bind to the CA hexamer with at least 10-fold higher affinities compared with nonassembled CA or isolated CA domains.  The crystal structure of PF74 in complex with the CA hexamer reveals that PF74 binds in a preformed pocket encompassing the NTD-CTD interface, suggesting that the principal inhibitory target of PF74 is the assembled capsid.  Likewise, CPSF6 binds in the same pocket.  Given that the NTD-CTD interface is a specific mol. signature of assembled hexamers in the capsid, binding of NUP153 at this site suggests that key features of capsid architecture remain intact upon delivery of the preintegration complex to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpis5JJGK8jYLVg90H21EOLACvtfcHk0ljOZZnDNE5fmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrt7%252FE&md5=9e7927ef280400df591c52ca51363b65</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1419945112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1419945112%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DAlam%26aufirst%3DS.%2BL.%26aulast%3DFricke%26aufirst%3DT.%26aulast%3DZadrozny%26aufirst%3DK.%26aulast%3DSedzicki%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DA.%2BB.%26aulast%3DDemeler%26aufirst%3DB.%26aulast%3DPornillos%26aufirst%3DO.%26aulast%3DGanser-Pornillos%26aufirst%3DB.%2BK.%26aulast%3DDiaz-Griffero%26aufirst%3DF.%26aulast%3DIvanov%26aufirst%3DD.%2BN.%26aulast%3DYeager%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520of%2520HIV-1%2520capsid%2520recognition%2520by%2520PF74%2520and%2520CPSF6%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D18625%26epage%3D18630%26doi%3D10.1073%2Fpnas.1419945112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span><span class="refDoi"> DOI: 10.2174/092986710790416335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986710790416335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20015032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1KktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=495-503&author=P.+Zhanauthor=X.+Liuauthor=E.+De+Clercq&title=Blocking+nuclear+import+of+pre-integration+complex%3A+an+emerging+anti-HIV-1+drug+discovery+paradigm&doi=10.2174%2F092986710790416335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although recent progress in highly active antiretroviral therapy (HAART) has provided an effective way to treat AIDS patients, the emergence of drug-resistant HIV-1 strains and drug toxicity during long-term treatment of HIV-infected patients necessitate the search for new targets that can be used to develop novel antiviral agents.  One such target is the nuclear important process of the HIV pre-integration complex (PIC).  The ability of HIV-1 using host cell nuclear import machinery to translocate the viral PIC into the cell nucleus is the crit. determinant in the replication of the virus in non-dividing cells, such as macrophages.  Compds. inhibiting HIV-1 nuclear important may be attractive candidates for novel anti-HIV development.  In this review, we will describe the mechanisms of HIV-1 PIC translocation into the nucleus and the structure-function of the viral and cellular factors involved in this process, as well as several classes of novel anti-HIV compds. which target the nuclear import of HIV-1 PIC and effectively block viral replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIv7MMe3xM3LVg90H21EOLACvtfcHk0ljOZZnDNE5fmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1KktLg%253D&md5=f72b856dc68c69ddee991f402322162d</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.2174%2F092986710790416335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790416335%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DBlocking%2520nuclear%2520import%2520of%2520pre-integration%2520complex%253A%2520an%2520emerging%2520anti-HIV-1%2520drug%2520discovery%2520paradigm%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D495%26epage%3D503%26doi%3D10.2174%2F092986710790416335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berkhout, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velden, Y. U.</span><span> </span><span class="NLM_article-title">ABX464: a good drug candidate instead of a magic bullet</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="refDoi"> DOI: 10.1186/s12977-015-0189-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2Fs12977-015-0189-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=64&author=B.+Berkhoutauthor=Y.+U.+van+der+Velden&title=ABX464%3A+a+good+drug+candidate+instead+of+a+magic+bullet&doi=10.1186%2Fs12977-015-0189-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159a&amp;dbid=16384&amp;doi=10.1186%2Fs12977-015-0189-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-015-0189-x%26sid%3Dliteratum%253Aachs%26aulast%3DBerkhout%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BVelden%26aufirst%3DY.%2BU.%26atitle%3DABX464%253A%2520a%2520good%2520drug%2520candidate%2520instead%2520of%2520a%2520magic%2520bullet%26jtitle%3DRetrovirology%26date%3D2015%26volume%3D12%26spage%3D64%26doi%3D10.1186%2Fs12977-015-0189-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit159b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Campos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myburgh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vautrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapasset, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basyuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séveno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="refDoi"> DOI: 10.1186/s12977-015-0159-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2Fs12977-015-0159-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=30&author=N.+Camposauthor=R.+Myburghauthor=A.+Garcelauthor=A.+Vautrinauthor=L.+Lapassetauthor=E.+S.+Nadalauthor=F.+Mahuteau-Betzerauthor=R.+Najmanauthor=P.+Fornarelliauthor=K.+Tantaleauthor=E.+Basyukauthor=M.+S%C3%A9venoauthor=J.+P.+Venablesauthor=B.+Pauauthor=E.+Bertrandauthor=M.+A.+Wainbergauthor=R.+F.+Speckauthor=D.+Scherrerauthor=J.+Tazi&title=Long+lasting+control+of+viral+rebound+with+a+new+drug+ABX464+targeting+Rev+-+mediated+viral+RNA+biogenesis&doi=10.1186%2Fs12977-015-0159-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159b&amp;dbid=16384&amp;doi=10.1186%2Fs12977-015-0159-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-015-0159-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampos%26aufirst%3DN.%26aulast%3DMyburgh%26aufirst%3DR.%26aulast%3DGarcel%26aufirst%3DA.%26aulast%3DVautrin%26aufirst%3DA.%26aulast%3DLapasset%26aufirst%3DL.%26aulast%3DNadal%26aufirst%3DE.%2BS.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DNajman%26aufirst%3DR.%26aulast%3DFornarelli%26aufirst%3DP.%26aulast%3DTantale%26aufirst%3DK.%26aulast%3DBasyuk%26aufirst%3DE.%26aulast%3DS%25C3%25A9veno%26aufirst%3DM.%26aulast%3DVenables%26aufirst%3DJ.%2BP.%26aulast%3DPau%26aufirst%3DB.%26aulast%3DBertrand%26aufirst%3DE.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26aulast%3DSpeck%26aufirst%3DR.%2BF.%26aulast%3DScherrer%26aufirst%3DD.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DLong%2520lasting%2520control%2520of%2520viral%2520rebound%2520with%2520a%2520new%2520drug%2520ABX464%2520targeting%2520Rev%2520-%2520mediated%2520viral%2520RNA%2520biogenesis%26jtitle%3DRetrovirology%26date%3D2015%26volume%3D12%26spage%3D30%26doi%3D10.1186%2Fs12977-015-0159-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit159c"><span><span class="NLM_label">(c) </span>ABIVAX Press Release. <a href="http://www.abivax.com/en/com-abivax-title-medias/news-events/press-releases/92-mechanism-of-action-of-abivax-s-first-in-class-anti-hiv-drug-published-today-in-peer-reviewed-journal-retrovirology.html" class="extLink">http://www.abivax.com/en/com-abivax-title-medias/news-events/press-releases/92-mechanism-of-action-of-abivax-s-first-in-class-anti-hiv-drug-published-today-in-peer-reviewed-journal-retrovirology.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ABIVAX+Press+Release.+http%3A%2F%2Fwww.abivax.com%2Fen%2Fcom-abivax-title-medias%2Fnews-events%2Fpress-releases%2F92-mechanism-of-action-of-abivax-s-first-in-class-anti-hiv-drug-published-today-in-peer-reviewed-journal-retrovirology.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Nguyen, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feasley, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Air, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakalian, M.</span><span> </span><span class="NLM_article-title">The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="refDoi"> DOI: 10.1186/1742-4690-8-101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-8-101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22151792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVWltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=101&author=A.+T.+Nguyenauthor=C.+L.+Feasleyauthor=K.+W.+Jacksonauthor=T.+J.+Nitzauthor=K.+Salzwedelauthor=G.+M.+Airauthor=M.+Sakalian&title=The+prototype+HIV-1+maturation+inhibitor%2C+bevirimat%2C+binds+to+the+CA-SP1+cleavage+site+in+immature+Gag+particles&doi=10.1186%2F1742-4690-8-101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">The prototype HIV-1 maturation inhibitor, bevirimat, binds to The CA-SP1 cleavage site in immature Gag particles</span></div><div class="casAuthors">Nguyen, Albert T.; Feasley, Christa L.; Jackson, Ken W.; Nitz, Theodore J.; Salzwedel, Karl; Air, Gillian M.; Sakalian, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Bevirimat, the prototype Human Immunodeficiency Virus type 1 (HIV-1) maturation inhibitor, is highly potent in cell culture and efficacious in HIV-1 infected patients.  In contrast to inhibitors that target the active site of the viral protease, bevirimat specifically inhibits a single cleavage event, the final processing step for the Gag precursor where p25 (CA-SP1) is cleaved to p24 (CA) and SP1.  Results: In this study, photoaffinity analogs of bevirimat and mass spectrometry were employed to map the binding site of bevirimat to Gag within immature virus-like particles.  Bevirimat analogs were found to crosslink to sequences overlapping, or proximal to, the CA-SP1 cleavage site, consistent with previous biochem. data on the effect of bevirimat on Gag processing and with genetic data from resistance mutations, in a region predicted by NMR and mutational studies to have α-helical character.  Unexpectedly, a second region of interaction was found within the Major Homol. Region (MHR).  Extensive prior genetic evidence suggests that the MHR is crit. for virus assembly.  Conclusions: This is the first demonstration of a direct interaction between the maturation inhibitor, bevirimat and its target, Gag.  Information gained from this study sheds light on the mechanisms by which the virus develops resistance to this class of drug and may aid in the design of next-generation maturation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOqf2xxMbTKLVg90H21EOLACvtfcHk0lhYj44qZmglDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVWltr0%253D&md5=f39dcd66a43fa33c710357f128809206</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-8-101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-8-101%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DA.%2BT.%26aulast%3DFeasley%26aufirst%3DC.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DAir%26aufirst%3DG.%2BM.%26aulast%3DSakalian%26aufirst%3DM.%26atitle%3DThe%2520prototype%2520HIV-1%2520maturation%2520inhibitor%252C%2520bevirimat%252C%2520binds%2520to%2520the%2520CA-SP1%2520cleavage%2520site%2520in%2520immature%2520Gag%2520particles%26jtitle%3DRetrovirology%26date%3D2011%26volume%3D8%26spage%3D101%26doi%3D10.1186%2F1742-4690-8-101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Meng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, A. M.</span><span> </span><span class="NLM_article-title">Wrapping up the bad news: HIV assembly and release</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="refDoi"> DOI: 10.1186/1742-4690-10-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-10-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23305486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC3s3osVShtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=5&author=B.+Mengauthor=A.+M.+Lever&title=Wrapping+up+the+bad+news%3A+HIV+assembly+and+release&doi=10.1186%2F1742-4690-10-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Wrapping up the bad news: HIV assembly and release</span></div><div class="casAuthors">Meng Bo; Lever Andrew Ml</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The late Nobel Laureate Sir Peter Medawar once memorably described viruses as 'bad news wrapped in protein'.  Virus assembly in HIV is a remarkably well coordinated process in which the virus achieves extracellular budding using primarily intracellular budding machinery and also the unusual phenomenon of export from the cell of an RNA.  Recruitment of the ESCRT system by HIV is one of the best documented examples of the comprehensive way in which a virus hijacks a normal cellular process.  This review is a summary of our current understanding of the budding process of HIV, from genomic RNA capture through budding and on to viral maturation, but centering on the proteins of the ESCRT pathway and highlighting some recent advances in our understanding of the cellular components involved and the complex interplay between the Gag protein and the genomic RNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnnXkfsezHDBfKb6ELK8t0fW6udTcc2eYZSrXZY7jkArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3osVShtQ%253D%253D&md5=4ab88b1b589275aa6e392361d61923c2</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-5%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DB.%26aulast%3DLever%26aufirst%3DA.%2BM.%26atitle%3DWrapping%2520up%2520the%2520bad%2520news%253A%2520HIV%2520assembly%2520and%2520release%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D5%26doi%3D10.1186%2F1742-4690-10-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Vercruysse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehaen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debaene, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanglier-Cianférani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mély, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daelemans, D.</span><span> </span><span class="NLM_article-title">A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="refDoi"> DOI: 10.1186/1742-4690-9-95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-9-95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23146561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=95&author=T.+Vercruysseauthor=B.+Bastaauthor=W.+Dehaenauthor=N.+Humbertauthor=J.+Balzariniauthor=F.+Debaeneauthor=S.+Sanglier-Cianf%C3%A9raniauthor=C.+Pannecouqueauthor=Y.+M%C3%A9lyauthor=D.+Daelemans&title=A+phenyl-thiadiazolylidene-amine+derivative+ejects+zinc+from+retroviral+nucleocapsid+zinc+fingers+and+inactivates+HIV+virions&doi=10.1186%2F1742-4690-9-95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions</span></div><div class="casAuthors">Vercruysse, Thomas; Basta, Beata; Dehaen, Wim; Humbert, Nicolas; Balzarini, Jan; Debaene, Francois; Sanglier-Cianferani, Sarah; Pannecouque, Christophe; Mely, Yves; Daelemans, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Sexual acquisition of the human immunodeficiency virus (HIV) through mucosal transmission may be prevented by using topically applied agents that block HIV transmission from one individual to another.  Therefore, virucidal agents that inactivate HIV virions may be used as a component in topical microbicides.  Results: Here, we have identified 2-methyl-3-phenyl-2H-[1,2,4]thiadiazol-5-ylideneamine (WDO-217) as a low-mol.-wt. mol. that inactivates HIV particles.  Both HIV-1 and HIV-2 virions pretreated with this compd. were unable to infect permissive cells.  Moreover, WDO-217 was able to inhibit infections of a wide spectrum of wild-type and drug-resistant HIV-1, including clin. isolates, HIV-2 and SIV strains.  Whereas the capture of virus by DC-SIGN was unaffected by the compd., it efficiently prevented the transmission of DC-SIGN-captured virus to CD4+ T-lymphocytes.  Interestingly, exposure of virions to WDO-217 reduced the amt. of virion-assocd. genomic RNA as measured by real-time RT-qPCR.  Further mechanism-of-action studies demonstrated that WDO-217 efficiently ejects zinc from the zinc fingers of the retroviral nucleocapsid protein NCp7 and inhibits the cTAR destabilization properties of this protein.  Importantly, WDO-217 was able to eject zinc from both zinc fingers, even when NCp7 was bound to oligonucleotides, while no covalent interaction between NCp7 and WDO-217 could be obsd.  Conclusion: This compd. is a new lead structure that can be used for the development of a new series of NCp7 zinc ejectors as candidate topical microbicide agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMkbg7wzqeAbVg90H21EOLACvtfcHk0ljc2WUybqPsTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVeksLs%253D&md5=d1a5120d0699a4716c84e92bc8fc3978</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-9-95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-9-95%26sid%3Dliteratum%253Aachs%26aulast%3DVercruysse%26aufirst%3DT.%26aulast%3DBasta%26aufirst%3DB.%26aulast%3DDehaen%26aufirst%3DW.%26aulast%3DHumbert%26aufirst%3DN.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DSanglier-Cianf%25C3%25A9rani%26aufirst%3DS.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DM%25C3%25A9ly%26aufirst%3DY.%26aulast%3DDaelemans%26aufirst%3DD.%26atitle%3DA%2520phenyl-thiadiazolylidene-amine%2520derivative%2520ejects%2520zinc%2520from%2520retroviral%2520nucleocapsid%2520zinc%2520fingers%2520and%2520inactivates%2520HIV%2520virions%26jtitle%3DRetrovirology%26date%3D2012%26volume%3D9%26spage%3D95%26doi%3D10.1186%2F1742-4690-9-95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debaene, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanglier-Cianferani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schult-Dietrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisné, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mely, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1950</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span><span class="refDoi"> DOI: 10.1021/cb500316h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500316h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyit7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1950-1955&author=M.+Moriauthor=A.+Nucciauthor=M.+C.+Langauthor=N.+Humbertauthor=C.+Boudierauthor=F.+Debaeneauthor=S.+Sanglier-Cianferaniauthor=M.+Catalaauthor=P.+Schult-Dietrichauthor=U.+Dietrichauthor=C.+Tisn%C3%A9author=Y.+Melyauthor=M.+Botta&title=Functional+and+structural+characterization+of+2-amino-4-phenylthiazole+inhibitors+of+the+HIV-1+nucleocapsid+protein+with+antiviral+activity&doi=10.1021%2Fcb500316h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and Structural Characterization of 2-Amino-4-phenylthiazole Inhibitors of the HIV-1 Nucleocapsid Protein with Antiviral Activity</span></div><div class="casAuthors">Mori, Mattia; Nucci, Alessandro; Lang, Maria Chiara Dasso; Humbert, Nicolas; Boudier, Christian; Debaene, Francois; Sanglier-Cianferani, Sarah; Catala, Marjorie; Schult-Dietrich, Patricia; Dietrich, Ursula; Tisne, Carine; Mely, Yves; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1950-1955</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nucleocapsid protein (NC) is a highly conserved protein in diverse HIV-1 subtypes that plays a central role in virus replication, mainly by interacting with conserved nucleic acid sequences.  NC is considered a highly profitable drug target to inhibit multiple steps in the HIV-1 life cycle with just one compd., a unique property not shown by any of the other antiretroviral classes.  However, most of NC inhibitors developed so far act through an unspecific and potentially toxic mechanism (zinc ejection) and are mainly being investigated as topical microbicides.  In an effort to provide specific NC inhibitors that compete for the binding of nucleic acids to NC, here we combined mol. modeling, org. synthesis, biophys. studies, NMR spectroscopy, and antiviral assays to design, synthesize, and characterize an efficient NC inhibitor endowed with antiviral activity in vitro, a desirable property for the development of efficient antiretroviral lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos_1MGxIrbnrVg90H21EOLACvtfcHk0ljc2WUybqPsTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyit7jF&md5=65db5476599202f80a4325c5fbad237f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fcb500316h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500316h%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DM.%26aulast%3DNucci%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DM.%2BC.%26aulast%3DHumbert%26aufirst%3DN.%26aulast%3DBoudier%26aufirst%3DC.%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DSanglier-Cianferani%26aufirst%3DS.%26aulast%3DCatala%26aufirst%3DM.%26aulast%3DSchult-Dietrich%26aufirst%3DP.%26aulast%3DDietrich%26aufirst%3DU.%26aulast%3DTisn%25C3%25A9%26aufirst%3DC.%26aulast%3DMely%26aufirst%3DY.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DFunctional%2520and%2520structural%2520characterization%2520of%25202-amino-4-phenylthiazole%2520inhibitors%2520of%2520the%2520HIV-1%2520nucleocapsid%2520protein%2520with%2520antiviral%2520activity%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1950%26epage%3D1955%26doi%3D10.1021%2Fcb500316h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Sloan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Harnessing the therapeutic potential of host antiviral restriction factors that target HIV</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1586/eri.12.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1586%2Feri.12.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23428096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1an" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=1-4&author=R.+D.+Sloanauthor=M.+A.+Wainberg&title=Harnessing+the+therapeutic+potential+of+host+antiviral+restriction+factors+that+target+HIV&doi=10.1586%2Feri.12.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the therapeutic potential of host antiviral restriction factors that target HIV</span></div><div class="casAuthors">Sloan, Richard D.; Wainberg, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Restriction factors are typically interferon-induced proteins that when expressed as single gene products can antagonize viral replication.  While modifying cellular factor function directly may lead to cytotoxic off-target effects, inhibiting viral countermeasures to restriction factors might not, and should render virus susceptible to their antagonizing effects.  Due to these attractive properties, there is much interest in developing new therapeutic strategies based on the antiviral properties of restriction factors.  Currently there are no restriction factor-based antivirals in clin. development, but the rapid progress from their identification to functional understanding and preliminary evaluation of antiviral strategies is impressive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8s29Iz6xtGbVg90H21EOLACvtfcHk0lixpF_Md_viOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1an&md5=3cfd2d7bf9bb1d0fa1a8aa4d024eefed</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1586%2Feri.12.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.12.146%26sid%3Dliteratum%253Aachs%26aulast%3DSloan%26aufirst%3DR.%2BD.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DHarnessing%2520the%2520therapeutic%2520potential%2520of%2520host%2520antiviral%2520restriction%2520factors%2520that%2520target%2520HIV%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2013%26volume%3D11%26spage%3D1%26epage%3D4%26doi%3D10.1586%2Feri.12.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallay, P.</span><span> </span><span class="NLM_article-title">Curing a viral infection by targeting the host: the example of cyclophilin inhibitors</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23578729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2013&pages=68-77&author=K.+Linauthor=P.+Gallay&title=Curing+a+viral+infection+by+targeting+the+host%3A+the+example+of+cyclophilin+inhibitors&doi=10.1016%2Fj.antiviral.2013.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Curing a viral infection by targeting the host: The example of cyclophilin inhibitors</span></div><div class="casAuthors">Lin, Kai; Gallay, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Every step of the viral life cycle is dependent on the host, which potentially can be explored for antiviral targets.  Historically, however, drug discovery has focused mainly on viral targets, because of their perceived specificity.  Efforts to pursue host targets were largely hampered by concern over potential on-target toxicity, the lack of predictive cell culture and animal models, and the complexity of host-virus interactions.  On the other hand, there are distinct advantages of targeting the host, such as creating a high barrier to resistance, providing broad coverage of different genotypes/serotypes and possibly even multiple viruses, and expanding the list of potential targets, when druggable viral targets are limited.  Taking hepatitis C virus (HCV) as the example, there are more than 20 inhibitors of the viral protease, polymerase, and NS5A protein currently in advanced clin. testing.  However, resistance has become a main challenge with these direct-acting antivirals, because HCV, an RNA virus, is notoriously prone to mutation, and a single mutation in the viral target may prevent the binding of an inhibitor, and rendering it ineffective.  Host cyclophilin inhibitors have shown promising effects both in vitro and in patients to prevent the emergence of resistance and to cure HCV infection, either alone or in combination with other agents.  They are also capable of blocking the replication of a no. of other viral pathogens.  While the road to developing host-targeting antivirals was less traveled, and significant challenges remain, delivering the most effective antiviral regimen, which may comprise inhibitors of both host and viral targets, should be well worth the effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRrqhubiLpjrVg90H21EOLACvtfcHk0lixpF_Md_viOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSkt7g%253D&md5=1cd0276a92da531cb85c2b165e8dcd0e</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%26aulast%3DGallay%26aufirst%3DP.%26atitle%3DCuring%2520a%2520viral%2520infection%2520by%2520targeting%2520the%2520host%253A%2520the%2520example%2520of%2520cyclophilin%2520inhibitors%26jtitle%3DAntiviral%2520Res.%26date%3D2013%26volume%3D99%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.antiviral.2013.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Busschots, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rijck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span> </span><span class="NLM_article-title">In search of small molecules blocking interactions between HIV proteins and intracellular cofactors</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1039/B810306B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FB810306B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19081927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOnur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=21-31&author=K.+Busschotsauthor=J.+De+Rijckauthor=F.+Christauthor=Z.+Debyser&title=In+search+of+small+molecules+blocking+interactions+between+HIV+proteins+and+intracellular+cofactors&doi=10.1039%2FB810306B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">In search of small molecules blocking interactions between HIV proteins and intracellular cofactors</span></div><div class="casAuthors">Busschots, Katrien; De Rijck, Jan; Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-31</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  One of the major obstacles to pursue the discovery of small mol. inhibitors targeting protein-protein interactions is the flat nature of their interface.  X-ray structures have indeed shown that a large part of the interaction area is buried with atoms closely packed together, implying a lack of available cavities for small mol. binding.  Yet, it has become clear that some protein-protein interfaces have a well-defined compact area, commonly referred to as a hot spot, that plays a major role in the affinity of the interaction.  These hot spots define potential targets for the development of small mol. protein-protein interaction inhibitors (SMPPIIs).  In this review we discuss the interactions between viral and host proteins that have the potential for the future development of SMPPIIs.  In light of the current anti-HIV therapy a short overview of protein-protein interactions that may serve as targets for novel drugs is provided.  Our hypothesis will exemplify and discuss the interaction between HIV-1 integrase and its cellular cofactor LEDGF/p75, which, as evidenced by crystallog. and site directed mutagenesis, displays favorable properties needed for the development of interaction inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhua1w8mTUSbVg90H21EOLACvtfcHk0lixpF_Md_viOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOnur%252FE&md5=c9542c08fd7d1d5dbc82919f0539df2b</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1039%2FB810306B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB810306B%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DDe%2BRijck%26aufirst%3DJ.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DIn%2520search%2520of%2520small%2520molecules%2520blocking%2520interactions%2520between%2520HIV%2520proteins%2520and%2520intracellular%2520cofactors%26jtitle%3DMol.%2520BioSyst.%26date%3D2008%26volume%3D5%26spage%3D21%26epage%3D31%26doi%3D10.1039%2FB810306B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Pery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebane, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabuzda, D.</span><span> </span><span class="NLM_article-title">Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">10504</span><span class="NLM_x">–</span> <span class="NLM_lpage">10517</span><span class="refDoi"> DOI: 10.1074/jbc.M114.626903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M114.626903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=10504-10517&author=E.+Peryauthor=A.+Sheehyauthor=N.+M.+Nebaneauthor=A.+J.+Brazierauthor=V.+Misraauthor=K.+S.+Rajendranauthor=S.+J.+Buhrlageauthor=M.+K.+Mankowskiauthor=L.+Rasmussenauthor=E.+L.+Whiteauthor=R.+G.+Ptakauthor=D.+Gabuzda&title=Identification+of+a+novel+HIV-1+inhibitor+targeting+Vif-dependent+degradation+of+human+APOBEC3G&doi=10.1074%2Fjbc.M114.626903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.626903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.626903%26sid%3Dliteratum%253Aachs%26aulast%3DPery%26aufirst%3DE.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DNebane%26aufirst%3DN.%2BM.%26aulast%3DBrazier%26aufirst%3DA.%2BJ.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DRajendran%26aufirst%3DK.%2BS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DGabuzda%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520HIV-1%2520inhibitor%2520targeting%2520Vif-dependent%2520degradation%2520of%2520human%2520APOBEC3G%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D10504%26epage%3D10517%26doi%3D10.1074%2Fjbc.M114.626903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Heredia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartenhaus, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapata, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfield, R. R.</span><span> </span><span class="NLM_article-title">Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">9412</span><span class="NLM_x">–</span> <span class="NLM_lpage">9417</span><span class="refDoi"> DOI: 10.1073/pnas.1511144112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1511144112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=9412-9417&author=A.+Herediaauthor=N.+Leauthor=R.+B.+Gartenhausauthor=E.+Sausvilleauthor=S.+Medina-Morenoauthor=J.+C.+Zapataauthor=C.+Davisauthor=R.+C.+Galloauthor=R.+R.+Redfield&title=Targeting+of+mTOR+catalytic+site+inhibits+multiple+steps+of+the+HIV-1+lifecycle+and+suppresses+HIV-1+viremia+in+humanized+mice&doi=10.1073%2Fpnas.1511144112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1511144112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1511144112%26sid%3Dliteratum%253Aachs%26aulast%3DHeredia%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DN.%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DMedina-Moreno%26aufirst%3DS.%26aulast%3DZapata%26aufirst%3DJ.%2BC.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DGallo%26aufirst%3DR.%2BC.%26aulast%3DRedfield%26aufirst%3DR.%2BR.%26atitle%3DTargeting%2520of%2520mTOR%2520catalytic%2520site%2520inhibits%2520multiple%2520steps%2520of%2520the%2520HIV-1%2520lifecycle%2520and%2520suppresses%2520HIV-1%2520viremia%2520in%2520humanized%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D9412%26epage%3D9417%26doi%3D10.1073%2Fpnas.1511144112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">AMD3100/CXCR4 Inhibitor</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="refDoi"> DOI: 10.3389/fimmu.2015.00276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3389%2Ffimmu.2015.00276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26106388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbmslaksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276&author=E.+De+Clercq&title=AMD3100%2FCXCR4+Inhibitor&doi=10.3389%2Ffimmu.2015.00276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">AMD3100/CXCR4 Inhibitor</span></div><div class="casAuthors">De Clercq Erik</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">276</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThQWXPjMQFgkwlCcfExbvbfW6udTcc2eb4xd0BDM2ANbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbmslaksg%253D%253D&md5=29bd7fd37dca8c6c43a4c5abdf4b9fe2</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00276%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DAMD3100%252FCXCR4%2520Inhibitor%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D276%26doi%3D10.3389%2Ffimmu.2015.00276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span> </span><span class="NLM_article-title">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span><span class="refDoi"> DOI: 10.4155/fmc.15.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4155%2Ffmc.15.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26144264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1261-1283&author=J.+V%C3%A5ben%C3%B8author=B.+E.+Haugauthor=M.+M.+Rosenkilde&title=Progress+toward+rationally+designed+small-molecule+peptide+and+peptidomimetic+CXCR4+antagonists&doi=10.4155%2Ffmc.15.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span></div><div class="casAuthors">Vabeno, Jon; Haug, Bengt Erik; Rosenkilde, Mette M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-1283</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Over the last 5 years, X-ray structures of CXCR4 in complex with three different ligands (the small-mol. antagonist IT1t, the polypeptide antagonist CVX15 and the viral chemokine antagonist vMIP-II) have been released.  In addn. to the inherent scientific value of these specific X-ray structures, they provide a reliable structural foundation for studies of the mol. interactions between CXCR4 and its key peptide ligands (CXCL12 and HIV-1 gp120), and serve as valuable templates for further development of small-mol. CXCR4 antagonists with therapeutic potential.  We here review recent computational studies of the mol. interactions between CXCR4 and its peptide ligands - based on the X-ray structures of CXCR4 - and the current status of small-mol. peptide and peptidomimetic CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocFGE-iw60gbVg90H21EOLACvtfcHk0lhyZhoL9F9Vhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN&md5=217b88bf8ca537e333adffeaff189576</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.64%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26atitle%3DProgress%2520toward%2520rationally%2520designed%2520small-molecule%2520peptide%2520and%2520peptidomimetic%2520CXCR4%2520antagonists%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1261%26epage%3D1283%26doi%3D10.4155%2Ffmc.15.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tien, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullen, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1465</span><span class="refDoi"> DOI: 10.1021/jm501772w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501772w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1452-1465&author=C.+H.+Wuauthor=C.+J.+Wangauthor=C.+P.+Changauthor=Y.+C.+Chengauthor=J.+S.+Songauthor=J.+J.+Janauthor=M.+C.+Chouauthor=Y.+Y.+Keauthor=J.+Maauthor=Y.+C.+Wongauthor=T.+C.+Hsiehauthor=Y.+C.+Tienauthor=E.+A.+Gullenauthor=C.+F.+Loauthor=C.+Y.+Chengauthor=Y.+W.+Liuauthor=A.+A.+Sadaniauthor=C.+H.+Tsaiauthor=H.+P.+Hsiehauthor=L.+K.+Tsouauthor=K.+S.+Shia&title=Function-oriented+development+of+CXCR4+antagonists+as+selective+human+immunodeficiency+virus+%28HIV%29-1+entry+inhibitors&doi=10.1021%2Fjm501772w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm501772w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501772w%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BJ.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DHsieh%26aufirst%3DT.%2BC.%26aulast%3DTien%26aufirst%3DY.%2BC.%26aulast%3DGullen%26aufirst%3DE.%2BA.%26aulast%3DLo%26aufirst%3DC.%2BF.%26aulast%3DCheng%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DFunction-oriented%2520development%2520of%2520CXCR4%2520antagonists%2520as%2520selective%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-1%2520entry%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1452%26epage%3D1465%26doi%3D10.1021%2Fjm501772w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2014.09.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=481-90&author=T.+Liuauthor=B.+Huangauthor=P.+Zhanauthor=E.+De+Clercqauthor=X.+Liu&title=Discovery+of+small+molecular+inhibitors+targeting+HIV-1+gp120-CD4+interaction+drived+from+BMS-378806&doi=10.1016%2Fj.ejmech.2014.09.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520small%2520molecular%2520inhibitors%2520targeting%2520HIV-1%2520gp120-CD4%2520interaction%2520drived%2520from%2520BMS-378806%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D481%26epage%3D90%26doi%3D10.1016%2Fj.ejmech.2014.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Curreli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scacalossi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, A. K.</span><span> </span><span class="NLM_article-title">Structure-based design of a small molecule CD4-antagonist with broad spectrum anti-HIV-1 activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6909</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6909-27&author=F.+Curreliauthor=Y.+D.+Kwonauthor=H.+Zhangauthor=D.+Scacalossiauthor=D.+S.+Belovauthor=A.+A.+Tikhonovauthor=I.+A.+Andreevauthor=A.+Altieriauthor=A.+V.+Kurkinauthor=P.+D.+Kwongauthor=A.+K.+Debnath&title=Structure-based+design+of+a+small+molecule+CD4-antagonist+with+broad+spectrum+anti-HIV-1+activity&doi=10.1021%2Facs.jmedchem.5b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity</span></div><div class="casAuthors">Curreli, Francesca; Kwon, Young Do; Zhang, Hongtao; Scacalossi, Daniel; Belov, Dmitry S.; Tikhonov, Artur A.; Andreev, Ivan A.; Altieri, Andrea; Kurkin, Alexander V.; Kwong, Peter D.; Debnath, Asim K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6909-6927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Earlier the authors reported the discovery and design of NBD-556 and their analogs which demonstrated their potential as HIV-1 entry inhibitors.  However, progress in developing these inhibitors has been stymied by their CD4-agonist properties, an unfavorable trait for use as drug.  Here, the authors demonstrate the successful conversion of a full CD4-agonist (NBD-556) through a partial CD4-agonist (NBD-09027), to a full CD4-antagonist I (NBD-11021) by structure-based modification of the crit. oxalamide mid-region, previously thought to be intolerant of modification.  I showed unprecedented neutralization breath for this class of inhibitors, with pan-neutralization against a panel of 56 Env-pseudotyped HIV-1 representing diverse subtypes of clin. isolates (IC50 as low as 270 nM).  The cocrystal structure of NBD-11021 complexed to a monomeric HIV-1 gp120 core revealed its detail binding characteristics.  The study is expected to provide a framework for further development of NBD series as HIV-1 entry inhibitors for clin. application against AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsZjeIlR_smLVg90H21EOLACvtfcHk0lhlIHLEbRKcrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK&md5=db75d8df02d72d932b75596bec6fc1fc</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00709%26sid%3Dliteratum%253Aachs%26aulast%3DCurreli%26aufirst%3DF.%26aulast%3DKwon%26aufirst%3DY.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DScacalossi%26aufirst%3DD.%26aulast%3DBelov%26aufirst%3DD.%2BS.%26aulast%3DTikhonov%26aufirst%3DA.%2BA.%26aulast%3DAndreev%26aufirst%3DI.%2BA.%26aulast%3DAltieri%26aufirst%3DA.%26aulast%3DKurkin%26aufirst%3DA.%2BV.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26atitle%3DStructure-based%2520design%2520of%2520a%2520small%2520molecule%2520CD4-antagonist%2520with%2520broad%2520spectrum%2520anti-HIV-1%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6909%26epage%3D27%26doi%3D10.1021%2Facs.jmedchem.5b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span> </span><span class="NLM_article-title">Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1126/science.1261064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1126%2Fscience.1261064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25612609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1117-1122&author=L.+Qinauthor=I.+Kufarevaauthor=L.+G.+Holdenauthor=C.+Wangauthor=Y.+Zhengauthor=C.+Zhaoauthor=G.+Fenaltiauthor=H.+Wuauthor=G.+W.+Hanauthor=V.+Cherezovauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=T.+M.+Handel&title=Structural+biology.+Crystal+structure+of+the+chemokine+receptor+CXCR4+in+complex+with+a+viral+chemokine&doi=10.1126%2Fscience.1261064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span></div><div class="casAuthors">Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Wang, Chong; Zheng, Yi; Zhao, Chunxia; Fenalti, Gustavo; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Abagyan, Ruben; Stevens, Raymond C.; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6226</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokines and their receptors control cell migration during development, immune system responses, and in numerous diseases, including inflammation and cancer.  The structural basis of receptor:chemokine recognition has been a long-standing unanswered question due to the challenges of structure detn. for membrane protein complexes.  Here, we report the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at 3.1 angstrom resoln.  The structure revealed a 1:1 stoichiometry and a more extensive binding interface than anticipated from the paradigmatic two-site model.  The structure helped rationalize a large body of mutagenesis data and together with modeling provided insights into CXCR4 interactions with its endogenous ligand CXCL12, its ability to recognize diverse ligands, and the specificity of CC and CXC receptors for their resp. chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnK7RbAxjiYrVg90H21EOLACvtfcHk0lhlIHLEbRKcrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D&md5=9f3955c6afbd253be237bcf028d2e2dc</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1126%2Fscience.1261064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1261064%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHolden%26aufirst%3DL.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DStructural%2520biology.%2520Crystal%2520structure%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520complex%2520with%2520a%2520viral%2520chemokine%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1117%26epage%3D1122%26doi%3D10.1126%2Fscience.1261064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Sebastian, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K. L.</span><span> </span><span class="NLM_article-title">Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span><span class="refDoi"> DOI: 10.1586/14787210.2014.956094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1586%2F14787210.2014.956094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25189526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1187-1201&author=N.+T.+Sebastianauthor=K.+L.+Collins&title=Targeting+HIV+latency%3A+resting+memory+T+cells%2C+hematopoietic+progenitor+cells+and+future+directions&doi=10.1586%2F14787210.2014.956094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions</span></div><div class="casAuthors">Sebastian, Nadia T.; Collins, Kathleen L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1187-1201</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Current therapy for HIV effectively suppresses viral replication and prolongs life, but the infection persists due, at least in part, to latent infection of long-lived cells.  One favored strategy toward a cure targets latent virus in resting memory CD4+ T cells by stimulating viral prodn.  However, the existence of an addnl. reservoir in bone marrow hematopoietic progenitor cells has been detected in some treated HIV-infected people.  This review describes approaches investigators have used to reactivate latent proviral genomes in resting CD4+ T cells and hematopoietic progenitor cells.  In addn., the authors review approaches for clearance of these reservoirs along with other important topics related to HIV eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBFEFdLSV6gLVg90H21EOLACvtfcHk0lhs3I_lVC2qMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7jE&md5=5b016e8dd92a0538e7d435373db16a08</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1586%2F14787210.2014.956094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.2014.956094%26sid%3Dliteratum%253Aachs%26aulast%3DSebastian%26aufirst%3DN.%2BT.%26aulast%3DCollins%26aufirst%3DK.%2BL.%26atitle%3DTargeting%2520HIV%2520latency%253A%2520resting%2520memory%2520T%2520cells%252C%2520hematopoietic%2520progenitor%2520cells%2520and%2520future%2520directions%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2014%26volume%3D12%26spage%3D1187%26epage%3D1201%26doi%3D10.1586%2F14787210.2014.956094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Colin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Lint, C.</span><span> </span><span class="NLM_article-title">Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="refDoi"> DOI: 10.1186/1742-4690-6-111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-6-111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=111&author=L.+Colinauthor=C.+Van+Lint&title=Molecular+control+of+HIV-1+postintegration+latency%3A+implications+for+the+development+of+new+therapeutic+strategies&doi=10.1186%2F1742-4690-6-111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-6-111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-6-111%26sid%3Dliteratum%253Aachs%26aulast%3DColin%26aufirst%3DL.%26aulast%3DVan%2BLint%26aufirst%3DC.%26atitle%3DMolecular%2520control%2520of%2520HIV-1%2520postintegration%2520latency%253A%2520implications%2520for%2520the%2520development%2520of%2520new%2520therapeutic%2520strategies%26jtitle%3DRetrovirology%26date%3D2009%26volume%3D6%26spage%3D111%26doi%3D10.1186%2F1742-4690-6-111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Donahue, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Cellular and molecular mechanisms involved in the establishment of HIV-1 latency</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="refDoi"> DOI: 10.1186/1742-4690-10-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-10-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=11&author=D.+A.+Donahueauthor=M.+A.+Wainberg&title=Cellular+and+molecular+mechanisms+involved+in+the+establishment+of+HIV-1+latency&doi=10.1186%2F1742-4690-10-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-11%26sid%3Dliteratum%253Aachs%26aulast%3DDonahue%26aufirst%3DD.%2BA.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520involved%2520in%2520the%2520establishment%2520of%2520HIV-1%2520latency%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D11%26doi%3D10.1186%2F1742-4690-10-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Marsden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, J. A.</span><span> </span><span class="NLM_article-title">HIV/AIDS eradication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4003</span><span class="NLM_x">–</span> <span class="NLM_lpage">4010</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2013.05.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4003-4010&author=M.+D.+Marsdenauthor=J.+A.+Zack&title=HIV%2FAIDS+eradication&doi=10.1016%2Fj.bmcl.2013.05.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.032%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DM.%2BD.%26aulast%3DZack%26aufirst%3DJ.%2BA.%26atitle%3DHIV%252FAIDS%2520eradication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4003%26epage%3D4010%26doi%3D10.1016%2Fj.bmcl.2013.05.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Mbonye, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karn, J.</span><span> </span><span class="NLM_article-title">Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">454–455</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.1016/j.virol.2014.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.virol.2014.02.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454%E2%80%93455&publication_year=2014&pages=328-339&author=U.+Mbonyeauthor=J.+Karn&title=Transcriptional+control+of+HIV+latency%3A+cellular+signaling+pathways%2C+epigenetics%2C+happenstance+and+the+hope+for+a+cure&doi=10.1016%2Fj.virol.2014.02.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2014.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2014.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DMbonye%26aufirst%3DU.%26aulast%3DKarn%26aufirst%3DJ.%26atitle%3DTranscriptional%2520control%2520of%2520HIV%2520latency%253A%2520cellular%2520signaling%2520pathways%252C%2520epigenetics%252C%2520happenstance%2520and%2520the%2520hope%2520for%2520a%2520cure%26jtitle%3DVirology%26date%3D2014%26volume%3D454%25E2%2580%2593455%26spage%3D328%26epage%3D339%26doi%3D10.1016%2Fj.virol.2014.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano-Sarabia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Eradicating HIV-1 infection: seeking to clear a persistent pathogen</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">750</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1038/nrmicro3352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnrmicro3352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25402363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFanu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=750-764&author=N.+M.+Archinauthor=J.+M.+Sungauthor=C.+Garridoauthor=N.+Soriano-Sarabiaauthor=D.+M.+Margolis&title=Eradicating+HIV-1+infection%3A+seeking+to+clear+a+persistent+pathogen&doi=10.1038%2Fnrmicro3352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Eradicating HIV-1 infection: seeking to clear a persistent pathogen</span></div><div class="casAuthors">Archin, Nancie M.; Sung, Julia Marsh; Garrido, Carolina; Soriano-Sarabia, Natalia; Margolis, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">750-764</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Effective antiretroviral therapy (ART) blunts viremia, which enables HIV-1-infected individuals to control infection and live long, productive lives.  However, HIV-1 infection remains incurable owing to the persistence of a viral reservoir that harbours integrated provirus within host cellular DNA.  This latent infection is unaffected by ART and hidden from the immune system.  Recent studies have focused on the development of therapies to disrupt latency.  These efforts unmasked residual viral genomes and highlighted the need to enable the clearance of latently infected cells, perhaps via old and new strategies that improve the HIV-1-specific immune response.  In this Review, we explore new approaches to eradicate established HIV-1 infection and avoid the burden of lifelong ART.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyiDG1hd_6bLVg90H21EOLACvtfcHk0lhymOGxYU6bRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFanu7bK&md5=968cdd9411d013837c4aef34df0e0fea</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3352%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DSung%26aufirst%3DJ.%2BM.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DSoriano-Sarabia%26aufirst%3DN.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DEradicating%2520HIV-1%2520infection%253A%2520seeking%2520to%2520clear%2520a%2520persistent%2520pathogen%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2014%26volume%3D12%26spage%3D750%26epage%3D764%26doi%3D10.1038%2Fnrmicro3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Siliciano, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1016/j.jaci.2014.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.jaci.2014.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25117799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSmtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=12-19&author=J.+D.+Silicianoauthor=R.+F.+Siliciano&title=Recent+developments+in+the+search+for+a+cure+for+HIV-1+infection%3A+targeting+the+latent+reservoir+for+HIV-1&doi=10.1016%2Fj.jaci.2014.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the search for a cure for HIV-1 infection: Targeting the latent reservoir for HIV-1</span></div><div class="casAuthors">Siliciano, Janet D.; Siliciano, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-19</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  HIV-1 infection can now be readily controlled with combination antiretroviral therapy.  However, the virus persists indefinitely in a stable latent reservoir in resting CD4+ T cells.  This reservoir generally prevents cure of the infection with combination antiretroviral therapy alone.  However, several recent cases of potential HIV-1 cure have generated renewed optimism.  Here we review these cases and consider new developments in our understanding of the latent reservoir.  In addn., we consider clin. aspects of curative strategies to provide a more realistic picture of what a generally applicable cure for HIV-1 infection is likely to entail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVz2ar1oybPbVg90H21EOLACvtfcHk0lhymOGxYU6bRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSmtbnF&md5=57c5dd833f5afbd1a9a171866bb71652</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2014.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2014.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DSiliciano%26aufirst%3DJ.%2BD.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DRecent%2520developments%2520in%2520the%2520search%2520for%2520a%2520cure%2520for%2520HIV-1%2520infection%253A%2520targeting%2520the%2520latent%2520reservoir%2520for%2520HIV-1%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2014%26volume%3D134%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.jaci.2014.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lucera, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrowolski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabler, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haqqani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, J. C.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">10803</span><span class="NLM_x">–</span> <span class="NLM_lpage">10812</span><span class="refDoi"> DOI: 10.1128/JVI.00320-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.00320-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25008921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yktrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=10803-10812&author=M.+B.+Luceraauthor=C.+A.+Tiltonauthor=H.+Maoauthor=C.+Dobrowolskiauthor=C.+O.+Tablerauthor=A.+A.+Haqqaniauthor=J.+Karnauthor=J.+C.+Tilton&title=The+histone+deacetylase+inhibitor+vorinostat+%28SAHA%29+increases+the+susceptibility+of+uninfected+CD4%2B+T+cells+to+HIV+by+increasing+the+kinetics+and+efficiency+of+postentry+viral+events&doi=10.1128%2FJVI.00320-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182aR"><div class="casContent"><span class="casTitleNuber">182a</span><div class="casTitle"><span class="NLM_cas:atitle">The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events</span></div><div class="casAuthors">Lucera, Mark B.; Tilton, Carisa A.; Mao, Hongxia; Dobrowolski, Curtis; Tabler, Caroline O.; Haqqani, Aiman A.; Karn, Jonathan; Tilton, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10803-10812, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Latently infected cells remain a primary barrier to eradication of HIV-1.  Over the past decade, a better understanding of the mol. mechanisms by which latency is established and maintained has led to the discovery of a no. of compds. that selectively reactivate latent proviruses without inducing polyclonal T cell activation.  Recently, the histone deacetylase (HDAC) inhibitor vorinostat has been demonstrated to induce HIV transcription from latently infected cells when administered to patients.  While vorinostat will be given in the context of antiretroviral therapy (ART), infection of new cells by induced virus remains a clin. concern.  Here, we demonstrate that vorinostat significantly increases the susceptibility of CD4+ T cells to infection by HIV in a dose- and time-dependent manner that is independent of receptor and coreceptor usage.  Vorinostat does not enhance viral fusion with cells but rather enhances the kinetics and efficiency of postentry viral events, including reverse transcription, nuclear import and integration and enhances viral prodn. in a spreading-infection assay.  Selective inhibition of the cytoplasmic class IIb HDAC6 with tubacin recapitulated the effect of vorinostat.  These findings reveal a previously unknown cytoplasmic effect of HDAC inhibitors promoting productive infection of CD4+ T cells that is distinct from their well-characterized effects on nuclear histone acetylation and long-terminal-repeat (LTR) transcription.  Our results indicate that careful monitoring of patients and ART intensification are warranted during vorinostat treatment and indicate that HDAC inhibitors that selectively target nuclear class I HDACs could reactivate latent HIV without increasing the susceptibility of uninfected cells to HIV.  Importance: HDAC inhibitors, particularly vorinostat, are currently being investigated clin. as part of a "shock-and-kill" strategy to purge latent reservoirs of HIV.  We demonstrate here that vorinostat increases the susceptibility of uninfected CD4+ T cells to infection with HIV, raising clin. concerns that vorinostat may reseed the viral reservoirs it is meant to purge, particularly under conditions of suboptimal drug exposure.  We demonstrate that vorinostat acts following viral fusion and enhances the kinetics and efficiency of reverse transcription, nuclear import and integration.  The effect of vorinostat was recapitulated using the cytoplasmic histone deacetylase 6 (HDAC6) inhibitor tubacin, revealing a novel and previously unknown cytoplasmic mechanism of HDAC inhibitors on HIV replication that is distinct from their well-characterized effects of long-terminal-repeat (LTR)-driven gene expression.  Moreover, our results suggest that treatment of patients with class I-specific HDAC inhibitors could induce latent viruses without increasing the susceptibility of uninfected cells to HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHKMcK4aqbvbVg90H21EOLACvtfcHk0lhymOGxYU6bRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yktrzI&md5=27a0eed054c5279a9ab23b3f974a915e</span></div><a href="/servlet/linkout?suffix=cit182a&amp;dbid=16384&amp;doi=10.1128%2FJVI.00320-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00320-14%26sid%3Dliteratum%253Aachs%26aulast%3DLucera%26aufirst%3DM.%2BB.%26aulast%3DTilton%26aufirst%3DC.%2BA.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DDobrowolski%26aufirst%3DC.%26aulast%3DTabler%26aufirst%3DC.%2BO.%26aulast%3DHaqqani%26aufirst%3DA.%2BA.%26aulast%3DKarn%26aufirst%3DJ.%26aulast%3DTilton%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520vorinostat%2520%2528SAHA%2529%2520increases%2520the%2520susceptibility%2520of%2520uninfected%2520CD4%252B%2520T%2520cells%2520to%2520HIV%2520by%2520increasing%2520the%2520kinetics%2520and%2520efficiency%2520of%2520postentry%2520viral%2520events%26jtitle%3DJ.%2520Virol.%26date%3D2014%26volume%3D88%26spage%3D10803%26epage%3D10812%26doi%3D10.1128%2FJVI.00320-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit182b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liberty, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashuba, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruc, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strain, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudgens, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1038/nature11286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnature11286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22837004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=482-485&author=N.+M.+Archinauthor=A.+L.+Libertyauthor=A.+D.+Kashubaauthor=S.+K.+Choudharyauthor=J.+D.+Kurucauthor=A.+M.+Crooksauthor=D.+C.+Parkerauthor=E.+M.+Andersonauthor=M.+F.+Kearneyauthor=M.+C.+Strainauthor=D.+D.+Richmanauthor=M.+G.+Hudgensauthor=R.+J.+Boschauthor=J.+M.+Coffinauthor=J.+J.+Eronauthor=D.+J.+Hazudaauthor=D.+M.+Margolis&title=Administration+of+vorinostat+disrupts+HIV-1+latency+in+patients+on+antiretroviral+therapy&doi=10.1038%2Fnature11286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182bR"><div class="casContent"><span class="casTitleNuber">182b</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span></div><div class="casAuthors">Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7408</span>),
    <span class="NLM_cas:pages">482-485</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection.  Inducing the expression of latent genomes within resting CD4+ T cells is the primary strategy to clear this reservoir.  Although histone deacetylase inhibitors such as suberoylanilide hydroxamic acid (also known as vorinostat, VOR) can disrupt HIV-1 latency in vitro, the utility of this approach has never been directly proven in a translational clin. study of HIV-infected patients.  Here we isolated the circulating resting CD4+ T cells of patients in whom viremia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir.  In each of eight patients, a single dose of VOR increased both biomarkers of cellular acetylation, and simultaneously induced an increase in HIV RNA expression in resting CD4+ cells (mean increase, 4.8-fold).  This demonstrates that a mol. mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK97t6JvwKNrVg90H21EOLACvtfcHk0lh2gxRtppoS-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP&md5=bfe1b9c441d7eeda40d46897a9801311</span></div><a href="/servlet/linkout?suffix=cit182b&amp;dbid=16384&amp;doi=10.1038%2Fnature11286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11286%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DLiberty%26aufirst%3DA.%2BL.%26aulast%3DKashuba%26aufirst%3DA.%2BD.%26aulast%3DChoudhary%26aufirst%3DS.%2BK.%26aulast%3DKuruc%26aufirst%3DJ.%2BD.%26aulast%3DCrooks%26aufirst%3DA.%2BM.%26aulast%3DParker%26aufirst%3DD.%2BC.%26aulast%3DAnderson%26aufirst%3DE.%2BM.%26aulast%3DKearney%26aufirst%3DM.%2BF.%26aulast%3DStrain%26aufirst%3DM.%2BC.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DHudgens%26aufirst%3DM.%2BG.%26aulast%3DBosch%26aufirst%3DR.%2BJ.%26aulast%3DCoffin%26aufirst%3DJ.%2BM.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DAdministration%2520of%2520vorinostat%2520disrupts%2520HIV-1%2520latency%2520in%2520patients%2520on%2520antiretroviral%2520therapy%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D482%26epage%3D485%26doi%3D10.1038%2Fnature11286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit182c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wightman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harman, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dear, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, S. R.</span><span> </span><span class="NLM_article-title">Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2853</span><span class="NLM_x">–</span> <span class="NLM_lpage">2862</span><span class="refDoi"> DOI: 10.1097/QAD.0000000000000067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAD.0000000000000067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2853-2862&author=F.+Wightmanauthor=H.+K.+Luauthor=A.+E.+Solomonauthor=S.+Salehauthor=A.+N.+Harmanauthor=A.+L.+Cunninghamauthor=L.+Grayauthor=M.+Churchillauthor=P.+U.+Cameronauthor=A.+E.+Dearauthor=S.+R.+Lewin&title=Entinostat+is+a+histone+deacetylase+inhibitor+selective+for+class+1+histone+deacetylases+and+activates+HIV+production+from+latently+infected+primary+T+cells&doi=10.1097%2FQAD.0000000000000067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182c&amp;dbid=16384&amp;doi=10.1097%2FQAD.0000000000000067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0000000000000067%26sid%3Dliteratum%253Aachs%26aulast%3DWightman%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DH.%2BK.%26aulast%3DSolomon%26aufirst%3DA.%2BE.%26aulast%3DSaleh%26aufirst%3DS.%26aulast%3DHarman%26aufirst%3DA.%2BN.%26aulast%3DCunningham%26aufirst%3DA.%2BL.%26aulast%3DGray%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DP.%2BU.%26aulast%3DDear%26aufirst%3DA.%2BE.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26atitle%3DEntinostat%2520is%2520a%2520histone%2520deacetylase%2520inhibitor%2520selective%2520for%2520class%25201%2520histone%2520deacetylases%2520and%2520activates%2520HIV%2520production%2520from%2520latently%2520infected%2520primary%2520T%2520cells%26jtitle%3DAIDS%26date%3D2013%26volume%3D27%26spage%3D2853%26epage%3D2862%26doi%3D10.1097%2FQAD.0000000000000067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit182d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e48832</span><span class="refDoi"> DOI: 10.1371/journal.pone.0048832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0048832" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e48832&author=H.+Yingauthor=Y.+Zhangauthor=X.+Zhouauthor=X.+Quauthor=P.+Wangauthor=S.+Liuauthor=D.+Luauthor=H.+Zhu&title=Selective+histonedeacetylase+inhibitor+M344+intervenes+in+HIV-1+latency+through+increasing+histone+acetylation+and+activation+of+NF-kappaB&doi=10.1371%2Fjournal.pone.0048832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182d&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0048832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0048832%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DQu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DSelective%2520histonedeacetylase%2520inhibitor%2520M344%2520intervenes%2520in%2520HIV-1%2520latency%2520through%2520increasing%2520histone%2520acetylation%2520and%2520activation%2520of%2520NF-kappaB%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De48832%26doi%3D10.1371%2Fjournal.pone.0048832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit182e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines</span> <span class="citation_source-journal">Curr. HIV Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.2174/157016213804999249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F157016213804999249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23092175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=24-29&author=X.+Quauthor=H.+Yingauthor=X.+Wangauthor=C.+Kongauthor=X.+Zhouauthor=P.+Wangauthor=H.+Zhu&title=Histone+deacetylase+inhibitor+MC1293+induces+latent+HIV-1+reactivation+by+histone+modification+in+vitro+latency+cell+lines&doi=10.2174%2F157016213804999249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182eR"><div class="casContent"><span class="casTitleNuber">182e</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines</span></div><div class="casAuthors">Qu, Xiying; Ying, Hao; Wang, Xiaohui; Kong, Chuijin; Zhou, Xin; Wang, Pengfei; Zhu, Huanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">CHRUBF</span>;
        ISSN:<span class="NLM_cas:issn">1570-162X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">HIV-1 latency remains a major problem for the eradication of viruses in infected individuals.  We evaluated the effect of MC1293 on the epigenetic change at HIV-1 LTR and the induction of the latent viruses in the latency Jurkat T cell line.  We found MC1293 can activate HIV-1 gene expression, increase the acetylation level of H3 and H4 at the nuc-1 site of HIV-1 LTR.  In addn., MC1293 can synergize with prostratin to activate the HIV-1 promoter, and has relatively lower toxicity compared to Trichostatin A (TSA).  The results suggest that the acetylation of histone plays an important role in regulating HIV-1 LTR gene expression, and MC1293 is potential drug candidate for antilatency therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn6_R4aMO3fbVg90H21EOLACvtfcHk0lh2gxRtppoS-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeltbs%253D&md5=897be1895416e894786c62c5285448a1</span></div><a href="/servlet/linkout?suffix=cit182e&amp;dbid=16384&amp;doi=10.2174%2F157016213804999249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016213804999249%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DX.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKong%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520MC1293%2520induces%2520latent%2520HIV-1%2520reactivation%2520by%2520histone%2520modification%2520in%2520vitro%2520latency%2520cell%2520lines%26jtitle%3DCurr.%2520HIV%2520Res.%26date%3D2013%26volume%3D11%26spage%3D24%26epage%3D29%26doi%3D10.2174%2F157016213804999249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit182f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Matalon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nold, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furlan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascagni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e3181d3dca3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAI.0b013e3181d3dca3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20300007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1-9&author=S.+Matalonauthor=B.+E.+Palmerauthor=M.+F.+Noldauthor=A.+Furlanauthor=A.+Kassuauthor=G.+Fossatiauthor=P.+Mascagniauthor=C.+A.+Dinarello&title=The+histone+deacetylase+inhibitor+ITF2357+decreases+surface+CXCR4+and+CCR5+expression+on+CD4%28%2B%29+T-cells+and+monocytes+and+is+superior+to+valproic+acid+for+latent+HIV-1+expression+in+vitro&doi=10.1097%2FQAI.0b013e3181d3dca3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182fR"><div class="casContent"><span class="casTitleNuber">182f</span><div class="casTitle"><span class="NLM_cas:atitle">The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro</span></div><div class="casAuthors">Matalon, Shay; Palmer, Brent E.; Nold, Marcel F.; Furlan, Antonio; Kassu, Afework; Fossati, Gianluca; Mascagni, Paolo; Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Chromatin-assocd. repression is one mechanism that maintains HIV-1 latency.  Inhibition of histone deacetylases (HDAC) reverses this repression resulting in viral expression from quiescently infected cells.  Clin. studies with the HDAC inhibitor valproic acid (VPA) failed to substantially decrease the latent pool within resting CD4 cells.  Here we compared the efficacy of ITF2357, an orally active and safe HDAC inhibitor, with VPA for HIV-1 expression from latently infected cells in vitro.  We also evaluated the effect of ITF2357 on the surface expression of CXCR4 and CCR5.  Latently infected cell lines were incubated with either ITF2357 or VPA and p24 levels were measured.  Peripheral blood mononuclear cells of uninfected donors were treated with ITF2357 and HIV-1 coreceptors expression was assessed by flow cytometry.  At clin. relevant concns., ITF2357 increased p24 by 15-fold in ACH2 cells and by 9-fold in U1 cells, whereas VPA increased expression less than 2-fold.  Analogs of ITF2357 primarily targeting HDAC-1 increased p24 up to 30-fold.  In CD4 T cells treated with ITF2357, CXCR4 expression decreased by 54% (P < 0.001).  ITF2357 is superior to VPA in inducing HIV-1 from latently infected cells.  Safely used in humans, ITF2357 is an attractive candidate for HIV-1 clin. purging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPgJCLYVZvFrVg90H21EOLACvtfcHk0liTYyVHvcUTAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFCmtr8%253D&md5=00472fbb9d15158fb97d3f20d8bd230c</span></div><a href="/servlet/linkout?suffix=cit182f&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e3181d3dca3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e3181d3dca3%26sid%3Dliteratum%253Aachs%26aulast%3DMatalon%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DB.%2BE.%26aulast%3DNold%26aufirst%3DM.%2BF.%26aulast%3DFurlan%26aufirst%3DA.%26aulast%3DKassu%26aufirst%3DA.%26aulast%3DFossati%26aufirst%3DG.%26aulast%3DMascagni%26aufirst%3DP.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520ITF2357%2520decreases%2520surface%2520CXCR4%2520and%2520CCR5%2520expression%2520on%2520CD4%2528%252B%2529%2520T-cells%2520and%2520monocytes%2520and%2520is%2520superior%2520to%2520valproic%2520acid%2520for%2520latent%2520HIV-1%2520expression%2520in%2520vitro%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2010%26volume%3D54%26spage%3D1%26epage%3D9%26doi%3D10.1097%2FQAI.0b013e3181d3dca3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellors, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluis-Cremer, N.</span><span> </span><span class="NLM_article-title">Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">22211</span><span class="NLM_x">–</span> <span class="NLM_lpage">22218</span><span class="refDoi"> DOI: 10.1074/jbc.M110.180224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M110.180224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=22211-22218&author=K.+Huberauthor=G.+Doyonauthor=J.+Plaksauthor=E.+Fyneauthor=J.+W.+Mellorsauthor=N.+Sluis-Cremer&title=Inhibitors+of+histone+deacetylases%3A+correlation+between+isoform+specificity+and+reactivation+of+HIV+type+1+%28HIV-1%29+from+latently+infected+cells&doi=10.1074%2Fjbc.M110.180224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.180224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.180224%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DDoyon%26aufirst%3DG.%26aulast%3DPlaks%26aufirst%3DJ.%26aulast%3DFyne%26aufirst%3DE.%26aulast%3DMellors%26aufirst%3DJ.%2BW.%26aulast%3DSluis-Cremer%26aufirst%3DN.%26atitle%3DInhibitors%2520of%2520histone%2520deacetylases%253A%2520correlation%2520between%2520isoform%2520specificity%2520and%2520reactivation%2520of%2520HIV%2520type%25201%2520%2528HIV-1%2529%2520from%2520latently%2520infected%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D22211%26epage%3D22218%26doi%3D10.1074%2Fjbc.M110.180224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68669</span><span class="refDoi"> DOI: 10.1371/journal.pone.0068669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0068669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23874714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68669&author=T.+Suzukiauthor=Y.+Kasuyaauthor=Y.+Itohauthor=Y.+Otaauthor=P.+Zhanauthor=K.+Asamitsuauthor=H.+Nakagawaauthor=T.+Okamotoauthor=N.+Miyata&title=Identification+of+highly+selective+and+potent+histone+deacetylase+3+inhibitors+using+click+chemistry-based+combinatorial+fragment+assembly&doi=10.1371%2Fjournal.pone.0068669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184aR"><div class="casContent"><span class="casTitleNuber">184a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span></div><div class="casAuthors">Suzuki, Takayoshi; Kasuya, Yuki; Itoh, Yukihiro; Ota, Yosuke; Zhan, Peng; Asamitsu, Kaori; Nakagawa, Hidehiko; Okamoto, Takashi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68669</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">To find histone deacetylase 3 (HDAC3)-selective inhibitors, a series of 504 candidates was assembled using "click chem.", by reacting nine alkynes bearing a zinc-binding group with 56 azide building blocks in the presence of Cu(I) catalyst.  Screening of the 504-member triazole library against HDAC3 and other HDAC isoenzymes led to the identification of potent and selective HDAC3 inhibitors T247 and T326.  These compds. showed potent HDAC3 inhibition with submicromolar IC50s, whereas they did not strongly inhibit other isoenzymes.  Compds. T247 and T326 also induced a dose-dependent selective increase of NF-κB acetylation in human colon cancer HCT116 cells, indicating selective inhibition of HDAC3 in the cells.  In addn., these HDAC3-selective inhibitors induced growth inhibition of cancer cells, and activated HIV gene expression in latent HIV-infected cells.  These findings indicate that HDAC3-selective inhibitors are promising candidates for anticancer drugs and antiviral agents.  This work also suggests the usefulness of the click chem. approach to find isoenzyme-selective HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4CvS43ILxQLVg90H21EOLACvtfcHk0liTYyVHvcUTAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF&md5=74d12c8fb1f06f8e00691415434fd929</span></div><a href="/servlet/linkout?suffix=cit184a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068669%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520highly%2520selective%2520and%2520potent%2520histone%2520deacetylase%25203%2520inhibitors%2520using%2520click%2520chemistry-based%2520combinatorial%2520fragment%2520assembly%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68669%26doi%3D10.1371%2Fjournal.pone.0068669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit184b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Victoriano, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span> </span><span class="NLM_article-title">Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.febslet.2011.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.febslet.2011.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=1103-11&author=A.+F.+Victorianoauthor=K.+Imaiauthor=H.+Togamiauthor=T.+Uenoauthor=K.+Asamitsuauthor=T.+Suzukiauthor=N.+Miyataauthor=K.+Ochiaiauthor=T.+Okamoto&title=Novel+histone+deacetylase+inhibitor+NCH-51+activates+latent+HIV-1+gene+expression&doi=10.1016%2Fj.febslet.2011.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184b&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DVictoriano%26aufirst%3DA.%2BF.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DTogami%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DT.%26atitle%3DNovel%2520histone%2520deacetylase%2520inhibitor%2520NCH-51%2520activates%2520latent%2520HIV-1%2520gene%2520expression%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D1103%26epage%3D11%26doi%3D10.1016%2Fj.febslet.2011.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Rasmussen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstrup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckelmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Østergaard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søgaard, O. S.</span><span> </span><span class="NLM_article-title">Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials</span> <span class="citation_source-journal">Hum. Vaccines Immunother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span><span class="refDoi"> DOI: 10.4161/hv.23202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4161%2Fhv.23202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23563519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSks7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=790-799&author=T.+A.+Rasmussenauthor=M.+Tolstrupauthor=A.+Winckelmannauthor=L.+%C3%98stergaardauthor=O.+S.+S%C3%B8gaard&title=Eliminating+the+latent+HIV+reservoir+by+reactivation+strategies%3A+advancing+to+clinical+trials&doi=10.4161%2Fhv.23202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials</span></div><div class="casAuthors">Rasmussen, Thomas A.; Tolstrup, Martin; Winckelmann, Anni; Oestergaard, Lars; Soegaard, Ole S.</div><div class="citationInfo"><span class="NLM_cas:title">Human Vaccines & Immunotherapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">790-799</span>CODEN:
                <span class="NLM_cas:coden">HVIUAK</span>;
        ISSN:<span class="NLM_cas:issn">2164-5515</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Combination antiretroviral therapy (cART) has transformed HIV from a deadly to a chronic disease, but HIV patients are still burdened with excess morbidity and mortality, long-term toxicities from cART, stigmatization, and insufficient access to cART worldwide.  Thus, a cure for HIV would have enormous impact on society as well as the individual.  As the complexity and mechanisms of HIV persistence during therapy are being unraveled, new therapeutic targets for HIV eradication are discovered.  Substances that activate HIV prodn. in the latently infected cells have recently received much attention.  By turning on expression of latent HIV proviruses, reactivation strategies could contribute to the eradication HIV infection.  Compds. that are currently being or soon to be tested in clin. trials are emphasized in this review.  The results from these trials will provide important clues as to whether or not reactivating strategies could become significant components of a cure for HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6b0oFQRXFarVg90H21EOLACvtfcHk0lg33bMhYd7L2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSks7%252FO&md5=3ec6fd4bb7e8b81877a3b4a8e026e3f0</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.4161%2Fhv.23202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fhv.23202%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DT.%2BA.%26aulast%3DTolstrup%26aufirst%3DM.%26aulast%3DWinckelmann%26aufirst%3DA.%26aulast%3D%25C3%2598stergaard%26aufirst%3DL.%26aulast%3DS%25C3%25B8gaard%26aufirst%3DO.%2BS.%26atitle%3DEliminating%2520the%2520latent%2520HIV%2520reservoir%2520by%2520reactivation%2520strategies%253A%2520advancing%2520to%2520clinical%2520trials%26jtitle%3DHum.%2520Vaccines%2520Immunother.%26date%3D2013%26volume%3D9%26spage%3D790%26epage%3D799%26doi%3D10.4161%2Fhv.23202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Shirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvanese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">Reactivation of latent HIV by histone deacetylase inhibitors</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.1016/j.tim.2013.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.tim.2013.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23517573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlSjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=277-285&author=K.+Shirakawaauthor=L.+Chavezauthor=S.+Hakreauthor=V.+Calvaneseauthor=E.+Verdin&title=Reactivation+of+latent+HIV+by+histone+deacetylase+inhibitors&doi=10.1016%2Fj.tim.2013.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of latent HIV by histone deacetylase inhibitors</span></div><div class="casAuthors">Shirakawa, Kotaro; Chavez, Leonard; Hakre, Shweta; Calvanese, Vincenzo; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">TRMIEA</span>;
        ISSN:<span class="NLM_cas:issn">0966-842X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Latent HIV persists in CD4+ T cells in infected patients under antiretroviral therapy (ART).  Latency is assocd. with transcriptional silencing of the integrated provirus and driven, at least in part, by histone deacetylases (HDACs), a family of chromatin-assocd. proteins that regulate histone acetylation and the accessibility of DNA to transcription factors.  Remarkably, inhibition of HDACs is sufficient to reactivate a fraction of latent HIV in a variety of exptl. systems.  This basic observation led to the shock and kill idea that forcing the transcriptional activation of HIV might lead to virus expression, to virus- or host-induced cell death of the reactivated cells, and to the eradication of the pool of latently infected cells.  Such intervention might possibly lead to a cure for HIV-infected patients.  Here, we review the basic biol. of HDACs and their inhibitors, the role of HDACs in HIV latency, and recent efforts to use HDAC inhibitors to reactivate latent HIV in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQF9-sQLDUE7Vg90H21EOLACvtfcHk0lg33bMhYd7L2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlSjtbk%253D&md5=39bc7bd9e112acf1217e7a5c4ba238fa</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.tim.2013.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tim.2013.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DShirakawa%26aufirst%3DK.%26aulast%3DChavez%26aufirst%3DL.%26aulast%3DHakre%26aufirst%3DS.%26aulast%3DCalvanese%26aufirst%3DV.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DReactivation%2520of%2520latent%2520HIV%2520by%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DTrends%2520Microbiol.%26date%3D2013%26volume%3D21%26spage%3D277%26epage%3D285%26doi%3D10.1016%2Fj.tim.2013.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Pei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span> </span><span class="NLM_article-title">Systems biology brings new dimensions for structure-based drug design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">11556</span><span class="NLM_x">–</span> <span class="NLM_lpage">11565</span><span class="refDoi"> DOI: 10.1021/ja504810z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja504810z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ajtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=11556-11565&author=J.+Peiauthor=N.+Yinauthor=X.+Maauthor=L.+Lai&title=Systems+biology+brings+new+dimensions+for+structure-based+drug+design&doi=10.1021%2Fja504810z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Systems Biology Brings New Dimensions for Structure-Based Drug Design</span></div><div class="casAuthors">Pei, Jianfeng; Yin, Ning; Ma, Xiaomin; Lai, Luhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11556-11565</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this Perspective, we focus on new, systems-centric views of structure-based drug design (SBDD) that we believe will impact future drug discovery research and development.  We will first discuss new ways to identify drug targets based on systems intervention anal., and then we will introduce emerging SBDD methods driven by advancements in systems biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreR4j6y808PrVg90H21EOLACvtfcHk0lg33bMhYd7L2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ajtb3E&md5=7834c0474a316442c136bb601ee3882c</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fja504810z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja504810z%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DSystems%2520biology%2520brings%2520new%2520dimensions%2520for%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D11556%26epage%3D11565%26doi%3D10.1021%2Fja504810z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Fernandez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaikos, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behlke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeichner, S. L.</span><span> </span><span class="NLM_article-title">Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">3966</span><span class="NLM_x">–</span> <span class="NLM_lpage">3978</span><span class="refDoi"> DOI: 10.1128/JVI.03251-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.03251-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23365428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlymtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=3966-3978&author=G.+Fernandezauthor=T.+D.+Zaikosauthor=S.+Z.+Khanauthor=A.+M.+Jacobiauthor=M.+A.+Behlkeauthor=S.+L.+Zeichner&title=Targeting+I%CE%BAB+proteins+for+HIV+latency+activation%3A+the+role+of+individual+I%CE%BAB+and+NF-%CE%BAB+proteins&doi=10.1128%2FJVI.03251-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins</span></div><div class="casAuthors">Fernandez, Guerau; Zaikos, Thomas D.; Khan, Sohrab Z.; Jacobi, Ashley M.; Behlke, Mark A.; Zeichner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3966-3978</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Latently infected cell reservoirs represent the main barrier to HIV eradication.  Combination antiretroviral therapy (cART) effectively blocks viral replication but cannot purge latent provirus.  One approach to HIV eradication could include cART to block new infections plus an agent to activate latent provirus.  NF-κB activation induces HIV expression, ending latency.  Before activation, IκB proteins sequester NF-κB dimers in the cytoplasm.  Three canonical IκBs, IκBα, IκBβ, and IκBε, exist, but the IκB proteins' role in HIV activation regulation is not fully understood.  We studied the effects on HIV activation of targeting IκBs by single and pairwise small interfering RNA (siRNA) knockdown.  After detg. the relative abundance of the IκBs, the relative abundance of NF-κB subunits held by the IκBs, and the kinetics of IκB degrdn. and resynthesis following knockdown, we studied HIV activation by IκB knockdown, in comparison with those of known HIV activators, tumor necrosis factor alpha (TNF-α), tetradecanoyl phorbol acetate (TPA), and trichostatin A (TSA), in U1 monocytic and J-Lat 10.6 lymphocytic latently infected cells.  We found that IκBα knockdown activated HIV in both U1 and J-Lat 10.6 cells, IκBβ knockdown did not activate HIV, and, surprisingly, IκBε knockdown produced the most HIV activation, comparable to TSA activation.  Our data show that HIV reactivation can be triggered by targeting two different IκB proteins and that IκBε may be an effective target for HIV latency reactivation in T-cell and macrophage lineages.  IκBε knockdown may offer attractive therapeutic advantages for HIV activation because it is not essential for mammalian growth and development and because new siRNA delivery strategies may target siRNAs to HIV latently infected cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT8ITojoRt7Vg90H21EOLACvtfcHk0ljt7QHXZGSuyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlymtrY%253D&md5=abb3ed38790dbb85aeaf6918b856913d</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1128%2FJVI.03251-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03251-12%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DG.%26aulast%3DZaikos%26aufirst%3DT.%2BD.%26aulast%3DKhan%26aufirst%3DS.%2BZ.%26aulast%3DJacobi%26aufirst%3DA.%2BM.%26aulast%3DBehlke%26aufirst%3DM.%2BA.%26aulast%3DZeichner%26aufirst%3DS.%2BL.%26atitle%3DTargeting%2520I%25CE%25BAB%2520proteins%2520for%2520HIV%2520latency%2520activation%253A%2520the%2520role%2520of%2520individual%2520I%25CE%25BAB%2520and%2520NF-%25CE%25BAB%2520proteins%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D3966%26epage%3D3978%26doi%3D10.1128%2FJVI.03251-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Sakane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagans, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaehlcke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizusawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassen, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoelzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span> </span><span class="NLM_article-title">Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1)</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1002184</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1002184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.ppat.1002184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002184&author=N.+Sakaneauthor=H.+S.+Kwonauthor=S.+Pagansauthor=K.+Kaehlckeauthor=Y.+Mizusawaauthor=M.+Kamadaauthor=K.+G.+Lassenauthor=J.+Chanauthor=W.+C.+Greeneauthor=M.+Schnoelzerauthor=M.+Ott&title=Activation+of+HIV+transcription+by+the+viral+Tat+protein+requires+a+demethylation+step+mediated+by+lysine-specific+demethylase+1+%28LSD1%2FKDM1%29&doi=10.1371%2Fjournal.ppat.1002184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002184%26sid%3Dliteratum%253Aachs%26aulast%3DSakane%26aufirst%3DN.%26aulast%3DKwon%26aufirst%3DH.%2BS.%26aulast%3DPagans%26aufirst%3DS.%26aulast%3DKaehlcke%26aufirst%3DK.%26aulast%3DMizusawa%26aufirst%3DY.%26aulast%3DKamada%26aufirst%3DM.%26aulast%3DLassen%26aufirst%3DK.%2BG.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DW.%2BC.%26aulast%3DSchnoelzer%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DM.%26atitle%3DActivation%2520of%2520HIV%2520transcription%2520by%2520the%2520viral%2520Tat%2520protein%2520requires%2520a%2520demethylation%2520step%2520mediated%2520by%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%252FKDM1%2529%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26spage%3De1002184%26doi%3D10.1371%2Fjournal.ppat.1002184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">León, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadyar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleziunas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagratis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linington, R. G.</span><span> </span><span class="NLM_article-title">Abyssomicin 2 reactivates latent HIV-1 by a PKC- and HDAC-independent mechanism</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1021/ol503349y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol503349y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=262-265&author=B.+Le%C3%B3nauthor=G.+Navarroauthor=B.+J.+Dickeyauthor=G.+Stepanauthor=A.+Tsaiauthor=G.+S.+Jonesauthor=M.+E.+Moralesauthor=T.+Barnesauthor=S.+Ahmadyarauthor=M.+Tsiangauthor=R.+Geleziunasauthor=T.+Cihlarauthor=N.+Pagratisauthor=Y.+Tianauthor=H.+Yuauthor=R.+G.+Linington&title=Abyssomicin+2+reactivates+latent+HIV-1+by+a+PKC-+and+HDAC-independent+mechanism&doi=10.1021%2Fol503349y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fol503349y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol503349y%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DB.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DDickey%26aufirst%3DB.%2BJ.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DG.%2BS.%26aulast%3DMorales%26aufirst%3DM.%2BE.%26aulast%3DBarnes%26aufirst%3DT.%26aulast%3DAhmadyar%26aufirst%3DS.%26aulast%3DTsiang%26aufirst%3DM.%26aulast%3DGeleziunas%26aufirst%3DR.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DPagratis%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLinington%26aufirst%3DR.%2BG.%26atitle%3DAbyssomicin%25202%2520reactivates%2520latent%2520HIV-1%2520by%2520a%2520PKC-%2520and%2520HDAC-independent%2520mechanism%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D262%26epage%3D265%26doi%3D10.1021%2Fol503349y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rice, A. P.</span><span> </span><span class="NLM_article-title">P-TEFb as a target to reactivate latent HIV: two Birds are now in hand</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.4161/cc.23556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4161%2Fcc.23556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=392-393&author=A.+P.+Rice&title=P-TEFb+as+a+target+to+reactivate+latent+HIV%3A+two+Birds+are+now+in+hand&doi=10.4161%2Fcc.23556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191a&amp;dbid=16384&amp;doi=10.4161%2Fcc.23556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.23556%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DA.%2BP.%26atitle%3DP-TEFb%2520as%2520a%2520target%2520to%2520reactivate%2520latent%2520HIV%253A%2520two%2520Birds%2520are%2520now%2520in%2520hand%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26spage%3D392%26epage%3D393%26doi%3D10.4161%2Fcc.23556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit191b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Budhiraja, S.; Rice, A. P.</span><span> </span><span class="NLM_article-title">Reactivation of latent HIV: Do all roads go through P-TEFb?</span> <span class="citation_source-journal">Future Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span>). DOI: <span class="refDoi"> DOI: 10.2217/fvl.13.52</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2217%2Ffvl.13.52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24409197" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=7&author=S.+Budhiraja&author=A.+P.+Rice&title=Reactivation+of+latent+HIV%3A+Do+all+roads+go+through+P-TEFb%3F&doi=10.2217%2Ffvl.13.52"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191b&amp;dbid=16384&amp;doi=10.2217%2Ffvl.13.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffvl.13.52%26sid%3Dliteratum%253Aachs%26aulast%3DBudhiraja%26aufirst%3DS.%26atitle%3DReactivation%2520of%2520latent%2520HIV%253A%2520Do%2520all%2520roads%2520go%2520through%2520P-TEFb%253F%26jtitle%3DFuture%2520Virol.%26date%3D2013%26volume%3D8%26issue%3D7%26doi%3D10.2217%2Ffvl.13.52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">DeChristopher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, P. A.</span><span> </span><span class="NLM_article-title">Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1038/nchem.1395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchem.1395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22914190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=705-710&author=B.+A.+DeChristopherauthor=B.+A.+Loyauthor=M.+D.+Marsdenauthor=A.+J.+Schrierauthor=J.+A.+Zackauthor=P.+A.+Wender&title=Designed%2C+synthetically+accessible+bryostatin+analogues+potently+induce+activation+of+latent+HIV+reservoirs+in+vitro&doi=10.1038%2Fnchem.1395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192aR"><div class="casContent"><span class="casTitleNuber">192a</span><div class="casTitle"><span class="NLM_cas:atitle">Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro</span></div><div class="casAuthors">DeChristopher, Brian A.; Loy, Brian A.; Marsden, Matthew D.; Schrier, Adam J.; Zack, Jerome A.; Wender, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Seven bryostatin 1 analogs (bryologs) were prepd. using a highly convergent and step-economical route with a Prins macrocyclization reaction as the key step.  Bryostatin analogs, particularly I (R = AcO; R1 = HO; R2 = H, MeO2C), were up to 1000 times more potent than the phorbol analog prostratin (a clin. candidate for activation of latent HIV infection and for HIV treatment in concert with other anti-HIV agents) and more potent than bryostatin at inducing latent HIV expression.  Designed, synthetically accessible bryostatin analogs could serve as superior candidates for the eradication of HIV/AIDS through induction of latent viral reservoirs in conjunction with current antiretroviral therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEvjhdmkUYrVg90H21EOLACvtfcHk0ljPUM31k76pqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehtLbJ&md5=e99e87106311ee2c8e6f9193dcfc1645</span></div><a href="/servlet/linkout?suffix=cit192a&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1395%26sid%3Dliteratum%253Aachs%26aulast%3DDeChristopher%26aufirst%3DB.%2BA.%26aulast%3DLoy%26aufirst%3DB.%2BA.%26aulast%3DMarsden%26aufirst%3DM.%2BD.%26aulast%3DSchrier%26aufirst%3DA.%2BJ.%26aulast%3DZack%26aufirst%3DJ.%2BA.%26aulast%3DWender%26aufirst%3DP.%2BA.%26atitle%3DDesigned%252C%2520synthetically%2520accessible%2520bryostatin%2520analogues%2520potently%2520induce%2520activation%2520of%2520latent%2520HIV%2520reservoirs%2520in%2520vitro%26jtitle%3DNat.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D705%26epage%3D710%26doi%3D10.1038%2Fnchem.1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit192b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beans, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournogerakis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauntlett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heumann, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, P. A.</span><span> </span><span class="NLM_article-title">Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">11698</span><span class="NLM_x">–</span> <span class="NLM_lpage">11703</span><span class="refDoi"> DOI: 10.1073/pnas.1302634110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1302634110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23812750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=11698-11703&author=E.+J.+Beansauthor=D.+Fournogerakisauthor=C.+Gauntlettauthor=L.+V.+Heumannauthor=R.+Kramerauthor=M.+D.+Marsdenauthor=D.+Murrayauthor=T.+W.+Chunauthor=J.+A.+Zackauthor=P.+A.+Wender&title=Highly+potent%2C+synthetically+accessible+prostratin+analogs+induce+latent+HIV+expression+in+vitro+and+ex+vivo&doi=10.1073%2Fpnas.1302634110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192bR"><div class="casContent"><span class="casTitleNuber">192b</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo</span></div><div class="casAuthors">Beans, Elizabeth J.; Fournogerakis, Dennis; Gauntlett, Carolyn; Heumann, Lars V.; Kramer, Rainer; Marsden, Matthew D.; Murray, Danielle; Chun, Tae-Wook; Zack, Jerome A.; Wender, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11698-11703,S11698/1-S11698/32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Highly active antiretroviral therapy (HAART) decreases plasma viremia below the limits of detection in the majority of HIV-infected individuals, thus serving to slow disease progression.  However, HAART targets only actively replicating virus and is unable to eliminate latently infected, resting CD4+ T cells.  Such infected cells are potentially capable of reinitiating virus replication upon cessation of HAART, thus leading to viral rebound.  Agents that would eliminate these reservoirs, when used in combination with HAART, could thus provide a strategy for the eradication of HIV.  Prostratin is a preclin. candidate that induces HIV expression from latently infected CD4+ T cells, potentially leading to their elimination through a virus-induced cytopathic effect or host anti-HIV immunity.  Here, we report the synthesis of a series of designed prostratin analogs and report in vitro and ex vivo studies of their activity relevant to induction of HIV expression.  Members of this series are up to 100-fold more potent than the preclin. lead (prostratin) in binding to cell-free PKC, and in inducing HIV expression in a latently infected cell line and prostratin-like modulation of cell surface receptor expression in primary cells from HIV-neg. donors.  Significantly, selected members were also tested for HIV induction in resting CD4+ T cells isolated from infected individuals receiving HAART and were found to exhibit potent induction activity.  These more potent agents and by extension related tunable analogs now accessible through the studies described herein should facilitate research and preclin. advancement of this strategy for HIV/AIDS eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIwBT4usZkHbVg90H21EOLACvtfcHk0ljPUM31k76pqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emur3J&md5=d6f8cd63860c249f8f636e3da729573f</span></div><a href="/servlet/linkout?suffix=cit192b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302634110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302634110%26sid%3Dliteratum%253Aachs%26aulast%3DBeans%26aufirst%3DE.%2BJ.%26aulast%3DFournogerakis%26aufirst%3DD.%26aulast%3DGauntlett%26aufirst%3DC.%26aulast%3DHeumann%26aufirst%3DL.%2BV.%26aulast%3DKramer%26aufirst%3DR.%26aulast%3DMarsden%26aufirst%3DM.%2BD.%26aulast%3DMurray%26aufirst%3DD.%26aulast%3DChun%26aufirst%3DT.%2BW.%26aulast%3DZack%26aufirst%3DJ.%2BA.%26aulast%3DWender%26aufirst%3DP.%2BA.%26atitle%3DHighly%2520potent%252C%2520synthetically%2520accessible%2520prostratin%2520analogs%2520induce%2520latent%2520HIV%2520expression%2520in%2520vitro%2520and%2520ex%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D11698%26epage%3D11703%26doi%3D10.1073%2Fpnas.1302634110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Targeting HIV latency: pharmacologic strategies toward eradication</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1016/j.drudis.2012.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2012.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23270785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=541-551&author=S.+Xingauthor=R.+F.+Siliciano&title=Targeting+HIV+latency%3A+pharmacologic+strategies+toward+eradication&doi=10.1016%2Fj.drudis.2012.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HIV latency: pharmacologic strategies toward eradication</span></div><div class="casAuthors">Xing, Sifei; Siliciano, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">541-551</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The latent reservoir for HIV-1 in resting CD4+ T cells remains a major barrier to HIV-1 eradication, even though highly active antiretroviral therapy (HAART) can successfully reduce plasma HIV-1 levels to below the detection limit of clin. assays and reverse disease progression.  Proposed eradication strategies involve reactivation of this latent reservoir.  Multiple mechanisms are believed to be involved in maintaining HIV-1 latency, mostly through suppression of transcription.  These include cytoplasmic sequestration of host transcription factors and epigenetic modifications such as histone deacetylation, histone methylation and DNA methylation.  Therefore, strategies targeting these mechanisms have been explored for reactivation of the latent reservoir.  In this review, we discuss current pharmacol. approaches toward eradication, focusing on small mol. latency-reversing agents, their mechanisms, advantages and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQstdInNIA7Vg90H21EOLACvtfcHk0ljv514sFnkMLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktg%253D%253D&md5=ef4ddba65018cb4211de942bd66c4976</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DS.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DTargeting%2520HIV%2520latency%253A%2520pharmacologic%2520strategies%2520toward%2520eradication%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D541%26epage%3D551%26doi%3D10.1016%2Fj.drudis.2012.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Yang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinoso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrum, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolick, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3473</span><span class="NLM_x">–</span> <span class="NLM_lpage">3486</span><span class="refDoi"> DOI: 10.1172/JCI39199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1172%2FJCI39199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3473-3486&author=H.+C.+Yangauthor=S.+Xingauthor=L.+Shanauthor=K.+O%E2%80%99Connellauthor=J.+Dinosoauthor=A.+Shenauthor=Y.+Zhouauthor=C.+K.+Shrumauthor=Y.+Hanauthor=J.+O.+Liuauthor=H.+Zhangauthor=J.+B.+Margolickauthor=R.+F.+Siliciano&title=Small-molecule+screening+using+a+human+primary+cell+model+of+HIV+latency+identifies+compounds+that+reverse+latency+without+cellular+activation&doi=10.1172%2FJCI39199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1172%2FJCI39199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI39199%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BC.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DShan%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DK.%26aulast%3DDinoso%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShrum%26aufirst%3DC.%2BK.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMargolick%26aufirst%3DJ.%2BB.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DSmall-molecule%2520screening%2520using%2520a%2520human%2520primary%2520cell%2520model%2520of%2520HIV%2520latency%2520identifies%2520compounds%2520that%2520reverse%2520latency%2520without%2520cellular%2520activation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3473%26epage%3D3486%26doi%3D10.1172%2FJCI39199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Mejia, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveridge, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drašković, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleziunas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagratis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, P.</span><span> </span><span class="NLM_article-title">Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1021/np400889x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400889x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=618-624&author=E.+J.+Mejiaauthor=S.+T.+Loveridgeauthor=G.+Stepanauthor=A.+Tsaiauthor=G.+S.+Jonesauthor=T.+Barnesauthor=K.+N.+Whiteauthor=M.+Dra%C5%A1kovi%C4%87author=K.+Tenneyauthor=M.+Tsiangauthor=R.+Geleziunasauthor=T.+Cihlarauthor=N.+Pagratisauthor=Y.+Tianauthor=H.+Yuauthor=P.+Crews&title=Study+of+marine+natural+products+including+resorcyclic+acid+lactones+from+Humicola+fuscoatra+that+reactivate+latent+HIV-1+expression+in+an+in+vitro+model+of+central+memory+CD4%2B+T+cells&doi=10.1021%2Fnp400889x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1021%2Fnp400889x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400889x%26sid%3Dliteratum%253Aachs%26aulast%3DMejia%26aufirst%3DE.%2BJ.%26aulast%3DLoveridge%26aufirst%3DS.%2BT.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DG.%2BS.%26aulast%3DBarnes%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DK.%2BN.%26aulast%3DDra%25C5%25A1kovi%25C4%2587%26aufirst%3DM.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DTsiang%26aufirst%3DM.%26aulast%3DGeleziunas%26aufirst%3DR.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DPagratis%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DStudy%2520of%2520marine%2520natural%2520products%2520including%2520resorcyclic%2520acid%2520lactones%2520from%2520Humicola%2520fuscoatra%2520that%2520reactivate%2520latent%2520HIV-1%2520expression%2520in%2520an%2520in%2520vitro%2520model%2520of%2520central%2520memory%2520CD4%252B%2520T%2520cells%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D618%26epage%3D624%26doi%3D10.1021%2Fnp400889x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">How might we cure HIV?</span> <span class="citation_source-journal">Curr. Infect. Dis. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="refDoi"> DOI: 10.1007/s11908-014-0392-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2Fs11908-014-0392-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24562540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2cvnsVyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=392&author=D.+M.+Margolis&title=How+might+we+cure+HIV%3F&doi=10.1007%2Fs11908-014-0392-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">How Might We Cure HIV?</span></div><div class="casAuthors">Margolis David M</div><div class="citationInfo"><span class="NLM_cas:title">Current infectious disease reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">392</span>
        ISSN:<span class="NLM_cas:issn">1523-3847</span>.
    </div><div class="casAbstract">Antiretroviral therapy (ART) does not eliminate HIV-1 from latently infected reservoirs, and this remains the critical obstacle to the eradication of infection.  Although ART is effective in suppressing viral load, life-long ART is burdensome in many respects.  Given expanding numbers of HIV-infected individuals on ART worldwide, there is an urgent need to examine the possibility that innovative therapies might eradicate infection, and obviate the need for life-long medical therapy for HIV-positive people around the world.  Several approaches to eradicating the latent HIV reservoir and curing infection have been proposed and are under study.  An initial strategy seeks to induce the expression of the latent integrated proviral genomes within resting CD4+ T cells, so that viral proteins or particles may be revealed and allow these cellular reservoirs to be cleared.  The inducing agents that have been studied recently are inhibitors of histone deacetylase (HDAC) such as suberoylanilide hydroxamic acid (SAHA).  Such induction of viral expression seems unlikely in itself to efficiently clear all latently infected cells.  Therefore, it seems likely that parallel efforts to augment the HIV-specific immune response with specific immunotherapies or vaccination may be required.  Recently, efforts to achieve immune augmentation by ex vivo expansion of viral specific cytotoxic T-cell lymphocytes derived from HIV-infected patients have yielded an augmented HIV-specific immune response in vivo, as have cellular vaccinations delivered by administration of dendritic cells.  As HIV latency and the persistence of infection despite effective ART is multifactorial, the eradication of HIV infection may require multiple approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSghqLOnB_XCWhHGZei4OW9fW6udTcc2eZWJ-BumoiGErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvnsVyrtA%253D%253D&md5=9ec97403783ca27e523ca1d5e619ce03</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1007%2Fs11908-014-0392-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11908-014-0392-2%26sid%3Dliteratum%253Aachs%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DHow%2520might%2520we%2520cure%2520HIV%253F%26jtitle%3DCurr.%2520Infect.%2520Dis.%2520Rep.%26date%3D2014%26volume%3D16%26spage%3D392%26doi%3D10.1007%2Fs11908-014-0392-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Emerging strategies to deplete the HIV reservoir</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1097/QCO.0000000000000026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQCO.0000000000000026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24296585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVSqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=29-35&author=N.+M.+Archinauthor=D.+M.+Margolis&title=Emerging+strategies+to+deplete+the+HIV+reservoir&doi=10.1097%2FQCO.0000000000000026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging strategies to deplete the HIV reservoir</span></div><div class="casAuthors">Archin, Nancie M.; Margolis, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review highlights recent studies undertaken to further advance the search for successful approaches to eradicate HIV infection.  Recent findings: Small pharmacol. compds. such as histone deacetylase inhibitors, inhibitors of bromodomain and extraterminal proteins such as JQ1, and protein kinase C activators such as bryostatin and prostratin are proposed as putative candidates for inducing the expression of latent HIV in a so-called 'shock and kill' or 'kick and kill' strategy for HIV eradication.  However, in order to achieve viral clearance, it is thought likely these compds. will have to be administered in concert with strategies that augment clearance of virus-infected cells in patients that have long been aviremic on successful antiretroviral therapy (ART).  Several candidate therapies for this purpose are at hand, such as therapeutic HIV vaccines - recently shown to promote robust cytotoxic T cell responses and blunt viral rebound after ART interruption in clin. studies.  HIV-infected patients treated during early infection may be ideal candidates for early studies to test these strategies, as early ART has been shown to limit the establishment of an HIV reservoir.  Summary: HIV latency is multifactorial and thus the eradication of HIV infection may require multiple approaches.  Translational efforts employing pharmacol. methods to target HIV latency should evaluate in parallel the addnl. potential benefits of invigorating the immune response of HIV-infected individuals, and limiting the size of the reservoir via early ART.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPVsJCCIsa6bVg90H21EOLACvtfcHk0lgBeCkuy-6kOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVSqtLnN&md5=647c1054ff34a7d2fd22ac4887c8a2bb</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1097%2FQCO.0000000000000026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0000000000000026%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DEmerging%2520strategies%2520to%2520deplete%2520the%2520HIV%2520reservoir%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D27%26spage%3D29%26epage%3D35%26doi%3D10.1097%2FQCO.0000000000000026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melcher, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildreth, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandekar, S.</span><span> </span><span class="NLM_article-title">Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1005066</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1005066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.ppat.1005066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26225771" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1005066&author=G.+Jiangauthor=E.+A.+Mendesauthor=P.+Kaiserauthor=D.+P.+Wongauthor=Y.+Tangauthor=I.+Caiauthor=A.+Fentonauthor=G.+P.+Melcherauthor=J.+E.+Hildrethauthor=G.+R.+Thompsonauthor=J.+K.+Wongauthor=S.+Dandekar&title=Synergistic+Reactivation+of+Latent+HIV+Expression+by+Ingenol-3-Angelate%2C+PEP005%2C+Targeted+NF-kB+Signaling+in+Combination+with+JQ1+Induced+p-TEFb+Activation&doi=10.1371%2Fjournal.ppat.1005066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1005066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1005066%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMendes%26aufirst%3DE.%2BA.%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DD.%2BP.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DI.%26aulast%3DFenton%26aufirst%3DA.%26aulast%3DMelcher%26aufirst%3DG.%2BP.%26aulast%3DHildreth%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DJ.%2BK.%26aulast%3DDandekar%26aufirst%3DS.%26atitle%3DSynergistic%2520Reactivation%2520of%2520Latent%2520HIV%2520Expression%2520by%2520Ingenol-3-Angelate%252C%2520PEP005%252C%2520Targeted%2520NF-kB%2520Signaling%2520in%2520Combination%2520with%2520JQ1%2520Induced%2520p-TEFb%2520Activation%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26spage%3De1005066%26doi%3D10.1371%2Fjournal.ppat.1005066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Bosque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planelles, V.</span><span> </span><span class="NLM_article-title">Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2010.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ymeth.2010.10.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2011&pages=54-61&author=A.+Bosqueauthor=V.+Planelles&title=Studies+of+HIV-1+latency+in+an+ex+vivo+model+that+uses+primary+central+memory+T+cells&doi=10.1016%2Fj.ymeth.2010.10.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2010.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2010.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DBosque%26aufirst%3DA.%26aulast%3DPlanelles%26aufirst%3DV.%26atitle%3DStudies%2520of%2520HIV-1%2520latency%2520in%2520an%2520ex%2520vivo%2520model%2520that%2520uses%2520primary%2520central%2520memory%2520T%2520cells%26jtitle%3DMethods%26date%3D2011%26volume%3D53%26spage%3D54%26epage%3D61%26doi%3D10.1016%2Fj.ymeth.2010.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Micheva-Viteva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelstein, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graci, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelan, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ron, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, J. P.</span><span> </span><span class="NLM_article-title">High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">21083</span><span class="NLM_x">–</span> <span class="NLM_lpage">21091</span><span class="refDoi"> DOI: 10.1074/jbc.M110.195537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M110.195537" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=21083-21091&author=S.+Micheva-Vitevaauthor=Y.+Kobayashiauthor=L.+C.+Edelsteinauthor=A.+L.+Pacchiaauthor=H.+L.+Leeauthor=J.+D.+Graciauthor=J.+Breslinauthor=B.+D.+Phelanauthor=L.+K.+Millerauthor=J.+M.+Colacinoauthor=Z.+Guauthor=Y.+Ronauthor=S.+W.+Peltzauthor=J.+P.+Dougherty&title=High-throughput+screening+uncovers+a+compound+that+activates+latent+HIV-1+and+acts+cooperatively+with+a+histone+deacetylase+%28HDAC%29+inhibitor&doi=10.1074%2Fjbc.M110.195537"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.195537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.195537%26sid%3Dliteratum%253Aachs%26aulast%3DMicheva-Viteva%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DEdelstein%26aufirst%3DL.%2BC.%26aulast%3DPacchia%26aufirst%3DA.%2BL.%26aulast%3DLee%26aufirst%3DH.%2BL.%26aulast%3DGraci%26aufirst%3DJ.%2BD.%26aulast%3DBreslin%26aufirst%3DJ.%26aulast%3DPhelan%26aufirst%3DB.%2BD.%26aulast%3DMiller%26aufirst%3DL.%2BK.%26aulast%3DColacino%26aufirst%3DJ.%2BM.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DRon%26aufirst%3DY.%26aulast%3DPeltz%26aufirst%3DS.%2BW.%26aulast%3DDougherty%26aufirst%3DJ.%2BP.%26atitle%3DHigh-throughput%2520screening%2520uncovers%2520a%2520compound%2520that%2520activates%2520latent%2520HIV-1%2520and%2520acts%2520cooperatively%2520with%2520a%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D21083%26epage%3D21091%26doi%3D10.1074%2Fjbc.M110.195537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Klase, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yedavalli, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houzet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldarelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenchley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeang, K. T.</span><span> </span><span class="NLM_article-title">Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003997</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1003997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.ppat.1003997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1003997&author=Z.+Klaseauthor=V.+S.+Yedavalliauthor=L.+Houzetauthor=M.+Perkinsauthor=F.+Maldarelliauthor=J.+Brenchleyauthor=K.+Strebelauthor=P.+Liuauthor=K.+T.+Jeang&title=Activation+of+HIV-1+from+latent+infection+via+synergy+of+RUNX1+inhibitor+Ro5-3335+and+SAHA&doi=10.1371%2Fjournal.ppat.1003997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003997%26sid%3Dliteratum%253Aachs%26aulast%3DKlase%26aufirst%3DZ.%26aulast%3DYedavalli%26aufirst%3DV.%2BS.%26aulast%3DHouzet%26aufirst%3DL.%26aulast%3DPerkins%26aufirst%3DM.%26aulast%3DMaldarelli%26aufirst%3DF.%26aulast%3DBrenchley%26aufirst%3DJ.%26aulast%3DStrebel%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DJeang%26aufirst%3DK.%2BT.%26atitle%3DActivation%2520of%2520HIV-1%2520from%2520latent%2520infection%2520via%2520synergy%2520of%2520RUNX1%2520inhibitor%2520Ro5-3335%2520and%2520SAHA%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26spage%3De1003997%26doi%3D10.1371%2Fjournal.ppat.1003997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Margolis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span> </span><span class="NLM_article-title">Combined approaches for HIV cure</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1097/COH.0b013e32835ef089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FCOH.0b013e32835ef089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23446138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVWjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=230-235&author=D.+M.+Margolisauthor=D.+J.+Hazuda&title=Combined+approaches+for+HIV+cure&doi=10.1097%2FCOH.0b013e32835ef089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Combined approaches for HIV cure</span></div><div class="casAuthors">Margolis, David M.; Hazuda, Daria J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-235</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: A serious effort has begun to develop therapies that may be capable of eradicating established HIV infection in man.  Because of the biol. complexity of HIV infection that persists despite potent antiretroviral therapy, it is widely believed that if such therapies can be developed they will involve complex, multimodality approaches.  We highlight some of the recent studies in this effort.  Recent findings: An inhibitor of histone deacetylase has been demonstrated to disrupt latency in man, and new histone deacetylase inhibitors have been identified.  Other potential targets, such as histone methyltransferase, protein kinase C, and BRD4, have been recently studied.  Model systems, both in primary cells and in animal models, are beginning to be validated.  In the clinic, immune-based therapies to aid in the clearance of persistent infection are also being tested.  Summary: It is too early to know what combination eradication therapies for HIV infection will look like in the future, but candidate therapies and model systems to perform preclin. validation are beginning to take shape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnU3s8xSwIUrVg90H21EOLACvtfcHk0ljp8W-0XpsmXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVWjsb0%253D&md5=7845f7b4146c59f6b497f504bec91f21</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e32835ef089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e32835ef089%26sid%3Dliteratum%253Aachs%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DCombined%2520approaches%2520for%2520HIV%2520cure%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2013%26volume%3D8%26spage%3D230%26epage%3D235%26doi%3D10.1097%2FCOH.0b013e32835ef089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Quiñones-Mateu, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span> </span><span class="NLM_article-title">HIV microbicides: Where are we now?</span> <span class="citation_source-journal">Curr. HIV Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">2</span><span class="refDoi"> DOI: 10.2174/157016212799304724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F157016212799304724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22264039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1-2&author=M.+E.+Qui%C3%B1ones-Mateuauthor=G.+Vanham&title=HIV+microbicides%3A+Where+are+we+now%3F&doi=10.2174%2F157016212799304724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">HIV microbicides: where are we now?</span></div><div class="casAuthors">Quinones-Mateu, Miguel E.; Vanham, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-2</span>CODEN:
                <span class="NLM_cas:coden">CHRUBF</span>;
        ISSN:<span class="NLM_cas:issn">1570-162X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Most human immunodeficiency virus (HIV) infections are acquired during sexual contact, across the genital or rectal mucosal epithelium.  At present, HIV preventive strategies such as behavioral and structural interventions (e.g., counseling and condom use) or pre-exposure prophylaxis (e.g., topical microbicides or the oral administration of antiretroviral drugs) seem to be the only effective and most indicated methods against the establishment of systemic HIV infection.  The recent success of the CAPRISA 004 phase II clin. trial, using a tenofovir-based gel, as well as the iPreX trial, using oral TRUVADA, not only provided the proof-of-concept for reverse transcription inhibitor (RTI)-based vaginal microbicides but also demonstrated the real possibility of using topical or oral pre-exposure prophylaxis (PrEP) to prevent sexual HIV transmission.  Unfortunately, more recent failures in the FEMPreP and VOICE trial, using similar regimes, suggest that there is still room for improvement.  Therefore, ongoing and future studies will be key in the development of novel potent and safe strategies to block HIV transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HQT5SVVZtLVg90H21EOLACvtfcHk0ljp8W-0XpsmXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOgsL4%253D&md5=4c3ac1575cc28d7cd7df9aff57ace295</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.2174%2F157016212799304724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016212799304724%26sid%3Dliteratum%253Aachs%26aulast%3DQui%25C3%25B1ones-Mateu%26aufirst%3DM.%2BE.%26aulast%3DVanham%26aufirst%3DG.%26atitle%3DHIV%2520microbicides%253A%2520Where%2520are%2520we%2520now%253F%26jtitle%3DCurr.%2520HIV%2520Res.%26date%3D2012%26volume%3D10%26spage%3D1%26epage%3D2%26doi%3D10.2174%2F157016212799304724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Hankins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybul, M. R.</span><span> </span><span class="NLM_article-title">The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1097/COH.0b013e32835b809d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FCOH.0b013e32835b809d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23201856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFeqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=50-58&author=C.+A.+Hankinsauthor=M.+R.+Dybul&title=The+promise+of+pre-exposure+prophylaxis+with+antiretroviral+drugs+to+prevent+HIV+transmission%3A+a+review&doi=10.1097%2FCOH.0b013e32835b809d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review</span></div><div class="casAuthors">Hankins, Catherine A.; Dybul, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-58</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Public health experts are wrestling with how to translate recent scientific findings from pre-exposure prophylaxis (PrEP) effectiveness trials into real-world programs.  This review summarizes clin. trial findings on oral and topical PrEP, discusses how decision-makers can evaluate the place of PrEP within combination prevention and highlights anticipated developments that could be important in future HIV-prevention strategies.  Recent findings: PrEP taken daily as oral tablets to create systemic protection has been found to be effective in the Pre-Exposure Prophylaxis Initiative (iPrEx), Partners' PrEP and TDF2 trials, but not in Fem-PrEP or the Vaginal and Oral Interventions to Control the Epidemic (VOICE) tenofovir arm.  Tenofovir gel for topical protection was effective in CAPRISA 004 when used peri-coitally but not in VOICE with daily use.  These findings underscore the importance of adherence to achieve adequate drug levels and the potential additive role of PrEP within combination prevention.  Pivotal phase III trials are underway of the dapivirine ring, whereas phase I trials of injectable formulations show promise.  Summary: Antiretroviral-based HIV-prevention programs should be tailored to those most likely to be adherent, providing them with state-of-the-art counselling and support to achieve high adherence during the time period of use.  Long-acting products, if found well tolerated and effective, could be ideal for overcoming adherence challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2I3E3ouektLVg90H21EOLACvtfcHk0ljp8W-0XpsmXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFeqsrs%253D&md5=58503eef52bff99c205a454935e5817a</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e32835b809d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e32835b809d%26sid%3Dliteratum%253Aachs%26aulast%3DHankins%26aufirst%3DC.%2BA.%26aulast%3DDybul%26aufirst%3DM.%2BR.%26atitle%3DThe%2520promise%2520of%2520pre-exposure%2520prophylaxis%2520with%2520antiretroviral%2520drugs%2520to%2520prevent%2520HIV%2520transmission%253A%2520a%2520review%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2013%26volume%3D8%26spage%3D50%26epage%3D58%26doi%3D10.1097%2FCOH.0b013e32835b809d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">McGowan, I.</span><span> </span><span class="NLM_article-title">An overview of antiretroviral pre-exposure prophylaxis of HIV infection</span> <span class="citation_source-journal">Am. J. Reprod. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1111/aji.12225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Faji.12225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24635047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ygurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=624-630&author=I.+McGowan&title=An+overview+of+antiretroviral+pre-exposure+prophylaxis+of+HIV+infection&doi=10.1111%2Faji.12225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Antiretroviral Pre-Exposure Prophylaxis of HIV Infection</span></div><div class="casAuthors">McGowan, Ian</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Reproductive Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">624-630</span>CODEN:
                <span class="NLM_cas:coden">AJRIE8</span>;
        ISSN:<span class="NLM_cas:issn">1046-7408</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Despite improvements in access to antiretroviral therapy and the use of simplified dosing regimens, HIV infection is still an important global public health problem.  As a consequence, significant research efforts have been focused on the development of strategies to prevent the acquisition of HIV infection.  These efforts have begun to produce results.  The HPTN-052 study demonstrated the effectiveness of treating infected individuals as a means to prevent onward transmission of HIV infection.  In addn., Phase 2B/3 studies have shown that the use of oral and topical antiretroviral pre-exposure prophylaxis (PrEP) can significantly reduce the acquisition of HIV infection in serodiscordant couples, young women in sub-Saharan Africa, men who have sex with men, and i.v. drug users.  Despite these successes, challenges remain.  Adherence to daily PrEP is variable, and some large studies have failed to demonstrate the effectiveness of PrEP in reducing HIV acquisition.  Novel PrEP technologies, including sustained delivery intravaginal rings and long-acting injectable products, are being developed to try and circumvent adherence problems assocd. with daily PrEP regimens.  The purpose of this article is to briefly summarize recent progress in the development of antiretroviral PrEP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnaO6pOD5dm7Vg90H21EOLACvtfcHk0lhwkjUXz2xPeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ygurg%253D&md5=9bddeb3e0da8c7a488dcaa112680cd79</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1111%2Faji.12225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Faji.12225%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DI.%26atitle%3DAn%2520overview%2520of%2520antiretroviral%2520pre-exposure%2520prophylaxis%2520of%2520HIV%2520infection%26jtitle%3DAm.%2520J.%2520Reprod.%2520Immunol.%26date%3D2014%26volume%3D71%26spage%3D624%26epage%3D630%26doi%3D10.1111%2Faji.12225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">D’Cruz, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uckun, F. M.</span><span> </span><span class="NLM_article-title">Dawn of non-nucleoside inhibitor-based anti-HIV microbicides</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1093/jac/dki464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1093%2Fjac%2Fdki464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=16431862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2006&pages=411-423&author=O.+J.+D%E2%80%99Cruzauthor=F.+M.+Uckun&title=Dawn+of+non-nucleoside+inhibitor-based+anti-HIV+microbicides&doi=10.1093%2Fjac%2Fdki464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Dawn of non-nucleoside inhibitor-based anti-HIV microbicides</span></div><div class="casAuthors">D'Cruz, Osmond J.; Uckun, Fatih M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-423</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The emergence of HIV/AIDS as a disease spread through sexual intercourse has prompted the search for safe and effective vaginal and rectal microbicides for curbing mucosal viral transmission via semen.  Since endogenous reverse transcription is implicated in augmenting the sexual transmission of HIV-1 infection, potential microbicides should have the inherent ability to optimally inhibit both wild-type and drug-escape mutants.  The non-nucleoside reverse transcriptase inhibitors (NNRTIs), which bind to an allosteric site on RT, are an important arsenal of drugs against HIV-1.  The clin. success of NNRTI-based HIV/AIDS therapies has led to extensive structural and mol. modeling studies of enzyme complexes and chem. synthesis of second- and third-generation NNRTIs.  Rationally designed NNRTIs deduced from changes in binding pocket size, shape and residue character that result from clin. obsd. NNRTI resistance-assocd. mutations exhibit high binding affinity for HIV-1 RT and robust anti-HIV activity against the wild-type and drug-escape mutants without cytotoxicity.  Notably, membrane permeable tight binding NNRTIs have the ability to inactivate cell-free as well as cell-assocd. HIV-1 in semen without metabolic activation.  Consequently, NNRTIs currently under development as exptl. microbicides include thiourea-PETT (where PETT stands for phenethylthiazolylthiourea) derivs. (PHI-236, PHI-346 and PHI-443), urea-PETT derivs. (MIV-150), oxypyrimidines (S-DABOs), thiocarboxanilides (UC-781) and diarylpyrimidines (TMC-120).  Mucoadhesive formulations of these NNRTIs have been studied for safety and efficacy in animal models and some have entered Phase I safety testing in humans.  This review focuses on the structural, biol. and preclin. studies relevant to the clin. development of these NNRTIs as mol. virucides intended to prevent the sexual transmission of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7HUDMWcKWGbVg90H21EOLACvtfcHk0lhwkjUXz2xPeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOgt7s%253D&md5=1eb06f452c0d48fc455324ff856a9668</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdki464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdki464%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Cruz%26aufirst%3DO.%2BJ.%26aulast%3DUckun%26aufirst%3DF.%2BM.%26atitle%3DDawn%2520of%2520non-nucleoside%2520inhibitor-based%2520anti-HIV%2520microbicides%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2006%26volume%3D57%26spage%3D411%26epage%3D423%26doi%3D10.1093%2Fjac%2Fdki464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Ariën, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michiels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vereecken, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdellati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuylaerts, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crucitti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyndrickx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span> </span><span class="NLM_article-title">Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2038</span><span class="NLM_x">–</span> <span class="NLM_lpage">2047</span><span class="refDoi"> DOI: 10.1093/jac/dkt166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1093%2Fjac%2Fdkt166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23645585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht12hurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=2038-2047&author=K.+K.+Ari%C3%ABnauthor=M.+Venkatrajauthor=J.+Michielsauthor=J.+Joossensauthor=K.+Vereeckenauthor=P.+Van+der+Vekenauthor=S.+Abdellatiauthor=V.+Cuylaertsauthor=T.+Crucittiauthor=L.+Heyndrickxauthor=J.+Heeresauthor=K.+Augustynsauthor=P.+J.+Lewiauthor=G.+Vanham&title=Diaryltriazine+non-nucleoside+reverse+transcriptase+inhibitors+are+potent+candidates+for+pre-exposure+prophylaxis+in+the+prevention+of+sexual+HIV+transmission&doi=10.1093%2Fjac%2Fdkt166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission</span></div><div class="casAuthors">Arien, Kevin K.; Venkatraj, Muthusamy; Michiels, Johan; Joossens, Jurgen; Vereecken, Katleen; Van der Veken, Pieter; Abdellati, Said; Cuylaerts, Vicky; Crucitti, Tania; Heyndrickx, Leo; Heeres, Jan; Augustyns, Koen; Lewi, Paul J.; Vanham, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2038-2047</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Pre-exposure prophylaxis and topical microbicides are important strategies in the prevention of sexual HIV transmission, esp. since partial protection has been shown in proof-of-concept studies.  In search of new candidate drugs with an improved toxicity profile and with activity against common non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV, we have synthesized and investigated a library of 60 new diaryltriazine analogs.  From this library, 15 compds. were evaluated in depth using a broad armamentarium of in vitro assays that are part of a preclin. testing algorithm for microbicide development.  Antiviral activity was assessed in a cell line, and in primary human cells, against both subtype B and subtype C HIV-1 and against viruses resistant to therapeutic NNRTIs and the candidate NNRTI microbicide dapivirine.  Toxicity towards primary blood-derived cells, cell lines originating from the female reproductive tract and female genital microflora was also studied.  We identified several compds. with highly potent antiviral activity and toxicity profiles that are superior to that of dapivirine.  In particular, compd. UAMC01398 is an interesting new candidate that warrants further investigation because of its superior toxicity profile and potent activity against dapivirine-resistant viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhk_H7iaNz7Vg90H21EOLACvtfcHk0lhwkjUXz2xPeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht12hurzM&md5=785b846f457147abc903ef458a0d48b3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt166%26sid%3Dliteratum%253Aachs%26aulast%3DAri%25C3%25ABn%26aufirst%3DK.%2BK.%26aulast%3DVenkatraj%26aufirst%3DM.%26aulast%3DMichiels%26aufirst%3DJ.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DVereecken%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DAbdellati%26aufirst%3DS.%26aulast%3DCuylaerts%26aufirst%3DV.%26aulast%3DCrucitti%26aufirst%3DT.%26aulast%3DHeyndrickx%26aufirst%3DL.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DVanham%26aufirst%3DG.%26atitle%3DDiaryltriazine%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520are%2520potent%2520candidates%2520for%2520pre-exposure%2520prophylaxis%2520in%2520the%2520prevention%2520of%2520sexual%2520HIV%2520transmission%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D2038%26epage%3D2047%26doi%3D10.1093%2Fjac%2Fdkt166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Grammen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariën, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haenen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwers, J.</span><span> </span><span class="NLM_article-title">Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.11.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2014&pages=113-121&author=C.+Grammenauthor=K.+K.+Ari%C3%ABnauthor=M.+Venkatrajauthor=J.+Joossensauthor=P.+Van+der+Vekenauthor=J.+Heeresauthor=P.+J.+Lewiauthor=S.+Haenenauthor=K.+Augustynsauthor=G.+Vanhamauthor=P.+Augustijnsauthor=J.+Brouwers&title=Development+and+in+vitro+evaluation+of+a+vaginal+microbicide+gel+formulation+for+UAMC01398%2C+a+novel+diaryltriazine+NNRTI+against+HIV-1&doi=10.1016%2Fj.antiviral.2013.11.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DGrammen%26aufirst%3DC.%26aulast%3DAri%25C3%25ABn%26aufirst%3DK.%2BK.%26aulast%3DVenkatraj%26aufirst%3DM.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DHaenen%26aufirst%3DS.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVanham%26aufirst%3DG.%26aulast%3DAugustijns%26aufirst%3DP.%26aulast%3DBrouwers%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520in%2520vitro%2520evaluation%2520of%2520a%2520vaginal%2520microbicide%2520gel%2520formulation%2520for%2520UAMC01398%252C%2520a%2520novel%2520diaryltriazine%2520NNRTI%2520against%2520HIV-1%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D101%26spage%3D113%26epage%3D121%26doi%3D10.1016%2Fj.antiviral.2013.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Fetherston, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veazey, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klasse, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, R. K.</span><span> </span><span class="NLM_article-title">Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span><span class="refDoi"> DOI: 10.1093/jac/dks415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1093%2Fjac%2Fdks415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23109186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVektQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=394-403&author=S.+M.+Fetherstonauthor=L.+Geerauthor=R.+S.+Veazeyauthor=L.+Goldmanauthor=D.+J.+Murphyauthor=T.+J.+Ketasauthor=P.+J.+Klasseauthor=S.+Bloisauthor=P.+La+Collaauthor=J.+P.+Mooreauthor=R.+K.+Malcolm&title=Partial+protection+against+multiple+RT-SHIV162P3+vaginal+challenge+of+rhesus+macaques+by+a+silicone+elastomer+vaginal+ring+releasing+the+NNRTI+MC1220&doi=10.1093%2Fjac%2Fdks415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220</span></div><div class="casAuthors">Fetherston, Susan M.; Geer, Leslie; Veazey, Ronald S.; Goldman, Laurie; Murphy, Diarmaid J.; Ketas, Thomas J.; Klasse, Per Johan; Blois, Sylvain; La Colla, Paolo; Moore, John P.; Malcolm, R. Karl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">394-403</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives The non-nucleoside reverse transcriptase inhibitor MC1220 has potent in vitro activity against HIV type 1 (HIV-1).  A liposome gel formulation of MC1220 has previously been reported to partially protect rhesus macaques against vaginal challenge with a simian HIV (SHIV).  Here, we describe the pre-clin. development of an MC1220-releasing silicone elastomer vaginal ring (SEVR), including pharmacokinetic (PK) and efficacy studies in macaques.  Methods In vitro release studies were conducted on SEVRs loaded with 400 mg of MC1220, using simulated vaginal fluid (SVF, n = 4) and 1 : 1 isopropanol/water (IPA/H2O, n = 4) as release media.  For PK evaluation, SEVRs were inserted into adult female macaques (n = 6) for 30 days.  Following a 1 wk washout period, fresh rings were placed in the same animals, which were then challenged vaginally with RT-SHIV162P3 once weekly for 4 wk.  Results SEVRs released 1.66 and 101 mg of MC1220 into SVF and IPA/H2O, resp., over 30 days, the differential reflecting the low aq. soly. of the drug.  In macaque PK studies, MC1220 was consistently detected in vaginal fluid (peak 845 ng/mL) and plasma (peak 0.91 ng/mL).  Kaplan-Meier anal. over 9 wk showed significantly lower infection rates for animals given MC1220-contg. SEVRs than placebo rings (hazard ratio 0.20, P = 0.0037).  Conclusions An MC1220-releasing SEVR partially protected macaques from vaginal challenge.  Such ring devices are a practical method for providing sustained, coitally independent protection against vaginal exposure to HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TEP1JXL5kbVg90H21EOLACvtfcHk0ljm9HmZdm3LnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVektQ%253D%253D&md5=d887a5e04de9ebc390eda74eacdbae68</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks415%26sid%3Dliteratum%253Aachs%26aulast%3DFetherston%26aufirst%3DS.%2BM.%26aulast%3DGeer%26aufirst%3DL.%26aulast%3DVeazey%26aufirst%3DR.%2BS.%26aulast%3DGoldman%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DBlois%26aufirst%3DS.%26aulast%3DLa%2BColla%26aufirst%3DP.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DMalcolm%26aufirst%3DR.%2BK.%26atitle%3DPartial%2520protection%2520against%2520multiple%2520RT-SHIV162P3%2520vaginal%2520challenge%2520of%2520rhesus%2520macaques%2520by%2520a%2520silicone%2520elastomer%2520vaginal%2520ring%2520releasing%2520the%2520NNRTI%2520MC1220%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D394%26epage%3D403%26doi%3D10.1093%2Fjac%2Fdks415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group">Loksha, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliberti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, P.</span><span> </span><span class="NLM_article-title">Synthesis of novel fluoro analogues of MKC442 as microbicides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5169</span><span class="NLM_x">–</span> <span class="NLM_lpage">5178</span><span class="refDoi"> DOI: 10.1021/jm500139a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500139a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5169-5178&author=Y.+M.+Lokshaauthor=E.+B.+Pedersenauthor=R.+Loddoauthor=G.+Sannaauthor=G.+Colluauthor=G.+Gilibertiauthor=P.+La+Colla&title=Synthesis+of+novel+fluoro+analogues+of+MKC442+as+microbicides&doi=10.1021%2Fjm500139a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjm500139a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500139a%26sid%3Dliteratum%253Aachs%26aulast%3DLoksha%26aufirst%3DY.%2BM.%26aulast%3DPedersen%26aufirst%3DE.%2BB.%26aulast%3DLoddo%26aufirst%3DR.%26aulast%3DSanna%26aufirst%3DG.%26aulast%3DCollu%26aufirst%3DG.%26aulast%3DGiliberti%26aufirst%3DG.%26aulast%3DLa%2BColla%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520novel%2520fluoro%2520analogues%2520of%2520MKC442%2520as%2520microbicides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5169%26epage%3D5178%26doi%3D10.1021%2Fjm500139a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group">Haaland, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans-Strickfaden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pau, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholl, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikummao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chonwattana, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, C. E.</span><span> </span><span class="NLM_article-title">UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal application</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3592</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span><span class="refDoi"> DOI: 10.1128/AAC.00452-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.00452-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3592-3596&author=R.+E.+Haalandauthor=T.+Evans-Strickfadenauthor=A.+Holderauthor=C.+P.+Pauauthor=J.+M.+McNichollauthor=S.+Chaikummaoauthor=W.+Chonwattanaauthor=C.+E.+Hart&title=UC781+microbicide+gel+retains+anti-HIV+activity+in+cervicovaginal+lavage+fluids+collected+following+twice-daily+vaginal+application&doi=10.1128%2FAAC.00452-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1128%2FAAC.00452-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00452-12%26sid%3Dliteratum%253Aachs%26aulast%3DHaaland%26aufirst%3DR.%2BE.%26aulast%3DEvans-Strickfaden%26aufirst%3DT.%26aulast%3DHolder%26aufirst%3DA.%26aulast%3DPau%26aufirst%3DC.%2BP.%26aulast%3DMcNicholl%26aufirst%3DJ.%2BM.%26aulast%3DChaikummao%26aufirst%3DS.%26aulast%3DChonwattana%26aufirst%3DW.%26aulast%3DHart%26aufirst%3DC.%2BE.%26atitle%3DUC781%2520microbicide%2520gel%2520retains%2520anti-HIV%2520activity%2520in%2520cervicovaginal%2520lavage%2520fluids%2520collected%2520following%2520twice-daily%2520vaginal%2520application%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3592%26epage%3D3596%26doi%3D10.1128%2FAAC.00452-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group">D’Cruz, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qazi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiv, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uckun, F. M.</span><span> </span><span class="NLM_article-title">A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea])</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span><span class="refDoi"> DOI: 10.1517/13543784.2012.655422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F13543784.2012.655422" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=265-279&author=O.+J.+D%E2%80%99Cruzauthor=S.+Qaziauthor=S.+Yivauthor=F.+M.+Uckun&title=A+novel+vaginal+microbicide+containing+the+rationally+designed+anti-HIV+compound+HI-443+%28N%E2%80%B2-%5B2-%282-thiophene%29ethyl%5D-N%E2%80%B2-%5B2-%285-bromopyridyl%29%5D+thiourea%5D%29&doi=10.1517%2F13543784.2012.655422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1517%2F13543784.2012.655422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2012.655422%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Cruz%26aufirst%3DO.%2BJ.%26aulast%3DQazi%26aufirst%3DS.%26aulast%3DYiv%26aufirst%3DS.%26aulast%3DUckun%26aufirst%3DF.%2BM.%26atitle%3DA%2520novel%2520vaginal%2520microbicide%2520containing%2520the%2520rationally%2520designed%2520anti-HIV%2520compound%2520HI-443%2520%2528N%25E2%2580%25B2-%255B2-%25282-thiophene%2529ethyl%255D-N%25E2%2580%25B2-%255B2-%25285-bromopyridyl%2529%255D%2520thiourea%255D%2529%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D265%26epage%3D279%26doi%3D10.1517%2F13543784.2012.655422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group">Barnable, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calenda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnaire, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levendosky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooney, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Romero, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zydowsky, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teleshova, N.</span><span> </span><span class="NLM_article-title">MIV-150/Zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3829</span><span class="NLM_x">–</span> <span class="NLM_lpage">3837</span><span class="refDoi"> DOI: 10.1128/AAC.00073-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.00073-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=3829-3837&author=P.+Barnableauthor=G.+Calendaauthor=T.+Bonnaireauthor=R.+Menonauthor=K.+Levendoskyauthor=A.+Gettieauthor=J.+Blanchardauthor=M.+L.+Cooneyauthor=J.+A.+Fern%C3%A1ndez-Romeroauthor=T.+M.+Zydowskyauthor=N.+Teleshova&title=MIV-150%2FZinc+acetate+gel+inhibits+cell-associated+simian-human+immunodeficiency+virus+reverse+transcriptase+infection+in+a+macaque+vaginal+explant+model&doi=10.1128%2FAAC.00073-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1128%2FAAC.00073-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00073-15%26sid%3Dliteratum%253Aachs%26aulast%3DBarnable%26aufirst%3DP.%26aulast%3DCalenda%26aufirst%3DG.%26aulast%3DBonnaire%26aufirst%3DT.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DLevendosky%26aufirst%3DK.%26aulast%3DGettie%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DCooney%26aufirst%3DM.%2BL.%26aulast%3DFern%25C3%25A1ndez-Romero%26aufirst%3DJ.%2BA.%26aulast%3DZydowsky%26aufirst%3DT.%2BM.%26aulast%3DTeleshova%26aufirst%3DN.%26atitle%3DMIV-150%252FZinc%2520acetate%2520gel%2520inhibits%2520cell-associated%2520simian-human%2520immunodeficiency%2520virus%2520reverse%2520transcriptase%2520infection%2520in%2520a%2520macaque%2520vaginal%2520explant%2520model%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D3829%26epage%3D3837%26doi%3D10.1128%2FAAC.00073-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group">Bala, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jangir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandalapu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhonker, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushwaha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandasana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maikhuri, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V. L.</span><span> </span><span class="NLM_article-title">Dithiocarbamate-thiourea hybrids useful as vaginal microbicides also show reverse transcriptase inhibition: design, synthesis, docking and pharmacokinetic studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2014.12.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=881-886&author=V.+Balaauthor=S.+Jangirauthor=D.+Mandalapuauthor=S.+Guptaauthor=Y.+S.+Chhonkerauthor=N.+Lalauthor=B.+Kushwahaauthor=H.+Chandasanaauthor=S.+Krishnaauthor=K.+Rawatauthor=J.+P.+Maikhuriauthor=R.+S.+Bhattaauthor=M.+I.+Siddiqiauthor=R.+Tripathiauthor=G.+Guptaauthor=V.+L.+Sharma&title=Dithiocarbamate-thiourea+hybrids+useful+as+vaginal+microbicides+also+show+reverse+transcriptase+inhibition%3A+design%2C+synthesis%2C+docking+and+pharmacokinetic+studies&doi=10.1016%2Fj.bmcl.2014.12.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.062%26sid%3Dliteratum%253Aachs%26aulast%3DBala%26aufirst%3DV.%26aulast%3DJangir%26aufirst%3DS.%26aulast%3DMandalapu%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DChhonker%26aufirst%3DY.%2BS.%26aulast%3DLal%26aufirst%3DN.%26aulast%3DKushwaha%26aufirst%3DB.%26aulast%3DChandasana%26aufirst%3DH.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DRawat%26aufirst%3DK.%26aulast%3DMaikhuri%26aufirst%3DJ.%2BP.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DSiddiqi%26aufirst%3DM.%2BI.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DG.%26aulast%3DSharma%26aufirst%3DV.%2BL.%26atitle%3DDithiocarbamate-thiourea%2520hybrids%2520useful%2520as%2520vaginal%2520microbicides%2520also%2520show%2520reverse%2520transcriptase%2520inhibition%253A%2520design%252C%2520synthesis%252C%2520docking%2520and%2520pharmacokinetic%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D881%26epage%3D886%26doi%3D10.1016%2Fj.bmcl.2014.12.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group">Friend, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiser, P. F.</span><span> </span><span class="NLM_article-title">Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2013&pages=391-400&author=D.+R.+Friendauthor=P.+F.+Kiser&title=Assessment+of+topical+microbicides+to+prevent+HIV-1+transmission%3A+concepts%2C+testing%2C+lessons+learned&doi=10.1016%2Fj.antiviral.2013.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DFriend%26aufirst%3DD.%2BR.%26aulast%3DKiser%26aufirst%3DP.%2BF.%26atitle%3DAssessment%2520of%2520topical%2520microbicides%2520to%2520prevent%2520HIV-1%2520transmission%253A%2520concepts%252C%2520testing%252C%2520lessons%2520learned%26jtitle%3DAntiviral%2520Res.%26date%3D2013%26volume%3D99%26spage%3D391%26epage%3D400%26doi%3D10.1016%2Fj.antiviral.2013.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group">Celum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeten, J. M.</span><span> </span><span class="NLM_article-title">Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1097/QCO.0b013e32834ef5ef</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQCO.0b013e32834ef5ef" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22156901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Gls7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=51-57&author=C.+Celumauthor=J.+M.+Baeten&title=Tenofovir-based+pre-exposure+prophylaxis+for+HIV+prevention%3A+evolving+evidence&doi=10.1097%2FQCO.0b013e32834ef5ef"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence</span></div><div class="casAuthors">Celum, Connie; Baeten, Jared M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-57</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Topical tenofovir gel and oral tenofovir and emtricitabine-tenofovir [FTC/tenofovir disoproxyl fumarate (TDF)] have been demonstrated to have efficacy in preventing HIV-1 in some populations.  Preexposure prophylaxis (PrEP) trials and future directions are summarized.  Recent findings: Pericoital use of 1% tenofovir gel in the CAPRISA 004 study reduced HIV-1 acquisition by 39% and herpes simplex virus-2 acquisition by 51%.  Daily oral FTC/TDF demonstrated 44% redn. in HIV-1 acquisition among MSM in the iPrEx study (Pre-Exposure Prophylaxis Initiative).  Both studies showed higher efficacy among those with higher adherence.  Efficacy of daily oral TDF and FTC/TDF was 66 and 73%, resp., among HIV-1-uninfected partners in an HIV-1 serodiscordant partnership in the Partners PrEP Study.  Efficacy of daily oral FTC/TDF was 66% in young heterosexuals in Botswana in the TDF2 trial.  The FEM-PrEP and VOICE (Vaginal and Oral Interventions to Control the Epidemic) studies in African women found no efficacy with oral FTC/TDF and TDF, resp.  Safety and tolerability were excellent and limited resistance was obsd. in seroconverters.  Summary: Topical tenofovir gel showed efficacy in African women and daily oral TDF and FTC/TDF were efficacious in MSM, and African HIV-1 serodiscordant couples and young heterosexuals.  The reasons for lack of efficacy of oral FTC/TDF and TDF in two studies in African women are being investigated.  Longer-acting formulations, invtravaginal rings, and new candidate antiretrovirals are being evaluated for pre-exposure prophylaxis (PrEP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHrOXxRLciw7Vg90H21EOLACvtfcHk0lhoQh1IhuE57g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Gls7bF&md5=374054675c3740d66fde6b46d5706012</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e32834ef5ef&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e32834ef5ef%26sid%3Dliteratum%253Aachs%26aulast%3DCelum%26aufirst%3DC.%26aulast%3DBaeten%26aufirst%3DJ.%2BM.%26atitle%3DTenofovir-based%2520pre-exposure%2520prophylaxis%2520for%2520HIV%2520prevention%253A%2520evolving%2520evidence%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D25%26spage%3D51%26epage%3D57%26doi%3D10.1097%2FQCO.0b013e32834ef5ef" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group">Terrazas-Aranda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Herrewege, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span> </span><span class="NLM_article-title">Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2544</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span><span class="refDoi"> DOI: 10.1128/AAC.01627-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.01627-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2544-2554&author=K.+Terrazas-Arandaauthor=Y.+Van+Herrewegeauthor=D.+Hazudaauthor=P.+Lewiauthor=R.+Costiauthor=R.+Di+Santoauthor=A.+Caraauthor=G.+Vanham&title=Human+immunodeficiency+virus+type+1+%28HIV-1%29+integration%3A+a+potential+target+for+microbicides+to+prevent+cell-free+or+cell-associated+HIV-1+infection&doi=10.1128%2FAAC.01627-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1128%2FAAC.01627-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01627-07%26sid%3Dliteratum%253Aachs%26aulast%3DTerrazas-Aranda%26aufirst%3DK.%26aulast%3DVan%2BHerrewege%26aufirst%3DY.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DLewi%26aufirst%3DP.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCara%26aufirst%3DA.%26aulast%3DVanham%26aufirst%3DG.%26atitle%3DHuman%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520integration%253A%2520a%2520potential%2520target%2520for%2520microbicides%2520to%2520prevent%2520cell-free%2520or%2520cell-associated%2520HIV-1%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2544%26epage%3D2554%26doi%3D10.1128%2FAAC.01627-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liwang, P. J.</span><span> </span><span class="NLM_article-title">Highly potent chimeric inhibitors targeting two steps of HIV cell entry</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">28370</span><span class="NLM_x">–</span> <span class="NLM_lpage">28381</span><span class="refDoi"> DOI: 10.1074/jbc.M111.234799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M111.234799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21659523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=28370-28381&author=B.+Zhaoauthor=M.+K.+Mankowskiauthor=B.+A.+Snyderauthor=R.+G.+Ptakauthor=P.+J.+Liwang&title=Highly+potent+chimeric+inhibitors+targeting+two+steps+of+HIV+cell+entry&doi=10.1074%2Fjbc.M111.234799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry</span></div><div class="casAuthors">Zhao, Bo; Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.; LiWang, Patricia J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">28370-28381, S28370/1-S28370/5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Blocking HIV-1 cell entry has long been a major goal of anti-HIV drug development.  Here, we report a successful design of two highly potent chimeric HIV entry inhibitors composed of one CCR5-targeting RANTES (regulated on activation normal T cell expressed and secreted) variant (5P12-RANTES or 5P14-RANTES (Gaertner, H., Cerini, F., Escola, J. M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D., and Hartley, O. (2008) PROC: Natl. Acad. Sci. U.S.A. 105, 17706-17711)) linked to a gp41 fusion inhibitor, C37.  Chimeric inhibitors 5P12-linker-C37 and 5P14-linker-C37 showed extremely high antiviral potency in single cycle and replication-competent viral assays against R5-tropic viruses, with IC50 values as low as 0.004 nM.  This inhibition was somewhat strain-dependent and was up to 100-fold better than the RANTES variant alone or in combination with unlinked C37.  The chimeric inhibitors also fully retained the antiviral activity of C37 against X4-tropic viruses, and this inhibition can be further enhanced significantly if the target cell co-expresses CCR5 receptor.  On human peripheral blood mononuclear cells, the inhibitors showed very strong inhibition against R5-tropic Ba-L strain and X4-tropic IIIB strain, with IC50 values as low as 0.015 and 0.44 nM, which are 45- and 16-fold better than the parent inhibitors, resp.  A clear delivery mechanism requiring a covalent linkage between the two segments of the chimera was obsd. and characterized.  Furthermore, the two chimeric inhibitors are fully recombinant and are easily produced at low cost.  These attributes make them excellent candidates for anti-HIV microbicides.  The results of this study also suggest a potent approach for optimizing existing HIV entry inhibitors or designing new inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mgPhkmOu-bVg90H21EOLACvtfcHk0lhznrT_99p6Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D&md5=b8599136ca194462a3332b9b8b91495d</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.234799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.234799%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DLiwang%26aufirst%3DP.%2BJ.%26atitle%3DHighly%2520potent%2520chimeric%2520inhibitors%2520targeting%2520two%2520steps%2520of%2520HIV%2520cell%2520entry%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D28370%26epage%3D28381%26doi%3D10.1074%2Fjbc.M111.234799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group">Janssen, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daeyaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koymans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludovici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Béthune, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medaer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Knaep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohets, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffels, P.</span><span> </span><span class="NLM_article-title">In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">–</span> <span class="NLM_lpage">1909</span><span class="refDoi"> DOI: 10.1021/jm040840e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040840e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1901-1909&author=P.+A.+Janssenauthor=P.+J.+Lewiauthor=E.+Arnoldauthor=F.+Daeyaertauthor=M.+de+Jongeauthor=J.+Heeresauthor=L.+Koymansauthor=M.+Vinkersauthor=J.+Guillemontauthor=E.+Pasquierauthor=M.+Kuklaauthor=D.+Ludoviciauthor=K.+Andriesauthor=M.+P.+de+B%C3%A9thuneauthor=R.+Pauwelsauthor=K.+Dasauthor=A.+D.+Clarkauthor=Y.+V.+Frenkelauthor=S.+H.+Hughesauthor=B.+Medaerauthor=F.+De+Knaepauthor=H.+Bohetsauthor=F.+De+Clerckauthor=A.+Lampoauthor=P.+Williamsauthor=P.+Stoffels&title=In+search+of+a+novel+anti-HIV+drug%3A+multidisciplinary+coordination+in+the+discovery+of+4-%5B%5B4-%5B%5B4-%5B%281E%29-2-cyanoethenyl%5D-2%2C6-dimethylphenyl%5Damino%5D-2-pyrimidinyl%5Damino%5Dbenzonitrile+%28R278474%2C+rilpivirine%29&doi=10.1021%2Fjm040840e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)</span></div><div class="casAuthors">Janssen, Paul A. J.; Lewi, Paul J.; Arnold, Eddy; Daeyaert, Frits; de Jonge, Marc; Heeres, Jan; Koymans, Luc; Vinkers, Maarten; Guillemont, Jerome; Pasquier, Elisabeth; Kukla, Mike; Ludovici, Don; Andries, Koen; de Bethune, Marie-Pierre; Pauwels, Rudi; Das, Kalyan; Clark, Art D., Jr.; Frenkel, Yulia Volovik; Hughes, Stephen H.; Medaer, Bart; De Knaep, Fons; Bohets, Hilde; De Clerck, Fred; Lampo, Ann; Williams, Peter; Stoffels, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1901-1909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Ideally, an anti-HIV drug should (1) be highly active against wild-type and mutant HIV without allowing breakthrough; (2) have high oral bioavailability and long elimination half-life, allowing once-daily oral treatment at low doses; (3) have minimal adverse effects; and (4) be easy to synthesize and formulate.  R278474, a new diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitor (NNRTI), appears to meet these criteria and to be suitable for high compliance oral treatment of HIV-1 infection.  The discovery of R278474 was the result of a coordinated multidisciplinary effort involving medicinal chemists, virologists, crystallographers, mol. modelers, toxicologists, anal. chemists, pharmacists, and many others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8upgC3x1GuLVg90H21EOLACvtfcHk0lhznrT_99p6Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOisb8%253D&md5=d4b650dcaa248d5cdb1dd500135c8f7e</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1021%2Fjm040840e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040840e%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DDaeyaert%26aufirst%3DF.%26aulast%3Dde%2BJonge%26aufirst%3DM.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DKoymans%26aufirst%3DL.%26aulast%3DVinkers%26aufirst%3DM.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DPasquier%26aufirst%3DE.%26aulast%3DKukla%26aufirst%3DM.%26aulast%3DLudovici%26aufirst%3DD.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3Dde%2BB%25C3%25A9thune%26aufirst%3DM.%2BP.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DFrenkel%26aufirst%3DY.%2BV.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DMedaer%26aufirst%3DB.%26aulast%3DDe%2BKnaep%26aufirst%3DF.%26aulast%3DBohets%26aufirst%3DH.%26aulast%3DDe%2BClerck%26aufirst%3DF.%26aulast%3DLampo%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DP.%26aulast%3DStoffels%26aufirst%3DP.%26atitle%3DIn%2520search%2520of%2520a%2520novel%2520anti-HIV%2520drug%253A%2520multidisciplinary%2520coordination%2520in%2520the%2520discovery%2520of%25204-%255B%255B4-%255B%255B4-%255B%25281E%2529-2-cyanoethenyl%255D-2%252C6-dimethylphenyl%255Damino%255D-2-pyrimidinyl%255Damino%255Dbenzonitrile%2520%2528R278474%252C%2520rilpivirine%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1901%26epage%3D1909%26doi%3D10.1021%2Fjm040840e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group">Fang, Y.</span><span> </span><span class="NLM_article-title">Ligand-receptor interaction platforms and their applications for drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1517/17460441.2012.715631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2012.715631" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=969-988&author=Y.+Fang&title=Ligand-receptor+interaction+platforms+and+their+applications+for+drug+discovery&doi=10.1517%2F17460441.2012.715631"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.715631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.715631%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26atitle%3DLigand-receptor%2520interaction%2520platforms%2520and%2520their%2520applications%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D969%26epage%3D988%26doi%3D10.1517%2F17460441.2012.715631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paavilainen, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughhead, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karr, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritsen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1038/nchembio.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchembio.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26006010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=525-531&author=J.+M.+Bradshawauthor=J.+M.+McFarlandauthor=V.+O.+Paavilainenauthor=A.+Bisconteauthor=D.+Tamauthor=V.+T.+Phanauthor=S.+Romanovauthor=D.+Finkleauthor=J.+Shuauthor=V.+Patelauthor=T.+Tonauthor=X.+Liauthor=D.+G.+Loughheadauthor=P.+A.+Nunnauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=J.+O.+Funkauthor=T.+D.+Owensauthor=E.+Vernerauthor=K.+A.+Brameldauthor=R.+J.+Hillauthor=D.+M.+Goldsteinauthor=J.+Taunton&title=Prolonged+and+tunable+residence+time+using+reversible+covalent+kinase+inhibitors&doi=10.1038%2Fnchembio.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span></div><div class="casAuthors">Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Romanov, Sergei; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs with prolonged on-target residence times often show superior efficacy, yet general strategies for optimizing drug-target residence time are lacking.  Here the authors made progress toward this elusive goal by targeting a noncatalytic cysteine in Bruton's tyrosine kinase (BTK) with reversible covalent inhibitors.  Using an inverted orientation of the cysteine-reactive cyanoacrylamide electrophile, the authors identified potent and selective BTK inhibitors that demonstrated biochem. residence times spanning from minutes to 7 d.  An inverted cyanoacrylamide with prolonged residence time in vivo remained bound to BTK for more than 18 h after clearance from the circulation.  The inverted cyanoacrylamide strategy was further used to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with residence times of several days, demonstrating the generalizability of the approach.  Targeting of noncatalytic cysteines with inverted cyanoacrylamides may serve as a broadly applicable platform that facilitates 'residence time by design', the ability to modulate and improve the duration of target engagement in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCpNprhn6kLVg90H21EOLACvtfcHk0ljXj7wdYIL57A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE&md5=85a73d9ecd62695d03166f7009c68dd8</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1817%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DPaavilainen%26aufirst%3DV.%2BO.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DRomanov%26aufirst%3DS.%26aulast%3DFinkle%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DNunn%26aufirst%3DP.%2BA.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DProlonged%2520and%2520tunable%2520residence%2520time%2520using%2520reversible%2520covalent%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D525%26epage%3D531%26doi%3D10.1038%2Fnchembio.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clas, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nofsinger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lera Ruiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceglia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templeton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1002/cmdc.201402393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.201402393" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=245-252&author=A.+M.+Waljiauthor=R.+I.+Sanchezauthor=S.+D.+Clasauthor=R.+Nofsingerauthor=M.+de+Lera+Ruizauthor=J.+Liauthor=A.+Bennetauthor=C.+Johnauthor=D.+J.+Bennettauthor=J.+M.+Sandersauthor=C.+N.+Di+Marcoauthor=S.+H.+Kimauthor=J.+Balsellsauthor=S.+S.+Cegliaauthor=Q.+Dangauthor=K.+Manserauthor=B.+Nissleyauthor=J.+S.+Waiauthor=M.+Hafeyauthor=J.+Wangauthor=G.+Chessenauthor=A.+Templetonauthor=J.+Higginsauthor=R.+Smithauthor=Y.+Wuauthor=J.+Groblerauthor=P.+J.+Coleman&title=Discovery+of+MK-8970%3A+an+acetal+carbonate+prodrug+of+raltegravir+with+enhanced+colonic+absorption&doi=10.1002%2Fcmdc.201402393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402393%26sid%3Dliteratum%253Aachs%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DSanchez%26aufirst%3DR.%2BI.%26aulast%3DClas%26aufirst%3DS.%2BD.%26aulast%3DNofsinger%26aufirst%3DR.%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBennet%26aufirst%3DA.%26aulast%3DJohn%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DD.%2BJ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DCeglia%26aufirst%3DS.%2BS.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DManser%26aufirst%3DK.%26aulast%3DNissley%26aufirst%3DB.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChessen%26aufirst%3DG.%26aulast%3DTempleton%26aufirst%3DA.%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-8970%253A%2520an%2520acetal%2520carbonate%2520prodrug%2520of%2520raltegravir%2520with%2520enhanced%2520colonic%2520absorption%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D245%26epage%3D252%26doi%3D10.1002%2Fcmdc.201402393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit222b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tsou, N.; Shultz, C. S.; Andreani, T.; Ball, R. G.; Brunskill, A.; Balsells, J.; Cohen, R. D.; DaSilva, J.; Li, J.; Reamer, R. A.; de Lera Ruiz, M.; Variankaval, N.; Varsolona, R. J.; Yasuda, N.; York, G.</span><span> </span><span class="NLM_article-title">Careful navigation of the crystallographic landscape of MK-8970: A racemic acetal carbonate prodrug of Raltegravir</span>.  <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.oprd.5b00129</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.5b00129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Tsou&author=C.+S.+Shultz&author=T.+Andreani&author=R.+G.+Ball&author=A.+Brunskill&author=J.+Balsells&author=R.+D.+Cohen&author=J.+DaSilva&author=J.+Li&author=R.+A.+Reamer&author=M.+de+Lera+Ruiz&author=N.+Variankaval&author=R.+J.+Varsolona&author=N.+Yasuda&author=G.+York&title=Careful+navigation+of+the+crystallographic+landscape+of+MK-8970%3A+A+racemic+acetal+carbonate+prodrug+of+Raltegravir&doi=10.1021%2Facs.oprd.5b00129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222b&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.5b00129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.5b00129%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DN.%26atitle%3DCareful%2520navigation%2520of%2520the%2520crystallographic%2520landscape%2520of%2520MK-8970%253A%2520A%2520racemic%2520acetal%2520carbonate%2520prodrug%2520of%2520Raltegravir%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2015%26doi%3D10.1021%2Facs.oprd.5b00129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group">Raheem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walji, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywickrema, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clas, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartingh, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajkovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rearden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 2-pyridinone aminals: A prodrug strategy to advance a second generation of HIV-1 integrase strand transfer inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8154</span><span class="NLM_x">–</span> <span class="NLM_lpage">8165</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8154-8165&author=I.+Raheemauthor=A.+Waljiauthor=D.+Kleinauthor=J.+M.+Sandersauthor=D.+Powellauthor=P.+Abeywickremaauthor=G.+Barbeauthor=A.+Bennetauthor=S.+D.+Clasauthor=D.+Dubostauthor=M.+Embreyauthor=J.+Groblerauthor=M.+Hafeyauthor=T.+J.+Hartinghauthor=D.+J.+Hazudaauthor=M.+D.+Millerauthor=K.+P.+Mooreauthor=N.+Pajkovicauthor=S.+Patelauthor=V.+Radaauthor=P.+Reardenauthor=J.+D.+Schreierauthor=J.+Siskoauthor=T.+G.+Steeleauthor=J.+F.+Truchonauthor=J.+Waiauthor=M.+Xuauthor=P.+J.+Coleman&title=Discovery+of+2-pyridinone+aminals%3A+A+prodrug+strategy+to+advance+a+second+generation+of+HIV-1+integrase+strand+transfer+inhibitors&doi=10.1021%2Facs.jmedchem.5b01037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors</span></div><div class="casAuthors">Raheem, Izzat T.; Walji, Abbas M.; Klein, Daniel; Sanders, John M.; Powell, David A.; Abeywickrema, Pravien; Barbe, Guillaume; Bennet, Amrith; Childers, Karla; Christensen, Melodie; Clas, Sophie-Dorothee; Dubost, David; Embrey, Mark; Grobler, Jay; Hafey, Michael J.; Hartingh, Timothy J.; Hazuda, Daria J.; Kuethe, Jeffrey T.; Dunn, Jamie McCabe; Miller, Michael D.; Moore, Keith P.; Nolting, Andrew; Pajkovic, Natasa; Patel, Sangita; Peng, Zuihui; Rada, Vanessa; Rearden, Paul; Schreier, John D.; Sisko, John; Steele, Thomas G.; Truchon, Jean-Francois; Wai, John; Xu, Min; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8154-8165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The search for new mol. constructs that resemble the crit. two-metal binding pharmacophore required for HIV integrase strand transfer inhibition represents a vibrant area of research within drug discovery.  Here the authors present the discovery of a new class of HIV integrase strand transfer inhibitors based on the 2-pyridinone core of MK-0536.  These efforts led to the identification of two lead compds. I and II with excellent antiviral activity and preclin. pharmacokinetic profiles to support a once-daily human dose prediction.  Dose escalating PK studies in dog revealed significant issues with limited oral absorption and required an innovative prodrug strategy to enhance the high-dose plasma exposures of the parent mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGEsuT4C8WELVg90H21EOLACvtfcHk0lgypiSnwmyThg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ&md5=bec0c2f7710a1e4e8cc3a502067a2236</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01037%26sid%3Dliteratum%253Aachs%26aulast%3DRaheem%26aufirst%3DI.%26aulast%3DWalji%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DD.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DAbeywickrema%26aufirst%3DP.%26aulast%3DBarbe%26aufirst%3DG.%26aulast%3DBennet%26aufirst%3DA.%26aulast%3DClas%26aufirst%3DS.%2BD.%26aulast%3DDubost%26aufirst%3DD.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DHartingh%26aufirst%3DT.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DPajkovic%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRada%26aufirst%3DV.%26aulast%3DRearden%26aufirst%3DP.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DSisko%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DTruchon%26aufirst%3DJ.%2BF.%26aulast%3DWai%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25202-pyridinone%2520aminals%253A%2520A%2520prodrug%2520strategy%2520to%2520advance%2520a%2520second%2520generation%2520of%2520HIV-1%2520integrase%2520strand%2520transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8154%26epage%3D8165%26doi%3D10.1021%2Facs.jmedchem.5b01037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60a','cit60b','cit60c','cit60d','cit60e','cit60f'],'ref61':['cit61'],'ref62':['cit62a','cit62b'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106a','cit106b'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159a','cit159b','cit159c'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182a','cit182b','cit182c','cit182d','cit182e','cit182f'],'ref183':['cit183'],'ref184':['cit184a','cit184b'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191a','cit191b'],'ref192':['cit192a','cit192b'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222a','cit222b'],'ref223':['cit223']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 170 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jianrong Liu, Ling Ma, Chang Song, Hui Xing, Shan Cen, <span class="NLM_string-name hlFld-ContribAuthor">Wenhan Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HIV Effects of Baculiferins Are Regulated by the Potential Target Protein DARS. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.1c00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.1c00148%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAnti-HIV%252BEffects%252Bof%252BBaculiferins%252BAre%252BRegulated%252Bby%252Bthe%252BPotential%252BTarget%252BProtein%252BDARS%26aulast%3DLiu%26aufirst%3DJianrong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01032021%26date%3D20072021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nilanjana Jain
(Pancholi), Neha Sonker, Jaya Bajpai, <span class="NLM_string-name hlFld-ContribAuthor">Anil Kumar Bajpai</span>. </span><span class="cited-content_cbyCitation_article-title">Predictions of Drug–Protein Interactions and Study of Magnetically Assisted Release Dynamics of 5-Fluorouracil from Soya Protein-Coated Iron Oxide Core–Shell Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2020,</strong> <em>3 </em>
                                    (5)
                                     , 3170-3186. <a href="https://doi.org/10.1021/acsabm.0c00178" title="DOI URL">https://doi.org/10.1021/acsabm.0c00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.0c00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.0c00178%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DPredictions%252Bof%252BDrug%2525E2%252580%252593Protein%252BInteractions%252Band%252BStudy%252Bof%252BMagnetically%252BAssisted%252BRelease%252BDynamics%252Bof%252B5-Fluorouracil%252Bfrom%252BSoya%252BProtein-Coated%252BIron%252BOxide%252BCore%2525E2%252580%252593Shell%252BNanoparticles%26aulast%3DJain%2B%2528Pancholi%2529%26aufirst%3DNilanjana%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18022020%26date%3D11042020%26date%3D23042020%26date%3D12042020%26volume%3D3%26issue%3D5%26spage%3D3170%26epage%3D3186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin Sun, Alexej Dick, Megan E. Meuser, Tianguang Huang, Waleed A. Zalloum, Chin-Ho Chen, Srinivasulu Cherukupalli, Shujing Xu, Xiao Ding, Ping Gao, Dongwei Kang, Erik De Clercq, Christophe Pannecouque, Simon Cocklin, Kuo-Hsiung Lee, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4790-4810. <a href="https://doi.org/10.1021/acs.jmedchem.0c00015" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00015%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BMechanism%252BStudy%252Bof%252BBenzenesulfonamide-Containing%252BPhenylalanine%252BDerivatives%252Bas%252BNovel%252BHIV-1%252BCapsid%252BInhibitors%252Bwith%252BImproved%252BAntiviral%252BActivities%26aulast%3DSun%26aufirst%3DLin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05012020%26date%3D29042020%26date%3D16042020%26volume%3D63%26issue%3D9%26spage%3D4790%26epage%3D4810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dongwei Kang, Da Feng, Yanying Sun, Zengjun Fang, Fenju Wei, Erik De Clercq, Christophe Pannecouque, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4837-4848. <a href="https://doi.org/10.1021/acs.jmedchem.0c00117" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00117%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BBioisosterism%252BYields%252BHIV-1%252BNNRTIs%252Bwith%252BImproved%252BDrug-Resistance%252BProfiles%252Band%252BFavorable%252BPharmacokinetic%252BProperties%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22012020%26date%3D22042020%26date%3D15042020%26volume%3D63%26issue%3D9%26spage%3D4837%26epage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Savina Malancona, Mattia Mori, Paola Fezzardi, Marisabella Santoriello, Andreina Basta, Martina Nibbio, Lesia Kovalenko, Roberto Speziale, Maria Rosaria Battista, Antonella Cellucci, Nadia Gennari, Edith Monteagudo, Annalise Di Marco, Alessia Giannini, Rajhans Sharma, Manuel Pires, Eleonore Real, Maurizio Zazzi, Maria Chiara Dasso Lang, Davide De Forni, Francesco Saladini, Yves Mely, Vincenzo Summa, Steven Harper, <span class="NLM_string-name hlFld-ContribAuthor">Maurizio Botta</span>. </span><span class="cited-content_cbyCitation_article-title">5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 766-772. <a href="https://doi.org/10.1021/acsmedchemlett.9b00608" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00608%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D5%25252C6-Dihydroxypyrimidine%252BScaffold%252Bto%252BTarget%252BHIV-1%252BNucleocapsid%252BProtein%26aulast%3DMalancona%26aufirst%3DSavina%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D19032020%26date%3D23032020%26date%3D19032020%26volume%3D11%26issue%3D5%26spage%3D766%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pedro A. Sánchez-Murcia, Sonia de Castro, Carlos García-Aparicio, M. Angeles Jiménez, Angela Corona, Enzo Tramontano, Nicolas Sluis-Cremer, Luis Menéndez-Arias, Sonsoles Velázquez, Federico Gago, <span class="NLM_string-name hlFld-ContribAuthor">María-José Camarasa</span>. </span><span class="cited-content_cbyCitation_article-title">Peptides Mimicking the β7/β8 Loop of HIV-1 Reverse Transcriptase p51 as “Hotspot-Targeted” Dimerization Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 811-817. <a href="https://doi.org/10.1021/acsmedchemlett.9b00623" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00623%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPeptides%252BMimicking%252Bthe%252B%2525CE%2525B27%25252F%2525CE%2525B28%252BLoop%252Bof%252BHIV-1%252BReverse%252BTranscriptase%252Bp51%252Bas%252B%2525E2%252580%25259CHotspot-Targeted%2525E2%252580%25259D%252BDimerization%252BInhibitors%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DPedro%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D24012020%26date%3D28012020%26date%3D24012020%26volume%3D11%26issue%3D5%26spage%3D811%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sheng Han, Yali Sang, Yan Wu, Yuan Tao, Christophe Pannecouque, Erik De Clercq, Chunlin Zhuang, <span class="NLM_string-name hlFld-ContribAuthor">Fen-Er Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (5)
                                     , 787-801. <a href="https://doi.org/10.1021/acsinfecdis.9b00229" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DMolecular%252BHybridization-Inspired%252BOptimization%252Bof%252BDiarylbenzopyrimidines%252Bas%252BHIV-1%252BNonnucleoside%252BReverse%252BTranscriptase%252BInhibitors%252Bwith%252BImproved%252BActivity%252Bagainst%252BK103N%252Band%252BE138K%252BMutants%252Band%252BPharmacokinetic%252BProfiles%26aulast%3DHan%26aufirst%3DSheng%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D19062019%26date%3D24102019%26date%3D10102019%26volume%3D6%26issue%3D5%26spage%3D787%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carlos E. Ledezma, Evan M. Cornett, <span class="NLM_string-name hlFld-ContribAuthor">Dmitry M. Kolpashchikov</span>. </span><span class="cited-content_cbyCitation_article-title">Click Chemistry-Based Two-Component System for Efficient Inhibition of Human Immunodeficiency Virus (HIV) Reverse Transcriptase (RT). </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (8)
                                     , 4167-4171. <a href="https://doi.org/10.1021/acsomega.9b03942" title="DOI URL">https://doi.org/10.1021/acsomega.9b03942</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03942%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DClick%252BChemistry-Based%252BTwo-Component%252BSystem%252Bfor%252BEfficient%252BInhibition%252Bof%252BHuman%252BImmunodeficiency%252BVirus%252B%252528HIV%252529%252BReverse%252BTranscriptase%252B%252528RT%252529%26aulast%3DLedezma%26aufirst%3DCarlos%2BE.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18112019%26date%3D12022020%26date%3D21022020%26volume%3D5%26issue%3D8%26spage%3D4167%26epage%3D4171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dongwei Kang, F. Xavier Ruiz, Da Feng, Alyssa Pilch, Tong Zhao, Fenju Wei, Zhao Wang, Yanying Sun, Zengjun Fang, Erik De Clercq, Christophe Pannecouque, Eddy Arnold, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1298-1312. <a href="https://doi.org/10.1021/acs.jmedchem.9b01769" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01769%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BFluorine-Substituted%252BDiarylpyrimidine%252BDerivatives%252Bas%252BNovel%252BHIV-1%252BNNRTIs%252Bwith%252BHighly%252BImproved%252BResistance%252BProfiles%252Band%252BLow%252BActivity%252Bfor%252Bthe%252BhERG%252BIon%252BChannel%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D24102019%26date%3D24012020%26date%3D14012020%26volume%3D63%26issue%3D3%26spage%3D1298%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Belén Martínez-Gualda, Liang Sun, Olaia Martí-Marí, Sam Noppen, Rana Abdelnabi, Carol M. Bator, Ernesto Quesada, Leen Delang, Carmen Mirabelli, Hyunwook Lee, Dominique Schols, Johan Neyts, Susan Hafenstein, María-José Camarasa, Federico Gago, <span class="NLM_string-name hlFld-ContribAuthor">Ana San-Félix</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 349-368. <a href="https://doi.org/10.1021/acs.jmedchem.9b01737" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01737%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScaffold%252BSimplification%252BStrategy%252BLeads%252Bto%252Ba%252BNovel%252BGeneration%252Bof%252BDual%252BHuman%252BImmunodeficiency%252BVirus%252Band%252BEnterovirus-A71%252BEntry%252BInhibitors%26aulast%3DMart%25C3%25ADnez-Gualda%26aufirst%3DBel%25C3%25A9n%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D21102019%26date%3D20122019%26date%3D06122019%26volume%3D63%26issue%3D1%26spage%3D349%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Akanksha Upadhyay, Pragya Chandrakar, Sampa Gupta, Naveen Parmar, Sandeep Kumar Singh, Mamunur Rashid, Pragati Kushwaha, Muhammad Wahajuddin, Koneni V. Sashidhara, <span class="NLM_string-name hlFld-ContribAuthor">Susanta Kar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5655-5671. <a href="https://doi.org/10.1021/acs.jmedchem.9b00628" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00628%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BBiological%252BEvaluation%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationship%25252C%252Band%252BMechanism%252Bof%252BAction%252BStudies%252Bof%252BQuinoline%2525E2%252580%252593Metronidazole%252BDerivatives%252BAgainst%252BExperimental%252BVisceral%252BLeishmaniasis%26aulast%3DUpadhyay%26aufirst%3DAkanksha%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12042019%26date%3D24052019%26volume%3D62%26issue%3D11%26spage%3D5655%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vigneshwaran Namasivayam, Murugesan Vanangamudi, Victor G. Kramer, Sonali Kurup, Peng Zhan, Xinyong Liu, Jacob Kongsted, <span class="NLM_string-name hlFld-ContribAuthor">Siddappa N. Byrareddy</span>. </span><span class="cited-content_cbyCitation_article-title">The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4851-4883. <a href="https://doi.org/10.1021/acs.jmedchem.8b00843" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00843%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BJourney%252Bof%252BHIV-1%252BNon-Nucleoside%252BReverse%252BTranscriptase%252BInhibitors%252B%252528NNRTIs%252529%252Bfrom%252BLab%252Bto%252BClinic%26aulast%3DNamasivayam%26aufirst%3DVigneshwaran%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D28052018%26date%3D27122018%26date%3D05122018%26volume%3D62%26issue%3D10%26spage%3D4851%26epage%3D4883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Murugaiah A. M. Subbaiah, Sandhya Mandlekar, Sridhar Desikan, Thangeswaran Ramar, Lakshumanan Subramani, Mathiazhagan Annadurai, Salil D. Desai, Sarmistha Sinha, Susan M. Jenkins, Mark R. Krystal, Murali Subramanian, Srikanth Sridhar, Shweta Padmanabhan, Priyadeep Bhutani, Rambabu Arla, Shashyendra Singh, Jaydeep Sinha, Megha Thakur, John F. Kadow, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3553-3574. <a href="https://doi.org/10.1021/acs.jmedchem.9b00002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacokinetic%252BEvaluation%252Bof%252BPhosphate%252Band%252BAmino%252BAcid%252BEster%252BProdrugs%252Bfor%252BImproving%252Bthe%252BOral%252BBioavailability%252Bof%252Bthe%252BHIV-1%252BProtease%252BInhibitor%252BAtazanavir%26aulast%3DA.%2BM.%2BSubbaiah%26aufirst%3DMurugaiah%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01012019%26date%3D02042019%26volume%3D62%26issue%3D7%26spage%3D3553%26epage%3D3574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dongwei Kang, Heng Zhang, Zhao Wang, Tong Zhao, Tiziana Ginex, Francisco Javier Luque, Yang Yang, Gaochan Wu, Da Feng, Fenju Wei, Jian Zhang, Erik De Clercq, Christophe Pannecouque, Chin Ho Chen, Kuo-Hsiung Lee, N. Arul Murugan, Thomas A. Steitz, Peng Zhan, <span class="NLM_string-name hlFld-ContribAuthor">Xinyong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1484-1501. <a href="https://doi.org/10.1021/acs.jmedchem.8b01656" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01656%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BDihydrofuro%25255B3%25252C4-d%25255Dpyrimidine%252BDerivatives%252Bas%252BNovel%252BHIV-1%252BNon-Nucleoside%252BReverse%252BTranscriptase%252BInhibitors%252Bwith%252BPromising%252BAntiviral%252BActivities%252Band%252BDesirable%252BPhysicochemical%252BProperties%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D24102018%26date%3D18012019%26date%3D09012019%26volume%3D62%26issue%3D3%26spage%3D1484%26epage%3D1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicole Pribut, Adriaan E. Basson, Willem A. L. van Otterlo, Dennis C. Liotta, <span class="NLM_string-name hlFld-ContribAuthor">Stephen C. Pelly</span>. </span><span class="cited-content_cbyCitation_article-title">Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 196-202. <a href="https://doi.org/10.1021/acsmedchemlett.8b00549" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00549%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAryl%252BSubstituted%252BBenzimidazolones%252Bas%252BPotent%252BHIV-1%252BNon-Nucleoside%252BReverse%252BTranscriptase%252BInhibitors%26aulast%3DPribut%26aufirst%3DNicole%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D15112018%26date%3D17012019%26date%3D24012019%26date%3D17012019%26volume%3D10%26issue%3D2%26spage%3D196%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maxim
B. Nawrozkij, Mariantonietta Forgione, Alexandre S. Yablokov, Alessia Lucidi, Daniela Tomaselli, Alexandros Patsilinakos, Cristina Panella, Gebremedhin S. Hailu, Ivan A. Kirillov, Roger Badia, Eva Riveira-Muñoz, Emmanuele Crespan, Jorge I. Armijos Rivera, Roberto Cirilli, Rino Ragno, José A. Esté, Giovanni Maga, Antonello Mai, <span class="NLM_string-name hlFld-ContribAuthor">Dante Rotili</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 604-621. <a href="https://doi.org/10.1021/acs.jmedchem.8b01238" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01238%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffect%252Bof%252B%2525CE%2525B1-Methoxy%252BSubstitution%252Bon%252Bthe%252BAnti-HIV%252BActivity%252Bof%252BDihydropyrimidin-4%2525283H%252529-ones%26aulast%3DNawrozkij%26aufirst%3DMaxim%2BB.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05082018%26date%3D20122018%26date%3D07122018%26volume%3D62%26issue%3D2%26spage%3D604%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Wang, Yasu Ueda, Zhongxing Zhang, Zhiwei Yin, John Matiskella, Bradley C. Pearce, Zheng Yang, Ming Zheng, Dawn D. Parker, Gregory A. Yamanaka, Yi-Fei Gong, Hsu-Tso Ho, Richard J. Colonno, David R. Langley, Pin-Fang Lin, Nicholas A. Meanwell, <span class="NLM_string-name hlFld-ContribAuthor">John F. Kadow</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 6308-6327. <a href="https://doi.org/10.1021/acs.jmedchem.8b00759" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00759%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BHuman%252BImmunodeficiency%252BVirus%252BType%252B1%252B%252528HIV-1%252529%252BAttachment%252BInhibitor%252BTemsavir%252Band%252BIts%252BPhosphonooxymethyl%252BProdrug%252BFostemsavir%26aulast%3DWang%26aufirst%3DTao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11052018%26date%3D13072018%26date%3D19062018%26volume%3D61%26issue%3D14%26spage%3D6308%26epage%3D6327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Konstantin L. Obydennov, Liliya A. Khamidullina, Alexey N. Galushchinskiy, Svetlana A. Shatunova, Mariya F. Kosterina, Tatiana A. Kalinina, Zhijin Fan, Tatiana V. Glukhareva, <span class="NLM_string-name hlFld-ContribAuthor">Yuri Yu. Morzherin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Methyl (5Z)-[2-(2,4,5-Trioxopyrrolidin-3-ylidene)-4-oxo-1,3-thiazolidin-5-ylidene]acetates as Antifungal Agents against Potato Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2018,</strong> <em>66 </em>
                                    (24)
                                     , 6239-6245. <a href="https://doi.org/10.1021/acs.jafc.8b02151" title="DOI URL">https://doi.org/10.1021/acs.jafc.8b02151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.8b02151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.8b02151%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDiscovery%252Bof%252BMethyl%252B%2525285Z%252529-%25255B2-%2525282%25252C4%25252C5-Trioxopyrrolidin-3-ylidene%252529-4-oxo-1%25252C3-thiazolidin-5-ylidene%25255Dacetates%252Bas%252BAntifungal%252BAgents%252Bagainst%252BPotato%252BDiseases%26aulast%3DObydennov%26aufirst%3DKonstantin%2BL.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24042018%26date%3D25052018%26date%3D29052018%26date%3D07062018%26date%3D29052018%26volume%3D66%26issue%3D24%26spage%3D6239%26epage%3D6245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Murugaiah A. M. Subbaiah, Nicholas A. Meanwell, John F. Kadow, Lakshumanan Subramani, Mathiazhagan Annadurai, Thangeswaran Ramar, Salil D. Desai, Sarmistha Sinha, Murali Subramanian, Sandhya Mandlekar, Srikanth Sridhar, Shweta Padmanabhan, Priyadeep Bhutani, Rambabu Arla, Susan M. Jenkins, Mark R. Krystal, Chunfu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Ramakanth Sarabu</span>. </span><span class="cited-content_cbyCitation_article-title">Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 4176-4188. <a href="https://doi.org/10.1021/acs.jmedchem.8b00277" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00277%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCoupling%252Bof%252Ban%252BAcyl%252BMigration%252BProdrug%252BStrategy%252Bwith%252BBio-activation%252BTo%252BImprove%252BOral%252BDelivery%252Bof%252Bthe%252BHIV-1%252BProtease%252BInhibitor%252BAtazanavir%26aulast%3DSubbaiah%26aufirst%3DMurugaiah%2BA.%2BM.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21022018%26date%3D25042018%26volume%3D61%26issue%3D9%26spage%3D4176%26epage%3D4188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhipeng Huo, Heng Zhang, Dongwei Kang, Zhongxia Zhou, Gaochan Wu, Samuel Desta, Xiaofang Zuo, Zhao Wang, Lanlan Jing, Xiao Ding, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, <span class="NLM_string-name hlFld-ContribAuthor">Xinyong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the “NNRTI Adjacent” Binding Site. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (4)
                                     , 334-338. <a href="https://doi.org/10.1021/acsmedchemlett.7b00524" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00524%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BNovel%252BDiarylpyrimidine%252BDerivatives%252Bas%252BPotent%252BHIV-1%252BNNRTIs%252BTargeting%252Bthe%252B%2525E2%252580%25259CNNRTI%252BAdjacent%2525E2%252580%25259D%252BBinding%252BSite%26aulast%3DHuo%26aufirst%3DZhipeng%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D17122017%26date%3D27022018%26date%3D02032018%26date%3D27022018%26volume%3D9%26issue%3D4%26spage%3D334%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dongwei Kang, Zhao Wang, Heng Zhang, Gaochan Wu, Tong Zhao, Zhongxia Zhou, Zhipeng Huo, Boshi Huang, Da Feng, Xiao Ding, Jian Zhang, Xiaofang Zuo, Lanlan Jing, Wei Luo, Samuel Guma, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, <span class="NLM_string-name hlFld-ContribAuthor">Xinyong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (4)
                                     , 370-375. <a href="https://doi.org/10.1021/acsmedchemlett.8b00054" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00054%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFurther%252BExploring%252BSolvent-Exposed%252BTolerant%252BRegions%252Bof%252BAllosteric%252BBinding%252BPocket%252Bfor%252BNovel%252BHIV-1%252BNNRTIs%252BDiscovery%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02022018%26date%3D01032018%26date%3D05032018%26date%3D01032018%26volume%3D9%26issue%3D4%26spage%3D370%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Mark R.  Krystal</span>, <span class="hlFld-ContribAuthor ">Beata  Nowicka-Sans</span>, <span class="hlFld-ContribAuthor ">David R.  Langley</span>, <span class="hlFld-ContribAuthor ">David A.  Conlon</span>, <span class="hlFld-ContribAuthor ">Martin D.  Eastgate</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Peter  Timmins</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, and <span class="hlFld-ContribAuthor ">John F.  Kadow</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (1)
                                     , 62-80. <a href="https://doi.org/10.1021/acs.jmedchem.7b01337" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01337%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252BHIV-1%252BAttachment%25253A%252BThe%252BDiscovery%252Band%252BDevelopment%252Bof%252BTemsavir%252Band%252Bits%252BProdrug%252BFostemsavir%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D08092017%26date%3D22122017%26date%3D11012018%26volume%3D61%26issue%3D1%26spage%3D62%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Huo</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Tong  Zhao</span>, <span class="hlFld-ContribAuthor ">Da  Feng</span>, <span class="hlFld-ContribAuthor ">Zhao  Wang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBP. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 1188-1193. <a href="https://doi.org/10.1021/acsmedchemlett.7b00361" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00361%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BThiophene%25255B3%25252C2-d%25255Dpyrimidine%252BDerivatives%252Bas%252BPotent%252BHIV-1%252BNNRTIs%252BTargeting%252Bthe%252BTolerant%252BRegion%252BI%252Bof%252BNNIBP%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01092017%26date%3D19102017%26date%3D26102017%26date%3D09112017%26date%3D19102017%26volume%3D8%26issue%3D11%26spage%3D1188%26epage%3D1193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valeria  Famiglini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  La Regina</span>, <span class="hlFld-ContribAuthor ">Antonio  Coluccia</span>, <span class="hlFld-ContribAuthor ">Domiziana  Masci</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Roger  Badia</span>, <span class="hlFld-ContribAuthor ">Eva  Riveira-Muñoz</span>, <span class="hlFld-ContribAuthor ">José A.  Esté</span>, <span class="hlFld-ContribAuthor ">Emmanuele  Crespan</span>, <span class="hlFld-ContribAuthor ">Alessandro  Brambilla</span>, <span class="hlFld-ContribAuthor ">Giovanni  Maga</span>, <span class="hlFld-ContribAuthor ">Myriam  Catalano</span>, <span class="hlFld-ContribAuthor ">Cristina  Limatola</span>, <span class="hlFld-ContribAuthor ">Francesca Romana  Formica</span>, <span class="hlFld-ContribAuthor ">Roberto  Cirilli</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, and <span class="hlFld-ContribAuthor ">Romano  Silvestri</span>  . </span><span class="cited-content_cbyCitation_article-title">Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6528-6547. <a href="https://doi.org/10.1021/acs.jmedchem.6b01906" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChiral%252BIndolylarylsulfone%252BNon-Nucleoside%252BReverse%252BTranscriptase%252BInhibitors%252Bas%252BNew%252BPotent%252Band%252BBroad%252BSpectrum%252BAnti-HIV-1%252BAgents%26aulast%3DFamiglini%26aufirst%3DValeria%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D27122016%26date%3D05072017%26date%3D10082017%26date%3D19062017%26volume%3D60%26issue%3D15%26spage%3D6528%26epage%3D6547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengsheng  Xu</span> and <span class="hlFld-ContribAuthor ">Igor A.  Kaltashov</span>  . </span><span class="cited-content_cbyCitation_article-title">Overcoming the Hydrolytic Lability of a Reaction Intermediate in Production of Protein/Drug Conjugates: Conjugation of an Acyclic Nucleoside Phosphonate to a Model Carrier Protein. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (8)
                                     , 2843-2851. <a href="https://doi.org/10.1021/acs.molpharmaceut.7b00410" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.7b00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.7b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.7b00410%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DOvercoming%252Bthe%252BHydrolytic%252BLability%252Bof%252Ba%252BReaction%252BIntermediate%252Bin%252BProduction%252Bof%252BProtein%25252FDrug%252BConjugates%25253A%252BConjugation%252Bof%252Ban%252BAcyclic%252BNucleoside%252BPhosphonate%252Bto%252Ba%252BModel%252BCarrier%252BProtein%26aulast%3DXu%26aufirst%3DShengsheng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16052017%26date%3D16072017%26date%3D12072017%26date%3D28072017%26date%3D07082017%26date%3D17072017%26volume%3D14%26issue%3D8%26spage%3D2843%26epage%3D2851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Zengjun  Fang</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Xueyi  Lu</span>, <span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Haoran  Xu</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Huo</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhao  Yu</span>, <span class="hlFld-ContribAuthor ">Qing  Meng</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (10)
                                     , 4424-4443. <a href="https://doi.org/10.1021/acs.jmedchem.7b00332" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00332%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7991%26epage%3D8007%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BOptimization%252Bof%252BThiophene%25255B3%25252C2-d%25255Dpyrimidine%252BDerivatives%252Bas%252BPotent%252BHIV-1%252BNon-nucleoside%252BReverse%252BTranscriptase%252BInhibitors%252Bwith%252BImproved%252BPotency%252Bagainst%252BResistance-Associated%252BVariants%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09032017%26date%3D15052017%26date%3D25052017%26date%3D08052017%26volume%3D60%26issue%3D10%26spage%3D4424%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, and <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 9262-9268. <a href="https://doi.org/10.1021/acs.jmedchem.6b00461" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00461%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIncorporation%252Bof%252BPrivileged%252BStructures%252Binto%252BBevirimat%252BCan%252BImprove%252BActivity%252Bagainst%252BWild-Type%252Band%252BBevirimat-Resistant%252BHIV-1%26aulast%3DZhao%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11042016%26date%3D22092016%26date%3D13102016%26volume%3D59%26issue%3D19%26spage%3D9262%26epage%3D9268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Zengjun  Fang</span>, <span class="hlFld-ContribAuthor ">Zhenyu  Li</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xueyi  Lu</span>, <span class="hlFld-ContribAuthor ">Haoran  Xu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 7991-8007. <a href="https://doi.org/10.1021/acs.jmedchem.6b00738" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00738%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BThiophene%25255B3%25252C2-d%25255Dpyrimidine%252BDerivatives%252Bas%252BHIV-1%252BNon-nucleoside%252BReverse%252BTranscriptase%252BInhibitors%252Bwith%252BSignificantly%252BImproved%252BDrug%252BResistance%252BProfiles%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22052016%26date%3D26082016%26date%3D08092016%26date%3D19082016%26volume%3D59%26issue%3D17%26spage%3D7991%26epage%3D8007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Heather L.  Osswald</span>, and <span class="hlFld-ContribAuthor ">Gary  Prato</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (11)
                                     , 5172-5208. <a href="https://doi.org/10.1021/acs.jmedchem.5b01697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BHIV-1%252BProtease%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHIV%25252FAIDS%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D30102015%26date%3D22012016%26date%3D09062016%26volume%3D59%26issue%3D11%26spage%3D5172%26epage%3D5208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reena  Chawla</span>, <span class="hlFld-ContribAuthor ">Victor  Van Puyenbroeck</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Pflug</span>, <span class="hlFld-ContribAuthor ">Alekhya  Sama</span>, <span class="hlFld-ContribAuthor ">Rameez  Ali</span>, <span class="hlFld-ContribAuthor ">Dominique  Schols</span>, <span class="hlFld-ContribAuthor ">Kurt  Vermeire</span>, and <span class="hlFld-ContribAuthor ">Thomas W.  Bell</span>  . </span><span class="cited-content_cbyCitation_article-title">Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (6)
                                     , 2633-2647. <a href="https://doi.org/10.1021/acs.jmedchem.5b01832" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01832%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTuning%252BSide%252BArm%252BElectronics%252Bin%252BUnsymmetrical%252BCyclotriazadisulfonamide%252B%252528CADA%252529%252BEndoplasmic%252BReticulum%252B%252528ER%252529%252BTranslocation%252BInhibitors%252Bto%252BImprove%252Btheir%252BHuman%252BCluster%252Bof%252BDifferentiation%252B4%252B%252528CD4%252529%252BReceptor%252BDown-Modulating%252BPotencies%26aulast%3DChawla%26aufirst%3DReena%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D25112015%26date%3D14032016%26date%3D24032016%26volume%3D59%26issue%3D6%26spage%3D2633%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiapei  Yang</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Fu</span>, <span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">The development of an effective synthetic route of rilpivirine. </span><span class="cited-content_cbyCitation_journal-name">BMC Chemistry</span><span> <strong>2021,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13065-021-00749-y" title="DOI URL">https://doi.org/10.1186/s13065-021-00749-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13065-021-00749-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13065-021-00749-y%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Chemistry%26atitle%3DThe%252Bdevelopment%252Bof%252Ban%252Beffective%252Bsynthetic%252Broute%252Bof%252Brilpivirine%26aulast%3DZhang%26aufirst%3DTao%26date%3D2021%26date%3D2021%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuart  Ruddell</span>, <span class="hlFld-ContribAuthor ">Elena  Sugrue</span>, <span class="hlFld-ContribAuthor ">Sarah  Memarzadeh</span>, <span class="hlFld-ContribAuthor ">Lorna Mae  Hellam</span>, <span class="hlFld-ContribAuthor ">Sam J.  Wilson</span>, <span class="hlFld-ContribAuthor ">David J.  France</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Enantiomeric Resolution and Biological Evaluation of HIV Capsid Inhibition Activity for Racemic, (S)- and (R)-PF74. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (13)
                                     , 3919. <a href="https://doi.org/10.3390/molecules26133919" title="DOI URL">https://doi.org/10.3390/molecules26133919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26133919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26133919%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BEnantiomeric%252BResolution%252Band%252BBiological%252BEvaluation%252Bof%252BHIV%252BCapsid%252BInhibition%252BActivity%252Bfor%252BRacemic%25252C%252B%252528S%252529-%252Band%252B%252528R%252529-PF74%26aulast%3DRuddell%26aufirst%3DStuart%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D13%26spage%3D3919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Fu</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Shenghua  Gao</span>, <span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>42 </em>, 116239. <a href="https://doi.org/10.1016/j.bmc.2021.116239" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116239%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Bthe%252Bhydrophobic%252Bchannel%252Bof%252Bthe%252BNNIBP%25253A%252BDiscovery%252Bof%252Bnovel%252Bdiarylpyrimidines%252Bas%252BHIV-1%252BNNRTIs%252Bagainst%252Bwild-type%252Band%252BK103N%252Bmutant%252Bviruses%26aulast%3DFu%26aufirst%3DZhipeng%26date%3D2021%26volume%3D42%26spage%3D116239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Fu</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez‐Arias</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Natural Products‐Based Antiviral Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 21-42. <a href="https://doi.org/10.1002/9781119640929.ch2" title="DOI URL">https://doi.org/10.1002/9781119640929.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119640929.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119640929.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252BNatural%252BProducts%2525E2%252580%252590Based%252BAntiviral%252BAgents%26aulast%3DFu%26aufirst%3DZhipeng%26date%3D2021%26date%3D2021%26spage%3D21%26epage%3D42%26pub%3DWiley%26atitle%3DChemistry%252Bof%252BBiologically%252BPotent%252BNatural%252BProducts%252Band%252BSynthetic%252BCompounds%26aulast%3DShahid%25E2%2580%2590ul%25E2%2580%2590Islam%26date%3D2021%26date%3D2021%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Richardson</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>3 </em>, 1-26. <a href="https://doi.org/10.1080/17460441.2021.1933427" title="DOI URL">https://doi.org/10.1080/17460441.2021.1933427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1933427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1933427%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApplications%252Bof%252Bfluorine%252Bto%252Bthe%252Bconstruction%252Bof%252Bbioisosteric%252Belements%252Bfor%252Bthe%252Bpurposes%252Bof%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DRichardson%26aufirst%3DPaul%26date%3D2021%26date%3D2021%26volume%3D3%26spage%3D1%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Serral</span>, <span class="hlFld-ContribAuthor ">Florencia A.  Castello</span>, <span class="hlFld-ContribAuthor ">Ezequiel J.  Sosa</span>, <span class="hlFld-ContribAuthor ">Agustín M.  Pardo</span>, <span class="hlFld-ContribAuthor ">Miranda Clara  Palumbo</span>, <span class="hlFld-ContribAuthor ">Carlos  Modenutti</span>, <span class="hlFld-ContribAuthor ">María Mercedes  Palomino</span>, <span class="hlFld-ContribAuthor ">Alberto  Lazarowski</span>, <span class="hlFld-ContribAuthor ">Jerónimo  Auzmendi</span>, <span class="hlFld-ContribAuthor ">Pablo Ivan P.  Ramos</span>, <span class="hlFld-ContribAuthor ">Marisa F.  Nicolás</span>, <span class="hlFld-ContribAuthor ">Adrián G.  Turjanski</span>, <span class="hlFld-ContribAuthor ">Marcelo A.  Martí</span>, <span class="hlFld-ContribAuthor ">Darío  Fernández Do Porto</span>. </span><span class="cited-content_cbyCitation_article-title">From Genome to Drugs: New Approaches in Antimicrobial Discovery. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.647060" title="DOI URL">https://doi.org/10.3389/fphar.2021.647060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.647060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.647060%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DFrom%252BGenome%252Bto%252BDrugs%25253A%252BNew%252BApproaches%252Bin%252BAntimicrobial%252BDiscovery%26aulast%3DSerral%26aufirst%3DFederico%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Xujie  Zhang</span>, <span class="hlFld-ContribAuthor ">Shujing  Xu</span>, <span class="hlFld-ContribAuthor ">Tianguang  Huang</span>, <span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>217 </em>, 113380. <a href="https://doi.org/10.1016/j.ejmech.2021.113380" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113380%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Binsight%252Bon%252Bmedicinal%252Baspects%252Bof%252Bnovel%252BHIV-1%252Bcapsid%252Bprotein%252Binhibitors%26aulast%3DSun%26aufirst%3DLin%26date%3D2021%26volume%3D217%26spage%3D113380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Ma</span>, <span class="hlFld-ContribAuthor ">Estrella  Frutos-Beltrán</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (7)
                                     , 4514-4540. <a href="https://doi.org/10.1039/D0CS01084G" title="DOI URL">https://doi.org/10.1039/D0CS01084G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS01084G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS01084G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bdiscovering%252Bantivirals%252Beffective%252Bagainst%252Bdrug-resistant%252Bviruses%26aulast%3DMa%26aufirst%3DYue%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D7%26spage%3D4514%26epage%3D4540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113287. <a href="https://doi.org/10.1016/j.ejmech.2021.113287" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113287%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure%252Bactivity%252Brelationship%252Banalysis%252Bof%252Bnew%252Bbetulinic%252Bacid%252Bderivatives%252Bas%252Bpotent%252BHIV%252Binhibitors%26aulast%3DZhao%26aufirst%3DYu%26date%3D2021%26volume%3D215%26spage%3D113287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinling  Wang</span>, <span class="hlFld-ContribAuthor ">Miao  Cao</span>, <span class="hlFld-ContribAuthor ">Yanling  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlei  Ying</span>, <span class="hlFld-ContribAuthor ">Lu  Lu</span>, <span class="hlFld-ContribAuthor ">Shibo  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1964. <a href="https://doi.org/10.3390/molecules26071964" title="DOI URL">https://doi.org/10.3390/molecules26071964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071964%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynergistic%252BEffect%252Bby%252BCombining%252Ba%252Bgp120-Binding%252BProtein%252Band%252Ba%252Bgp41-Binding%252BAntibody%252Bto%252BInactivate%252BHIV-1%252BVirions%252Band%252BInhibit%252BHIV-1%252BInfection%26aulast%3DWang%26aufirst%3DXinling%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanying  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Feng  Da</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Pei  Li</span>, <span class="hlFld-ContribAuthor ">Baodan  Zhang</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs binding pocket. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113204. <a href="https://doi.org/10.1016/j.ejmech.2021.113204" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113204%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252Bpotent%252BHIV-1%252Binhibitors%252Bby%252Bexploiting%252Bthe%252Btolerant%252Bregions%252Bof%252Bthe%252BNNRTIs%252Bbinding%252Bpocket%26aulast%3DSun%26aufirst%3DYanying%26date%3D2021%26volume%3D214%26spage%3D113204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Da  Feng</span>, <span class="hlFld-ContribAuthor ">Fenju  Wei</span>, <span class="hlFld-ContribAuthor ">Yanying  Sun</span>, <span class="hlFld-ContribAuthor ">Prem Prakash  Sharma</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Lin</span>, <span class="hlFld-ContribAuthor ">Brijesh  Rathi</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Boronic acid-containing diarylpyrimidine derivatives as novel HIV-1 NNRTIs: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>59 </em><a href="https://doi.org/10.1016/j.cclet.2021.02.033" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.02.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.02.033%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DBoronic%252Bacid-containing%252Bdiarylpyrimidine%252Bderivatives%252Bas%252Bnovel%252BHIV-1%252BNNRTIs%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DFeng%26aufirst%3DDa%26date%3D2021%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yury V.  Zhernov</span>, <span class="hlFld-ContribAuthor ">Andrey I.  Konstantinov</span>, <span class="hlFld-ContribAuthor ">Alexander  Zherebker</span>, <span class="hlFld-ContribAuthor ">Eugene  Nikolaev</span>, <span class="hlFld-ContribAuthor ">Alexey  Orlov</span>, <span class="hlFld-ContribAuthor ">Mikhail I.  Savinykh</span>, <span class="hlFld-ContribAuthor ">Galina V.  Kornilaeva</span>, <span class="hlFld-ContribAuthor ">Eduard V.  Karamov</span>, <span class="hlFld-ContribAuthor ">Irina V.  Perminova</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral activity of natural humic substances and shilajit materials against HIV-1: Relation to structure. </span><span class="cited-content_cbyCitation_journal-name">Environmental Research</span><span> <strong>2021,</strong> <em>193 </em>, 110312. <a href="https://doi.org/10.1016/j.envres.2020.110312" title="DOI URL">https://doi.org/10.1016/j.envres.2020.110312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.envres.2020.110312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.envres.2020.110312%26sid%3Dliteratum%253Aachs%26jtitle%3DEnvironmental%2520Research%26atitle%3DAntiviral%252Bactivity%252Bof%252Bnatural%252Bhumic%252Bsubstances%252Band%252Bshilajit%252Bmaterials%252Bagainst%252BHIV-1%25253A%252BRelation%252Bto%252Bstructure%26aulast%3DZhernov%26aufirst%3DYury%2BV.%26date%3D2021%26volume%3D193%26spage%3D110312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harsha  Kharkwal</span>, <span class="hlFld-ContribAuthor ">Banoth K  Kumar</span>, <span class="hlFld-ContribAuthor ">Sankaranarayanan  Murugesan</span>, <span class="hlFld-ContribAuthor ">Gautam  Singhvi</span>, <span class="hlFld-ContribAuthor ">Preeti  Avasthi</span>, <span class="hlFld-ContribAuthor ">Ankush  Goyal</span>, <span class="hlFld-ContribAuthor ">Joazaizulfazli  Jamalis</span>, <span class="hlFld-ContribAuthor ">Subhash  Chander</span>. </span><span class="cited-content_cbyCitation_article-title">Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 269-286. <a href="https://doi.org/10.4155/fmc-2020-0257" title="DOI URL">https://doi.org/10.4155/fmc-2020-0257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0257%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSearch%252Bfor%252Bnew%252Btherapeutics%252Bagainst%252BHIV-1%252Bvia%252Bdual%252Binhibition%252Bof%252BRNase%252BH%252Band%252Bintegrase%25253A%252Bcurrent%252Bstatus%252Band%252Bfuture%252Bchallenges%26aulast%3DKharkwal%26aufirst%3DHarsha%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D269%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Da  Feng</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Zuo</span>, <span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Hao  Lin</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Soliman</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of “dual-site”-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113063. <a href="https://doi.org/10.1016/j.ejmech.2020.113063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252B%2525E2%252580%25259Cdual-site%2525E2%252580%25259D-binding%252Bdiarylpyrimidines%252Btargeting%252Bboth%252BNNIBP%252Band%252Bthe%252BNNRTI%252Badjacent%252Bsite%252Bof%252Bthe%252BHIV-1%252Breverse%252Btranscriptase%26aulast%3DFeng%26aufirst%3DDa%26date%3D2021%26volume%3D211%26spage%3D113063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Estrella  Frutos-Beltrán</span>, <span class="hlFld-ContribAuthor ">Wenxin  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jinmi  Zou</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>30 </em>, 115927. <a href="https://doi.org/10.1016/j.bmc.2020.115927" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115927%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bindolylarylsulfone%252Bderivatives%252Bas%252Bcovalent%252BHIV-1%252Breverse%252Btranscriptase%252Binhibitors%252Bspecifically%252Btargeting%252Bthe%252Bdrug-resistant%252Bmutant%252BY181C%26aulast%3DGao%26aufirst%3DPing%26date%3D2021%26volume%3D30%26spage%3D115927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of piperidinyl‐substituted [1,2,4]triazolo[1,5‐a]pyrimidine derivatives as potential anti‐HIV‐1 agents with reduced cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (1)
                                     , 67-76. <a href="https://doi.org/10.1111/cbdd.13760" title="DOI URL">https://doi.org/10.1111/cbdd.13760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13760%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bpiperidinyl%2525E2%252580%252590substituted%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5%2525E2%252580%252590a%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotential%252Banti%2525E2%252580%252590HIV%2525E2%252580%2525901%252Bagents%252Bwith%252Breduced%252Bcytotoxicity%26aulast%3DHuang%26aufirst%3DBoshi%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D1%26spage%3D67%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liezel A.  Lumangtad</span>, <span class="hlFld-ContribAuthor ">Elisa  Claeys</span>, <span class="hlFld-ContribAuthor ">Sunil  Hamal</span>, <span class="hlFld-ContribAuthor ">Amarawan  Intasiri</span>, <span class="hlFld-ContribAuthor ">Courtney  Basrai</span>, <span class="hlFld-ContribAuthor ">Expedite  Yen-Pon</span>, <span class="hlFld-ContribAuthor ">Davison  Beenfeldt</span>, <span class="hlFld-ContribAuthor ">Kurt  Vermeire</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Bell</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115816. <a href="https://doi.org/10.1016/j.bmc.2020.115816" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115816%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSyntheses%252Band%252Banti-HIV%252Band%252Bhuman%252Bcluster%252Bof%252Bdifferentiation%252B4%252B%252528CD4%252529%252Bdown-modulating%252Bpotencies%252Bof%252Bpyridine-fused%252Bcyclotriazadisulfonamide%252B%252528CADA%252529%252Bcompounds%26aulast%3DLumangtad%26aufirst%3DLiezel%2BA.%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marianna  Nalli</span>, <span class="hlFld-ContribAuthor ">Jorge I.  Armijos Rivera</span>, <span class="hlFld-ContribAuthor ">Domiziana  Masci</span>, <span class="hlFld-ContribAuthor ">Antonio  Coluccia</span>, <span class="hlFld-ContribAuthor ">Roger  Badia</span>, <span class="hlFld-ContribAuthor ">Eva  Riveira-Muñoz</span>, <span class="hlFld-ContribAuthor ">Alessandro  Brambilla</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Cinquina</span>, <span class="hlFld-ContribAuthor ">Ombretta  Turriziani</span>, <span class="hlFld-ContribAuthor ">Francesca  Falasca</span>, <span class="hlFld-ContribAuthor ">Myriam  Catalano</span>, <span class="hlFld-ContribAuthor ">Cristina  Limatola</span>, <span class="hlFld-ContribAuthor ">José A.  Esté</span>, <span class="hlFld-ContribAuthor ">Giovanni  Maga</span>, <span class="hlFld-ContribAuthor ">Romano  Silvestri</span>, <span class="hlFld-ContribAuthor ">Emmanuele  Crespan</span>, <span class="hlFld-ContribAuthor ">Giuseppe  La Regina</span>. </span><span class="cited-content_cbyCitation_article-title">New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112696. <a href="https://doi.org/10.1016/j.ejmech.2020.112696" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112696%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bindolylarylsulfone%252Bnon-nucleoside%252Breverse%252Btranscriptase%252Binhibitors%252Bshow%252Blow%252Bnanomolar%252Binhibition%252Bof%252Bsingle%252Band%252Bdouble%252BHIV-1%252Bmutant%252Bstrains%26aulast%3DNalli%26aufirst%3DMarianna%26date%3D2020%26volume%3D208%26spage%3D112696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjiu  Chen</span>, <span class="hlFld-ContribAuthor ">Juan  Ma</span>, <span class="hlFld-ContribAuthor ">Ming  Xu</span>, <span class="hlFld-ContribAuthor ">Sijin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral nanoagents: More attention and effort needed?. </span><span class="cited-content_cbyCitation_journal-name">Nano Today</span><span> <strong>2020,</strong> <em>35 </em>, 100976. <a href="https://doi.org/10.1016/j.nantod.2020.100976" title="DOI URL">https://doi.org/10.1016/j.nantod.2020.100976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nantod.2020.100976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nantod.2020.100976%26sid%3Dliteratum%253Aachs%26jtitle%3DNano%2520Today%26atitle%3DAntiviral%252Bnanoagents%25253A%252BMore%252Battention%252Band%252Beffort%252Bneeded%25253F%26aulast%3DChen%26aufirst%3DYongjiu%26date%3D2020%26volume%3D35%26spage%3D100976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kwok-Fong  Chan</span>, <span class="hlFld-ContribAuthor ">Chinh Tran-To  Su</span>, <span class="hlFld-ContribAuthor ">Alexander  Krah</span>, <span class="hlFld-ContribAuthor ">Ser-Xian  Phua</span>, <span class="hlFld-ContribAuthor ">Joshua Yi  Yeo</span>, <span class="hlFld-ContribAuthor ">Wei-Li  Ling</span>, <span class="hlFld-ContribAuthor ">Peter J.  Bond</span>, <span class="hlFld-ContribAuthor ">Samuel Ken-En  Gan</span>. </span><span class="cited-content_cbyCitation_article-title">An Alternative HIV-1 Non-Nucleoside Reverse Transcriptase Inhibition Mechanism: Targeting the p51 Subunit. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 5902. <a href="https://doi.org/10.3390/molecules25245902" title="DOI URL">https://doi.org/10.3390/molecules25245902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25245902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25245902%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAn%252BAlternative%252BHIV-1%252BNon-Nucleoside%252BReverse%252BTranscriptase%252BInhibition%252BMechanism%25253A%252BTargeting%252Bthe%252Bp51%252BSubunit%26aulast%3DChan%26aufirst%3DKwok-Fong%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D5902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai Shashank  Chavali</span>, <span class="hlFld-ContribAuthor ">Sachitanand M.  Mali</span>, <span class="hlFld-ContribAuthor ">Jermaine L.  Jenkins</span>, <span class="hlFld-ContribAuthor ">Rudi  Fasan</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Wedekind</span>. </span><span class="cited-content_cbyCitation_article-title">Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2020,</strong> <em>295 </em>
                                    (49)
                                     , 16470-16486. <a href="https://doi.org/10.1074/jbc.RA120.015444" title="DOI URL">https://doi.org/10.1074/jbc.RA120.015444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA120.015444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA120.015444%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DCo-crystal%252Bstructures%252Bof%252BHIV%252BTAR%252BRNA%252Bbound%252Bto%252Blab-evolved%252Bproteins%252Bshow%252Bkey%252Broles%252Bfor%252Barginine%252Brelevant%252Bto%252Bthe%252Bdesign%252Bof%252Bcyclic%252Bpeptide%252BTAR%252Binhibitors%26aulast%3DChavali%26aufirst%3DSai%2BShashank%26date%3D2020%26volume%3D295%26issue%3D49%26spage%3D16470%26epage%3D16486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhao  Wang</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Da  Feng</span>, <span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Fu</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting dual tolerant regions of binding pocket: Discovery of novel morpholine-substituted diarylpyrimidines as potent HIV-1 NNRTIs with significantly improved water solubility. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112811. <a href="https://doi.org/10.1016/j.ejmech.2020.112811" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112811%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bdual%252Btolerant%252Bregions%252Bof%252Bbinding%252Bpocket%25253A%252BDiscovery%252Bof%252Bnovel%252Bmorpholine-substituted%252Bdiarylpyrimidines%252Bas%252Bpotent%252BHIV-1%252BNNRTIs%252Bwith%252Bsignificantly%252Bimproved%252Bwater%252Bsolubility%26aulast%3DWang%26aufirst%3DZhao%26date%3D2020%26volume%3D206%26spage%3D112811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattia  Mori</span>, <span class="hlFld-ContribAuthor ">Stefano  Ciaco</span>, <span class="hlFld-ContribAuthor ">Yves  Mély</span>, <span class="hlFld-ContribAuthor ">Anastasia  Karioti</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5434. <a href="https://doi.org/10.3390/molecules25225434" title="DOI URL">https://doi.org/10.3390/molecules25225434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225434%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DInhibitory%252BEffect%252Bof%252BLithospermic%252BAcid%252Bon%252Bthe%252BHIV-1%252BNucleocapsid%252BProtein%26aulast%3DMori%26aufirst%3DMattia%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Chu</span>, <span class="hlFld-ContribAuthor ">Qing-xiu  He</span>, <span class="hlFld-ContribAuthor ">Jun-wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ya-ting  Deng</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Hu</span>, <span class="hlFld-ContribAuthor ">Yuan-qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-hua  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR, molecular docking, and molecular dynamics simulation of a novel thieno[3,4-d]pyrimidine inhibitor targeting human immunodeficiency virus type 1 reverse transcriptase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (15)
                                     , 4567-4578. <a href="https://doi.org/10.1080/07391102.2019.1697366" title="DOI URL">https://doi.org/10.1080/07391102.2019.1697366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1697366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1697366%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3D3D-QSAR%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulation%252Bof%252Ba%252Bnovel%252Bthieno%25255B3%25252C4-d%25255Dpyrimidine%252Binhibitor%252Btargeting%252Bhuman%252Bimmunodeficiency%252Bvirus%252Btype%252B1%252Breverse%252Btranscriptase%26aulast%3DChu%26aufirst%3DHan%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D15%26spage%3D4567%26epage%3D4578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahya I  Asiri</span>, <span class="hlFld-ContribAuthor ">Abdulrhman  Alsayari</span>, <span class="hlFld-ContribAuthor ">Abdullatif B  Muhsinah</span>, <span class="hlFld-ContribAuthor ">Yahia N  Mabkhot</span>, <span class="hlFld-ContribAuthor ">Mohd Z  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Benzothiazoles as potential antiviral agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2020,</strong> <em>72 </em>
                                    (11)
                                     , 1459-1480. <a href="https://doi.org/10.1111/jphp.13331" title="DOI URL">https://doi.org/10.1111/jphp.13331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.13331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.13331%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DBenzothiazoles%252Bas%252Bpotential%252Bantiviral%252Bagents%26aulast%3DAsiri%26aufirst%3DYahya%2BI%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D11%26spage%3D1459%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Luo</span>, <span class="hlFld-ContribAuthor ">Cherukupalli  Srinivasulu</span>, <span class="hlFld-ContribAuthor ">Xia  Hao</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">The increasing impact of Chinese innovative drug research on the global stage with a focus on drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 1115-1120. <a href="https://doi.org/10.1080/17460441.2020.1775577" title="DOI URL">https://doi.org/10.1080/17460441.2020.1775577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1775577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1775577%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bincreasing%252Bimpact%252Bof%252BChinese%252Binnovative%252Bdrug%252Bresearch%252Bon%252Bthe%252Bglobal%252Bstage%252Bwith%252Ba%252Bfocus%252Bon%252Bdrug%252Bdiscovery%26aulast%3DLuo%26aufirst%3DWei%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D1115%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuang-Xi  Gu</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Gen-Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Shuang  Cao</span>, <span class="hlFld-ContribAuthor ">Lu  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent discoveries in HIV-1 reverse transcriptase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2020,</strong> <em>54 </em>, 166-172. <a href="https://doi.org/10.1016/j.coph.2020.09.017" title="DOI URL">https://doi.org/10.1016/j.coph.2020.09.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.09.017%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DRecent%252Bdiscoveries%252Bin%252BHIV-1%252Breverse%252Btranscriptase%252Binhibitors%26aulast%3DGu%26aufirst%3DShuang-Xi%26date%3D2020%26volume%3D54%26spage%3D166%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murugesan  Vanangamudi</span>, <span class="hlFld-ContribAuthor ">Sonali  Kurup</span>, <span class="hlFld-ContribAuthor ">Vigneshwaran  Namasivayam</span>. </span><span class="cited-content_cbyCitation_article-title">Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2020,</strong> <em>54 </em>, 179-187. <a href="https://doi.org/10.1016/j.coph.2020.10.009" title="DOI URL">https://doi.org/10.1016/j.coph.2020.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DNon-nucleoside%252Breverse%252Btranscriptase%252Binhibitors%252B%252528NNRTIs%252529%25253A%252Ba%252Bbrief%252Boverview%252Bof%252Bclinically%252Bapproved%252Bdrugs%252Band%252Bcombination%252Bregimens%26aulast%3DVanangamudi%26aufirst%3DMurugesan%26date%3D2020%26volume%3D54%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanzheng  Xie</span>, <span class="hlFld-ContribAuthor ">Lei  Xie</span>, <span class="hlFld-ContribAuthor ">Ailan  Chen</span>, <span class="hlFld-ContribAuthor ">Shengnan  Wu</span>, <span class="hlFld-ContribAuthor ">Yuxiao  Mo</span>, <span class="hlFld-ContribAuthor ">Xiaoqiang  Guo</span>, <span class="hlFld-ContribAuthor ">Changchun  Zeng</span>, <span class="hlFld-ContribAuthor ">Xinan  Huang</span>, <span class="hlFld-ContribAuthor ">Jinyang  He</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HIV/SIV activity of icariin and its metabolite anhydroicaritin mainly involve reverse transcriptase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2020,</strong> <em>884 </em>, 173327. <a href="https://doi.org/10.1016/j.ejphar.2020.173327" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.173327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.173327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.173327%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DAnti-HIV%25252FSIV%252Bactivity%252Bof%252Bicariin%252Band%252Bits%252Bmetabolite%252Banhydroicaritin%252Bmainly%252Binvolve%252Breverse%252Btranscriptase%26aulast%3DXie%26aufirst%3DYanzheng%26date%3D2020%26volume%3D884%26spage%3D173327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olujide O.  Olubiyi</span>, <span class="hlFld-ContribAuthor ">Thomas O.  Idowu</span>, <span class="hlFld-ContribAuthor ">Abiodun O.  Ogundaini</span>, <span class="hlFld-ContribAuthor ">Goodness  Orhuah</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Prospecting for the Pharmacological Mechanism of Activity: HIV-1 Inhibition by Ixoratannin A-2. </span><span class="cited-content_cbyCitation_journal-name">Current Computer-Aided Drug Design</span><span> <strong>2020,</strong> <em>16 </em>
                                    (4)
                                     , 376-388. <a href="https://doi.org/10.2174/1573409915666190702111023" title="DOI URL">https://doi.org/10.2174/1573409915666190702111023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573409915666190702111023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573409915666190702111023%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Computer-Aided%2520Drug%2520Design%26atitle%3DComputational%252BProspecting%252Bfor%252Bthe%252BPharmacological%252BMechanism%252Bof%252BActivity%25253A%252BHIV-1%252BInhibition%252Bby%252BIxoratannin%252BA-2%26aulast%3DOlubiyi%26aufirst%3DOlujide%2BO.%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D376%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songkai  Sun</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhuo  Li</span>, <span class="hlFld-ContribAuthor ">Zhao  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (16)
                                     , 127287. <a href="https://doi.org/10.1016/j.bmcl.2020.127287" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127287%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotential%252Bdual-target%252Bprodrugs%252Bof%252BHIV-1%252Breverse%252Btranscriptase%252Band%252Bnucleocapsid%252Bprotein%252B7%26aulast%3DSun%26aufirst%3DSongkai%26date%3D2020%26volume%3D30%26issue%3D16%26spage%3D127287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanjing  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Xiong</span>, <span class="hlFld-ContribAuthor ">Aman Chandra  Kaushik</span>, <span class="hlFld-ContribAuthor ">Junaid  Muhammad</span>, <span class="hlFld-ContribAuthor ">Abbas  Khan</span>, <span class="hlFld-ContribAuthor ">Hao  Dai</span>, <span class="hlFld-ContribAuthor ">Dong-Qing  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">New strategy for identifying potential natural HIV-1 non-nucleoside reverse transcriptase inhibitors against drug-resistance: an
              in silico
              study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (11)
                                     , 3327-3341. <a href="https://doi.org/10.1080/07391102.2019.1656673" title="DOI URL">https://doi.org/10.1080/07391102.2019.1656673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1656673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1656673%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DNew%252Bstrategy%252Bfor%252Bidentifying%252Bpotential%252Bnatural%252BHIV-1%252Bnon-nucleoside%252Breverse%252Btranscriptase%252Binhibitors%252Bagainst%252Bdrug-resistance%25253A%252Ban%252Bin%252Bsilico%252Bstudy%26aulast%3DWang%26aufirst%3DYanjing%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D11%26spage%3D3327%26epage%3D3341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jintong  Du</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Jianbing  Wu</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Guobo  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Li  Rao</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">New techniques and strategies in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2020,</strong> <em>31 </em>
                                    (7)
                                     , 1695-1708. <a href="https://doi.org/10.1016/j.cclet.2020.03.028" title="DOI URL">https://doi.org/10.1016/j.cclet.2020.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2020.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2020.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DNew%252Btechniques%252Band%252Bstrategies%252Bin%252Bdrug%252Bdiscovery%26aulast%3DDu%26aufirst%3DJintong%26date%3D2020%26volume%3D31%26issue%3D7%26spage%3D1695%26epage%3D1708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divine Mbom  Yufanyi</span>, <span class="hlFld-ContribAuthor ">Hanna S.  Abbo</span>, <span class="hlFld-ContribAuthor ">Salam J.J.  Titinchi</span>, <span class="hlFld-ContribAuthor ">Tambua  Neville</span>. </span><span class="cited-content_cbyCitation_article-title">Platinum(II) and Ruthenium(II) complexes in medicine: Antimycobacterial and Anti-HIV activities. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2020,</strong> <em>414 </em>, 213285. <a href="https://doi.org/10.1016/j.ccr.2020.213285" title="DOI URL">https://doi.org/10.1016/j.ccr.2020.213285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2020.213285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2020.213285%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DPlatinum%252528II%252529%252Band%252BRuthenium%252528II%252529%252Bcomplexes%252Bin%252Bmedicine%25253A%252BAntimycobacterial%252Band%252BAnti-HIV%252Bactivities%26aulast%3DYufanyi%26aufirst%3DDivine%2BMbom%26date%3D2020%26volume%3D414%26spage%3D213285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Dumond</span>, <span class="hlFld-ContribAuthor ">Jean-Marcel Julien  Tronchet</span>, <span class="hlFld-ContribAuthor ">Serge  Kirkiacharian</span>, <span class="hlFld-ContribAuthor ">Michel  Seman</span>, <span class="hlFld-ContribAuthor ">Michèle  Reboud-Ravaux</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into Biophysical Methods to Study Interactions Between HIV-1 Reverse Transcriptase and Non-nucleoside Reverse Transcriptase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (6)
                                     , 818-825. <a href="https://doi.org/10.2174/1570180816666190723121845" title="DOI URL">https://doi.org/10.2174/1570180816666190723121845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180816666190723121845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180816666190723121845%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DInsights%252Binto%252BBiophysical%252BMethods%252Bto%252BStudy%252BInteractions%252BBetween%252BHIV-1%252BReverse%252BTranscriptase%252Band%252BNon-nucleoside%252BReverse%252BTranscriptase%252BInhibitors%26aulast%3DDumond%26aufirst%3DJulien%26date%3D2020%26volume%3D17%26issue%3D6%26spage%3D818%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fenju  Wei</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez‐Arias</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in Small Molecular HIV‐1 and Hepatitis B Virus RNase H Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 273-292. <a href="https://doi.org/10.1002/9781119640868.ch9" title="DOI URL">https://doi.org/10.1002/9781119640868.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119640868.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119640868.ch9%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BDevelopments%252Bin%252BSmall%252BMolecular%252BHIV%2525E2%252580%2525901%252Band%252BHepatitis%252BB%252BVirus%252BRNase%252BH%252BInhibitors%26aulast%3DWei%26aufirst%3DFenju%26date%3D2020%26date%3D2020%26spage%3D273%26epage%3D292%26pub%3DWiley%26atitle%3DAdvances%252Bin%252BMetallodrugs%26aulast%3DShahid%25E2%2580%2590ul%25E2%2580%2590Islam%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergey  Ivanov</span>, <span class="hlFld-ContribAuthor ">Alexey  Lagunin</span>, <span class="hlFld-ContribAuthor ">Dmitry  Filimonov</span>, <span class="hlFld-ContribAuthor ">Olga  Tarasova</span>. </span><span class="cited-content_cbyCitation_article-title">Network-Based Analysis of OMICs Data to Understand the HIV–Host Interaction. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fmicb.2020.01314" title="DOI URL">https://doi.org/10.3389/fmicb.2020.01314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2020.01314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2020.01314%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DNetwork-Based%252BAnalysis%252Bof%252BOMICs%252BData%252Bto%252BUnderstand%252Bthe%252BHIV%2525E2%252580%252593Host%252BInteraction%26aulast%3DIvanov%26aufirst%3DSergey%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahanonu  SAVİOUR</span>, <span class="hlFld-ContribAuthor ">Gideon Adamu  SHALLANGWA</span>, <span class="hlFld-ContribAuthor ">Adamu  UZAIRU</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Structure and activity Relationship of 3a, 6a – Dihydro-1H- pyrrolo[ 3,4-c] pyrazole-4,6-dione Derivatives as anti HIV-1 Agents. </span><span class="cited-content_cbyCitation_journal-name">Turkish Computational and Theoretical Chemistry</span><span> <strong>2020,</strong> <em>4 </em>
                                    (1)
                                     , 32-38. <a href="https://doi.org/10.33435/tcandtc.624157" title="DOI URL">https://doi.org/10.33435/tcandtc.624157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.33435/tcandtc.624157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.33435%2Ftcandtc.624157%26sid%3Dliteratum%253Aachs%26jtitle%3DTurkish%2520Computational%2520and%2520Theoretical%2520Chemistry%26atitle%3DQuantitative%252BStructure%252Band%252Bactivity%252BRelationship%252Bof%252B3a%25252C%252B6a%252B%2525E2%252580%252593%252BDihydro-1H-%252Bpyrrolo%25255B%252B3%25252C4-c%25255D%252Bpyrazole-4%25252C6-dione%252BDerivatives%252Bas%252Banti%252BHIV-1%252BAgents%26aulast%3DSAV%25C4%25B0OUR%26aufirst%3DAhanonu%26date%3D2020%26date%3D2020%26volume%3D4%26issue%3D1%26spage%3D32%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>, <span class="hlFld-ContribAuthor ">Ronel  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Highlights in Anti‐infective Medicinal Chemistry from South Africa. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 809-826. <a href="https://doi.org/10.1002/cmdc.202000086" title="DOI URL">https://doi.org/10.1002/cmdc.202000086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000086%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BHighlights%252Bin%252BAnti%2525E2%252580%252590infective%252BMedicinal%252BChemistry%252Bfrom%252BSouth%252BAfrica%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D809%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Da  Feng</span>, <span class="hlFld-ContribAuthor ">Tiziana  Ginex</span>, <span class="hlFld-ContribAuthor ">Jinmi  Zou</span>, <span class="hlFld-ContribAuthor ">Fenju  Wei</span>, <span class="hlFld-ContribAuthor ">Tong  Zhao</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Yanying  Sun</span>, <span class="hlFld-ContribAuthor ">Samuel  Desta</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (5)
                                     , 878-894. <a href="https://doi.org/10.1016/j.apsb.2019.08.013" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.08.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.08.013%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DExploring%252Bthe%252Bhydrophobic%252Bchannel%252Bof%252BNNIBP%252Bleads%252Bto%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bpiperidine-substituted%252Bthiophene%25255B3%25252C2-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotent%252BHIV-1%252BNNRTIs%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2020%26volume%3D10%26issue%3D5%26spage%3D878%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Da  Feng</span>, <span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Yanying  Sun</span>, <span class="hlFld-ContribAuthor ">Fenju  Wei</span>, <span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>193 </em>, 112237. <a href="https://doi.org/10.1016/j.ejmech.2020.112237" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112237%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252Bsitu%252Bclick%252Bchemistry-based%252Brapid%252Bdiscovery%252Bof%252Bnovel%252BHIV-1%252BNNRTIs%252Bby%252Bexploiting%252Bthe%252Bhydrophobic%252Bchannel%252Band%252Btolerant%252Bregions%252Bof%252BNNIBP%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2020%26volume%3D193%26spage%3D112237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishal K.  Singh</span>, <span class="hlFld-ContribAuthor ">Ritika  Srivastava</span>, <span class="hlFld-ContribAuthor ">Parth Sarthi Sen  Gupta</span>, <span class="hlFld-ContribAuthor ">Farha  Naaz</span>, <span class="hlFld-ContribAuthor ">Himani  Chaurasia</span>, <span class="hlFld-ContribAuthor ">Richa  Mishra</span>, <span class="hlFld-ContribAuthor ">Malay Kumar  Rana</span>, <span class="hlFld-ContribAuthor ">Ramendra K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HIV potential of diarylpyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors: design, synthesis, docking, TOPKAT analysis and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>7 </em>, 1-17. <a href="https://doi.org/10.1080/07391102.2020.1748111" title="DOI URL">https://doi.org/10.1080/07391102.2020.1748111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1748111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1748111%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DAnti-HIV%252Bpotential%252Bof%252Bdiarylpyrimidine%252Bderivatives%252Bas%252Bnon-nucleoside%252Breverse%252Btranscriptase%252Binhibitors%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252Bdocking%25252C%252BTOPKAT%252Banalysis%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DSingh%26aufirst%3DVishal%2BK.%26date%3D2020%26date%3D2020%26volume%3D7%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting-Ting  Li</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Chun-Lin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Fen-Er  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1581. <a href="https://doi.org/10.3390/molecules25071581" title="DOI URL">https://doi.org/10.3390/molecules25071581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071581%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DScaffold%252BHopping%252Bin%252BDiscovery%252Bof%252BHIV-1%252BNon-Nucleoside%252BReverse%252BTranscriptase%252BInhibitors%25253A%252BFrom%252BCH%252528CN%252529-DABOs%252Bto%252BCH%252528CN%252529-DAPYs%26aulast%3DLi%26aufirst%3DTing-Ting%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. A.  Zolottsev</span>, <span class="hlFld-ContribAuthor ">A. S.  Latysheva</span>, <span class="hlFld-ContribAuthor ">V. S.  Pokrovsky</span>, <span class="hlFld-ContribAuthor ">I. I.  Khan</span>, <span class="hlFld-ContribAuthor ">R. L. M.  Almanza</span>, <span class="hlFld-ContribAuthor ">A. Y.  Misharin</span>. </span><span class="cited-content_cbyCitation_article-title">STEROID CONJUGATES AS POTENTIAL ANTI-CANCER AGENTS. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Biotherapy</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     , 22-52. <a href="https://doi.org/10.17650/1726-9784-2019-19-1-22-52" title="DOI URL">https://doi.org/10.17650/1726-9784-2019-19-1-22-52</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.17650/1726-9784-2019-19-1-22-52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.17650%2F1726-9784-2019-19-1-22-52%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Biotherapy%26atitle%3DSTEROID%252BCONJUGATES%252BAS%252BPOTENTIAL%252BANTI-CANCER%252BAGENTS%26aulast%3DZolottsev%26aufirst%3DV.%2BA.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D1%26spage%3D22%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Long-Sheng  Zheng</span>, <span class="hlFld-ContribAuthor ">Qi-Wei  Lang</span>, <span class="hlFld-ContribAuthor ">Congcong  Yin</span>, <span class="hlFld-ContribAuthor ">Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Phannarath  Phansavath</span>, <span class="hlFld-ContribAuthor ">Gen-Qiang  Chen</span>, <span class="hlFld-ContribAuthor ">Virginie  Ratovelomanana-Vidal</span>, <span class="hlFld-ContribAuthor ">Xumu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(
              iii
              )-Catalyzed diastereoselective transfer hydrogenation: an efficient entry to key intermediates of HIV protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (21)
                                     , 3119-3122. <a href="https://doi.org/10.1039/C9CC09793G" title="DOI URL">https://doi.org/10.1039/C9CC09793G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC09793G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC09793G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DRh%252528%252Biii%252B%252529-Catalyzed%252Bdiastereoselective%252Btransfer%252Bhydrogenation%25253A%252Ban%252Befficient%252Bentry%252Bto%252Bkey%252Bintermediates%252Bof%252BHIV%252Bprotease%252Binhibitors%26aulast%3DWang%26aufirst%3DFangyuan%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D21%26spage%3D3119%26epage%3D3122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Deng</span>, <span class="hlFld-ContribAuthor ">Jing  Liang</span>, <span class="hlFld-ContribAuthor ">Guang-Heng  Dong</span>, <span class="hlFld-ContribAuthor ">Yuan-Ling  Xia</span>, <span class="hlFld-ContribAuthor ">Yun-Xin  Fu</span>, <span class="hlFld-ContribAuthor ">Shu-Qun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulations reveal distinct differences in conformational dynamics and thermodynamics between the unliganded and CD4-bound states of HIV-1 gp120. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2020,</strong> <em>22 </em>
                                    (10)
                                     , 5548-5560. <a href="https://doi.org/10.1039/C9CP06706J" title="DOI URL">https://doi.org/10.1039/C9CP06706J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CP06706J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CP06706J%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DMolecular%252Bdynamics%252Bsimulations%252Breveal%252Bdistinct%252Bdifferences%252Bin%252Bconformational%252Bdynamics%252Band%252Bthermodynamics%252Bbetween%252Bthe%252Bunliganded%252Band%252BCD4-bound%252Bstates%252Bof%252BHIV-1%252Bgp120%26aulast%3DLi%26aufirst%3DYi%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D10%26spage%3D5548%26epage%3D5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yumeng  Wu</span>, <span class="hlFld-ContribAuthor ">Chengrun  Tang</span>, <span class="hlFld-ContribAuthor ">Ruomei  Rui</span>, <span class="hlFld-ContribAuthor ">Liumeng  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Ding</span>, <span class="hlFld-ContribAuthor ">Jiangyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiming  Li</span>, <span class="hlFld-ContribAuthor ">Christopher C.  Lai</span>, <span class="hlFld-ContribAuthor ">Yueping  Wang</span>, <span class="hlFld-ContribAuthor ">Ronghua  Luo</span>, <span class="hlFld-ContribAuthor ">Weilie  Xiao</span>, <span class="hlFld-ContribAuthor ">Hongbing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongtang  Zheng</span>, <span class="hlFld-ContribAuthor ">Yanping  He</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 512-528. <a href="https://doi.org/10.1016/j.apsb.2019.08.009" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bseries%252Bof%252B2-%252528%252528%2525285-akly%25252Faryl-1H-pyrazol-3-yl%252529methyl%252529thio%252529-5-alkyl-6-%252528cyclohexylmethyl%252529-pyrimidin-4%2525283H%252529-ones%252Bas%252Bpotential%252BHIV-1%252Binhibitors%26aulast%3DWu%26aufirst%3DYumeng%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D512%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Tianguang  Huang</span>, <span class="hlFld-ContribAuthor ">Alexej  Dick</span>, <span class="hlFld-ContribAuthor ">Megan E.  Meuser</span>, <span class="hlFld-ContribAuthor ">Waleed A.  Zalloum</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Simon  Cocklin</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112085. <a href="https://doi.org/10.1016/j.ejmech.2020.112085" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112085%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationships%252Bof%252B4-phenyl-1H-1%25252C2%25252C3-triazole%252Bphenylalanine%252Bderivatives%252Bas%252Bnovel%252BHIV-1%252Bcapsid%252Binhibitors%252Bwith%252Bpromising%252Bantiviral%252Bactivities%26aulast%3DSun%26aufirst%3DLin%26date%3D2020%26volume%3D190%26spage%3D112085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sui-Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Wei  Yan</span>, <span class="hlFld-ContribAuthor ">Bo-Lun  Hu</span>, <span class="hlFld-ContribAuthor ">Xing-Guo  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal and base-free thioannulation of propynamides with sodium sulfide and dichloromethane for the selective synthesis of 1,3-thiazin-4-ones and thiazolidine-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (12)
                                     , 131021. <a href="https://doi.org/10.1016/j.tet.2020.131021" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131021%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DTransition-metal%252Band%252Bbase-free%252Bthioannulation%252Bof%252Bpropynamides%252Bwith%252Bsodium%252Bsulfide%252Band%252Bdichloromethane%252Bfor%252Bthe%252Bselective%252Bsynthesis%252Bof%252B1%25252C3-thiazin-4-ones%252Band%252Bthiazolidine-4-ones%26aulast%3DWang%26aufirst%3DSui-Qian%26date%3D2020%26volume%3D76%26issue%3D12%26spage%3D131021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Lei</span>, <span class="hlFld-ContribAuthor ">Sheng  Han</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Fen-Er  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1050. <a href="https://doi.org/10.3390/molecules25051050" title="DOI URL">https://doi.org/10.3390/molecules25051050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051050%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Bof%252BBiphenyl-Substituted%252BDiarylpyrimidines%252Bwith%252Ba%252BCyanomethyl%252BLinker%252Bas%252BHIV-1%252BNNRTIs%252Bvia%252Ba%252BMolecular%252BHybridization%252BStrategy%26aulast%3DLei%26aufirst%3DYuan%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pouria  Shirvani</span>, <span class="hlFld-ContribAuthor ">Afshin  Fassihi</span>, <span class="hlFld-ContribAuthor ">Lotfollah  Saghaie</span>, <span class="hlFld-ContribAuthor ">Siska  Van Belle</span>, <span class="hlFld-ContribAuthor ">Zeger  Debyser</span>, <span class="hlFld-ContribAuthor ">Frauke  Christ</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anti-HIV-1 and antiproliferative evaluation of novel 4-nitroimidazole derivatives combined with 5-hydroxy-4-pyridinone moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1202 </em>, 127344. <a href="https://doi.org/10.1016/j.molstruc.2019.127344" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.127344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.127344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.127344%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Banti-HIV-1%252Band%252Bantiproliferative%252Bevaluation%252Bof%252Bnovel%252B4-nitroimidazole%252Bderivatives%252Bcombined%252Bwith%252B5-hydroxy-4-pyridinone%252Bmoiety%26aulast%3DShirvani%26aufirst%3DPouria%26date%3D2020%26volume%3D1202%26spage%3D127344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid  Stolbov</span>, <span class="hlFld-ContribAuthor ">Dmitry  Druzhilovskiy</span>, <span class="hlFld-ContribAuthor ">Anastasia  Rudik</span>, <span class="hlFld-ContribAuthor ">Dmitry  Filimonov</span>, <span class="hlFld-ContribAuthor ">Vladimir  Poroikov</span>, <span class="hlFld-ContribAuthor ">Marc  Nicklaus</span>, . </span><span class="cited-content_cbyCitation_article-title">AntiHIV-Pred: web-resource for in silico prediction of anti-HIV/AIDS activity. </span><span class="cited-content_cbyCitation_journal-name">Bioinformatics</span><span> <strong>2020,</strong> <em>36 </em>
                                    (3)
                                     , 978-979. <a href="https://doi.org/10.1093/bioinformatics/btz638" title="DOI URL">https://doi.org/10.1093/bioinformatics/btz638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bioinformatics/btz638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbioinformatics%2Fbtz638%26sid%3Dliteratum%253Aachs%26jtitle%3DBioinformatics%26atitle%3DAntiHIV-Pred%25253A%252Bweb-resource%252Bfor%252Bin%252Bsilico%252Bprediction%252Bof%252Banti-HIV%25252FAIDS%252Bactivity%26aulast%3DStolbov%26aufirst%3DLeonid%26date%3D2020%26date%3D2019%26volume%3D36%26issue%3D3%26spage%3D978%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhurvas Chandrasekaran  Dinesh</span>, <span class="hlFld-ContribAuthor ">Selvaraj  Tamilarasan</span>, <span class="hlFld-ContribAuthor ">Kaushik  Rajaram</span>, <span class="hlFld-ContribAuthor ">Evžen  Bouřa</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2020,</strong> <em>21 </em>
                                    (2)
                                     , 105-124. <a href="https://doi.org/10.2174/1389450119666190920153247" title="DOI URL">https://doi.org/10.2174/1389450119666190920153247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450119666190920153247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450119666190920153247%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DAntiviral%252BDrug%252BTargets%252Bof%252BSingle-Stranded%252BRNA%252BViruses%252BCausing%252BChronic%252BHuman%252BDiseases%26aulast%3DDinesh%26aufirst%3DDhurvas%2BChandrasekaran%26date%3D2020%26volume%3D21%26issue%3D2%26spage%3D105%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mrinmoy  Saha</span>, <span class="hlFld-ContribAuthor ">Shreya  Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">A Brief Overview on HIV Infection, Diagnosis and Treatment. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>19 </em>
                                    (30)
                                     , 2739-2741. <a href="https://doi.org/10.2174/156802661930200103091335" title="DOI URL">https://doi.org/10.2174/156802661930200103091335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/156802661930200103091335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F156802661930200103091335%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DA%252BBrief%252BOverview%252Bon%252BHIV%252BInfection%25252C%252BDiagnosis%252Band%252BTreatment%26aulast%3DSaha%26aufirst%3DMrinmoy%26date%3D2020%26volume%3D19%26issue%3D30%26spage%3D2739%26epage%3D2741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei  Zhu</span>, <span class="hlFld-ContribAuthor ">Ling  Ma</span>, <span class="hlFld-ContribAuthor ">Huiyu  Zhou</span>, <span class="hlFld-ContribAuthor ">Biao  Dong</span>, <span class="hlFld-ContribAuthor ">Yujia  Wang</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Jinming  Zhou</span>, <span class="hlFld-ContribAuthor ">Guoning  Zhang</span>, <span class="hlFld-ContribAuthor ">Juxian  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Liang</span>, <span class="hlFld-ContribAuthor ">Shan  Cen</span>, <span class="hlFld-ContribAuthor ">Yucheng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111866. <a href="https://doi.org/10.1016/j.ejmech.2019.111866" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111866</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111866%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPreliminary%252BSAR%252Band%252Bbiological%252Bevaluation%252Bof%252Bpotent%252BHIV-1%252Bprotease%252Binhibitors%252Bwith%252Bpyrimidine%252Bbases%252Bas%252Bnovel%252BP2%252Bligands%252Bto%252Benhance%252Bactivity%252Bagainst%252BDRV-resistant%252BHIV-1%252Bvariants%26aulast%3DZhu%26aufirst%3DMei%26date%3D2020%26volume%3D185%26spage%3D111866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MuhammadSulaiman  Zubair</span>, <span class="hlFld-ContribAuthor ">Saipul  Maulana</span>, <span class="hlFld-ContribAuthor ">Agustinus  Widodo</span>, <span class="hlFld-ContribAuthor ">Alwiyah  Mukaddas</span>, <span class="hlFld-ContribAuthor ">Ramadanil  Pitopang</span>. </span><span class="cited-content_cbyCitation_article-title">Docking study on anti-HIV-1 activity of secondary metabolites from Zingiberaceae plants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy And Bioallied Sciences</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 763. <a href="https://doi.org/10.4103/jpbs.JPBS_261_19" title="DOI URL">https://doi.org/10.4103/jpbs.JPBS_261_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/jpbs.JPBS_261_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2Fjpbs.JPBS_261_19%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520And%2520Bioallied%2520Sciences%26atitle%3DDocking%252Bstudy%252Bon%252Banti-HIV-1%252Bactivity%252Bof%252Bsecondary%252Bmetabolites%252Bfrom%252BZingiberaceae%252Bplants%26aulast%3DZubair%26aufirst%3DMuhammadSulaiman%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leandro S.  Sangenito</span>, <span class="hlFld-ContribAuthor ">Rubem F.S.  Menna-Barreto</span>, <span class="hlFld-ContribAuthor ">Cláudia M.  d'Avila-Levy</span>, <span class="hlFld-ContribAuthor ">Marta H.  Branquinha</span>, <span class="hlFld-ContribAuthor ">André L.S.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Repositioning of HIV Aspartyl Peptidase Inhibitors for Combating the Neglected Human Pathogen Trypanosoma cruzi. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (36)
                                     , 6590-6613. <a href="https://doi.org/10.2174/0929867326666190610152934" title="DOI URL">https://doi.org/10.2174/0929867326666190610152934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190610152934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190610152934%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRepositioning%252Bof%252BHIV%252BAspartyl%252BPeptidase%252BInhibitors%252Bfor%252BCombating%252Bthe%252BNeglected%252BHuman%252BPathogen%252BTrypanosoma%252Bcruzi%26aulast%3DSangenito%26aufirst%3DLeandro%2BS.%26date%3D2019%26volume%3D26%26issue%3D36%26spage%3D6590%26epage%3D6613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Tong  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhao  Wang</span>, <span class="hlFld-ContribAuthor ">Da  Feng</span>, <span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Fenju  Wei</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Zuo</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Communications Chemistry</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42004-019-0174-8" title="DOI URL">https://doi.org/10.1038/s42004-019-0174-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42004-019-0174-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42004-019-0174-8%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpiperidine-substituted%252Bthiazolo%25255B5%25252C4-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bbioavailable%252BHIV-1%252Bnon-nucleoside%252Breverse%252Btranscriptase%252Binhibitors%26aulast%3DKang%26aufirst%3DDongwei%26date%3D2019%26date%3D2019%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel N.  Solyev</span>, <span class="hlFld-ContribAuthor ">Daria K.  Sherman</span>, <span class="hlFld-ContribAuthor ">Roman A.  Novikov</span>, <span class="hlFld-ContribAuthor ">Eugenia A.  Levina</span>, <span class="hlFld-ContribAuthor ">Sergey N.  Kochetkov</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrazo coupling: the efficient transition-metal-free C–H functionalization of 8-hydroxyquinoline and phenol through base catalysis. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 6381-6389. <a href="https://doi.org/10.1039/C9GC02824B" title="DOI URL">https://doi.org/10.1039/C9GC02824B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC02824B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC02824B%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DHydrazo%252Bcoupling%25253A%252Bthe%252Befficient%252Btransition-metal-free%252BC%2525E2%252580%252593H%252Bfunctionalization%252Bof%252B8-hydroxyquinoline%252Band%252Bphenol%252Bthrough%252Bbase%252Bcatalysis%26aulast%3DSolyev%26aufirst%3DPavel%2BN.%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D23%26spage%3D6381%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Konstantin L.  Obydennov</span>, <span class="hlFld-ContribAuthor ">Tatiana V.  Glukhareva</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and properties of bi- and tricyclic 1,3-thiazoline/thiazolidine assemblies linked by an exocyclic С=С double bond. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2019,</strong> <em>55 </em>
                                    (11)
                                     , 1013-1034. <a href="https://doi.org/10.1007/s10593-019-02571-w" title="DOI URL">https://doi.org/10.1007/s10593-019-02571-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-019-02571-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-019-02571-w%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Band%252Bproperties%252Bof%252Bbi-%252Band%252Btricyclic%252B1%25252C3-thiazoline%25252Fthiazolidine%252Bassemblies%252Blinked%252Bby%252Ban%252Bexocyclic%252B%2525D0%2525A1%25253D%2525D0%2525A1%252Bdouble%252Bbond%26aulast%3DObydennov%26aufirst%3DKonstantin%2BL.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D11%26spage%3D1013%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tong  Zhao</span>, <span class="hlFld-ContribAuthor ">Qing  Meng</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jianbo  Ji</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111619. <a href="https://doi.org/10.1016/j.ejmech.2019.111619" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111619%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bindolylarylsulfones%252Bas%252Bpotent%252BHIV-1%252BNNRTIs%252Bvia%252Bstructure-guided%252Bscaffold%252Bmorphing%26aulast%3DZhao%26aufirst%3DTong%26date%3D2019%26volume%3D182%26spage%3D111619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zahra  Hajimahdi</span>, <span class="hlFld-ContribAuthor ">Rezvan  Zabihollahi</span>, <span class="hlFld-ContribAuthor ">Mohamad Reza  Aghasadeghi</span>, <span class="hlFld-ContribAuthor ">Afshin  Zarghi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Docking Studies and Biological Activities Novel 2,3- Diaryl-4-Quinazolinone Derivatives as Anti-HIV-1 Agents. </span><span class="cited-content_cbyCitation_journal-name">Current HIV Research</span><span> <strong>2019,</strong> <em>17 </em>
                                    (3)
                                     , 214-222. <a href="https://doi.org/10.2174/1570162X17666190911125359" title="DOI URL">https://doi.org/10.2174/1570162X17666190911125359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570162X17666190911125359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570162X17666190911125359%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520HIV%2520Research%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BDocking%252BStudies%252Band%252BBiological%252BActivities%252BNovel%252B2%25252C3-%252BDiaryl-4-Quinazolinone%252BDerivatives%252Bas%252BAnti-HIV-1%252BAgents%26aulast%3DHajimahdi%26aufirst%3DZahra%26date%3D2019%26volume%3D17%26issue%3D3%26spage%3D214%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mrinmoy  Saha</span>, <span class="hlFld-ContribAuthor ">Shreya  Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in the Medicinal Chemistry for New Small-Molecule Therapeutics to Treat HIV-AIDS. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (18)
                                     , 1569-1570. <a href="https://doi.org/10.2174/156802661918191009110427" title="DOI URL">https://doi.org/10.2174/156802661918191009110427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/156802661918191009110427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F156802661918191009110427%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BDevelopments%252Bin%252Bthe%252BMedicinal%252BChemistry%252Bfor%252BNew%252BSmall-Molecule%252BTherapeutics%252Bto%252BTreat%252BHIV-AIDS%26aulast%3DSaha%26aufirst%3DMrinmoy%26date%3D2019%26volume%3D19%26issue%3D18%26spage%3D1569%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uladzimir  Bildziukevich</span>, <span class="hlFld-ContribAuthor ">Zülal  Özdemir</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Wimmer</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Achievements in Medicinal and Supramolecular Chemistry of Betulinic Acid and Its Derivatives ‡. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (19)
                                     , 3546. <a href="https://doi.org/10.3390/molecules24193546" title="DOI URL">https://doi.org/10.3390/molecules24193546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24193546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24193546%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAchievements%252Bin%252BMedicinal%252Band%252BSupramolecular%252BChemistry%252Bof%252BBetulinic%252BAcid%252Band%252BIts%252BDerivatives%252B%2525E2%252580%2525A1%26aulast%3DBildziukevich%26aufirst%3DUladzimir%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D19%26spage%3D3546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Waleed A.  Zalloum</span>, <span class="hlFld-ContribAuthor ">Megan E.  Meuser</span>, <span class="hlFld-ContribAuthor ">Alexej  Dick</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Chin-Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Ruifang  Jia</span>, <span class="hlFld-ContribAuthor ">Simon  Cocklin</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (50)
                                     , 28961-28986. <a href="https://doi.org/10.1039/C9RA05869A" title="DOI URL">https://doi.org/10.1039/C9RA05869A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA05869A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA05869A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Bof%252Bnovel%252B1%25252C4-disubstituted%252B1%25252C2%25252C3-triazole%252Bphenylalanine%252Bderivatives%252Bas%252BHIV-1%252Bcapsid%252Binhibitors%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D50%26spage%3D28961%26epage%3D28986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Hao</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Zuo</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Contemporary medicinal-chemistry strategies for discovery of blood coagulation factor Xa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , 915-931. <a href="https://doi.org/10.1080/17460441.2019.1626821" title="DOI URL">https://doi.org/10.1080/17460441.2019.1626821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1626821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1626821%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DContemporary%252Bmedicinal-chemistry%252Bstrategies%252Bfor%252Bdiscovery%252Bof%252Bblood%252Bcoagulation%252Bfactor%252BXa%252Binhibitors%26aulast%3DHao%26aufirst%3DXia%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3D915%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Xiqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Mar  Álvarez</span>, <span class="hlFld-ContribAuthor ">Joanna  Luczkowiak</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (17)
                                     , 3836-3845. <a href="https://doi.org/10.1016/j.bmc.2019.07.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-hydroxyquinazoline-2%25252C4%2525281H%25252C3H%252529-diones%252Bas%252Bdual%252Binhibitors%252Bof%252BHIV-1%252Breverse%252Btranscriptase-associated%252BRNase%252BH%252Band%252Bintegrase%26aulast%3DGao%26aufirst%3DPing%26date%3D2019%26volume%3D27%26issue%3D17%26spage%3D3836%26epage%3D3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Herman  Nikolayevskiy</span>, <span class="hlFld-ContribAuthor ">Marco  Robello</span>, <span class="hlFld-ContribAuthor ">Michael T.  Scerba</span>, <span class="hlFld-ContribAuthor ">Evan H.  Pasternak</span>, <span class="hlFld-ContribAuthor ">Mrinmoy  Saha</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Hartman</span>, <span class="hlFld-ContribAuthor ">Caitlin A.  Buchholz</span>, <span class="hlFld-ContribAuthor ">Robert W.  Buckheit</span>, <span class="hlFld-ContribAuthor ">Stewart R.  Durell</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Appella</span>. </span><span class="cited-content_cbyCitation_article-title">The structure-activity profile of mercaptobenzamides’ anti-HIV activity suggests that thermodynamics of metabolism is more important than binding affinity to the target. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 818-837. <a href="https://doi.org/10.1016/j.ejmech.2019.06.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bstructure-activity%252Bprofile%252Bof%252Bmercaptobenzamides%2525E2%252580%252599%252Banti-HIV%252Bactivity%252Bsuggests%252Bthat%252Bthermodynamics%252Bof%252Bmetabolism%252Bis%252Bmore%252Bimportant%252Bthan%252Bbinding%252Baffinity%252Bto%252Bthe%252Btarget%26aulast%3DNikolayevskiy%26aufirst%3DHerman%26date%3D2019%26volume%3D178%26spage%3D818%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.5b00497&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00497%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=170&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0035.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of small molecules at novel sites of HIV PR. Protein Data Bank codes are the following: for <b>1</b> in the outside/top of the flap, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJ8">4EJ8</a>; for <b>2</b> in the outside/top of flap, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJK">4EJK</a>; for <b>3</b> in the flap site, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4Q">4K4Q</a>; for <b>4</b> in the exosite, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4R">4K4R</a>.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of fragments <b>5</b> and <b>6a</b> targeting dynamic pockets of HIV-1 PR by virtual screening and the results of further derivatization to afford <b>6b</b>,<b>c</b>, <b>7</b>, and <b>8a</b>,<b>b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Structures of new RT ligands <b>9</b>–<b>13</b> and the NNRTI <b>14</b> and (b–e) the results of crystallography of RT complexed with TMC278 and the corresponding ligands: (b) fragment <b>10</b> at the site adjacent to NNRTI (exemplified by TMC278) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFB">4KFB</a>); (c, d) fragments <b>11</b>,<b>12</b> near the Knuckles site (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IG3">4IG3</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IFY">4IFY</a>); (e) fragment <b>13</b> at the incoming dNTP binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ICL">4ICL</a>). (f) HIV-1 RT binders identified by STD NMR and functional assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Fragment-based screening and hit identification: (a) benzodioxole-based IN binder <b>20</b>; (b) LEDGF/p75 inhibitors <b>22</b> and <b>23</b>; (c) thioenylaminopyrazole fragment <b>24</b> (gp41 binder).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Flowchart of discovery of <b>25</b> and <b>26</b> as inhibitors of HIV-1 IN-LEDGF/p75 interaction via the privileged fragment-based reconstruction approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Discovery of a potent HIV-1 PR inhibitor by DLS employing AAC. When the reaction components simultaneously bind to the target, the rate of the usually slow cycloaddition significantly increases. Though the azide and the alkyne themselves are likely to be weak binders, the triazole is a much stronger ligand, as it is accessing to two binding sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Principle of the triazole-forming reaction to generate a library of HIV PR inhibitors, coupled with high-throughput screening (compounds <b>29</b>, <b>30</b>) and further modifications (compound <b>31</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery of HIV PR inhibitors via a hierarchical computational strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Flow diagram of discovery of piperidinylethanamine-base CXCR4 antagonist <b>37</b> via a hierarchical multiple-filter database searching protocol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Discovery of fused or highly merged RT/IN dual inhibitors based on the combination of RT inhibitor <b>38</b> with IN inhibitor <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Schematic representation of heterobivalent HIV-1 RT ligands consisting of NRTI and NNRTI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Antibody-recruiting small molecules <b>46</b> and <b>48</b> that target HIV gp120 and the mechanism of action of chemically programmed antibodies <b>49</b> and <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Discovery of NNRTI candidate lersivirine via scaffold refining and LE/LLE-guided optimization. HLM = human liver microsomes. LE (binding energy per heavy atom, kcal mol<sup>–1</sup>) = −1.4 log(RT IC<sub>50</sub>)/number of heavy atoms. LLE = −log(RT IC<sub>50</sub>) – clog P. RT IC<sub>50</sub> = <i>K</i><sub>i</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Discovery of HIV-1 IN strand-transfer inhibitor <b>53</b> and indole-based attachment inhibitor <b>55</b> by means of LE/LLE-guided optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Overcoming hERG affinity in the discovery of the CCR5 antagonist <b>56</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Novel indazole NNRTIs <b>69a</b>,<b>b</b> using crystallographic overlay-based molecular hybridization. Crystallographic overlay of the published RT cocrystal structures of <b>51</b> (green) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKO">1FKO</a>) and <b>68</b> (pink) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EP4">1EP4</a>) (other residues removed for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Crystallographic structure of <b>69a</b> (pink) in the NNRTI binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JLE">2JLE</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Two rotational isomers of the IN inhibitor <b>70</b> arise from rotation around the amide bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Crystal structure of the prototype foamy virus (PFV) intasome (a homologous protein of HIV IN) complexed with <b>70</b> (pale) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYF">3OYF</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Design of conformationally restricted HIV IN inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0022.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Development of (a) 1-[2-(diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazoles (DAMNIs) (exemplified by <b>78</b>),<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> (b) phenethylthiazolylthioureas (PETTs) (exemplified by <b>80</b>),<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> (c) 2,3-diaryl-1,3-thiazolidin-4-one (exemplified by <b>82</b>),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> 1,3-dihydro-2<i>H</i>-benzimidazol-2-one (exemplified by <b>84</b>),<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> and 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)benzimidazole (exemplified by <b>83</b>)<a onclick="showRef(event, 'ref117 ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref117 ref118 ref119">(117-119)</a> by dismantling parts of the rigid tricyclic scaffold of prototype leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0023.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Illustration of the phosphooxymethyl prodrug approach (top, hydrolysis of <b>85</b> via an unstable intermediate <b>86</b> to liberate <b>87</b>) and some examples of derivatization to obtain prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0024.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Schematic diagram illustrating the substrate envelope hypothesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0025.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Discovery of novel HIV-1 PR inhibitors <b>97</b> and <b>98</b> based on the substrate envelope hypothesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0026.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structure of <b>56</b> (pink carbons) complexed with CCR5 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS">4MBS</a>). (a) Key residues (blue carbons, in stick representation) in the CCR5 binding pocket involved in the interaction with <b>56</b>. A water molecule is displayed as a red sphere. (b) Schematic representation of interactions between CCR5 and <b>56</b> for surface presentation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0027.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structure of <b>99</b>, targeting Rev-mediated viral RNA biogenesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0028.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Function-oriented development of CXCR4 antagonists as selective HIV-1 entry inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0029.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Structure of the approved CXCR4 antagonist <b>104</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0030.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Conversion workflow of <b>105</b>–<b>106</b> (a partial CD4 agonist) to a full CD4 antagonist <b>107</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0031.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Disruption of HIV latency by HDAC inhibitors:<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> (a) structures of representative HDAC inhibitors; (b) mechanisms involved in the reactivation of latent HIV-1 by HDAC inhibitors. LTR: long-terminal repeat.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0032.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Representative NNRTIs as HIV microbicides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0033.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Schematic illustration of key issues in anti-HIV therapy and innovative medicinal chemistry methodologies and approaches available for anti-HIV drug discovery and development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/medium/jm-2015-004975_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0034.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures of HIV-1 integrase inhibitors <b>122</b> and <b>123</b> and their acetal carbonate prodrugs <b>124</b> and <b>125</b> (also an acetal carbonate–phosphate double prodrug).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b00497/20160804/images/large/jm-2015-004975_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00497&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 223 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Menéndez-Arias, L.</span><span> </span><span class="NLM_article-title">Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23403210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Cjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2013&pages=93-120&author=L.+Men%C3%A9ndez-Arias&title=Molecular+basis+of+human+immunodeficiency+virus+type+1+drug+resistance%3A+overview+and+recent+developments&doi=10.1016%2Fj.antiviral.2013.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments</span></div><div class="casAuthors">Menendez-Arias, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-120</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The introduction of potent combination therapies in the mid-90s had a tremendous effect on AIDS mortality.  However, drug resistance has been a major factor contributing to antiretroviral therapy failure.  Currently, there are 26 drugs approved for treating human immunodeficiency virus (HIV) infections, although some of them are no longer prescribed.  Most of the available antiretroviral drugs target HIV genome replication (i.e. reverse transcriptase inhibitors) and viral maturation (i.e. viral protease inhibitors).  Other drugs in clin. use include a viral coreceptor antagonist (maraviroc), a fusion inhibitor (enfuvirtide) and two viral integrase inhibitors (raltegravir and elvitegravir).  Elvitegravir and the nonnucleoside reverse transcriptase inhibitor rilpivirine have been the most recent addns. to the antiretroviral drug armamentarium.  An overview of the mol. mechanisms involved in antiretroviral drug resistance and the role of drug resistance-assocd. mutations was previously presented (Menendez-Arias, L., 2010. Mol. basis of human immunodeficiency virus drug resistance: an update. Antiviral Res. 85, 210-231).  This article provides now an updated review that covers currently approved drugs, new exptl. agents (e.g. neutralizing antibodies) and selected drugs in preclin. or early clin. development (e.g. exptl. integrase inhibitors).  Special attention is dedicated to recent research on resistance to reverse transcriptase and integrase inhibitors.  In addn., recently discovered interactions between HIV and host proteins and novel strategies to block HIV assembly or viral entry emerge as promising alternatives for the development of effective antiretroviral treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvrS_xWc_nfrVg90H21EOLACvtfcHk0ljHm0dc4CTW8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Cjs74%253D&md5=4d2d4cecae563206aab0c7fe23d19011</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DMen%25C3%25A9ndez-Arias%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520drug%2520resistance%253A%2520overview%2520and%2520recent%2520developments%26jtitle%3DAntiviral%2520Res.%26date%3D2013%26volume%3D98%26spage%3D93%26epage%3D120%26doi%3D10.1016%2Fj.antiviral.2013.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ghosh, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chawla, S.</span><span> </span><span class="NLM_article-title">Recent advances in antiretroviral drugs</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1517/14656566.2010.509345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F14656566.2010.509345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20698725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKqurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=31-46&author=R.+K.+Ghoshauthor=S.+M.+Ghoshauthor=S.+Chawla&title=Recent+advances+in+antiretroviral+drugs&doi=10.1517%2F14656566.2010.509345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in antiretroviral drugs</span></div><div class="casAuthors">Ghosh, Raktim Kumar; Ghosh, Samhati Mondal; Chawla, Shalini</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-46</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Acquired immunodeficiency syndrome (AIDS) is one of the leading causes of death worldwide.  Although the combination therapies of highly active antiretroviral therapy (HAART) have significantly contributed to virol. suppression, improved immune function and quality of life, issues such as tolerability, drug-drug interactions and cross-resistance amongst members of a particular drug class still pose a significant barrier to long-term successful treatment.  There is a const. need for newer anti HIV drugs with increased potency and improved pharmacokinetic properties either in the existing classes or drugs from new classes that target several new steps in HIV replication cycle.  Areas covered in this review: The authors have discussed newer antiretroviral drugs belonging to second-generation nucleoside analog reverse transcriptase inhibitors (amdoxovir, elvucitabine, apricitabine, racivir), non-nucleoside analog reverse transcriptase inhibitors (etravirine, rilpivirine), protease inhibitors (darunavir, tipranavir) as well as emerging new classes, i.e., fusion inhibitors (enfuvirtide, sifuvirtide), CCR5 inhibitors (maraviroc, vicriviroc, PRO 140, PRO 542), CD4-receptor inhibitors (ibalizumab), integrase inhibitors (raltegravir, elvitegravir, GSK-1349572), maturation inhibitors (bevirimat), cobicistat (pharmacoenhancer), lens epithelium-derived growth factor inhibitors and capsid assembly inhibitors.  What the reader will gain: The reader will gain an understanding of the mechanism of action, mechanism of resistance, stages of development and important clin. trials related to the newer antiretroviral drugs and future potential of these drugs.  Take home message: The initial clin. trial data of these newer drugs are very encouraging for the long-term successful control of HIV in both treatment-naive and treatment-experienced patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-A8fskGp2WrVg90H21EOLACvtfcHk0ljHm0dc4CTW8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKqurjO&md5=3bc4b28ebf919cbe449f3f94c28d7c7a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14656566.2010.509345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2010.509345%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DR.%2BK.%26aulast%3DGhosh%26aufirst%3DS.%2BM.%26aulast%3DChawla%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520antiretroviral%2520drugs%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26spage%3D31%26epage%3D46%26doi%3D10.1517%2F14656566.2010.509345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumpacker, C.</span><span> </span><span class="NLM_article-title">Eradication of HIV and cure of AIDS, now and how?</span> <span class="citation_source-journal">Front Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="refDoi"> DOI: 10.3389/fimmu.2013.00337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3389%2Ffimmu.2013.00337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24151495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2cfltlClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=337&author=J.+Zhangauthor=C.+Crumpacker&title=Eradication+of+HIV+and+cure+of+AIDS%2C+now+and+how%3F&doi=10.3389%2Ffimmu.2013.00337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Eradication of HIV and Cure of AIDS, Now and How?</span></div><div class="casAuthors">Zhang Jielin; Crumpacker Clyde</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">337</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">Recent studies have highlighted the importance of eradication of human immunodeficiency virus (HIV) and cure of acquired immunodeficiency syndrome (AIDS).  However, a pivotal point that the patient immunity controls HIV reactivation after highly active anti-retroviral therapy [HAART or combination anti-retroviral therapy (cART)] remains less well addressed.  In spite of the fact that both innate and adaptive immunities are indispensable and numerous cells participate in the anti-HIV immunity, memory CD4 T-cells are indisputably the key cells organizing all immune actions against HIV while being the targets of HIV.  Here we present a view and multidisciplinary approaches to HIV/AIDS eradication and cure.  We aim at memory CD4 T-cells, utilizing the stem cell properties of these cells to reprogram an anti-HIV memory repertoire to eliminate the viral reservoir, toward achieving an AIDS-free world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0LHjcR5VvfMkU0YCbOU3EfW6udTcc2eaLBJhjozQ2sLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfltlClsw%253D%253D&md5=d1124b8ac1a5dbc4923c0dde52a77e00</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2013.00337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2013.00337%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCrumpacker%26aufirst%3DC.%26atitle%3DEradication%2520of%2520HIV%2520and%2520cure%2520of%2520AIDS%252C%2520now%2520and%2520how%253F%26jtitle%3DFront%2520Immunol.%26date%3D2013%26volume%3D4%26spage%3D337%26doi%3D10.3389%2Ffimmu.2013.00337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Antiretroviral drugs</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1016/j.coph.2010.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.coph.2010.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20471318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygurbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=507-515&author=E.+De+Clercq&title=Antiretroviral+drugs&doi=10.1016%2Fj.coph.2010.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antiretroviral drugs</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-515</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In Oct. 2010, it will be exactly 25 years ago that the first antiretroviral drug, AZT (zidovudine, 3'-azido-2',3'-dideoxythymidine), was described.  It was the first of 25 antiretroviral drugs that in the past 25 years have been formally licensed for clin. use.  These antiretroviral drugs fall into seven categories nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FIs), co-receptor inhibitors (CRIs) and integrase inhibitors (INIs).  The INIs (i.e. raltegravir) represent the most recent advance in the search for effective and selective anti-HIV agents.  Combination of several anti-HIV drugs [often referred to as highly active antiretroviral therapy (HAART)] has drastically altered AIDS from an almost uniformly fatal disease to a chronic manageable one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCPVCVhWJFaLVg90H21EOLACvtfcHk0li8aLOfwQwVMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygurbP&md5=420f862f94677ac5d961f4462a4d4797</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DAntiretroviral%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D507%26epage%3D515%26doi%3D10.1016%2Fj.coph.2010.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS)</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1016/B978-0-12-405880-4.00009-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FB978-0-12-405880-4.00009-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23886005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=317-358&author=E.+De+Clercq&title=The+nucleoside+reverse+transcriptase+inhibitors%2C+nonnucleoside+reverse+transcriptase+inhibitors%2C+and+protease+inhibitors+in+the+treatment+of+HIV+infections+%28AIDS%29&doi=10.1016%2FB978-0-12-405880-4.00009-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS)</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">Antiviral Agents</span>),
    <span class="NLM_cas:pages">317-358</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The majority of the drugs currently used for the treatment of HIV infections (AIDS) belong to either of the following three classes: nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs).  At present, there are 7 NRTIs, 5 NNRTIs, and 10 PIs approved for clin. use.  They are discussed from the following viewpoints: (i) chem. formulas; (ii) mechanism of action; (iii) drug combinations; (iv) clin. aspects; (v) preexposure prophylaxis; (vi) prevention of mother-to-child transmission; (vii) their use in children; (viii) toxicity; (ix) adherence (compliance); (x) resistance; (xi) new NRTIs, NNRTIs, or PIs in (pre)clin. development; and (xii) the prospects for a "cure" of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1maBDcG5yerVg90H21EOLACvtfcHk0li8aLOfwQwVMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kku7jP&md5=aff6298471b1d27934035206151f75c5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-405880-4.00009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-405880-4.00009-3%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520nucleoside%2520reverse%2520transcriptase%2520inhibitors%252C%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitors%252C%2520and%2520protease%2520inhibitors%2520in%2520the%2520treatment%2520of%2520HIV%2520infections%2520%2528AIDS%2529%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2013%26volume%3D67%26spage%3D317%26epage%3D358%26doi%3D10.1016%2FB978-0-12-405880-4.00009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Dancing with chemical formulae of antivirals: a personal account</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bcp.2013.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23876344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=711-725&author=E.+De+Clercq&title=Dancing+with+chemical+formulae+of+antivirals%3A+a+personal+account&doi=10.1016%2Fj.bcp.2013.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Dancing with chemical formulae of antivirals: A personal account</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">711-725</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A chem. structure is a joy forever, and this is how I perceived the chem. structures of a no. of antiviral compds. with which I have been personally acquainted over the past 3 decades: (1) amino acid esters of acyclovir (i.e. valaciclovir); (2) 5-substituted 2'-deoxyuridines (i.e. brivudin); (3) 2',3'-dideoxynucleoside analogs (i.e. stavudine); (4) acyclic nucleoside phosphonates (ANPs) (i.e. cidofovir, adefovir); (5) tenofovir disoproxil fumarate (TDF) and drug combinations therewith; (6) tenofovir alafenamide (TAF, GS-7340), a new phosphonoamidate prodrug of tenofovir; (7) pro-prodrugs of PMEG (i.e. GS-9191 and GS-9219); (8) new ANPs: O-DAPy and 5-aza-C phosphonates; (9) non-nucleoside reverse transcriptase inhibitors (NNRTIs): HEPT and TIBO derivs.; and (10) bicyclam derivs. (i.e. AMD3100).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPuHJzFVMivrVg90H21EOLACvtfcHk0lgHISJb9I_AAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emt77I&md5=db37a140f4d8443380b6e5d378d962d5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DDancing%2520with%2520chemical%2520formulae%2520of%2520antivirals%253A%2520a%2520personal%2520account%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D711%26epage%3D725%26doi%3D10.1016%2Fj.bcp.2013.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Dancing with chemical formulae of antivirals: A panoramic view (Part 2)</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bcp.2013.09.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=1397-1410&author=E.+De+Clercq&title=Dancing+with+chemical+formulae+of+antivirals%3A+A+panoramic+view+%28Part+2%29&doi=10.1016%2Fj.bcp.2013.09.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DDancing%2520with%2520chemical%2520formulae%2520of%2520antivirals%253A%2520A%2520panoramic%2520view%2520%2528Part%25202%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D1397%26epage%3D1410%26doi%3D10.1016%2Fj.bcp.2013.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kim, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, J. C.</span><span> </span><span class="NLM_article-title">Identification of a novel type of small molecule inhibitor against HIV-1</span> <span class="citation_source-journal">BMB Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.5483/BMBRep.2015.48.2.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.5483%2FBMBRep.2015.48.2.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25413304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=121-126&author=B.+S.+Kimauthor=J.+A.+Parkauthor=M.+J.+Kimauthor=S.+H.+Kimauthor=K.+L.+Yuauthor=J.+C.+You&title=Identification+of+a+novel+type+of+small+molecule+inhibitor+against+HIV-1&doi=10.5483%2FBMBRep.2015.48.2.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel type of small molecule inhibitor against HIV-1</span></div><div class="casAuthors">Kim, Byung Soo; Park, Jung Ae; Kim, Min-Jung; Kim, Seon Hee; Yu, Kyung Lee; You, Ji Chang</div><div class="citationInfo"><span class="NLM_cas:title">BMB Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-126</span>CODEN:
                <span class="NLM_cas:coden">BRMEC2</span>;
        ISSN:<span class="NLM_cas:issn">1976-670X</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Here we report a new chem. inhibitor against HIV-1 with a novel structure and mode of action.  The inhibitor, designated as A1836, inhibited HIV-1 replication and virus prodn. with a 50% inhibitory concn. (IC50) of 2.0 μM in an MT-4 cell-based and cytopathic protection antiviral assay, while its 50% cytotoxic concn. (CC50) was much higher than 50 μM.  Examn. of the effect of A1836 on in vitro HIV-1 reverse transcriptase (RT) and integrase showed that neither were mol. targets of A1836.  The characterization and re-infection assay of the HIV-1 virions generated in the presence of A1836 showed that the synthesis of early RT products in the cells infected with the virions was inhibited dose-dependently, due in part to abnormal protein formation within the virions, thus resulting in an impaired infectivity.  These results suggest that A1836 might be a novel candidate for the development of a new type of HIV-1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Rr6_7JYh9rVg90H21EOLACvtfcHk0lgHISJb9I_AAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGqsrzL&md5=8f1d00396d450ad95a40eaf65c7fae5c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2015.48.2.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2015.48.2.239%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DYu%26aufirst%3DK.%2BL.%26aulast%3DYou%26aufirst%3DJ.%2BC.%26atitle%3DIdentification%2520of%2520a%2520novel%2520type%2520of%2520small%2520molecule%2520inhibitor%2520against%2520HIV-1%26jtitle%3DBMB%2520Rep.%26date%3D2015%26volume%3D48%26spage%3D121%26epage%3D126%26doi%3D10.5483%2FBMBRep.2015.48.2.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kim, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cechetto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boese, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenistein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brondani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, P.</span><span> </span><span class="NLM_article-title">Identification of a novel sulfonamide non-nucleoside reverse transcriptase inhibitor by a phenotypic HIV-1 full replication assay</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68767</span><span class="refDoi"> DOI: 10.1371/journal.pone.0068767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0068767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68767&author=T.+H.+Kimauthor=Y.+Koauthor=T.+Christopheauthor=J.+Cechettoauthor=J.+Kimauthor=K.+A.+Kimauthor=A.+S.+Boeseauthor=J.+M.+Garciaauthor=D.+Fenisteinauthor=M.+K.+Juauthor=J.+Kimauthor=S.+J.+Hanauthor=H.+J.+Kwonauthor=V.+Brondaniauthor=P.+Sommer&title=Identification+of+a+novel+sulfonamide+non-nucleoside+reverse+transcriptase+inhibitor+by+a+phenotypic+HIV-1+full+replication+assay&doi=10.1371%2Fjournal.pone.0068767"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068767%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.%2BH.%26aulast%3DKo%26aufirst%3DY.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DCechetto%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%2BA.%26aulast%3DBoese%26aufirst%3DA.%2BS.%26aulast%3DGarcia%26aufirst%3DJ.%2BM.%26aulast%3DFenistein%26aufirst%3DD.%26aulast%3DJu%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DS.%2BJ.%26aulast%3DKwon%26aufirst%3DH.%2BJ.%26aulast%3DBrondani%26aufirst%3DV.%26aulast%3DSommer%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520a%2520novel%2520sulfonamide%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitor%2520by%2520a%2520phenotypic%2520HIV-1%2520full%2520replication%2520assay%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68767%26doi%3D10.1371%2Fjournal.pone.0068767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span> </span><span class="NLM_article-title">Combining biophysical screening and X-ray crystallography for fragment-based drug discovery</span> <span class="citation_source-journal">Top. Curr. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1007/128_2011_225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2F128_2011_225" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=115-143&author=M.+Hennigauthor=A.+Rufauthor=W.+Huber&title=Combining+biophysical+screening+and+X-ray+crystallography+for+fragment-based+drug+discovery&doi=10.1007%2F128_2011_225"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F128_2011_225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2011_225%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DHuber%26aufirst%3DW.%26atitle%3DCombining%2520biophysical%2520screening%2520and%2520X-ray%2520crystallography%2520for%2520fragment-based%2520drug%2520discovery%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2011%26volume%3D317%26spage%3D115%26epage%3D143%26doi%3D10.1007%2F128_2011_225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Scott, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyne, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abell, C.</span><span> </span><span class="NLM_article-title">Fragment-based approaches in drug discovery and chemical biology</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4990</span><span class="NLM_x">–</span> <span class="NLM_lpage">5003</span><span class="refDoi"> DOI: 10.1021/bi3005126</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3005126" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4990-5003&author=D.+E.+Scottauthor=A.+G.+Coyneauthor=S.+A.+Hudsonauthor=C.+Abell&title=Fragment-based+approaches+in+drug+discovery+and+chemical+biology&doi=10.1021%2Fbi3005126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approaches in Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Scott, Duncan E.; Coyne, Anthony G.; Hudson, Sean A.; Abell, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4990-5003</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fragment-based approaches to finding novel small mols. that bind to proteins are now firmly established in drug discovery and chem. biol.  Initially developed primarily in a few centers in the biotech and pharma industry, this methodol. has now been adopted widely in both the pharmaceutical industry and academia.  After the initial success with kinase targets, the versatility of this approach has now expanded to a broad range of different protein classes.  Herein we describe recent fragment-based approaches to a wide range of target types, including Hsp90, β-secretase, and allosteric sites in human immunodeficiency virus protease and fanesyl pyrophosphate synthase.  The role of fragment-based approaches in an academic research environment is also examd. with an emphasis on neglected diseases such as tuberculosis.  The development of a fragment library, the fragment screening process, and the subsequent fragment hit elaboration will be discussed using examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2ry6mWC83bVg90H21EOLACvtfcHk0lgoMXuyY9XIjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosV2qsLY%253D&md5=39a6f0f741e711fd572e24c95142f55d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi3005126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3005126%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DCoyne%26aufirst%3DA.%2BG.%26aulast%3DHudson%26aufirst%3DS.%2BA.%26aulast%3DAbell%26aufirst%3DC.%26atitle%3DFragment-based%2520approaches%2520in%2520drug%2520discovery%2520and%2520chemical%2520biology%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D4990%26epage%3D5003%26doi%3D10.1021%2Fbi3005126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Krimm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancelin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praly, J. P.</span><span> </span><span class="NLM_article-title">Binding evaluation of fragment-based scaffolds for probing allosteric enzymes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1287</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span><span class="refDoi"> DOI: 10.1021/jm201439b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201439b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1287-1295&author=I.+Krimmauthor=J.+M.+Lancelinauthor=J.+P.+Praly&title=Binding+evaluation+of+fragment-based+scaffolds+for+probing+allosteric+enzymes&doi=10.1021%2Fjm201439b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm201439b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201439b%26sid%3Dliteratum%253Aachs%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DLancelin%26aufirst%3DJ.%2BM.%26aulast%3DPraly%26aufirst%3DJ.%2BP.%26atitle%3DBinding%2520evaluation%2520of%2520fragment-based%2520scaffolds%2520for%2520probing%2520allosteric%2520enzymes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1287%26epage%3D1295%26doi%3D10.1021%2Fjm201439b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baksh, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Happer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perryman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torbett, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Small molecule regulation of protein conformation by binding in the Flap of HIV protease</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span><span class="refDoi"> DOI: 10.1021/cb300611p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300611p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1223-1231&author=T.+Tiefenbrunnauthor=S.+Forliauthor=M.+M.+Bakshauthor=M.+W.+Changauthor=M.+Happerauthor=Y.+C.+Linauthor=A.+L.+Perrymanauthor=J.+K.+Rheeauthor=B.+E.+Torbettauthor=A.+J.+Olsonauthor=J.+H.+Elderauthor=M.+G.+Finnauthor=C.+D.+Stout&title=Small+molecule+regulation+of+protein+conformation+by+binding+in+the+Flap+of+HIV+protease&doi=10.1021%2Fcb300611p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcb300611p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300611p%26sid%3Dliteratum%253Aachs%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DBaksh%26aufirst%3DM.%2BM.%26aulast%3DChang%26aufirst%3DM.%2BW.%26aulast%3DHapper%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DPerryman%26aufirst%3DA.%2BL.%26aulast%3DRhee%26aufirst%3DJ.%2BK.%26aulast%3DTorbett%26aufirst%3DB.%2BE.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DSmall%2520molecule%2520regulation%2520of%2520protein%2520conformation%2520by%2520binding%2520in%2520the%2520Flap%2520of%2520HIV%2520protease%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1223%26epage%3D1231%26doi%3D10.1021%2Fcb300611p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Happer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Crystallographic fragment-based drug discovery: use of a brominated fragment library targeting HIV protease</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1111/cbdd.12227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fcbdd.12227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23998903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=141-148&author=T.+Tiefenbrunnauthor=S.+Forliauthor=M.+Happerauthor=A.+Gonzalezauthor=Y.+Tsaiauthor=M.+Soltisauthor=J.+H.+Elderauthor=A.+J.+Olsonauthor=C.+D.+Stout&title=Crystallographic+fragment-based+drug+discovery%3A+use+of+a+brominated+fragment+library+targeting+HIV+protease&doi=10.1111%2Fcbdd.12227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease</span></div><div class="casAuthors">Tiefenbrunn, Theresa; Forli, Stefano; Happer, Meaghan; Gonzalez, Ana; Tsai, Yingssu; Soltis, Michael; Elder, John H.; Olson, Arthur J.; Stout, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A library of 68 brominated fragments was screened against a new crystal form of inhibited HIV-1 protease in order to probe surface sites in soaking expts.  Often, fragments are weak binders with partial occupancy, resulting in weak, difficult-to-fit electron d.  The use of a brominated fragment library addresses this challenge, as bromine can be located unequivocally via anomalous scattering.  Data collection was carried out in an automated fashion using AutoDrug at SSRL.  Novel hits were identified in the known surface sites: 3-bromo-2,6-dimethoxybenzoic acid (Br6) in the flap site and 1-bromo-2-naphthoic acid (Br27) in the exosite, expanding the chem. of known fragments for development of higher affinity potential allosteric inhibitors.  At the same time, mapping the binding sites of a no. of weaker binding Br-fragments provides further insight into the nature of these surface pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhTrhnhMsliLVg90H21EOLACvtfcHk0lhA7quL-zzhHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFymsg%253D%253D&md5=1fc5fec8c0511d4b288795ccc407cf3e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12227%26sid%3Dliteratum%253Aachs%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHapper%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DTsai%26aufirst%3DY.%26aulast%3DSoltis%26aufirst%3DM.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DCrystallographic%2520fragment-based%2520drug%2520discovery%253A%2520use%2520of%2520a%2520brominated%2520fragment%2520library%2520targeting%2520HIV%2520protease%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D83%26spage%3D141%26epage%3D148%26doi%3D10.1111%2Fcbdd.12227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Deng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perryman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span> </span><span class="NLM_article-title">Distinguishing Binders from false positives by free energy calculations: fragment screening against the flap site of HIV protease</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1021/jp506376z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp506376z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVykur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2015&pages=976-988&author=N.+Dengauthor=S.+Forliauthor=P.+Heauthor=A.+Perrymanauthor=L.+Wickstromauthor=R.+S.+Vijayanauthor=T.+Tiefenbrunnauthor=D.+Stoutauthor=E.+Gallicchioauthor=A.+J.+Olsonauthor=R.+M.+Levy&title=Distinguishing+Binders+from+false+positives+by+free+energy+calculations%3A+fragment+screening+against+the+flap+site+of+HIV+protease&doi=10.1021%2Fjp506376z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease</span></div><div class="casAuthors">Deng, Nanjie; Forli, Stefano; He, Peng; Perryman, Alex; Wickstrom, Lauren; Vijayan, R. S. K.; Tiefenbrunn, Theresa; Stout, David; Gallicchio, Emilio; Olson, Arthur J.; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">976-988</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. docking is a powerful tool used in drug discovery and structural biol. for predicting the structures of ligand-receptor complexes.  However, the accuracy of docking calcns. can be limited by factors such as the neglect of protein reorganization in the scoring function; as a result, ligand screening can produce a high rate of false pos. hits.  Although abs. binding free energy methods still have difficulty in accurately rank-ordering binders, we believe that they can be fruitfully employed to distinguish binders from nonbinders and reduce the false pos. rate.  Here we study a set of ligands that dock favorably to a newly discovered, potentially allosteric site on the flap of HIV-1 protease.  Fragment binding to this site stabilizes a closed form of protease, which could be exploited for the design of allosteric inhibitors.  Twenty-three top-ranked protein-ligand complexes from AutoDock were subject to the free energy screening using two methods, the recently developed binding energy anal. method (BEDAM) and the std. double decoupling method (DDM).  Free energy calcns. correctly identified most of the false positives (≥83%) and recovered all the confirmed binders.  The results show a gap averaging ≥3.7 kcal/mol, sepg. the binders and the false positives.  We present a formula that breaks the binding free energy down into contributions from the receptor conformational macrostates, which provides insights into the roles of different binding modes.  Our binding free energy component anal. further suggests that improving the treatment for the desolvation penalty assocd. with the unfulfilled polar groups could reduce the rate of false pos. hits in docking.  The current study demonstrates that the combination of docking with free energy methods can be very useful for more accurate ligand screening against valuable drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRSRY59SZJ8LVg90H21EOLACvtfcHk0lhNvDno6gcciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVykur3L&md5=f359ec844a65149cb1aba2451d46ddeb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjp506376z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp506376z%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DForli%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DPerryman%26aufirst%3DA.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DVijayan%26aufirst%3DR.%2BS.%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DStout%26aufirst%3DD.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DDistinguishing%2520Binders%2520from%2520false%2520positives%2520by%2520free%2520energy%2520calculations%253A%2520fragment%2520screening%2520against%2520the%2520flap%2520site%2520of%2520HIV%2520protease%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2015%26volume%3D119%26spage%3D976%26epage%3D988%26doi%3D10.1021%2Fjp506376z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kunze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todoroff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geppert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreuder, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baringhaus, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, G.</span><span> </span><span class="NLM_article-title">Targeting dynamic pockets of HIV-1 protease by structure-based computational screening for allosteric inhibitors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span><span class="refDoi"> DOI: 10.1021/ci400712h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400712h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisV2gsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=987-991&author=J.+Kunzeauthor=N.+Todoroffauthor=P.+Schneiderauthor=T.+Rodriguesauthor=T.+Geppertauthor=F.+Reisenauthor=H.+Schreuderauthor=J.+Saasauthor=G.+Hesslerauthor=K.+H.+Baringhausauthor=G.+Schneider&title=Targeting+dynamic+pockets+of+HIV-1+protease+by+structure-based+computational+screening+for+allosteric+inhibitors&doi=10.1021%2Fci400712h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Dynamic Pockets of HIV-1 Protease by Structure-Based Computational Screening for Allosteric Inhibitors</span></div><div class="casAuthors">Kunze, Jens; Todoroff, Nickolay; Schneider, Petra; Rodrigues, Tiago; Geppert, Tim; Reisen, Felix; Schreuder, Herman; Saas, Joachim; Hessler, Gerhard; Baringhaus, Karl-Heinz; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">987-991</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present the discovery of low mol. wt. inhibitors of human immunodeficiency virus 1 (HIV-1) protease subtype B that were identified by structure-based virtual screening as ligands of an allosteric surface cavity.  For pocket identification and prioritization, we performed a mol. dynamics simulation and obsd. several flexible, partially transient surface cavities.  For one of these presumable ligand-binding pockets that are located in the so-called "hinge region" of the identical protease chains, we computed a receptor-derived pharmacophore model, with which we retrieved fragment-like inhibitors from a screening compd. pool.  The most potent hit inhibited protease activity in vitro in a noncompetitive mode of action.  Although attempts failed to crystallize this ligand bound to the enzyme, the study provides proof-of-concept for identifying innovative tool compds. for chem. biol. by addressing flexible protein models with receptor pocket-derived pharmacophore screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUMUEo8-6gbVg90H21EOLACvtfcHk0lhNvDno6gcciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisV2gsbk%253D&md5=6239b51f01499776c9a6ef60d82b6648</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fci400712h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400712h%26sid%3Dliteratum%253Aachs%26aulast%3DKunze%26aufirst%3DJ.%26aulast%3DTodoroff%26aufirst%3DN.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DGeppert%26aufirst%3DT.%26aulast%3DReisen%26aufirst%3DF.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DSaas%26aufirst%3DJ.%26aulast%3DHessler%26aufirst%3DG.%26aulast%3DBaringhaus%26aufirst%3DK.%2BH.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DTargeting%2520dynamic%2520pockets%2520of%2520HIV-1%2520protease%2520by%2520structure-based%2520computational%2520screening%2520for%2520allosteric%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D987%26epage%3D991%26doi%3D10.1021%2Fci400712h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Dimova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikamp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3345</span><span class="refDoi"> DOI: 10.1021/jm400147j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400147j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFSqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3339-3345&author=D.+Dimovaauthor=K.+Heikampauthor=D.+Stumpfeauthor=J.+Bajorath&title=Do+medicinal+chemists+learn+from+activity+cliffs%3F+A+systematic+evaluation+of+cliff+progression+in+evolving+compound+data+sets&doi=10.1021%2Fjm400147j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Do Medicinal Chemists Learn from Activity Cliffs? A Systematic Evaluation of Cliff Progression in Evolving Compound Data Sets</span></div><div class="casAuthors">Dimova, Dilyana; Heikamp, Kathrin; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3339-3345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity cliffs are defined as pairs of structurally similar compds. with a significant difference in potency.  These compd. pairs have high SAR information content because they represent small structural changes leading to large potency alterations.  Accordingly, activity cliffs are of prime interest for SAR exploration and compd. optimization.  It is currently unknown to what extent activity cliff information is utilized in practical medicinal chem.  Therefore, we have assembled 56 compd. data sets that evolved over time and searched for analogs of activity cliff-forming compds. with further increased potency.  For ∼75% of all activity cliffs, there was no evidence for further chem. exploration.  For ∼25% of all cliffs, potency progression was detected.  In total, for ∼15% of all activity cliffs, pos. cliff progression was obsd. that often involved multiple analogs.  Given these findings, chem. unexplored activity cliffs should provide significant opportunities for further study in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhIU8CUIW4FLVg90H21EOLACvtfcHk0lhw9ipJRglE0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFSqtLs%253D&md5=78fa4942501fdddc6f77db79fbfdfcac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm400147j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400147j%26sid%3Dliteratum%253Aachs%26aulast%3DDimova%26aufirst%3DD.%26aulast%3DHeikamp%26aufirst%3DK.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DDo%2520medicinal%2520chemists%2520learn%2520from%2520activity%2520cliffs%253F%2520A%2520systematic%2520evaluation%2520of%2520cliff%2520progression%2520in%2520evolving%2520compound%2520data%2520sets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3339%26epage%3D3345%26doi%3D10.1021%2Fjm400147j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dimova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Activity cliff clusters as a source of structure-activity relationship information</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1517/17460441.2015.1019861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2015.1019861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=441-447&author=D.+Dimovaauthor=D.+Stumpfeauthor=Y.+Huauthor=J.+Bajorath&title=Activity+cliff+clusters+as+a+source+of+structure-activity+relationship+information&doi=10.1517%2F17460441.2015.1019861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1019861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1019861%26sid%3Dliteratum%253Aachs%26aulast%3DDimova%26aufirst%3DD.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DActivity%2520cliff%2520clusters%2520as%2520a%2520source%2520of%2520structure-activity%2520relationship%2520information%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D441%26epage%3D447%26doi%3D10.1517%2F17460441.2015.1019861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Geitmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elinder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Identification of a novel scaffold for allosteric inhibition of wild type and drug resistant HIV-1 reverse transcriptase by fragment library screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span><span class="refDoi"> DOI: 10.1021/jm1010513</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1010513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=699-708&author=M.+Geitmannauthor=M.+Elinderauthor=C.+Seegerauthor=P.+Brandtauthor=I.+J.+de+Eschauthor=U.+H.+Danielson&title=Identification+of+a+novel+scaffold+for+allosteric+inhibition+of+wild+type+and+drug+resistant+HIV-1+reverse+transcriptase+by+fragment+library+screening&doi=10.1021%2Fjm1010513"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm1010513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010513%26sid%3Dliteratum%253Aachs%26aulast%3DGeitmann%26aufirst%3DM.%26aulast%3DElinder%26aufirst%3DM.%26aulast%3DSeeger%26aufirst%3DC.%26aulast%3DBrandt%26aufirst%3DP.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DIdentification%2520of%2520a%2520novel%2520scaffold%2520for%2520allosteric%2520inhibition%2520of%2520wild%2520type%2520and%2520drug%2520resistant%2520HIV-1%2520reverse%2520transcriptase%2520by%2520fragment%2520library%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D699%26epage%3D708%26doi%3D10.1021%2Fjm1010513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Fragment screening and HIV therapeutics</span> <span class="citation_source-journal">Top. Curr. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1007/128_2011_232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2F128_2011_232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=181-200&author=J.+D.+Baumanauthor=D.+Patelauthor=E.+Arnold&title=Fragment+screening+and+HIV+therapeutics&doi=10.1007%2F128_2011_232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1007%2F128_2011_232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F128_2011_232%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DFragment%2520screening%2520and%2520HIV%2520therapeutics%26jtitle%3DTop.%2520Curr.%2520Chem.%26date%3D2011%26volume%3D317%26spage%3D181%26epage%3D200%26doi%3D10.1007%2F128_2011_232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bauman, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromer, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shatkin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2738</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span><span class="refDoi"> DOI: 10.1021/jm301271j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301271j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2738-2746&author=J.+D.+Baumanauthor=D.+Patelauthor=C.+Dhariaauthor=M.+W.+Fromerauthor=S.+Ahmedauthor=Y.+Frenkelauthor=R.+S.+Vijayanauthor=J.+T.+Eckauthor=W.+C.+Hoauthor=K.+Dasauthor=A.+J.+Shatkinauthor=E.+Arnold&title=Detecting+allosteric+sites+of+HIV-1+reverse+transcriptase+by+X-ray+crystallographic+fragment+screening&doi=10.1021%2Fjm301271j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening</span></div><div class="casAuthors">Bauman, Joseph D.; Patel, Disha; Dharia, Chhaya; Fromer, Marc W.; Ahmed, Sameer; Frenkel, Yulia; Vijayan, R. S. K.; Eck, J. Thomas; Ho, William C.; Das, Kalyan; Shatkin, Aaron J.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2738-2746</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV-1 reverse transcriptase (RT) undergoes a series of conformational changes during viral replication and is a central target for antiretroviral therapy.  The intrinsic flexibility of RT can provide novel allosteric sites for inhibition.  Crystals of RT that diffract X-rays to better than 2 Å resoln. facilitated the probing of RT for new druggable sites using fragment screening by X-ray crystallog.  A total of 775 fragments were grouped into 143 cocktails, which were soaked into crystals of RT in complex with the non-nucleoside drug rilpivirine (TMC278).  Seven new sites were discovered, including the Incoming Nucleotide Binding, Knuckles, NNRTI Adjacent, and 399 sites, located in the polymerase region of RT, and the 428, RNase H Primer Grip Adjacent, and 507 sites, located in the RNase H region.  Three of these sites (Knuckles, NNRTI Adjacent, and Incoming Nucleotide Binding) are inhibitory and provide opportunities for discovery of new anti-AIDS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXzUWRf_7PLVg90H21EOLACvtfcHk0lh8vK1BXo7Qhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrs%253D&md5=73cbd7d266cea42eac4b1cd9a06d0279</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm301271j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301271j%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DDharia%26aufirst%3DC.%26aulast%3DFromer%26aufirst%3DM.%2BW.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DFrenkel%26aufirst%3DY.%26aulast%3DVijayan%26aufirst%3DR.%2BS.%26aulast%3DEck%26aufirst%3DJ.%2BT.%26aulast%3DHo%26aufirst%3DW.%2BC.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DShatkin%26aufirst%3DA.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DDetecting%2520allosteric%2520sites%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520X-ray%2520crystallographic%2520fragment%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2738%26epage%3D2746%26doi%3D10.1021%2Fjm301271j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">La, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinetti, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyssen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluis-Cremer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachedjian, G.</span><span> </span><span class="NLM_article-title">Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">6979</span><span class="NLM_x">–</span> <span class="NLM_lpage">6984</span><span class="refDoi"> DOI: 10.1073/pnas.1423900112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1423900112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26038551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVKrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=6979-6984&author=J.+Laauthor=C.+F.+Lathamauthor=R.+N.+Tinettiauthor=A.+Johnsonauthor=D.+Tyssenauthor=K.+D.+Huberauthor=N.+Sluis-Cremerauthor=J.+S.+Simpsonauthor=S.+J.+Headeyauthor=D.+K.+Chalmersauthor=G.+Tachedjian&title=Identification+of+mechanistically+distinct+inhibitors+of+HIV-1+reverse+transcriptase+through+fragment+screening&doi=10.1073%2Fpnas.1423900112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening</span></div><div class="casAuthors">La, Jennifer; Latham, Catherine F.; Tinetti, Ricky N.; Johnson, Adam; Tyssen, David; Huber, Kelly D.; Sluis-Cremer, Nicolas; Simpson, Jamie S.; Headey, Stephen J.; Chalmers, David K.; Tachedjian, Gilda</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6979-6984</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fragment-based screening methods can be used to discover novel active site or allosteric inhibitors for therapeutic intervention.  Using satn. transfer difference (STD) NMR and in vitro activity assays, we have identified fragment-sized inhibitors of HIV-1 reverse transcriptase (RT) with distinct chem. scaffolds and mechanisms compared to nonnucleoside RT inhibitors (NNRTIs) and nucleoside/nucleotide RT inhibitors (NRTIs).  Three compds. were found to inhibit RNA- and DNA-dependent DNA polymerase activity of HIV-1 RT in the micromolar range while retaining potency against RT variants carrying one of three major NNRTI resistance mutations: K103N, Y181C, or G190A.  These compds. also inhibit Moloney murine leukemia virus RT but not the Klenow fragment of Escherichia coli DNA polymerase I.  Steady-state kinetic analyses demonstrate that one of these fragments is a competitive inhibitor of HIV-1 RT with respect to deoxyribonucleoside triphosphate (dNTP) substrate, whereas a second compd. is a competitive inhibitor of RT polymerase activity with respect to the DNA template/primer (T/P), and consequently also inhibits RNase H activity.  The dNTP competing RT inhibitor retains activity against the NRTI-resistant mutants K65R and M184V, demonstrating a drug resistance profile distinct from the nucleotide competing RT inhibitors indolopyridone-1 (INDOPY-1) and 4-dimethylamino-6-vinylpyrimidine-1 (DAVP-1).  In antiviral assays, the T/P competing compd. inhibits HIV-1 replication at a step consistent with an RT inhibitor.  Screening of addnl. structurally related compds. to the three fragments led to the discovery of mols. with improved potency against HIV-1 RT.  These fragment inhibitors represent previously unidentified scaffolds for development of novel drugs for HIV-1 prevention or treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L7MqNPmod7Vg90H21EOLACvtfcHk0lhzhmh8EIuZmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVKrtb8%253D&md5=302b6938dde7584167248eec03d3d7b6</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1423900112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1423900112%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DJ.%26aulast%3DLatham%26aufirst%3DC.%2BF.%26aulast%3DTinetti%26aufirst%3DR.%2BN.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DTyssen%26aufirst%3DD.%26aulast%3DHuber%26aufirst%3DK.%2BD.%26aulast%3DSluis-Cremer%26aufirst%3DN.%26aulast%3DSimpson%26aufirst%3DJ.%2BS.%26aulast%3DHeadey%26aufirst%3DS.%2BJ.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DTachedjian%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520mechanistically%2520distinct%2520inhibitors%2520of%2520HIV-1%2520reverse%2520transcriptase%2520through%2520fragment%2520screening%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D6979%26epage%3D6984%26doi%3D10.1073%2Fpnas.1423900112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wielens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlon, M. J.</span><span> </span><span class="NLM_article-title">Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1002/cmdc.201000483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.201000483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=258-261&author=J.+Wielensauthor=S.+J.+Headeyauthor=J.+J.+Deadmanauthor=D.+I.+Rhodesauthor=G.+T.+Leauthor=M.+W.+Parkerauthor=D.+K.+Chalmersauthor=M.+J.+Scanlon&title=Fragment-based+design+of+ligands+targeting+a+novel+site+on+the+integrase+enzyme+of+human+immunodeficiency+virus+1&doi=10.1002%2Fcmdc.201000483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000483%26sid%3Dliteratum%253Aachs%26aulast%3DWielens%26aufirst%3DJ.%26aulast%3DHeadey%26aufirst%3DS.%2BJ.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26atitle%3DFragment-based%2520design%2520of%2520ligands%2520targeting%2520a%2520novel%2520site%2520on%2520the%2520integrase%2520enzyme%2520of%2520human%2520immunodeficiency%2520virus%25201%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D258%26epage%3D261%26doi%3D10.1002%2Fcmdc.201000483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandegraaff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeevarajah, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winfield, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thienthong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</span> <span class="citation_source-journal">Antivir. Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.3851/IMP1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3851%2FIMP1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21602613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2mtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=155-168&author=D.+I.+Rhodesauthor=T.+S.+Peatauthor=N.+Vandegraaffauthor=D.+Jeevarajahauthor=G.+Leauthor=E.+D.+Jonesauthor=J.+A.+Smithauthor=J.+A.+Coatesauthor=L.+J.+Winfieldauthor=N.+Thienthongauthor=J.+Newmanauthor=D.+Lucentauthor=J.+H.+Ryanauthor=G.+P.+Savageauthor=C.+L.+Francisauthor=J.+J.+Deadman&title=Structural+basis+for+a+new+mechanism+of+inhibition+of+HIV-1+integrase+identified+by+fragment+screening+and+structure-based+design&doi=10.3851%2FIMP1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</span></div><div class="casAuthors">Rhodes, David I.; Peat, Thomas S.; Vandegraaff, Nick; Jeevarajah, Dharshini; Le, Giang; Jones, Eric D.; Smith, Jessica A.; Coates, Jonathan A. V.; Winfield, Lisa J.; Thienthong, Neeranat; Newman, Janet; Lucent, Del; Ryan, John H.; Savage, G. Paul; Francis, Craig L.; Deadman, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    
            (<span class="NLM_cas:orgname">International Medical Press, Ltd.</span>)
        </div><div class="casAbstract">Background: HIV-1 integrase is a clin. validated therapeutic target for the treatment of HIV-1 infection, with one approved therapeutic currently on the market.  This enzyme represents an attractive target for the development of new inhibitors to HIV-1 that are effective against the current resistance mutations.  Methods: A fragment-based screening method employing surface plasmon resonance and NMR was initially used to detect interactions between integrase and fragments.  The binding sites of the fragments were elucidated by crystallog. and the structural information used to design and synthesize improved ligands.  Results: The location of binding of fragments to the catalytic core of integrase was found to be in a previously undescribed binding site, adjacent to the mobile loop.  Enzyme assays confirmed that formation of enzyme-fragment complexes inhibits the catalytic activity of integrase and the structural data was utilized to further develop these fragments into more potent novel enzyme inhibitors.  Conclusions: The authors have defined a new site in integrase as a valid region for the structure-based design of allosteric integrase inhibitors.  Using a structure-based design process the authors have improved the activity of the initial fragments 45-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIC4puV2Mqt7Vg90H21EOLACvtfcHk0lgnmB0LgO3L_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2mtLc%253D&md5=236dfc80ddb1930185f1c5ede9d1b66d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3851%2FIMP1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP1716%26sid%3Dliteratum%253Aachs%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DVandegraaff%26aufirst%3DN.%26aulast%3DJeevarajah%26aufirst%3DD.%26aulast%3DLe%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DE.%2BD.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DCoates%26aufirst%3DJ.%2BA.%26aulast%3DWinfield%26aufirst%3DL.%2BJ.%26aulast%3DThienthong%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DLucent%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DJ.%2BH.%26aulast%3DSavage%26aufirst%3DG.%2BP.%26aulast%3DFrancis%26aufirst%3DC.%2BL.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520a%2520new%2520mechanism%2520of%2520inhibition%2520of%2520HIV-1%2520integrase%2520identified%2520by%2520fragment%2520screening%2520and%2520structure-based%2520design%26jtitle%3DAntivir.%2520Chem.%2520Chemother.%26date%3D2011%26volume%3D21%26spage%3D155%26epage%3D168%26doi%3D10.3851%2FIMP1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Peat, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandegraaff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thienthong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of the LEDGF site of human immunodeficiency virus integrase identified by fragment screening and structure based design</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e40147</span><span class="refDoi"> DOI: 10.1371/journal.pone.0040147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0040147" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e40147&author=T.+S.+Peatauthor=D.+I.+Rhodesauthor=N.+Vandegraaffauthor=G.+Leauthor=J.+A.+Smithauthor=L.+J.+Clarkauthor=E.+D.+Jonesauthor=J.+A.+Coatesauthor=N.+Thienthongauthor=J.+Newmanauthor=O.+Dolezalauthor=R.+Mulderauthor=J.+H.+Ryanauthor=G.+P.+Savageauthor=C.+L.+Francisauthor=J.+J.+Deadman&title=Small+molecule+inhibitors+of+the+LEDGF+site+of+human+immunodeficiency+virus+integrase+identified+by+fragment+screening+and+structure+based+design&doi=10.1371%2Fjournal.pone.0040147"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0040147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0040147%26sid%3Dliteratum%253Aachs%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DVandegraaff%26aufirst%3DN.%26aulast%3DLe%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DClark%26aufirst%3DL.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BD.%26aulast%3DCoates%26aufirst%3DJ.%2BA.%26aulast%3DThienthong%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DO.%26aulast%3DMulder%26aufirst%3DR.%26aulast%3DRyan%26aufirst%3DJ.%2BH.%26aulast%3DSavage%26aufirst%3DG.%2BP.%26aulast%3DFrancis%26aufirst%3DC.%2BL.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520the%2520LEDGF%2520site%2520of%2520human%2520immunodeficiency%2520virus%2520integrase%2520identified%2520by%2520fragment%2520screening%2520and%2520structure%2520based%2520design%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De40147%26doi%3D10.1371%2Fjournal.pone.0040147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gochin, M.</span><span> </span><span class="NLM_article-title">Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5114</span><span class="NLM_x">–</span> <span class="NLM_lpage">5118</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2013.07.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5114-5118&author=S.+Chuauthor=M.+Gochin&title=Identification+of+fragments+targeting+an+alternative+pocket+on+HIV-1+gp41+by+NMR+screening+and+similarity+searching&doi=10.1016%2Fj.bmcl.2013.07.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DS.%26aulast%3DGochin%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520fragments%2520targeting%2520an%2520alternative%2520pocket%2520on%2520HIV-1%2520gp41%2520by%2520NMR%2520screening%2520and%2520similarity%2520searching%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5114%26epage%3D5118%26doi%3D10.1016%2Fj.bmcl.2013.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tiefenbrunn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, C. D.</span><span> </span><span class="NLM_article-title">Towards novel therapeutics for HIV through fragment-based screening and drug design</span> <span class="citation_source-journal">Prog. Biophys. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.1016/j.pbiomolbio.2014.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.pbiomolbio.2014.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25455312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSlsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2014&pages=124-140&author=T.+Tiefenbrunnauthor=C.+D.+Stout&title=Towards+novel+therapeutics+for+HIV+through+fragment-based+screening+and+drug+design&doi=10.1016%2Fj.pbiomolbio.2014.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Towards novel therapeutics for HIV through fragment-based screening and drug design</span></div><div class="casAuthors">Tiefenbrunn, Theresa; Stout, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">124-140</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fragment-based drug discovery has been applied with varying levels of success to a no. of proteins involved in the HIV (Human Immunodeficiency Virus) life cycle.  Fragment-based approaches have led to the discovery of novel binding sites within protease, reverse transcriptase, integrase, and gp41.  Novel compds. that bind to known pockets within CCR5 have also been identified via fragment screening, and a fragment-based approach to target the TAR-Tat interaction was explored.  In the context of HIV-1 reverse transcriptase (RT), fragment-based approaches have yielded fragment hits with mid-μM activity in an in vitro activity assay, as well as fragment hits that are active against drug-resistant variants of RT.  Fragment-based drug discovery is a powerful method to elucidate novel binding sites within proteins, and the method has had significant success in the context of HIV proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHcrmdqaWPFrVg90H21EOLACvtfcHk0li3-BHnjWg5Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSlsr7L&md5=464daa30e33cf3ce924069e998aa1cd4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2014.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2014.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DTiefenbrunn%26aufirst%3DT.%26aulast%3DStout%26aufirst%3DC.%2BD.%26atitle%3DTowards%2520novel%2520therapeutics%2520for%2520HIV%2520through%2520fragment-based%2520screening%2520and%2520drug%2520design%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D116%26spage%3D124%26epage%3D140%26doi%3D10.1016%2Fj.pbiomolbio.2014.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wielens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolezal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peat, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanlon, M. J.</span><span> </span><span class="NLM_article-title">Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1177/1087057112465979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1177%2F1087057112465979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23139382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC3s7itFGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=147-159&author=J.+Wielensauthor=S.+J.+Headeyauthor=D.+I.+Rhodesauthor=R.+J.+Mulderauthor=O.+Dolezalauthor=J.+J.+Deadmanauthor=J.+Newmanauthor=D.+K.+Chalmersauthor=M.+W.+Parkerauthor=T.+S.+Peatauthor=M.+J.+Scanlon&title=Parallel+screening+of+low+molecular+weight+fragment+libraries%3A+do+differences+in+methodology+affect+hit+identification%3F&doi=10.1177%2F1087057112465979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</span></div><div class="casAuthors">Wielens Jerome; Headey Stephen J; Rhodes David I; Mulder Roger J; Dolezal Olan; Deadman John J; Newman Janet; Chalmers David K; Parker Michael W; Peat Thomas S; Scanlon Martin J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fragment screening is becoming widely accepted as a technique to identify hit compounds for the development of novel lead compounds.  In neighboring laboratories, we have recently, and independently, performed a fragment screening campaign on the HIV-1 integrase core domain (IN) using similar commercially purchased fragment libraries.  The two campaigns used different screening methods for the preliminary identification of fragment hits; one used saturation transfer difference nuclear magnetic resonance spectroscopy (STD-NMR), and the other used surface plasmon resonance (SPR) spectroscopy.  Both initial screens were followed by X-ray crystallography.  Using the STD-NMR/X-ray approach, 15 IN/fragment complexes were identified, whereas the SPR/X-ray approach found 6 complexes.  In this article, we compare the approaches that were taken by each group and the results obtained, and we look at what factors could potentially influence the final results.  We find that despite using different approaches with little overlap of initial hits, both approaches identified binding sites on IN that provided a basis for fragment-based lead discovery and further lead development.  Comparison of hits identified in the two studies highlights a key role for both the conditions under which fragment binding is measured and the criteria selected to classify hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQaYsG71Pu6x669lAbTj9rGfW6udTcc2eYpPgCE9Dsddrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7itFGluw%253D%253D&md5=9061e308aecbffc35d50a29b5b682283</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F1087057112465979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112465979%26sid%3Dliteratum%253Aachs%26aulast%3DWielens%26aufirst%3DJ.%26aulast%3DHeadey%26aufirst%3DS.%2BJ.%26aulast%3DRhodes%26aufirst%3DD.%2BI.%26aulast%3DMulder%26aufirst%3DR.%2BJ.%26aulast%3DDolezal%26aufirst%3DO.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DPeat%26aufirst%3DT.%2BS.%26aulast%3DScanlon%26aufirst%3DM.%2BJ.%26atitle%3DParallel%2520screening%2520of%2520low%2520molecular%2520weight%2520fragment%2520libraries%253A%2520do%2520differences%2520in%2520methodology%2520affect%2520hit%2520identification%253F%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2013%26volume%3D18%26spage%3D147%26epage%3D159%26doi%3D10.1177%2F1087057112465979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">A “rule of three” for fragment-based lead discovery?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%E2%80%9Crule+of+three%E2%80%9D+for+fragment-based+lead+discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2eYpPgCE9Dsddrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%25E2%2580%259Crule%2520of%2520three%25E2%2580%259D%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">“Old friends in new guise”: exploiting privileged structures for scaffold re-evolution/refining</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.2174/1386207317666140122101631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F1386207317666140122101631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24446784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOgsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=536-553&author=Y.+Songauthor=W.+Chenauthor=D.+Kangauthor=Q.+Zhangauthor=P.+Zhanauthor=X.+Liu&title=%E2%80%9COld+friends+in+new+guise%E2%80%9D%3A+exploiting+privileged+structures+for+scaffold+re-evolution%2Frefining&doi=10.2174%2F1386207317666140122101631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">"Old Friends in New Guise": Exploiting Privileged Structures for Scaffold Re-Evolution/Refining</span></div><div class="casAuthors">Song, Yu'ning; Chen, Wenmin; Kang, Dongwei; Zhang, Qingzhu; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">536-553</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The attempts to increase novel drug productivity through creative discovery technologies have fallen short of producing the satisfactory results.  For these reasons, evolved from the concept of drug repositioning, "privileged structure"-guided scaffold re-evolution/refining is a primary strategy to identify structurally novel chemotypes by modifying the central core structure and the side-chain of the existing active compds., or to exploit undescribed bioactivites by making full use of readily derivatized motifs with well-established synthetic protocols.  Herein, we review the basic tricks of exploiting privileged structures for scaffold re-evolution/refining.  The power of this strategy is exemplified in the discovery of other new therapeutic applications by refining privileged structures in anti-viral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUo4fL_STkjrVg90H21EOLACvtfcHk0lhnrqmgXhd-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOgsLvF&md5=4353d66dbd43353caefcd150938f94cd</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.2174%2F1386207317666140122101631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207317666140122101631%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DKang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3D%25E2%2580%259COld%2520friends%2520in%2520new%2520guise%25E2%2580%259D%253A%2520exploiting%2520privileged%2520structures%2520for%2520scaffold%2520re-evolution%252Frefining%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2014%26volume%3D17%26spage%3D536%26epage%3D553%26doi%3D10.2174%2F1386207317666140122101631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Repurposing of HDAC inhibitors toward anti-hepatitis C virus drug discovery: teaching an old dog new tricks</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span><span class="refDoi"> DOI: 10.4155/fmc.15.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4155%2Ffmc.15.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26230876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1367-1371&author=F.+Zhaoauthor=N.+Liuauthor=P.+Zhanauthor=X.+Liu&title=Repurposing+of+HDAC+inhibitors+toward+anti-hepatitis+C+virus+drug+discovery%3A+teaching+an+old+dog+new+tricks&doi=10.4155%2Ffmc.15.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing of HDAC inhibitors toward anti-hepatitis C virus drug discovery: teaching an old dog new tricks</span></div><div class="casAuthors">Zhao, Fabao; Liu, Na; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1367-1371</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc7dMC-jpz_rVg90H21EOLACvtfcHk0lhnrqmgXhd-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmtrvO&md5=817927f51219a6e23073d4b26e6c1ac0</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.76%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRepurposing%2520of%2520HDAC%2520inhibitors%2520toward%2520anti-hepatitis%2520C%2520virus%2520drug%2520discovery%253A%2520teaching%2520an%2520old%2520dog%2520new%2520tricks%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1367%26epage%3D1371%26doi%3D10.4155%2Ffmc.15.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2014.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25263697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=105-113&author=H.+Chenauthor=X.+Zhouauthor=A.+Wangauthor=Y.+Zhengauthor=Y.+Gaoauthor=J.+Zhou&title=Evolutions+in+fragment-based+drug+design%3A+the+deconstruction-reconstruction+approach&doi=10.1016%2Fj.drudis.2014.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutions in fragment-based drug design: the deconstruction-reconstruction approach</span></div><div class="casAuthors">Chen, Haijun; Zhou, Xiaobin; Wang, Ailan; Zheng, Yunquan; Gao, Yu; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of mol. recognition and protein-ligand interactions have facilitated rapid development of potent and selective ligands for therapeutically relevant targets.  Over the past two decades, a variety of useful approaches and emerging techniques have been developed to promote the identification and optimization of leads that have high potential for generating new therapeutic agents.  Intriguingly, the innovation of a fragment-based drug design (FBDD) approach has enabled rapid and efficient progress in drug discovery.  In this crit. review, we focus on the construction of fragment libraries and the advantages and disadvantages of various fragment-based screening (FBS) for constructing such libraries.  We also highlight the deconstruction-reconstruction strategy by utilizing privileged fragments of reported ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWzbA5c5707Vg90H21EOLACvtfcHk0liBgVW4HbSrcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1KgtL%252FO&md5=13ce52517b336a860136ac3eb4151b16</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEvolutions%2520in%2520fragment-based%2520drug%2520design%253A%2520the%2520deconstruction-reconstruction%2520approach%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D105%26epage%3D113%26doi%3D10.1016%2Fj.drudis.2014.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">8-Hydroxyquinoline: a privileged structure with broad-ranging pharmacological potentials</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span><span class="refDoi"> DOI: 10.1039/C4MD00284A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4MD00284A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=61-74&author=Y.+Songauthor=H.+Xuauthor=W.+Chenauthor=P.+Zhanauthor=X.+Liu&title=8-Hydroxyquinoline%3A+a+privileged+structure+with+broad-ranging+pharmacological+potentials&doi=10.1039%2FC4MD00284A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC4MD00284A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00284A%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3D8-Hydroxyquinoline%253A%2520a%2520privileged%2520structure%2520with%2520broad-ranging%2520pharmacological%2520potentials%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D61%26epage%3D74%26doi%3D10.1039%2FC4MD00284A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Serrao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2322</span><span class="refDoi"> DOI: 10.1021/jm301632e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301632e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2311-2322&author=E.+Serraoauthor=B.+Debnathauthor=H.+Otakeauthor=Y.+Kuangauthor=F.+Christauthor=Z.+Debyserauthor=N.+Neamati&title=Fragment-based+discovery+of+8-hydroxyquinoline+inhibitors+of+the+HIV-1+integrase-lens+epithelium-derived+growth+factor%2Fp75+%28IN-LEDGF%2Fp75%29+interaction&doi=10.1021%2Fjm301632e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm301632e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301632e%26sid%3Dliteratum%253Aachs%26aulast%3DSerrao%26aufirst%3DE.%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DOtake%26aufirst%3DH.%26aulast%3DKuang%26aufirst%3DY.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DFragment-based%2520discovery%2520of%25208-hydroxyquinoline%2520inhibitors%2520of%2520the%2520HIV-1%2520integrase-lens%2520epithelium-derived%2520growth%2520factor%252Fp75%2520%2528IN-LEDGF%252Fp75%2529%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2311%26epage%3D2322%26doi%3D10.1021%2Fjm301632e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mondal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, A. K.</span><span> </span><span class="NLM_article-title">Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2455</span><span class="NLM_x">–</span> <span class="NLM_lpage">2488</span><span class="refDoi"> DOI: 10.1039/C4CS00493K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4CS00493K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25706945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFCjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=2455-2488&author=M.+Mondalauthor=A.+K.+Hirsch&title=Dynamic+combinatorial+chemistry%3A+a+tool+to+facilitate+the+identification+of+inhibitors+for+protein+targets&doi=10.1039%2FC4CS00493K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets</span></div><div class="casAuthors">Mondal, Milon; Hirsch, Anna K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2455-2488</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dynamic combinatorial chem. (DCC) has emerged as a powerful strategy to identify ligands for biol. targets given that it enables the target to direct the synthesis and amplification of its strongest binder(s) from the library of interconverting compds.  Since the first report of DCC applied to the discovery of binders for a protein, this elegant tool has been employed on a range of protein targets at various stages of medicinal-chem. projects.  A series of suitable, reversible reactions that are biocompatible have been established and the portfolio of anal. techniques is growing.  Despite progress, in most cases, the libraries employed remain of moderate size.  We present here the most recent advances in the field of DCC applied to protein targets, paying particular attention to the exptl. conditions and anal. methods chosen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaA7XHQ6x8xrVg90H21EOLACvtfcHk0lifg43ZDg4tTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFCjsbk%253D&md5=78c0c6047db102c978432fb92397c68a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FC4CS00493K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00493K%26sid%3Dliteratum%253Aachs%26aulast%3DMondal%26aufirst%3DM.%26aulast%3DHirsch%26aufirst%3DA.%2BK.%26atitle%3DDynamic%2520combinatorial%2520chemistry%253A%2520a%2520tool%2520to%2520facilitate%2520the%2520identification%2520of%2520inhibitors%2520for%2520protein%2520targets%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D2455%26epage%3D2488%26doi%3D10.1039%2FC4CS00493K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Oueis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P. Y.</span><span> </span><span class="NLM_article-title">New insights into the kinetic target-guided synthesis of protein ligands</span> <span class="citation_source-journal">Chem. Commun. (Cambridge, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">12158</span><span class="NLM_x">–</span> <span class="NLM_lpage">12169</span><span class="refDoi"> DOI: 10.1039/C5CC04183J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC5CC04183J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26144842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWgtbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=12158-12169&author=E.+Oueisauthor=C.+Sabotauthor=P.+Y.+Renard&title=New+insights+into+the+kinetic+target-guided+synthesis+of+protein+ligands&doi=10.1039%2FC5CC04183J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the kinetic target-guided synthesis of protein ligands</span></div><div class="casAuthors">Oueis, Emilia; Sabot, Cyrille; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">12158-12169</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The kinetic target-guided synthesis (KTGS) strategy is an unconventional discovery approach that takes advantage of the presence of the biol. target itself in order to irreversibly assemble the best inhibitors from an array of building blocks.  This strategy has grown over the last two decades notably after the introduction of the in situ click chem. concept by Sharpless and colleagues in the early 2000s based on the use of the Huisgen cycloaddn. between terminal alkynes and azides.  KTGS is a captivating area of research offering an unprecedented and powerful strategy to probe the macromol. complexity and dynamics of biol. targets.  After a brief introduction listing all chem. ligation reactions reported to date in KTGS, this review focuses on the last five years' progress to expand the repertoire of the click or "click-like" tool box targeting proteins, as well as to overcome limitations arising in particular from false negatives, i.e. potent ligands that are not formed, or formed in undetectable trace amts.  Furthermore, we wish to analyze the new twists and novelties described in some of these applications in order to better understand the conditions that govern this strategy and the extent to which it can be developed and generalized for a more efficient process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3mdKSqL3JKLVg90H21EOLACvtfcHk0lifg43ZDg4tTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWgtbbE&md5=76af69545c88c006feb0fe7a544b3805</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC5CC04183J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC04183J%26sid%3Dliteratum%253Aachs%26aulast%3DOueis%26aufirst%3DE.%26aulast%3DSabot%26aufirst%3DC.%26aulast%3DRenard%26aufirst%3DP.%2BY.%26atitle%3DNew%2520insights%2520into%2520the%2520kinetic%2520target-guided%2520synthesis%2520of%2520protein%2520ligands%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2015%26volume%3D51%26spage%3D12158%26epage%3D12169%26doi%3D10.1039%2FC5CC04183J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetsch, R.</span><span> </span><span class="NLM_article-title">Kinetic target-guided synthesis</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1039/b904092g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2Fb904092g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20309488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1316-24&author=X.+Huauthor=R.+Manetsch&title=Kinetic+target-guided+synthesis&doi=10.1039%2Fb904092g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic target-guided synthesis</span></div><div class="casAuthors">Hu, Xiangdong; Manetsch, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1316-1324</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In the last decade, various target-guided synthesis (TGS) approaches have been developed in which a target protein is actively engaged in the assembly of its own bidentate ligand from a pool of smaller reactive fragments.  Although TGS is relatively less explored, it demonstrates great promise to streamline drug discovery by combining screening and synthesis into a single step.  In this review, the authors focus on the class of kinetic TGS approaches which utilize irreversible reactions to combine two reactive fragments into the inhibitory compd.  These kinetic TGS applications have been successful due to the unique combination of the slow nature of the chem. reaction combining the two fragments into a single mol. and the use of reactive fragments displaying good affinities toward one of the binding sites.  So far, kinetic TGS and esp. in situ click chem., a kinetic TGS variant using the 1,3-dipolar cycloaddn. of azides and alkynes, have led to the identification of highly potent inhibitors.  This tutorial review focuses on kinetic TGS approaches aside from those employing the 1,3-dipolar cycloaddn. of azides and alkynes, and discusses the features and advantages of these TGS approaches in detail.  The successes of in silt click chem. dramatically changed kinetic TGS approaches.  Predicted and developed more than 30 years ago, early kinetic TGS approaches suffered from serious limitations, making lead discovery projects impossible.  Logically, biol. targets will favor certain reactions over the others; thus research should continue to focus on the development of bioorthogonal reactions and their use in kinetic TGS approaches.  Although significant progress has been achieved over the last decade, kinetic TGS is still relatively less explored and hence represents an interesting area rich in research opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5y6kP6omeuLVg90H21EOLACvtfcHk0li86ZMhaAo3ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1Ggu70%253D&md5=97936395184abe8dc367c3b6a4829193</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fb904092g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb904092g%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DManetsch%26aufirst%3DR.%26atitle%3DKinetic%2520target-guided%2520synthesis%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D1316%26epage%3D24%26doi%3D10.1039%2Fb904092g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Thirumurugan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matosiuk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jozwiak, K.</span><span> </span><span class="NLM_article-title">Click chemistry for drug development and diverse chemical-biology applications</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">4905</span><span class="NLM_x">–</span> <span class="NLM_lpage">4979</span><span class="refDoi"> DOI: 10.1021/cr200409f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200409f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslahtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=4905-4979&author=P.+Thirumuruganauthor=D.+Matosiukauthor=K.+Jozwiak&title=Click+chemistry+for+drug+development+and+diverse+chemical-biology+applications&doi=10.1021%2Fcr200409f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Click Chemistry for Drug Development and Diverse Chemical-Biology Applications</span></div><div class="casAuthors">Thirumurugan, Prakasam; Matosiuk, Dariusz; Jozwiak, Krzysztof</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4905-4979</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 303 refs. on application of lick chem. reactions in chem., biochem., and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnNgMztlQYCLVg90H21EOLACvtfcHk0li86ZMhaAo3ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslahtLY%253D&md5=d9c664c199b63c7d556c60fe9cd1507d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr200409f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200409f%26sid%3Dliteratum%253Aachs%26aulast%3DThirumurugan%26aufirst%3DP.%26aulast%3DMatosiuk%26aufirst%3DD.%26aulast%3DJozwiak%26aufirst%3DK.%26atitle%3DClick%2520chemistry%2520for%2520drug%2520development%2520and%2520diverse%2520chemical-biology%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26spage%3D4905%26epage%3D4979%26doi%3D10.1021%2Fcr200409f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Whiting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muldoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 protease by using in situ click chemistry</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1435</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span><span class="refDoi"> DOI: 10.1002/anie.200502161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fanie.200502161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28XitF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=1435-1439&author=M.+Whitingauthor=J.+Muldoonauthor=Y.+C.+Linauthor=S.+M.+Silvermanauthor=W.+Lindstromauthor=A.+J.+Olsonauthor=H.+C.+Kolbauthor=M.+G.+Finnauthor=K.+B.+Sharplessauthor=J.+H.+Elderauthor=V.+V.+Fokin&title=Inhibitors+of+HIV-1+protease+by+using+in+situ+click+chemistry&doi=10.1002%2Fanie.200502161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 protease by using in situ click chemistry</span></div><div class="casAuthors">Whiting, Matthew; Muldoon, John; Lin, Ying-Chuan; Silverman, Steven M.; Lindstrom, William; Olson, Arthur J.; Kolb, Hartmuth C.; Finn, M. G.; Sharpless, K. Barry; Elder, John H.; Fokin, Valery V.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1435-1439</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Twice poor equals potent: HIV-1 Protease assembles its own potent inhibitor through formation of the triazole linkage from azide- and alkyne-contg. fragments that are themselves poor binders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxygIXDTyVz7Vg90H21EOLACvtfcHk0li86ZMhaAo3ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitF2qtLg%253D&md5=d575780546dbc314eb9df85bc2459539</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fanie.200502161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200502161%26sid%3Dliteratum%253Aachs%26aulast%3DWhiting%26aufirst%3DM.%26aulast%3DMuldoon%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DSilverman%26aufirst%3DS.%2BM.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease%2520by%2520using%2520in%2520situ%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D1435%26epage%3D1439%26doi%3D10.1002%2Fanie.200502161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutsuga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">An unexpected example of protein-templated click chemistry</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6817</span><span class="NLM_x">–</span> <span class="NLM_lpage">6820</span><span class="refDoi"> DOI: 10.1002/anie.201002205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fanie.201002205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6817-6820&author=T.+Suzukiauthor=Y.+Otaauthor=Y.+Kasuyaauthor=M.+Mutsugaauthor=Y.+Kawamuraauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+G.+Finnauthor=N.+Miyata&title=An+unexpected+example+of+protein-templated+click+chemistry&doi=10.1002%2Fanie.201002205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An Unexpected Example of Protein-Templated Click Chemistry</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Kasuya, Yuki; Mutsuga, Motoh; Kawamura, Yoko; Tsumoto, Hiroki; Nakagawa, Hidehiko; Finn, M. G.; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6817-6820, S6817/1-S6817/10</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors have established that a Cu(I) complex of HDAC8 (human recombinant histone deacetylase) accelerates a selective azide-alkyne cycloaddn. (AAC) between an azide and an alkyne, thereby forming a triazole deriv. with greater inhibitory power towards the enzyme than either of the reactants alone.  In this case, the unwavering regioselectivity of the CuAAC process overrides the tendency of the Cu-free in situ click reaction to form the more potent (syn-isomer, 1,5-triazolyl) of the two triazole isomers.  Thus, regiospecific formation of triazole adducts from alkyne I and azide II in presence of HDAC8 gave rise to a significant peak in HPLC corresponding to anti-isomer (1,4-triazolyl) adduct III along with a smaller peak being the syn-isomer (1,5-triazolyl) adduct IV.  To examine whether Cu(I) is required for the cycloaddn., AAC was conducted using I and II in presence of HDAC8 and bathocuproine disulfonic acid [BCDSA; a Cu(I)-specific chelator and inhibitor of the CuAAC reaction].  The results showed that BCDSA inhibited the triazole formation.  In addn., Zn(OAc)2 was added to the mixt. of reactants I and II along with HDAC8 to displace Cu from the protein.  This treatment completely suppressed the formation of anti-isomer III, whereas in soln., Zn(II) had no effect on the CuAAC reaction.  In summary, the authors regard this study as an important precedent in the search for highly active protein catalysts of the CuAAC reaction, as well as an interesting and potentially useful example of in situ inhibitor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5wSD48iQp7Vg90H21EOLACvtfcHk0lgZwKnznKvQzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbnK&md5=f6e6a2b9aa0a51df9a9828c8a4c1f92c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fanie.201002205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201002205%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520unexpected%2520example%2520of%2520protein-templated%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6817%26epage%3D6820%26doi%3D10.1002%2Fanie.201002205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Brik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muldoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. H.</span><span> </span><span class="NLM_article-title">Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1002/cbic.200300724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcbic.200300724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=14613121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFajt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=1246-1248&author=A.+Brikauthor=J.+Muldoonauthor=Y.+C.+Linauthor=J.+H.+Elderauthor=D.+S.+Goodsellauthor=A.+J.+Olsonauthor=V.+V.+Fokinauthor=K.+B.+Sharplessauthor=C.+H.+Wong&title=Rapid+diversity-oriented+synthesis+in+microtiter+plates+for+in+situ+screening+of+HIV+protease+inhibitors&doi=10.1002%2Fcbic.200300724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors</span></div><div class="casAuthors">Brik, Ashraf; Muldoon, John; Lin, Ying-chuan; Elder, John H.; Goodsell, David S.; Olson, Arthur J.; Fokin, Valery V.; Sharpless, K. Barry; Wong, Chi-huey</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1246-1248</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The azide cores I and II were prepd. and converted to libraries of triazoles for in situ screening for HIV protease inhibitor activity by cycloaddn. with acetylenes.  The triazoles III and IV had IC50 for inhibition of HIV protease of 6±0.5 and 13±0.5 nM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9NCHXJLlkrVg90H21EOLACvtfcHk0lgZwKnznKvQzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFajt7k%253D&md5=1f0285eb738c69c6b70132f373e80092</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200300724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200300724%26sid%3Dliteratum%253Aachs%26aulast%3DBrik%26aufirst%3DA.%26aulast%3DMuldoon%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DRapid%2520diversity-oriented%2520synthesis%2520in%2520microtiter%2520plates%2520for%2520in%2520situ%2520screening%2520of%2520HIV%2520protease%2520inhibitors%26jtitle%3DChemBioChem%26date%3D2003%26volume%3D4%26spage%3D1246%26epage%3D1248%26doi%3D10.1002%2Fcbic.200300724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Whiting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripp, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span> </span><span class="NLM_article-title">Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7697</span><span class="NLM_x">–</span> <span class="NLM_lpage">7710</span><span class="refDoi"> DOI: 10.1021/jm060754+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060754%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GjsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7697-7710&author=M.+Whitingauthor=J.+C.+Trippauthor=Y.+C.+Linauthor=W.+Lindstromauthor=A.+J.+Olsonauthor=J.+H.+Elderauthor=K.+B.+Sharplessauthor=V.+V.+Fokin&title=Rapid+discovery+and+structure-activity+profiling+of+novel+inhibitors+of+human+immunodeficiency+virus+type+1+protease+enabled+by+the+copper%28I%29-catalyzed+synthesis+of+1%2C2%2C3-triazoles+and+their+further+functionalization&doi=10.1021%2Fjm060754%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery and Structure-Activity Profiling of Novel Inhibitors of Human Immunodeficiency Virus Type 1 Protease Enabled by the Copper(I)-Catalyzed Synthesis of 1,2,3-Triazoles and Their Further Functionalization</span></div><div class="casAuthors">Whiting, Matthew; Tripp, Jonathan C.; Lin, Ying-Chuan; Lindstrom, William; Olson, Arthur J.; Elder, John H.; Sharpless, K. Barry; Fokin, Valery V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7697-7710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building from the results of a computational screen of a range of triazole-contg. compds. for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed.  The copper(I)-catalyzed azide-alkyne cycloaddn. (CuAAC), which provides ready access to 1,4-disubstituted-1,2,3-triazoles, was used to unite a focused library of azide-contg. fragments with a diverse array of functionalized alkyne-contg. building blocks.  In combination with direct screening of the crude reaction products, this method led to the rapid identification of a lead structure and readily enabled optimization of both azide and alkyne fragments.  Replacement of the triazole with a range of alternative linkers led to greatly reduced protease inhibition; however, further functionalization of the triazoles at the 5-position gave a series of compds. with increased activity, exhibiting Ki values as low as 8 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxP4sXbJdAZbVg90H21EOLACvtfcHk0lgYomjMR8LTzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GjsbjL&md5=252fb639055fb8e55a1e1a0eb0842853</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm060754%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060754%252B%26sid%3Dliteratum%253Aachs%26aulast%3DWhiting%26aufirst%3DM.%26aulast%3DTripp%26aufirst%3DJ.%2BC.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DElder%26aufirst%3DJ.%2BH.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26atitle%3DRapid%2520discovery%2520and%2520structure-activity%2520profiling%2520of%2520novel%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520enabled%2520by%2520the%2520copper%2528I%2529-catalyzed%2520synthesis%2520of%25201%252C2%252C3-triazoles%2520and%2520their%2520further%2520functionalization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7697%26epage%3D7710%26doi%3D10.1021%2Fjm060754%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wannberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larhed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span><span class="refDoi"> DOI: 10.1021/cc050016r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc050016r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFWhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=611-617&author=J.+Wannbergauthor=N.+F.+Kaiserauthor=L.+Vrangauthor=B.+Samuelssonauthor=M.+Larhedauthor=A.+Hallberg&title=High-speed+synthesis+of+potent+C2-symmetric+HIV-1+protease+inhibitors+by+in-situ+aminocarbonylations&doi=10.1021%2Fcc050016r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">High-Speed Synthesis of Potent C2-Symmetric HIV-1 Protease Inhibitors by In-Situ Aminocarbonylations</span></div><div class="casAuthors">Wannberg, Johan; Kaiser, Nils-Fredrik K.; Vrang, Lotta; Samuelsson, Bertil; Larhed, Mats; Hallberg, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel series of C2-sym. HIV-1 protease inhibitors were synthesized by microwave-promoted, palladium-catalyzed amino carbonylation of the o-iodo- and m-bromo benzyloxy P1/P1' substituted core structures.  Molybdenum hexacarbonyl was used as a convenient solid source of carbon monoxide in these transformations.  After the initial high-speed library generation, biol. testing identified highly active HIV-1 protease inhibitors.  Selected ortho- and meta-decorated inhibitors were subsequently re-synthesized on a larger scale and re-tested for their affinity toward HIV-1 protease, showing micro-molar to low nanomolar inhibition.  The discovery of highly active inhibitors contg. large Ph amide ortho substituents in the P1/P1' positions indicates that larger groups than previously believed are tolerated in this part of the S1/S1' pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjaH7YrpIcYLVg90H21EOLACvtfcHk0lgYomjMR8LTzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFWhur0%253D&md5=a418a85404c8f477bf739475ffb51eb5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcc050016r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc050016r%26sid%3Dliteratum%253Aachs%26aulast%3DWannberg%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DN.%2BF.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DHigh-speed%2520synthesis%2520of%2520potent%2520C2-symmetric%2520HIV-1%2520protease%2520inhibitors%2520by%2520in-situ%2520aminocarbonylations%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2005%26volume%3D7%26spage%3D611%26epage%3D617%26doi%3D10.1021%2Fcc050016r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Strategies for the discovery of target-specific or isoform-selective modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7611</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVans7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7611-7633&author=P.+Zhanauthor=Y.+Itohauthor=T.+Suzukiauthor=X.+Liu&title=Strategies+for+the+discovery+of+target-specific+or+isoform-selective+modulators&doi=10.1021%2Facs.jmedchem.5b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators</span></div><div class="casAuthors">Zhan, Peng; Itoh, Yukihiro; Suzuki, Takayoshi; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7611-7633</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Currently, the creation of class- and isoform-selective modulators of biol. important targets is a particularly challenging problem because different isoforms within a protein family often show striking similarity in spatial quaternary structure, esp. at the catalytic sites or binding pockets.  Therefore, an understanding of both the precise three-dimensional structure of the target protein and the mechanisms of action of modulators is important for developing more effective and selective agents.  In this Perspective, the authors discuss currently available rational design strategies for obtaining class- and isoform-selective inhibitors and the authors illustrate these strategies with the aid of specific examples from the recent literature.  The strategies covered include: (1) target-derived (-dependent) de novo drug discovery methodologies, and (2) follow-on derivatization approaches from initially identified active mols. (hit-to-lead and lead-to-candidate efforts).  The authors also comment on prospects for further development and integration of strategies to achieve target-specific or isoform-selective inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9nLY2BYFSobVg90H21EOLACvtfcHk0limAcF0VgWBxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVans7rK&md5=2fdffce4f0c8c57a266468dcb8a901ae</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00229%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DStrategies%2520for%2520the%2520discovery%2520of%2520target-specific%2520or%2520isoform-selective%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7611%26epage%3D7633%26doi%3D10.1021%2Facs.jmedchem.5b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span> </span><span class="NLM_article-title">Hierarchical virtual screening approaches in small molecule drug discovery</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2014.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ymeth.2014.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25072167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12mt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=26-37&author=A.+Kumarauthor=K.+Y.+Zhang&title=Hierarchical+virtual+screening+approaches+in+small+molecule+drug+discovery&doi=10.1016%2Fj.ymeth.2014.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchical virtual screening approaches in small molecule drug discovery</span></div><div class="casAuthors">Kumar, Ashutosh; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-37</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Virtual screening has played a significant role in the discovery of small mol. inhibitors of therapeutic targets in last two decades.  Various ligand and structure-based virtual screening approaches are employed to identify small mol. ligands for proteins of interest.  These approaches are often combined in either hierarchical or parallel manner to take advantage of the strength and avoid the limitations assocd. with individual methods.  Hierarchical combination of ligand and structure-based virtual screening approaches has received noteworthy success in numerous drug discovery campaigns.  In hierarchical virtual screening, several filters using ligand and structure-based approaches are sequentially applied to reduce a large screening library to a no. small enough for exptl. testing.  In this review, we focus on different hierarchical virtual screening strategies and their application in the discovery of small mol. modulators of important drug targets.  Several virtual screening studies are discussed to demonstrate the successful application of hierarchical virtual screening in small mol. drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5IS_ELjp3rVg90H21EOLACvtfcHk0limAcF0VgWBxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12mt7bO&md5=37afd198e391774598a72214a377fd05</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2014.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2014.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26atitle%3DHierarchical%2520virtual%2520screening%2520approaches%2520in%2520small%2520molecule%2520drug%2520discovery%26jtitle%3DMethods%26date%3D2015%26volume%3D71%26spage%3D26%26epage%3D37%26doi%3D10.1016%2Fj.ymeth.2014.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2432</span><span class="NLM_x">–</span> <span class="NLM_lpage">2444</span><span class="refDoi"> DOI: 10.1021/jm049606e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049606e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsF2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2432-2444&author=J.+Wangauthor=X.+Kangauthor=I.+D.+Kuntzauthor=P.+A.+Kollman&title=Hierarchical+database+screenings+for+HIV-1+reverse+transcriptase+using+a+pharmacophore+model%2C+rigid+docking%2C+solvation+docking%2C+and+MM-PB%2FSA&doi=10.1021%2Fjm049606e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM-PB/SA</span></div><div class="casAuthors">Wang, Junmei; Kang, Xinshan; Kuntz, Irwin D.; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2432-2444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work, an efficient strategy was presented to search drug leads for human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) using hierarchical database screenings, which included a pharmacophore model, multiple-conformation rigid docking, solvation docking, and mol. mechanics-Poisson-Boltzmann/surface area (MM-PB/SA) sequentially.  Encouraging results were achieved in searching a refined available chem. directory (ACD) database: the enrichment factor after the first three filters was estd. to be 25-fold; the hit rate for all the four filters was predicted to be 41% in a control test using 37 known HIV-1 non-nucleoside reverse transcriptase inhibitors; 10 out of 30 promising solvation-docking hits had MM-PB/SA binding free energies better than -6.8 kcal/mol and the best one, HIT15, had -17.0 kcal/mol.  In conclusion, the hierarchical multiple-filter database searching strategy is an attractive strategy in drug lead exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWs2lXBbUFbbVg90H21EOLACvtfcHk0lgzVoShePASjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsF2isb8%253D&md5=6a0dfb0307674ba5f2caa91b78fbe509</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm049606e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049606e%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DX.%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHierarchical%2520database%2520screenings%2520for%2520HIV-1%2520reverse%2520transcriptase%2520using%2520a%2520pharmacophore%2520model%252C%2520rigid%2520docking%252C%2520solvation%2520docking%252C%2520and%2520MM-PB%252FSA%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2432%26epage%3D2444%26doi%3D10.1021%2Fjm049606e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Leitão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andricopulo, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, C. A.</span><span> </span><span class="NLM_article-title">In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1412</span><span class="NLM_x">–</span> <span class="NLM_lpage">1422</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2007.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2007.08.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1412-1422&author=A.+Leit%C3%A3oauthor=A.+D.+Andricopuloauthor=C.+A.+Montanari&title=In+silico+screening+of+HIV-1+non-nucleoside+reverse+transcriptase+and+protease+inhibitors&doi=10.1016%2Fj.ejmech.2007.08.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DAndricopulo%26aufirst%3DA.%2BD.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DIn%2520silico%2520screening%2520of%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520and%2520protease%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1412%26epage%3D1422%26doi%3D10.1016%2Fj.ejmech.2007.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainsworth, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Using hierarchical virtual screening to combat drug resistance of the HIV-1 protease</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1400</span><span class="NLM_x">–</span> <span class="NLM_lpage">1412</span><span class="refDoi"> DOI: 10.1021/acs.jcim.5b00056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1aksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1400-1412&author=N.+Liauthor=R.+I.+Ainsworthauthor=B.+Dingauthor=T.+Houauthor=W.+Wang&title=Using+hierarchical+virtual+screening+to+combat+drug+resistance+of+the+HIV-1+protease&doi=10.1021%2Facs.jcim.5b00056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease</span></div><div class="casAuthors">Li, Nan; Ainsworth, Richard I.; Ding, Bo; Hou, Tingjun; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1400-1412</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV) protease inhibitors (PIs) are important components of highly active anti-retroviral therapy (HAART) that block the catalytic site of HIV protease, thus preventing maturation of the HIV virion.  However, with two decades of PI prescriptions in clin. practice, drug-resistant HIV mutants have now been found for all of the PI drugs.  Therefore, the continuous development of new PI drugs is crucial both to combat the existing drug-resistant HIV strains and to provide treatments for future patients.  Here we purpose an HIV PI drug design strategy to select candidate PIs with binding energy distributions dominated by interactions with conserved protease residues in both wild-type and various drug-resistant mutants.  On the basis of this strategy, we have constructed a virtual screening pipeline including combinatorial library construction, combinatorial docking, MM/GBSA-based rescoring, and reranking on the basis of the binding energy distribution.  We have tested our strategy on lopinavir by modifying its two functional groups.  From an initial 751 689 candidate mols., 18 candidate inhibitors were selected using the pipeline for exptl. validation.  IC50 measurements and drug resistance predictions successfully identified two ligands with both HIV protease inhibitor activity and an improved drug resistance profile on 2382 HIV mutants.  This study provides a proof of concept for the integration of MM/GBSA energy anal. and drug resistance information at the stage of virtual screening and sheds light on future HIV drug design and the use of virtual screening to combat drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHHiHtaG7NVLVg90H21EOLACvtfcHk0lgzVoShePASjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1aksLs%253D&md5=088bbeb88cf6971bcca3b666d71d7e30</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00056%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DAinsworth%26aufirst%3DR.%2BI.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DUsing%2520hierarchical%2520virtual%2520screening%2520to%2520combat%2520drug%2520resistance%2520of%2520the%2520HIV-1%2520protease%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D1400%26epage%3D1412%26doi%3D10.1021%2Facs.jcim.5b00056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Multistage virtual screening and identification of novel HIV-1 protease inhibitors by integrating SVM, shape, pharmacophore and docking methods</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2015.06.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=409-418&author=Y.+Weiauthor=J.+Liauthor=Z.+Chenauthor=F.+Wangauthor=W.+Huangauthor=Z.+Hongauthor=J.+Lin&title=Multistage+virtual+screening+and+identification+of+novel+HIV-1+protease+inhibitors+by+integrating+SVM%2C+shape%2C+pharmacophore+and+docking+methods&doi=10.1016%2Fj.ejmech.2015.06.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DMultistage%2520virtual%2520screening%2520and%2520identification%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520by%2520integrating%2520SVM%252C%2520shape%252C%2520pharmacophore%2520and%2520docking%2520methods%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D409%26epage%3D418%26doi%3D10.1016%2Fj.ejmech.2015.06.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavande, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, H.</span><span> </span><span class="NLM_article-title">Insights into the mechanism of inhibition of CXCR4: identification of piperidinylethanamine analogs as anti-HIV-1 inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span><span class="refDoi"> DOI: 10.1128/AAC.04654-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.04654-14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1895-1904&author=D.+Dasauthor=K.+Maedaauthor=Y.+Hayashiauthor=N.+Gavandeauthor=D.+V.+Desaiauthor=S.+B.+Changauthor=A.+K.+Ghoshauthor=H.+Mitsuya&title=Insights+into+the+mechanism+of+inhibition+of+CXCR4%3A+identification+of+piperidinylethanamine+analogs+as+anti-HIV-1+inhibitors&doi=10.1128%2FAAC.04654-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FAAC.04654-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04654-14%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DD.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DGavande%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DD.%2BV.%26aulast%3DChang%26aufirst%3DS.%2BB.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DInsights%2520into%2520the%2520mechanism%2520of%2520inhibition%2520of%2520CXCR4%253A%2520identification%2520of%2520piperidinylethanamine%2520analogs%2520as%2520anti-HIV-1%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D1895%26epage%3D1904%26doi%3D10.1128%2FAAC.04654-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Targeting protein-protein interactions: a promising avenue of anti-HIV drug discovery</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3393</span><span class="NLM_x">–</span> <span class="NLM_lpage">3409</span><span class="refDoi"> DOI: 10.2174/092986710793176357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986710793176357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20712566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cms7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3393-3409&author=P.+Zhanauthor=W.+Liauthor=H.+Chenauthor=X.+Liu&title=Targeting+protein-protein+interactions%3A+a+promising+avenue+of+anti-HIV+drug+discovery&doi=10.2174%2F092986710793176357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein-protein interactions: a promising avenue of anti-HIV drug discovery</span></div><div class="casAuthors">Zhan, Peng; Li, Wenjun; Chen, Hongfei; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3393-3409</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, the no. of useful chem. biol. information of protein-protein interactions in the HIV life cycle and related inhibitors, is growing rapidly, which makes protein-protein interactions a new investigative area for antiviral drug intervention.  This review will summarize recent work in this field, mainly focusing on the utilization of small mols. targeted against a variety of protein-protein interactions that have great therapeutic feasibility for HIV infection, and lastly outline some other important protein-protein interactions with a potential to advance into novel anti-HIV drug targets in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVauv4e2ym_bVg90H21EOLACvtfcHk0liYDqDwXU0ZzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cms7fL&md5=ea38fcd5e399a420bbcc011780c41d1c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F092986710793176357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710793176357%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DTargeting%2520protein-protein%2520interactions%253A%2520a%2520promising%2520avenue%2520of%2520anti-HIV%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3393%26epage%3D3409%26doi%3D10.2174%2F092986710793176357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desimmie, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardiot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Remoortel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelkov, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Maeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaltin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span> </span><span class="NLM_article-title">Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span><span class="refDoi"> DOI: 10.1038/nchembio.370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchembio.370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20473303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFaltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=442-448&author=F.+Christauthor=A.+Voetauthor=A.+Marchandauthor=S.+Nicoletauthor=B.+A.+Desimmieauthor=D.+Marchandauthor=D.+Bardiotauthor=N.+J.+Van+der+Vekenauthor=B.+Van+Remoortelauthor=S.+V.+Strelkovauthor=M.+De+Maeyerauthor=P.+Chaltinauthor=Z.+Debyser&title=Rational+design+of+small-molecule+inhibitors+of+the+LEDGF%2Fp75-integrase+interaction+and+HIV+replication&doi=10.1038%2Fnchembio.370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication</span></div><div class="casAuthors">Christ, Frauke; Voet, Arnout; Marchand, Arnaud; Nicolet, Stefan; Desimmie, Belete A.; Marchand, Damien; Bardiot, Dorothee; Van der Veken, Nam Joo; Van Remoortel, Barbara; Strelkov, Sergei V.; De Maeyer, Marc; Chaltin, Patrick; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">442-448</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lens epithelium-derived growth factor (LEDGF/p75) is a cellular cofactor of HIV-1 integrase that promotes viral integration by tethering the preintegration complex to the chromatin.  By virtue of its crucial role in the early steps of HIV replication, the interaction between LEDGF/p75 and integrase represents an attractive target for antiviral therapy.  We have rationally designed a series of 2-(quinolin-3-yl)acetic acid derivs. (LEDGINs) that act as potent inhibitors of the LEDGF/p75-integrase interaction and HIV-1 replication at submicromolar concn. by blocking the integration step.  A 1.84-Å resoln. crystal structure corroborates the binding of the inhibitor in the LEDGF/p75-binding pocket of integrase.  Together with the lack of cross-resistance with two clin. integrase inhibitors, these findings define the 2-(quinolin-3-yl)acetic acid derivs. as the first genuine allosteric HIV-1 integrase inhibitors.  Our work demonstrates the feasibility of rational design of small mols. inhibiting the protein-protein interaction between a viral protein and a cellular host factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRSR1oWvr1XrVg90H21EOLACvtfcHk0liKsHO9dJ1ktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFaltr4%253D&md5=2f77b35a182fbee6d7b49da563e3447f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.370%26sid%3Dliteratum%253Aachs%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DVoet%26aufirst%3DA.%26aulast%3DMarchand%26aufirst%3DA.%26aulast%3DNicolet%26aufirst%3DS.%26aulast%3DDesimmie%26aufirst%3DB.%2BA.%26aulast%3DMarchand%26aufirst%3DD.%26aulast%3DBardiot%26aufirst%3DD.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DN.%2BJ.%26aulast%3DVan%2BRemoortel%26aufirst%3DB.%26aulast%3DStrelkov%26aufirst%3DS.%2BV.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DChaltin%26aufirst%3DP.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DRational%2520design%2520of%2520small-molecule%2520inhibitors%2520of%2520the%2520LEDGF%252Fp75-integrase%2520interaction%2520and%2520HIV%2520replication%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D442%26epage%3D448%26doi%3D10.1038%2Fnchembio.370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morreale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitto, R.</span><span> </span><span class="NLM_article-title">New scaffolds of natural origin as integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2013.07.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=405-411&author=L.+De+Lucaauthor=F.+Morrealeauthor=F.+Christauthor=Z.+Debyserauthor=S.+Ferroauthor=R.+Gitto&title=New+scaffolds+of+natural+origin+as+integrase-LEDGF%2Fp75+interaction+inhibitors%3A+virtual+screening+and+activity+assays&doi=10.1016%2Fj.ejmech.2013.07.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DMorreale%26aufirst%3DF.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DGitto%26aufirst%3DR.%26atitle%3DNew%2520scaffolds%2520of%2520natural%2520origin%2520as%2520integrase-LEDGF%252Fp75%2520interaction%2520inhibitors%253A%2520virtual%2520screening%2520and%2520activity%2520assays%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D68%26spage%3D405%26epage%3D411%26doi%3D10.1016%2Fj.ejmech.2013.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iraci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span> </span><span class="NLM_article-title">Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1316</span><span class="refDoi"> DOI: 10.1002/cmdc.200900070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.200900070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1311-1316&author=L.+De+Lucaauthor=M.+L.+Barrecaauthor=S.+Ferroauthor=F.+Christauthor=N.+Iraciauthor=R.+Gittoauthor=A.+M.+Monforteauthor=Z.+Debyserauthor=A.+Chimirri&title=Pharmacophore-based+discovery+of+small-molecule+inhibitors+of+protein-protein+interactions+between+HIV-1+integrase+and+cellular+cofactor+LEDGF%2Fp75&doi=10.1002%2Fcmdc.200900070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900070%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DIraci%26aufirst%3DN.%26aulast%3DGitto%26aufirst%3DR.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DChimirri%26aufirst%3DA.%26atitle%3DPharmacophore-based%2520discovery%2520of%2520small-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%2520between%2520HIV-1%2520integrase%2520and%2520cellular%2520cofactor%2520LEDGF%252Fp75%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1311%26epage%3D1316%26doi%3D10.1002%2Fcmdc.200900070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10108</span><span class="NLM_x">–</span> <span class="NLM_lpage">10117</span><span class="refDoi"> DOI: 10.1021/jm301226a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301226a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10108-10117&author=G.+Huauthor=X.+Liauthor=X.+Zhangauthor=Y.+Liauthor=L.+Maauthor=L.+M.+Yangauthor=G.+Liuauthor=W.+Liauthor=J.+Huangauthor=X.+Shenauthor=L.+Huauthor=Y.+T.+Zhengauthor=Y.+Tang&title=Discovery+of+inhibitors+to+block+interactions+of+HIV-1+integrase+with+human+LEDGF%2Fp75+via+structure-based+virtual+screening+and+bioassays&doi=10.1021%2Fjm301226a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm301226a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301226a%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520inhibitors%2520to%2520block%2520interactions%2520of%2520HIV-1%2520integrase%2520with%2520human%2520LEDGF%252Fp75%2520via%2520structure-based%2520virtual%2520screening%2520and%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10108%26epage%3D10117%26doi%3D10.1021%2Fjm301226a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Restouin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arold, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrot, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerlesquin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collette, Y.</span><span> </span><span class="NLM_article-title">Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">19256</span><span class="NLM_x">–</span> <span class="NLM_lpage">19261</span><span class="refDoi"> DOI: 10.1073/pnas.0707130104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.0707130104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=18042718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVKqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=19256-19261&author=S.+Betziauthor=A.+Restouinauthor=S.+Opiauthor=S.+T.+Aroldauthor=I.+Parrotauthor=F.+Guerlesquinauthor=X.+Morelliauthor=Y.+Collette&title=Protein+protein+interaction+inhibition+%282P2I%29+combining+high+throughput+and+virtual+screening%3A+Application+to+the+HIV-1+Nef+protein&doi=10.1073%2Fpnas.0707130104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-protein interaction inhibition (2P2I) combining high throughput and virtual screening: application to the HIV-1 nef protein</span></div><div class="casAuthors">Betzi, Stephane; Restouin, Audrey; Opi, Sandrine; Arold, Stefan T.; Parrot, Isabelle; Guerlesquin, Francoise; Morelli, Xavier; Collette, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19256-19261</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein-protein recognition is the cornerstone of multiple cellular and pathol. functions.  Therefore, protein-protein interaction inhibition (2P2I) is endowed with great therapeutic potential despite the initial belief that 2P2I was refractory to small-mol. intervention.  Improved knowledge of complex mol. binding surfaces has recently stimulated renewed interest for 2P2I, esp. after identification of "hot spots" and first inhibitory compds.  However, the combination of target complexity and lack of starting compd. has thwarted exptl. results and created intellectual barriers.  Here we combined virtual and exptl. screening when no previously known inhibitors can be used as starting point in a structure-based research program that targets an SH3 binding surface of the HIV type I Nef protein.  High-throughput docking and application of a pharmacophoric filter on one hand and search for analogy on the other hand identified drug-like compds. that were further confirmed to bind Nef in the micromolar range (isothermal titrn. calorimetry), to target the Nef SH3 binding surface (NMR expts.), and to efficiently compete for Nef-SH3 interactions (cell-based assay, GST pull-down).  Initial identification of these compds. by virtual screening was validated by screening of the very same library of compds. in the cell-based assay, demonstrating that a significant enrichment factor was attained by the in silico screening.  To our knowledge, our results identify the first set of drug-like compds. that functionally target the HIV-1 Nef SH3 binding surface and provide the basis for a powerful discovery process that should help to speed up 2P2I strategies and open avenues for new class of antiviral mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm0hLpNUw_G7Vg90H21EOLACvtfcHk0lj-1JsIV-rO8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVKqsA%253D%253D&md5=1c8a22ad645fd87ba9a7affaa3e0f6f4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0707130104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0707130104%26sid%3Dliteratum%253Aachs%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DRestouin%26aufirst%3DA.%26aulast%3DOpi%26aufirst%3DS.%26aulast%3DArold%26aufirst%3DS.%2BT.%26aulast%3DParrot%26aufirst%3DI.%26aulast%3DGuerlesquin%26aufirst%3DF.%26aulast%3DMorelli%26aufirst%3DX.%26aulast%3DCollette%26aufirst%3DY.%26atitle%3DProtein%2520protein%2520interaction%2520inhibition%2520%25282P2I%2529%2520combining%2520high%2520throughput%2520and%2520virtual%2520screening%253A%2520Application%2520to%2520the%2520HIV-1%2520Nef%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D19256%26epage%3D19261%26doi%3D10.1073%2Fpnas.0707130104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Rationally designed multitarget anti-HIV agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1743</span><span class="NLM_x">–</span> <span class="NLM_lpage">1758</span><span class="refDoi"> DOI: 10.2174/0929867311320130011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F0929867311320130011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23410170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1743-1758&author=P.+Zhanauthor=X.+Liu&title=Rationally+designed+multitarget+anti-HIV+agents&doi=10.2174%2F0929867311320130011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally designed multitarget anti-HIV agents</span></div><div class="casAuthors">Zhan, P.; Liu, X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1743-1758</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multitarget-directed ligands (MTDLs), an emerging and appealing drug discovery strategy, utilizing a single chem. entity to inhibit multitargets, was confirmed to be effective in reducing the likelihood of drug resistance, diminishing problems of dosing complexity, drug-drug interactions and toxicities, as well as improving patient compliance.  The exploration of MTDL strategy should be valuable in anti-HIV drug discovery.  In this article, current knowledge and strategies for the rational design of the multitarget and selective anti-HIV agents are described and a no. of illustrative examples are given.  Moreover, the challenges, limitations and outlook of such novel drug design strategies are also presented, with a goal to highlight the representative paradigms in the rational design of MTDLs, and to help medicinal chemists discover the next generation of multitarget anti-HIV agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNRXcarV8VEbVg90H21EOLACvtfcHk0lj-1JsIV-rO8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jurw%253D&md5=b553b36a0107949cf8813b342aaeda1e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F0929867311320130011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320130011%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRationally%2520designed%2520multitarget%2520anti-HIV%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1743%26epage%3D1758%26doi%3D10.2174%2F0929867311320130011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Designed multiple ligands: an emerging anti-HIV drug discovery paradigm</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span><span class="refDoi"> DOI: 10.2174/138161209788453266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161209788453266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19519431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFCgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1893-1917&author=P.+Zhanauthor=X.+Liu&title=Designed+multiple+ligands%3A+an+emerging+anti-HIV+drug+discovery+paradigm&doi=10.2174%2F138161209788453266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Designed multiple ligands: an emerging anti-HIV drug discovery paradigm</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1893-1917</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently, the effect of AIDS single-target chemotherapy is severely compromised by the quick emergence of resistant HIV strains.  Highly active antiretroviral therapy (HAART) combines HIV reverse transcriptase inhibitors with protease inhibitors or integrase inhibitors, and successfully suppresses HIV viral load to an undetectable level, dramatically improving the life quality of AIDS patients.  However, the benefits of this approach are often compromised by poor patient compliance.  Recently, there has been a move toward multicomponent drugs whereby two or more agents are coformulated in a single tablet to make dosing regimes simpler and thereby to improve patient compliance, but there are significant risks involved in the development of multicomponent drugs.  Designed multiple ligands (DMLs) therapy as an emerging anti-HIV drug discovery paradigm, using a single entity to inhibit multitargets could yield improved patient compliance, thus reducing the likelihood of drug resistance.  The exploration of such multifunctional ligands has proven valuable for anti-HIV leads discovery.  However, presently many multifunctional scaffolds were first discovered by serendipity or screening; rational design by combining existing monofunctional scaffolds remains an enormous challenge.  A key issue in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  This review of literature examples introduce numerous attractive lead compds., capable of interfering with different stages of HIV infection and AIDS pathogenesis, which reveals trends and insights that might provide valuable clues for novel anti-HIV drug design and help medicinal chemists discover the next generation of multiple ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAXjh7m9EEnbVg90H21EOLACvtfcHk0lgizVJGM6q52g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFCgtro%253D&md5=7d3bba631dac7febeaf5e17af81cae6b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F138161209788453266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209788453266%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDesigned%2520multiple%2520ligands%253A%2520an%2520emerging%2520anti-HIV%2520drug%2520discovery%2520paradigm%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D1893%26epage%3D1917%26doi%3D10.2174%2F138161209788453266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span> </span><span class="NLM_article-title">Rationally designed dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3416</span><span class="NLM_x">–</span> <span class="NLM_lpage">3419</span><span class="refDoi"> DOI: 10.1021/jm070512p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070512p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3416-3419&author=Z.+Wangauthor=E.+M.+Bennettauthor=D.+J.+Wilsonauthor=C.+Salomonauthor=R.+Vince&title=Rationally+designed+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1021%2Fjm070512p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase</span></div><div class="casAuthors">Wang, Zhengqiang; Bennett, Eric M.; Wilson, Daniel J.; Salomon, Christine; Vince, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3416-3419</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bifunctional inhibitors were designed and synthesized based on 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) non-nucleoside reverse transcriptase (RT) inhibitors and diketoacid (DKA) integrase (IN) inhibitors.  Biochem. studies revealed activity against RT and IN at low nanomolar and low micromolar concns., resp.  Exceptionally low IC50 values from a cell-based assay were achieved along with remarkably high therapeutic indexes.  Compd. I was identified as the best compd. of the series (IC50: 24 nM against RT, 4.4 μM against IN, and 10 nM against HIV-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKQ5ZDoIQqLVg90H21EOLACvtfcHk0lgizVJGM6q52g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVehtbo%253D&md5=021d763f7f62919cc1fe9d010ab56e60</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm070512p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070512p%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DSalomon%26aufirst%3DC.%26aulast%3DVince%26aufirst%3DR.%26atitle%3DRationally%2520designed%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3416%26epage%3D3419%26doi%3D10.1021%2Fjm070512p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span> </span><span class="NLM_article-title">Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4202</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmc.2010.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20576573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntV2rtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4202-4211&author=Z.+Wangauthor=J.+Tangauthor=C.+E.+Salomonauthor=C.+D.+Dreisauthor=R.+Vince&title=Pharmacophore+and+structure-activity+relationships+of+integrase+inhibition+within+a+dual+inhibitor+scaffold+of+HIV+reverse+transcriptase+and+integrase&doi=10.1016%2Fj.bmc.2010.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase</span></div><div class="casAuthors">Wang, Zhengqiang; Tang, Jing; Salomon, Christine E.; Dreis, Christine D.; Vince, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4202-4211</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rational design of dually active inhibitors against human immunodeficiency virus (HIV) reverse transcriptase (RT) and integrase (IN) has proved viable with 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) type of non-nucleoside RT inhibitors (NNRTIs).  To establish the pharmacophore and study the structure-activity relationships (SAR) of integrase inhibition within a previously disclosed RT/IN dual inhibitor scaffold, new analogs featuring substitution at different sites of the HEPT ring were designed and synthesized.  These studies have revealed an IN inhibition pharmacophore that is merged with the known RT pharmacophore through a shared C-6 benzyl group.  Further SAR also demonstrated that optimal IN inhibition within our dual inhibitor scaffold requires a regiospecific (N-1) diketoacid (DKA)-carrying pendant with a certain length.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhRvNGIpI8pbVg90H21EOLACvtfcHk0ljgbradDxY-SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntV2rtb4%253D&md5=603652ca80d40b34489c6d6f1fa28dd6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DSalomon%26aufirst%3DC.%2BE.%26aulast%3DDreis%26aufirst%3DC.%2BD.%26aulast%3DVince%26aufirst%3DR.%26atitle%3DPharmacophore%2520and%2520structure-activity%2520relationships%2520of%2520integrase%2520inhibition%2520within%2520a%2520dual%2520inhibitor%2520scaffold%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4202%26epage%3D4211%26doi%3D10.1016%2Fj.bmc.2010.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">N-3 hydroxylation of pyrimidine-2,4-diones yields dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1021/ml1002162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlalurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=63-67&author=J.+Tangauthor=K.+Maddaliauthor=C.+D.+Dreisauthor=Y.+Y.+Shamauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=N-3+hydroxylation+of+pyrimidine-2%2C4-diones+yields+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1021%2Fml1002162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase</span></div><div class="casAuthors">Tang, Jing; Maddali, Kasthuraiah; Dreis, Christine D.; Sham, Yuk Y.; Vince, Robert; Pommier, Yves; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-67</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new mol. scaffold featuring an N-hydroxyimide functionality and capable of inhibiting both reverse transcriptase (RT) and integrase (IN) of human immunodeficiency virus (HIV) was rationally designed based on 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) non-nucleoside RT inhibitors (NNRTIs).  The design involves a minimal 3-N hydroxylation of the pyrimidine ring of HEPT compd. to yield a chelating triad which, along with the existing benzyl group, appeared to satisfy major structural requirements for IN binding.  In the mean time, this chem. modification did not severely compromise the compd.'s ability to inhibit RT.  A preliminary structure-activity relationship (SAR) study reveals that this N-3 OH is essential for IN inhibition and that the benzyl group on N-1 side chain is more important for IN binding than the one on C-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqONtaoARK-6bVg90H21EOLACvtfcHk0ljgbradDxY-SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlalurzP&md5=8b20b2ac50ef44513cdcfe51664790ca</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml1002162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002162%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DDreis%26aufirst%3DC.%2BD.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DN-3%2520hydroxylation%2520of%2520pyrimidine-2%252C4-diones%2520yields%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D63%26epage%3D67%26doi%3D10.1021%2Fml1002162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2282</span><span class="NLM_x">–</span> <span class="NLM_lpage">2292</span><span class="refDoi"> DOI: 10.1021/jm1014378</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1014378" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisl2qu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2282-2292&author=J.+Tangauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Y.+Shamauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=3-Hydroxypyrimidine-2%2C4-diones+as+an+inhibitor+scaffold+of+HIV+integrase&doi=10.1021%2Fjm1014378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase</span></div><div class="casAuthors">Tang, Jing; Maddali, Kasthuraiah; Sham, Yuk Y.; Vince, Robert; Pommier, Yves; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2282-2292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Integrase (IN) represents a clin. validated target for the development of antivirals against human immunodeficiency virus (HIV).  Inhibitors with a novel structure core are essential for combating resistance assocd. with known IN inhibitors (INIs).  We have previously disclosed a novel dual inhibitor scaffold of HIV IN and reverse transcriptase (RT).  Here we report the complete structure-activity relationship (SAR), mol. modeling, and resistance profile of this inhibitor type on IN inhibition.  These studies support an antiviral mechanism of dual inhibition against both IN and RT and validate 3-hydroxypyrimidine-2,4-diones as an IN inhibitor scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBxF_3fkEp67Vg90H21EOLACvtfcHk0lhrwB6ptJqxPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisl2qu7Y%253D&md5=8b53b8997bd2623f3f17851dce6c2ed0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm1014378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1014378%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D3-Hydroxypyrimidine-2%252C4-diones%2520as%2520an%2520inhibitor%2520scaffold%2520of%2520HIV%2520integrase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2282%26epage%3D2292%26doi%3D10.1021%2Fjm1014378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreis, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vince, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2400</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2011.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21392991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12ku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2400-2402&author=J.+Tangauthor=K.+Maddaliauthor=C.+D.+Dreisauthor=Y.+Y.+Shamauthor=R.+Vinceauthor=Y.+Pommierauthor=Z.+Wang&title=6-Benzoyl-3-hydroxypyrimidine-2%2C4-diones+as+dual+inhibitors+of+HIV+reverse+transcriptase+and+integrase&doi=10.1016%2Fj.bmcl.2011.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase</span></div><div class="casAuthors">Tang, Jing; Maddali, Kasthuraiah; Dreis, Christine D.; Sham, Yuk Y.; Vince, Robert; Pommier, Yves; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2400-2402</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-3-Hydroxylation of pyrimidine-2,4-diones was recently found to yield inhibitors of both HIV-1 reverse transcriptase (RT) and integrase (IN).  An extended series of analogs featuring a benzoyl group at the C-6 position of the pyrimidine ring was synthesized.  Through biochem. studies it was found that these new analogs are dually active against both RT and IN in low micromolar range.  Antiviral assays confirmed that these new inhibitors are active against HIV-1 in cell culture at nanomolar to low micromolar range, further validating 3-hydroxypyrimidine-2,4-diones as a viable scaffold for antiviral development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsIm-OLOGzF7Vg90H21EOLACvtfcHk0lhrwB6ptJqxPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12ku7w%253D&md5=bcbbf988ce7835a8c6fcdf43241dc24e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DDreis%26aufirst%3DC.%2BD.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DVince%26aufirst%3DR.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3D6-Benzoyl-3-hydroxypyrimidine-2%252C4-diones%2520as%2520dual%2520inhibitors%2520of%2520HIV%2520reverse%2520transcriptase%2520and%2520integrase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2400%26epage%3D2402%26doi%3D10.1016%2Fj.bmcl.2011.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009–2013 update</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.2174/09298673113206660298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F09298673113206660298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24164196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=329-355&author=Y.+Songauthor=Z.+Fangauthor=P.+Zhanauthor=X.+Liu&title=Recent+advances+in+the+discovery+and+development+of+novel+HIV-1+NNRTI+platforms+%28Part+II%29%3A+2009%E2%80%932013+update&doi=10.2174%2F09298673113206660298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms (Part II): 2009-2013 Update</span></div><div class="casAuthors">Song, Yu-ning; Fang, Zengjun; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-355</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The long-term usage of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) eventually leads to rapid emergence of drug-resistant viruses and severe side effect.  Therefore, it is imperative to seek the addnl. NNRTIs with potent and broad spectrum anti-mutant activities, and excellent pharmacokinetic profiles.  The discovery of etravirine, rilpivirine and other successful examples has influenced the NNRTIs design strategy profoundly.  Sustained efforts in this area have led to the identification of many promising NNRTIs hits, leads and candidates for the last few years.  Hence, this review aims to highlight recent prominent advances in this field as well as contributions from our lab. toward the discovery of novel potent NNRTIs from 2009 to 2013 (by May).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zOLPDI7Lg7Vg90H21EOLACvtfcHk0lhrwB6ptJqxPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOisb4%253D&md5=10535ebea845f8acaff293bc414216f1</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.2174%2F09298673113206660298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113206660298%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520HIV-1%2520NNRTI%2520platforms%2520%2528Part%2520II%2529%253A%25202009%25E2%2580%25932013%2520update%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D329%26epage%3D355%26doi%3D10.2174%2F09298673113206660298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit60b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006–2008 update</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2876</span><span class="NLM_x">–</span> <span class="NLM_lpage">2889</span><span class="refDoi"> DOI: 10.2174/092986709788803231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986709788803231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19689270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2876-2889&author=P.+Zhanauthor=X.+Liuauthor=Z.+Li&title=Recent+advances+in+the+discovery+and+development+of+novel+HIV-1+NNRTI+platforms%3A+2006%E2%80%932008+update&doi=10.2174%2F092986709788803231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60bR"><div class="casContent"><span class="casTitleNuber">60b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong; Li, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2876-2889</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently, the long-term usage of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV/AIDS patients eventually leads to the development of drug resistance and severe side effect.  Therefore, it is imperative to look for the novel NNRTIs with potent and broad spectrum anti-mutant activity that are also safe and have excellent pharmacokinetic profiles.  In this article, newly emerging NNRTIs scaffolds in recent three years, together with the underlying strategies for developing new generation HIV-1 NNRTIs with improved resilience to current drug resistant mutants, are reviewed and analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFdlFyWSotibVg90H21EOLACvtfcHk0likewdWpE_BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVyntLw%253D&md5=378adc5bb5cb7bf9345ae9ef2a7f5d09</span></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=10.2174%2F092986709788803231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803231%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520HIV-1%2520NNRTI%2520platforms%253A%25202006%25E2%2580%25932008%2520update%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2876%26epage%3D2889%26doi%3D10.2174%2F092986709788803231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit60c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">E1</span><span class="NLM_x">–</span> <span class="NLM_lpage">E72</span><span class="refDoi"> DOI: 10.1002/med.20241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fmed.20241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21523792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=E1-E72&issue=Suppl.+1&author=P.+Zhanauthor=X.+Chenauthor=D.+Liauthor=Z.+Fangauthor=E.+De+Clercqauthor=X.+Liu&title=HIV-1+NNRTIs%3A+structural+diversity%2C+pharmacophore+similarity%2C+and+implications+for+drug+design&doi=10.1002%2Fmed.20241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60cR"><div class="casContent"><span class="casTitleNuber">60c</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design</span></div><div class="casAuthors">Zhan, Peng; Chen, Xuwang; Li, Dongyue; Fang, Zengjun; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">E1-E72</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nonnucleoside reverse transcriptase inhibitors (NNRTIs) nowadays represent very potent and most promising anti-AIDS agents that specifically target the HIV-1 reverse transcriptase (RT).  However, the effectiveness of NNRTI drugs can be hampered by rapid emergence of drug-resistant viruses and severe side effects upon long-term use.  Therefore, there is an urgent need to develop novel, highly potent NNRTIs with broad spectrum antiviral activity and improved pharmacokinetic properties, and more efficient strategies that facilitate and shorten the drug discovery process would be extremely beneficial.  Fortunately, the structural diversity of NNRTIs provided a wide space for novel lead discovery, and the pharmacophore similarity of NNRTIs gave valuable hints for lead discovery and optimization.  More importantly, with the continued efforts in the development of computational tools and increased crystallog. information on RT/NNRTI complexes, structure-based approaches using a combination of traditional medicinal chem., structural biol., and computational chem. are being used increasingly in the design of NNRTIs.  First, this review covers two decades of research and development for various NNRTI families based on their chem. scaffolds, and then describes the structural similarity of NNRTIs.  We have attempted to assemble a comprehensive overview of the general approaches in NNRTI lead discovery and optimization reported in the literature during the last decade.  The successful applications of medicinal chem. strategies, crystallog., and computational tools for designing novel NNRTIs are highlighted.  Future directions for research are also outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7jjFerOFrbVg90H21EOLACvtfcHk0likewdWpE_BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWmsbo%253D&md5=08cc3f8e0815f70ee052ccda81d75dfb</span></div><a href="/servlet/linkout?suffix=cit60c&amp;dbid=16384&amp;doi=10.1002%2Fmed.20241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20241%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DHIV-1%2520NNRTIs%253A%2520structural%2520diversity%252C%2520pharmacophore%2520similarity%252C%2520and%2520implications%2520for%2520drug%2520design%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26issue%3DSuppl.%25201%26spage%3DE1%26epage%3DE72%26doi%3D10.1002%2Fmed.20241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit60d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span><span class="refDoi"> DOI: 10.1517/13543776.2011.568481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F13543776.2011.568481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21457080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFantrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=717-796&author=P.+Zhanauthor=X.+Liu&title=Novel+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors%3A+a+patent+review+%282005+-+2010%29&doi=10.1517%2F13543776.2011.568481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60dR"><div class="casContent"><span class="casTitleNuber">60d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 -- 2010)</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">717-796</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Non-nucleoside reverse transcriptase inhibitors (NNRTIs) form the backbone of antiretroviral treatment for many HIV-infected individuals.  The unique antiviral activity, high specificity and low toxicity assocd. with this class of agents make them a frequent choice for first-line therapy.  However, the effectiveness of NNRTI drugs can be hampered by the rapid emergence of drug-resistant viruses, poor pharmacokinetic (PK) properties and severe side effects in long-term usage.  Therefore, there is an urgent need to develop novel NNRTIs without such limitations.  An anal. of this vast group of already existing inhibitors should constitute the basis of the effort toward the development of more potent, promising drugs or candidates.Areas covered: The present review provides an overview of NNRTI research from 2005 to 2010, and highlights some important medicinal chem. principles and strategies in the development of NNRTIs.Expert opinion: An in-depth anal. of the common binding configuration and structural features of NNRTIs, as well as the underlying clues to the follow-on''-based chem. evolution efforts (including the key medicinal chem. principles and strategies: bioisosteric replacement, mol. hybridization, scaffold hopping, prodrug, etc.) has greatly accelerated the optimization of the pharmacodynamic (PD) and PK profiles.  There is still a good deal of opportunity to discover new highly potent NNRTIs or novel scaffolds with unconventional mechanisms for reverse transcriptase (RT) inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYU8akFVz6W7Vg90H21EOLACvtfcHk0lgqXr0ESfMj9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFantrc%253D&md5=a6b5c62bd7d1183413c380397bc610c1</span></div><a href="/servlet/linkout?suffix=cit60d&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.568481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.568481%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DNovel%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282005%2520-%25202010%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D717%26epage%3D796%26doi%3D10.1517%2F13543776.2011.568481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit60e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Design strategies of novel NNRTIs to overcome drug resistance</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3903</span><span class="NLM_x">–</span> <span class="NLM_lpage">3917</span><span class="refDoi"> DOI: 10.2174/092986709789178019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986709789178019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19747133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=3903-3917&author=P.+Zhanauthor=X.+Liuauthor=Z.+Liauthor=C.+Pannecouqueauthor=E.+De+Clercq&title=Design+strategies+of+novel+NNRTIs+to+overcome+drug+resistance&doi=10.2174%2F092986709789178019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60eR"><div class="casContent"><span class="casTitleNuber">60e</span><div class="casTitle"><span class="NLM_cas:atitle">Design strategies of novel NNRTIs to overcome drug resistance</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong; Li, Zhenyu; Pannecouque, Christophe; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3903-3917</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are very potent and most promising anti-AIDS drugs that specifically inhibit HIV-1 reverse transcriptase (RT).  However, to a great extent, the efficacy of NNRTI drugs is impaired by rapid emergence of drug-resistance mutations.  Fortunately, detailed anal. of a wide range of crystal structures of HIV-1 RT/NNRTI complexes together with data on drug resistance mutations has identified factors important for design of inhibitors and resilience to mutations, such as, exhibiting conformational flexibility and positional adaptability of NNRTIs, forming extensive main chain hydrogen bonding, targeting highly conserved residues in HIV-1 RT and possessing unconventional mechanisms for NNRTI-mediated inhibition of RT.  Besides, the plasticity of NNRTIs binding pocket (NNIBP) also provides a broad space for the discovery of new generations of NNRTIs.  For instance, the composite binding pocket, integrating all available crystal structure information about the NNRTI binding site of HIV RT, was demonstrated to be an effective tool to better understand the flexible nature of the binding pocket and to identify specific inhibitors.  The RT/solvent interface proved to be an attractive site for incorporating a moiety to improve water soly. and pharmacokinetics or introducing a second pharmacophore to construct multifunctional ligand.  Totally, the characterization of NNRTIs and NNIBP may help in the design of more effective drugs that are potent toward wild type and drug-resistant strains of RT.  In this paper we attempt to translate the general knowledge gained from a large no. of related literature into a set of medicinal chem. strategies to improve the drug resistance profile of NNRTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfBY0F4M_eN7Vg90H21EOLACvtfcHk0lgqXr0ESfMj9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCktbvM&md5=4834066bfce8ae018df14be7e84d5a90</span></div><a href="/servlet/linkout?suffix=cit60e&amp;dbid=16384&amp;doi=10.2174%2F092986709789178019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709789178019%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DDesign%2520strategies%2520of%2520novel%2520NNRTIs%2520to%2520overcome%2520drug%2520resistance%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D3903%26epage%3D3917%26doi%3D10.2174%2F092986709789178019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit60f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 - 2014)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span><span class="refDoi"> DOI: 10.1517/13543776.2014.964685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F13543776.2014.964685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25313716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1199-1227&author=X.+Liauthor=L.+Zhangauthor=Y.+Tianauthor=Y.+Songauthor=P.+Zhanauthor=X.+Liu&title=Novel+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors%3A+a+patent+review+%282011+-+2014%29&doi=10.1517%2F13543776.2014.964685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60fR"><div class="casContent"><span class="casTitleNuber">60f</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 - 2014)</span></div><div class="casAuthors">Li, Xiao; Zhang, Lingzi; Tian, Ye; Song, Yu'ning; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1199-1227</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: There is a continuous need for next-generation non-nucleoside RT inhibitors (NNRTIs) with different resistance profiles, improved safety, excellent tolerability, and favorable physicochem. properties.  Areas covered: In this review we intend to narrate a general and cutting-edge overview of current state of NNRTI patents during the 2011 - 2014 (June) period and future perspectives.  Particular focus is placed on the highlighting of some emerging medicinal chem. principles and insights in the discovery and development of NNRTIs.  Expert opinion: The development of effective NNRTIs is moving on from trial-and-error approaches to sophisticated subconscious strategies.  Several newly emerging structure-based virtual screening methodologies (such as Monte Carlo free energy perturbation calcns.) or new drug design insights, such as taking full use of the specific noncovalent reverse transcriptase/NNRTIs interactions, stereochem. diversity-oriented conformational restriction, novel strategies to enhance soly. and early absorption, distribution, metab., excretion, and toxicity (ADMET) assessment, will continue to evolve to complement the classical NNRTIs discovery approaches (structure-based core-refining and substituents-decorating).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovB7ip_ksH-7Vg90H21EOLACvtfcHk0livO7zJT7wYxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgur%252FP&md5=52fbb7a65dd285055d8450f5e0cc7cd7</span></div><a href="/servlet/linkout?suffix=cit60f&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.964685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.964685%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DNovel%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282011%2520-%25202014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1199%26epage%3D1227%26doi%3D10.1517%2F13543776.2014.964685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Vernekar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kankanala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parniak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span><span class="refDoi"> DOI: 10.1021/jm501132s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501132s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=651-664&author=S.+K.+Vernekarauthor=Z.+Liuauthor=E.+Nagyauthor=L.+Millerauthor=K.+A.+Kirbyauthor=D.+J.+Wilsonauthor=J.+Kankanalaauthor=S.+G.+Sarafianosauthor=M.+A.+Parniakauthor=Z.+Wang&title=Design%2C+synthesis%2C+biochemical%2C+and+antiviral+evaluations+of+C6+benzyl+and+C6+biarylmethyl+substituted+2-hydroxylisoquinoline-1%2C3-diones%3A+dual+inhibition+against+HIV+reverse+transcriptase-associated+RNase+H+and+polymerase+with+antiviral+activities&doi=10.1021%2Fjm501132s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities</span></div><div class="casAuthors">Vernekar, Sanjeev Kumar V.; Liu, Zheng; Nagy, Eva; Miller, Lena; Kirby, Karen A.; Wilson, Daniel J.; Kankanala, Jayakanth; Sarafianos, Stefan G.; Parniak, Michael A.; Wang, Zhengqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reverse transcriptase (RT) assocd. RNase H (RNase H) remains the only virally encoded enzymic function not targeted by current chemotherapy against human immunodeficiency virus (HIV).  Although numerous chemotypes have been reported to inhibit HIV RNase H biochem., few show significant antiviral activity against HIV.  We report herein the design, synthesis, and biol. evaluations of a novel variant of 2-hydroxyisoquinoline-1,3-dione (HID) scaffold featuring a crucial C-6 benzyl or biarylmethyl moiety, e. g., I.  The synthesis involved a recently reported metal-free direct benzylation between tosylhydrazone and boronic acid, which allowed the generation of structural diversity for the hydrophobic arom. region.  Biochem. studies showed that the C-6 benzyl and biarylmethyl HID analogs, previously unknown chemotypes, consistently inhibited HIV RT-assocd. RNase H and polymerase with IC50s in low to submicromolar range.  The obsd. dual inhibitory activity remained uncompromised against RT mutants resistant to non-nucleoside RT inhibitors (NNRTIs), suggesting the involvement of binding site(s) other than the NNRTI binding pocket.  Intriguingly, these same compds. inhibited the polymerase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Escherichia coli RNase H.  Addnl. biochem. testing revealed a substantially reduced level of inhibition against HIV integrase.  Mol. docking corroborates favorable binding of these analogs to the active site of HIV RNase H.  Finally, a no. of these analogs also demonstrated antiviral activity at low micromolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeenALml-35bVg90H21EOLACvtfcHk0livO7zJT7wYxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOhu7rO&md5=a4574233b65a5a0efd3634a2011fc94f</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm501132s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501132s%26sid%3Dliteratum%253Aachs%26aulast%3DVernekar%26aufirst%3DS.%2BK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DNagy%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DKankanala%26aufirst%3DJ.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%252C%2520biochemical%252C%2520and%2520antiviral%2520evaluations%2520of%2520C6%2520benzyl%2520and%2520C6%2520biarylmethyl%2520substituted%25202-hydroxylisoquinoline-1%252C3-diones%253A%2520dual%2520inhibition%2520against%2520HIV%2520reverse%2520transcriptase-associated%2520RNase%2520H%2520and%2520polymerase%2520with%2520antiviral%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D651%26epage%3D664%26doi%3D10.1021%2Fjm501132s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pescatori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Métifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masoaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzucoli Crucitti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madia, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccoliti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scipione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Leva, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grice, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">N-Substituted quinolinonyl diketo acid derivatives as HIV integrase strand transfer inhibitors and their activity against RNase H function of reverse transcriptase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4610</span><span class="NLM_x">–</span> <span class="NLM_lpage">4623</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00159</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00159" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXot1Sqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4610-4623&author=L.+Pescatoriauthor=M.+M%C3%A9tifiotauthor=S.+Chungauthor=T.+Masoakaauthor=G.+Cuzzucoli+Crucittiauthor=A.+Messoreauthor=G.+Pupoauthor=V.+N.+Madiaauthor=F.+Saccolitiauthor=L.+Scipioneauthor=S.+Tortorellaauthor=F.+S.+Di+Levaauthor=S.+Cosconatiauthor=L.+Marinelliauthor=E.+Novellinoauthor=S.+F.+Le+Griceauthor=Y.+Pommierauthor=C.+Marchandauthor=R.+Costiauthor=R.+Di+Santo&title=N-Substituted+quinolinonyl+diketo+acid+derivatives+as+HIV+integrase+strand+transfer+inhibitors+and+their+activity+against+RNase+H+function+of+reverse+transcriptase&doi=10.1021%2Facs.jmedchem.5b00159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62aR"><div class="casContent"><span class="casTitleNuber">62a</span><div class="casTitle"><span class="NLM_cas:atitle">N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase</span></div><div class="casAuthors">Pescatori, Luca; Metifiot, Mathieu; Chung, Suhman; Masoaka, Takashi; Cuzzucoli Crucitti, Giuliana; Messore, Antonella; Pupo, Giovanni; Madia, Valentina Noemi; Saccoliti, Francesco; Scipione, Luigi; Tortorella, Silvano; Di Leva, Francesco Saverio; Cosconati, Sandro; Marinelli, Luciana; Novellino, Ettore; Le Grice, Stuart F. J.; Pommier, Yves; Marchand, Christophe; Costi, Roberta; Di Santo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4610-4623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Aralkyl)oxoquinolinyl hydroxyoxobutenoates I [R = ArCH2, Ph(CH2)4; R1 = H, Cl; R2 = H, Cl; R3 = H, Et; Ar = Ph, 2-FC6H4, 2-MeOC6H4, 3-FC6H4, 3-MeOC6H4, 4-ClC6H4, 4-HOC6H4, 4-MeOC6H4, 4-O2NC6H4, 2,4-F2C6H3, 2,5-F2C6H3, 2,6-F2C6H3, 3,4-F2C6H3, 3,5-F2C6H3, 2,4-Cl2C6H3, 2,6-Cl2C6H3, 2,4-Me2C6H3, 3,5-Me2C6H3, 3-Cl-2-FC6H3, 3-Cl-4-FC6H3, 4-pyridinyl, 2-naphthyl, 2-quinolinyl] were prepd. as HIV-1 integrase inhibitors selective for inhibition of strand transfer over 3'-processing and RNase H activities; their inhibition of HIV-1 integrase and their inhibition of HIV-1 and toxicity to human cells were detd.  In vitro, the most potent compd. was I (R = 2,4-F2C6H3CH2; R1 = R2 = R3 = H) (IC50 = 10 nM), while the most active compds. against HIV-infected cells were ester derivs. I (R = 2,4-F2C6H3CH2, 2,6-F2C6H3CH2; R1 = R2 = H; R3 = Et).  In general, the activity of I against RNase H was negligible, with only a few compds. active at concns. higher than 10 μM.  The binding mode of I (R = 2,4-F2C6H3CH2; R1 = R2 = R3 = H) within the integrase catalytic core domain (CCD) is described as well as its binding mode within the RNase H catalytic site to rationalize its selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkRG7fbljvyLVg90H21EOLACvtfcHk0lgmg0VN8V069A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXot1Sqs78%253D&md5=c539fa70d35ac98be4f8e6b0d813a722</span></div><a href="/servlet/linkout?suffix=cit62a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00159%26sid%3Dliteratum%253Aachs%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DM%25C3%25A9tifiot%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DMasoaka%26aufirst%3DT.%26aulast%3DCuzzucoli%2BCrucitti%26aufirst%3DG.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DPupo%26aufirst%3DG.%26aulast%3DMadia%26aufirst%3DV.%2BN.%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLe%2BGrice%26aufirst%3DS.%2BF.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DN-Substituted%2520quinolinonyl%2520diketo%2520acid%2520derivatives%2520as%2520HIV%2520integrase%2520strand%2520transfer%2520inhibitors%2520and%2520their%2520activity%2520against%2520RNase%2520H%2520function%2520of%2520reverse%2520transcriptase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4610%26epage%3D4623%26doi%3D10.1021%2Facs.jmedchem.5b00159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit62b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cuzzucoli Crucitti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Métifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madia, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pupo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccoliti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scipione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corona, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadeddu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1928</span><span class="refDoi"> DOI: 10.1021/jm501799k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501799k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1915-1928&author=G.+Cuzzucoli+Crucittiauthor=M.+M%C3%A9tifiotauthor=L.+Pescatoriauthor=A.+Messoreauthor=V.+N.+Madiaauthor=G.+Pupoauthor=F.+Saccolitiauthor=L.+Scipioneauthor=S.+Tortorellaauthor=F.+Espositoauthor=A.+Coronaauthor=M.+Cadedduauthor=C.+Marchandauthor=Y.+Pommierauthor=E.+Tramontanoauthor=R.+Costiauthor=R.+Di+Santo&title=Structure-activity+relationship+of+pyrrolyl+diketo+acid+derivatives+as+dual+inhibitors+of+HIV-1+integrase+and+reverse+transcriptase+ribonuclease+H+domain&doi=10.1021%2Fjm501799k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62b&amp;dbid=16384&amp;doi=10.1021%2Fjm501799k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501799k%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzucoli%2BCrucitti%26aufirst%3DG.%26aulast%3DM%25C3%25A9tifiot%26aufirst%3DM.%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DMadia%26aufirst%3DV.%2BN.%26aulast%3DPupo%26aufirst%3DG.%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DCorona%26aufirst%3DA.%26aulast%3DCadeddu%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DTramontano%26aufirst%3DE.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520of%2520pyrrolyl%2520diketo%2520acid%2520derivatives%2520as%2520dual%2520inhibitors%2520of%2520HIV-1%2520integrase%2520and%2520reverse%2520transcriptase%2520ribonuclease%2520H%2520domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1915%26epage%3D1928%26doi%3D10.1021%2Fjm501799k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span><span class="refDoi"> DOI: 10.2174/092986713805076649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986713805076649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23116144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=815-832&author=Y.+Songauthor=P.+Zhanauthor=X.+Liauthor=D.+Raiauthor=E.+De+Clercqauthor=X.+Liu&title=Multivalent+agents%3A+a+novel+concept+and+preliminary+practice+in+anti-HIV+drug+discovery&doi=10.2174%2F092986713805076649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span></div><div class="casAuthors">Song, Yu-ning; Zhan, Peng; Li, Xiao; Rai, Diwakar; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">815-832</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The term multivalency (polyvalency) in the biol. science is defined as the simultaneous binding of multiple ligands to one receptor (or multiple receptors to one ligand).  The possibility of gaining potency and selectivity was significantly increased through the use of multivalent ligand as a homo- or hetero-dimer, thus multivalent ligands provided a more attractive strategy to design novel anti-HIV agents with therapeutic applications.  Moreover, similar to phenomenon of multivalency, an alternative strategy is called the "mixed sites inhibitor", viz. a single mol. that possesses enough chem. space to maximize interactions with its complementary binding pocket, or to bind simultaneously in more than one regions in a target.  Actually, the addn. of a third heterocyclic nucleus to the parent compd. resulted in "mixed sites" anti-HIV agents with broad spectrum of activities against the mutant HIV-1 strains.  Based on current representative examples, the present article provided a brief review on the rationale for the design of different classes of multivalency anti-HIV agents and also discussed the advantages over their monomeric counterparts, providing a novel paradigm to facilitate the development of anti-HIV/AIDS therapeutic agents in treatment of HIV infected community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeQQtvZeCCbVg90H21EOLACvtfcHk0liXVjQbfW3boQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D&md5=118fe3f5df6cced753c2e27fdcf77112</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F092986713805076649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986713805076649%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRai%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DMultivalent%2520agents%253A%2520a%2520novel%2520concept%2520and%2520preliminary%2520practice%2520in%2520anti-HIV%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D815%26epage%3D832%26doi%3D10.2174%2F092986713805076649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Bailey, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyidogan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Caro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span> </span><span class="NLM_article-title">Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3959</span><span class="NLM_x">–</span> <span class="NLM_lpage">3968</span><span class="refDoi"> DOI: 10.1021/jm400160s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400160s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3959-3968&author=C.+M.+Baileyauthor=T.+J.+Sullivanauthor=P.+Iyidoganauthor=J.+Tirado-Rivesauthor=R.+Chungauthor=J.+Ruiz-Caroauthor=E.+Mohamedauthor=W.+L.+Jorgensenauthor=R.+Hunterauthor=K.+S.+Anderson&title=Bifunctional+inhibition+of+human+immunodeficiency+virus+type+1+reverse+transcriptase%3A+mechanism+and+proof-of-concept+as+a+novel+therapeutic+design+strategy&doi=10.1021%2Fjm400160s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy</span></div><div class="casAuthors">Bailey, Christopher M.; Sullivan, Todd J.; Iyidogan, Pinar; Tirado-Rives, Julian; Chung, Raymond; Ruiz-Caro, Juliana; Mohamed, Ebrahim; Jorgensen, William L.; Hunter, Roger; Anderson, Karen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3959-3968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is a major target for currently approved anti-HIV drugs.  These drugs are divided into two classes: nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs).  This study illustrates the synthesis and biochem. evaluation of a novel bifunctional RT inhibitor utilizing d4T (NRTI) and a TMC-deriv. (a diarylpyrimidine NNRTI) linked via a poly(ethylene glycol) (PEG) linker.  HIV-1 RT successfully incorporates the triphosphate of d4T-4PEG-TMC bifunctional inhibitor in a base-specific manner.  Moreover, this inhibitor demonstrates low nanomolar potency that has 4.3-fold and 4300-fold enhancement of polymn. inhibition in vitro relative to the parent TMC-deriv. and d4T, resp.  This study serves as a proof-of-concept for the development and optimization of bifunctional RT inhibitors as potent inhibitors of HIV-1 viral replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruGVBT61MtubVg90H21EOLACvtfcHk0liXVjQbfW3boQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWitr8%253D&md5=47a61d684ef88a76a90e3aae9b40b93e</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm400160s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400160s%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DC.%2BM.%26aulast%3DSullivan%26aufirst%3DT.%2BJ.%26aulast%3DIyidogan%26aufirst%3DP.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DRuiz-Caro%26aufirst%3DJ.%26aulast%3DMohamed%26aufirst%3DE.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26atitle%3DBifunctional%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%253A%2520mechanism%2520and%2520proof-of-concept%2520as%2520a%2520novel%2520therapeutic%2520design%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3959%26epage%3D3968%26doi%3D10.1021%2Fjm400160s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Piao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basavapathruni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyidogan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutschman, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span> </span><span class="NLM_article-title">Bifunctional inhibition of HIV-1 reverse transcriptase: a first step in designing a bifunctional triphosphate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1518</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.12.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1511-1518&author=D.+Piaoauthor=A.+Basavapathruniauthor=P.+Iyidoganauthor=G.+Daiauthor=W.+Hinzauthor=A.+S.+Rayauthor=E.+Murakamiauthor=J.+Y.+Fengauthor=F.+Youauthor=G.+E.+Dutschmanauthor=D.+J.+Austinauthor=K.+A.+Parkerauthor=K.+S.+Anderson&title=Bifunctional+inhibition+of+HIV-1+reverse+transcriptase%3A+a+first+step+in+designing+a+bifunctional+triphosphate&doi=10.1016%2Fj.bmcl.2012.12.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPiao%26aufirst%3DD.%26aulast%3DBasavapathruni%26aufirst%3DA.%26aulast%3DIyidogan%26aufirst%3DP.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DHinz%26aufirst%3DW.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DYou%26aufirst%3DF.%26aulast%3DDutschman%26aufirst%3DG.%2BE.%26aulast%3DAustin%26aufirst%3DD.%2BJ.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26atitle%3DBifunctional%2520inhibition%2520of%2520HIV-1%2520reverse%2520transcriptase%253A%2520a%2520first%2520step%2520in%2520designing%2520a%2520bifunctional%2520triphosphate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1511%26epage%3D1518%26doi%3D10.1016%2Fj.bmcl.2012.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Adair, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, K. A.</span><span> </span><span class="NLM_article-title">Antibody-drug conjugates - a perfect synergy</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span><span class="refDoi"> DOI: 10.1517/14712598.2012.693473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F14712598.2012.693473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22650648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Wls73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1191-1206&author=J.+R.+Adairauthor=P.+W.+Howardauthor=J.+A.+Hartleyauthor=D.+G.+Williamsauthor=K.+A.+Chester&title=Antibody-drug+conjugates+-+a+perfect+synergy&doi=10.1517%2F14712598.2012.693473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-drug conjugates - a perfect synergy</span></div><div class="casAuthors">Adair, John R.; Howard, Philip W.; Hartley, John A.; Williams, David G.; Chester, Kerry A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1191-1206</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: There is a great unmet need for effective new treatments in cancer, which continues to be a major cause of death.  Antibody-drug conjugates (ADCs) are emerging, after a long gestation, as a class of biopharmaceuticals with the potential to address this need by directing highly potent cytotoxic drugs to their point of action.  There is increasing interest in ADCs by major pharmaceutical companies and a growing pipeline of candidates for clin. use.  This review summarises progress with development of this new class of drugs.Areas covered: The authors describe sep. the antibody and drug elements of ADCs and then examine the technol. and consequences of linkage.  The work is presented in the light of recent developments in the design, using clin. examples where possible.Expert opinion: Since their emergence as independent drugs, antibodies and chemotherapy are being brought together in effective synergy.  The conjunction is timely: many of the tech. challenges in prepg. antibodies have been addressed; potent new drugs are available and linker technol. is advancing apace.  ADCs however are not just a sum of their individual parts.  The current challenge is in understanding the holistic nature of this exciting class of drugs that promise a new avenue for cancer treatment.  Target selection, the interaction of ADC with tumor and off-tumor targets and the internalisation of ADCs, are crit. to the effective maturation of ADC technol.  Ongoing recent developments in attachment sites and linker chem. can provide fine-tuning of drug loading, elements of ADC PK and off-target ADC toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY30NZYFPh-rVg90H21EOLACvtfcHk0lhRpQMt-CIbCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Wls73P&md5=e3604ba9b52c917335b4c5568e54057c</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1517%2F14712598.2012.693473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2012.693473%26sid%3Dliteratum%253Aachs%26aulast%3DAdair%26aufirst%3DJ.%2BR.%26aulast%3DHoward%26aufirst%3DP.%2BW.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BG.%26aulast%3DChester%26aufirst%3DK.%2BA.%26atitle%3DAntibody-drug%2520conjugates%2520-%2520a%2520perfect%2520synergy%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2012%26volume%3D12%26spage%3D1191%26epage%3D1206%26doi%3D10.1517%2F14712598.2012.693473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Parker, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domaoal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, D. A.</span><span> </span><span class="NLM_article-title">An antibody-recruiting small molecule that targets HIV gp120</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">16392</span><span class="NLM_x">–</span> <span class="NLM_lpage">16394</span><span class="refDoi"> DOI: 10.1021/ja9057647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9057647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1yjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=16392-16394&author=C.+G.+Parkerauthor=R.+A.+Domaoalauthor=K.+S.+Andersonauthor=D.+A.+Spiegel&title=An+antibody-recruiting+small+molecule+that+targets+HIV+gp120&doi=10.1021%2Fja9057647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">An Antibody-Recruiting Small Molecule That Targets HIV gp120</span></div><div class="casAuthors">Parker, Christopher G.; Domaoal, Robert A.; Anderson, Karen S.; Spiegel, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16392-16394</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV/AIDS is a global pandemic for which new treatment strategies are desperately needed.  The authors have designed a novel small mol.I [X = (CH2CH2O)5, Y = = (CH2CH2O)3], designated as ARM-H, that has the potential to interfere with HIV survival through two mechanisms: (1) by recruiting antibodies to gp120-expressing virus particles and infected human cells, thus enhancing their uptake and destruction by the human immune system, and (2) by binding the viral glycoprotein gp120, inhibiting its interaction with the human protein CD4 and preventing virus entry.  Here the authors demonstrate that ARM-H I is capable of simultaneously binding gp120, a component of the Env surface viral glycoprotein (found on the surface of both HIV and virus-infected cells) and anti-2,4-dinitrophenyl antibodies (already present in the human bloodstream).  The ternary complex formed between the antibody, ARM-H I, and gp120 is immunol. active and leads to the complement-mediated destruction of Env-expressing cells.  Furthermore, ARM-H prevents virus entry into human T-cells and should therefore be capable of inhibiting virus replication through two mutually reinforcing mechanisms (inhibition of virus entry and antibody-mediated killing).  These studies demonstrate the viable anti-HIV activity of antibody-recruiting small mols. and have the potential to initiate novel paradigms in HIV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb1oDLtlzoG7Vg90H21EOLACvtfcHk0lhRpQMt-CIbCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1yjtLvN&md5=1c8913f7b4ac456ac7ccf2138f29fe0a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja9057647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9057647%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DDomaoal%26aufirst%3DR.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26aulast%3DSpiegel%26aufirst%3DD.%2BA.%26atitle%3DAn%2520antibody-recruiting%2520small%2520molecule%2520that%2520targets%2520HIV%2520gp120%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D16392%26epage%3D16394%26doi%3D10.1021%2Fja9057647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Parker, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlgren, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglass, E. F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jawanda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spasov, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domaoal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, D. A.</span><span> </span><span class="NLM_article-title">Illuminating HIV gp120-ligand recognition through computationally-driven optimization of antibody-recruiting molecules</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2317</span><span class="refDoi"> DOI: 10.1039/c4sc00484a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2Fc4sc00484a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25379167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFSqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2311-2317&author=C.+G.+Parkerauthor=M.+K.+Dahlgrenauthor=R.+N.+Taoauthor=D.+T.+Liauthor=E.+F.+Douglassauthor=T.+Shodaauthor=N.+Jawandaauthor=K.+A.+Spasovauthor=S.+Leeauthor=N.+Zhouauthor=R.+A.+Domaoalauthor=R.+E.+Suttonauthor=K.+S.+Andersonauthor=W.+L.+Jorgensenauthor=M.+Krystalauthor=D.+A.+Spiegel&title=Illuminating+HIV+gp120-ligand+recognition+through+computationally-driven+optimization+of+antibody-recruiting+molecules&doi=10.1039%2Fc4sc00484a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating HIV gp120-ligand recognition through computationally-driven optimization of antibody-recruiting molecules</span></div><div class="casAuthors">Parker, Christopher G.; Dahlgren, Markus K.; Tao, Ran N.; Li, Don T.; Douglass, Eugene F.; Shoda, Takuji; Jawanda, Navneet; Spasov, Krasimir A.; Lee, Sangil; Zhou, Nannan; Domaoal, Robert A.; Sutton, Richard E.; Anderson, Karen S.; Krystal, Mark; Jorgensen, William L.; Spiegel, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2311-2317</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Here we report on the structure-based optimization of antibody-recruiting mols. targeting HIV gp120 (ARM-H).  These studies have leveraged a combination of medicinal chem., biochem. and cellular assay anal., and computation.  Our findings have afforded an optimized analog of ARM-H, which is ∼1000 fold more potent in gp120-binding and MT-2 antiviral assays than our previously reported deriv.  Furthermore, computational anal., taken together with exptl. data, provides evidence that azaindole- and indole-based attachment inhibitors bind gp120 at an accessory hydrophobic pocket beneath the CD4-binding site and can also adopt multiple distinct binding modes in interacting with gp120.  These results are likely to prove enabling in the development of novel HIV attachment inhibitors, and more broadly, they suggest novel applications for ARMs as probes of conformationally flexible systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1hVkLLcqd7Vg90H21EOLACvtfcHk0liom-fMn1MKVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFSqs7s%253D&md5=9ecc41d0ae77c6f0a5804d3b74127687</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1039%2Fc4sc00484a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4sc00484a%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DTao%26aufirst%3DR.%2BN.%26aulast%3DLi%26aufirst%3DD.%2BT.%26aulast%3DDouglass%26aufirst%3DE.%2BF.%26aulast%3DShoda%26aufirst%3DT.%26aulast%3DJawanda%26aufirst%3DN.%26aulast%3DSpasov%26aufirst%3DK.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DDomaoal%26aufirst%3DR.%2BA.%26aulast%3DSutton%26aufirst%3DR.%2BE.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DKrystal%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DD.%2BA.%26atitle%3DIlluminating%2520HIV%2520gp120-ligand%2520recognition%2520through%2520computationally-driven%2520optimization%2520of%2520antibody-recruiting%2520molecules%26jtitle%3DChem.%2520Sci.%26date%3D2014%26volume%3D5%26spage%3D2311%26epage%3D2317%26doi%3D10.1039%2Fc4sc00484a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inokuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsubo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbas, C. F.,  3rd</span><span> </span><span class="NLM_article-title">Chemically programmed antibodies as hiv-1 attachment inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">460</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1021/ml400097z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400097z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=460-465&author=S.+Satoauthor=T.+Inokumaauthor=N.+Otsuboauthor=D.+R.+Burtonauthor=C.+F.+Barbas&title=Chemically+programmed+antibodies+as+hiv-1+attachment+inhibitors&doi=10.1021%2Fml400097z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fml400097z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400097z%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DInokuma%26aufirst%3DT.%26aulast%3DOtsubo%26aufirst%3DN.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DChemically%2520programmed%2520antibodies%2520as%2520hiv-1%2520attachment%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D460%26epage%3D465%26doi%3D10.1021%2Fml400097z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Segall, M. D.</span><span> </span><span class="NLM_article-title">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span><span class="refDoi"> DOI: 10.2174/138161212799436430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161212799436430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22316157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1292-1310&author=M.+D.+Segall&title=Multi-parameter+optimization%3A+identifying+high+quality+compounds+with+a+balance+of+properties&doi=10.2174%2F138161212799436430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span></div><div class="casAuthors">Segall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1292-1310</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful, efficacious and safe drug must have a balance of properties, including potency against its intended target, appropriate absorption, distribution, metab., and elimination (ADME) properties and an acceptable safety profile.  Achieving this balance of, often conflicting, requirements is a major challenge in drug discovery.  Approaches to simultaneously optimizing many factors in a design are broadly described under the term "multi-parameter optimization" (MPO).  In this review, we will describe how MPO can be applied to efficiently design and select high quality compds. and describe the range of methods that have been employed in drug discovery, including; simple "rules of thumb" such as Lipinski's rule; desirability functions; Pareto optimization; and probabilistic approaches that take into consideration the uncertainty in all drug discovery data due to predictive error and exptl. variability.  We will explore how these methods have been applied to predicted and exptl. data to reduce attrition and improve the productivity of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPFOVyg2ehWbVg90H21EOLACvtfcHk0lgmR9zxYoW8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D&md5=43f90ad751fd2c0bc47715f465ef31b3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.2174%2F138161212799436430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436430%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26atitle%3DMulti-parameter%2520optimization%253A%2520identifying%2520high%2520quality%2520compounds%2520with%2520a%2520balance%2520of%2520properties%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1292%26epage%3D1310%26doi%3D10.2174%2F138161212799436430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Nicolaou, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span> </span><span class="NLM_article-title">Multi-objective optimization methods in drug design</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e427</span><span class="NLM_x">–</span> <span class="NLM_lpage">e435</span><span class="refDoi"> DOI: 10.1016/j.ddtec.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ddtec.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24050140" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=e427-e435&author=C.+A.+Nicolaouauthor=N.+Brown&title=Multi-objective+optimization+methods+in+drug+design&doi=10.1016%2Fj.ddtec.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DC.%2BA.%26aulast%3DBrown%26aufirst%3DN.%26atitle%3DMulti-objective%2520optimization%2520methods%2520in%2520drug%2520design%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2013%26volume%3D10%26spage%3De427%26epage%3De435%26doi%3D10.1016%2Fj.ddtec.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Nicolaou, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kannas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loizidou, E.</span><span> </span><span class="NLM_article-title">Multi-objective optimization methods in de novo drug design</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.2174/138955712802762284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138955712802762284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22420573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=979-987&author=C.+A.+Nicolaouauthor=C.+Kannasauthor=E.+Loizidou&title=Multi-objective+optimization+methods+in+de+novo+drug+design&doi=10.2174%2F138955712802762284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-objective optimization methods in De novo drug design</span></div><div class="casAuthors">Nicolaou, C. A.; Kannas, C.; Loizidou, E.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">979-987</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  De-novo drug design (DND) is a complex procedure, requiring the satisfaction of many pharmaceutically important objectives.  Several computational methodologies employing various optimization approaches have been developed to search for satisfactory solns. to this multi-objective problem varying from composite methods, which transform the problem to a single objective one to Pareto methods searching for numerous solns. compromising the objectives.  In this review we initially focus on the DND problem and the challenges it poses to computational methods, followed by an examn. of the reported methodologies and specific applications.  Emphasis is placed on the multiobjective nature of the problem, related considerations and the solns. proposed by the drug discovery community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHVpLH0SRre7Vg90H21EOLACvtfcHk0ljhZ6qHEM_umQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWku7fK&md5=428931bacd115a2db249699f6f3889fc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F138955712802762284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955712802762284%26sid%3Dliteratum%253Aachs%26aulast%3DNicolaou%26aufirst%3DC.%2BA.%26aulast%3DKannas%26aufirst%3DC.%26aulast%3DLoizidou%26aufirst%3DE.%26atitle%3DMulti-objective%2520optimization%2520methods%2520in%2520de%2520novo%2520drug%2520design%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D979%26epage%3D987%26doi%3D10.2174%2F138955712802762284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ea2XeAfqMHiw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perišić, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. E.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20727982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KqurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=804-811&author=C.+Abad-Zapateroauthor=O.+Peri%C5%A1i%C4%87author=J.+Wassauthor=A.+P.+Bentoauthor=J.+Overingtonauthor=B.+Al-Lazikaniauthor=M.+E.+Johnson&title=Ligand+efficiency+indices+for+an+effective+mapping+of+chemico-biological+space%3A+the+concept+of+an+atlas-like+representation&doi=10.1016%2Fj.drudis.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation</span></div><div class="casAuthors">Abad-Zapatero, Cele; Perisic, Ognjen; Wass, John; Bento, A. Patricia; Overington, John; Al-Lazikani, Bissan; Johnson, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">804-811</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  We propose a numerical framework that permits an effective atlas-like representation of chemico-biol. space based on a series of Cartesian planes mapping the ligands with the corresponding targets connected by an affinity parameter (K i or related).  The numerical framework is derived from the concept of ligand efficiency indexes, which provide a natural coordinate system combining the potency toward the target (biol. space) with the physicochem. properties of the ligand (chem. space).  This framework facilitates navigation in the multidimensional drug discovery space using map-like representations based on pairs of combined variables related to the efficiency of the ligands per Dalton (mol. wt. or no. of non-hydrogen atoms) and per unit of polar surface area (or no. of polar atoms).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM4D5FkxdfoLVg90H21EOLACvtfcHk0lgu08i227U5IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KqurrJ&md5=8ccee251c53513905dbd13c93a4ec1ed</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DPeri%25C5%25A1i%25C4%2587%26aufirst%3DO.%26aulast%3DWass%26aufirst%3DJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DOverington%26aufirst%3DJ.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DM.%2BE.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520an%2520effective%2520mapping%2520of%2520chemico-biological%2520space%253A%2520the%2520concept%2520of%2520an%2520atlas-like%2520representation%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D804%26epage%3D811%26doi%3D10.1016%2Fj.drudis.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgu08i227U5IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0ljbsCbCLy7nfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 1: design and initial optimisation of a novel template</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5599</span><span class="NLM_x">–</span> <span class="NLM_lpage">5602</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.08.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5599-5602&author=C.+E.+Mowbrayauthor=C.+Burtauthor=R.+Corbauauthor=M.+Perrosauthor=I.+Tranauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+1%3A+design+and+initial+optimisation+of+a+novel+template&doi=10.1016%2Fj.bmcl.2009.08.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25201%253A%2520design%2520and%2520initial%2520optimisation%2520of%2520a%2520novel%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5599%26epage%3D5602%26doi%3D10.1016%2Fj.bmcl.2009.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 3: optimisation of physicochemical properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5603</span><span class="NLM_x">–</span> <span class="NLM_lpage">5606</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.08.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19717303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5603-5606&author=C.+E.+Mowbrayauthor=R.+Corbauauthor=M.+Hawesauthor=L.+H.+Jonesauthor=J.+E.+Millsauthor=M.+Perrosauthor=M.+D.+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+3%3A+optimisation+of+physicochemical+properties&doi=10.1016%2Fj.bmcl.2009.08.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole NNRTIs 3: Optimisation of physicochemical properties</span></div><div class="casAuthors">Mowbray, Charles E.; Corbau, Romuald; Hawes, Michael; Jones, Lyn H.; Mills, James E.; Perros, Manos; Selby, Matthew D.; Stupple, Paul A.; Webster, Rob; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5603-5606</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our efforts to reduce overall lipophilicity and increase ligand-lipophilicity efficiency (LLE) by modification of the 3- and 5-substituents of pyrazole I, a novel non-nucleoside HIV reverse transcriptase inhibitor (NNRTI) prototype were unsuccessful.  In contrast replacement of the substituted benzyl group with corresponding phenylthio or phenoxy groups resulted in marked improvements in potency, ligand efficiency (LE) and LLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoctiZUAaZLMrVg90H21EOLACvtfcHk0ljbsCbCLy7nfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7E&md5=f25509e8183b985daae551f052c3e3e7</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.043%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMills%26aufirst%3DJ.%2BE.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25203%253A%2520optimisation%2520of%2520physicochemical%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5603%26epage%3D5606%26doi%3D10.1016%2Fj.bmcl.2009.08.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gayton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinton, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5857</span><span class="NLM_x">–</span> <span class="NLM_lpage">5860</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2009.08.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5857-5860&author=C.+E.+Mowbrayauthor=C.+Burtauthor=R.+Corbauauthor=S.+Gaytonauthor=M.+Hawesauthor=M.+Perrosauthor=I.+Tranauthor=D.+A.+Priceauthor=F.+J.+Quintonauthor=M.+D.+Selbyauthor=P.+A.+Stuppleauthor=R.+Websterauthor=A.+Wood&title=Pyrazole+NNRTIs+4%3A+selection+of+UK-453%2C061+%28lersivirine%29+as+a+development+candidate&doi=10.1016%2Fj.bmcl.2009.08.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.080%26sid%3Dliteratum%253Aachs%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DGayton%26aufirst%3DS.%26aulast%3DHawes%26aufirst%3DM.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DQuinton%26aufirst%3DF.%2BJ.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DPyrazole%2520NNRTIs%25204%253A%2520selection%2520of%2520UK-453%252C061%2520%2528lersivirine%2529%2520as%2520a%2520development%2520candidate%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5857%26epage%3D5860%26doi%3D10.1016%2Fj.bmcl.2009.08.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Fätkenheuer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plettenburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hackman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, T. M.</span><span> </span><span class="NLM_article-title">Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2115</span><span class="NLM_x">–</span> <span class="NLM_lpage">2122</span><span class="refDoi"> DOI: 10.1097/QAD.0b013e32832fef5b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAD.0b013e32832fef5b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=2115-2122&author=G.+F%C3%A4tkenheuerauthor=S.+Staszewskiauthor=A.+Plettenburgauthor=F.+Hackmanauthor=G.+Laytonauthor=L.+McFadyenauthor=J.+Davisauthor=T.+M.+Jenkins&title=Activity%2C+pharmacokinetics+and+safety+of+lersivirine+%28UK-453%2C061%29%2C+a+next-generation+nonnucleoside+reverse+transcriptase+inhibitor%2C+during+7-day+monotherapy+in+HIV-1-infected+patients&doi=10.1097%2FQAD.0b013e32832fef5b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1097%2FQAD.0b013e32832fef5b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0b013e32832fef5b%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25A4tkenheuer%26aufirst%3DG.%26aulast%3DStaszewski%26aufirst%3DS.%26aulast%3DPlettenburg%26aufirst%3DA.%26aulast%3DHackman%26aufirst%3DF.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DMcFadyen%26aufirst%3DL.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DJenkins%26aufirst%3DT.%2BM.%26atitle%3DActivity%252C%2520pharmacokinetics%2520and%2520safety%2520of%2520lersivirine%2520%2528UK-453%252C061%2529%252C%2520a%2520next-generation%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitor%252C%2520during%25207-day%2520monotherapy%2520in%2520HIV-1-infected%2520patients%26jtitle%3DAIDS%26date%3D2009%26volume%3D23%26spage%3D2115%26epage%3D2122%26doi%3D10.1097%2FQAD.0b013e32832fef5b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishburn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowbray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Burchnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringrose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knöchel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span> </span><span class="NLM_article-title">Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4451</span><span class="NLM_x">–</span> <span class="NLM_lpage">4463</span><span class="refDoi"> DOI: 10.1128/AAC.01455-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.01455-09" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4451-4463&author=R.+Corbauauthor=J.+Moriauthor=C.+Phillipsauthor=L.+Fishburnauthor=A.+Martinauthor=C.+Mowbrayauthor=W.+Pantonauthor=C.+Smith-Burchnellauthor=A.+Thornberryauthor=H.+Ringroseauthor=T.+Kn%C3%B6chelauthor=S.+Irvingauthor=M.+Westbyauthor=A.+Woodauthor=M.+Perros&title=Lersivirine%2C+a+nonnucleoside+reverse+transcriptase+inhibitor+with+activity+against+drug-resistant+human+immunodeficiency+virus+type+1&doi=10.1128%2FAAC.01455-09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1128%2FAAC.01455-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01455-09%26sid%3Dliteratum%253Aachs%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DFishburn%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DMowbray%26aufirst%3DC.%26aulast%3DPanton%26aufirst%3DW.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DThornberry%26aufirst%3DA.%26aulast%3DRingrose%26aufirst%3DH.%26aulast%3DKn%25C3%25B6chel%26aufirst%3DT.%26aulast%3DIrving%26aufirst%3DS.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DLersivirine%252C%2520a%2520nonnucleoside%2520reverse%2520transcriptase%2520inhibitor%2520with%2520activity%2520against%2520drug-resistant%2520human%2520immunodeficiency%2520virus%2520type%25201%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4451%26epage%3D4463%26doi%3D10.1128%2FAAC.01455-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">García-Sosa, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takkis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, U.</span><span> </span><span class="NLM_article-title">Combined approach using ligand efficiency, cross-docking, and antitarget hits for wild-type and drug-resistant Y181C HIV-1 reverse transcriptase</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2595</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span><span class="refDoi"> DOI: 10.1021/ci200203h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200203h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2595-2611&author=A.+T.+Garc%C3%ADa-Sosaauthor=S.+Sildauthor=K.+Takkisauthor=U.+Maran&title=Combined+approach+using+ligand+efficiency%2C+cross-docking%2C+and+antitarget+hits+for+wild-type+and+drug-resistant+Y181C+HIV-1+reverse+transcriptase&doi=10.1021%2Fci200203h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase</span></div><div class="casAuthors">Garcia-Sosa, Alfonso T.; Sild, Sulev; Takkis, Kalev; Maran, Uko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2595-2611</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New hits against HIV-1 wild-type and Y181C drug-resistant reverse transcriptases were predicted taking into account the possibility of some of the known metab. interactions.  In silico hits against a set of antitargets (i.e., proteins or nucleic acids that are off-targets from the desired pharmaceutical target objective) are used to predict a simple, visual measure of possible interactions for the ligands, which helps to introduce early safety considerations into the design of compds. before lead optimization.  This combined approach consists of consensus docking and scoring: cross-docking to a group of wild-type and drug-resistant mutant proteins, ligand efficiency (also called binding efficiency) indexes as new ranking measures, pre- and postdocking filters, a set of antitargets and estn., and minimization of at. clashes.  Diverse, small-mol. compds. with new chem. (such as a triazine core with arom. side chains) as well as known drugs for different applications (oxazepam, chlorthalidone) were highly ranked to the targets having binding interactions and functional group spatial arrangements similar to those of known inhibitors, while being moderate to low binders to the antitargets.  The results are discussed on the basis of their relevance to medicinal and computational chem.  Optimization of ligands to targets and off-targets or antitargets is foreseen to be crit. for compds. directed at several simultaneous sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNNU7H0dMB5bVg90H21EOLACvtfcHk0lg__QXsjINTww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKrs7%252FO&md5=29c705ababd0d3280b64206136a8ccc9</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fci200203h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200203h%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Sosa%26aufirst%3DA.%2BT.%26aulast%3DSild%26aufirst%3DS.%26aulast%3DTakkis%26aufirst%3DK.%26aulast%3DMaran%26aufirst%3DU.%26atitle%3DCombined%2520approach%2520using%2520ligand%2520efficiency%252C%2520cross-docking%252C%2520and%2520antitarget%2520hits%2520for%2520wild-type%2520and%2520drug-resistant%2520Y181C%2520HIV-1%2520reverse%2520transcriptase%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2595%26epage%3D2611%26doi%3D10.1021%2Fci200203h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Bustanji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Masri, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qasem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Bakri, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taha, M. O.</span><span> </span><span class="NLM_article-title">In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2009.00852.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fj.1747-0285.2009.00852.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19703027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=258-265&author=Y.+Bustanjiauthor=I.+M.+Al-Masriauthor=A.+Qasemauthor=A.+G.+Al-Bakriauthor=M.+O.+Taha&title=In+silico+screening+for+non-nucleoside+HIV-1+reverse+transcriptase+inhibitors+using+physicochemical+filters+and+high-throughput+docking+followed+by+in+vitro+evaluation&doi=10.1111%2Fj.1747-0285.2009.00852.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation</span></div><div class="casAuthors">Bustanji, Yasser; Al-Masri, Ihab M.; Qasem, Ahmad; Al-Bakri, Amal G.; Taha, Mutasem Omar</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-265</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Reverse transcriptase, being the pivot in human immunodeficiency virus replication, is one of the most attractive targets for the development of new antiretroviral agents.  A virtual screening workflow based on a combination of physicochem. filters with high-throughput rigid mol. docking was applied to discover novel efficient lead scaffolds for human immunodeficiency virus type 1 reverse transcriptase inhibition.  In the protocol, different filters were employed to enrich the lead-likeness and improve the ligands efficiency of the filtered compds.  Out of the 238,819 compds. included in the National Cancer Institute database, 500 virtual screening hits were retrieved employing FILTER and FRED (mol. docking engine) softwares.  Four compds. from the 20 highest ranking scored hits tested pos. in human immunodeficiency virus type 1 reverse transcriptase using non-radioactive colorimetric assay method.  These results demonstrate that the virtual screening protocol is able to enrich novel scaffolds for human immunodeficiency virus type 1 reverse transcriptase inhibition that could be useful for drug development in the area of acquired immune-deficiency syndrome treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9SiartewbzLVg90H21EOLACvtfcHk0lg__QXsjINTww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7bI&md5=d1e6d2371f5ac357073625f5621fd721</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00852.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00852.x%26sid%3Dliteratum%253Aachs%26aulast%3DBustanji%26aufirst%3DY.%26aulast%3DAl-Masri%26aufirst%3DI.%2BM.%26aulast%3DQasem%26aufirst%3DA.%26aulast%3DAl-Bakri%26aufirst%3DA.%2BG.%26aulast%3DTaha%26aufirst%3DM.%2BO.%26atitle%3DIn%2520silico%2520screening%2520for%2520non-nucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitors%2520using%2520physicochemical%2520filters%2520and%2520high-throughput%2520docking%2520followed%2520by%2520in%2520vitro%2520evaluation%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D258%26epage%3D265%26doi%3D10.1111%2Fj.1747-0285.2009.00852.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boros, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koble, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">425</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.11.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=422-425&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=E.+E.+Borosauthor=J.+B.+Thompsonauthor=C.+S.+Kobleauthor=E.+P.+Garveyauthor=S.+A.+Fosterauthor=J.+L.+Jeffreyauthor=T.+Fujiwara&title=Naphthyridinone+%28NTD%29+integrase+inhibitors%3A+N1+protio+and+methyl+combination+substituent+effects+with+C3+amide+groups&doi=10.1016%2Fj.bmcl.2012.11.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.071%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DBoros%26aufirst%3DE.%2BE.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DKoble%26aufirst%3DC.%2BS.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DJeffrey%26aufirst%3DJ.%2BL.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DNaphthyridinone%2520%2528NTD%2529%2520integrase%2520inhibitors%253A%2520N1%2520protio%2520and%2520methyl%2520combination%2520substituent%2520effects%2520with%2520C3%2520amide%2520groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D422%26epage%3D425%26doi%3D10.1016%2Fj.bmcl.2012.11.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Yeung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trehan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadjura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santone, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 attachment. Part 8: the effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.10.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.10.117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=203-208&author=K.+S.+Yeungauthor=Z.+Qiuauthor=Z.+Yinauthor=A.+Trehanauthor=H.+Fangauthor=B.+Pearceauthor=Z.+Yangauthor=L.+Zadjuraauthor=C.+J.+D%E2%80%99Arienzoauthor=K.+Riccardiauthor=P.+Y.+Shiauthor=T.+P.+Spicerauthor=Y.+F.+Gongauthor=M.+R.+Browningauthor=S.+Hanselauthor=K.+Santoneauthor=J.+Barkerauthor=T.+Coulterauthor=P.+F.+Linauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Inhibitors+of+HIV-1+attachment.+Part+8%3A+the+effect+of+C7-heteroaryl+substitution+on+the+potency%2C+and+in+vitro+and+in+vivo+profiles+of+indole-based+inhibitors&doi=10.1016%2Fj.bmcl.2012.10.117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.10.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.10.117%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DTrehan%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DPearce%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZadjura%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DRiccardi%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DP.%2BY.%26aulast%3DSpicer%26aufirst%3DT.%2BP.%26aulast%3DGong%26aufirst%3DY.%2BF.%26aulast%3DBrowning%26aufirst%3DM.%2BR.%26aulast%3DHansel%26aufirst%3DS.%26aulast%3DSantone%26aufirst%3DK.%26aulast%3DBarker%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DP.%2BF.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DInhibitors%2520of%2520HIV-1%2520attachment.%2520Part%25208%253A%2520the%2520effect%2520of%2520C7-heteroaryl%2520substitution%2520on%2520the%2520potency%252C%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520profiles%2520of%2520indole-based%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D203%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2012.10.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Narayana Moorthy, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. A.</span><span> </span><span class="NLM_article-title">Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.2174/138945013804806460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138945013804806460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23061466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FkslGhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=102-113&author=N.+S.+Narayana+Moorthyauthor=M.+J.+Ramosauthor=P.+A.+Fernandes&title=Human+ether-a-go-go-related+gene+channel+blockers+and+its+structural+analysis+for+drug+design&doi=10.2174%2F138945013804806460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design</span></div><div class="casAuthors">Narayana Moorthy Narayana S Hari; Ramos Maria J; Fernandes Pedro A</div><div class="citationInfo"><span class="NLM_cas:title">Current drug targets</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The human ether-a-go-go-related gene (hERG) is a K+ channel protein mainly expressed in the heart and the nervous systems and its blockade by non-cardiovascular acting drugs resulted in tachycardia and sudden death.  In this present review, we have focused the physicochemical properties responsible for the hERG blocking activity of structurally different compounds.  The reported research works showed that the hydrophobicity on the van der Waals (vdW) surface of the molecules (aroused from the aromatic ring) necessary for the hERG blocking activity along with topological and electronic properties.  The quinolizidine alkaloids (natural products) such as oxymatrine, sophoridine, sophocarpine and matrine carry the common molecular structure of O=C=N-C-C-C-N that possessed positive ionotropic effect and hERG blocking activity.  Acehytisine hydrochloride (previously named Guangfu base A) was isolated from the root of Aconitum coreanum (Levl.), is an anti-arrhythmic drug in phase IV clinical trial.  The isoquinoline alkaloid, neferine (Nef) induces a concentration-dependent decrease in current amplitude (IC50 of 7.419 MM).  Most of these natural product compounds contain non-flexible aromatic structures but have significant activity due to the presence of optimum hydrophobicity.  Recent research works revealed that Eag and hERG channels are expressed by a variety of cancer cell lines and tissues.  The Eag channel showed an oncogenic potential while hERG channels are associated with more aggressive tumors and have a role in mediating invasion.  This review concluded that the consideration of physicochemical properties necessary for the hERG blocking activity will guide to develop novel drugs with less cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9xQpaoQZPkRgd2Wuil24tfW6udTcc2eYnNWCBuAh-lLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FkslGhuw%253D%253D&md5=a1e8607483efd5dd60f068ca51f35f0e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.2174%2F138945013804806460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945013804806460%26sid%3Dliteratum%253Aachs%26aulast%3DNarayana%2BMoorthy%26aufirst%3DN.%2BS.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26atitle%3DHuman%2520ether-a-go-go-related%2520gene%2520channel%2520blockers%2520and%2520its%2520structural%2520analysis%2520for%2520drug%2520design%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2013%26volume%3D14%26spage%3D102%26epage%3D113%26doi%3D10.2174%2F138945013804806460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leishman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIV</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span><span class="refDoi"> DOI: 10.2174/156802608785700007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F156802608785700007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=18782009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1140-1151&author=D.+A.+Priceauthor=D.+Armourauthor=M.+de+Grootauthor=D.+Leishmanauthor=C.+Napierauthor=M.+Perrosauthor=B.+L.+Stammenauthor=A.+Wood&title=Overcoming+hERG+affinity+in+the+discovery+of+maraviroc%3B+a+CCR5+antagonist+for+the+treatment+of+HIV&doi=10.2174%2F156802608785700007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIV</span></div><div class="casAuthors">Price, David A.; Armour, Duncan; de Groot, Marcel; Leishman, Derek; Napier, Carolyn; Perros, Manos; Stammen, Blanda L.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1140-1151</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Avoiding cardiac liability assocd. with blockade of hERG (human ether a go-go) is key for successful drug discovery and development.  This paper describes the work undertaken in the discovery of a potent CCR5 antagonist, maraviroc 34, for the treatment of HIV.  In particular the use of a pharmacophore model of the hERG channel and a high throughput binding assay for the hERG channel are described that were crit. to elucidate SAR to overcome hERG liabilities.  The key SAR involves the introduction of polar substituents into regions of the mol. where it is postulated to undergo hydrophobic interactions with the ion channel.  Within the CCR5 project there appeared to be no strong correlation between hERG affinity and physiochem. parameters such as pKa or lipophilicity.  It is believed that chemists could apply these same strategies early in drug discovery to remove hERG interactions assocd. with lead compds. while retaining potency at the primary target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxIPJP8rohLLVg90H21EOLACvtfcHk0ljs01v4pU6DLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrnN&md5=7bcb98bc1409d6d73a8a28a5caebfe8c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.2174%2F156802608785700007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700007%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DLeishman%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOvercoming%2520hERG%2520affinity%2520in%2520the%2520discovery%2520of%2520maraviroc%253B%2520a%2520CCR5%2520antagonist%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1140%26epage%3D1151%26doi%3D10.2174%2F156802608785700007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leishman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span> </span><span class="NLM_article-title">Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4633</span><span class="NLM_x">–</span> <span class="NLM_lpage">4637</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2006.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=16782336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4633-4637&author=D.+A.+Priceauthor=D.+Armourauthor=M.+de+Grootauthor=D.+Leishmanauthor=C.+Napierauthor=M.+Perrosauthor=B.+L.+Stammenauthor=A.+Wood&title=Overcoming+HERG+affinity+in+the+discovery+of+the+CCR5+antagonist+maraviroc&doi=10.1016%2Fj.bmcl.2006.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc</span></div><div class="casAuthors">Price, David A.; Armour, Duncan; De Groot, Marcel; Leishman, Derek; Napier, Carolyn; Perros, Manos; Stammen, Blanda L.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4633-4637</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of maraviroc (I) is described with particular ref. to the generation of high selectivity over affinity for the HERG potassium channel.  This was achieved through the use of a high throughput binding assay for the HERG channel that is known to show an excellent correlation with functional effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6P6g23qVq_LVg90H21EOLACvtfcHk0ljs01v4pU6DLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlurw%253D&md5=a77b63c145102df315c3931fd3814b64</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3Dde%2BGroot%26aufirst%3DM.%26aulast%3DLeishman%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DStammen%26aufirst%3DB.%2BL.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOvercoming%2520HERG%2520affinity%2520in%2520the%2520discovery%2520of%2520the%2520CCR5%2520antagonist%2520maraviroc%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4633%26epage%3D4637%26doi%3D10.1016%2Fj.bmcl.2006.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Dorr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macartney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Burchnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span> </span><span class="NLM_article-title">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4732</span><span class="refDoi"> DOI: 10.1128/AAC.49.11.4721-4732.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.49.11.4721-4732.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=16251317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4721-4732&author=P.+Dorrauthor=M.+Westbyauthor=S.+Dobbsauthor=P.+Griffinauthor=B.+Irvineauthor=M.+Macartneyauthor=J.+Moriauthor=G.+Rickettauthor=C.+Smith-Burchnellauthor=C.+Napierauthor=R.+Websterauthor=D.+Armourauthor=D.+Priceauthor=B.+Stammenauthor=A.+Woodauthor=M.+Perros&title=Maraviroc+%28UK-427%2C857%29%2C+a+potent%2C+orally+bioavailable%2C+and+selective+small-molecule+inhibitor+of+chemokine+receptor+CCR5+with+broad-spectrum+anti-human+immunodeficiency+virus+type+1+activity&doi=10.1128%2FAAC.49.11.4721-4732.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span></div><div class="casAuthors">Dorr, Patrick; Westby, Mike; Dobbs, Susan; Griffin, Paul; Irvine, Becky; Macartney, Malcolm; Mori, Julie; Rickett, Graham; Smith-Burchnell, Caroline; Napier, Carolyn; Webster, Rob; Armour, Duncan; Price, David; Stammen, Blanda; Wood, Anthony; Perros, Manos</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4721-4732</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent antihuman immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacol. properties.  Maraviroc is the product of a medicinal chem. effort initiated following identification of an imidazopyridine CCR5 ligand from a high-throughput screen of the Pfizer compd. file.  Maraviroc demonstrated potent antiviral activity against all CCR5-tropic HIV-1 viruses tested, including 43 primary isolates from various clades and diverse geog. origin (geometric mean 90% inhibitory concn. of 2.0 nM).  Maraviroc was active against 200 clin. derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.  There was little difference in the sensitivity of the 200 viruses to maraviroc, as illustrated by the biol. cutoff in this assay (= geometric mean plus two std. deviations [SD] of 1.7-fold).  The mechanism of action of maraviroc was established using cell-based assays, where it blocked binding of viral envelope, gp120, to CCR5 to prevent the membrane fusion events necessary for viral entry.  Maraviroc did not affect CCR5 cell surface levels or assocd. intracellular signaling, confirming it as a functional antagonist of CCR5.  Maraviroc has no detectable in vitro cytotoxicity and is highly selective for CCR5, as confirmed against a wide range of receptors and enzymes, including the hERG ion channel (50% inhibitory concn., > 10 μM), indicating potential for an excellent clin. safety profile.  Studies in preclin. in vitro and in vivo models predicted maraviroc to have human pharmacokinetics consistent with once- or twice-daily dosing following oral administration.  Clin. trials are ongoing to further investigate the potential of using maraviroc for the treatment of HIV-1 infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN0Z8KdsHODrVg90H21EOLACvtfcHk0lhSE8gb7wfCYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM&md5=561aea68490f7c6d3ec0f65676450155</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.11.4721-4732.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.11.4721-4732.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DP.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DDobbs%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DIrvine%26aufirst%3DB.%26aulast%3DMacartney%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DRickett%26aufirst%3DG.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DStammen%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DMaraviroc%2520%2528UK-427%252C857%2529%252C%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520chemokine%2520receptor%2520CCR5%2520with%2520broad-spectrum%2520anti-human%2520immunodeficiency%2520virus%2520type%25201%2520activity%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4721%26epage%3D4732%26doi%3D10.1128%2FAAC.49.11.4721-4732.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.2174/138161212798919084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161212798919084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22236118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVehsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=100-112&author=W.+Chenauthor=P.+Zhanauthor=E.+De+Clercqauthor=X.+Liu&title=Recent+progress+in+small+molecule+CCR5+antagonists+as+potential+HIV-1+entry+inhibitors&doi=10.2174%2F138161212798919084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors</span></div><div class="casAuthors">Chen, Wenwen; Zhan, Peng; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-112</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently the long-term usage of traditional anti-HIV drugs, such as nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), eventually leads to the emergence of drug resistance and severe side effects.  Thus it is imperative to design and develop more promising HIV-1 inhibitors to overcome these drawbacks.  Fortunately, with the identification of some fascinating targets in the entry process of viral life cycle, HIV-1 entry inhibitors (EIs) with low cytotoxicity and mild side effects turned out as novel and effective anti-HIV agents.  Esp., of these potent EIs, small mol. CCR5 antagonist maraviroc was approved by US FDA in 2007, which significantly increased the therapeutic options for the clin. treatment of HIV-infected patients.  Subsequently, as promising anti-HIV drug candidates, kinds of small mol. CCR5 antagonists have been synthesized and evaluated in clin. trials.  In this article, current progress in the development of novel small mol. CCR5 antagonists will be reviewed on the basis of their chem. structures with a special attention to their discovery stories.  Simultaneously, binding mode anal. based on mol. modeling studies will also be introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_kc6j05FgPrVg90H21EOLACvtfcHk0lhSE8gb7wfCYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVehsbo%253D&md5=d1256ed12bc6b05137dbae48a5bb71fc</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.2174%2F138161212798919084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212798919084%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520small%2520molecule%2520CCR5%2520antagonists%2520as%2520potential%2520HIV-1%2520entry%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D100%26epage%3D112%26doi%3D10.2174%2F138161212798919084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Veljkovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucicevic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glisic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veljkovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span> </span><span class="NLM_article-title">Preclinical discovery and development of maraviroc for the treatment of HIV</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1517/17460441.2015.1041497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2015.1041497" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=671-684&author=N.+Veljkovicauthor=J.+Vucicevicauthor=S.+Tassiniauthor=S.+Glisicauthor=V.+Veljkovicauthor=M.+Radi&title=Preclinical+discovery+and+development+of+maraviroc+for+the+treatment+of+HIV&doi=10.1517%2F17460441.2015.1041497"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1041497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1041497%26sid%3Dliteratum%253Aachs%26aulast%3DVeljkovic%26aufirst%3DN.%26aulast%3DVucicevic%26aufirst%3DJ.%26aulast%3DTassini%26aufirst%3DS.%26aulast%3DGlisic%26aufirst%3DS.%26aulast%3DVeljkovic%26aufirst%3DV.%26aulast%3DRadi%26aufirst%3DM.%26atitle%3DPreclinical%2520discovery%2520and%2520development%2520of%2520maraviroc%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D671%26epage%3D684%26doi%3D10.1517%2F17460441.2015.1041497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Van Der Ryst, E.</span><span> </span><span class="NLM_article-title">Maraviroc—A CCR5 antagonist for the treatment of HIV-1 infection</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="refDoi"> DOI: 10.3389/fimmu.2015.00277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3389%2Ffimmu.2015.00277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26097475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2MblvVartQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=277&author=E.+Van+Der+Ryst&title=Maraviroc%E2%80%94A+CCR5+antagonist+for+the+treatment+of+HIV-1+infection&doi=10.3389%2Ffimmu.2015.00277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc - A CCR5 Antagonist for the Treatment of HIV-1 Infection</span></div><div class="casAuthors">Van Der Ryst Elna</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">277</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_r26tYzfmojW1zwg2yUK5fW6udTcc2ebomhY2IpWYVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MblvVartQ%253D%253D&md5=cc5d64b64bf4836c4a7e85f06996f7e2</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00277%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BRyst%26aufirst%3DE.%26atitle%3DMaraviroc%25E2%2580%2594A%2520CCR5%2520antagonist%2520for%2520the%2520treatment%2520of%2520HIV-1%2520infection%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D277%26doi%3D10.3389%2Ffimmu.2015.00277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, T.</span><span> </span><span class="NLM_article-title">Recent developments in computational prediction of HERG blockage</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1326</span><span class="refDoi"> DOI: 10.2174/15680266113139990036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F15680266113139990036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23675938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wntr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1317-1326&author=S.+Wangauthor=Y.+Liauthor=L.+Xuauthor=D.+Liauthor=T.+Hou&title=Recent+developments+in+computational+prediction+of+HERG+blockage&doi=10.2174%2F15680266113139990036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Developments in Computational Prediction of hERG Blockage</span></div><div class="casAuthors">Wang, Sichao; Li, Youyong; Xu, Lei; Li, Dan; Hou, Tingjun</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1317-1326</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The blockage of the voltage dependent ion channel encoded by human ether-a-go-go related gene (hERG) may lead to drug-induced QT interval prolongation, which is a crit. side-effect of non-cardiovascular therapeutic agents.  Therefore, identification of potential hERG channel blockers at the early stage of drug discovery process will decrease the risk of cardiotoxicity-related attritions in the later and more expensive development stage.  Computational approaches provide economic and efficient ways to evaluate the hERG liability for large-scale compd. libraries.  In this review, the structure of the hERG channel is briefly outlined first.  Then, the latest developments in the computational predictions of hERG channel blockers and the theor. studies on modeling hERG-blocker interactions are summarized.  Finally, the challenges of developing reliable prediction models of hERG blockers, as well as the strategies for surmounting these challenges, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQUN7vGQ4e7Vg90H21EOLACvtfcHk0li7Eq5O4dfKGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wntr7M&md5=e73ab899e6a0556bcfd18191063bcd61</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990036%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DT.%26atitle%3DRecent%2520developments%2520in%2520computational%2520prediction%2520of%2520HERG%2520blockage%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1317%26epage%3D1326%26doi%3D10.2174%2F15680266113139990036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Applying thermodynamic profiling in lead finding and optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1038/nrd4486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnrd4486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25614222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVemtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=95-110&author=G.+Klebe&title=Applying+thermodynamic+profiling+in+lead+finding+and+optimization&doi=10.1038%2Fnrd4486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Applying thermodynamic profiling in lead finding and optimization</span></div><div class="casAuthors">Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-110</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. drug discovery involves the optimization of various physicochem. properties of a ligand, particularly its binding affinity for its target receptor (or receptors).  In recent years, there has been growing interest in using thermodn. profiling of ligand-receptor interactions in order to select and optimize those ligands that might be most likely to become drug candidates with desirable physicochem. properties.  The thermodn. of binding is influenced by multiple factors, including hydrogen bonding and hydrophobic interactions, desolvation, residual mobility, dynamics and the local water structure.  This article discusses key issues in understanding the effects of these factors and applying this knowledge in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtHj7SsL6rrVg90H21EOLACvtfcHk0ljbVxieOIf5gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVemtr4%253D&md5=c2e12760623de81335ce252cb804c602</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnrd4486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4486%26sid%3Dliteratum%253Aachs%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DApplying%2520thermodynamic%2520profiling%2520in%2520lead%2520finding%2520and%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D95%26epage%3D110%26doi%3D10.1038%2Fnrd4486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Cusack, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoemann, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marjanovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasudevan, A.</span><span> </span><span class="NLM_article-title">Design strategies to address kinetics of drug binding and residence time</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2019</span><span class="NLM_x">–</span> <span class="NLM_lpage">2027</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2015.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25782745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2019-2027&author=K.+P.+Cusackauthor=Y.+Wangauthor=M.+Z.+Hoemannauthor=J.+Marjanovicauthor=R.+G.+Heymauthor=A.+Vasudevan&title=Design+strategies+to+address+kinetics+of+drug+binding+and+residence+time&doi=10.1016%2Fj.bmcl.2015.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Design strategies to address kinetics of drug binding and residence time</span></div><div class="casAuthors">Cusack, Kevin P.; Wang, Ying; Hoemann, Michael Z.; Marjanovic, Jasmina; Heym, Roland G.; Vasudevan, Anil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2019-2027</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The kinetics of drug binding and drug residence time are recognized to be important in the clin. effectiveness of drug candidates.  In most cases a long residence time of the drug-target complex results in an extended duration of pharmacodynamic activity, even when systemic concns. of drug have been notably reduced through elimination routes.  Hence, if selective for target, long residence times can increase the duration of drug efficacy in vivo and can significantly diminish the potential for off-target-mediated toxicities.  Furthermore, a compd. with a slower dissocn. rate may allow a reduced dosing schedule relative to a compd. with a rapid dissocn. rate.  Factors contributing to long residence time that could be useful to medicinal chemists in the prospective design of compds. with long residence times will be discussed in this perspective.  Particular emphasis will be on case studies highlighting how kinetics can be measured, modulated based on supporting structure kinetic relationships and whether these effects are translatable into man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru6nmUGLHP_rVg90H21EOLACvtfcHk0ljbVxieOIf5gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCjsLg%253D&md5=c3735de36094915768dbecc7472917d4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DCusack%26aufirst%3DK.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHoemann%26aufirst%3DM.%2BZ.%26aulast%3DMarjanovic%26aufirst%3DJ.%26aulast%3DHeym%26aufirst%3DR.%2BG.%26aulast%3DVasudevan%26aufirst%3DA.%26atitle%3DDesign%2520strategies%2520to%2520address%2520kinetics%2520of%2520drug%2520binding%2520and%2520residence%2520time%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2019%26epage%3D2027%26doi%3D10.1016%2Fj.bmcl.2015.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hämäläinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlén, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Relationships between structure and interaction kinetics for HIV-1 protease inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5430</span><span class="NLM_x">–</span> <span class="NLM_lpage">5439</span><span class="refDoi"> DOI: 10.1021/jm0208370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0208370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFSru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5430-5439&author=P.+O.+Markgrenauthor=W.+Schaalauthor=M.+H%C3%A4m%C3%A4l%C3%A4inenauthor=A.+Karl%C3%A9nauthor=A.+Hallbergauthor=B.+Samuelssonauthor=U.+H.+Danielson&title=Relationships+between+structure+and+interaction+kinetics+for+HIV-1+protease+inhibitors&doi=10.1021%2Fjm0208370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between Structure and Interaction Kinetics for HIV-1 Protease Inhibitors</span></div><div class="casAuthors">Markgren, Per-Olof; Schaal, Wesley; Haemaelaeinen, Markku; Karlen, Anders; Hallberg, Anders; Samuelsson, Bertil; Danielson, U. Helena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5430-5439</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interaction between HIV-1 protease and 58 structurally diverse transition-state analog inhibitors has been analyzed by a surface plasmon resonance based biosensor.  Assocn. and dissocn. rate consts. and affinities were detd. and displayed as kon-koff-KD maps.  It was shown that different classes of inhibitors fall into distinct clusters in these maps.  Significant changes in assocn. and dissocn. rates were found as a result of modifying the P1/P1' or P2/P2' side chains of a linear lead compd.  Similarly, cyclic urea and cyclic sulfamide inhibitors displayed different kinetic features and the affinities of both classes of cyclic compds. were limited by fast dissocn. rates.  These results confirm that assocn. and dissocn. rates are important features of drug-target interactions and indicate that optimization of inhibitor efficacy may be guided by aiming for high assocn. and low dissocn. rates rather than high affinity alone.  The present approach thus provides a new tool for structure-interaction kinetic anal. and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-IpythylbjrVg90H21EOLACvtfcHk0lgrFFO3g_y-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFSru7w%253D&md5=11099efcbe75d675ecf31f3b80166862</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm0208370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208370%26sid%3Dliteratum%253Aachs%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DSchaal%26aufirst%3DW.%26aulast%3DH%25C3%25A4m%25C3%25A4l%25C3%25A4inen%26aufirst%3DM.%26aulast%3DKarl%25C3%25A9n%26aufirst%3DA.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DRelationships%2520between%2520structure%2520and%2520interaction%2520kinetics%2520for%2520HIV-1%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5430%26epage%3D5439%26doi%3D10.1021%2Fjm0208370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Shuman, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Improved structure-activity relationship analysis of HIV-1 protease inhibitors using interaction kinetic data</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5953</span><span class="NLM_x">–</span> <span class="NLM_lpage">5961</span><span class="refDoi"> DOI: 10.1021/jm0499110</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0499110" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5953-5961&author=C.+F.+Shumanauthor=L.+Vrangauthor=U.+H.+Danielson&title=Improved+structure-activity+relationship+analysis+of+HIV-1+protease+inhibitors+using+interaction+kinetic+data&doi=10.1021%2Fjm0499110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm0499110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0499110%26sid%3Dliteratum%253Aachs%26aulast%3DShuman%26aufirst%3DC.%2BF.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DImproved%2520structure-activity%2520relationship%2520analysis%2520of%2520HIV-1%2520protease%2520inhibitors%2520using%2520interaction%2520kinetic%2520data%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5953%26epage%3D5961%26doi%3D10.1021%2Fjm0499110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Dierynck, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Wit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keuleers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandersmissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertogs, K.</span><span> </span><span class="NLM_article-title">Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">13845</span><span class="NLM_x">–</span> <span class="NLM_lpage">13851</span><span class="refDoi"> DOI: 10.1128/JVI.01184-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.01184-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17928344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsValsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=13845-13851&author=I.+Dierynckauthor=M.+De+Witauthor=E.+Gustinauthor=I.+Keuleersauthor=J.+Vandersmissenauthor=S.+Hallenbergerauthor=K.+Hertogs&title=Binding+kinetics+of+darunavir+to+human+immunodeficiency+virus+type+1+protease+explain+the+potent+antiviral+activity+and+high+genetic+barrier&doi=10.1128%2FJVI.01184-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier</span></div><div class="casAuthors">Dierynck, Inge; De Wit, Mieke; Gustin, Emmanuel; Keuleers, Inge; Vandersmissen, Johan; Hallenberger, Sabine; Hertogs, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13845-13851</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The high incidence of cross-resistance between human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) limits their sequential use.  This necessitates the development of PIs with a high genetic barrier and a broad spectrum of activity against PI-resistant HIV, such as tipranavir and darunavir (TMC114).  We performed a surface plasmon resonance-based kinetic study to investigate the impact of PI resistance-assocd. mutations on the protease binding of five PIs used clin.: amprenavir, atazanavir, darunavir, lopinavir, and tipranavir.  With wild-type protease, the binding affinity of darunavir was more than 100-fold higher than with the other PIs, due to a very slow dissocn. rate.  Consequently, the dissociative half-life of darunavir was much higher (>240 h) than that of the other PIs, including darunavir's structural analog amprenavir.  The influence of protease mutations on the binding kinetics was tested with five multidrug-resistant (MDR) proteases derived from clin. isolates harboring 10 to 14 PI resistance-assocd. mutations with a decreased susceptibility to various PIs.  In general, all PIs bound to the MDR proteases with lower binding affinities, caused mainly by a faster dissocn. rate.  For amprenavir, atazanavir, lopinavir, and tipranavir, the decrease in affinity with MDR proteases resulted in reduced antiviral activity.  For darunavir, however, a nearly 1000-fold decrease in binding affinity did not translate into a weaker antiviral activity; a further decrease in affinity was required for the reduced antiviral effect.  These observations provide a mechanistic explanation for darunavir's potent antiviral activity and high genetic barrier to the development of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCX6QtrwFLLVg90H21EOLACvtfcHk0lgrFFO3g_y-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsValsbbF&md5=9a75941452df1d51d8aab351be05600f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1128%2FJVI.01184-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01184-07%26sid%3Dliteratum%253Aachs%26aulast%3DDierynck%26aufirst%3DI.%26aulast%3DDe%2BWit%26aufirst%3DM.%26aulast%3DGustin%26aufirst%3DE.%26aulast%3DKeuleers%26aufirst%3DI.%26aulast%3DVandersmissen%26aufirst%3DJ.%26aulast%3DHallenberger%26aufirst%3DS.%26aulast%3DHertogs%26aufirst%3DK.%26atitle%3DBinding%2520kinetics%2520of%2520darunavir%2520to%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520explain%2520the%2520potent%2520antiviral%2520activity%2520and%2520high%2520genetic%2520barrier%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D13845%26epage%3D13851%26doi%3D10.1128%2FJVI.01184-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">King, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabu-Jeyabalan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalivaika, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Béthune, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">12012</span><span class="NLM_x">–</span> <span class="NLM_lpage">12021</span><span class="refDoi"> DOI: 10.1128/JVI.78.21.12012-12021.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.78.21.12012-12021.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=15479840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=12012-12021&author=N.+M.+Kingauthor=M.+Prabu-Jeyabalanauthor=E.+A.+Nalivaikaauthor=P.+Wigerinckauthor=M.+P.+de+B%C3%A9thuneauthor=C.+A.+Schiffer&title=Structural+and+thermodynamic+basis+for+the+binding+of+TMC114%2C+a+next-generation+human+immunodeficiency+virus+type+1+protease+inhibitor&doi=10.1128%2FJVI.78.21.12012-12021.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor</span></div><div class="casAuthors">King, Nancy M.; Prabu-Jeyabalan, Moses; Nalivaika, Ellen A.; Wigerinck, Piet; de Bethune, Marie-Pierre; Schiffer, Celia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12012-12021</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">TMC114, a newly designed human immunodeficiency virus type 1 (HIV-1) protease inhibitor, is extremely potent against both wild-type (wt.) and multidrug-resistant (MDR) viruses in vitro as well as in vivo.  Although chem. similar to amprenavir (APV), the potency of TMC114 is substantially greater.  To examine the basis for this potency, we solved crystal structures of TMC114 complexed with wt. HIV-1 protease and TMC114 and APV complexed with an MDR (L63P, V82T, and I84V) protease variant.  In addn., we detd. the corresponding binding thermodn. by isothermal titrn. calorimetry.  TMC114 binds approx. 2 orders of magnitude more tightly to the wt. enzyme (Kd = 4.5×10-12 M) than APV (Kd = 3.9×10-10 M).  Our x-ray data (resoln. ranging from 2.2 to 1.2 Å) reveal strong interactions between the bis-tetrahydrofuranyl urethane moiety of TMC114 and main-chain atoms of D29 and D30.  These interactions appear largely responsible for TMC114's very favorable binding enthalpy to the wt. protease (-12.1 kcal/mol).  However, TMC114 binding to the MDR HIV-1 protease is reduced by a factor of 13.3, whereas the APV binding const. is reduced only by a factor of 5.1.  However, even with the redn. in binding affinity to the MDR HIV protease, TMC114 still binds with an affinity that is more than 1.5 orders of magnitude tighter than the first-generation inhibitors.  Both APV and TMC114 fit predominantly within the substrate envelope, a property that may be assocd. with decreased susceptibility to drug-resistant mutations relative to that of first-generation inhibitors.  Overall, TMC114's potency against MDR viruses is likely a combination of its extremely high affinity and close fit within the substrate envelope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRCtpDBSgPLVg90H21EOLACvtfcHk0liYLbGRCuofiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKlsbw%253D&md5=dbe410a8b7dc6a5078c312e90f24a538</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1128%2FJVI.78.21.12012-12021.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.78.21.12012-12021.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DN.%2BM.%26aulast%3DPrabu-Jeyabalan%26aufirst%3DM.%26aulast%3DNalivaika%26aufirst%3DE.%2BA.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3Dde%2BB%25C3%25A9thune%26aufirst%3DM.%2BP.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DStructural%2520and%2520thermodynamic%2520basis%2520for%2520the%2520binding%2520of%2520TMC114%252C%2520a%2520next-generation%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520inhibitor%26jtitle%3DJ.%2520Virol.%26date%3D2004%26volume%3D78%26spage%3D12012%26epage%3D12021%26doi%3D10.1128%2FJVI.78.21.12012-12021.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2012.01417.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fj.1747-0285.2012.01417.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22621379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2iur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=440-454&author=D.+Liauthor=M.+S.+Liuauthor=B.+Jiauthor=K.+C.+Hwangauthor=Y.+Huang&title=Identifying+the+molecular+mechanics+and+binding+dynamics+characteristics+of+potent+inhibitors+to+HIV-1+protease&doi=10.1111%2Fj.1747-0285.2012.01417.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease inhibitors</span></div><div class="casAuthors">Li, Dechang; Liu, Ming S.; Ji, Baohua; Hwang, Keh-Chih; Huang, Yonggang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">440-454</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 protease (HIV-1 PR) is one of the primary inhibition targets for chemotherapy of AIDS because of its crit. role in the replication cycle of the HIV.  In this work, a combinatory coarse-grained and atomistic simulation method was developed for dissecting mol. mechanisms and binding process of inhibitors to the active site of HIV-1 PR, in which 35 typical inhibitors were tried.  We found that the mol. size and stiffness of the inhibitors and the binding energy between the inhibitors and PR play important roles in regulating the binding process.  Comparatively, the smaller and more flexible inhibitors have larger binding energy and higher binding rates; they even bind into PR without opening the flaps.  In contrast, the larger and stiffer inhibitors have lower binding energy and lower binding rate, and their binding is subjected to the opening and gating of the PR flaps.  Furthermore, the components of binding free energy were quantified and analyzed by their dependence on the mol. size, structures, and hydrogen bond networks of inhibitors.  Our results also deduce significant dynamics descriptors for detg. the quant. structure and property relation in potent drug ligands for HIV-1 PR inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohtrnMySv_K7Vg90H21EOLACvtfcHk0liYLbGRCuofiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2iur7F&md5=bbbe7942fd7d9a06e4872a6cf8f93e6e</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2012.01417.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2012.01417.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DHwang%26aufirst%3DK.%2BC.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DIdentifying%2520the%2520molecular%2520mechanics%2520and%2520binding%2520dynamics%2520characteristics%2520of%2520potent%2520inhibitors%2520to%2520HIV-1%2520protease%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D440%26epage%3D454%26doi%3D10.1111%2Fj.1747-0285.2012.01417.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Geitmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2367</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span><span class="refDoi"> DOI: 10.1021/jm0504048</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2367-2374&author=M.+Geitmannauthor=T.+Ungeauthor=U.+H.+Danielson&title=Biosensor-based+kinetic+characterization+of+the+interaction+between+HIV-1+reverse+transcriptase+and+non-nucleoside+inhibitors&doi=10.1021%2Fjm0504048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm0504048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504048%26sid%3Dliteratum%253Aachs%26aulast%3DGeitmann%26aufirst%3DM.%26aulast%3DUnge%26aufirst%3DT.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DBiosensor-based%2520kinetic%2520characterization%2520of%2520the%2520interaction%2520between%2520HIV-1%2520reverse%2520transcriptase%2520and%2520non-nucleoside%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2367%26epage%3D2374%26doi%3D10.1021%2Fjm0504048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beavis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deval, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dioszegi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravendran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankuratri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vauquelin, G.</span><span> </span><span class="NLM_article-title">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3364</span><span class="NLM_x">–</span> <span class="NLM_lpage">3375</span><span class="refDoi"> DOI: 10.1111/bph.12683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Fbph.12683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24628038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3364-3375&author=D.+C.+Swinneyauthor=P.+Beavisauthor=K.+T.+Chuangauthor=Y.+Zhengauthor=I.+Leeauthor=P.+Geeauthor=J.+Devalauthor=D.+M.+Rotsteinauthor=M.+Dioszegiauthor=P.+Ravendranauthor=J.+Zhangauthor=S.+Sankuratriauthor=R.+Kondruauthor=G.+Vauquelin&title=A+study+of+the+molecular+mechanism+of+binding+kinetics+and+long+residence+times+of+human+CCR5+receptor+small+molecule+allosteric+ligands&doi=10.1111%2Fbph.12683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands</span></div><div class="casAuthors">Swinney, David C.; Beavis, Paul; Chuang, Kai-Ting; Zheng, Yue; Lee, Ina; Gee, Peter; Deval, Jerome; Rotstein, David M.; Dioszegi, Marianna; Ravendran, Palani; Zhang, Jun; Sankuratri, Surya; Kondru, Rama; Vauquelin, Georges</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3364-3375</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The human CCR5 receptor is a co-receptor for HIV-1 infection and a target for anti-viral therapy.  A greater understanding of the binding kinetics of small mol. allosteric ligand interactions with CCR5 will lead to a better understanding of the binding process and may help discover new mols. that avoid resistance.  Exptl. Approach : Using [3H] maraviroc as a radioligand, a no. of different binding protocols were employed in conjunction with simulations to det. rate consts., kinetic mechanism and mutant kinetic fingerprints for wild-type and mutant human CCR5 with maraviroc, aplaviroc and vicriviroc.  Key Results : Kinetic characterization of maraviroc binding to the wild-type CCR5 was consistent with a two-step kinetic mechanism that involved an initial receptor-ligand complex (RA), which transitioned to a more stable complex, R'A, with at least a 13-fold increase in affinity.  The dissocn. rate from R'A, k-2, was 1.2 × 10-3 min-1.  The maraviroc time-dependent transition was influenced by F85L, W86A, Y108A, I198A and Y251A mutations of CCR5.  Conclusions and Implications : The interaction between maraviroc and CCR5 proceeded according to a multi-step kinetic mechanism, whereby initial mass action binding and later reorganizations of the initial maraviroc-receptor complex lead to a complex with longer residence time.  Site-directed mutagenesis identified a kinetic fingerprint of residues that affected the binding kinetics, leading to the conclusion that allosteric ligand binding to CCR5 involved the rearrangement of the binding site in a manner specific to each allosteric ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ko1PQQH-V7Vg90H21EOLACvtfcHk0lgZs6a6wscerQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVahtbvK&md5=400071d4fb6418a133752ddcd95a0d9c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1111%2Fbph.12683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12683%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DBeavis%26aufirst%3DP.%26aulast%3DChuang%26aufirst%3DK.%2BT.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DDeval%26aufirst%3DJ.%26aulast%3DRotstein%26aufirst%3DD.%2BM.%26aulast%3DDioszegi%26aufirst%3DM.%26aulast%3DRavendran%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DVauquelin%26aufirst%3DG.%26atitle%3DA%2520study%2520of%2520the%2520molecular%2520mechanism%2520of%2520binding%2520kinetics%2520and%2520long%2520residence%2520times%2520of%2520human%2520CCR5%2520receptor%2520small%2520molecule%2520allosteric%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3364%26epage%3D3375%26doi%3D10.1111%2Fbph.12683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Cimitan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span> </span><span class="NLM_article-title">Early absorption and distribution analysis of antitumor and anti-AIDS drugs: lipid membrane and plasma protein interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3536</span><span class="NLM_x">–</span> <span class="NLM_lpage">3546</span><span class="refDoi"> DOI: 10.1021/jm049343o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049343o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3536-3546&author=S.+Cimitanauthor=M.+T.+Lindgrenauthor=C.+Bertucciauthor=U.+H.+Danielson&title=Early+absorption+and+distribution+analysis+of+antitumor+and+anti-AIDS+drugs%3A+lipid+membrane+and+plasma+protein+interactions&doi=10.1021%2Fjm049343o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Early Absorption and Distribution Analysis of Antitumor and Anti-AIDS Drugs: Lipid Membrane and Plasma Protein Interactions</span></div><div class="casAuthors">Cimitan, Samanta; Lindgren, Maria T.; Bertucci, Carlo; Danielson, U. Helena</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3536-3546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interactions of a set of compds. of potential importance for anticancer and AIDS chemotherapy with lipid membranes and plasma proteins were studied with a surface plasmon resonance (SPR) based optical biosensor, giving valuable information on the absorption and distribution of the compds.  The technique allowed both effective screening of compds. and more detailed kinetic and mechanistic anal. of specific interactions.  The interaction with two different types of lipid membranes could be reliably measured at a drug concn. as low as 20 μM, allowing anal. of poorly sol. compds.  Distribution was evaluated by investigation of the interactions with two human plasma proteins, human serum albumin (HSA) and α1-acid glycoprotein (AGP).  Two apparent binding sites were clearly defined for HSA: one with rapid and one with slow assocn. and dissocn. rates.  The sites appear to differ in accessibility and recognition characteristics rather than in their capacities to form strong complexes with drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnw84D06UeLVg90H21EOLACvtfcHk0lhsKQmzxbpaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWnt7k%253D&md5=4cd97d0bf7a351b607f5b9fae49aa6fc</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm049343o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049343o%26sid%3Dliteratum%253Aachs%26aulast%3DCimitan%26aufirst%3DS.%26aulast%3DLindgren%26aufirst%3DM.%2BT.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26atitle%3DEarly%2520absorption%2520and%2520distribution%2520analysis%2520of%2520antitumor%2520and%2520anti-AIDS%2520drugs%253A%2520lipid%2520membrane%2520and%2520plasma%2520protein%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3536%26epage%3D3546%26doi%3D10.1021%2Fjm049343o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent advances in the structure-based rational design of TNKSIs</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2783</span><span class="NLM_x">–</span> <span class="NLM_lpage">2799</span><span class="refDoi"> DOI: 10.1039/C4MB00385C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4MB00385C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25211064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2783-2799&author=P.+Zhanauthor=Y.+Songauthor=Y.+Itohauthor=T.+Suzukiauthor=X.+Liu&title=Recent+advances+in+the+structure-based+rational+design+of+TNKSIs&doi=10.1039%2FC4MB00385C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the structure-based rational design of TNKSIs</span></div><div class="casAuthors">Zhan, Peng; Song, Yu'ning; Itoh, Yukihiro; Suzuki, Takayoshi; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2783-2799</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Human tankyrases 1 and 2 (TNKS1/2) are attractive pharmacol. biotargets, esp. for the treatment of specific types of cancer.  This article provides a fairly comprehensive overview of the structural biol. of the TNKS-inhibitor complex and the current medicinal chem. strategies being used in the structure-based rational design of tankyrase-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKsymkDwCMxLVg90H21EOLACvtfcHk0lhsKQmzxbpaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP&md5=ff91450e15ffa81a39ef5667f300d77b</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1039%2FC4MB00385C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00385C%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520advances%2520in%2520the%2520structure-based%2520rational%2520design%2520of%2520TNKSIs%26jtitle%3DMol.%2520BioSyst.%26date%3D2014%26volume%3D10%26spage%3D2783%26epage%3D2799%26doi%3D10.1039%2FC4MB00385C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Jones, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barba, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knöchel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mowbray, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringrose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swain, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span> </span><span class="NLM_article-title">Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1223</span><span class="refDoi"> DOI: 10.1021/jm801322h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801322h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Oitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1219-1223&author=L.+H.+Jonesauthor=G.+Allanauthor=O.+Barbaauthor=C.+Burtauthor=R.+Corbauauthor=T.+Dupontauthor=T.+Kn%C3%B6chelauthor=S.+Irvingauthor=D.+S.+Middletonauthor=C.+E.+Mowbrayauthor=M.+Perrosauthor=H.+Ringroseauthor=N.+A.+Swainauthor=R.+Websterauthor=M.+Westbyauthor=C.+Phillips&title=Novel+indazole+non-nucleoside+reverse+transcriptase+inhibitors+using+molecular+hybridization+based+on+crystallographic+overlays&doi=10.1021%2Fjm801322h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Indazole Non-Nucleoside Reverse Transcriptase Inhibitors Using Molecular Hybridization Based on Crystallographic Overlays</span></div><div class="casAuthors">Jones, Lyn H.; Allan, Gill; Barba, Oscar; Burt, Catherine; Corbau, Romuald; Dupont, Thomas; Knochel, Thorsten; Irving, Steve; Middleton, Donald S.; Mowbray, Charles E.; Perros, Manos; Ringrose, Heather; Swain, Nigel A.; Webster, Robert; Westby, Mike; Phillips, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1219-1223</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major problem assocd. with non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV is their lack of resilience to mutations in the reverse transcriptase (RT) enzyme.  Using structural overlays of the known inhibitors efavirenz and capravirine complexed in RT as a starting point, and structure-based drug design techniques, we have created a novel series of indazole NNRTIs that possess excellent metabolic stability and mutant resilience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWWogFxi8kLVg90H21EOLACvtfcHk0lhsKQmzxbpaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Oitrc%253D&md5=6dc8758049f0c1a33b1ce3ba9a1513a0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm801322h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801322h%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DAllan%26aufirst%3DG.%26aulast%3DBarba%26aufirst%3DO.%26aulast%3DBurt%26aufirst%3DC.%26aulast%3DCorbau%26aufirst%3DR.%26aulast%3DDupont%26aufirst%3DT.%26aulast%3DKn%25C3%25B6chel%26aufirst%3DT.%26aulast%3DIrving%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DMowbray%26aufirst%3DC.%2BE.%26aulast%3DPerros%26aufirst%3DM.%26aulast%3DRingrose%26aufirst%3DH.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DC.%26atitle%3DNovel%2520indazole%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520using%2520molecular%2520hybridization%2520based%2520on%2520crystallographic%2520overlays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1219%26epage%3D1223%26doi%3D10.1021%2Fjm801322h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2014.09.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=52-62&author=Z.+Liuauthor=W.+Chenauthor=P.+Zhanauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=X.+Liu&title=Design%2C+synthesis+and+anti-HIV+evaluation+of+novel+diarylnicotinamide+derivatives+%28DANAs%29+targeting+the+entrance+channel+of+the+NNRTI+binding+pocket+through+structure-guided+molecular+hybridization&doi=10.1016%2Fj.ejmech.2014.09.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.054%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%2520and%2520anti-HIV%2520evaluation%2520of%2520novel%2520diarylnicotinamide%2520derivatives%2520%2528DANAs%2529%2520targeting%2520the%2520entrance%2520channel%2520of%2520the%2520NNRTI%2520binding%2520pocket%2520through%2520structure-guided%2520molecular%2520hybridization%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.ejmech.2014.09.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit106b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmc.2014.01.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1863-72&author=W.+Chenauthor=P.+Zhanauthor=D.+Raiauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=J.+Balzariniauthor=Z.+Zhouauthor=H.+Liuauthor=X.+Liu&title=Discovery+of+2-pyridone+derivatives+as+potent+HIV-1+NNRTIs+using+molecular+hybridization+based+on+crystallographic+overlays&doi=10.1016%2Fj.bmc.2014.01.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.054%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DRai%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25202-pyridone%2520derivatives%2520as%2520potent%2520HIV-1%2520NNRTIs%2520using%2520molecular%2520hybridization%2520based%2520on%2520crystallographic%2520overlays%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1863%26epage%3D72%26doi%3D10.1016%2Fj.bmc.2014.01.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Conformational restriction: an effective tactic in “follow-on”-based drug discovery</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span><span class="refDoi"> DOI: 10.4155/fmc.14.50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4155%2Ffmc.14.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24962281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=885-901&author=Z.+Fangauthor=Y.+Songauthor=P.+Zhanauthor=Q.+Zhangauthor=X.+Liu&title=Conformational+restriction%3A+an+effective+tactic+in+%E2%80%9Cfollow-on%E2%80%9D-based+drug+discovery&doi=10.4155%2Ffmc.14.50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational restriction: an effective tactic in 'follow-on'-based drug discovery</span></div><div class="casAuthors">Fang, Zengjun; Song, Yu'ning; Zhan, Peng; Zhang, Qingzhu; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">885-901</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The conformational restriction (rigidification) of a flexible ligand has often been a commonly used strategy in drug design, as it can minimize the entropic loss assocd. with the ligand adopting a preferred conformation for binding, which leads to enhanced potency for a given physiol. target, improved selectivity for isoforms and reduced the possibility of drug metab.  Therefore, the application of conformational restriction strategy is a core aspect of drug discovery and development that is widely practiced by medicinal chemists either deliberately or subliminally.  The present review will highlight current representative examples and a brief overview on the rational design of conformationally restricted agents as well as discuss its advantages over the flexible counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoupMomfg9J_bVg90H21EOLACvtfcHk0lhTy_31cNrxdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE&md5=dcf5fa6cead84c77b3603c7e0800f49b</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.50%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DConformational%2520restriction%253A%2520an%2520effective%2520tactic%2520in%2520%25E2%2580%259Cfollow-on%25E2%2580%259D-based%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D885%26epage%3D901%26doi%3D10.4155%2Ffmc.14.50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Egbertson, M. S.</span><span> </span><span class="NLM_article-title">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at Merck West Point and Merck Rome (IRBM)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1272</span><span class="refDoi"> DOI: 10.2174/156802607781212248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F156802607781212248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17627556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1251-1272&author=M.+S.+Egbertson&title=HIV+integrase+inhibitors%3A+from+diketoacids+to+heterocyclic+templates%3A+a+history+of+HIV+integrase+medicinal+chemistry+at+Merck+West+Point+and+Merck+Rome+%28IRBM%29&doi=10.2174%2F156802607781212248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">HIV integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at merck west point and merck rome (IRBM)</span></div><div class="casAuthors">Egbertson, Melissa S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1251-1272</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Replication of the human immunodeficiency virus (HIV) is dependent upon the enzyme HIV integrase (IN), one of three essential enzymes encoded in the viral genome.  HIV-1 IN catalyzes the insertion of the proviral DNA into the host genome (strand transfer).  HIV-1 IN therefore presents an attractive chemotherapeutic target for the treatment of HIV infection and AIDS that could provide patients and physicians with an addnl. option for treatment.  Assays were developed to identify inhibitors of IN strand transfer.  Diketoacid lead compds. were explored and developed into a variety of heterocyclic templates that are potent inhibitors of integrase strand transfer with suitable medicinal chem. properties for treating HIV infection and AIDS.  The 1,6-naphthyridine L-870810 (Antiviral activity in cells IC95 NHS = 102 nM, n = 237), was shown to be efficacious in reducing viral RNA by 1.7 log units after doses of 400mg BID to HIV infected patients.  Optimization of phys. properties led to L-900564, an inhibitor of HIV IN that has excellent cell potency in the presence of protein (Antiviral activity in cells IC95 NHS = 16 nM, n = 15), excellent activity against mutants raised to HIV integrase inhibitors, and a very good pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnZK4Ww16-rVg90H21EOLACvtfcHk0li_LVcryiBCSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvN&md5=63978cc76f8e9036b73f0932d0470585</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.2174%2F156802607781212248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212248%26sid%3Dliteratum%253Aachs%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26atitle%3DHIV%2520integrase%2520inhibitors%253A%2520from%2520diketoacids%2520to%2520heterocyclic%2520templates%253A%2520a%2520history%2520of%2520HIV%2520integrase%2520medicinal%2520chemistry%2520at%2520Merck%2520West%2520Point%2520and%2520Merck%2520Rome%2520%2528IRBM%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1251%26epage%3D1272%26doi%3D10.2174%2F156802607781212248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Fardis, M.; Jin, H.; Chen, X.; Tsiang, M.; Chen, J.; Kim, C.; Wright, M.</span><span> </span><span class="NLM_article-title">Conformationally constrained tricyclic HIV integrase inhibitors</span>. In  <span class="citation_source-book">HIV-1 Integrase: Mechanism and Inhibitor Design</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Neamati, N.</span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Chapter 16.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2F9781118015377.ch16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+Fardis&author=H.+Jin&author=X.+Chen&author=M.+Tsiang&author=J.+Chen&author=C.+Kim&author=M.+Wrightauthor=N.+Neamati&title=HIV-1+Integrase%3A+Mechanism+and+Inhibitor+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1002%2F9781118015377.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118015377.ch16%26sid%3Dliteratum%253Aachs%26aulast%3DFardis%26aufirst%3DM.%26atitle%3DConformationally%2520constrained%2520tricyclic%2520HIV%2520integrase%2520inhibitors%26btitle%3DHIV-1%2520Integrase%253A%2520Mechanism%2520and%2520Inhibitor%2520Design%26aulast%3DNeamati%26aufirst%3DN.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delisle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flahive, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3393</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span><span class="refDoi"> DOI: 10.1021/jm200208d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200208d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3393-3417&author=T.+W.+Johnsonauthor=S.+P.+Tanisauthor=S.+L.+Butlerauthor=D.+Dalvieauthor=D.+M.+Delisleauthor=K.+R.+Dressauthor=E.+J.+Flahiveauthor=Q.+Huauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=W.+Liuauthor=G.+A.+McClellanauthor=Q.+Pengauthor=M.+B.+Pleweauthor=P.+F.+Richardsonauthor=G.+L.+Smithauthor=J.+Solowiejauthor=K.+T.+Tranauthor=H.+Wangauthor=X.+Yuauthor=J.+Zhangauthor=H.+Zhu&title=Design+and+synthesis+of+novel+N-hydroxy-dihydronaphthyridinones+as+potent+and+orally+bioavailable+HIV-1+integrase+inhibitors&doi=10.1021%2Fjm200208d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm200208d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200208d%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDelisle%26aufirst%3DD.%2BM.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DFlahive%26aufirst%3DE.%2BJ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcClellan%26aufirst%3DG.%2BA.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520N-hydroxy-dihydronaphthyridinones%2520as%2520potent%2520and%2520orally%2520bioavailable%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3393%26epage%3D3417%26doi%3D10.1021%2Fjm200208d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stead, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bru, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisselle, R. A.</span><span> </span><span class="NLM_article-title">Discovery of an HIV integrase inhibitor with an excellent resistance profile</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span><span class="refDoi"> DOI: 10.1039/c3md00014a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2Fc3md00014a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=709-719&author=D.+C.+Prydeauthor=R.+Websterauthor=S.+L.+Butlerauthor=E.+J.+Murrayauthor=K.+Whitbyauthor=C.+Pickfordauthor=M.+Westbyauthor=M.+J.+Palmerauthor=D.+J.+Bullauthor=H.+Vuongauthor=D.+C.+Blakemoreauthor=D.+Steadauthor=C.+Ashcroftauthor=I.+Gardnerauthor=C.+Bruauthor=W.+Y.+Cheungauthor=I.+O.+Robertsauthor=J.+Mortoneauthor=R.+A.+Bisselle&title=Discovery+of+an+HIV+integrase+inhibitor+with+an+excellent+resistance+profile&doi=10.1039%2Fc3md00014a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1039%2Fc3md00014a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00014a%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DMurray%26aufirst%3DE.%2BJ.%26aulast%3DWhitby%26aufirst%3DK.%26aulast%3DPickford%26aufirst%3DC.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DM.%2BJ.%26aulast%3DBull%26aufirst%3DD.%2BJ.%26aulast%3DVuong%26aufirst%3DH.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DStead%26aufirst%3DD.%26aulast%3DAshcroft%26aufirst%3DC.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DBru%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DW.%2BY.%26aulast%3DRoberts%26aufirst%3DI.%2BO.%26aulast%3DMortone%26aufirst%3DJ.%26aulast%3DBisselle%26aufirst%3DR.%2BA.%26atitle%3DDiscovery%2520of%2520an%2520HIV%2520integrase%2520inhibitor%2520with%2520an%2520excellent%2520resistance%2520profile%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D709%26epage%3D719%26doi%3D10.1039%2Fc3md00014a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Anderson, A. C.</span><span> </span><span class="NLM_article-title">Winning the arms race by improving drug discovery against mutating targets</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1021/cb200394t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200394t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=278-288&author=A.+C.+Anderson&title=Winning+the+arms+race+by+improving+drug+discovery+against+mutating+targets&doi=10.1021%2Fcb200394t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fcb200394t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200394t%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DWinning%2520the%2520arms%2520race%2520by%2520improving%2520drug%2520discovery%2520against%2520mutating%2520targets%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D278%26epage%3D288%26doi%3D10.1021%2Fcb200394t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Silvestri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marceddu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, P.</span><span> </span><span class="NLM_article-title">1-[2-(Diphenylmethoxy)ethyl]-2-methyl-5-nitroimidazole: a potent lead for the design of novel NNRTIs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span><span class="refDoi"> DOI: 10.1016/S0960-894X(99)00664-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS0960-894X%2899%2900664-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=253-256&author=R.+Silvestriauthor=M.+Articoauthor=S.+Massaauthor=T.+Marcedduauthor=F.+De+Montisauthor=P.+La+Colla&title=1-%5B2-%28Diphenylmethoxy%29ethyl%5D-2-methyl-5-nitroimidazole%3A+a+potent+lead+for+the+design+of+novel+NNRTIs&doi=10.1016%2FS0960-894X%2899%2900664-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900664-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900664-2%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DMarceddu%26aufirst%3DT.%26aulast%3DDe%2BMontis%26aufirst%3DF.%26aulast%3DLa%2BColla%26aufirst%3DP.%26atitle%3D1-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-2-methyl-5-nitroimidazole%253A%2520a%2520potent%2520lead%2520for%2520the%2520design%2520of%2520novel%2520NNRTIs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D253%26epage%3D256%26doi%3D10.1016%2FS0960-894X%2899%2900664-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Ahgren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeter, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaskunas, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasher, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J. R. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muesing, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noreen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paget, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkowitz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pranc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rippy, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydergard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahlberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ternansky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasileff, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X. X.</span><span> </span><span class="NLM_article-title">The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1335</span><span class="refDoi"> DOI: 10.1128/AAC.39.6.1329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.39.6.1329" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=1329-1335&author=C.+Ahgrenauthor=K.+Backroauthor=F.+W.+Bellauthor=A.+S.+Cantrellauthor=M.+Clemensauthor=J.+M.+Colacinoauthor=J.+B.+Deeterauthor=J.+A.+Engelhardtauthor=M.+Hogbergauthor=S.+R.+Jaskunasauthor=N.+G.+Johanssonauthor=C.+L.+Jordanauthor=J.+S.+Kasherauthor=M.+D.+Kinnickauthor=P.+Lindauthor=C.+Lopezauthor=J.+R.+J.+M.+Morinauthor=M.+A.+Muesingauthor=R.+Noreenauthor=B.+Obergauthor=C.+J.+Pagetauthor=J.+A.+Palkowitzauthor=C.+A.+Parrishauthor=P.+Prancauthor=M.+K.+Rippyauthor=C.+Rydergardauthor=C.+Sahlbergauthor=S.+Swansonauthor=R.+J.+Ternanskyauthor=T.+Ungeauthor=R.+T.+Vasileffauthor=L.+Vrangauthor=S.+J.+Westauthor=H.+Zhangauthor=X.+X.+Zhou&title=The+PETT+series%2C+a+new+class+of+potent+nonnucleoside+inhibitors+of+human+immunodeficiency+virus+type+1+reverse+transcriptase&doi=10.1128%2FAAC.39.6.1329"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1128%2FAAC.39.6.1329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.39.6.1329%26sid%3Dliteratum%253Aachs%26aulast%3DAhgren%26aufirst%3DC.%26aulast%3DBackro%26aufirst%3DK.%26aulast%3DBell%26aufirst%3DF.%2BW.%26aulast%3DCantrell%26aufirst%3DA.%2BS.%26aulast%3DClemens%26aufirst%3DM.%26aulast%3DColacino%26aufirst%3DJ.%2BM.%26aulast%3DDeeter%26aufirst%3DJ.%2BB.%26aulast%3DEngelhardt%26aufirst%3DJ.%2BA.%26aulast%3DHogberg%26aufirst%3DM.%26aulast%3DJaskunas%26aufirst%3DS.%2BR.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DJordan%26aufirst%3DC.%2BL.%26aulast%3DKasher%26aufirst%3DJ.%2BS.%26aulast%3DKinnick%26aufirst%3DM.%2BD.%26aulast%3DLind%26aufirst%3DP.%26aulast%3DLopez%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DJ.%2BR.%2BJ.%2BM.%26aulast%3DMuesing%26aufirst%3DM.%2BA.%26aulast%3DNoreen%26aufirst%3DR.%26aulast%3DOberg%26aufirst%3DB.%26aulast%3DPaget%26aufirst%3DC.%2BJ.%26aulast%3DPalkowitz%26aufirst%3DJ.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DPranc%26aufirst%3DP.%26aulast%3DRippy%26aufirst%3DM.%2BK.%26aulast%3DRydergard%26aufirst%3DC.%26aulast%3DSahlberg%26aufirst%3DC.%26aulast%3DSwanson%26aufirst%3DS.%26aulast%3DTernansky%26aufirst%3DR.%2BJ.%26aulast%3DUnge%26aufirst%3DT.%26aulast%3DVasileff%26aufirst%3DR.%2BT.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%2BX.%26atitle%3DThe%2520PETT%2520series%252C%2520a%2520new%2520class%2520of%2520potent%2520nonnucleoside%2520inhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D1329%26epage%3D1335%26doi%3D10.1128%2FAAC.39.6.1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappalà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span> </span><span class="NLM_article-title">Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1796</span><span class="refDoi"> DOI: 10.1016/S0960-894X(01)00304-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2FS0960-894X%2801%2900304-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1793-1796&author=M.+L.+Barrecaauthor=A.+Chimirriauthor=L.+De+Lucaauthor=A.+M.+Monforteauthor=P.+Monforteauthor=A.+Raoauthor=M.+Zappal%C3%A0author=J.+Balzariniauthor=E.+De+Clercqauthor=C.+Pannecouqueauthor=M.+Witvrouw&title=Discovery+of+2%2C3-diaryl-1%2C3-thiazolidin-4-ones+as+potent+anti-HIV-1+agents&doi=10.1016%2FS0960-894X%2801%2900304-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900304-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900304-3%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DChimirri%26aufirst%3DA.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DMonforte%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DZappal%25C3%25A0%26aufirst%3DM.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DWitvrouw%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25202%252C3-diaryl-1%252C3-thiazolidin-4-ones%2520as%2520potent%2520anti-HIV-1%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1793%26epage%3D1796%26doi%3D10.1016%2FS0960-894X%2801%2900304-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Barreca, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappalà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimirri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monforte, P.</span><span> </span><span class="NLM_article-title">Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3433</span><span class="NLM_x">–</span> <span class="NLM_lpage">3437</span><span class="refDoi"> DOI: 10.1021/jm049279a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049279a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3433-3437&author=M.+L.+Barrecaauthor=A.+Raoauthor=L.+De+Lucaauthor=M.+Zappal%C3%A0author=A.+M.+Monforteauthor=G.+Magaauthor=C.+Pannecouqueauthor=J.+Balzariniauthor=E.+De+Clercqauthor=A.+Chimirriauthor=P.+Monforte&title=Computational+strategies+in+discovering+novel+non-nucleoside+inhibitors+of+HIV-1+RT&doi=10.1021%2Fjm049279a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fjm049279a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049279a%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DM.%2BL.%26aulast%3DRao%26aufirst%3DA.%26aulast%3DDe%2BLuca%26aufirst%3DL.%26aulast%3DZappal%25C3%25A0%26aufirst%3DM.%26aulast%3DMonforte%26aufirst%3DA.%2BM.%26aulast%3DMaga%26aufirst%3DG.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DChimirri%26aufirst%3DA.%26aulast%3DMonforte%26aufirst%3DP.%26atitle%3DComputational%2520strategies%2520in%2520discovering%2520novel%2520non-nucleoside%2520inhibitors%2520of%2520HIV-1%2520RT%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3433%26epage%3D3437%26doi%3D10.1021%2Fjm049279a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Kroeger Smith, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hose, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipchock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnsworth, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirado-Rives, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michejda, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. H.,  Jr.</span><span> </span><span class="NLM_article-title">Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span><span class="refDoi"> DOI: 10.1021/jm020271f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020271f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1940-1947&author=M.+B.+Kroeger+Smithauthor=B.+M.+Hoseauthor=A.+Hawkinsauthor=J.+Lipchockauthor=D.+W.+Farnsworthauthor=R.+C.+Rizzoauthor=J.+Tirado-Rivesauthor=E.+Arnoldauthor=W.+Zhangauthor=S.+H.+Hughesauthor=W.+L.+Jorgensenauthor=C.+J.+Michejdaauthor=R.+H.+Smith&title=Molecular+modeling+calculations+of+HIV-1+reverse+transcriptase+nonnucleoside+inhibitors%3A+correlation+of+binding+energy+with+biological+activity+for+novel+2-aryl-substituted+benzimidazole+analogues&doi=10.1021%2Fjm020271f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm020271f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020271f%26sid%3Dliteratum%253Aachs%26aulast%3DKroeger%2BSmith%26aufirst%3DM.%2BB.%26aulast%3DHose%26aufirst%3DB.%2BM.%26aulast%3DHawkins%26aufirst%3DA.%26aulast%3DLipchock%26aufirst%3DJ.%26aulast%3DFarnsworth%26aufirst%3DD.%2BW.%26aulast%3DRizzo%26aufirst%3DR.%2BC.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%2BH.%26atitle%3DMolecular%2520modeling%2520calculations%2520of%2520HIV-1%2520reverse%2520transcriptase%2520nonnucleoside%2520inhibitors%253A%2520correlation%2520of%2520binding%2520energy%2520with%2520biological%2520activity%2520for%2520novel%25202-aryl-substituted%2520benzimidazole%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1940%26epage%3D1947%26doi%3D10.1021%2Fjm020271f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Morningstar, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnsworth, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckheit, R. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julias, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michejda, C. J.</span><span> </span><span class="NLM_article-title">Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4003</span><span class="NLM_x">–</span> <span class="NLM_lpage">4015</span><span class="refDoi"> DOI: 10.1021/jm060103d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060103d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot12ht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4003-4015&author=M.+L.+Morningstarauthor=T.+Rothauthor=D.+W.+Farnsworthauthor=M.+K.+Smithauthor=K.+Watsonauthor=R.+W.+Buckheitauthor=K.+Dasauthor=W.+Zhangauthor=E.+Arnoldauthor=J.+G.+Juliasauthor=S.+H.+Hughesauthor=C.+J.+Michejda&title=Synthesis%2C+biological+activity%2C+and+crystal+structure+of+potent+nonnucleoside+inhibitors+of+HIV-1+reverse+transcriptase+that+retain+activity+against+mutant+forms+of+the+enzyme&doi=10.1021%2Fjm060103d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Activity, and Crystal Structure of Potent Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase That Retain Activity against Mutant Forms of the Enzyme</span></div><div class="casAuthors">Morningstar, Marshall L.; Roth, Thomas; Farnsworth, David W.; Smith, Marilyn Kroeger; Watson, Karen; Buckheit, Robert W., Jr.; Das, Kalyan; Zhang, Wanyi; Arnold, Eddy; Julias, John G.; Hughes, Stephen H.; Michejda, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4003-4015</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an ongoing effort to develop novel and potent nonnucleoside HIV-1 reverse transcriptase (RT) inhibitors that are effective against the wild type (WT) virus and clin. obsd. mutants, 1,2-bis-substituted benzimidazoles were synthesized and tested.  Optimization of the N1 and C2 positions of benzimidazole led to the development of 1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-4-methylbenzimidazole (I) (IC50 = 0.2 μM, EC50 = 0.44 μM, and TC50 ≥ 100 against WT).  This paper describes how substitution on the benzimidazole ring profoundly affects activity.  Substituents at the benzimidazole C4 dramatically enhanced potency, while at C5 or C6 substituents were generally detrimental or neutral to activity, resp.  A 7-Me analog did not inhibit HIV-1 RT.  Detn. of the crystal structure of I bound to RT provided the basis for accurate modeling of addnl. analogs, which were synthesized and tested.  Several derivs. were nanomolar inhibitors of wild-type virus and were effective against clin. relevant HIV-1 mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYm2PeluuHVrVg90H21EOLACvtfcHk0lhVf9uahrSkzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot12ht7s%253D&md5=6798e7613857ba5bf97845e6aeaa5bc5</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm060103d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060103d%26sid%3Dliteratum%253Aachs%26aulast%3DMorningstar%26aufirst%3DM.%2BL.%26aulast%3DRoth%26aufirst%3DT.%26aulast%3DFarnsworth%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DM.%2BK.%26aulast%3DWatson%26aufirst%3DK.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DJulias%26aufirst%3DJ.%2BG.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520activity%252C%2520and%2520crystal%2520structure%2520of%2520potent%2520nonnucleoside%2520inhibitors%2520of%2520HIV-1%2520reverse%2520transcriptase%2520that%2520retain%2520activity%2520against%2520mutant%2520forms%2520of%2520the%2520enzyme%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4003%26epage%3D4015%26doi%3D10.1021%2Fjm060103d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Michejda, C. J.; Morningstar, M.; Roth, T.</span><span> </span><span class="NLM_article-title">Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase</span>. WO1998037072 A1,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=C.+J.+Michejda&author=M.+Morningstar&author=T.+Roth&title=Substituted+benzimidazoles+as+non-nucleoside+inhibitors+of+reverse+transcriptase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMichejda%26aufirst%3DC.%2BJ.%26atitle%3DSubstituted%2520benzimidazoles%2520as%2520non-nucleoside%2520inhibitors%2520of%2520reverse%2520transcriptase%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Walker, M. A.</span><span> </span><span class="NLM_article-title">Novel tactics for designing water-soluble molecules in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span><span class="refDoi"> DOI: 10.1517/17460441.2014.960839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2014.960839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25226793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2ltbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1421-1433&author=M.+A.+Walker&title=Novel+tactics+for+designing+water-soluble+molecules+in+drug+discovery&doi=10.1517%2F17460441.2014.960839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Novel tactics for designing water-soluble molecules in drug discovery</span></div><div class="casAuthors">Walker, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1421-1433</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Physiochem. drug properties, such as aq. soly. are considered to be a major factor in detg. the ultimate success or failure of exptl. agents.  Soly. is important because it dets. the max. dose which can be taken up.  As the size and hydrophobicity of drug candidates has increased over the years, poor soly. has become a more prevalent issue.  Recent examples from the literature show that an improved understanding of the relationship between mol. structure and soly. allows this issue to be approached using rational design.  Areas covered: This review provides selected examples from the recent drug discovery literature that demonstrate various tactics, which have been applied successfully towards improving drug soly.  The examples that were selected demonstrate the underlying principles behind aq. soly., such as hydrophobicity and cryst. stability.  Expert opinion: From a strategic point of view, improving the soly. of a compd. should be straightforward because it can be accomplished by simply reducing hydrophobicity or cryst. stability.  However, the structural elements and phys. properties which control soly. also influence potency, pharmacokinetics and toxicity.  Furthermore, there are practical aspects such as the quantity and quality of soly.-related data, which hamper the development of structure-soly. relationships.  Given that poor aq. soly. remains a primary issue in drug discovery, there is a continuous need for novel methods to overcome it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcCkPIepQBjLVg90H21EOLACvtfcHk0ljBoIs2Njz3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2ltbfO&md5=373cda72cecfa7b5077ed1551a6d1dd9</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1517%2F17460441.2014.960839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2014.960839%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520tactics%2520for%2520designing%2520water-soluble%2520molecules%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2014%26volume%3D9%26spage%3D1421%26epage%3D1433%26doi%3D10.1517%2F17460441.2014.960839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Jolly, S. M.; Anthony, N.; Gomez, R.; Dubost, D. C.; Woodward, R. G.</span><span> </span><span class="NLM_article-title">Prodrugs of an HIV reverse transcriptase inhibitor</span>. WO2011126969 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+M.+Jolly&author=N.+Anthony&author=R.+Gomez&author=D.+C.+Dubost&author=R.+G.+Woodward&title=Prodrugs+of+an+HIV+reverse+transcriptase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJolly%26aufirst%3DS.%2BM.%26atitle%3DProdrugs%2520of%2520an%2520HIV%2520reverse%2520transcriptase%2520inhibitor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Timmins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span> </span><span class="NLM_article-title">Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1288</span><span class="NLM_x">–</span> <span class="NLM_lpage">1293</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2014.03.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1288-1293&author=P.+Timminsauthor=J.+Brownauthor=N.+A.+Meanwellauthor=G.+J.+Hannaauthor=L.+Zhuauthor=J.+F.+Kadow&title=Enabled+clinical+use+of+an+HIV-1+attachment+inhibitor+through+drug+delivery&doi=10.1016%2Fj.drudis.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DTimmins%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHanna%26aufirst%3DG.%2BJ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DEnabled%2520clinical%2520use%2520of%2520an%2520HIV-1%2520attachment%2520inhibitor%2520through%2520drug%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1288%26epage%3D1293%26doi%3D10.1016%2Fj.drudis.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Leahy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pack, S. K.</span><span> </span><span class="NLM_article-title">Preparation of phosphonooxymethyl prodrugs of HIV-1 attachment inhibitors</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span><span class="refDoi"> DOI: 10.1021/op400225q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op400225q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=1440-1444&author=D.+K.+Leahyauthor=S.+K.+Pack&title=Preparation+of+phosphonooxymethyl+prodrugs+of+HIV-1+attachment+inhibitors&doi=10.1021%2Fop400225q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fop400225q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop400225q%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DD.%2BK.%26aulast%3DPack%26aufirst%3DS.%2BK.%26atitle%3DPreparation%2520of%2520phosphonooxymethyl%2520prodrugs%2520of%2520HIV-1%2520attachment%2520inhibitors%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2013%26volume%3D17%26spage%3D1440%26epage%3D1444%26doi%3D10.1021%2Fop400225q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D.</span><span> </span><span class="NLM_article-title">Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2048</span><span class="NLM_x">–</span> <span class="NLM_lpage">2056</span><span class="refDoi"> DOI: 10.1021/jm201218m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201218m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2048-2056&author=J.+F.+Kadowauthor=Y.+Uedaauthor=N.+A.+Meanwellauthor=T.+P.+Connollyauthor=T.+Wangauthor=C.+P.+Chenauthor=K.+S.+Yeungauthor=J.+Zhuauthor=J.+A.+Benderauthor=Z.+Yangauthor=D.+Parkerauthor=P.+F.+Linauthor=R.+J.+Colonnoauthor=M.+Mathewauthor=D.+Morganauthor=M.+Zhengauthor=C.+Chienauthor=D.+Grasela&title=Inhibitors+of+human+immunodeficiency+virus+type+1+%28HIV-1%29+attachment+6.+Preclinical+and+human+pharmacokinetic+profiling+of+BMS-663749%2C+a+phosphonooxymethyl+prodrug+of+the+HIV-1+attachment+inhibitor+2-%284-benzoyl-1-piperazinyl%29-1-%284%2C7-dimethoxy-1H-pyrrolo%5B2%2C3-c%5Dpyridin-3-yl%29-2-oxoethanone+%28BMS-488043%29&doi=10.1021%2Fjm201218m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm201218m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201218m%26sid%3Dliteratum%253Aachs%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DConnolly%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%2BP.%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DP.%2BF.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DMathew%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DGrasela%26aufirst%3DD.%26atitle%3DInhibitors%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520attachment%25206.%2520Preclinical%2520and%2520human%2520pharmacokinetic%2520profiling%2520of%2520BMS-663749%252C%2520a%2520phosphonooxymethyl%2520prodrug%2520of%2520the%2520HIV-1%2520attachment%2520inhibitor%25202-%25284-benzoyl-1-piperazinyl%2529-1-%25284%252C7-dimethoxy-1H-pyrrolo%255B2%252C3-c%255Dpyridin-3-yl%2529-2-oxoethanone%2520%2528BMS-488043%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2048%26epage%3D2056%26doi%3D10.1021%2Fjm201218m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">DeGoey, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grampovnik, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flosi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span> </span><span class="NLM_article-title">Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2970</span><span class="refDoi"> DOI: 10.1021/jm900080g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900080g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2964-2970&author=D.+A.+DeGoeyauthor=D.+J.+Grampovnikauthor=W.+J.+Flosiauthor=K.+C.+Marshauthor=X.+C.+Wangauthor=L.+L.+Kleinauthor=K.+F.+McDanielauthor=Y.+Liuauthor=M.+A.+Longauthor=W.+M.+Katiauthor=A.+Mollaauthor=D.+J.+Kempf&title=Water-soluble+prodrugs+of+the+human+immunodeficiency+virus+protease+inhibitors+lopinavir+and+ritonavir&doi=10.1021%2Fjm900080g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Water-Soluble Prodrugs of the Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir</span></div><div class="casAuthors">DeGoey, David A.; Grampovnik, David J.; Flosi, William J.; Marsh, Kennan C.; Wang, Xiu C.; Klein, Larry L.; McDaniel, Keith F.; Liu, Yaya; Long, Michelle A.; Kati, Warren M.; Molla, Akhteruzzaman; Kempf, Dale J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2964-2970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We studied the synthesis, cleavage rates, and oral administration of prodrugs of the HIV protease inhibitors (PIs) lopinavir and ritonavir.  Phosphate esters attached directly to the central hydroxyl groups of these PIs did not demonstrate enzyme-mediated cleavage in vitro and did not provide measurable plasma levels of the parent drugs in vivo.  However, oxymethylphosphate (OMP) and oxyethylphosphate (OEP) prodrugs provided improved rates of cleavage, high levels of aq. soly., and high plasma levels of the parent drugs when dosed orally in rats and dogs.  Dosing unformulated capsules contg. the solid prodrugs led to plasma levels equiv. to those obsd. for dosing formulated solns. of the parent drugs.  A direct synthetic process for the prepn. of OMP and OEP prodrugs was developed, and the improved synthetic method may be applicable to the prepn. of analogous sol. prodrugs of other drug classes with limited soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeiB07ekQMJ7Vg90H21EOLACvtfcHk0ljB3CtmO2Y2GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D&md5=6e64ddfeabd5725929cac142bdfe782d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm900080g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900080g%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DGrampovnik%26aufirst%3DD.%2BJ.%26aulast%3DFlosi%26aufirst%3DW.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DKlein%26aufirst%3DL.%2BL.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%2BA.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26atitle%3DWater-soluble%2520prodrugs%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520protease%2520inhibitors%2520lopinavir%2520and%2520ritonavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2964%26epage%3D2970%26doi%3D10.1021%2Fjm900080g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Logsdon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickrey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proteasa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koepke, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terlecky, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wawrzak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merigan, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, L. C.</span><span> </span><span class="NLM_article-title">Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">3123</span><span class="NLM_x">–</span> <span class="NLM_lpage">3132</span><span class="refDoi"> DOI: 10.1128/JVI.78.6.3123-3132.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.78.6.3123-3132.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=14990731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlSnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=3123-3132&author=B.+C.+Logsdonauthor=J.+F.+Vickreyauthor=P.+Martinauthor=G.+Proteasaauthor=J.+I.+Koepkeauthor=S.+R.+Terleckyauthor=Z.+Wawrzakauthor=M.+A.+Wintersauthor=T.+C.+Meriganauthor=L.+C.+Kovari&title=Crystal+structures+of+a+multidrug-resistant+human+immunodeficiency+virus+type+1+protease+reveal+an+expanded+active-site+cavity&doi=10.1128%2FJVI.78.6.3123-3132.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity</span></div><div class="casAuthors">Logsdon, Bradley C.; Vickrey, John F.; Martin, Philip; Proteasa, Gheorghe; Koepke, Jay I.; Terlecky, Stanley R.; Wawrzak, Zdzislaw; Winters, Mark A.; Merigan, Thomas C.; Kovari, Ladislau C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3123-3132</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The goal of this study was to use X-ray crystallog. to investigate the structural basis of resistance to human immunodeficiency virus type 1 (HIV-1) protease inhibitors.  We overexpressed, purified, and crystd. a multidrug-resistant (MDR) HIV-1 protease enzyme derived from a patient failing on several protease inhibitor-contg. regimens.  This HIV-1 variant contained codon mutations at positions 10, 36, 46, 54, 63, 71, 82, 84, and 90 that confer drug resistance to protease inhibitors.  The 1.8-angstrom (Å) crystal structure of this MDR patient isolate reveals an expanded active-site cavity.  The active-site expansion includes position 82 and 84 mutations due to the alterations in the amino acid side chains from longer to shorter (e.g., V82A and I84V).  The MDR isolate 769 protease "flaps" stay open wider, and the difference in the flap tip distances in the MDR 769 variant is 12 Å.  The MDR 769 protease crystal complexes with lopinavir and DMP450 reveal completely different binding modes.  The network of interactions between the ligands and the MDR 769 protease is completely different from that seen with the wild-type protease-ligand complexes.  The water mol.-forming hydrogen bonds bridging between the two flaps and either the substrate or the peptide-based inhibitor are lacking in the MDR 769 clin. isolate.  The S1, S1', S3, and S3' pockets show expansion and conformational change.  Surface plasmon resonance measurements with the MDR 769 protease indicate higher koff rates, resulting in a change of binding affinity.  Surface plasmon resonance measurements provide kon and koff data (Kd = koff/kon) to measure binding of the multidrug-resistant protease to various ligands.  This MDR 769 protease represents a new antiviral target, presenting the possibility of designing novel inhibitors with activity against the open and expanded protease forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryLkwNDos2YrVg90H21EOLACvtfcHk0lgLyEztr0EJ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlSnu78%253D&md5=cd6270a3d879c2e0965ee0013f7e8e5b</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1128%2FJVI.78.6.3123-3132.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.78.6.3123-3132.2004%26sid%3Dliteratum%253Aachs%26aulast%3DLogsdon%26aufirst%3DB.%2BC.%26aulast%3DVickrey%26aufirst%3DJ.%2BF.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DProteasa%26aufirst%3DG.%26aulast%3DKoepke%26aufirst%3DJ.%2BI.%26aulast%3DTerlecky%26aufirst%3DS.%2BR.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DWinters%26aufirst%3DM.%2BA.%26aulast%3DMerigan%26aufirst%3DT.%2BC.%26aulast%3DKovari%26aufirst%3DL.%2BC.%26atitle%3DCrystal%2520structures%2520of%2520a%2520multidrug-resistant%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520reveal%2520an%2520expanded%2520active-site%2520cavity%26jtitle%3DJ.%2520Virol.%26date%3D2004%26volume%3D78%26spage%3D3123%26epage%3D3132%26doi%3D10.1128%2FJVI.78.6.3123-3132.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Prabu-Jeyabalan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalivaika, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilek-Snyder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1518</span><span class="NLM_x">–</span> <span class="NLM_lpage">1521</span><span class="refDoi"> DOI: 10.1128/AAC.50.4.1518-1521.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.50.4.1518-1521.2006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1518-1521&author=M.+Prabu-Jeyabalanauthor=N.+M.+Kingauthor=E.+A.+Nalivaikaauthor=G.+Heilek-Snyderauthor=N.+Cammackauthor=C.+A.+Schiffer&title=Substrate+envelope+and+drug+resistance%3A+crystal+structure+of+RO1+in+complex+with+wild-type+human+immunodeficiency+virus+type+1+protease&doi=10.1128%2FAAC.50.4.1518-1521.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.4.1518-1521.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.4.1518-1521.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPrabu-Jeyabalan%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DN.%2BM.%26aulast%3DNalivaika%26aufirst%3DE.%2BA.%26aulast%3DHeilek-Snyder%26aufirst%3DG.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DSubstrate%2520envelope%2520and%2520drug%2520resistance%253A%2520crystal%2520structure%2520of%2520RO1%2520in%2520complex%2520with%2520wild-type%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1518%26epage%3D1521%26doi%3D10.1128%2FAAC.50.4.1518-1521.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anjum, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">6099</span><span class="NLM_x">–</span> <span class="NLM_lpage">6113</span><span class="refDoi"> DOI: 10.1021/ja076558p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja076558p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Klsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=6099-6113&author=M.+D.+Altmanauthor=A.+Aliauthor=G.+S.+Reddyauthor=M.+N.+Nalamauthor=S.+G.+Anjumauthor=H.+Caoauthor=S.+Chellappanauthor=V.+Kairysauthor=M.+X.+Fernandesauthor=M.+K.+Gilsonauthor=C.+A.+Schifferauthor=T.+M.+Ranaauthor=B.+Tidor&title=HIV-1+protease+inhibitors+from+inverse+design+in+the+substrate+envelope+exhibit+subnanomolar+binding+to+drug-resistant+variants&doi=10.1021%2Fja076558p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants</span></div><div class="casAuthors">Altman, Michael D.; Ali, Akbar; Reddy, G. S. Kiran Kumar; Nalam, Madhavi N. L.; Anjum, Saima Ghafoor; Cao, Hong; Chellappan, Sripriya; Kairys, Visvaldas; Fernandes, Miguel X.; Gilson, Michael K.; Schiffer, Celia A.; Rana, Tariq M.; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6099-6113</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The acquisition of drug-resistant mutations by infectious pathogens remains a pressing health concern, and the development of strategies to combat this threat is a priority.  Here the authors have applied a general strategy, inverse design using the substrate envelope, to develop inhibitors of HIV-1 protease.  Structure-based computation was used to design inhibitors predicted to stay within a consensus substrate vol. in the binding site.  Two rounds of design, synthesis, exptl. testing, and structural anal. were carried out, resulting in a total of 51 compds.  Improvements in design methodol. led to a roughly 1000-fold affinity enhancement to a wild-type protease for the best binders, from a Ki of 30-50 nM in round one to below 100 pM in round two.  Crystal structures of a subset of complexes revealed a binding mode similar to each design that respected the substrate envelope in nearly all cases.  All four best binders from round one exhibited broad specificity against a clin. relevant panel of drug-resistant HIV-1 protease variants, losing no more than 6-13-fold affinity relative to wild type.  Testing a subset of second-round compds. against the panel of resistant variants revealed three classes of inhibitors: robust binders (max. affinity loss of 14-16-fold), moderate binders (35-80-fold), and susceptible binders (greater than 100-fold).  Although for esp. high-affinity inhibitors addnl. factors may also be important, overall, these results suggest that designing inhibitors using the substrate envelope may be a useful strategy in the development of therapeutics with low susceptibility to resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyQ3p-W7ytzbVg90H21EOLACvtfcHk0lgLyEztr0EJ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Klsr4%253D&md5=24700edba306ef3fd764c813c4adde7f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fja076558p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja076558p%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DG.%2BS.%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DAnjum%26aufirst%3DS.%2BG.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DChellappan%26aufirst%3DS.%26aulast%3DKairys%26aufirst%3DV.%26aulast%3DFernandes%26aufirst%3DM.%2BX.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DHIV-1%2520protease%2520inhibitors%2520from%2520inverse%2520design%2520in%2520the%2520substrate%2520envelope%2520exhibit%2520subnanomolar%2520binding%2520to%2520drug-resistant%2520variants%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D6099%26epage%3D6113%26doi%3D10.1021%2Fja076558p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1097/COH.0b013e3283136cee</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FCOH.0b013e3283136cee" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19373036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ot1Kksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=642-646&author=M.+N.+Nalamauthor=C.+A.+Schiffer&title=New+approaches+to+HIV+protease+inhibitor+drug+design+II%3A+testing+the+substrate+envelope+hypothesis+to+avoid+drug+resistance+and+discover+robust+inhibitors&doi=10.1097%2FCOH.0b013e3283136cee"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors</span></div><div class="casAuthors">Nalam Madhavi N L; Schiffer Celia A</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in HIV and AIDS</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">642-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Drug resistance results when the balance between the binding of inhibitors and the turnover of substrates is perturbed in favor of the substrates.  Resistance is quite widespread to the HIV-1 protease inhibitors permitting the protease to process its 10 different substrates.  This processing of the substrates permits the virus HIV-1 to mature and become infectious.  The design of HIV-1 protease inhibitors that closely fit within the substrate-binding region is proposed to be a strategy to avoid drug resistance.  RECENT FINDINGS:  Cocrystal structures of HIV-1 protease with its substrates define an overlapping substrate-binding region or substrate envelope.  Novel HIV-1 protease inhibitors that were designed to fit within this substrate envelope were found to retain high binding affinity and have a flat binding profile against a panel of drug-resistant HIV-1 proteases.  SUMMARY:  The avoidance of drug resistance needs to be considered in the initial design of inhibitors to quickly evolving targets such as HIV-1 protease.  Using a detailed knowledge of substrate binding appears to be a promising strategy for achieving this goal to obtain robust HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHjlj55d1hQJw7prLlxLOzfW6udTcc2ebZIVh2sPyQhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ot1Kksw%253D%253D&md5=e2a26e14ec6852789724650080db65f6</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e3283136cee&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e3283136cee%26sid%3Dliteratum%253Aachs%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DNew%2520approaches%2520to%2520HIV%2520protease%2520inhibitor%2520drug%2520design%2520II%253A%2520testing%2520the%2520substrate%2520envelope%2520hypothesis%2520to%2520avoid%2520drug%2520resistance%2520and%2520discover%2520robust%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2008%26volume%3D3%26spage%3D642%26epage%3D646%26doi%3D10.1097%2FCOH.0b013e3283136cee" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">5368</span><span class="NLM_x">–</span> <span class="NLM_lpage">5378</span><span class="refDoi"> DOI: 10.1128/JVI.02531-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.02531-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20237088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVWgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=5368-5378&author=M.+N.+Nalamauthor=A.+Aliauthor=M.+D.+Altmanauthor=G.+S.+Reddyauthor=S.+Chellappanauthor=V.+Kairysauthor=A.+Ozenauthor=H.+Caoauthor=M.+K.+Gilsonauthor=B.+Tidorauthor=T.+M.+Ranaauthor=C.+A.+Schiffer&title=Evaluating+the+substrate-envelope+hypothesis%3A+structural+analysis+of+novel+HIV-1+protease+inhibitors+designed+to+be+robust+against+drug+resistance&doi=10.1128%2FJVI.02531-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance</span></div><div class="casAuthors">Nalam, Madhavi N. L.; Ali, Akbar; Altman, Michael D.; Reddy, G. S. Kiran Kumar; Chellappan, Sripriya; Kairys, Visvaldas; Ozen, Aysegul; Cao, Hong; Gilson, Michael K.; Tidor, Bruce; Rana, Tariq M.; Schiffer, Celia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5368-5378</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Drug resistance mutations in HIV-1 protease selectively alter inhibitor binding without significantly affecting substrate recognition and cleavage.  This alteration in mol. recognition led us to develop the substrate-envelope hypothesis which predicts that HIV-1 protease inhibitors that fit within the overlapping consensus vol. of the substrates are less likely to be susceptible to drug-resistant mutations, as a mutation impacting such inhibitors would simultaneously impact the processing of substrates.  To evaluate this hypothesis, over 130 HIV-1 protease inhibitors were designed and synthesized using three different approaches with and without substrate-envelope constraints.  A subset of 16 representative inhibitors with binding affinities to wild-type protease ranging from 58 nM to 0.8 pM was chosen for crystallog. anal.  The inhibitor-protease complexes revealed that tightly binding inhibitors (at the picomolar level of affinity) appear to "lock" into the protease active site by forming hydrogen bonds to particular active-site residues.  Both this hydrogen bonding pattern and subtle variations in protein-ligand van der Waals interactions distinguish nanomolar from picomolar inhibitors.  In general, inhibitors that fit within the substrate envelope, regardless of whether they are picomolar or nanomolar, have flatter profiles with respect to drug-resistant protease variants than inhibitors that protrude beyond the substrate envelope; this provides a strong rationale for incorporating substrate-envelope constraints into structure-based design strategies to develop new HIV-1 protease inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1FdWkZ1EQDLVg90H21EOLACvtfcHk0ljkXLsTPYH2sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVWgtrc%253D&md5=09e55d24a9ff7382cefd2fccc5206ada</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1128%2FJVI.02531-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02531-09%26sid%3Dliteratum%253Aachs%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DReddy%26aufirst%3DG.%2BS.%26aulast%3DChellappan%26aufirst%3DS.%26aulast%3DKairys%26aufirst%3DV.%26aulast%3DOzen%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DEvaluating%2520the%2520substrate-envelope%2520hypothesis%253A%2520structural%2520analysis%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520designed%2520to%2520be%2520robust%2520against%2520drug%2520resistance%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D5368%26epage%3D5378%26doi%3D10.1128%2FJVI.02531-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunzelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, L. C.</span><span> </span><span class="NLM_article-title">Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease</span> <span class="citation_source-journal">Protein J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1007/s10930-011-9316-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2Fs10930-011-9316-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21394574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=173-183&author=Z.+Liuauthor=Y.+Wangauthor=J.+Brunzelleauthor=I.+A.+Kovariauthor=L.+C.+Kovari&title=Nine+crystal+structures+determine+the+substrate+envelope+of+the+MDR+HIV-1+protease&doi=10.1007%2Fs10930-011-9316-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Nine Crystal Structures Determine the Substrate Envelope of the MDR HIV-1 Protease</span></div><div class="casAuthors">Liu, Zhigang; Wang, Yong; Brunzelle, Joseph; Kovari, Iulia A.; Kovari, Ladislau C.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-183</span>CODEN:
                <span class="NLM_cas:coden">PJROAH</span>;
        ISSN:<span class="NLM_cas:issn">1572-3887</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Under drug selection pressure, emerging mutations render HIV-1 protease drug resistant, leading to the therapy failure in anti-HIV treatment.  It is known that nine substrate cleavage site peptides bind to wild type (WT) HIV-1 protease in a conserved pattern.  However, how the multidrug-resistant (MDR) HIV-1 protease binds to the substrate cleavage site peptides is yet to be detd.  MDR769 HIV-1 protease (resistant mutations at residues 10, 36, 46, 54, 62, 63, 71, 82, 84, and 90) was selected for present study to understand the binding to its natural substrates.  MDR769 HIV-1 protease was co-crystd. with nine substrate cleavage site hepta-peptides.  Crystallog. studies show that MDR769 HIV-1 protease has an expanded substrate envelope with wide open flaps.  Furthermore, ligand binding energy calcns. indicate weaker binding in MDR769 HIV-1 protease-substrate complexes.  These results help in designing the next generation of HIV-1 protease inhibitors by targeting the MDR HIV-1 protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrktms43A2Ug7Vg90H21EOLACvtfcHk0ljkXLsTPYH2sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2jsrk%253D&md5=719994f70a7b6b38458d5e444a06f46a</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2Fs10930-011-9316-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10930-011-9316-2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBrunzelle%26aufirst%3DJ.%26aulast%3DKovari%26aufirst%3DI.%2BA.%26aulast%3DKovari%26aufirst%3DL.%2BC.%26atitle%3DNine%2520crystal%2520structures%2520determine%2520the%2520substrate%2520envelope%2520of%2520the%2520MDR%2520HIV-1%2520protease%26jtitle%3DProtein%2520J.%26date%3D2011%26volume%3D30%26spage%3D173%26epage%3D183%26doi%3D10.1007%2Fs10930-011-9316-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Parai, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huggins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6328</span><span class="NLM_x">–</span> <span class="NLM_lpage">6341</span><span class="refDoi"> DOI: 10.1021/jm300238h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300238h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6328-6341&author=M.+K.+Paraiauthor=D.+J.+Hugginsauthor=H.+Caoauthor=M.+N.+Nalamauthor=A.+Aliauthor=C.+A.+Schifferauthor=B.+Tidorauthor=T.+M.+Rana&title=Design%2C+synthesis%2C+and+biological+and+structural+evaluations+of+novel+HIV-1+protease+inhibitors+to+combat+drug+resistance&doi=10.1021%2Fjm300238h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm300238h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300238h%26sid%3Dliteratum%253Aachs%26aulast%3DParai%26aufirst%3DM.%2BK.%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DTidor%26aufirst%3DB.%26aulast%3DRana%26aufirst%3DT.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520and%2520structural%2520evaluations%2520of%2520novel%2520HIV-1%2520protease%2520inhibitors%2520to%2520combat%2520drug%2520resistance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6328%26epage%3D6341%26doi%3D10.1021%2Fjm300238h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalam, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">Testing the substrate-envelope hypothesis with designed pairs of compounds</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2441</span><span class="refDoi"> DOI: 10.1021/cb400468c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400468c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yiur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2433-2441&author=Y.+Shenauthor=M.+D.+Altmanauthor=A.+Aliauthor=M.+N.+Nalamauthor=H.+Caoauthor=T.+M.+Ranaauthor=C.+A.+Schifferauthor=B.+Tidor&title=Testing+the+substrate-envelope+hypothesis+with+designed+pairs+of+compounds&doi=10.1021%2Fcb400468c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Testing the substrate-envelope hypothesis with designed pairs of compounds</span></div><div class="casAuthors">Shen, Yang; Altman, Michael D.; Ali, Akbar; Nalam, Madhavi N. L.; Cao, Hong; Rana, Tariq M.; Schiffer, Celia A.; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2433-2441</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acquired resistance to therapeutic agents is a significant barrier to the development of clin. effective treatments for diseases in which evolution occurs on clin. time scales, frequently arising from target mutations.  We previously reported a general strategy to design effective inhibitors for rapidly mutating enzyme targets, which we demonstrated for HIV-1 protease inhibition.  Specifically, we developed a computational inverse design procedure with the added constraint that designed inhibitors bind entirely inside the substrate envelope, a consensus vol. occupied by natural substrates.  The rationale for the substrate-envelope constraint is that it prevents designed inhibitors from making interactions beyond those required by substrates and thus limits the availability of mutations tolerated by substrates but not by designed inhibitors.  The strategy resulted in subnanomolar inhibitors that bind robustly across a clin. derived panel of drug-resistant variants.  To further test the substrate-envelope hypothesis, here we have designed, synthesized, and assayed derivs. of our original compds. that are larger and extend outside the substrate envelope.  Our designs resulted in pairs of compds. that are very similar to one another, but one respects and one violates the substrate envelope.  The envelope-respecting inhibitor demonstrates robust binding across a panel of drug-resistant protease variants, whereas the envelope-violating one binds tightly to wild type but loses affinity to at least one variant.  This study provides strong support for the substrate-envelope hypothesis as a design strategy for inhibitors that reduce susceptibility to resistance mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxEZ752OIVobVg90H21EOLACvtfcHk0lhg5xZpMTE_qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yiur%252FE&md5=8febc495df52db0dd9463e25a2f5284d</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fcb400468c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400468c%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DNalam%26aufirst%3DM.%2BN.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DTesting%2520the%2520substrate-envelope%2520hypothesis%2520with%2520designed%2520pairs%2520of%2520compounds%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2433%26epage%3D2441%26doi%3D10.1021%2Fcb400468c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Tuske, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarafianos, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeger, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffney, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerina, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span> </span><span class="NLM_article-title">Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1038/nsmb760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnsmb760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=15107837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=469-474&author=S.+Tuskeauthor=S.+G.+Sarafianosauthor=A.+D.+Clarkauthor=J.+Dingauthor=L.+K.+Naegerauthor=K.+L.+Whiteauthor=M.+D.+Millerauthor=C.+S.+Gibbsauthor=P.+L.+Boyerauthor=P.+Clarkauthor=G.+Wangauthor=B.+L.+Gaffneyauthor=R.+A.+Jonesauthor=D.+M.+Jerinaauthor=S.+H.+Hughesauthor=E.+Arnold&title=Structures+of+HIV-1+RT-DNA+complexes+before+and+after+incorporation+of+the+anti-AIDS+drug+tenofovir&doi=10.1038%2Fnsmb760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir</span></div><div class="casAuthors">Tuske, Steve; Sarafianos, Stefan G.; Clark, Arthur D.; Ding, Jianping; Naeger, Lisa K.; White, Kirsten L.; Miller, Michael D.; Gibbs, Craig S.; Boyer, Paul L.; Clark, Patrick; Wang, Gang; Gaffney, Barbara L.; Jones, Roger A.; Jerina, Donald M.; Hughes, Stephen H.; Arnold, Eddy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">469-474</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tenofovir, also known as PMPA, R-9-2-(phosphonomethoxypropyl)adenine, is a nucleotide reverse transcriptase (RT) inhibitor.  We have detd. the crystal structures of two related complexes of HIV-1 RT with template primer and tenofovir: (i) a ternary complex at a resoln. of 3.0 Å of RT crosslinked to a dideoxy-terminated DNA with tenofovir-diphosphate bound as the incoming substrate; and (ii) a RT-DNA complex at a resoln. of 3.1 Å with tenofovir at the 3' primer terminus.  The tenofovir nucleotide in the tenofovir-terminated structure seems to adopt multiple conformations.  Some nucleoside reverse transcriptase inhibitors, including 3TC and AZT, have elements ('handles') that project beyond the corresponding elements on normal dNTPs (the 'substrate envelope').  HIV-1 RT resistance mechanisms to AZT and 3TC take advantage of these handles; tenofovir's structure lacks handles that could protrude through the substrate envelope to cause resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi1ei68A2R6bVg90H21EOLACvtfcHk0lhg5xZpMTE_qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVCqsL8%253D&md5=da428445f0276f07fd66dbde46732fbf</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fnsmb760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb760%26sid%3Dliteratum%253Aachs%26aulast%3DTuske%26aufirst%3DS.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DNaeger%26aufirst%3DL.%2BK.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DGibbs%26aufirst%3DC.%2BS.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DGaffney%26aufirst%3DB.%2BL.%26aulast%3DJones%26aufirst%3DR.%2BA.%26aulast%3DJerina%26aufirst%3DD.%2BM.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DArnold%26aufirst%3DE.%26atitle%3DStructures%2520of%2520HIV-1%2520RT-DNA%2520complexes%2520before%2520and%2520after%2520incorporation%2520of%2520the%2520anti-AIDS%2520drug%2520tenofovir%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D469%26epage%3D474%26doi%3D10.1038%2Fnsmb760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Xue, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span> </span><span class="NLM_article-title">Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span><span class="refDoi"> DOI: 10.1021/ci400060j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400060j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=621-633&author=W.+Xueauthor=Y.+Banauthor=H.+Liuauthor=X.+Yao&title=Computational+study+on+the+drug+resistance+mechanism+against+HCV+NS3%2F4A+protease+inhibitors+vaniprevir+and+MK-5172+by+the+combination+use+of+molecular+dynamics+simulation%2C+residue+interaction+network%2C+and+substrate+envelope+analysis&doi=10.1021%2Fci400060j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Study on the Drug Resistance Mechanism against HCV NS3/4A Protease Inhibitors Vaniprevir and MK-5172 by the Combination Use of Molecular Dynamics Simulation, Residue Interaction Network, and Substrate Envelope Analysis</span></div><div class="casAuthors">Xue, Weiwei; Ban, Yihe; Liu, Huanxiang; Yao, Xiaojun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">621-633</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) NS3/4A protease is an important and attractive target for anti-HCV drug development and discovery.  Vaniprevir (phase III clin. trials) and MK-5172 (phase II clin. trials) are two potent antiviral compds. that target NS3/4A protease.  However, the emergence of resistance to these two inhibitors reduced the effectiveness of vaniprevir and MK-5172 against viral replication.  Among the drug resistance mutations, three single-site mutations at residues Arg155, Ala156, and Asp168 in NS3/4A protease are esp. important due to their resistance to nearly all inhibitors in clin. development.  A detailed understanding of drug resistance mechanism to vaniprevir and MK-5172 is therefore very crucial for the design of novel potent agents targeting viral variants.  In this work, mol. dynamics (MD) simulation, binding free energy calcn., free energy decompn., residue interaction network (RIN), and substrate envelope anal. were used to study the detailed drug resistance mechanism of the three mutants R155K, A156T, and D168A to vaniprevir and MK-5172.  MD simulation was used to investigate the binding mode for these two inhibitors to wild-type and resistant mutants of HCV NS3/4A protease.  Binding free energy calcn. and free energy decompn. anal. reveal that drug resistance mutations reduced the interactions between the active site residues and substituent in the P2 to P4 linker of vaniprevir and MK-5172.  Furthermore, RIN and substrate envelope anal. indicate that the studied mutations of the residues are located outside the substrate (4B5A) binding site and selectively decrease the affinity of inhibitors but not the activity of the enzyme and consequently help NS3/4A protease escape from the effect of the inhibitors without influencing the affinity of substrate binding.  These findings can provide useful information for understanding the drug resistance mechanism against vaniprevir and MK-5172.  The results can also provide some potential clues for further design of novel inhibitors that are less susceptible to drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpue_rx5rWDtrVg90H21EOLACvtfcHk0liasCYl4l2NoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOjsrg%253D&md5=34a5874ce873bf38334d21fad486dbaf</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fci400060j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400060j%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DW.%26aulast%3DBan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DX.%26atitle%3DComputational%2520study%2520on%2520the%2520drug%2520resistance%2520mechanism%2520against%2520HCV%2520NS3%252F4A%2520protease%2520inhibitors%2520vaniprevir%2520and%2520MK-5172%2520by%2520the%2520combination%2520use%2520of%2520molecular%2520dynamics%2520simulation%252C%2520residue%2520interaction%2520network%252C%2520and%2520substrate%2520envelope%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D621%26epage%3D633%26doi%3D10.1021%2Fci400060j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Ozen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, C. A.</span><span> </span><span class="NLM_article-title">Improving the resistance profile of hepatitis C NS3/4A inhibitors: dynamic substrate envelope guided design</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">5693</span><span class="NLM_x">–</span> <span class="NLM_lpage">5705</span><span class="refDoi"> DOI: 10.1021/ct400603p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct400603p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1amt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=5693-5705&author=A.+Ozenauthor=W.+Shermanauthor=C.+A.+Schiffer&title=Improving+the+resistance+profile+of+hepatitis+C+NS3%2F4A+inhibitors%3A+dynamic+substrate+envelope+guided+design&doi=10.1021%2Fct400603p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Resistance Profile of Hepatitis C NS3/4A Inhibitors: Dynamic Substrate Envelope Guided Design</span></div><div class="casAuthors">Ozen, Aysegul; Sherman, Woody; Schiffer, Celia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5693-5705</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug resistance is a principal concern in the treatment of quickly evolving diseases.  The viral protease NS3/4A is a primary drug target for the hepatitis C virus (HCV) and is known to evolve resistance mutations in response to drug therapy.  At the mol. level, drug resistance reflects a subtle change in the balance of mol. recognition by NS3/4A; the drug resistant protease variants are no longer effectively inhibited by the competitive active site inhibitors but can still process the natural substrates with enough efficiency for viral survival.  In previous works, the authors have developed the "substrate envelope" hypothesis, which posits that inhibitors should be less susceptible to drug resistance if they better mimic the natural substrate mol. recognition features.  The authors perform mol. dynamics simulations on four native substrates bound to NS3/4A and discover a clearly conserved dynamic substrate envelope.  The authors show that the most severe drug resistance mutations in NS3/4A occur at residues that are outside the substrate envelope.  Comparative anal. of three NS3/4A inhibitors reveals structural and dynamic characteristics of inhibitors that could lead to resistance.  The authors also suggest inhibitor modifications to improve resistance profiles based on the dynamic substrate envelope.  This study provides a general framework for guiding the development of novel inhibitors that will be more robust against resistance by mimicking the static and dynamic binding characteristics of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk2uHtoexId7Vg90H21EOLACvtfcHk0liasCYl4l2NoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1amt7%252FF&md5=91c75667e5fc91c1c07d59c71e995283</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fct400603p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct400603p%26sid%3Dliteratum%253Aachs%26aulast%3DOzen%26aufirst%3DA.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DSchiffer%26aufirst%3DC.%2BA.%26atitle%3DImproving%2520the%2520resistance%2520profile%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520inhibitors%253A%2520dynamic%2520substrate%2520envelope%2520guided%2520design%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2013%26volume%3D9%26spage%3D5693%26epage%3D5705%26doi%3D10.1021%2Fct400603p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Hartman, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckheit, R. W.,  Jr.</span><span> </span><span class="NLM_article-title">The continuing evolution of HIV-1 therapy: identification and development of novel antiretroviral agents targeting viral and cellular targets</span> <span class="citation_source-journal">Mol. Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">401965</span><span class="refDoi"> DOI: 10.1155/2012/401965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1155%2F2012%2F401965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22848825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC38fpslymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=401965&author=T.+L.+Hartmanauthor=R.+W.+Buckheit&title=The+continuing+evolution+of+HIV-1+therapy%3A+identification+and+development+of+novel+antiretroviral+agents+targeting+viral+and+cellular+targets&doi=10.1155%2F2012%2F401965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets</span></div><div class="casAuthors">Hartman Tracy L; Buckheit Robert W Jr</div><div class="citationInfo"><span class="NLM_cas:title">Molecular biology international</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">401965</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the past three decades, over thirty-five anti-HIV-1 therapies have been developed for use in humans and the progression from monotherapeutic treatment regimens to today's highly active combination antiretroviral therapies has had a dramatic impact on disease progression in HIV-1-infected individuals.  In spite of the success of AIDS therapies and the existence of inhibitors of HIV-1 reverse transcriptase, protease, entry and fusion, and integrase, HIV-1 therapies still have a variety of problems which require continued development efforts to improve efficacy and reduce toxicity, while making drugs that can be used throughout both the developed and developing world, in pediatric populations, and in pregnant women.  Highly active antiretroviral therapies (HAARTs) have significantly delayed the progression to AIDS, and in the developed world HIV-1-infected individuals might be expected to live normal life spans while on lifelong therapies.  However, the difficult treatment regimens, the presence of class-specific drug toxicities, and the emergence of drug-resistant virus isolates highlight the fact that improvements in our therapeutic regimens and the identification of new and novel viral and cellular targets for therapy are still necessary.  Antiretroviral therapeutic strategies and targets continue to be explored, and the development of increasingly potent molecules within existing classes of drugs and the development of novel strategies are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHnpGf4gD5z5ZoeNcnHOQ9fW6udTcc2eZ_RBCWts9Kt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fpslymtA%253D%253D&md5=888be26cabfda3660f263881932fae3b</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1155%2F2012%2F401965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F401965%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DT.%2BL.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26atitle%3DThe%2520continuing%2520evolution%2520of%2520HIV-1%2520therapy%253A%2520identification%2520and%2520development%2520of%2520novel%2520antiretroviral%2520agents%2520targeting%2520viral%2520and%2520cellular%2520targets%26jtitle%3DMol.%2520Biol.%2520Int.%26date%3D2012%26volume%3D2012%26spage%3D401965%26doi%3D10.1155%2F2012%2F401965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Kang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">“Old Dogs with New Tricks”: exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1998</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span><span class="refDoi"> DOI: 10.1039/C4MB00147H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FC4MB00147H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24841339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2qtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1998-2022&author=D.+Kangauthor=Y.+Songauthor=W.+Chenauthor=P.+Zhanauthor=X.+Liu&title=%E2%80%9COld+Dogs+with+New+Tricks%E2%80%9D%3A+exploiting+alternative+mechanisms+of+action+and+new+drug+design+strategies+for+clinically+validated+HIV+targets&doi=10.1039%2FC4MB00147H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">"Old Dogs with New Tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets</span></div><div class="casAuthors">Kang, Dongwei; Song, Yu'ning; Chen, Wenmin; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1998-2022</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  HIV-1 reverse transcriptase, protease and integrase have been recognized as clin. validated but still underexploited targets for antiretroviral treatment.  Although a large no. of inhibitors have been used in clin. trials, the rapid emergence of multiple drug-resistant strains requires the identification of not only novel classes of antiretroviral drugs that act via the unprecedented mechanism of action but also innovative drug discovery strategies towards these three important targets.  This review summarizes and discusses current endeavours towards the discovery and development of novel inhibitors with alternative mechanisms of action, and also provides examples illustrating new methodologies in medicinal chem. that contribute to the identification of novel antiretroviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojDxKGIeu30LVg90H21EOLACvtfcHk0lgRTX_UcSNdSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2qtLnM&md5=aa42a7ee57c401cbade15a54737b21a8</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1039%2FC4MB00147H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00147H%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3D%25E2%2580%259COld%2520Dogs%2520with%2520New%2520Tricks%25E2%2580%259D%253A%2520exploiting%2520alternative%2520mechanisms%2520of%2520action%2520and%2520new%2520drug%2520design%2520strategies%2520for%2520clinically%2520validated%2520HIV%2520targets%26jtitle%3DMol.%2520BioSyst.%26date%3D2014%26volume%3D10%26spage%3D1998%26epage%3D2022%26doi%3D10.1039%2FC4MB00147H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Cao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent progress in the research of small molecule HIV-1 RNase H inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span><span class="refDoi"> DOI: 10.2174/0929867321666140120121158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F0929867321666140120121158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24438523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1956-1967&author=L.+Caoauthor=W.+Songauthor=E.+De+Clercqauthor=P.+Zhanauthor=X.+Liu&title=Recent+progress+in+the+research+of+small+molecule+HIV-1+RNase+H+inhibitors&doi=10.2174%2F0929867321666140120121158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors</span></div><div class="casAuthors">Cao, Lili; Song, Weiguo; De Clercq, Erik; Zhan, Peng; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reverse transcription of human immunodeficiency virus type 1 (HIV-1) is a crucial step in the life cycle initiated by the viral-coded reverse transcriptase (RT), functioning as RNA- and DNA-dependent DNA polymerase (RDDP and DDDP) and the RNase H (RNase H).  The RNase H functions to degrade the RNA strand of the RNA:DNA heteroduplex, which makes it an attractive target for rational anti-HIV-1 drug design and development.  Although development of drugs targeting the DNA polymerase have been highly successful, the discovery of drugable inhibitors of HIV RNase H is still in its infancy and none of RNase H inhibitors has reached the clin. development stage currently.  This review describes the recent progress in the HIV-1 RNase H inhibitors, focusing on their chem. feature, mechanism and the structure-activity relationship (SAR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1aiiPIvi0xLVg90H21EOLACvtfcHk0lhTU69qXxr_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnt1emt78%253D&md5=b304a792478d2ffcbe8d85405c74f0c1</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140120121158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140120121158%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520progress%2520in%2520the%2520research%2520of%2520small%2520molecule%2520HIV-1%2520RNase%2520H%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1956%26epage%3D1967%26doi%3D10.2174%2F0929867321666140120121158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Maga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ennifar, E.</span><span> </span><span class="NLM_article-title">HIV-1 RT inhibitors with a novel mechanism of action: NNRTIs that compete with the nucleotide substrate</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span><span class="refDoi"> DOI: 10.3390/v2040880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3390%2Fv2040880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21994659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXks1Oitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=880-899&author=G.+Magaauthor=M.+Radiauthor=M.+A.+Gerardauthor=M.+Bottaauthor=E.+Ennifar&title=HIV-1+RT+inhibitors+with+a+novel+mechanism+of+action%3A+NNRTIs+that+compete+with+the+nucleotide+substrate&doi=10.3390%2Fv2040880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 RT inhibitors with a novel mechanism of action: NNRTIs that compete with the nucleotide substrate</span></div><div class="casAuthors">Maga, Giovanni; Radi, Marco; Gerard, Marie-Aline; Botta, Maurizio; Ennifar, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">880-899</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided into two classes: (i) nucleoside analog RT inhibitors (NRTIs), which compete with natural nucleoside substrates and act as terminators of proviral DNA synthesis, and (ii) non-nucleoside RT inhibitors (NNRTIs), which bind to a hydrophobic pocket close to the RT active site.  In spite of the efficiency of NRTIs and NNRTIs, the rapid emergence of multidrug-resistant mutations requires the development of new RT inhibitors with an alternative mechanism of action.  Recently, several studies reported the discovery of novel non-nucleoside inhibitors with a distinct mechanism of action.  Unlike classical NNRTIs, they compete with the nucleotide substrate, thus forming a new class of RT inhibitors: nucleotide-competing RT inhibitors (NcRTIs).  In this review, we discuss current progress in the understanding of the peculiar behavior of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraGrAxfc35n7Vg90H21EOLACvtfcHk0lhTU69qXxr_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXks1Oitbw%253D&md5=52fdf085818b9e8c3d2807df8d1ae9d9</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.3390%2Fv2040880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv2040880%26sid%3Dliteratum%253Aachs%26aulast%3DMaga%26aufirst%3DG.%26aulast%3DRadi%26aufirst%3DM.%26aulast%3DGerard%26aufirst%3DM.%2BA.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DEnnifar%26aufirst%3DE.%26atitle%3DHIV-1%2520RT%2520inhibitors%2520with%2520a%2520novel%2520mechanism%2520of%2520action%253A%2520NNRTIs%2520that%2520compete%2520with%2520the%2520nucleotide%2520substrate%26jtitle%3DViruses%26date%3D2010%26volume%3D2%26spage%3D880%26epage%3D899%26doi%3D10.3390%2Fv2040880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Tan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1390</span><span class="refDoi"> DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-HIV+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0liuvGE_BnI6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-HIV%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Qiu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span> </span><span class="NLM_article-title">Identification and characterization of a subpocket on the N-trimer of HIV-1 gp41: implication for viral entry and drug target</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span><span class="refDoi"> DOI: 10.1097/QAD.0000000000000683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAD.0000000000000683" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1015-1024&author=Z.+Qiuauthor=H.+Chongauthor=X.+Yaoauthor=Y.+Suauthor=S.+Cuiauthor=Y.+He&title=Identification+and+characterization+of+a+subpocket+on+the+N-trimer+of+HIV-1+gp41%3A+implication+for+viral+entry+and+drug+target&doi=10.1097%2FQAD.0000000000000683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1097%2FQAD.0000000000000683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0000000000000683%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DZ.%26aulast%3DChong%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520subpocket%2520on%2520the%2520N-trimer%2520of%2520HIV-1%2520gp41%253A%2520implication%2520for%2520viral%2520entry%2520and%2520drug%2520target%26jtitle%3DAIDS%26date%3D2015%26volume%3D29%26spage%3D1015%26epage%3D1024%26doi%3D10.1097%2FQAD.0000000000000683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Muzammil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelmer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">5144</span><span class="NLM_x">–</span> <span class="NLM_lpage">5154</span><span class="refDoi"> DOI: 10.1128/JVI.02706-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.02706-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=17360759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1GrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=5144-5154&author=S.+Muzammilauthor=A.+A.+Armstrongauthor=L.+W.+Kangauthor=A.+Jakalianauthor=P.+R.+Bonneauauthor=V.+Schmelmerauthor=L.+M.+Amzelauthor=E.+Freire&title=Unique+thermodynamic+response+of+tipranavir+to+human+immunodeficiency+virus+type+1+protease+drug+resistance+mutations&doi=10.1128%2FJVI.02706-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations</span></div><div class="casAuthors">Muzammil, S.; Armstrong, A. A.; Kang, L. W.; Jakalian, A.; Bonneau, P. R.; Schmelmer, V.; Amzel, L. M.; Freire, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5144-5154</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Drug resistance is a major problem affecting the clin. efficacy of antiretroviral agents, including protease inhibitors, in the treatment of infection with human immunodeficiency virus type 1 (HIV-1)/AIDS.  Consequently, the elucidation of the mechanisms by which HIV-1 protease inhibitors maintain antiviral activity in the presence of mutations is crit. to the development of superior inhibitors.  Tipranavir, a nonpeptidic HIV-1 protease inhibitor, has been recently approved for the treatment of HIV infection.  Tipranavir inhibits wild-type protease with high potency (Ki = 19 pM) and demonstrates durable efficacy in the treatment of patients infected with HIV-1 strains contg. multiple common mutations assocd. with resistance.  The high potency of tipranavir results from a very large favorable entropy change (-TΔS = -14.6 kcal/mol) combined with a favorable, albeit small, enthalpy change (ΔH = -0.7 kcal/mol, 25°).  Characterization of tipranavir binding to wild-type protease, active site mutants I50V and V82F/I84V, the multidrug-resistant mutant L10I/L33I/M46I/I54V/L63I/V82A/I84V/L90M, and the tipranavir in vitro-selected mutant I13V/V32L/L33F/K45I/V82L/I84V was performed by isothermal titrn. calorimetry and crystallog.  Thermodynamically, the good response of tipranavir arises from a unique behavior: it compensates for entropic losses by actual enthalpic gains or by sustaining minimal enthalpic losses when facing the mutants.  The net result is a small loss in binding affinity.  Structurally, tipranavir establishes a very strong hydrogen bond network with invariant regions of the protease, which is maintained with the mutants, including catalytic Asp25 and the backbone of Asp29, Asp30, Gly48 and Ile50.  Moreover, tipranavir forms hydrogen bonds directly to Ile50, while all other inhibitors do so by being mediated by a water mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKelAppM3mbrVg90H21EOLACvtfcHk0lgPj7f7F43qSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1GrsLY%253D&md5=57b7379d383b8f5948100bbf0d9b7eb1</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1128%2FJVI.02706-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02706-06%26sid%3Dliteratum%253Aachs%26aulast%3DMuzammil%26aufirst%3DS.%26aulast%3DArmstrong%26aufirst%3DA.%2BA.%26aulast%3DKang%26aufirst%3DL.%2BW.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DBonneau%26aufirst%3DP.%2BR.%26aulast%3DSchmelmer%26aufirst%3DV.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DUnique%2520thermodynamic%2520response%2520of%2520tipranavir%2520to%2520human%2520immunodeficiency%2520virus%2520type%25201%2520protease%2520drug%2520resistance%2520mutations%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D5144%26epage%3D5154%26doi%3D10.1128%2FJVI.02706-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, D. K.</span><span> </span><span class="NLM_article-title">Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">14316</span><span class="NLM_x">–</span> <span class="NLM_lpage">14320</span><span class="refDoi"> DOI: 10.1074/jbc.275.19.14316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.275.19.14316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10799511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjt1Cns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=14316-14320&author=J.+Renauthor=C.+Nicholsauthor=L.+E.+Birdauthor=T.+Fujiwaraauthor=H.+Sugimotoauthor=D.+I.+Stuartauthor=D.+K.+Stammers&title=Binding+of+the+second+generation+non-nucleoside+inhibitor+S-1153+to+HIV-1+reverse+transcriptase+involves+extensive+main+chain+hydrogen+bonding&doi=10.1074%2Fjbc.275.19.14316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding</span></div><div class="casAuthors">Ren, Jingshan; Nichols, Charles; Bird, Louise E.; Fujiwara, Tamio; Sugimoto, Hirohiko; Stuart, David I.; Stammers, David K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">14316-14320</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">S-1153 (AG1549) is perhaps the most promising nonnucleoside inhibitor of HIV-1 reverse transcriptase currently under development as a potential anti-AIDS drug, because it has a favorable profile of resilience to many drug resistance mutations.  We have detd. the crystal structure of S-1153 in a complex with HIV-1 reverse transcriptase.  The complex possesses some novel features, including an extensive network of hydrogen bonds involving the main chain of residues 101, 103, and 236 of the p66 reverse transcriptase subunit.  Such interactions are unlikely to be disrupted by side chain mutations.  The reverse transcriptase/S-1153 complex suggests different ways in which resilience to mutations in the non-nucleoside inhibitors of reverse transcriptase binding site can be achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr72giIIu1rVg90H21EOLACvtfcHk0lgPj7f7F43qSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjt1Cns70%253D&md5=0b643e074b66456de58f65679f298d2a</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.19.14316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.19.14316%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DNichols%26aufirst%3DC.%26aulast%3DBird%26aufirst%3DL.%2BE.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DStammers%26aufirst%3DD.%2BK.%26atitle%3DBinding%2520of%2520the%2520second%2520generation%2520non-nucleoside%2520inhibitor%2520S-1153%2520to%2520HIV-1%2520reverse%2520transcriptase%2520involves%2520extensive%2520main%2520chain%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D14316%26epage%3D14320%26doi%3D10.1074%2Fjbc.275.19.14316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osswald, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agniswamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuya, H.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Potent HIV-1 Protease Inhibitors with Modified P1-Biphenyl Ligands: Synthesis, Biological Evaluation, and Enzyme-Inhibitor X-ray Structural Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5334</span><span class="NLM_x">–</span> <span class="NLM_lpage">5343</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00676</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00676" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5334-5343&author=A.+K.+Ghoshauthor=X.+Yuauthor=H.+L.+Osswaldauthor=J.+Agniswamyauthor=Y.+F.+Wangauthor=M.+Amanoauthor=I.+T.+Weberauthor=H.+Mitsuya&title=Structure-Based+Design+of+Potent+HIV-1+Protease+Inhibitors+with+Modified+P1-Biphenyl+Ligands%3A+Synthesis%2C+Biological+Evaluation%2C+and+Enzyme-Inhibitor+X-ray+Structural+Studies&doi=10.1021%2Facs.jmedchem.5b00676"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00676%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26aulast%3DAgniswamy%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DStructure-Based%2520Design%2520of%2520Potent%2520HIV-1%2520Protease%2520Inhibitors%2520with%2520Modified%2520P1-Biphenyl%2520Ligands%253A%2520Synthesis%252C%2520Biological%2520Evaluation%252C%2520and%2520Enzyme-Inhibitor%2520X-ray%2520Structural%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5334%26epage%3D5343%26doi%3D10.1021%2Facs.jmedchem.5b00676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span> </span><span class="NLM_article-title">ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1838</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2013.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bbamem.2013.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24388952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslOmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1838&publication_year=2014&pages=1296-1305&author=F.+Yuauthor=L.+Luauthor=Q.+Liuauthor=X.+Yuauthor=L.+Wangauthor=E.+Heauthor=P.+Zouauthor=L.+Duauthor=R.+W.+Sandersauthor=S.+Liuauthor=S.+Jiang&title=ADS-J1+inhibits+HIV-1+infection+and+membrane+fusion+by+targeting+the+highly+conserved+pocket+in+the+gp41+NHR-trimer&doi=10.1016%2Fj.bbamem.2013.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer</span></div><div class="casAuthors">Yu, Fei; Lu, Lu; Liu, Qi; Yu, Xiaowen; Wang, Lili; He, Elaine; Zou, Peng; Du, Lanying; Sanders, Rogier W.; Liu, Shuwen; Jiang, Shibo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1838</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1296-1305</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We previously identified a potent small-mol. human immunodeficiency virus type 1 (HIV-1) fusion inhibitor, termed ADS-J1, and hypothesized that it mainly targeted the hydrophobic pocket in the gp41 N-terminal heptad repeat (NHR) trimer.  However, this hypothesis has been challenged by the fact that ADS-J1 cannot induce drug-resistance mutation in the gp41 pocket region.  Therefore, we show herein that HIV-1 mutants resistant to T2635, a peptide derived from the gp41 C-terminal heptad repeat (CHR) region with pocket-binding domain (PBD), were also resistant to ADS-J1.  We also show that pseudoviruses with mutations at positions 64 and 67 in the gp41 pocket region were highly resistant to ADS-J1 and C34, another CHR-peptide with PBD, but relatively sensitive to T20, a CHR-peptide without PBD.  ADS-J1 could effectively bind to N36Fd, a mimic of the gp41 NHR-trimer with pocket exposed, and block binding of C34 to N36Fd trimer to form six-helix bundle (6-HB).  However, ADS-J1 was less effective in binding to N36Fd trimer with mutations in the gp41 pocket region, such as N36(Q64A)Fd, N36(Q64L)Fd, N36(A67G)Fd, N36(A67S)Fd, and N36(Q66R)Fd, as well as less effective in blocking 6-HB formation between C34 and these mutant N36Fd trimers.  These results confirm that ADS-J1 mainly targets the pocket region in the HIV-1 gp41 NHR trimer and suggest that it could be used as a lead for developing small-mol. HIV fusion inhibitors and as a mol. probe for studying the mechanisms of gp41-mediated membrane fusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm_XbLY-vlIrVg90H21EOLACvtfcHk0liER41FSEL2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslOmur0%253D&md5=addc5f2cf75d2c4ecd780bfe5cc966f7</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2013.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2013.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DE.%26aulast%3DZou%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26atitle%3DADS-J1%2520inhibits%2520HIV-1%2520infection%2520and%2520membrane%2520fusion%2520by%2520targeting%2520the%2520highly%2520conserved%2520pocket%2520in%2520the%2520gp41%2520NHR-trimer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2014%26volume%3D1838%26spage%3D1296%26epage%3D1305%26doi%3D10.1016%2Fj.bbamem.2013.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapy</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3713</span><span class="NLM_x">–</span> <span class="NLM_lpage">3728</span><span class="refDoi"> DOI: 10.2174/138161211798220972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F138161211798220972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21875413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3713-3728&author=M.+Moriauthor=F.+Manettiauthor=M.+Botta&title=Targeting+protein-protein+and+protein-nucleic+acid+interactions+for+anti-HIV+therapy&doi=10.2174%2F138161211798220972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapy</span></div><div class="casAuthors">Mori, Mattia; Manetti, Fabrizio; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">3713-3728</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Protein-protein and protein-nucleic acid interactions are involved in many regulatory cellular pathways, playing a key role in cell growth and proliferation, as well as in the progression and development of various diseases such as infectious diseases.  Esp. in the anti-AIDS research, protein-protein and protein-nucleic acid complexes are being considered as promising targets for pharmaceutical interventions aimed at overcoming the drug resistance obsd. for most of the classic enzyme inhibitors.  Consequently, more and more protein-protein and protein-nucleic acid interaction inhibitors have being identified and developed as candidate agents for antiretroviral therapy.  Here, we review the state of the art in the discovery and development of protein-protein and protein-nucleic acid interaction inhibitors that block the main steps of the HIV-1 replication cycle, giving a medicinal chem.-oriented view of strategies for inhibiting these regulatory interactions that are involved in the entry process, in the dimerization of reverse transcriptase and protease enzymes, and in the activity of the nucleocapsid protein by means of small mol. potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hDghABbo8LVg90H21EOLACvtfcHk0liER41FSEL2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVGluw%253D%253D&md5=b12d5bc2ae23ed9a6f2272df65eb12c3</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F138161211798220972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211798220972%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DM.%26aulast%3DManetti%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DTargeting%2520protein-protein%2520and%2520protein-nucleic%2520acid%2520interactions%2520for%2520anti-HIV%2520therapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D3713%26epage%3D3728%26doi%3D10.2174%2F138161211798220972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Amrane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedrat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vialet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreola, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergny, J. L.</span><span> </span><span class="NLM_article-title">Topology of a DNA G-quadruplex structure formed in the HIV-1 promoter: a potential target for anti-HIV drug development</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">5249</span><span class="NLM_x">–</span> <span class="NLM_lpage">5252</span><span class="refDoi"> DOI: 10.1021/ja501500c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja501500c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=5249-5252&author=S.+Amraneauthor=A.+Kerkourauthor=A.+Bedratauthor=B.+Vialetauthor=M.+L.+Andreolaauthor=J.+L.+Mergny&title=Topology+of+a+DNA+G-quadruplex+structure+formed+in+the+HIV-1+promoter%3A+a+potential+target+for+anti-HIV+drug+development&doi=10.1021%2Fja501500c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fja501500c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja501500c%26sid%3Dliteratum%253Aachs%26aulast%3DAmrane%26aufirst%3DS.%26aulast%3DKerkour%26aufirst%3DA.%26aulast%3DBedrat%26aufirst%3DA.%26aulast%3DVialet%26aufirst%3DB.%26aulast%3DAndreola%26aufirst%3DM.%2BL.%26aulast%3DMergny%26aufirst%3DJ.%2BL.%26atitle%3DTopology%2520of%2520a%2520DNA%2520G-quadruplex%2520structure%2520formed%2520in%2520the%2520HIV-1%2520promoter%253A%2520a%2520potential%2520target%2520for%2520anti-HIV%2520drug%2520development%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D5249%26epage%3D5252%26doi%3D10.1021%2Fja501500c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Herschhorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J. G.</span><span> </span><span class="NLM_article-title">A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1038/nchembio.1623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchembio.1623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25174000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVCrtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=845-852&author=A.+Herschhornauthor=C.+Guauthor=N.+Espyauthor=J.+Richardauthor=A.+Finziauthor=J.+G.+Sodroski&title=A+broad+HIV-1+inhibitor+blocks+envelope+glycoprotein+transitions+critical+for+entry&doi=10.1038%2Fnchembio.1623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry</span></div><div class="casAuthors">Herschhorn, Alon; Gu, Christopher; Espy, Nicole; Richard, Jonathan; Finzi, Andres; Sodroski, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">845-852</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Binding to the primary receptor, CD4, triggers conformational changes in the metastable HIV-1 envelope glycoprotein (Env) trimer ((gp120-gp41)3) that are important for virus entry into host cells.  These changes include an 'opening' of the trimer, creation of a binding site for the CCR5 co-receptor and formation and/or exposure of a gp41 coiled coil.  Here we identify a new compd., 18A (1), that specifically inhibits the entry of a wide range of HIV-1 isolates. 18A does not interfere with CD4 or CCR5 binding, but it inhibits the CD4-induced disruption of quaternary structures at the trimer apex and the exposure of the gp41 HR1 coiled coil.  Anal. of HIV-1 variants with increased or reduced sensitivity to 18A suggests that the inhibitor can distinguish distinct conformational states of gp120 in the unliganded Env trimer.  The broad-range activity and obsd. hypersensitivity of resistant mutants to antibody neutralization support further investigation of 18A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdMNhL1zmpCrVg90H21EOLACvtfcHk0ljhRvJQThULVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVCrtb7K&md5=4760afdc82c060b2cf1d7607f412b58c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1623%26sid%3Dliteratum%253Aachs%26aulast%3DHerschhorn%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DC.%26aulast%3DEspy%26aufirst%3DN.%26aulast%3DRichard%26aufirst%3DJ.%26aulast%3DFinzi%26aufirst%3DA.%26aulast%3DSodroski%26aufirst%3DJ.%2BG.%26atitle%3DA%2520broad%2520HIV-1%2520inhibitor%2520blocks%2520envelope%2520glycoprotein%2520transitions%2520critical%2520for%2520entry%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D845%26epage%3D852%26doi%3D10.1038%2Fnchembio.1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Ennifar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslam, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, F. L.</span><span> </span><span class="NLM_article-title">Structure-guided discovery of a novel aminoglycoside conjugate targeting HIV-1 RNA viral genome</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2509</span><span class="NLM_x">–</span> <span class="NLM_lpage">2517</span><span class="refDoi"> DOI: 10.1021/cb400498n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400498n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2509-2517&author=E.+Ennifarauthor=M.+W.+Aslamauthor=P.+Strasserauthor=G.+Hoffmannauthor=P.+Dumasauthor=F.+L.+van+Delft&title=Structure-guided+discovery+of+a+novel+aminoglycoside+conjugate+targeting+HIV-1+RNA+viral+genome&doi=10.1021%2Fcb400498n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fcb400498n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400498n%26sid%3Dliteratum%253Aachs%26aulast%3DEnnifar%26aufirst%3DE.%26aulast%3DAslam%26aufirst%3DM.%2BW.%26aulast%3DStrasser%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DG.%26aulast%3DDumas%26aufirst%3DP.%26aulast%3Dvan%2BDelft%26aufirst%3DF.%2BL.%26atitle%3DStructure-guided%2520discovery%2520of%2520a%2520novel%2520aminoglycoside%2520conjugate%2520targeting%2520HIV-1%2520RNA%2520viral%2520genome%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2509%26epage%3D2517%26doi%3D10.1021%2Fcb400498n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Tam, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tor, Y.</span><span> </span><span class="NLM_article-title">Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">3257</span><span class="NLM_x">–</span> <span class="NLM_lpage">3266</span><span class="refDoi"> DOI: 10.1021/ja0675797</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0675797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=3257-3266&author=V.+K.+Tamauthor=D.+Kwongauthor=Y.+Tor&title=Fluorescent+HIV-1+Dimerization+Initiation+Site%3A+design%2C+properties%2C+and+use+for+ligand+discovery&doi=10.1021%2Fja0675797"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fja0675797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0675797%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DV.%2BK.%26aulast%3DKwong%26aufirst%3DD.%26aulast%3DTor%26aufirst%3DY.%26atitle%3DFluorescent%2520HIV-1%2520Dimerization%2520Initiation%2520Site%253A%2520design%252C%2520properties%252C%2520and%2520use%2520for%2520ligand%2520discovery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D3257%26epage%3D3266%26doi%3D10.1021%2Fja0675797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Zentner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciunas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinnik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedichev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-García, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocklin, S.</span><span> </span><span class="NLM_article-title">Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix protein</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1002/cmdc.201200577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.201200577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23361947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=426-432&author=I.+Zentnerauthor=L.+J.+Sierraauthor=A.+K.+Fraserauthor=L.+Maciunasauthor=M.+K.+Mankowskiauthor=A.+Vinnikauthor=P.+Fedichevauthor=R.+G.+Ptakauthor=J.+Mart%C3%ADn-Garc%C3%ADaauthor=S.+Cocklin&title=Identification+of+a+small-molecule+inhibitor+of+HIV-1+assembly+that+targets+the+phosphatidylinositol+%284%2C5%29-bisphosphate+binding+site+of+the+HIV-1+matrix+protein&doi=10.1002%2Fcmdc.201200577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Small-Molecule Inhibitor of HIV-1 Assembly that Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein</span></div><div class="casAuthors">Zentner, Isaac; Sierra, Luz-Jeannette; Fraser, Ayesha K.; Maciunas, Lina; Mankowski, Marie K.; Vinnik, Andrei; Fedichev, Peter; Ptak, Roger G.; Martin-Garcia, Julio; Cocklin, Simon</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">426-432</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The development of drug resistance remains a crit. problem for current HIV-1 antiviral therapies, creating a need for new inhibitors of HIV-1 replication.  We previously reported on a novel anti-HIV-1 compd., N2-(phenoxyacetyl)-N-[4-(1-piperidinylcarbonyl)benzyl]glycinamide (14), that binds to the highly conserved phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) binding pocket of the HIV-1 matrix (MA) protein.  In this study, we re-evaluate the hits from the virtual screen used to identify compd. 14 and test them directly in an HIV-1 replication assay using primary human peripheral blood mononuclear cells.  This study resulted in the identification of three new compds. with antiviral activity; 2-(4-{[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl})-1-piperazinyl)-N-(4-methylphenyl)acetamide (7), 3-(2-ethoxyphenyl)-5-[[4-(4-nitrophenyl)piperazin-1-yl]methyl]-1,2,4-oxadiazole (17), and N-[4-ethoxy-3-(1-piperidinylsulfonyl)phenyl]-2-(imidazo[2,1-b][1,3]thiazol-6-yl)acetamide (18), with compd. 7 being the most potent of these hits.  Mechanistic studies on 7 demonstrated that it directly interacts with and functions through HIV-1 MA.  In accordance with our drug target, compd. 7 competes with PI(4,5)P2 for MA binding and, as a result, diminishes the prodn. of new virus.  Mutation of residues within the PI(4,5)P2 binding site of MA decreased the antiviral effect of compd. 7.  Addnl., compd. 7 displays a broadly neutralizing anti-HIV activity, with IC50 values of 7.5-15.6 μM for the group M isolates tested.  Taken together, these results point towards a novel chem. probe that can be used to more closely study the biol. role of MA and could, through further optimization, lead to a new class of anti-HIV-1 therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr11-gHfqPpe7Vg90H21EOLACvtfcHk0liK-W4YjeU8SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGiurY%253D&md5=19c5f1741bbf8c4bd87716021fa20e19</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200577%26sid%3Dliteratum%253Aachs%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSierra%26aufirst%3DL.%2BJ.%26aulast%3DFraser%26aufirst%3DA.%2BK.%26aulast%3DMaciunas%26aufirst%3DL.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DVinnik%26aufirst%3DA.%26aulast%3DFedichev%26aufirst%3DP.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DMart%25C3%25ADn-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DCocklin%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520small-molecule%2520inhibitor%2520of%2520HIV-1%2520assembly%2520that%2520targets%2520the%2520phosphatidylinositol%2520%25284%252C5%2529-bisphosphate%2520binding%2520site%2520of%2520the%2520HIV-1%2520matrix%2520protein%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D426%26epage%3D432%26doi%3D10.1002%2Fcmdc.201200577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Zentner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciunas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinnik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedichev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-García, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocklin, S.</span><span> </span><span class="NLM_article-title">Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1132</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2012.11.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1132-1135&author=I.+Zentnerauthor=L.+J.+Sierraauthor=L.+Maciunasauthor=A.+Vinnikauthor=P.+Fedichevauthor=M.+K.+Mankowskiauthor=R.+G.+Ptakauthor=J.+Mart%C3%ADn-Garc%C3%ADaauthor=S.+Cocklin&title=Discovery+of+a+small-molecule+antiviral+targeting+the+HIV-1+matrix+protein&doi=10.1016%2Fj.bmcl.2012.11.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSierra%26aufirst%3DL.%2BJ.%26aulast%3DMaciunas%26aufirst%3DL.%26aulast%3DVinnik%26aufirst%3DA.%26aulast%3DFedichev%26aufirst%3DP.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DMart%25C3%25ADn-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DCocklin%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520small-molecule%2520antiviral%2520targeting%2520the%2520HIV-1%2520matrix%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1132%26epage%3D1135%26doi%3D10.1016%2Fj.bmcl.2012.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maître, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacoste, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenfant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, S. W.</span><span> </span><span class="NLM_article-title">Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span><span class="refDoi"> DOI: 10.1021/cb400075f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400075f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1074-1082&author=N.+Goudreauauthor=C.+T.+Lemkeauthor=A.+M.+Faucherauthor=C.+Grand-Ma%C3%AEtreauthor=S.+Gouletauthor=J.+E.+Lacosteauthor=J.+Rancourtauthor=E.+Malenfantauthor=J.+F.+Mercierauthor=S.+Titoloauthor=S.+W.+Mason&title=Novel+inhibitor+binding+site+discovery+on+HIV-1+capsid+N-terminal+domain+by+NMR+and+X-ray+crystallography&doi=10.1021%2Fcb400075f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fcb400075f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400075f%26sid%3Dliteratum%253Aachs%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DGrand-Ma%25C3%25AEtre%26aufirst%3DC.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DLacoste%26aufirst%3DJ.%2BE.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DMalenfant%26aufirst%3DE.%26aulast%3DMercier%26aufirst%3DJ.%2BF.%26aulast%3DTitolo%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DS.%2BW.%26atitle%3DNovel%2520inhibitor%2520binding%2520site%2520discovery%2520on%2520HIV-1%2520capsid%2520N-terminal%2520domain%2520by%2520NMR%2520and%2520X-ray%2520crystallography%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1074%26epage%3D1082%26doi%3D10.1021%2Fcb400075f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Dewan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahasenan, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musier-Forsyth, K.</span><span> </span><span class="NLM_article-title">Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.1021/cb200450w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200450w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=761-769&author=V.+Dewanauthor=T.+Liuauthor=K.+M.+Chenauthor=Z.+Qianauthor=Y.+Xiaoauthor=L.+Kleimanauthor=K.+V.+Mahasenanauthor=C.+Liauthor=H.+Matsuoauthor=D.+Peiauthor=K.+Musier-Forsyth&title=Cyclic+peptide+inhibitors+of+HIV-1+capsid-human+lysyl-tRNA+synthetase+interaction&doi=10.1021%2Fcb200450w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fcb200450w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200450w%26sid%3Dliteratum%253Aachs%26aulast%3DDewan%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DK.%2BM.%26aulast%3DQian%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DKleiman%26aufirst%3DL.%26aulast%3DMahasenan%26aufirst%3DK.%2BV.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMatsuo%26aufirst%3DH.%26aulast%3DPei%26aufirst%3DD.%26aulast%3DMusier-Forsyth%26aufirst%3DK.%26atitle%3DCyclic%2520peptide%2520inhibitors%2520of%2520HIV-1%2520capsid-human%2520lysyl-tRNA%2520synthetase%2520interaction%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D761%26epage%3D769%26doi%3D10.1021%2Fcb200450w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Kortagere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schön, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princiotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passic, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-García, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  3rd.</span><span> </span><span class="NLM_article-title">Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">8472</span><span class="NLM_x">–</span> <span class="NLM_lpage">8481</span><span class="refDoi"> DOI: 10.1128/JVI.05006-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.05006-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22647699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2jtLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=8472-8481&author=S.+Kortagereauthor=N.+Madaniauthor=M.+K.+Mankowskiauthor=A.+Sch%C3%B6nauthor=I.+Zentnerauthor=G.+Swaminathanauthor=A.+Princiottoauthor=K.+Anthonyauthor=A.+Ozaauthor=L.+J.+Sierraauthor=S.+R.+Passicauthor=X.+Wangauthor=D.+M.+Jonesauthor=E.+Stavaleauthor=F.+C.+Krebsauthor=J.+Mart%C3%ADn-Garc%C3%ADaauthor=E.+Freireauthor=R.+G.+Ptakauthor=J.+Sodroskiauthor=S.+Cocklinauthor=A.+B.+Smith&title=Inhibiting+early-stage+events+in+HIV-1+replication+by+small-molecule+targeting+of+the+HIV-1+capsid&doi=10.1128%2FJVI.05006-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid</span></div><div class="casAuthors">Kortagere, Sandhya; Madani, Navid; Mankowski, Marie K.; Schon, Arne; Zentner, Isaac; Swaminathan, Gokul; Princiotto, Amy; Anthony, Kevin; Oza, Apara; Sierra, Luz-Jeannette; Passic, Shendra R.; Wang, Xiaozhao; Jones, David M.; Stavale, Eric; Krebs, Fred C.; Martin-Garcia, Julio; Freire, Ernesto; Ptak, Roger G.; Sodroski, Joseph; Cocklin, Simon; Smith, Amos B., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8472-8481</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 capsid (CA) protein plays essential roles in both early and late stages of virl replication and has emerged as a novel drug target.  We report hybrid structure-based virtual screening to identify small mols. with the potential to interact with the N-terminal domain (NTD) of HIV-1 CA and disrupt early, preintegration steps of the HIV-1 replication cycle.  The small mol. 4,4'-[dibenzo[b,d]furan-2,8-diylbis(5-phenyl-1H-imidazole-4,2-diyl)]dibenzoic acid (CK026), which had anti-HIV-1 activity in single- and multiple-round infections but failed to inhibit viral replication in peripheral blood mononuclear cells (PBMCs), was identified.  Three analogs of CK026 with reduced size and better drug-like properties were synthesized and assessed.  Compd. I-XW-053 (4-(4,5-diphenyl-1H-imidazol-2-yl)benzoic acid) retained all of the antiviral activity of the parental compd. and inhibited the replication of a diverse panel of primary HIV-1 isolates in PBMCs, while displaying no appreciable cytotoxicity.  This antiviral activity was specific to HIV-1, as I-XW-053 displayed no effect on the replication of SIV or against a panel of nonretroviruses.  Direct interaction of I-XW-053 was quantified with wild-type and mutant CA protein using surface plasmon resonance and isothermal titrn. calorimetry.  Mutation of Ile37 and Arg173, which are required for interaction with compd. I-XW-053, crippled the virus at an early, preintegration step.  Using quant. PCR, we demonstrated that treatment with I-XW-053 inhibited HIV-1 reverse transcription in multiple cell types, indirectly pointing to dysfunction in the uncoating process.  In summary, we have identified a CA-specific compd. that targets and inhibits a novel region in the NTD-NTD interface, affects uncoating, and possesses broad-spectrum anti-HIV-1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Tdf1mUZ85bVg90H21EOLACvtfcHk0lgywMc_CHisiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2jtLzE&md5=324cf8cda7a0aa6e07b5b8e529c91aaf</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1128%2FJVI.05006-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05006-11%26sid%3Dliteratum%253Aachs%26aulast%3DKortagere%26aufirst%3DS.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSch%25C3%25B6n%26aufirst%3DA.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSwaminathan%26aufirst%3DG.%26aulast%3DPrinciotto%26aufirst%3DA.%26aulast%3DAnthony%26aufirst%3DK.%26aulast%3DOza%26aufirst%3DA.%26aulast%3DSierra%26aufirst%3DL.%2BJ.%26aulast%3DPassic%26aufirst%3DS.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJones%26aufirst%3DD.%2BM.%26aulast%3DStavale%26aufirst%3DE.%26aulast%3DKrebs%26aufirst%3DF.%2BC.%26aulast%3DMart%25C3%25ADn-Garc%25C3%25ADa%26aufirst%3DJ.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DCocklin%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DInhibiting%2520early-stage%2520events%2520in%2520HIV-1%2520replication%2520by%2520small-molecule%2520targeting%2520of%2520the%2520HIV-1%2520capsid%26jtitle%3DJ.%2520Virol.%26date%3D2012%26volume%3D86%26spage%3D8472%26epage%3D8481%26doi%3D10.1128%2FJVI.05006-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadrozny, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedzicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pornillos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganser-Pornillos, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Griffero, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, M.</span><span> </span><span class="NLM_article-title">Structural basis of HIV-1 capsid recognition by PF74 and CPSF6</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">18625</span><span class="NLM_x">–</span> <span class="NLM_lpage">18630</span><span class="refDoi"> DOI: 10.1073/pnas.1419945112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1419945112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25518861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrt7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=18625-18630&author=A.+Bhattacharyaauthor=S.+L.+Alamauthor=T.+Frickeauthor=K.+Zadroznyauthor=J.+Sedzickiauthor=A.+B.+Taylorauthor=B.+Demelerauthor=O.+Pornillosauthor=B.+K.+Ganser-Pornillosauthor=F.+Diaz-Grifferoauthor=D.+N.+Ivanovauthor=M.+Yeager&title=Structural+basis+of+HIV-1+capsid+recognition+by+PF74+and+CPSF6&doi=10.1073%2Fpnas.1419945112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV-1 capsid recognition by PF74 and CPSF6</span></div><div class="casAuthors">Bhattacharya, Akash; Alam, Steven L.; Fricke, Thomas; Zadrozny, Kaneil; Sedzicki, Jaroslaw; Taylor, Alexander B.; Demeler, Borries; Pornillos, Owen; Ganser-Pornillos, Barbie K.; Diaz-Griffero, Felipe; Ivanov, Dmitri N.; Yeager, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">18625-18630</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Upon infection of susceptible cells by HIV-1, the conical capsid formed by ∼250 hexamers and 12 pentamers of the CA protein is delivered to the cytoplasm.  The capsid shields the RNA genome and proteins required for reverse transcription.  In addn., the surface of the capsid mediates numerous host-virus interactions, which either promote infection or enable viral restriction by innate immune responses.  In the intact capsid, there is an intermol. interface between the N-terminal domain (NTD) of one subunit and the C-terminal domain (CTD) of the adjacent subunit within the same hexameric ring.  The NTD-CTD interface is crit. for capsid assembly, both as an architectural element of the CA hexamer and pentamer and as a mechanistic element for generating lattice curvature.  Here we report biochem. expts. showing that PF-3450074 (PF74), a drug that inhibits HIV-1 infection, as well as host proteins cleavage and polyadenylation specific factor 6 (CPSF6) and nucleoporin 153 kDa (NUP153), bind to the CA hexamer with at least 10-fold higher affinities compared with nonassembled CA or isolated CA domains.  The crystal structure of PF74 in complex with the CA hexamer reveals that PF74 binds in a preformed pocket encompassing the NTD-CTD interface, suggesting that the principal inhibitory target of PF74 is the assembled capsid.  Likewise, CPSF6 binds in the same pocket.  Given that the NTD-CTD interface is a specific mol. signature of assembled hexamers in the capsid, binding of NUP153 at this site suggests that key features of capsid architecture remain intact upon delivery of the preintegration complex to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpis5JJGK8jYLVg90H21EOLACvtfcHk0lhf9YrCknhVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrt7%252FE&md5=9e7927ef280400df591c52ca51363b65</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1419945112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1419945112%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DAlam%26aufirst%3DS.%2BL.%26aulast%3DFricke%26aufirst%3DT.%26aulast%3DZadrozny%26aufirst%3DK.%26aulast%3DSedzicki%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DA.%2BB.%26aulast%3DDemeler%26aufirst%3DB.%26aulast%3DPornillos%26aufirst%3DO.%26aulast%3DGanser-Pornillos%26aufirst%3DB.%2BK.%26aulast%3DDiaz-Griffero%26aufirst%3DF.%26aulast%3DIvanov%26aufirst%3DD.%2BN.%26aulast%3DYeager%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520of%2520HIV-1%2520capsid%2520recognition%2520by%2520PF74%2520and%2520CPSF6%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D18625%26epage%3D18630%26doi%3D10.1073%2Fpnas.1419945112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span><span class="refDoi"> DOI: 10.2174/092986710790416335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F092986710790416335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20015032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1KktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=495-503&author=P.+Zhanauthor=X.+Liuauthor=E.+De+Clercq&title=Blocking+nuclear+import+of+pre-integration+complex%3A+an+emerging+anti-HIV-1+drug+discovery+paradigm&doi=10.2174%2F092986710790416335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm</span></div><div class="casAuthors">Zhan, Peng; Liu, Xinyong; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although recent progress in highly active antiretroviral therapy (HAART) has provided an effective way to treat AIDS patients, the emergence of drug-resistant HIV-1 strains and drug toxicity during long-term treatment of HIV-infected patients necessitate the search for new targets that can be used to develop novel antiviral agents.  One such target is the nuclear important process of the HIV pre-integration complex (PIC).  The ability of HIV-1 using host cell nuclear import machinery to translocate the viral PIC into the cell nucleus is the crit. determinant in the replication of the virus in non-dividing cells, such as macrophages.  Compds. inhibiting HIV-1 nuclear important may be attractive candidates for novel anti-HIV development.  In this review, we will describe the mechanisms of HIV-1 PIC translocation into the nucleus and the structure-function of the viral and cellular factors involved in this process, as well as several classes of novel anti-HIV compds. which target the nuclear import of HIV-1 PIC and effectively block viral replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIv7MMe3xM3LVg90H21EOLACvtfcHk0lhf9YrCknhVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1KktLg%253D&md5=f72b856dc68c69ddee991f402322162d</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.2174%2F092986710790416335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790416335%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DBlocking%2520nuclear%2520import%2520of%2520pre-integration%2520complex%253A%2520an%2520emerging%2520anti-HIV-1%2520drug%2520discovery%2520paradigm%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D495%26epage%3D503%26doi%3D10.2174%2F092986710790416335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berkhout, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Velden, Y. U.</span><span> </span><span class="NLM_article-title">ABX464: a good drug candidate instead of a magic bullet</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="refDoi"> DOI: 10.1186/s12977-015-0189-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2Fs12977-015-0189-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=64&author=B.+Berkhoutauthor=Y.+U.+van+der+Velden&title=ABX464%3A+a+good+drug+candidate+instead+of+a+magic+bullet&doi=10.1186%2Fs12977-015-0189-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159a&amp;dbid=16384&amp;doi=10.1186%2Fs12977-015-0189-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-015-0189-x%26sid%3Dliteratum%253Aachs%26aulast%3DBerkhout%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BVelden%26aufirst%3DY.%2BU.%26atitle%3DABX464%253A%2520a%2520good%2520drug%2520candidate%2520instead%2520of%2520a%2520magic%2520bullet%26jtitle%3DRetrovirology%26date%3D2015%26volume%3D12%26spage%3D64%26doi%3D10.1186%2Fs12977-015-0189-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit159b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Campos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myburgh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vautrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapasset, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuteau-Betzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornarelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantale, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basyuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séveno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tazi, J.</span><span> </span><span class="NLM_article-title">Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="refDoi"> DOI: 10.1186/s12977-015-0159-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2Fs12977-015-0159-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=30&author=N.+Camposauthor=R.+Myburghauthor=A.+Garcelauthor=A.+Vautrinauthor=L.+Lapassetauthor=E.+S.+Nadalauthor=F.+Mahuteau-Betzerauthor=R.+Najmanauthor=P.+Fornarelliauthor=K.+Tantaleauthor=E.+Basyukauthor=M.+S%C3%A9venoauthor=J.+P.+Venablesauthor=B.+Pauauthor=E.+Bertrandauthor=M.+A.+Wainbergauthor=R.+F.+Speckauthor=D.+Scherrerauthor=J.+Tazi&title=Long+lasting+control+of+viral+rebound+with+a+new+drug+ABX464+targeting+Rev+-+mediated+viral+RNA+biogenesis&doi=10.1186%2Fs12977-015-0159-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159b&amp;dbid=16384&amp;doi=10.1186%2Fs12977-015-0159-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12977-015-0159-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampos%26aufirst%3DN.%26aulast%3DMyburgh%26aufirst%3DR.%26aulast%3DGarcel%26aufirst%3DA.%26aulast%3DVautrin%26aufirst%3DA.%26aulast%3DLapasset%26aufirst%3DL.%26aulast%3DNadal%26aufirst%3DE.%2BS.%26aulast%3DMahuteau-Betzer%26aufirst%3DF.%26aulast%3DNajman%26aufirst%3DR.%26aulast%3DFornarelli%26aufirst%3DP.%26aulast%3DTantale%26aufirst%3DK.%26aulast%3DBasyuk%26aufirst%3DE.%26aulast%3DS%25C3%25A9veno%26aufirst%3DM.%26aulast%3DVenables%26aufirst%3DJ.%2BP.%26aulast%3DPau%26aufirst%3DB.%26aulast%3DBertrand%26aufirst%3DE.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26aulast%3DSpeck%26aufirst%3DR.%2BF.%26aulast%3DScherrer%26aufirst%3DD.%26aulast%3DTazi%26aufirst%3DJ.%26atitle%3DLong%2520lasting%2520control%2520of%2520viral%2520rebound%2520with%2520a%2520new%2520drug%2520ABX464%2520targeting%2520Rev%2520-%2520mediated%2520viral%2520RNA%2520biogenesis%26jtitle%3DRetrovirology%26date%3D2015%26volume%3D12%26spage%3D30%26doi%3D10.1186%2Fs12977-015-0159-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit159c"><span><span class="NLM_label">(c) </span>ABIVAX Press Release. <a href="http://www.abivax.com/en/com-abivax-title-medias/news-events/press-releases/92-mechanism-of-action-of-abivax-s-first-in-class-anti-hiv-drug-published-today-in-peer-reviewed-journal-retrovirology.html" class="extLink">http://www.abivax.com/en/com-abivax-title-medias/news-events/press-releases/92-mechanism-of-action-of-abivax-s-first-in-class-anti-hiv-drug-published-today-in-peer-reviewed-journal-retrovirology.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ABIVAX+Press+Release.+http%3A%2F%2Fwww.abivax.com%2Fen%2Fcom-abivax-title-medias%2Fnews-events%2Fpress-releases%2F92-mechanism-of-action-of-abivax-s-first-in-class-anti-hiv-drug-published-today-in-peer-reviewed-journal-retrovirology.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Nguyen, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feasley, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzwedel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Air, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakalian, M.</span><span> </span><span class="NLM_article-title">The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="refDoi"> DOI: 10.1186/1742-4690-8-101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-8-101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22151792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVWltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=101&author=A.+T.+Nguyenauthor=C.+L.+Feasleyauthor=K.+W.+Jacksonauthor=T.+J.+Nitzauthor=K.+Salzwedelauthor=G.+M.+Airauthor=M.+Sakalian&title=The+prototype+HIV-1+maturation+inhibitor%2C+bevirimat%2C+binds+to+the+CA-SP1+cleavage+site+in+immature+Gag+particles&doi=10.1186%2F1742-4690-8-101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">The prototype HIV-1 maturation inhibitor, bevirimat, binds to The CA-SP1 cleavage site in immature Gag particles</span></div><div class="casAuthors">Nguyen, Albert T.; Feasley, Christa L.; Jackson, Ken W.; Nitz, Theodore J.; Salzwedel, Karl; Air, Gillian M.; Sakalian, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Bevirimat, the prototype Human Immunodeficiency Virus type 1 (HIV-1) maturation inhibitor, is highly potent in cell culture and efficacious in HIV-1 infected patients.  In contrast to inhibitors that target the active site of the viral protease, bevirimat specifically inhibits a single cleavage event, the final processing step for the Gag precursor where p25 (CA-SP1) is cleaved to p24 (CA) and SP1.  Results: In this study, photoaffinity analogs of bevirimat and mass spectrometry were employed to map the binding site of bevirimat to Gag within immature virus-like particles.  Bevirimat analogs were found to crosslink to sequences overlapping, or proximal to, the CA-SP1 cleavage site, consistent with previous biochem. data on the effect of bevirimat on Gag processing and with genetic data from resistance mutations, in a region predicted by NMR and mutational studies to have α-helical character.  Unexpectedly, a second region of interaction was found within the Major Homol. Region (MHR).  Extensive prior genetic evidence suggests that the MHR is crit. for virus assembly.  Conclusions: This is the first demonstration of a direct interaction between the maturation inhibitor, bevirimat and its target, Gag.  Information gained from this study sheds light on the mechanisms by which the virus develops resistance to this class of drug and may aid in the design of next-generation maturation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOqf2xxMbTKLVg90H21EOLACvtfcHk0ljsmZy_gcSQPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVWltr0%253D&md5=f39dcd66a43fa33c710357f128809206</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-8-101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-8-101%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DA.%2BT.%26aulast%3DFeasley%26aufirst%3DC.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DSalzwedel%26aufirst%3DK.%26aulast%3DAir%26aufirst%3DG.%2BM.%26aulast%3DSakalian%26aufirst%3DM.%26atitle%3DThe%2520prototype%2520HIV-1%2520maturation%2520inhibitor%252C%2520bevirimat%252C%2520binds%2520to%2520the%2520CA-SP1%2520cleavage%2520site%2520in%2520immature%2520Gag%2520particles%26jtitle%3DRetrovirology%26date%3D2011%26volume%3D8%26spage%3D101%26doi%3D10.1186%2F1742-4690-8-101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Meng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, A. M.</span><span> </span><span class="NLM_article-title">Wrapping up the bad news: HIV assembly and release</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="refDoi"> DOI: 10.1186/1742-4690-10-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-10-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23305486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC3s3osVShtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=5&author=B.+Mengauthor=A.+M.+Lever&title=Wrapping+up+the+bad+news%3A+HIV+assembly+and+release&doi=10.1186%2F1742-4690-10-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Wrapping up the bad news: HIV assembly and release</span></div><div class="casAuthors">Meng Bo; Lever Andrew Ml</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The late Nobel Laureate Sir Peter Medawar once memorably described viruses as 'bad news wrapped in protein'.  Virus assembly in HIV is a remarkably well coordinated process in which the virus achieves extracellular budding using primarily intracellular budding machinery and also the unusual phenomenon of export from the cell of an RNA.  Recruitment of the ESCRT system by HIV is one of the best documented examples of the comprehensive way in which a virus hijacks a normal cellular process.  This review is a summary of our current understanding of the budding process of HIV, from genomic RNA capture through budding and on to viral maturation, but centering on the proteins of the ESCRT pathway and highlighting some recent advances in our understanding of the cellular components involved and the complex interplay between the Gag protein and the genomic RNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnnXkfsezHDBfKb6ELK8t0fW6udTcc2eYIvenOyZEv_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3osVShtQ%253D%253D&md5=4ab88b1b589275aa6e392361d61923c2</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-5%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DB.%26aulast%3DLever%26aufirst%3DA.%2BM.%26atitle%3DWrapping%2520up%2520the%2520bad%2520news%253A%2520HIV%2520assembly%2520and%2520release%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D5%26doi%3D10.1186%2F1742-4690-10-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Vercruysse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehaen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debaene, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanglier-Cianférani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mély, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daelemans, D.</span><span> </span><span class="NLM_article-title">A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="refDoi"> DOI: 10.1186/1742-4690-9-95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-9-95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23146561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=95&author=T.+Vercruysseauthor=B.+Bastaauthor=W.+Dehaenauthor=N.+Humbertauthor=J.+Balzariniauthor=F.+Debaeneauthor=S.+Sanglier-Cianf%C3%A9raniauthor=C.+Pannecouqueauthor=Y.+M%C3%A9lyauthor=D.+Daelemans&title=A+phenyl-thiadiazolylidene-amine+derivative+ejects+zinc+from+retroviral+nucleocapsid+zinc+fingers+and+inactivates+HIV+virions&doi=10.1186%2F1742-4690-9-95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions</span></div><div class="casAuthors">Vercruysse, Thomas; Basta, Beata; Dehaen, Wim; Humbert, Nicolas; Balzarini, Jan; Debaene, Francois; Sanglier-Cianferani, Sarah; Pannecouque, Christophe; Mely, Yves; Daelemans, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Sexual acquisition of the human immunodeficiency virus (HIV) through mucosal transmission may be prevented by using topically applied agents that block HIV transmission from one individual to another.  Therefore, virucidal agents that inactivate HIV virions may be used as a component in topical microbicides.  Results: Here, we have identified 2-methyl-3-phenyl-2H-[1,2,4]thiadiazol-5-ylideneamine (WDO-217) as a low-mol.-wt. mol. that inactivates HIV particles.  Both HIV-1 and HIV-2 virions pretreated with this compd. were unable to infect permissive cells.  Moreover, WDO-217 was able to inhibit infections of a wide spectrum of wild-type and drug-resistant HIV-1, including clin. isolates, HIV-2 and SIV strains.  Whereas the capture of virus by DC-SIGN was unaffected by the compd., it efficiently prevented the transmission of DC-SIGN-captured virus to CD4+ T-lymphocytes.  Interestingly, exposure of virions to WDO-217 reduced the amt. of virion-assocd. genomic RNA as measured by real-time RT-qPCR.  Further mechanism-of-action studies demonstrated that WDO-217 efficiently ejects zinc from the zinc fingers of the retroviral nucleocapsid protein NCp7 and inhibits the cTAR destabilization properties of this protein.  Importantly, WDO-217 was able to eject zinc from both zinc fingers, even when NCp7 was bound to oligonucleotides, while no covalent interaction between NCp7 and WDO-217 could be obsd.  Conclusion: This compd. is a new lead structure that can be used for the development of a new series of NCp7 zinc ejectors as candidate topical microbicide agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMkbg7wzqeAbVg90H21EOLACvtfcHk0li6JfhBcBUrjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVeksLs%253D&md5=d1a5120d0699a4716c84e92bc8fc3978</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-9-95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-9-95%26sid%3Dliteratum%253Aachs%26aulast%3DVercruysse%26aufirst%3DT.%26aulast%3DBasta%26aufirst%3DB.%26aulast%3DDehaen%26aufirst%3DW.%26aulast%3DHumbert%26aufirst%3DN.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DSanglier-Cianf%25C3%25A9rani%26aufirst%3DS.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DM%25C3%25A9ly%26aufirst%3DY.%26aulast%3DDaelemans%26aufirst%3DD.%26atitle%3DA%2520phenyl-thiadiazolylidene-amine%2520derivative%2520ejects%2520zinc%2520from%2520retroviral%2520nucleocapsid%2520zinc%2520fingers%2520and%2520inactivates%2520HIV%2520virions%26jtitle%3DRetrovirology%26date%3D2012%26volume%3D9%26spage%3D95%26doi%3D10.1186%2F1742-4690-9-95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debaene, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanglier-Cianferani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schult-Dietrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisné, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mely, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span> </span><span class="NLM_article-title">Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1950</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span><span class="refDoi"> DOI: 10.1021/cb500316h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500316h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyit7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1950-1955&author=M.+Moriauthor=A.+Nucciauthor=M.+C.+Langauthor=N.+Humbertauthor=C.+Boudierauthor=F.+Debaeneauthor=S.+Sanglier-Cianferaniauthor=M.+Catalaauthor=P.+Schult-Dietrichauthor=U.+Dietrichauthor=C.+Tisn%C3%A9author=Y.+Melyauthor=M.+Botta&title=Functional+and+structural+characterization+of+2-amino-4-phenylthiazole+inhibitors+of+the+HIV-1+nucleocapsid+protein+with+antiviral+activity&doi=10.1021%2Fcb500316h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and Structural Characterization of 2-Amino-4-phenylthiazole Inhibitors of the HIV-1 Nucleocapsid Protein with Antiviral Activity</span></div><div class="casAuthors">Mori, Mattia; Nucci, Alessandro; Lang, Maria Chiara Dasso; Humbert, Nicolas; Boudier, Christian; Debaene, Francois; Sanglier-Cianferani, Sarah; Catala, Marjorie; Schult-Dietrich, Patricia; Dietrich, Ursula; Tisne, Carine; Mely, Yves; Botta, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1950-1955</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nucleocapsid protein (NC) is a highly conserved protein in diverse HIV-1 subtypes that plays a central role in virus replication, mainly by interacting with conserved nucleic acid sequences.  NC is considered a highly profitable drug target to inhibit multiple steps in the HIV-1 life cycle with just one compd., a unique property not shown by any of the other antiretroviral classes.  However, most of NC inhibitors developed so far act through an unspecific and potentially toxic mechanism (zinc ejection) and are mainly being investigated as topical microbicides.  In an effort to provide specific NC inhibitors that compete for the binding of nucleic acids to NC, here we combined mol. modeling, org. synthesis, biophys. studies, NMR spectroscopy, and antiviral assays to design, synthesize, and characterize an efficient NC inhibitor endowed with antiviral activity in vitro, a desirable property for the development of efficient antiretroviral lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos_1MGxIrbnrVg90H21EOLACvtfcHk0li6JfhBcBUrjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyit7jF&md5=65db5476599202f80a4325c5fbad237f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fcb500316h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500316h%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DM.%26aulast%3DNucci%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DM.%2BC.%26aulast%3DHumbert%26aufirst%3DN.%26aulast%3DBoudier%26aufirst%3DC.%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DSanglier-Cianferani%26aufirst%3DS.%26aulast%3DCatala%26aufirst%3DM.%26aulast%3DSchult-Dietrich%26aufirst%3DP.%26aulast%3DDietrich%26aufirst%3DU.%26aulast%3DTisn%25C3%25A9%26aufirst%3DC.%26aulast%3DMely%26aufirst%3DY.%26aulast%3DBotta%26aufirst%3DM.%26atitle%3DFunctional%2520and%2520structural%2520characterization%2520of%25202-amino-4-phenylthiazole%2520inhibitors%2520of%2520the%2520HIV-1%2520nucleocapsid%2520protein%2520with%2520antiviral%2520activity%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1950%26epage%3D1955%26doi%3D10.1021%2Fcb500316h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Sloan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Harnessing the therapeutic potential of host antiviral restriction factors that target HIV</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1586/eri.12.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1586%2Feri.12.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23428096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1an" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=1-4&author=R.+D.+Sloanauthor=M.+A.+Wainberg&title=Harnessing+the+therapeutic+potential+of+host+antiviral+restriction+factors+that+target+HIV&doi=10.1586%2Feri.12.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the therapeutic potential of host antiviral restriction factors that target HIV</span></div><div class="casAuthors">Sloan, Richard D.; Wainberg, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Restriction factors are typically interferon-induced proteins that when expressed as single gene products can antagonize viral replication.  While modifying cellular factor function directly may lead to cytotoxic off-target effects, inhibiting viral countermeasures to restriction factors might not, and should render virus susceptible to their antagonizing effects.  Due to these attractive properties, there is much interest in developing new therapeutic strategies based on the antiviral properties of restriction factors.  Currently there are no restriction factor-based antivirals in clin. development, but the rapid progress from their identification to functional understanding and preliminary evaluation of antiviral strategies is impressive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8s29Iz6xtGbVg90H21EOLACvtfcHk0li6JfhBcBUrjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1an&md5=3cfd2d7bf9bb1d0fa1a8aa4d024eefed</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1586%2Feri.12.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.12.146%26sid%3Dliteratum%253Aachs%26aulast%3DSloan%26aufirst%3DR.%2BD.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DHarnessing%2520the%2520therapeutic%2520potential%2520of%2520host%2520antiviral%2520restriction%2520factors%2520that%2520target%2520HIV%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2013%26volume%3D11%26spage%3D1%26epage%3D4%26doi%3D10.1586%2Feri.12.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallay, P.</span><span> </span><span class="NLM_article-title">Curing a viral infection by targeting the host: the example of cyclophilin inhibitors</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.03.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.03.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23578729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2013&pages=68-77&author=K.+Linauthor=P.+Gallay&title=Curing+a+viral+infection+by+targeting+the+host%3A+the+example+of+cyclophilin+inhibitors&doi=10.1016%2Fj.antiviral.2013.03.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Curing a viral infection by targeting the host: The example of cyclophilin inhibitors</span></div><div class="casAuthors">Lin, Kai; Gallay, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Every step of the viral life cycle is dependent on the host, which potentially can be explored for antiviral targets.  Historically, however, drug discovery has focused mainly on viral targets, because of their perceived specificity.  Efforts to pursue host targets were largely hampered by concern over potential on-target toxicity, the lack of predictive cell culture and animal models, and the complexity of host-virus interactions.  On the other hand, there are distinct advantages of targeting the host, such as creating a high barrier to resistance, providing broad coverage of different genotypes/serotypes and possibly even multiple viruses, and expanding the list of potential targets, when druggable viral targets are limited.  Taking hepatitis C virus (HCV) as the example, there are more than 20 inhibitors of the viral protease, polymerase, and NS5A protein currently in advanced clin. testing.  However, resistance has become a main challenge with these direct-acting antivirals, because HCV, an RNA virus, is notoriously prone to mutation, and a single mutation in the viral target may prevent the binding of an inhibitor, and rendering it ineffective.  Host cyclophilin inhibitors have shown promising effects both in vitro and in patients to prevent the emergence of resistance and to cure HCV infection, either alone or in combination with other agents.  They are also capable of blocking the replication of a no. of other viral pathogens.  While the road to developing host-targeting antivirals was less traveled, and significant challenges remain, delivering the most effective antiviral regimen, which may comprise inhibitors of both host and viral targets, should be well worth the effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRrqhubiLpjrVg90H21EOLACvtfcHk0lijPMl7k1YBog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSkt7g%253D&md5=1cd0276a92da531cb85c2b165e8dcd0e</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.03.020%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%26aulast%3DGallay%26aufirst%3DP.%26atitle%3DCuring%2520a%2520viral%2520infection%2520by%2520targeting%2520the%2520host%253A%2520the%2520example%2520of%2520cyclophilin%2520inhibitors%26jtitle%3DAntiviral%2520Res.%26date%3D2013%26volume%3D99%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.antiviral.2013.03.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Busschots, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rijck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span> </span><span class="NLM_article-title">In search of small molecules blocking interactions between HIV proteins and intracellular cofactors</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1039/B810306B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1039%2FB810306B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=19081927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOnur%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=21-31&author=K.+Busschotsauthor=J.+De+Rijckauthor=F.+Christauthor=Z.+Debyser&title=In+search+of+small+molecules+blocking+interactions+between+HIV+proteins+and+intracellular+cofactors&doi=10.1039%2FB810306B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">In search of small molecules blocking interactions between HIV proteins and intracellular cofactors</span></div><div class="casAuthors">Busschots, Katrien; De Rijck, Jan; Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-31</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  One of the major obstacles to pursue the discovery of small mol. inhibitors targeting protein-protein interactions is the flat nature of their interface.  X-ray structures have indeed shown that a large part of the interaction area is buried with atoms closely packed together, implying a lack of available cavities for small mol. binding.  Yet, it has become clear that some protein-protein interfaces have a well-defined compact area, commonly referred to as a hot spot, that plays a major role in the affinity of the interaction.  These hot spots define potential targets for the development of small mol. protein-protein interaction inhibitors (SMPPIIs).  In this review we discuss the interactions between viral and host proteins that have the potential for the future development of SMPPIIs.  In light of the current anti-HIV therapy a short overview of protein-protein interactions that may serve as targets for novel drugs is provided.  Our hypothesis will exemplify and discuss the interaction between HIV-1 integrase and its cellular cofactor LEDGF/p75, which, as evidenced by crystallog. and site directed mutagenesis, displays favorable properties needed for the development of interaction inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhua1w8mTUSbVg90H21EOLACvtfcHk0lijPMl7k1YBog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOnur%252FE&md5=c9542c08fd7d1d5dbc82919f0539df2b</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1039%2FB810306B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB810306B%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DDe%2BRijck%26aufirst%3DJ.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DIn%2520search%2520of%2520small%2520molecules%2520blocking%2520interactions%2520between%2520HIV%2520proteins%2520and%2520intracellular%2520cofactors%26jtitle%3DMol.%2520BioSyst.%26date%3D2008%26volume%3D5%26spage%3D21%26epage%3D31%26doi%3D10.1039%2FB810306B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Pery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebane, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhrlage, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabuzda, D.</span><span> </span><span class="NLM_article-title">Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">10504</span><span class="NLM_x">–</span> <span class="NLM_lpage">10517</span><span class="refDoi"> DOI: 10.1074/jbc.M114.626903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M114.626903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=10504-10517&author=E.+Peryauthor=A.+Sheehyauthor=N.+M.+Nebaneauthor=A.+J.+Brazierauthor=V.+Misraauthor=K.+S.+Rajendranauthor=S.+J.+Buhrlageauthor=M.+K.+Mankowskiauthor=L.+Rasmussenauthor=E.+L.+Whiteauthor=R.+G.+Ptakauthor=D.+Gabuzda&title=Identification+of+a+novel+HIV-1+inhibitor+targeting+Vif-dependent+degradation+of+human+APOBEC3G&doi=10.1074%2Fjbc.M114.626903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.626903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.626903%26sid%3Dliteratum%253Aachs%26aulast%3DPery%26aufirst%3DE.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DNebane%26aufirst%3DN.%2BM.%26aulast%3DBrazier%26aufirst%3DA.%2BJ.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DRajendran%26aufirst%3DK.%2BS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DGabuzda%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520HIV-1%2520inhibitor%2520targeting%2520Vif-dependent%2520degradation%2520of%2520human%2520APOBEC3G%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D10504%26epage%3D10517%26doi%3D10.1074%2Fjbc.M114.626903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Heredia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartenhaus, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapata, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redfield, R. R.</span><span> </span><span class="NLM_article-title">Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">9412</span><span class="NLM_x">–</span> <span class="NLM_lpage">9417</span><span class="refDoi"> DOI: 10.1073/pnas.1511144112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1511144112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=9412-9417&author=A.+Herediaauthor=N.+Leauthor=R.+B.+Gartenhausauthor=E.+Sausvilleauthor=S.+Medina-Morenoauthor=J.+C.+Zapataauthor=C.+Davisauthor=R.+C.+Galloauthor=R.+R.+Redfield&title=Targeting+of+mTOR+catalytic+site+inhibits+multiple+steps+of+the+HIV-1+lifecycle+and+suppresses+HIV-1+viremia+in+humanized+mice&doi=10.1073%2Fpnas.1511144112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1511144112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1511144112%26sid%3Dliteratum%253Aachs%26aulast%3DHeredia%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DN.%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26aulast%3DSausville%26aufirst%3DE.%26aulast%3DMedina-Moreno%26aufirst%3DS.%26aulast%3DZapata%26aufirst%3DJ.%2BC.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DGallo%26aufirst%3DR.%2BC.%26aulast%3DRedfield%26aufirst%3DR.%2BR.%26atitle%3DTargeting%2520of%2520mTOR%2520catalytic%2520site%2520inhibits%2520multiple%2520steps%2520of%2520the%2520HIV-1%2520lifecycle%2520and%2520suppresses%2520HIV-1%2520viremia%2520in%2520humanized%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D9412%26epage%3D9417%26doi%3D10.1073%2Fpnas.1511144112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">AMD3100/CXCR4 Inhibitor</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="refDoi"> DOI: 10.3389/fimmu.2015.00276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.3389%2Ffimmu.2015.00276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26106388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2Mbmslaksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276&author=E.+De+Clercq&title=AMD3100%2FCXCR4+Inhibitor&doi=10.3389%2Ffimmu.2015.00276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">AMD3100/CXCR4 Inhibitor</span></div><div class="casAuthors">De Clercq Erik</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">276</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThQWXPjMQFgkwlCcfExbvbfW6udTcc2eaRk6uZv2ObPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mbmslaksg%253D%253D&md5=29bd7fd37dca8c6c43a4c5abdf4b9fe2</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00276%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DAMD3100%252FCXCR4%2520Inhibitor%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D276%26doi%3D10.3389%2Ffimmu.2015.00276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span> </span><span class="NLM_article-title">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span><span class="refDoi"> DOI: 10.4155/fmc.15.64</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4155%2Ffmc.15.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26144264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1261-1283&author=J.+V%C3%A5ben%C3%B8author=B.+E.+Haugauthor=M.+M.+Rosenkilde&title=Progress+toward+rationally+designed+small-molecule+peptide+and+peptidomimetic+CXCR4+antagonists&doi=10.4155%2Ffmc.15.64"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists</span></div><div class="casAuthors">Vabeno, Jon; Haug, Bengt Erik; Rosenkilde, Mette M.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1261-1283</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Over the last 5 years, X-ray structures of CXCR4 in complex with three different ligands (the small-mol. antagonist IT1t, the polypeptide antagonist CVX15 and the viral chemokine antagonist vMIP-II) have been released.  In addn. to the inherent scientific value of these specific X-ray structures, they provide a reliable structural foundation for studies of the mol. interactions between CXCR4 and its key peptide ligands (CXCL12 and HIV-1 gp120), and serve as valuable templates for further development of small-mol. CXCR4 antagonists with therapeutic potential.  We here review recent computational studies of the mol. interactions between CXCR4 and its peptide ligands - based on the X-ray structures of CXCR4 - and the current status of small-mol. peptide and peptidomimetic CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocFGE-iw60gbVg90H21EOLACvtfcHk0ljJfSIAcYRaJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FN&md5=217b88bf8ca537e333adffeaff189576</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.64%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DHaug%26aufirst%3DB.%2BE.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26atitle%3DProgress%2520toward%2520rationally%2520designed%2520small-molecule%2520peptide%2520and%2520peptidomimetic%2520CXCR4%2520antagonists%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D1261%26epage%3D1283%26doi%3D10.4155%2Ffmc.15.64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tien, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullen, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, K. S.</span><span> </span><span class="NLM_article-title">Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1465</span><span class="refDoi"> DOI: 10.1021/jm501772w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501772w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1452-1465&author=C.+H.+Wuauthor=C.+J.+Wangauthor=C.+P.+Changauthor=Y.+C.+Chengauthor=J.+S.+Songauthor=J.+J.+Janauthor=M.+C.+Chouauthor=Y.+Y.+Keauthor=J.+Maauthor=Y.+C.+Wongauthor=T.+C.+Hsiehauthor=Y.+C.+Tienauthor=E.+A.+Gullenauthor=C.+F.+Loauthor=C.+Y.+Chengauthor=Y.+W.+Liuauthor=A.+A.+Sadaniauthor=C.+H.+Tsaiauthor=H.+P.+Hsiehauthor=L.+K.+Tsouauthor=K.+S.+Shia&title=Function-oriented+development+of+CXCR4+antagonists+as+selective+human+immunodeficiency+virus+%28HIV%29-1+entry+inhibitors&doi=10.1021%2Fjm501772w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm501772w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501772w%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BJ.%26aulast%3DChang%26aufirst%3DC.%2BP.%26aulast%3DCheng%26aufirst%3DY.%2BC.%26aulast%3DSong%26aufirst%3DJ.%2BS.%26aulast%3DJan%26aufirst%3DJ.%2BJ.%26aulast%3DChou%26aufirst%3DM.%2BC.%26aulast%3DKe%26aufirst%3DY.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DHsieh%26aufirst%3DT.%2BC.%26aulast%3DTien%26aufirst%3DY.%2BC.%26aulast%3DGullen%26aufirst%3DE.%2BA.%26aulast%3DLo%26aufirst%3DC.%2BF.%26aulast%3DCheng%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DSadani%26aufirst%3DA.%2BA.%26aulast%3DTsai%26aufirst%3DC.%2BH.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DShia%26aufirst%3DK.%2BS.%26atitle%3DFunction-oriented%2520development%2520of%2520CXCR4%2520antagonists%2520as%2520selective%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-1%2520entry%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1452%26epage%3D1465%26doi%3D10.1021%2Fjm501772w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Liu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ejmech.2014.09.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=481-90&author=T.+Liuauthor=B.+Huangauthor=P.+Zhanauthor=E.+De+Clercqauthor=X.+Liu&title=Discovery+of+small+molecular+inhibitors+targeting+HIV-1+gp120-CD4+interaction+drived+from+BMS-378806&doi=10.1016%2Fj.ejmech.2014.09.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520small%2520molecular%2520inhibitors%2520targeting%2520HIV-1%2520gp120-CD4%2520interaction%2520drived%2520from%2520BMS-378806%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D481%26epage%3D90%26doi%3D10.1016%2Fj.ejmech.2014.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Curreli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scacalossi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, A. K.</span><span> </span><span class="NLM_article-title">Structure-based design of a small molecule CD4-antagonist with broad spectrum anti-HIV-1 activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6909</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6909-27&author=F.+Curreliauthor=Y.+D.+Kwonauthor=H.+Zhangauthor=D.+Scacalossiauthor=D.+S.+Belovauthor=A.+A.+Tikhonovauthor=I.+A.+Andreevauthor=A.+Altieriauthor=A.+V.+Kurkinauthor=P.+D.+Kwongauthor=A.+K.+Debnath&title=Structure-based+design+of+a+small+molecule+CD4-antagonist+with+broad+spectrum+anti-HIV-1+activity&doi=10.1021%2Facs.jmedchem.5b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity</span></div><div class="casAuthors">Curreli, Francesca; Kwon, Young Do; Zhang, Hongtao; Scacalossi, Daniel; Belov, Dmitry S.; Tikhonov, Artur A.; Andreev, Ivan A.; Altieri, Andrea; Kurkin, Alexander V.; Kwong, Peter D.; Debnath, Asim K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6909-6927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Earlier the authors reported the discovery and design of NBD-556 and their analogs which demonstrated their potential as HIV-1 entry inhibitors.  However, progress in developing these inhibitors has been stymied by their CD4-agonist properties, an unfavorable trait for use as drug.  Here, the authors demonstrate the successful conversion of a full CD4-agonist (NBD-556) through a partial CD4-agonist (NBD-09027), to a full CD4-antagonist I (NBD-11021) by structure-based modification of the crit. oxalamide mid-region, previously thought to be intolerant of modification.  I showed unprecedented neutralization breath for this class of inhibitors, with pan-neutralization against a panel of 56 Env-pseudotyped HIV-1 representing diverse subtypes of clin. isolates (IC50 as low as 270 nM).  The cocrystal structure of NBD-11021 complexed to a monomeric HIV-1 gp120 core revealed its detail binding characteristics.  The study is expected to provide a framework for further development of NBD series as HIV-1 entry inhibitors for clin. application against AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsZjeIlR_smLVg90H21EOLACvtfcHk0ljpdiC1NFbzuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOqu7jK&md5=db75d8df02d72d932b75596bec6fc1fc</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00709%26sid%3Dliteratum%253Aachs%26aulast%3DCurreli%26aufirst%3DF.%26aulast%3DKwon%26aufirst%3DY.%2BD.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DScacalossi%26aufirst%3DD.%26aulast%3DBelov%26aufirst%3DD.%2BS.%26aulast%3DTikhonov%26aufirst%3DA.%2BA.%26aulast%3DAndreev%26aufirst%3DI.%2BA.%26aulast%3DAltieri%26aufirst%3DA.%26aulast%3DKurkin%26aufirst%3DA.%2BV.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26atitle%3DStructure-based%2520design%2520of%2520a%2520small%2520molecule%2520CD4-antagonist%2520with%2520broad%2520spectrum%2520anti-HIV-1%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6909%26epage%3D27%26doi%3D10.1021%2Facs.jmedchem.5b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span> </span><span class="NLM_article-title">Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1126/science.1261064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1126%2Fscience.1261064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25612609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1117-1122&author=L.+Qinauthor=I.+Kufarevaauthor=L.+G.+Holdenauthor=C.+Wangauthor=Y.+Zhengauthor=C.+Zhaoauthor=G.+Fenaltiauthor=H.+Wuauthor=G.+W.+Hanauthor=V.+Cherezovauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=T.+M.+Handel&title=Structural+biology.+Crystal+structure+of+the+chemokine+receptor+CXCR4+in+complex+with+a+viral+chemokine&doi=10.1126%2Fscience.1261064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span></div><div class="casAuthors">Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Wang, Chong; Zheng, Yi; Zhao, Chunxia; Fenalti, Gustavo; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Abagyan, Ruben; Stevens, Raymond C.; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6226</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokines and their receptors control cell migration during development, immune system responses, and in numerous diseases, including inflammation and cancer.  The structural basis of receptor:chemokine recognition has been a long-standing unanswered question due to the challenges of structure detn. for membrane protein complexes.  Here, we report the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at 3.1 angstrom resoln.  The structure revealed a 1:1 stoichiometry and a more extensive binding interface than anticipated from the paradigmatic two-site model.  The structure helped rationalize a large body of mutagenesis data and together with modeling provided insights into CXCR4 interactions with its endogenous ligand CXCL12, its ability to recognize diverse ligands, and the specificity of CC and CXC receptors for their resp. chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnK7RbAxjiYrVg90H21EOLACvtfcHk0ljpdiC1NFbzuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D&md5=9f3955c6afbd253be237bcf028d2e2dc</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1126%2Fscience.1261064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1261064%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHolden%26aufirst%3DL.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DStructural%2520biology.%2520Crystal%2520structure%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520complex%2520with%2520a%2520viral%2520chemokine%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1117%26epage%3D1122%26doi%3D10.1126%2Fscience.1261064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Sebastian, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K. L.</span><span> </span><span class="NLM_article-title">Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span><span class="refDoi"> DOI: 10.1586/14787210.2014.956094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1586%2F14787210.2014.956094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25189526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1187-1201&author=N.+T.+Sebastianauthor=K.+L.+Collins&title=Targeting+HIV+latency%3A+resting+memory+T+cells%2C+hematopoietic+progenitor+cells+and+future+directions&doi=10.1586%2F14787210.2014.956094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions</span></div><div class="casAuthors">Sebastian, Nadia T.; Collins, Kathleen L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1187-1201</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Current therapy for HIV effectively suppresses viral replication and prolongs life, but the infection persists due, at least in part, to latent infection of long-lived cells.  One favored strategy toward a cure targets latent virus in resting memory CD4+ T cells by stimulating viral prodn.  However, the existence of an addnl. reservoir in bone marrow hematopoietic progenitor cells has been detected in some treated HIV-infected people.  This review describes approaches investigators have used to reactivate latent proviral genomes in resting CD4+ T cells and hematopoietic progenitor cells.  In addn., the authors review approaches for clearance of these reservoirs along with other important topics related to HIV eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBFEFdLSV6gLVg90H21EOLACvtfcHk0ljpdiC1NFbzuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7jE&md5=5b016e8dd92a0538e7d435373db16a08</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1586%2F14787210.2014.956094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.2014.956094%26sid%3Dliteratum%253Aachs%26aulast%3DSebastian%26aufirst%3DN.%2BT.%26aulast%3DCollins%26aufirst%3DK.%2BL.%26atitle%3DTargeting%2520HIV%2520latency%253A%2520resting%2520memory%2520T%2520cells%252C%2520hematopoietic%2520progenitor%2520cells%2520and%2520future%2520directions%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2014%26volume%3D12%26spage%3D1187%26epage%3D1201%26doi%3D10.1586%2F14787210.2014.956094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Colin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Lint, C.</span><span> </span><span class="NLM_article-title">Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="refDoi"> DOI: 10.1186/1742-4690-6-111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-6-111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=111&author=L.+Colinauthor=C.+Van+Lint&title=Molecular+control+of+HIV-1+postintegration+latency%3A+implications+for+the+development+of+new+therapeutic+strategies&doi=10.1186%2F1742-4690-6-111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-6-111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-6-111%26sid%3Dliteratum%253Aachs%26aulast%3DColin%26aufirst%3DL.%26aulast%3DVan%2BLint%26aufirst%3DC.%26atitle%3DMolecular%2520control%2520of%2520HIV-1%2520postintegration%2520latency%253A%2520implications%2520for%2520the%2520development%2520of%2520new%2520therapeutic%2520strategies%26jtitle%3DRetrovirology%26date%3D2009%26volume%3D6%26spage%3D111%26doi%3D10.1186%2F1742-4690-6-111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Donahue, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Cellular and molecular mechanisms involved in the establishment of HIV-1 latency</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="refDoi"> DOI: 10.1186/1742-4690-10-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1186%2F1742-4690-10-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=11&author=D.+A.+Donahueauthor=M.+A.+Wainberg&title=Cellular+and+molecular+mechanisms+involved+in+the+establishment+of+HIV-1+latency&doi=10.1186%2F1742-4690-10-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-11%26sid%3Dliteratum%253Aachs%26aulast%3DDonahue%26aufirst%3DD.%2BA.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520involved%2520in%2520the%2520establishment%2520of%2520HIV-1%2520latency%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D11%26doi%3D10.1186%2F1742-4690-10-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Marsden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, J. A.</span><span> </span><span class="NLM_article-title">HIV/AIDS eradication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4003</span><span class="NLM_x">–</span> <span class="NLM_lpage">4010</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2013.05.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4003-4010&author=M.+D.+Marsdenauthor=J.+A.+Zack&title=HIV%2FAIDS+eradication&doi=10.1016%2Fj.bmcl.2013.05.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.032%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DM.%2BD.%26aulast%3DZack%26aufirst%3DJ.%2BA.%26atitle%3DHIV%252FAIDS%2520eradication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4003%26epage%3D4010%26doi%3D10.1016%2Fj.bmcl.2013.05.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Mbonye, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karn, J.</span><span> </span><span class="NLM_article-title">Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">454–455</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.1016/j.virol.2014.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.virol.2014.02.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454%E2%80%93455&publication_year=2014&pages=328-339&author=U.+Mbonyeauthor=J.+Karn&title=Transcriptional+control+of+HIV+latency%3A+cellular+signaling+pathways%2C+epigenetics%2C+happenstance+and+the+hope+for+a+cure&doi=10.1016%2Fj.virol.2014.02.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2014.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2014.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DMbonye%26aufirst%3DU.%26aulast%3DKarn%26aufirst%3DJ.%26atitle%3DTranscriptional%2520control%2520of%2520HIV%2520latency%253A%2520cellular%2520signaling%2520pathways%252C%2520epigenetics%252C%2520happenstance%2520and%2520the%2520hope%2520for%2520a%2520cure%26jtitle%3DVirology%26date%3D2014%26volume%3D454%25E2%2580%2593455%26spage%3D328%26epage%3D339%26doi%3D10.1016%2Fj.virol.2014.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano-Sarabia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Eradicating HIV-1 infection: seeking to clear a persistent pathogen</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">750</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1038/nrmicro3352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnrmicro3352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25402363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFanu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=750-764&author=N.+M.+Archinauthor=J.+M.+Sungauthor=C.+Garridoauthor=N.+Soriano-Sarabiaauthor=D.+M.+Margolis&title=Eradicating+HIV-1+infection%3A+seeking+to+clear+a+persistent+pathogen&doi=10.1038%2Fnrmicro3352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Eradicating HIV-1 infection: seeking to clear a persistent pathogen</span></div><div class="casAuthors">Archin, Nancie M.; Sung, Julia Marsh; Garrido, Carolina; Soriano-Sarabia, Natalia; Margolis, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">750-764</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Effective antiretroviral therapy (ART) blunts viremia, which enables HIV-1-infected individuals to control infection and live long, productive lives.  However, HIV-1 infection remains incurable owing to the persistence of a viral reservoir that harbours integrated provirus within host cellular DNA.  This latent infection is unaffected by ART and hidden from the immune system.  Recent studies have focused on the development of therapies to disrupt latency.  These efforts unmasked residual viral genomes and highlighted the need to enable the clearance of latently infected cells, perhaps via old and new strategies that improve the HIV-1-specific immune response.  In this Review, we explore new approaches to eradicate established HIV-1 infection and avoid the burden of lifelong ART.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyiDG1hd_6bLVg90H21EOLACvtfcHk0lj9qddHUXU3Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFanu7bK&md5=968cdd9411d013837c4aef34df0e0fea</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3352%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DSung%26aufirst%3DJ.%2BM.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DSoriano-Sarabia%26aufirst%3DN.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DEradicating%2520HIV-1%2520infection%253A%2520seeking%2520to%2520clear%2520a%2520persistent%2520pathogen%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2014%26volume%3D12%26spage%3D750%26epage%3D764%26doi%3D10.1038%2Fnrmicro3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Siliciano, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1016/j.jaci.2014.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.jaci.2014.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25117799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSmtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=12-19&author=J.+D.+Silicianoauthor=R.+F.+Siliciano&title=Recent+developments+in+the+search+for+a+cure+for+HIV-1+infection%3A+targeting+the+latent+reservoir+for+HIV-1&doi=10.1016%2Fj.jaci.2014.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the search for a cure for HIV-1 infection: Targeting the latent reservoir for HIV-1</span></div><div class="casAuthors">Siliciano, Janet D.; Siliciano, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-19</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  HIV-1 infection can now be readily controlled with combination antiretroviral therapy.  However, the virus persists indefinitely in a stable latent reservoir in resting CD4+ T cells.  This reservoir generally prevents cure of the infection with combination antiretroviral therapy alone.  However, several recent cases of potential HIV-1 cure have generated renewed optimism.  Here we review these cases and consider new developments in our understanding of the latent reservoir.  In addn., we consider clin. aspects of curative strategies to provide a more realistic picture of what a generally applicable cure for HIV-1 infection is likely to entail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVz2ar1oybPbVg90H21EOLACvtfcHk0lj9qddHUXU3Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSmtbnF&md5=57c5dd833f5afbd1a9a171866bb71652</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2014.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2014.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DSiliciano%26aufirst%3DJ.%2BD.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DRecent%2520developments%2520in%2520the%2520search%2520for%2520a%2520cure%2520for%2520HIV-1%2520infection%253A%2520targeting%2520the%2520latent%2520reservoir%2520for%2520HIV-1%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2014%26volume%3D134%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.jaci.2014.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lucera, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrowolski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabler, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haqqani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, J. C.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">10803</span><span class="NLM_x">–</span> <span class="NLM_lpage">10812</span><span class="refDoi"> DOI: 10.1128/JVI.00320-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.00320-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=25008921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yktrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=10803-10812&author=M.+B.+Luceraauthor=C.+A.+Tiltonauthor=H.+Maoauthor=C.+Dobrowolskiauthor=C.+O.+Tablerauthor=A.+A.+Haqqaniauthor=J.+Karnauthor=J.+C.+Tilton&title=The+histone+deacetylase+inhibitor+vorinostat+%28SAHA%29+increases+the+susceptibility+of+uninfected+CD4%2B+T+cells+to+HIV+by+increasing+the+kinetics+and+efficiency+of+postentry+viral+events&doi=10.1128%2FJVI.00320-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182aR"><div class="casContent"><span class="casTitleNuber">182a</span><div class="casTitle"><span class="NLM_cas:atitle">The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events</span></div><div class="casAuthors">Lucera, Mark B.; Tilton, Carisa A.; Mao, Hongxia; Dobrowolski, Curtis; Tabler, Caroline O.; Haqqani, Aiman A.; Karn, Jonathan; Tilton, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10803-10812, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Latently infected cells remain a primary barrier to eradication of HIV-1.  Over the past decade, a better understanding of the mol. mechanisms by which latency is established and maintained has led to the discovery of a no. of compds. that selectively reactivate latent proviruses without inducing polyclonal T cell activation.  Recently, the histone deacetylase (HDAC) inhibitor vorinostat has been demonstrated to induce HIV transcription from latently infected cells when administered to patients.  While vorinostat will be given in the context of antiretroviral therapy (ART), infection of new cells by induced virus remains a clin. concern.  Here, we demonstrate that vorinostat significantly increases the susceptibility of CD4+ T cells to infection by HIV in a dose- and time-dependent manner that is independent of receptor and coreceptor usage.  Vorinostat does not enhance viral fusion with cells but rather enhances the kinetics and efficiency of postentry viral events, including reverse transcription, nuclear import and integration and enhances viral prodn. in a spreading-infection assay.  Selective inhibition of the cytoplasmic class IIb HDAC6 with tubacin recapitulated the effect of vorinostat.  These findings reveal a previously unknown cytoplasmic effect of HDAC inhibitors promoting productive infection of CD4+ T cells that is distinct from their well-characterized effects on nuclear histone acetylation and long-terminal-repeat (LTR) transcription.  Our results indicate that careful monitoring of patients and ART intensification are warranted during vorinostat treatment and indicate that HDAC inhibitors that selectively target nuclear class I HDACs could reactivate latent HIV without increasing the susceptibility of uninfected cells to HIV.  Importance: HDAC inhibitors, particularly vorinostat, are currently being investigated clin. as part of a "shock-and-kill" strategy to purge latent reservoirs of HIV.  We demonstrate here that vorinostat increases the susceptibility of uninfected CD4+ T cells to infection with HIV, raising clin. concerns that vorinostat may reseed the viral reservoirs it is meant to purge, particularly under conditions of suboptimal drug exposure.  We demonstrate that vorinostat acts following viral fusion and enhances the kinetics and efficiency of reverse transcription, nuclear import and integration.  The effect of vorinostat was recapitulated using the cytoplasmic histone deacetylase 6 (HDAC6) inhibitor tubacin, revealing a novel and previously unknown cytoplasmic mechanism of HDAC inhibitors on HIV replication that is distinct from their well-characterized effects of long-terminal-repeat (LTR)-driven gene expression.  Moreover, our results suggest that treatment of patients with class I-specific HDAC inhibitors could induce latent viruses without increasing the susceptibility of uninfected cells to HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHKMcK4aqbvbVg90H21EOLACvtfcHk0ljT5BIae3FC7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yktrzI&md5=27a0eed054c5279a9ab23b3f974a915e</span></div><a href="/servlet/linkout?suffix=cit182a&amp;dbid=16384&amp;doi=10.1128%2FJVI.00320-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00320-14%26sid%3Dliteratum%253Aachs%26aulast%3DLucera%26aufirst%3DM.%2BB.%26aulast%3DTilton%26aufirst%3DC.%2BA.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DDobrowolski%26aufirst%3DC.%26aulast%3DTabler%26aufirst%3DC.%2BO.%26aulast%3DHaqqani%26aufirst%3DA.%2BA.%26aulast%3DKarn%26aufirst%3DJ.%26aulast%3DTilton%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520vorinostat%2520%2528SAHA%2529%2520increases%2520the%2520susceptibility%2520of%2520uninfected%2520CD4%252B%2520T%2520cells%2520to%2520HIV%2520by%2520increasing%2520the%2520kinetics%2520and%2520efficiency%2520of%2520postentry%2520viral%2520events%26jtitle%3DJ.%2520Virol.%26date%3D2014%26volume%3D88%26spage%3D10803%26epage%3D10812%26doi%3D10.1128%2FJVI.00320-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit182b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liberty, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashuba, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruc, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strain, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudgens, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eron, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span><span class="refDoi"> DOI: 10.1038/nature11286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnature11286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22837004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2012&pages=482-485&author=N.+M.+Archinauthor=A.+L.+Libertyauthor=A.+D.+Kashubaauthor=S.+K.+Choudharyauthor=J.+D.+Kurucauthor=A.+M.+Crooksauthor=D.+C.+Parkerauthor=E.+M.+Andersonauthor=M.+F.+Kearneyauthor=M.+C.+Strainauthor=D.+D.+Richmanauthor=M.+G.+Hudgensauthor=R.+J.+Boschauthor=J.+M.+Coffinauthor=J.+J.+Eronauthor=D.+J.+Hazudaauthor=D.+M.+Margolis&title=Administration+of+vorinostat+disrupts+HIV-1+latency+in+patients+on+antiretroviral+therapy&doi=10.1038%2Fnature11286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182bR"><div class="casContent"><span class="casTitleNuber">182b</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy</span></div><div class="casAuthors">Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">7408</span>),
    <span class="NLM_cas:pages">482-485</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection.  Inducing the expression of latent genomes within resting CD4+ T cells is the primary strategy to clear this reservoir.  Although histone deacetylase inhibitors such as suberoylanilide hydroxamic acid (also known as vorinostat, VOR) can disrupt HIV-1 latency in vitro, the utility of this approach has never been directly proven in a translational clin. study of HIV-infected patients.  Here we isolated the circulating resting CD4+ T cells of patients in whom viremia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir.  In each of eight patients, a single dose of VOR increased both biomarkers of cellular acetylation, and simultaneously induced an increase in HIV RNA expression in resting CD4+ cells (mean increase, 4.8-fold).  This demonstrates that a mol. mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK97t6JvwKNrVg90H21EOLACvtfcHk0ljT5BIae3FC7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWjtrfP&md5=bfe1b9c441d7eeda40d46897a9801311</span></div><a href="/servlet/linkout?suffix=cit182b&amp;dbid=16384&amp;doi=10.1038%2Fnature11286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11286%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DLiberty%26aufirst%3DA.%2BL.%26aulast%3DKashuba%26aufirst%3DA.%2BD.%26aulast%3DChoudhary%26aufirst%3DS.%2BK.%26aulast%3DKuruc%26aufirst%3DJ.%2BD.%26aulast%3DCrooks%26aufirst%3DA.%2BM.%26aulast%3DParker%26aufirst%3DD.%2BC.%26aulast%3DAnderson%26aufirst%3DE.%2BM.%26aulast%3DKearney%26aufirst%3DM.%2BF.%26aulast%3DStrain%26aufirst%3DM.%2BC.%26aulast%3DRichman%26aufirst%3DD.%2BD.%26aulast%3DHudgens%26aufirst%3DM.%2BG.%26aulast%3DBosch%26aufirst%3DR.%2BJ.%26aulast%3DCoffin%26aufirst%3DJ.%2BM.%26aulast%3DEron%26aufirst%3DJ.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DAdministration%2520of%2520vorinostat%2520disrupts%2520HIV-1%2520latency%2520in%2520patients%2520on%2520antiretroviral%2520therapy%26jtitle%3DNature%26date%3D2012%26volume%3D487%26spage%3D482%26epage%3D485%26doi%3D10.1038%2Fnature11286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit182c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wightman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harman, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dear, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, S. R.</span><span> </span><span class="NLM_article-title">Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells</span> <span class="citation_source-journal">AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2853</span><span class="NLM_x">–</span> <span class="NLM_lpage">2862</span><span class="refDoi"> DOI: 10.1097/QAD.0000000000000067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAD.0000000000000067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2853-2862&author=F.+Wightmanauthor=H.+K.+Luauthor=A.+E.+Solomonauthor=S.+Salehauthor=A.+N.+Harmanauthor=A.+L.+Cunninghamauthor=L.+Grayauthor=M.+Churchillauthor=P.+U.+Cameronauthor=A.+E.+Dearauthor=S.+R.+Lewin&title=Entinostat+is+a+histone+deacetylase+inhibitor+selective+for+class+1+histone+deacetylases+and+activates+HIV+production+from+latently+infected+primary+T+cells&doi=10.1097%2FQAD.0000000000000067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182c&amp;dbid=16384&amp;doi=10.1097%2FQAD.0000000000000067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0000000000000067%26sid%3Dliteratum%253Aachs%26aulast%3DWightman%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DH.%2BK.%26aulast%3DSolomon%26aufirst%3DA.%2BE.%26aulast%3DSaleh%26aufirst%3DS.%26aulast%3DHarman%26aufirst%3DA.%2BN.%26aulast%3DCunningham%26aufirst%3DA.%2BL.%26aulast%3DGray%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DP.%2BU.%26aulast%3DDear%26aufirst%3DA.%2BE.%26aulast%3DLewin%26aufirst%3DS.%2BR.%26atitle%3DEntinostat%2520is%2520a%2520histone%2520deacetylase%2520inhibitor%2520selective%2520for%2520class%25201%2520histone%2520deacetylases%2520and%2520activates%2520HIV%2520production%2520from%2520latently%2520infected%2520primary%2520T%2520cells%26jtitle%3DAIDS%26date%3D2013%26volume%3D27%26spage%3D2853%26epage%3D2862%26doi%3D10.1097%2FQAD.0000000000000067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit182d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e48832</span><span class="refDoi"> DOI: 10.1371/journal.pone.0048832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0048832" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e48832&author=H.+Yingauthor=Y.+Zhangauthor=X.+Zhouauthor=X.+Quauthor=P.+Wangauthor=S.+Liuauthor=D.+Luauthor=H.+Zhu&title=Selective+histonedeacetylase+inhibitor+M344+intervenes+in+HIV-1+latency+through+increasing+histone+acetylation+and+activation+of+NF-kappaB&doi=10.1371%2Fjournal.pone.0048832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182d&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0048832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0048832%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DQu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DSelective%2520histonedeacetylase%2520inhibitor%2520M344%2520intervenes%2520in%2520HIV-1%2520latency%2520through%2520increasing%2520histone%2520acetylation%2520and%2520activation%2520of%2520NF-kappaB%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De48832%26doi%3D10.1371%2Fjournal.pone.0048832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit182e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines</span> <span class="citation_source-journal">Curr. HIV Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.2174/157016213804999249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F157016213804999249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23092175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=24-29&author=X.+Quauthor=H.+Yingauthor=X.+Wangauthor=C.+Kongauthor=X.+Zhouauthor=P.+Wangauthor=H.+Zhu&title=Histone+deacetylase+inhibitor+MC1293+induces+latent+HIV-1+reactivation+by+histone+modification+in+vitro+latency+cell+lines&doi=10.2174%2F157016213804999249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182eR"><div class="casContent"><span class="casTitleNuber">182e</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines</span></div><div class="casAuthors">Qu, Xiying; Ying, Hao; Wang, Xiaohui; Kong, Chuijin; Zhou, Xin; Wang, Pengfei; Zhu, Huanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">CHRUBF</span>;
        ISSN:<span class="NLM_cas:issn">1570-162X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">HIV-1 latency remains a major problem for the eradication of viruses in infected individuals.  We evaluated the effect of MC1293 on the epigenetic change at HIV-1 LTR and the induction of the latent viruses in the latency Jurkat T cell line.  We found MC1293 can activate HIV-1 gene expression, increase the acetylation level of H3 and H4 at the nuc-1 site of HIV-1 LTR.  In addn., MC1293 can synergize with prostratin to activate the HIV-1 promoter, and has relatively lower toxicity compared to Trichostatin A (TSA).  The results suggest that the acetylation of histone plays an important role in regulating HIV-1 LTR gene expression, and MC1293 is potential drug candidate for antilatency therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn6_R4aMO3fbVg90H21EOLACvtfcHk0lir4w9bUL-3sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeltbs%253D&md5=897be1895416e894786c62c5285448a1</span></div><a href="/servlet/linkout?suffix=cit182e&amp;dbid=16384&amp;doi=10.2174%2F157016213804999249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016213804999249%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DX.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKong%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520MC1293%2520induces%2520latent%2520HIV-1%2520reactivation%2520by%2520histone%2520modification%2520in%2520vitro%2520latency%2520cell%2520lines%26jtitle%3DCurr.%2520HIV%2520Res.%26date%3D2013%26volume%3D11%26spage%3D24%26epage%3D29%26doi%3D10.2174%2F157016213804999249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit182f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Matalon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nold, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furlan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascagni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e3181d3dca3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQAI.0b013e3181d3dca3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=20300007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1-9&author=S.+Matalonauthor=B.+E.+Palmerauthor=M.+F.+Noldauthor=A.+Furlanauthor=A.+Kassuauthor=G.+Fossatiauthor=P.+Mascagniauthor=C.+A.+Dinarello&title=The+histone+deacetylase+inhibitor+ITF2357+decreases+surface+CXCR4+and+CCR5+expression+on+CD4%28%2B%29+T-cells+and+monocytes+and+is+superior+to+valproic+acid+for+latent+HIV-1+expression+in+vitro&doi=10.1097%2FQAI.0b013e3181d3dca3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182fR"><div class="casContent"><span class="casTitleNuber">182f</span><div class="casTitle"><span class="NLM_cas:atitle">The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro</span></div><div class="casAuthors">Matalon, Shay; Palmer, Brent E.; Nold, Marcel F.; Furlan, Antonio; Kassu, Afework; Fossati, Gianluca; Mascagni, Paolo; Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Chromatin-assocd. repression is one mechanism that maintains HIV-1 latency.  Inhibition of histone deacetylases (HDAC) reverses this repression resulting in viral expression from quiescently infected cells.  Clin. studies with the HDAC inhibitor valproic acid (VPA) failed to substantially decrease the latent pool within resting CD4 cells.  Here we compared the efficacy of ITF2357, an orally active and safe HDAC inhibitor, with VPA for HIV-1 expression from latently infected cells in vitro.  We also evaluated the effect of ITF2357 on the surface expression of CXCR4 and CCR5.  Latently infected cell lines were incubated with either ITF2357 or VPA and p24 levels were measured.  Peripheral blood mononuclear cells of uninfected donors were treated with ITF2357 and HIV-1 coreceptors expression was assessed by flow cytometry.  At clin. relevant concns., ITF2357 increased p24 by 15-fold in ACH2 cells and by 9-fold in U1 cells, whereas VPA increased expression less than 2-fold.  Analogs of ITF2357 primarily targeting HDAC-1 increased p24 up to 30-fold.  In CD4 T cells treated with ITF2357, CXCR4 expression decreased by 54% (P < 0.001).  ITF2357 is superior to VPA in inducing HIV-1 from latently infected cells.  Safely used in humans, ITF2357 is an attractive candidate for HIV-1 clin. purging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPgJCLYVZvFrVg90H21EOLACvtfcHk0lir4w9bUL-3sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFCmtr8%253D&md5=00472fbb9d15158fb97d3f20d8bd230c</span></div><a href="/servlet/linkout?suffix=cit182f&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e3181d3dca3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e3181d3dca3%26sid%3Dliteratum%253Aachs%26aulast%3DMatalon%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DB.%2BE.%26aulast%3DNold%26aufirst%3DM.%2BF.%26aulast%3DFurlan%26aufirst%3DA.%26aulast%3DKassu%26aufirst%3DA.%26aulast%3DFossati%26aufirst%3DG.%26aulast%3DMascagni%26aufirst%3DP.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DThe%2520histone%2520deacetylase%2520inhibitor%2520ITF2357%2520decreases%2520surface%2520CXCR4%2520and%2520CCR5%2520expression%2520on%2520CD4%2528%252B%2529%2520T-cells%2520and%2520monocytes%2520and%2520is%2520superior%2520to%2520valproic%2520acid%2520for%2520latent%2520HIV-1%2520expression%2520in%2520vitro%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2010%26volume%3D54%26spage%3D1%26epage%3D9%26doi%3D10.1097%2FQAI.0b013e3181d3dca3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellors, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluis-Cremer, N.</span><span> </span><span class="NLM_article-title">Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">22211</span><span class="NLM_x">–</span> <span class="NLM_lpage">22218</span><span class="refDoi"> DOI: 10.1074/jbc.M110.180224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M110.180224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=22211-22218&author=K.+Huberauthor=G.+Doyonauthor=J.+Plaksauthor=E.+Fyneauthor=J.+W.+Mellorsauthor=N.+Sluis-Cremer&title=Inhibitors+of+histone+deacetylases%3A+correlation+between+isoform+specificity+and+reactivation+of+HIV+type+1+%28HIV-1%29+from+latently+infected+cells&doi=10.1074%2Fjbc.M110.180224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.180224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.180224%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DDoyon%26aufirst%3DG.%26aulast%3DPlaks%26aufirst%3DJ.%26aulast%3DFyne%26aufirst%3DE.%26aulast%3DMellors%26aufirst%3DJ.%2BW.%26aulast%3DSluis-Cremer%26aufirst%3DN.%26atitle%3DInhibitors%2520of%2520histone%2520deacetylases%253A%2520correlation%2520between%2520isoform%2520specificity%2520and%2520reactivation%2520of%2520HIV%2520type%25201%2520%2528HIV-1%2529%2520from%2520latently%2520infected%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D22211%26epage%3D22218%26doi%3D10.1074%2Fjbc.M110.180224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68669</span><span class="refDoi"> DOI: 10.1371/journal.pone.0068669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.pone.0068669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23874714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68669&author=T.+Suzukiauthor=Y.+Kasuyaauthor=Y.+Itohauthor=Y.+Otaauthor=P.+Zhanauthor=K.+Asamitsuauthor=H.+Nakagawaauthor=T.+Okamotoauthor=N.+Miyata&title=Identification+of+highly+selective+and+potent+histone+deacetylase+3+inhibitors+using+click+chemistry-based+combinatorial+fragment+assembly&doi=10.1371%2Fjournal.pone.0068669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184aR"><div class="casContent"><span class="casTitleNuber">184a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span></div><div class="casAuthors">Suzuki, Takayoshi; Kasuya, Yuki; Itoh, Yukihiro; Ota, Yosuke; Zhan, Peng; Asamitsu, Kaori; Nakagawa, Hidehiko; Okamoto, Takashi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68669</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">To find histone deacetylase 3 (HDAC3)-selective inhibitors, a series of 504 candidates was assembled using "click chem.", by reacting nine alkynes bearing a zinc-binding group with 56 azide building blocks in the presence of Cu(I) catalyst.  Screening of the 504-member triazole library against HDAC3 and other HDAC isoenzymes led to the identification of potent and selective HDAC3 inhibitors T247 and T326.  These compds. showed potent HDAC3 inhibition with submicromolar IC50s, whereas they did not strongly inhibit other isoenzymes.  Compds. T247 and T326 also induced a dose-dependent selective increase of NF-κB acetylation in human colon cancer HCT116 cells, indicating selective inhibition of HDAC3 in the cells.  In addn., these HDAC3-selective inhibitors induced growth inhibition of cancer cells, and activated HIV gene expression in latent HIV-infected cells.  These findings indicate that HDAC3-selective inhibitors are promising candidates for anticancer drugs and antiviral agents.  This work also suggests the usefulness of the click chem. approach to find isoenzyme-selective HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4CvS43ILxQLVg90H21EOLACvtfcHk0lj1z7mHZMVPvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF&md5=74d12c8fb1f06f8e00691415434fd929</span></div><a href="/servlet/linkout?suffix=cit184a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068669%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520highly%2520selective%2520and%2520potent%2520histone%2520deacetylase%25203%2520inhibitors%2520using%2520click%2520chemistry-based%2520combinatorial%2520fragment%2520assembly%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68669%26doi%3D10.1371%2Fjournal.pone.0068669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit184b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Victoriano, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span> </span><span class="NLM_article-title">Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.febslet.2011.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.febslet.2011.03.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=1103-11&author=A.+F.+Victorianoauthor=K.+Imaiauthor=H.+Togamiauthor=T.+Uenoauthor=K.+Asamitsuauthor=T.+Suzukiauthor=N.+Miyataauthor=K.+Ochiaiauthor=T.+Okamoto&title=Novel+histone+deacetylase+inhibitor+NCH-51+activates+latent+HIV-1+gene+expression&doi=10.1016%2Fj.febslet.2011.03.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184b&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DVictoriano%26aufirst%3DA.%2BF.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DTogami%26aufirst%3DH.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DOchiai%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DT.%26atitle%3DNovel%2520histone%2520deacetylase%2520inhibitor%2520NCH-51%2520activates%2520latent%2520HIV-1%2520gene%2520expression%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D1103%26epage%3D11%26doi%3D10.1016%2Fj.febslet.2011.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Rasmussen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstrup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckelmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Østergaard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søgaard, O. S.</span><span> </span><span class="NLM_article-title">Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials</span> <span class="citation_source-journal">Hum. Vaccines Immunother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span><span class="refDoi"> DOI: 10.4161/hv.23202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4161%2Fhv.23202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23563519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSks7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=790-799&author=T.+A.+Rasmussenauthor=M.+Tolstrupauthor=A.+Winckelmannauthor=L.+%C3%98stergaardauthor=O.+S.+S%C3%B8gaard&title=Eliminating+the+latent+HIV+reservoir+by+reactivation+strategies%3A+advancing+to+clinical+trials&doi=10.4161%2Fhv.23202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials</span></div><div class="casAuthors">Rasmussen, Thomas A.; Tolstrup, Martin; Winckelmann, Anni; Oestergaard, Lars; Soegaard, Ole S.</div><div class="citationInfo"><span class="NLM_cas:title">Human Vaccines & Immunotherapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">790-799</span>CODEN:
                <span class="NLM_cas:coden">HVIUAK</span>;
        ISSN:<span class="NLM_cas:issn">2164-5515</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Combination antiretroviral therapy (cART) has transformed HIV from a deadly to a chronic disease, but HIV patients are still burdened with excess morbidity and mortality, long-term toxicities from cART, stigmatization, and insufficient access to cART worldwide.  Thus, a cure for HIV would have enormous impact on society as well as the individual.  As the complexity and mechanisms of HIV persistence during therapy are being unraveled, new therapeutic targets for HIV eradication are discovered.  Substances that activate HIV prodn. in the latently infected cells have recently received much attention.  By turning on expression of latent HIV proviruses, reactivation strategies could contribute to the eradication HIV infection.  Compds. that are currently being or soon to be tested in clin. trials are emphasized in this review.  The results from these trials will provide important clues as to whether or not reactivating strategies could become significant components of a cure for HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6b0oFQRXFarVg90H21EOLACvtfcHk0lj1z7mHZMVPvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSks7%252FO&md5=3ec6fd4bb7e8b81877a3b4a8e026e3f0</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.4161%2Fhv.23202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fhv.23202%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DT.%2BA.%26aulast%3DTolstrup%26aufirst%3DM.%26aulast%3DWinckelmann%26aufirst%3DA.%26aulast%3D%25C3%2598stergaard%26aufirst%3DL.%26aulast%3DS%25C3%25B8gaard%26aufirst%3DO.%2BS.%26atitle%3DEliminating%2520the%2520latent%2520HIV%2520reservoir%2520by%2520reactivation%2520strategies%253A%2520advancing%2520to%2520clinical%2520trials%26jtitle%3DHum.%2520Vaccines%2520Immunother.%26date%3D2013%26volume%3D9%26spage%3D790%26epage%3D799%26doi%3D10.4161%2Fhv.23202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Shirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvanese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">Reactivation of latent HIV by histone deacetylase inhibitors</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.1016/j.tim.2013.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.tim.2013.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23517573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlSjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=277-285&author=K.+Shirakawaauthor=L.+Chavezauthor=S.+Hakreauthor=V.+Calvaneseauthor=E.+Verdin&title=Reactivation+of+latent+HIV+by+histone+deacetylase+inhibitors&doi=10.1016%2Fj.tim.2013.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of latent HIV by histone deacetylase inhibitors</span></div><div class="casAuthors">Shirakawa, Kotaro; Chavez, Leonard; Hakre, Shweta; Calvanese, Vincenzo; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">TRMIEA</span>;
        ISSN:<span class="NLM_cas:issn">0966-842X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Latent HIV persists in CD4+ T cells in infected patients under antiretroviral therapy (ART).  Latency is assocd. with transcriptional silencing of the integrated provirus and driven, at least in part, by histone deacetylases (HDACs), a family of chromatin-assocd. proteins that regulate histone acetylation and the accessibility of DNA to transcription factors.  Remarkably, inhibition of HDACs is sufficient to reactivate a fraction of latent HIV in a variety of exptl. systems.  This basic observation led to the shock and kill idea that forcing the transcriptional activation of HIV might lead to virus expression, to virus- or host-induced cell death of the reactivated cells, and to the eradication of the pool of latently infected cells.  Such intervention might possibly lead to a cure for HIV-infected patients.  Here, we review the basic biol. of HDACs and their inhibitors, the role of HDACs in HIV latency, and recent efforts to use HDAC inhibitors to reactivate latent HIV in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQF9-sQLDUE7Vg90H21EOLACvtfcHk0lgxPp5fvjFheg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlSjtbk%253D&md5=39bc7bd9e112acf1217e7a5c4ba238fa</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.tim.2013.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tim.2013.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DShirakawa%26aufirst%3DK.%26aulast%3DChavez%26aufirst%3DL.%26aulast%3DHakre%26aufirst%3DS.%26aulast%3DCalvanese%26aufirst%3DV.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DReactivation%2520of%2520latent%2520HIV%2520by%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DTrends%2520Microbiol.%26date%3D2013%26volume%3D21%26spage%3D277%26epage%3D285%26doi%3D10.1016%2Fj.tim.2013.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Pei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span> </span><span class="NLM_article-title">Systems biology brings new dimensions for structure-based drug design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">11556</span><span class="NLM_x">–</span> <span class="NLM_lpage">11565</span><span class="refDoi"> DOI: 10.1021/ja504810z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja504810z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ajtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=11556-11565&author=J.+Peiauthor=N.+Yinauthor=X.+Maauthor=L.+Lai&title=Systems+biology+brings+new+dimensions+for+structure-based+drug+design&doi=10.1021%2Fja504810z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Systems Biology Brings New Dimensions for Structure-Based Drug Design</span></div><div class="casAuthors">Pei, Jianfeng; Yin, Ning; Ma, Xiaomin; Lai, Luhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">11556-11565</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this Perspective, we focus on new, systems-centric views of structure-based drug design (SBDD) that we believe will impact future drug discovery research and development.  We will first discuss new ways to identify drug targets based on systems intervention anal., and then we will introduce emerging SBDD methods driven by advancements in systems biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreR4j6y808PrVg90H21EOLACvtfcHk0lgxPp5fvjFheg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ajtb3E&md5=7834c0474a316442c136bb601ee3882c</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fja504810z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja504810z%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DSystems%2520biology%2520brings%2520new%2520dimensions%2520for%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D11556%26epage%3D11565%26doi%3D10.1021%2Fja504810z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Fernandez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaikos, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behlke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeichner, S. L.</span><span> </span><span class="NLM_article-title">Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">3966</span><span class="NLM_x">–</span> <span class="NLM_lpage">3978</span><span class="refDoi"> DOI: 10.1128/JVI.03251-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FJVI.03251-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23365428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlymtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=3966-3978&author=G.+Fernandezauthor=T.+D.+Zaikosauthor=S.+Z.+Khanauthor=A.+M.+Jacobiauthor=M.+A.+Behlkeauthor=S.+L.+Zeichner&title=Targeting+I%CE%BAB+proteins+for+HIV+latency+activation%3A+the+role+of+individual+I%CE%BAB+and+NF-%CE%BAB+proteins&doi=10.1128%2FJVI.03251-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins</span></div><div class="casAuthors">Fernandez, Guerau; Zaikos, Thomas D.; Khan, Sohrab Z.; Jacobi, Ashley M.; Behlke, Mark A.; Zeichner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3966-3978</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Latently infected cell reservoirs represent the main barrier to HIV eradication.  Combination antiretroviral therapy (cART) effectively blocks viral replication but cannot purge latent provirus.  One approach to HIV eradication could include cART to block new infections plus an agent to activate latent provirus.  NF-κB activation induces HIV expression, ending latency.  Before activation, IκB proteins sequester NF-κB dimers in the cytoplasm.  Three canonical IκBs, IκBα, IκBβ, and IκBε, exist, but the IκB proteins' role in HIV activation regulation is not fully understood.  We studied the effects on HIV activation of targeting IκBs by single and pairwise small interfering RNA (siRNA) knockdown.  After detg. the relative abundance of the IκBs, the relative abundance of NF-κB subunits held by the IκBs, and the kinetics of IκB degrdn. and resynthesis following knockdown, we studied HIV activation by IκB knockdown, in comparison with those of known HIV activators, tumor necrosis factor alpha (TNF-α), tetradecanoyl phorbol acetate (TPA), and trichostatin A (TSA), in U1 monocytic and J-Lat 10.6 lymphocytic latently infected cells.  We found that IκBα knockdown activated HIV in both U1 and J-Lat 10.6 cells, IκBβ knockdown did not activate HIV, and, surprisingly, IκBε knockdown produced the most HIV activation, comparable to TSA activation.  Our data show that HIV reactivation can be triggered by targeting two different IκB proteins and that IκBε may be an effective target for HIV latency reactivation in T-cell and macrophage lineages.  IκBε knockdown may offer attractive therapeutic advantages for HIV activation because it is not essential for mammalian growth and development and because new siRNA delivery strategies may target siRNAs to HIV latently infected cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXT8ITojoRt7Vg90H21EOLACvtfcHk0ljWb1btaQRqVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlymtrY%253D&md5=abb3ed38790dbb85aeaf6918b856913d</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1128%2FJVI.03251-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03251-12%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DG.%26aulast%3DZaikos%26aufirst%3DT.%2BD.%26aulast%3DKhan%26aufirst%3DS.%2BZ.%26aulast%3DJacobi%26aufirst%3DA.%2BM.%26aulast%3DBehlke%26aufirst%3DM.%2BA.%26aulast%3DZeichner%26aufirst%3DS.%2BL.%26atitle%3DTargeting%2520I%25CE%25BAB%2520proteins%2520for%2520HIV%2520latency%2520activation%253A%2520the%2520role%2520of%2520individual%2520I%25CE%25BAB%2520and%2520NF-%25CE%25BAB%2520proteins%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D3966%26epage%3D3978%26doi%3D10.1128%2FJVI.03251-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Sakane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagans, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaehlcke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizusawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassen, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoelzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span> </span><span class="NLM_article-title">Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1)</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1002184</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1002184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.ppat.1002184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002184&author=N.+Sakaneauthor=H.+S.+Kwonauthor=S.+Pagansauthor=K.+Kaehlckeauthor=Y.+Mizusawaauthor=M.+Kamadaauthor=K.+G.+Lassenauthor=J.+Chanauthor=W.+C.+Greeneauthor=M.+Schnoelzerauthor=M.+Ott&title=Activation+of+HIV+transcription+by+the+viral+Tat+protein+requires+a+demethylation+step+mediated+by+lysine-specific+demethylase+1+%28LSD1%2FKDM1%29&doi=10.1371%2Fjournal.ppat.1002184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002184%26sid%3Dliteratum%253Aachs%26aulast%3DSakane%26aufirst%3DN.%26aulast%3DKwon%26aufirst%3DH.%2BS.%26aulast%3DPagans%26aufirst%3DS.%26aulast%3DKaehlcke%26aufirst%3DK.%26aulast%3DMizusawa%26aufirst%3DY.%26aulast%3DKamada%26aufirst%3DM.%26aulast%3DLassen%26aufirst%3DK.%2BG.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DW.%2BC.%26aulast%3DSchnoelzer%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DM.%26atitle%3DActivation%2520of%2520HIV%2520transcription%2520by%2520the%2520viral%2520Tat%2520protein%2520requires%2520a%2520demethylation%2520step%2520mediated%2520by%2520lysine-specific%2520demethylase%25201%2520%2528LSD1%252FKDM1%2529%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26spage%3De1002184%26doi%3D10.1371%2Fjournal.ppat.1002184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">León, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadyar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleziunas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagratis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linington, R. G.</span><span> </span><span class="NLM_article-title">Abyssomicin 2 reactivates latent HIV-1 by a PKC- and HDAC-independent mechanism</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1021/ol503349y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol503349y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=262-265&author=B.+Le%C3%B3nauthor=G.+Navarroauthor=B.+J.+Dickeyauthor=G.+Stepanauthor=A.+Tsaiauthor=G.+S.+Jonesauthor=M.+E.+Moralesauthor=T.+Barnesauthor=S.+Ahmadyarauthor=M.+Tsiangauthor=R.+Geleziunasauthor=T.+Cihlarauthor=N.+Pagratisauthor=Y.+Tianauthor=H.+Yuauthor=R.+G.+Linington&title=Abyssomicin+2+reactivates+latent+HIV-1+by+a+PKC-+and+HDAC-independent+mechanism&doi=10.1021%2Fol503349y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fol503349y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol503349y%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DB.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DDickey%26aufirst%3DB.%2BJ.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DG.%2BS.%26aulast%3DMorales%26aufirst%3DM.%2BE.%26aulast%3DBarnes%26aufirst%3DT.%26aulast%3DAhmadyar%26aufirst%3DS.%26aulast%3DTsiang%26aufirst%3DM.%26aulast%3DGeleziunas%26aufirst%3DR.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DPagratis%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLinington%26aufirst%3DR.%2BG.%26atitle%3DAbyssomicin%25202%2520reactivates%2520latent%2520HIV-1%2520by%2520a%2520PKC-%2520and%2520HDAC-independent%2520mechanism%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D262%26epage%3D265%26doi%3D10.1021%2Fol503349y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rice, A. P.</span><span> </span><span class="NLM_article-title">P-TEFb as a target to reactivate latent HIV: two Birds are now in hand</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.4161/cc.23556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.4161%2Fcc.23556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=392-393&author=A.+P.+Rice&title=P-TEFb+as+a+target+to+reactivate+latent+HIV%3A+two+Birds+are+now+in+hand&doi=10.4161%2Fcc.23556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191a&amp;dbid=16384&amp;doi=10.4161%2Fcc.23556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.23556%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DA.%2BP.%26atitle%3DP-TEFb%2520as%2520a%2520target%2520to%2520reactivate%2520latent%2520HIV%253A%2520two%2520Birds%2520are%2520now%2520in%2520hand%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26spage%3D392%26epage%3D393%26doi%3D10.4161%2Fcc.23556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit191b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Budhiraja, S.; Rice, A. P.</span><span> </span><span class="NLM_article-title">Reactivation of latent HIV: Do all roads go through P-TEFb?</span> <span class="citation_source-journal">Future Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span>). DOI: <span class="refDoi"> DOI: 10.2217/fvl.13.52</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2217%2Ffvl.13.52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24409197" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=7&author=S.+Budhiraja&author=A.+P.+Rice&title=Reactivation+of+latent+HIV%3A+Do+all+roads+go+through+P-TEFb%3F&doi=10.2217%2Ffvl.13.52"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191b&amp;dbid=16384&amp;doi=10.2217%2Ffvl.13.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffvl.13.52%26sid%3Dliteratum%253Aachs%26aulast%3DBudhiraja%26aufirst%3DS.%26atitle%3DReactivation%2520of%2520latent%2520HIV%253A%2520Do%2520all%2520roads%2520go%2520through%2520P-TEFb%253F%26jtitle%3DFuture%2520Virol.%26date%3D2013%26volume%3D8%26issue%3D7%26doi%3D10.2217%2Ffvl.13.52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">DeChristopher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, P. A.</span><span> </span><span class="NLM_article-title">Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1038/nchem.1395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchem.1395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22914190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=705-710&author=B.+A.+DeChristopherauthor=B.+A.+Loyauthor=M.+D.+Marsdenauthor=A.+J.+Schrierauthor=J.+A.+Zackauthor=P.+A.+Wender&title=Designed%2C+synthetically+accessible+bryostatin+analogues+potently+induce+activation+of+latent+HIV+reservoirs+in+vitro&doi=10.1038%2Fnchem.1395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192aR"><div class="casContent"><span class="casTitleNuber">192a</span><div class="casTitle"><span class="NLM_cas:atitle">Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro</span></div><div class="casAuthors">DeChristopher, Brian A.; Loy, Brian A.; Marsden, Matthew D.; Schrier, Adam J.; Zack, Jerome A.; Wender, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">705-710</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Seven bryostatin 1 analogs (bryologs) were prepd. using a highly convergent and step-economical route with a Prins macrocyclization reaction as the key step.  Bryostatin analogs, particularly I (R = AcO; R1 = HO; R2 = H, MeO2C), were up to 1000 times more potent than the phorbol analog prostratin (a clin. candidate for activation of latent HIV infection and for HIV treatment in concert with other anti-HIV agents) and more potent than bryostatin at inducing latent HIV expression.  Designed, synthetically accessible bryostatin analogs could serve as superior candidates for the eradication of HIV/AIDS through induction of latent viral reservoirs in conjunction with current antiretroviral therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEvjhdmkUYrVg90H21EOLACvtfcHk0ljWb1btaQRqVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehtLbJ&md5=e99e87106311ee2c8e6f9193dcfc1645</span></div><a href="/servlet/linkout?suffix=cit192a&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1395%26sid%3Dliteratum%253Aachs%26aulast%3DDeChristopher%26aufirst%3DB.%2BA.%26aulast%3DLoy%26aufirst%3DB.%2BA.%26aulast%3DMarsden%26aufirst%3DM.%2BD.%26aulast%3DSchrier%26aufirst%3DA.%2BJ.%26aulast%3DZack%26aufirst%3DJ.%2BA.%26aulast%3DWender%26aufirst%3DP.%2BA.%26atitle%3DDesigned%252C%2520synthetically%2520accessible%2520bryostatin%2520analogues%2520potently%2520induce%2520activation%2520of%2520latent%2520HIV%2520reservoirs%2520in%2520vitro%26jtitle%3DNat.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D705%26epage%3D710%26doi%3D10.1038%2Fnchem.1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit192b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beans, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournogerakis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauntlett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heumann, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wender, P. A.</span><span> </span><span class="NLM_article-title">Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">11698</span><span class="NLM_x">–</span> <span class="NLM_lpage">11703</span><span class="refDoi"> DOI: 10.1073/pnas.1302634110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1073%2Fpnas.1302634110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23812750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1emur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=11698-11703&author=E.+J.+Beansauthor=D.+Fournogerakisauthor=C.+Gauntlettauthor=L.+V.+Heumannauthor=R.+Kramerauthor=M.+D.+Marsdenauthor=D.+Murrayauthor=T.+W.+Chunauthor=J.+A.+Zackauthor=P.+A.+Wender&title=Highly+potent%2C+synthetically+accessible+prostratin+analogs+induce+latent+HIV+expression+in+vitro+and+ex+vivo&doi=10.1073%2Fpnas.1302634110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192bR"><div class="casContent"><span class="casTitleNuber">192b</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo</span></div><div class="casAuthors">Beans, Elizabeth J.; Fournogerakis, Dennis; Gauntlett, Carolyn; Heumann, Lars V.; Kramer, Rainer; Marsden, Matthew D.; Murray, Danielle; Chun, Tae-Wook; Zack, Jerome A.; Wender, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">11698-11703,S11698/1-S11698/32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Highly active antiretroviral therapy (HAART) decreases plasma viremia below the limits of detection in the majority of HIV-infected individuals, thus serving to slow disease progression.  However, HAART targets only actively replicating virus and is unable to eliminate latently infected, resting CD4+ T cells.  Such infected cells are potentially capable of reinitiating virus replication upon cessation of HAART, thus leading to viral rebound.  Agents that would eliminate these reservoirs, when used in combination with HAART, could thus provide a strategy for the eradication of HIV.  Prostratin is a preclin. candidate that induces HIV expression from latently infected CD4+ T cells, potentially leading to their elimination through a virus-induced cytopathic effect or host anti-HIV immunity.  Here, we report the synthesis of a series of designed prostratin analogs and report in vitro and ex vivo studies of their activity relevant to induction of HIV expression.  Members of this series are up to 100-fold more potent than the preclin. lead (prostratin) in binding to cell-free PKC, and in inducing HIV expression in a latently infected cell line and prostratin-like modulation of cell surface receptor expression in primary cells from HIV-neg. donors.  Significantly, selected members were also tested for HIV induction in resting CD4+ T cells isolated from infected individuals receiving HAART and were found to exhibit potent induction activity.  These more potent agents and by extension related tunable analogs now accessible through the studies described herein should facilitate research and preclin. advancement of this strategy for HIV/AIDS eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIwBT4usZkHbVg90H21EOLACvtfcHk0lhxlnIO3TfhWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1emur3J&md5=d6f8cd63860c249f8f636e3da729573f</span></div><a href="/servlet/linkout?suffix=cit192b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302634110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302634110%26sid%3Dliteratum%253Aachs%26aulast%3DBeans%26aufirst%3DE.%2BJ.%26aulast%3DFournogerakis%26aufirst%3DD.%26aulast%3DGauntlett%26aufirst%3DC.%26aulast%3DHeumann%26aufirst%3DL.%2BV.%26aulast%3DKramer%26aufirst%3DR.%26aulast%3DMarsden%26aufirst%3DM.%2BD.%26aulast%3DMurray%26aufirst%3DD.%26aulast%3DChun%26aufirst%3DT.%2BW.%26aulast%3DZack%26aufirst%3DJ.%2BA.%26aulast%3DWender%26aufirst%3DP.%2BA.%26atitle%3DHighly%2520potent%252C%2520synthetically%2520accessible%2520prostratin%2520analogs%2520induce%2520latent%2520HIV%2520expression%2520in%2520vitro%2520and%2520ex%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D11698%26epage%3D11703%26doi%3D10.1073%2Fpnas.1302634110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Targeting HIV latency: pharmacologic strategies toward eradication</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">551</span><span class="refDoi"> DOI: 10.1016/j.drudis.2012.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.drudis.2012.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23270785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=541-551&author=S.+Xingauthor=R.+F.+Siliciano&title=Targeting+HIV+latency%3A+pharmacologic+strategies+toward+eradication&doi=10.1016%2Fj.drudis.2012.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HIV latency: pharmacologic strategies toward eradication</span></div><div class="casAuthors">Xing, Sifei; Siliciano, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">541-551</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The latent reservoir for HIV-1 in resting CD4+ T cells remains a major barrier to HIV-1 eradication, even though highly active antiretroviral therapy (HAART) can successfully reduce plasma HIV-1 levels to below the detection limit of clin. assays and reverse disease progression.  Proposed eradication strategies involve reactivation of this latent reservoir.  Multiple mechanisms are believed to be involved in maintaining HIV-1 latency, mostly through suppression of transcription.  These include cytoplasmic sequestration of host transcription factors and epigenetic modifications such as histone deacetylation, histone methylation and DNA methylation.  Therefore, strategies targeting these mechanisms have been explored for reactivation of the latent reservoir.  In this review, we discuss current pharmacol. approaches toward eradication, focusing on small mol. latency-reversing agents, their mechanisms, advantages and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQstdInNIA7Vg90H21EOLACvtfcHk0lhxlnIO3TfhWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFaktg%253D%253D&md5=ef4ddba65018cb4211de942bd66c4976</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DS.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DTargeting%2520HIV%2520latency%253A%2520pharmacologic%2520strategies%2520toward%2520eradication%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D541%26epage%3D551%26doi%3D10.1016%2Fj.drudis.2012.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Yang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinoso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrum, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolick, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siliciano, R. F.</span><span> </span><span class="NLM_article-title">Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3473</span><span class="NLM_x">–</span> <span class="NLM_lpage">3486</span><span class="refDoi"> DOI: 10.1172/JCI39199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1172%2FJCI39199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3473-3486&author=H.+C.+Yangauthor=S.+Xingauthor=L.+Shanauthor=K.+O%E2%80%99Connellauthor=J.+Dinosoauthor=A.+Shenauthor=Y.+Zhouauthor=C.+K.+Shrumauthor=Y.+Hanauthor=J.+O.+Liuauthor=H.+Zhangauthor=J.+B.+Margolickauthor=R.+F.+Siliciano&title=Small-molecule+screening+using+a+human+primary+cell+model+of+HIV+latency+identifies+compounds+that+reverse+latency+without+cellular+activation&doi=10.1172%2FJCI39199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1172%2FJCI39199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI39199%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BC.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DShan%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DK.%26aulast%3DDinoso%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShrum%26aufirst%3DC.%2BK.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMargolick%26aufirst%3DJ.%2BB.%26aulast%3DSiliciano%26aufirst%3DR.%2BF.%26atitle%3DSmall-molecule%2520screening%2520using%2520a%2520human%2520primary%2520cell%2520model%2520of%2520HIV%2520latency%2520identifies%2520compounds%2520that%2520reverse%2520latency%2520without%2520cellular%2520activation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3473%26epage%3D3486%26doi%3D10.1172%2FJCI39199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Mejia, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveridge, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drašković, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleziunas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cihlar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagratis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, P.</span><span> </span><span class="NLM_article-title">Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1021/np400889x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400889x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=618-624&author=E.+J.+Mejiaauthor=S.+T.+Loveridgeauthor=G.+Stepanauthor=A.+Tsaiauthor=G.+S.+Jonesauthor=T.+Barnesauthor=K.+N.+Whiteauthor=M.+Dra%C5%A1kovi%C4%87author=K.+Tenneyauthor=M.+Tsiangauthor=R.+Geleziunasauthor=T.+Cihlarauthor=N.+Pagratisauthor=Y.+Tianauthor=H.+Yuauthor=P.+Crews&title=Study+of+marine+natural+products+including+resorcyclic+acid+lactones+from+Humicola+fuscoatra+that+reactivate+latent+HIV-1+expression+in+an+in+vitro+model+of+central+memory+CD4%2B+T+cells&doi=10.1021%2Fnp400889x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1021%2Fnp400889x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400889x%26sid%3Dliteratum%253Aachs%26aulast%3DMejia%26aufirst%3DE.%2BJ.%26aulast%3DLoveridge%26aufirst%3DS.%2BT.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DG.%2BS.%26aulast%3DBarnes%26aufirst%3DT.%26aulast%3DWhite%26aufirst%3DK.%2BN.%26aulast%3DDra%25C5%25A1kovi%25C4%2587%26aufirst%3DM.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DTsiang%26aufirst%3DM.%26aulast%3DGeleziunas%26aufirst%3DR.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DPagratis%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DStudy%2520of%2520marine%2520natural%2520products%2520including%2520resorcyclic%2520acid%2520lactones%2520from%2520Humicola%2520fuscoatra%2520that%2520reactivate%2520latent%2520HIV-1%2520expression%2520in%2520an%2520in%2520vitro%2520model%2520of%2520central%2520memory%2520CD4%252B%2520T%2520cells%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D618%26epage%3D624%26doi%3D10.1021%2Fnp400889x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">How might we cure HIV?</span> <span class="citation_source-journal">Curr. Infect. Dis. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="refDoi"> DOI: 10.1007/s11908-014-0392-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1007%2Fs11908-014-0392-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24562540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A280%3ADC%252BC2cvnsVyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=392&author=D.+M.+Margolis&title=How+might+we+cure+HIV%3F&doi=10.1007%2Fs11908-014-0392-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">How Might We Cure HIV?</span></div><div class="casAuthors">Margolis David M</div><div class="citationInfo"><span class="NLM_cas:title">Current infectious disease reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">392</span>
        ISSN:<span class="NLM_cas:issn">1523-3847</span>.
    </div><div class="casAbstract">Antiretroviral therapy (ART) does not eliminate HIV-1 from latently infected reservoirs, and this remains the critical obstacle to the eradication of infection.  Although ART is effective in suppressing viral load, life-long ART is burdensome in many respects.  Given expanding numbers of HIV-infected individuals on ART worldwide, there is an urgent need to examine the possibility that innovative therapies might eradicate infection, and obviate the need for life-long medical therapy for HIV-positive people around the world.  Several approaches to eradicating the latent HIV reservoir and curing infection have been proposed and are under study.  An initial strategy seeks to induce the expression of the latent integrated proviral genomes within resting CD4+ T cells, so that viral proteins or particles may be revealed and allow these cellular reservoirs to be cleared.  The inducing agents that have been studied recently are inhibitors of histone deacetylase (HDAC) such as suberoylanilide hydroxamic acid (SAHA).  Such induction of viral expression seems unlikely in itself to efficiently clear all latently infected cells.  Therefore, it seems likely that parallel efforts to augment the HIV-specific immune response with specific immunotherapies or vaccination may be required.  Recently, efforts to achieve immune augmentation by ex vivo expansion of viral specific cytotoxic T-cell lymphocytes derived from HIV-infected patients have yielded an augmented HIV-specific immune response in vivo, as have cellular vaccinations delivered by administration of dendritic cells.  As HIV latency and the persistence of infection despite effective ART is multifactorial, the eradication of HIV infection may require multiple approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSghqLOnB_XCWhHGZei4OW9fW6udTcc2eYXbJbUwT1JC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvnsVyrtA%253D%253D&md5=9ec97403783ca27e523ca1d5e619ce03</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1007%2Fs11908-014-0392-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11908-014-0392-2%26sid%3Dliteratum%253Aachs%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DHow%2520might%2520we%2520cure%2520HIV%253F%26jtitle%3DCurr.%2520Infect.%2520Dis.%2520Rep.%26date%3D2014%26volume%3D16%26spage%3D392%26doi%3D10.1007%2Fs11908-014-0392-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Archin, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. M.</span><span> </span><span class="NLM_article-title">Emerging strategies to deplete the HIV reservoir</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1097/QCO.0000000000000026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQCO.0000000000000026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24296585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVSqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=29-35&author=N.+M.+Archinauthor=D.+M.+Margolis&title=Emerging+strategies+to+deplete+the+HIV+reservoir&doi=10.1097%2FQCO.0000000000000026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging strategies to deplete the HIV reservoir</span></div><div class="casAuthors">Archin, Nancie M.; Margolis, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review highlights recent studies undertaken to further advance the search for successful approaches to eradicate HIV infection.  Recent findings: Small pharmacol. compds. such as histone deacetylase inhibitors, inhibitors of bromodomain and extraterminal proteins such as JQ1, and protein kinase C activators such as bryostatin and prostratin are proposed as putative candidates for inducing the expression of latent HIV in a so-called 'shock and kill' or 'kick and kill' strategy for HIV eradication.  However, in order to achieve viral clearance, it is thought likely these compds. will have to be administered in concert with strategies that augment clearance of virus-infected cells in patients that have long been aviremic on successful antiretroviral therapy (ART).  Several candidate therapies for this purpose are at hand, such as therapeutic HIV vaccines - recently shown to promote robust cytotoxic T cell responses and blunt viral rebound after ART interruption in clin. studies.  HIV-infected patients treated during early infection may be ideal candidates for early studies to test these strategies, as early ART has been shown to limit the establishment of an HIV reservoir.  Summary: HIV latency is multifactorial and thus the eradication of HIV infection may require multiple approaches.  Translational efforts employing pharmacol. methods to target HIV latency should evaluate in parallel the addnl. potential benefits of invigorating the immune response of HIV-infected individuals, and limiting the size of the reservoir via early ART.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPVsJCCIsa6bVg90H21EOLACvtfcHk0ljmigSgjocGiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVSqtLnN&md5=647c1054ff34a7d2fd22ac4887c8a2bb</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1097%2FQCO.0000000000000026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0000000000000026%26sid%3Dliteratum%253Aachs%26aulast%3DArchin%26aufirst%3DN.%2BM.%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26atitle%3DEmerging%2520strategies%2520to%2520deplete%2520the%2520HIV%2520reservoir%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D27%26spage%3D29%26epage%3D35%26doi%3D10.1097%2FQCO.0000000000000026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melcher, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildreth, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandekar, S.</span><span> </span><span class="NLM_article-title">Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1005066</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1005066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.ppat.1005066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26225771" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1005066&author=G.+Jiangauthor=E.+A.+Mendesauthor=P.+Kaiserauthor=D.+P.+Wongauthor=Y.+Tangauthor=I.+Caiauthor=A.+Fentonauthor=G.+P.+Melcherauthor=J.+E.+Hildrethauthor=G.+R.+Thompsonauthor=J.+K.+Wongauthor=S.+Dandekar&title=Synergistic+Reactivation+of+Latent+HIV+Expression+by+Ingenol-3-Angelate%2C+PEP005%2C+Targeted+NF-kB+Signaling+in+Combination+with+JQ1+Induced+p-TEFb+Activation&doi=10.1371%2Fjournal.ppat.1005066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1005066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1005066%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMendes%26aufirst%3DE.%2BA.%26aulast%3DKaiser%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DD.%2BP.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DI.%26aulast%3DFenton%26aufirst%3DA.%26aulast%3DMelcher%26aufirst%3DG.%2BP.%26aulast%3DHildreth%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DG.%2BR.%26aulast%3DWong%26aufirst%3DJ.%2BK.%26aulast%3DDandekar%26aufirst%3DS.%26atitle%3DSynergistic%2520Reactivation%2520of%2520Latent%2520HIV%2520Expression%2520by%2520Ingenol-3-Angelate%252C%2520PEP005%252C%2520Targeted%2520NF-kB%2520Signaling%2520in%2520Combination%2520with%2520JQ1%2520Induced%2520p-TEFb%2520Activation%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26spage%3De1005066%26doi%3D10.1371%2Fjournal.ppat.1005066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Bosque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planelles, V.</span><span> </span><span class="NLM_article-title">Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1016/j.ymeth.2010.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.ymeth.2010.10.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2011&pages=54-61&author=A.+Bosqueauthor=V.+Planelles&title=Studies+of+HIV-1+latency+in+an+ex+vivo+model+that+uses+primary+central+memory+T+cells&doi=10.1016%2Fj.ymeth.2010.10.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2010.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2010.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DBosque%26aufirst%3DA.%26aulast%3DPlanelles%26aufirst%3DV.%26atitle%3DStudies%2520of%2520HIV-1%2520latency%2520in%2520an%2520ex%2520vivo%2520model%2520that%2520uses%2520primary%2520central%2520memory%2520T%2520cells%26jtitle%3DMethods%26date%3D2011%26volume%3D53%26spage%3D54%26epage%3D61%26doi%3D10.1016%2Fj.ymeth.2010.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Micheva-Viteva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelstein, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graci, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelan, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ron, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peltz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, J. P.</span><span> </span><span class="NLM_article-title">High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">21083</span><span class="NLM_x">–</span> <span class="NLM_lpage">21091</span><span class="refDoi"> DOI: 10.1074/jbc.M110.195537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M110.195537" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=21083-21091&author=S.+Micheva-Vitevaauthor=Y.+Kobayashiauthor=L.+C.+Edelsteinauthor=A.+L.+Pacchiaauthor=H.+L.+Leeauthor=J.+D.+Graciauthor=J.+Breslinauthor=B.+D.+Phelanauthor=L.+K.+Millerauthor=J.+M.+Colacinoauthor=Z.+Guauthor=Y.+Ronauthor=S.+W.+Peltzauthor=J.+P.+Dougherty&title=High-throughput+screening+uncovers+a+compound+that+activates+latent+HIV-1+and+acts+cooperatively+with+a+histone+deacetylase+%28HDAC%29+inhibitor&doi=10.1074%2Fjbc.M110.195537"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.195537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.195537%26sid%3Dliteratum%253Aachs%26aulast%3DMicheva-Viteva%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DEdelstein%26aufirst%3DL.%2BC.%26aulast%3DPacchia%26aufirst%3DA.%2BL.%26aulast%3DLee%26aufirst%3DH.%2BL.%26aulast%3DGraci%26aufirst%3DJ.%2BD.%26aulast%3DBreslin%26aufirst%3DJ.%26aulast%3DPhelan%26aufirst%3DB.%2BD.%26aulast%3DMiller%26aufirst%3DL.%2BK.%26aulast%3DColacino%26aufirst%3DJ.%2BM.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DRon%26aufirst%3DY.%26aulast%3DPeltz%26aufirst%3DS.%2BW.%26aulast%3DDougherty%26aufirst%3DJ.%2BP.%26atitle%3DHigh-throughput%2520screening%2520uncovers%2520a%2520compound%2520that%2520activates%2520latent%2520HIV-1%2520and%2520acts%2520cooperatively%2520with%2520a%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D21083%26epage%3D21091%26doi%3D10.1074%2Fjbc.M110.195537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Klase, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yedavalli, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houzet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldarelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenchley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeang, K. T.</span><span> </span><span class="NLM_article-title">Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003997</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1003997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1371%2Fjournal.ppat.1003997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1003997&author=Z.+Klaseauthor=V.+S.+Yedavalliauthor=L.+Houzetauthor=M.+Perkinsauthor=F.+Maldarelliauthor=J.+Brenchleyauthor=K.+Strebelauthor=P.+Liuauthor=K.+T.+Jeang&title=Activation+of+HIV-1+from+latent+infection+via+synergy+of+RUNX1+inhibitor+Ro5-3335+and+SAHA&doi=10.1371%2Fjournal.ppat.1003997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003997%26sid%3Dliteratum%253Aachs%26aulast%3DKlase%26aufirst%3DZ.%26aulast%3DYedavalli%26aufirst%3DV.%2BS.%26aulast%3DHouzet%26aufirst%3DL.%26aulast%3DPerkins%26aufirst%3DM.%26aulast%3DMaldarelli%26aufirst%3DF.%26aulast%3DBrenchley%26aufirst%3DJ.%26aulast%3DStrebel%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DJeang%26aufirst%3DK.%2BT.%26atitle%3DActivation%2520of%2520HIV-1%2520from%2520latent%2520infection%2520via%2520synergy%2520of%2520RUNX1%2520inhibitor%2520Ro5-3335%2520and%2520SAHA%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26spage%3De1003997%26doi%3D10.1371%2Fjournal.ppat.1003997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Margolis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span> </span><span class="NLM_article-title">Combined approaches for HIV cure</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1097/COH.0b013e32835ef089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FCOH.0b013e32835ef089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23446138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVWjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=230-235&author=D.+M.+Margolisauthor=D.+J.+Hazuda&title=Combined+approaches+for+HIV+cure&doi=10.1097%2FCOH.0b013e32835ef089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Combined approaches for HIV cure</span></div><div class="casAuthors">Margolis, David M.; Hazuda, Daria J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-235</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: A serious effort has begun to develop therapies that may be capable of eradicating established HIV infection in man.  Because of the biol. complexity of HIV infection that persists despite potent antiretroviral therapy, it is widely believed that if such therapies can be developed they will involve complex, multimodality approaches.  We highlight some of the recent studies in this effort.  Recent findings: An inhibitor of histone deacetylase has been demonstrated to disrupt latency in man, and new histone deacetylase inhibitors have been identified.  Other potential targets, such as histone methyltransferase, protein kinase C, and BRD4, have been recently studied.  Model systems, both in primary cells and in animal models, are beginning to be validated.  In the clinic, immune-based therapies to aid in the clearance of persistent infection are also being tested.  Summary: It is too early to know what combination eradication therapies for HIV infection will look like in the future, but candidate therapies and model systems to perform preclin. validation are beginning to take shape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnU3s8xSwIUrVg90H21EOLACvtfcHk0lg93HMBrr1kKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVWjsb0%253D&md5=7845f7b4146c59f6b497f504bec91f21</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e32835ef089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e32835ef089%26sid%3Dliteratum%253Aachs%26aulast%3DMargolis%26aufirst%3DD.%2BM.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26atitle%3DCombined%2520approaches%2520for%2520HIV%2520cure%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2013%26volume%3D8%26spage%3D230%26epage%3D235%26doi%3D10.1097%2FCOH.0b013e32835ef089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Quiñones-Mateu, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span> </span><span class="NLM_article-title">HIV microbicides: Where are we now?</span> <span class="citation_source-journal">Curr. HIV Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">2</span><span class="refDoi"> DOI: 10.2174/157016212799304724</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.2174%2F157016212799304724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22264039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1-2&author=M.+E.+Qui%C3%B1ones-Mateuauthor=G.+Vanham&title=HIV+microbicides%3A+Where+are+we+now%3F&doi=10.2174%2F157016212799304724"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">HIV microbicides: where are we now?</span></div><div class="casAuthors">Quinones-Mateu, Miguel E.; Vanham, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Current HIV Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-2</span>CODEN:
                <span class="NLM_cas:coden">CHRUBF</span>;
        ISSN:<span class="NLM_cas:issn">1570-162X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Most human immunodeficiency virus (HIV) infections are acquired during sexual contact, across the genital or rectal mucosal epithelium.  At present, HIV preventive strategies such as behavioral and structural interventions (e.g., counseling and condom use) or pre-exposure prophylaxis (e.g., topical microbicides or the oral administration of antiretroviral drugs) seem to be the only effective and most indicated methods against the establishment of systemic HIV infection.  The recent success of the CAPRISA 004 phase II clin. trial, using a tenofovir-based gel, as well as the iPreX trial, using oral TRUVADA, not only provided the proof-of-concept for reverse transcription inhibitor (RTI)-based vaginal microbicides but also demonstrated the real possibility of using topical or oral pre-exposure prophylaxis (PrEP) to prevent sexual HIV transmission.  Unfortunately, more recent failures in the FEMPreP and VOICE trial, using similar regimes, suggest that there is still room for improvement.  Therefore, ongoing and future studies will be key in the development of novel potent and safe strategies to block HIV transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HQT5SVVZtLVg90H21EOLACvtfcHk0lg93HMBrr1kKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOgsL4%253D&md5=4c3ac1575cc28d7cd7df9aff57ace295</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.2174%2F157016212799304724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157016212799304724%26sid%3Dliteratum%253Aachs%26aulast%3DQui%25C3%25B1ones-Mateu%26aufirst%3DM.%2BE.%26aulast%3DVanham%26aufirst%3DG.%26atitle%3DHIV%2520microbicides%253A%2520Where%2520are%2520we%2520now%253F%26jtitle%3DCurr.%2520HIV%2520Res.%26date%3D2012%26volume%3D10%26spage%3D1%26epage%3D2%26doi%3D10.2174%2F157016212799304724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Hankins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybul, M. R.</span><span> </span><span class="NLM_article-title">The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.1097/COH.0b013e32835b809d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FCOH.0b013e32835b809d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23201856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFeqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=50-58&author=C.+A.+Hankinsauthor=M.+R.+Dybul&title=The+promise+of+pre-exposure+prophylaxis+with+antiretroviral+drugs+to+prevent+HIV+transmission%3A+a+review&doi=10.1097%2FCOH.0b013e32835b809d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review</span></div><div class="casAuthors">Hankins, Catherine A.; Dybul, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-58</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Public health experts are wrestling with how to translate recent scientific findings from pre-exposure prophylaxis (PrEP) effectiveness trials into real-world programs.  This review summarizes clin. trial findings on oral and topical PrEP, discusses how decision-makers can evaluate the place of PrEP within combination prevention and highlights anticipated developments that could be important in future HIV-prevention strategies.  Recent findings: PrEP taken daily as oral tablets to create systemic protection has been found to be effective in the Pre-Exposure Prophylaxis Initiative (iPrEx), Partners' PrEP and TDF2 trials, but not in Fem-PrEP or the Vaginal and Oral Interventions to Control the Epidemic (VOICE) tenofovir arm.  Tenofovir gel for topical protection was effective in CAPRISA 004 when used peri-coitally but not in VOICE with daily use.  These findings underscore the importance of adherence to achieve adequate drug levels and the potential additive role of PrEP within combination prevention.  Pivotal phase III trials are underway of the dapivirine ring, whereas phase I trials of injectable formulations show promise.  Summary: Antiretroviral-based HIV-prevention programs should be tailored to those most likely to be adherent, providing them with state-of-the-art counselling and support to achieve high adherence during the time period of use.  Long-acting products, if found well tolerated and effective, could be ideal for overcoming adherence challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2I3E3ouektLVg90H21EOLACvtfcHk0ljs4Jvpcjw0Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFeqsrs%253D&md5=58503eef52bff99c205a454935e5817a</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e32835b809d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e32835b809d%26sid%3Dliteratum%253Aachs%26aulast%3DHankins%26aufirst%3DC.%2BA.%26aulast%3DDybul%26aufirst%3DM.%2BR.%26atitle%3DThe%2520promise%2520of%2520pre-exposure%2520prophylaxis%2520with%2520antiretroviral%2520drugs%2520to%2520prevent%2520HIV%2520transmission%253A%2520a%2520review%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2013%26volume%3D8%26spage%3D50%26epage%3D58%26doi%3D10.1097%2FCOH.0b013e32835b809d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">McGowan, I.</span><span> </span><span class="NLM_article-title">An overview of antiretroviral pre-exposure prophylaxis of HIV infection</span> <span class="citation_source-journal">Am. J. Reprod. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1111/aji.12225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1111%2Faji.12225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=24635047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ygurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=624-630&author=I.+McGowan&title=An+overview+of+antiretroviral+pre-exposure+prophylaxis+of+HIV+infection&doi=10.1111%2Faji.12225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Antiretroviral Pre-Exposure Prophylaxis of HIV Infection</span></div><div class="casAuthors">McGowan, Ian</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Reproductive Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">624-630</span>CODEN:
                <span class="NLM_cas:coden">AJRIE8</span>;
        ISSN:<span class="NLM_cas:issn">1046-7408</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Despite improvements in access to antiretroviral therapy and the use of simplified dosing regimens, HIV infection is still an important global public health problem.  As a consequence, significant research efforts have been focused on the development of strategies to prevent the acquisition of HIV infection.  These efforts have begun to produce results.  The HPTN-052 study demonstrated the effectiveness of treating infected individuals as a means to prevent onward transmission of HIV infection.  In addn., Phase 2B/3 studies have shown that the use of oral and topical antiretroviral pre-exposure prophylaxis (PrEP) can significantly reduce the acquisition of HIV infection in serodiscordant couples, young women in sub-Saharan Africa, men who have sex with men, and i.v. drug users.  Despite these successes, challenges remain.  Adherence to daily PrEP is variable, and some large studies have failed to demonstrate the effectiveness of PrEP in reducing HIV acquisition.  Novel PrEP technologies, including sustained delivery intravaginal rings and long-acting injectable products, are being developed to try and circumvent adherence problems assocd. with daily PrEP regimens.  The purpose of this article is to briefly summarize recent progress in the development of antiretroviral PrEP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnaO6pOD5dm7Vg90H21EOLACvtfcHk0ljs4Jvpcjw0Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ygurg%253D&md5=9bddeb3e0da8c7a488dcaa112680cd79</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1111%2Faji.12225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Faji.12225%26sid%3Dliteratum%253Aachs%26aulast%3DMcGowan%26aufirst%3DI.%26atitle%3DAn%2520overview%2520of%2520antiretroviral%2520pre-exposure%2520prophylaxis%2520of%2520HIV%2520infection%26jtitle%3DAm.%2520J.%2520Reprod.%2520Immunol.%26date%3D2014%26volume%3D71%26spage%3D624%26epage%3D630%26doi%3D10.1111%2Faji.12225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">D’Cruz, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uckun, F. M.</span><span> </span><span class="NLM_article-title">Dawn of non-nucleoside inhibitor-based anti-HIV microbicides</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1093/jac/dki464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1093%2Fjac%2Fdki464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=16431862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2006&pages=411-423&author=O.+J.+D%E2%80%99Cruzauthor=F.+M.+Uckun&title=Dawn+of+non-nucleoside+inhibitor-based+anti-HIV+microbicides&doi=10.1093%2Fjac%2Fdki464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Dawn of non-nucleoside inhibitor-based anti-HIV microbicides</span></div><div class="casAuthors">D'Cruz, Osmond J.; Uckun, Fatih M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-423</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The emergence of HIV/AIDS as a disease spread through sexual intercourse has prompted the search for safe and effective vaginal and rectal microbicides for curbing mucosal viral transmission via semen.  Since endogenous reverse transcription is implicated in augmenting the sexual transmission of HIV-1 infection, potential microbicides should have the inherent ability to optimally inhibit both wild-type and drug-escape mutants.  The non-nucleoside reverse transcriptase inhibitors (NNRTIs), which bind to an allosteric site on RT, are an important arsenal of drugs against HIV-1.  The clin. success of NNRTI-based HIV/AIDS therapies has led to extensive structural and mol. modeling studies of enzyme complexes and chem. synthesis of second- and third-generation NNRTIs.  Rationally designed NNRTIs deduced from changes in binding pocket size, shape and residue character that result from clin. obsd. NNRTI resistance-assocd. mutations exhibit high binding affinity for HIV-1 RT and robust anti-HIV activity against the wild-type and drug-escape mutants without cytotoxicity.  Notably, membrane permeable tight binding NNRTIs have the ability to inactivate cell-free as well as cell-assocd. HIV-1 in semen without metabolic activation.  Consequently, NNRTIs currently under development as exptl. microbicides include thiourea-PETT (where PETT stands for phenethylthiazolylthiourea) derivs. (PHI-236, PHI-346 and PHI-443), urea-PETT derivs. (MIV-150), oxypyrimidines (S-DABOs), thiocarboxanilides (UC-781) and diarylpyrimidines (TMC-120).  Mucoadhesive formulations of these NNRTIs have been studied for safety and efficacy in animal models and some have entered Phase I safety testing in humans.  This review focuses on the structural, biol. and preclin. studies relevant to the clin. development of these NNRTIs as mol. virucides intended to prevent the sexual transmission of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7HUDMWcKWGbVg90H21EOLACvtfcHk0ljs4Jvpcjw0Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOgt7s%253D&md5=1eb06f452c0d48fc455324ff856a9668</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdki464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdki464%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Cruz%26aufirst%3DO.%2BJ.%26aulast%3DUckun%26aufirst%3DF.%2BM.%26atitle%3DDawn%2520of%2520non-nucleoside%2520inhibitor-based%2520anti-HIV%2520microbicides%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2006%26volume%3D57%26spage%3D411%26epage%3D423%26doi%3D10.1093%2Fjac%2Fdki464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Ariën, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michiels, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vereecken, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdellati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuylaerts, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crucitti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyndrickx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span> </span><span class="NLM_article-title">Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2038</span><span class="NLM_x">–</span> <span class="NLM_lpage">2047</span><span class="refDoi"> DOI: 10.1093/jac/dkt166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1093%2Fjac%2Fdkt166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23645585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht12hurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=2038-2047&author=K.+K.+Ari%C3%ABnauthor=M.+Venkatrajauthor=J.+Michielsauthor=J.+Joossensauthor=K.+Vereeckenauthor=P.+Van+der+Vekenauthor=S.+Abdellatiauthor=V.+Cuylaertsauthor=T.+Crucittiauthor=L.+Heyndrickxauthor=J.+Heeresauthor=K.+Augustynsauthor=P.+J.+Lewiauthor=G.+Vanham&title=Diaryltriazine+non-nucleoside+reverse+transcriptase+inhibitors+are+potent+candidates+for+pre-exposure+prophylaxis+in+the+prevention+of+sexual+HIV+transmission&doi=10.1093%2Fjac%2Fdkt166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission</span></div><div class="casAuthors">Arien, Kevin K.; Venkatraj, Muthusamy; Michiels, Johan; Joossens, Jurgen; Vereecken, Katleen; Van der Veken, Pieter; Abdellati, Said; Cuylaerts, Vicky; Crucitti, Tania; Heyndrickx, Leo; Heeres, Jan; Augustyns, Koen; Lewi, Paul J.; Vanham, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2038-2047</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Pre-exposure prophylaxis and topical microbicides are important strategies in the prevention of sexual HIV transmission, esp. since partial protection has been shown in proof-of-concept studies.  In search of new candidate drugs with an improved toxicity profile and with activity against common non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV, we have synthesized and investigated a library of 60 new diaryltriazine analogs.  From this library, 15 compds. were evaluated in depth using a broad armamentarium of in vitro assays that are part of a preclin. testing algorithm for microbicide development.  Antiviral activity was assessed in a cell line, and in primary human cells, against both subtype B and subtype C HIV-1 and against viruses resistant to therapeutic NNRTIs and the candidate NNRTI microbicide dapivirine.  Toxicity towards primary blood-derived cells, cell lines originating from the female reproductive tract and female genital microflora was also studied.  We identified several compds. with highly potent antiviral activity and toxicity profiles that are superior to that of dapivirine.  In particular, compd. UAMC01398 is an interesting new candidate that warrants further investigation because of its superior toxicity profile and potent activity against dapivirine-resistant viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhk_H7iaNz7Vg90H21EOLACvtfcHk0lgk2Y4yG6TG8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht12hurzM&md5=785b846f457147abc903ef458a0d48b3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt166%26sid%3Dliteratum%253Aachs%26aulast%3DAri%25C3%25ABn%26aufirst%3DK.%2BK.%26aulast%3DVenkatraj%26aufirst%3DM.%26aulast%3DMichiels%26aufirst%3DJ.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DVereecken%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DAbdellati%26aufirst%3DS.%26aulast%3DCuylaerts%26aufirst%3DV.%26aulast%3DCrucitti%26aufirst%3DT.%26aulast%3DHeyndrickx%26aufirst%3DL.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DVanham%26aufirst%3DG.%26atitle%3DDiaryltriazine%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520are%2520potent%2520candidates%2520for%2520pre-exposure%2520prophylaxis%2520in%2520the%2520prevention%2520of%2520sexual%2520HIV%2520transmission%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D2038%26epage%3D2047%26doi%3D10.1093%2Fjac%2Fdkt166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Grammen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariën, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haenen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwers, J.</span><span> </span><span class="NLM_article-title">Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.11.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2014&pages=113-121&author=C.+Grammenauthor=K.+K.+Ari%C3%ABnauthor=M.+Venkatrajauthor=J.+Joossensauthor=P.+Van+der+Vekenauthor=J.+Heeresauthor=P.+J.+Lewiauthor=S.+Haenenauthor=K.+Augustynsauthor=G.+Vanhamauthor=P.+Augustijnsauthor=J.+Brouwers&title=Development+and+in+vitro+evaluation+of+a+vaginal+microbicide+gel+formulation+for+UAMC01398%2C+a+novel+diaryltriazine+NNRTI+against+HIV-1&doi=10.1016%2Fj.antiviral.2013.11.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DGrammen%26aufirst%3DC.%26aulast%3DAri%25C3%25ABn%26aufirst%3DK.%2BK.%26aulast%3DVenkatraj%26aufirst%3DM.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DHaenen%26aufirst%3DS.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVanham%26aufirst%3DG.%26aulast%3DAugustijns%26aufirst%3DP.%26aulast%3DBrouwers%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520in%2520vitro%2520evaluation%2520of%2520a%2520vaginal%2520microbicide%2520gel%2520formulation%2520for%2520UAMC01398%252C%2520a%2520novel%2520diaryltriazine%2520NNRTI%2520against%2520HIV-1%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D101%26spage%3D113%26epage%3D121%26doi%3D10.1016%2Fj.antiviral.2013.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Fetherston, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veazey, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klasse, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, R. K.</span><span> </span><span class="NLM_article-title">Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span><span class="refDoi"> DOI: 10.1093/jac/dks415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1093%2Fjac%2Fdks415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=23109186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVektQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=394-403&author=S.+M.+Fetherstonauthor=L.+Geerauthor=R.+S.+Veazeyauthor=L.+Goldmanauthor=D.+J.+Murphyauthor=T.+J.+Ketasauthor=P.+J.+Klasseauthor=S.+Bloisauthor=P.+La+Collaauthor=J.+P.+Mooreauthor=R.+K.+Malcolm&title=Partial+protection+against+multiple+RT-SHIV162P3+vaginal+challenge+of+rhesus+macaques+by+a+silicone+elastomer+vaginal+ring+releasing+the+NNRTI+MC1220&doi=10.1093%2Fjac%2Fdks415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220</span></div><div class="casAuthors">Fetherston, Susan M.; Geer, Leslie; Veazey, Ronald S.; Goldman, Laurie; Murphy, Diarmaid J.; Ketas, Thomas J.; Klasse, Per Johan; Blois, Sylvain; La Colla, Paolo; Moore, John P.; Malcolm, R. Karl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">394-403</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives The non-nucleoside reverse transcriptase inhibitor MC1220 has potent in vitro activity against HIV type 1 (HIV-1).  A liposome gel formulation of MC1220 has previously been reported to partially protect rhesus macaques against vaginal challenge with a simian HIV (SHIV).  Here, we describe the pre-clin. development of an MC1220-releasing silicone elastomer vaginal ring (SEVR), including pharmacokinetic (PK) and efficacy studies in macaques.  Methods In vitro release studies were conducted on SEVRs loaded with 400 mg of MC1220, using simulated vaginal fluid (SVF, n = 4) and 1 : 1 isopropanol/water (IPA/H2O, n = 4) as release media.  For PK evaluation, SEVRs were inserted into adult female macaques (n = 6) for 30 days.  Following a 1 wk washout period, fresh rings were placed in the same animals, which were then challenged vaginally with RT-SHIV162P3 once weekly for 4 wk.  Results SEVRs released 1.66 and 101 mg of MC1220 into SVF and IPA/H2O, resp., over 30 days, the differential reflecting the low aq. soly. of the drug.  In macaque PK studies, MC1220 was consistently detected in vaginal fluid (peak 845 ng/mL) and plasma (peak 0.91 ng/mL).  Kaplan-Meier anal. over 9 wk showed significantly lower infection rates for animals given MC1220-contg. SEVRs than placebo rings (hazard ratio 0.20, P = 0.0037).  Conclusions An MC1220-releasing SEVR partially protected macaques from vaginal challenge.  Such ring devices are a practical method for providing sustained, coitally independent protection against vaginal exposure to HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TEP1JXL5kbVg90H21EOLACvtfcHk0lgk2Y4yG6TG8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVektQ%253D%253D&md5=d887a5e04de9ebc390eda74eacdbae68</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks415%26sid%3Dliteratum%253Aachs%26aulast%3DFetherston%26aufirst%3DS.%2BM.%26aulast%3DGeer%26aufirst%3DL.%26aulast%3DVeazey%26aufirst%3DR.%2BS.%26aulast%3DGoldman%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DD.%2BJ.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DBlois%26aufirst%3DS.%26aulast%3DLa%2BColla%26aufirst%3DP.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DMalcolm%26aufirst%3DR.%2BK.%26atitle%3DPartial%2520protection%2520against%2520multiple%2520RT-SHIV162P3%2520vaginal%2520challenge%2520of%2520rhesus%2520macaques%2520by%2520a%2520silicone%2520elastomer%2520vaginal%2520ring%2520releasing%2520the%2520NNRTI%2520MC1220%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D394%26epage%3D403%26doi%3D10.1093%2Fjac%2Fdks415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group">Loksha, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loddo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliberti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, P.</span><span> </span><span class="NLM_article-title">Synthesis of novel fluoro analogues of MKC442 as microbicides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5169</span><span class="NLM_x">–</span> <span class="NLM_lpage">5178</span><span class="refDoi"> DOI: 10.1021/jm500139a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500139a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5169-5178&author=Y.+M.+Lokshaauthor=E.+B.+Pedersenauthor=R.+Loddoauthor=G.+Sannaauthor=G.+Colluauthor=G.+Gilibertiauthor=P.+La+Colla&title=Synthesis+of+novel+fluoro+analogues+of+MKC442+as+microbicides&doi=10.1021%2Fjm500139a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjm500139a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500139a%26sid%3Dliteratum%253Aachs%26aulast%3DLoksha%26aufirst%3DY.%2BM.%26aulast%3DPedersen%26aufirst%3DE.%2BB.%26aulast%3DLoddo%26aufirst%3DR.%26aulast%3DSanna%26aufirst%3DG.%26aulast%3DCollu%26aufirst%3DG.%26aulast%3DGiliberti%26aufirst%3DG.%26aulast%3DLa%2BColla%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520novel%2520fluoro%2520analogues%2520of%2520MKC442%2520as%2520microbicides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5169%26epage%3D5178%26doi%3D10.1021%2Fjm500139a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group">Haaland, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans-Strickfaden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pau, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholl, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikummao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chonwattana, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, C. E.</span><span> </span><span class="NLM_article-title">UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal application</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3592</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span><span class="refDoi"> DOI: 10.1128/AAC.00452-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.00452-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3592-3596&author=R.+E.+Haalandauthor=T.+Evans-Strickfadenauthor=A.+Holderauthor=C.+P.+Pauauthor=J.+M.+McNichollauthor=S.+Chaikummaoauthor=W.+Chonwattanaauthor=C.+E.+Hart&title=UC781+microbicide+gel+retains+anti-HIV+activity+in+cervicovaginal+lavage+fluids+collected+following+twice-daily+vaginal+application&doi=10.1128%2FAAC.00452-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1128%2FAAC.00452-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00452-12%26sid%3Dliteratum%253Aachs%26aulast%3DHaaland%26aufirst%3DR.%2BE.%26aulast%3DEvans-Strickfaden%26aufirst%3DT.%26aulast%3DHolder%26aufirst%3DA.%26aulast%3DPau%26aufirst%3DC.%2BP.%26aulast%3DMcNicholl%26aufirst%3DJ.%2BM.%26aulast%3DChaikummao%26aufirst%3DS.%26aulast%3DChonwattana%26aufirst%3DW.%26aulast%3DHart%26aufirst%3DC.%2BE.%26atitle%3DUC781%2520microbicide%2520gel%2520retains%2520anti-HIV%2520activity%2520in%2520cervicovaginal%2520lavage%2520fluids%2520collected%2520following%2520twice-daily%2520vaginal%2520application%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3592%26epage%3D3596%26doi%3D10.1128%2FAAC.00452-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group">D’Cruz, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qazi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiv, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uckun, F. M.</span><span> </span><span class="NLM_article-title">A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea])</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span><span class="refDoi"> DOI: 10.1517/13543784.2012.655422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F13543784.2012.655422" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=265-279&author=O.+J.+D%E2%80%99Cruzauthor=S.+Qaziauthor=S.+Yivauthor=F.+M.+Uckun&title=A+novel+vaginal+microbicide+containing+the+rationally+designed+anti-HIV+compound+HI-443+%28N%E2%80%B2-%5B2-%282-thiophene%29ethyl%5D-N%E2%80%B2-%5B2-%285-bromopyridyl%29%5D+thiourea%5D%29&doi=10.1517%2F13543784.2012.655422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1517%2F13543784.2012.655422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2012.655422%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Cruz%26aufirst%3DO.%2BJ.%26aulast%3DQazi%26aufirst%3DS.%26aulast%3DYiv%26aufirst%3DS.%26aulast%3DUckun%26aufirst%3DF.%2BM.%26atitle%3DA%2520novel%2520vaginal%2520microbicide%2520containing%2520the%2520rationally%2520designed%2520anti-HIV%2520compound%2520HI-443%2520%2528N%25E2%2580%25B2-%255B2-%25282-thiophene%2529ethyl%255D-N%25E2%2580%25B2-%255B2-%25285-bromopyridyl%2529%255D%2520thiourea%255D%2529%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D265%26epage%3D279%26doi%3D10.1517%2F13543784.2012.655422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group">Barnable, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calenda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnaire, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levendosky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooney, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Romero, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zydowsky, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teleshova, N.</span><span> </span><span class="NLM_article-title">MIV-150/Zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3829</span><span class="NLM_x">–</span> <span class="NLM_lpage">3837</span><span class="refDoi"> DOI: 10.1128/AAC.00073-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.00073-15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=3829-3837&author=P.+Barnableauthor=G.+Calendaauthor=T.+Bonnaireauthor=R.+Menonauthor=K.+Levendoskyauthor=A.+Gettieauthor=J.+Blanchardauthor=M.+L.+Cooneyauthor=J.+A.+Fern%C3%A1ndez-Romeroauthor=T.+M.+Zydowskyauthor=N.+Teleshova&title=MIV-150%2FZinc+acetate+gel+inhibits+cell-associated+simian-human+immunodeficiency+virus+reverse+transcriptase+infection+in+a+macaque+vaginal+explant+model&doi=10.1128%2FAAC.00073-15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1128%2FAAC.00073-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00073-15%26sid%3Dliteratum%253Aachs%26aulast%3DBarnable%26aufirst%3DP.%26aulast%3DCalenda%26aufirst%3DG.%26aulast%3DBonnaire%26aufirst%3DT.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DLevendosky%26aufirst%3DK.%26aulast%3DGettie%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DCooney%26aufirst%3DM.%2BL.%26aulast%3DFern%25C3%25A1ndez-Romero%26aufirst%3DJ.%2BA.%26aulast%3DZydowsky%26aufirst%3DT.%2BM.%26aulast%3DTeleshova%26aufirst%3DN.%26atitle%3DMIV-150%252FZinc%2520acetate%2520gel%2520inhibits%2520cell-associated%2520simian-human%2520immunodeficiency%2520virus%2520reverse%2520transcriptase%2520infection%2520in%2520a%2520macaque%2520vaginal%2520explant%2520model%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D3829%26epage%3D3837%26doi%3D10.1128%2FAAC.00073-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group">Bala, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jangir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandalapu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhonker, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushwaha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandasana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maikhuri, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V. L.</span><span> </span><span class="NLM_article-title">Dithiocarbamate-thiourea hybrids useful as vaginal microbicides also show reverse transcriptase inhibition: design, synthesis, docking and pharmacokinetic studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.bmcl.2014.12.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=881-886&author=V.+Balaauthor=S.+Jangirauthor=D.+Mandalapuauthor=S.+Guptaauthor=Y.+S.+Chhonkerauthor=N.+Lalauthor=B.+Kushwahaauthor=H.+Chandasanaauthor=S.+Krishnaauthor=K.+Rawatauthor=J.+P.+Maikhuriauthor=R.+S.+Bhattaauthor=M.+I.+Siddiqiauthor=R.+Tripathiauthor=G.+Guptaauthor=V.+L.+Sharma&title=Dithiocarbamate-thiourea+hybrids+useful+as+vaginal+microbicides+also+show+reverse+transcriptase+inhibition%3A+design%2C+synthesis%2C+docking+and+pharmacokinetic+studies&doi=10.1016%2Fj.bmcl.2014.12.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.062%26sid%3Dliteratum%253Aachs%26aulast%3DBala%26aufirst%3DV.%26aulast%3DJangir%26aufirst%3DS.%26aulast%3DMandalapu%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DChhonker%26aufirst%3DY.%2BS.%26aulast%3DLal%26aufirst%3DN.%26aulast%3DKushwaha%26aufirst%3DB.%26aulast%3DChandasana%26aufirst%3DH.%26aulast%3DKrishna%26aufirst%3DS.%26aulast%3DRawat%26aufirst%3DK.%26aulast%3DMaikhuri%26aufirst%3DJ.%2BP.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DSiddiqi%26aufirst%3DM.%2BI.%26aulast%3DTripathi%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DG.%26aulast%3DSharma%26aufirst%3DV.%2BL.%26atitle%3DDithiocarbamate-thiourea%2520hybrids%2520useful%2520as%2520vaginal%2520microbicides%2520also%2520show%2520reverse%2520transcriptase%2520inhibition%253A%2520design%252C%2520synthesis%252C%2520docking%2520and%2520pharmacokinetic%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D881%26epage%3D886%26doi%3D10.1016%2Fj.bmcl.2014.12.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group">Friend, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiser, P. F.</span><span> </span><span class="NLM_article-title">Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2013.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1016%2Fj.antiviral.2013.06.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2013&pages=391-400&author=D.+R.+Friendauthor=P.+F.+Kiser&title=Assessment+of+topical+microbicides+to+prevent+HIV-1+transmission%3A+concepts%2C+testing%2C+lessons+learned&doi=10.1016%2Fj.antiviral.2013.06.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2013.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2013.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DFriend%26aufirst%3DD.%2BR.%26aulast%3DKiser%26aufirst%3DP.%2BF.%26atitle%3DAssessment%2520of%2520topical%2520microbicides%2520to%2520prevent%2520HIV-1%2520transmission%253A%2520concepts%252C%2520testing%252C%2520lessons%2520learned%26jtitle%3DAntiviral%2520Res.%26date%3D2013%26volume%3D99%26spage%3D391%26epage%3D400%26doi%3D10.1016%2Fj.antiviral.2013.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group">Celum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeten, J. M.</span><span> </span><span class="NLM_article-title">Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1097/QCO.0b013e32834ef5ef</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1097%2FQCO.0b013e32834ef5ef" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=22156901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Gls7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=51-57&author=C.+Celumauthor=J.+M.+Baeten&title=Tenofovir-based+pre-exposure+prophylaxis+for+HIV+prevention%3A+evolving+evidence&doi=10.1097%2FQCO.0b013e32834ef5ef"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence</span></div><div class="casAuthors">Celum, Connie; Baeten, Jared M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-57</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: Topical tenofovir gel and oral tenofovir and emtricitabine-tenofovir [FTC/tenofovir disoproxyl fumarate (TDF)] have been demonstrated to have efficacy in preventing HIV-1 in some populations.  Preexposure prophylaxis (PrEP) trials and future directions are summarized.  Recent findings: Pericoital use of 1% tenofovir gel in the CAPRISA 004 study reduced HIV-1 acquisition by 39% and herpes simplex virus-2 acquisition by 51%.  Daily oral FTC/TDF demonstrated 44% redn. in HIV-1 acquisition among MSM in the iPrEx study (Pre-Exposure Prophylaxis Initiative).  Both studies showed higher efficacy among those with higher adherence.  Efficacy of daily oral TDF and FTC/TDF was 66 and 73%, resp., among HIV-1-uninfected partners in an HIV-1 serodiscordant partnership in the Partners PrEP Study.  Efficacy of daily oral FTC/TDF was 66% in young heterosexuals in Botswana in the TDF2 trial.  The FEM-PrEP and VOICE (Vaginal and Oral Interventions to Control the Epidemic) studies in African women found no efficacy with oral FTC/TDF and TDF, resp.  Safety and tolerability were excellent and limited resistance was obsd. in seroconverters.  Summary: Topical tenofovir gel showed efficacy in African women and daily oral TDF and FTC/TDF were efficacious in MSM, and African HIV-1 serodiscordant couples and young heterosexuals.  The reasons for lack of efficacy of oral FTC/TDF and TDF in two studies in African women are being investigated.  Longer-acting formulations, invtravaginal rings, and new candidate antiretrovirals are being evaluated for pre-exposure prophylaxis (PrEP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHrOXxRLciw7Vg90H21EOLACvtfcHk0lh-J5PyWZR3cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Gls7bF&md5=374054675c3740d66fde6b46d5706012</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e32834ef5ef&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e32834ef5ef%26sid%3Dliteratum%253Aachs%26aulast%3DCelum%26aufirst%3DC.%26aulast%3DBaeten%26aufirst%3DJ.%2BM.%26atitle%3DTenofovir-based%2520pre-exposure%2520prophylaxis%2520for%2520HIV%2520prevention%253A%2520evolving%2520evidence%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D25%26spage%3D51%26epage%3D57%26doi%3D10.1097%2FQCO.0b013e32834ef5ef" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group">Terrazas-Aranda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Herrewege, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanham, G.</span><span> </span><span class="NLM_article-title">Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2544</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span><span class="refDoi"> DOI: 10.1128/AAC.01627-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1128%2FAAC.01627-07" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2544-2554&author=K.+Terrazas-Arandaauthor=Y.+Van+Herrewegeauthor=D.+Hazudaauthor=P.+Lewiauthor=R.+Costiauthor=R.+Di+Santoauthor=A.+Caraauthor=G.+Vanham&title=Human+immunodeficiency+virus+type+1+%28HIV-1%29+integration%3A+a+potential+target+for+microbicides+to+prevent+cell-free+or+cell-associated+HIV-1+infection&doi=10.1128%2FAAC.01627-07"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1128%2FAAC.01627-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01627-07%26sid%3Dliteratum%253Aachs%26aulast%3DTerrazas-Aranda%26aufirst%3DK.%26aulast%3DVan%2BHerrewege%26aufirst%3DY.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DLewi%26aufirst%3DP.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCara%26aufirst%3DA.%26aulast%3DVanham%26aufirst%3DG.%26atitle%3DHuman%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%2520integration%253A%2520a%2520potential%2520target%2520for%2520microbicides%2520to%2520prevent%2520cell-free%2520or%2520cell-associated%2520HIV-1%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2544%26epage%3D2554%26doi%3D10.1128%2FAAC.01627-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankowski, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liwang, P. J.</span><span> </span><span class="NLM_article-title">Highly potent chimeric inhibitors targeting two steps of HIV cell entry</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">28370</span><span class="NLM_x">–</span> <span class="NLM_lpage">28381</span><span class="refDoi"> DOI: 10.1074/jbc.M111.234799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1074%2Fjbc.M111.234799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=21659523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=28370-28381&author=B.+Zhaoauthor=M.+K.+Mankowskiauthor=B.+A.+Snyderauthor=R.+G.+Ptakauthor=P.+J.+Liwang&title=Highly+potent+chimeric+inhibitors+targeting+two+steps+of+HIV+cell+entry&doi=10.1074%2Fjbc.M111.234799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry</span></div><div class="casAuthors">Zhao, Bo; Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.; LiWang, Patricia J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">28370-28381, S28370/1-S28370/5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Blocking HIV-1 cell entry has long been a major goal of anti-HIV drug development.  Here, we report a successful design of two highly potent chimeric HIV entry inhibitors composed of one CCR5-targeting RANTES (regulated on activation normal T cell expressed and secreted) variant (5P12-RANTES or 5P14-RANTES (Gaertner, H., Cerini, F., Escola, J. M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D., and Hartley, O. (2008) PROC: Natl. Acad. Sci. U.S.A. 105, 17706-17711)) linked to a gp41 fusion inhibitor, C37.  Chimeric inhibitors 5P12-linker-C37 and 5P14-linker-C37 showed extremely high antiviral potency in single cycle and replication-competent viral assays against R5-tropic viruses, with IC50 values as low as 0.004 nM.  This inhibition was somewhat strain-dependent and was up to 100-fold better than the RANTES variant alone or in combination with unlinked C37.  The chimeric inhibitors also fully retained the antiviral activity of C37 against X4-tropic viruses, and this inhibition can be further enhanced significantly if the target cell co-expresses CCR5 receptor.  On human peripheral blood mononuclear cells, the inhibitors showed very strong inhibition against R5-tropic Ba-L strain and X4-tropic IIIB strain, with IC50 values as low as 0.015 and 0.44 nM, which are 45- and 16-fold better than the parent inhibitors, resp.  A clear delivery mechanism requiring a covalent linkage between the two segments of the chimera was obsd. and characterized.  Furthermore, the two chimeric inhibitors are fully recombinant and are easily produced at low cost.  These attributes make them excellent candidates for anti-HIV microbicides.  The results of this study also suggest a potent approach for optimizing existing HIV entry inhibitors or designing new inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mgPhkmOu-bVg90H21EOLACvtfcHk0lh-J5PyWZR3cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D&md5=b8599136ca194462a3332b9b8b91495d</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.234799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.234799%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DLiwang%26aufirst%3DP.%2BJ.%26atitle%3DHighly%2520potent%2520chimeric%2520inhibitors%2520targeting%2520two%2520steps%2520of%2520HIV%2520cell%2520entry%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D28370%26epage%3D28381%26doi%3D10.1074%2Fjbc.M111.234799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group">Janssen, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewi, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daeyaert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koymans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludovici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Béthune, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medaer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Knaep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohets, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffels, P.</span><span> </span><span class="NLM_article-title">In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">–</span> <span class="NLM_lpage">1909</span><span class="refDoi"> DOI: 10.1021/jm040840e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040840e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1901-1909&author=P.+A.+Janssenauthor=P.+J.+Lewiauthor=E.+Arnoldauthor=F.+Daeyaertauthor=M.+de+Jongeauthor=J.+Heeresauthor=L.+Koymansauthor=M.+Vinkersauthor=J.+Guillemontauthor=E.+Pasquierauthor=M.+Kuklaauthor=D.+Ludoviciauthor=K.+Andriesauthor=M.+P.+de+B%C3%A9thuneauthor=R.+Pauwelsauthor=K.+Dasauthor=A.+D.+Clarkauthor=Y.+V.+Frenkelauthor=S.+H.+Hughesauthor=B.+Medaerauthor=F.+De+Knaepauthor=H.+Bohetsauthor=F.+De+Clerckauthor=A.+Lampoauthor=P.+Williamsauthor=P.+Stoffels&title=In+search+of+a+novel+anti-HIV+drug%3A+multidisciplinary+coordination+in+the+discovery+of+4-%5B%5B4-%5B%5B4-%5B%281E%29-2-cyanoethenyl%5D-2%2C6-dimethylphenyl%5Damino%5D-2-pyrimidinyl%5Damino%5Dbenzonitrile+%28R278474%2C+rilpivirine%29&doi=10.1021%2Fjm040840e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)</span></div><div class="casAuthors">Janssen, Paul A. J.; Lewi, Paul J.; Arnold, Eddy; Daeyaert, Frits; de Jonge, Marc; Heeres, Jan; Koymans, Luc; Vinkers, Maarten; Guillemont, Jerome; Pasquier, Elisabeth; Kukla, Mike; Ludovici, Don; Andries, Koen; de Bethune, Marie-Pierre; Pauwels, Rudi; Das, Kalyan; Clark, Art D., Jr.; Frenkel, Yulia Volovik; Hughes, Stephen H.; Medaer, Bart; De Knaep, Fons; Bohets, Hilde; De Clerck, Fred; Lampo, Ann; Williams, Peter; Stoffels, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1901-1909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Ideally, an anti-HIV drug should (1) be highly active against wild-type and mutant HIV without allowing breakthrough; (2) have high oral bioavailability and long elimination half-life, allowing once-daily oral treatment at low doses; (3) have minimal adverse effects; and (4) be easy to synthesize and formulate.  R278474, a new diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitor (NNRTI), appears to meet these criteria and to be suitable for high compliance oral treatment of HIV-1 infection.  The discovery of R278474 was the result of a coordinated multidisciplinary effort involving medicinal chemists, virologists, crystallographers, mol. modelers, toxicologists, anal. chemists, pharmacists, and many others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8upgC3x1GuLVg90H21EOLACvtfcHk0lhE_y7wA094sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOisb8%253D&md5=d4b650dcaa248d5cdb1dd500135c8f7e</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1021%2Fjm040840e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040840e%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DP.%2BA.%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DDaeyaert%26aufirst%3DF.%26aulast%3Dde%2BJonge%26aufirst%3DM.%26aulast%3DHeeres%26aufirst%3DJ.%26aulast%3DKoymans%26aufirst%3DL.%26aulast%3DVinkers%26aufirst%3DM.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DPasquier%26aufirst%3DE.%26aulast%3DKukla%26aufirst%3DM.%26aulast%3DLudovici%26aufirst%3DD.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3Dde%2BB%25C3%25A9thune%26aufirst%3DM.%2BP.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DFrenkel%26aufirst%3DY.%2BV.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DMedaer%26aufirst%3DB.%26aulast%3DDe%2BKnaep%26aufirst%3DF.%26aulast%3DBohets%26aufirst%3DH.%26aulast%3DDe%2BClerck%26aufirst%3DF.%26aulast%3DLampo%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DP.%26aulast%3DStoffels%26aufirst%3DP.%26atitle%3DIn%2520search%2520of%2520a%2520novel%2520anti-HIV%2520drug%253A%2520multidisciplinary%2520coordination%2520in%2520the%2520discovery%2520of%25204-%255B%255B4-%255B%255B4-%255B%25281E%2529-2-cyanoethenyl%255D-2%252C6-dimethylphenyl%255Damino%255D-2-pyrimidinyl%255Damino%255Dbenzonitrile%2520%2528R278474%252C%2520rilpivirine%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1901%26epage%3D1909%26doi%3D10.1021%2Fjm040840e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group">Fang, Y.</span><span> </span><span class="NLM_article-title">Ligand-receptor interaction platforms and their applications for drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1517/17460441.2012.715631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1517%2F17460441.2012.715631" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=969-988&author=Y.+Fang&title=Ligand-receptor+interaction+platforms+and+their+applications+for+drug+discovery&doi=10.1517%2F17460441.2012.715631"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.715631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.715631%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26atitle%3DLigand-receptor%2520interaction%2520platforms%2520and%2520their%2520applications%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D969%26epage%3D988%26doi%3D10.1517%2F17460441.2012.715631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paavilainen, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughhead, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karr, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritsen, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span> </span><span class="NLM_article-title">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1038/nchembio.1817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1038%2Fnchembio.1817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=26006010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=525-531&author=J.+M.+Bradshawauthor=J.+M.+McFarlandauthor=V.+O.+Paavilainenauthor=A.+Bisconteauthor=D.+Tamauthor=V.+T.+Phanauthor=S.+Romanovauthor=D.+Finkleauthor=J.+Shuauthor=V.+Patelauthor=T.+Tonauthor=X.+Liauthor=D.+G.+Loughheadauthor=P.+A.+Nunnauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=J.+O.+Funkauthor=T.+D.+Owensauthor=E.+Vernerauthor=K.+A.+Brameldauthor=R.+J.+Hillauthor=D.+M.+Goldsteinauthor=J.+Taunton&title=Prolonged+and+tunable+residence+time+using+reversible+covalent+kinase+inhibitors&doi=10.1038%2Fnchembio.1817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged and tunable residence time using reversible covalent kinase inhibitors</span></div><div class="casAuthors">Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.; Bisconte, Angelina; Tam, Danny; Phan, Vernon T.; Romanov, Sergei; Finkle, David; Shu, Jin; Patel, Vaishali; Ton, Tony; Li, Xiaoyan; Loughhead, David G.; Nunn, Philip A.; Karr, Dane E.; Gerritsen, Mary E.; Funk, Jens Oliver; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Hill, Ronald J.; Goldstein, David M.; Taunton, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs with prolonged on-target residence times often show superior efficacy, yet general strategies for optimizing drug-target residence time are lacking.  Here the authors made progress toward this elusive goal by targeting a noncatalytic cysteine in Bruton's tyrosine kinase (BTK) with reversible covalent inhibitors.  Using an inverted orientation of the cysteine-reactive cyanoacrylamide electrophile, the authors identified potent and selective BTK inhibitors that demonstrated biochem. residence times spanning from minutes to 7 d.  An inverted cyanoacrylamide with prolonged residence time in vivo remained bound to BTK for more than 18 h after clearance from the circulation.  The inverted cyanoacrylamide strategy was further used to discover fibroblast growth factor receptor (FGFR) kinase inhibitors with residence times of several days, demonstrating the generalizability of the approach.  Targeting of noncatalytic cysteines with inverted cyanoacrylamides may serve as a broadly applicable platform that facilitates 'residence time by design', the ability to modulate and improve the duration of target engagement in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCpNprhn6kLVg90H21EOLACvtfcHk0lhE_y7wA094sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7%252FE&md5=85a73d9ecd62695d03166f7009c68dd8</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1817%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DPaavilainen%26aufirst%3DV.%2BO.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DRomanov%26aufirst%3DS.%26aulast%3DFinkle%26aufirst%3DD.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DNunn%26aufirst%3DP.%2BA.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DTaunton%26aufirst%3DJ.%26atitle%3DProlonged%2520and%2520tunable%2520residence%2520time%2520using%2520reversible%2520covalent%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D525%26epage%3D531%26doi%3D10.1038%2Fnchembio.1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clas, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nofsinger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lera Ruiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceglia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templeton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1002/cmdc.201402393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=10.1002%2Fcmdc.201402393" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=245-252&author=A.+M.+Waljiauthor=R.+I.+Sanchezauthor=S.+D.+Clasauthor=R.+Nofsingerauthor=M.+de+Lera+Ruizauthor=J.+Liauthor=A.+Bennetauthor=C.+Johnauthor=D.+J.+Bennettauthor=J.+M.+Sandersauthor=C.+N.+Di+Marcoauthor=S.+H.+Kimauthor=J.+Balsellsauthor=S.+S.+Cegliaauthor=Q.+Dangauthor=K.+Manserauthor=B.+Nissleyauthor=J.+S.+Waiauthor=M.+Hafeyauthor=J.+Wangauthor=G.+Chessenauthor=A.+Templetonauthor=J.+Higginsauthor=R.+Smithauthor=Y.+Wuauthor=J.+Groblerauthor=P.+J.+Coleman&title=Discovery+of+MK-8970%3A+an+acetal+carbonate+prodrug+of+raltegravir+with+enhanced+colonic+absorption&doi=10.1002%2Fcmdc.201402393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402393%26sid%3Dliteratum%253Aachs%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DSanchez%26aufirst%3DR.%2BI.%26aulast%3DClas%26aufirst%3DS.%2BD.%26aulast%3DNofsinger%26aufirst%3DR.%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBennet%26aufirst%3DA.%26aulast%3DJohn%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DD.%2BJ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DCeglia%26aufirst%3DS.%2BS.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DManser%26aufirst%3DK.%26aulast%3DNissley%26aufirst%3DB.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChessen%26aufirst%3DG.%26aulast%3DTempleton%26aufirst%3DA.%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520MK-8970%253A%2520an%2520acetal%2520carbonate%2520prodrug%2520of%2520raltegravir%2520with%2520enhanced%2520colonic%2520absorption%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D245%26epage%3D252%26doi%3D10.1002%2Fcmdc.201402393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit222b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tsou, N.; Shultz, C. S.; Andreani, T.; Ball, R. G.; Brunskill, A.; Balsells, J.; Cohen, R. D.; DaSilva, J.; Li, J.; Reamer, R. A.; de Lera Ruiz, M.; Variankaval, N.; Varsolona, R. J.; Yasuda, N.; York, G.</span><span> </span><span class="NLM_article-title">Careful navigation of the crystallographic landscape of MK-8970: A racemic acetal carbonate prodrug of Raltegravir</span>.  <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.oprd.5b00129</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.5b00129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Tsou&author=C.+S.+Shultz&author=T.+Andreani&author=R.+G.+Ball&author=A.+Brunskill&author=J.+Balsells&author=R.+D.+Cohen&author=J.+DaSilva&author=J.+Li&author=R.+A.+Reamer&author=M.+de+Lera+Ruiz&author=N.+Variankaval&author=R.+J.+Varsolona&author=N.+Yasuda&author=G.+York&title=Careful+navigation+of+the+crystallographic+landscape+of+MK-8970%3A+A+racemic+acetal+carbonate+prodrug+of+Raltegravir&doi=10.1021%2Facs.oprd.5b00129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit222b&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.5b00129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.5b00129%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DN.%26atitle%3DCareful%2520navigation%2520of%2520the%2520crystallographic%2520landscape%2520of%2520MK-8970%253A%2520A%2520racemic%2520acetal%2520carbonate%2520prodrug%2520of%2520Raltegravir%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2015%26doi%3D10.1021%2Facs.oprd.5b00129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group">Raheem, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walji, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywickrema, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clas, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartingh, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajkovic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rearden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreier, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 2-pyridinone aminals: A prodrug strategy to advance a second generation of HIV-1 integrase strand transfer inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8154</span><span class="NLM_x">–</span> <span class="NLM_lpage">8165</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8154-8165&author=I.+Raheemauthor=A.+Waljiauthor=D.+Kleinauthor=J.+M.+Sandersauthor=D.+Powellauthor=P.+Abeywickremaauthor=G.+Barbeauthor=A.+Bennetauthor=S.+D.+Clasauthor=D.+Dubostauthor=M.+Embreyauthor=J.+Groblerauthor=M.+Hafeyauthor=T.+J.+Hartinghauthor=D.+J.+Hazudaauthor=M.+D.+Millerauthor=K.+P.+Mooreauthor=N.+Pajkovicauthor=S.+Patelauthor=V.+Radaauthor=P.+Reardenauthor=J.+D.+Schreierauthor=J.+Siskoauthor=T.+G.+Steeleauthor=J.+F.+Truchonauthor=J.+Waiauthor=M.+Xuauthor=P.+J.+Coleman&title=Discovery+of+2-pyridinone+aminals%3A+A+prodrug+strategy+to+advance+a+second+generation+of+HIV-1+integrase+strand+transfer+inhibitors&doi=10.1021%2Facs.jmedchem.5b01037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors</span></div><div class="casAuthors">Raheem, Izzat T.; Walji, Abbas M.; Klein, Daniel; Sanders, John M.; Powell, David A.; Abeywickrema, Pravien; Barbe, Guillaume; Bennet, Amrith; Childers, Karla; Christensen, Melodie; Clas, Sophie-Dorothee; Dubost, David; Embrey, Mark; Grobler, Jay; Hafey, Michael J.; Hartingh, Timothy J.; Hazuda, Daria J.; Kuethe, Jeffrey T.; Dunn, Jamie McCabe; Miller, Michael D.; Moore, Keith P.; Nolting, Andrew; Pajkovic, Natasa; Patel, Sangita; Peng, Zuihui; Rada, Vanessa; Rearden, Paul; Schreier, John D.; Sisko, John; Steele, Thomas G.; Truchon, Jean-Francois; Wai, John; Xu, Min; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8154-8165</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The search for new mol. constructs that resemble the crit. two-metal binding pharmacophore required for HIV integrase strand transfer inhibition represents a vibrant area of research within drug discovery.  Here the authors present the discovery of a new class of HIV integrase strand transfer inhibitors based on the 2-pyridinone core of MK-0536.  These efforts led to the identification of two lead compds. I and II with excellent antiviral activity and preclin. pharmacokinetic profiles to support a once-daily human dose prediction.  Dose escalating PK studies in dog revealed significant issues with limited oral absorption and required an innovative prodrug strategy to enhance the high-dose plasma exposures of the parent mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGEsuT4C8WELVg90H21EOLACvtfcHk0lhl-gZq22WbIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrvJ&md5=bec0c2f7710a1e4e8cc3a502067a2236</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01037%26sid%3Dliteratum%253Aachs%26aulast%3DRaheem%26aufirst%3DI.%26aulast%3DWalji%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DD.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DAbeywickrema%26aufirst%3DP.%26aulast%3DBarbe%26aufirst%3DG.%26aulast%3DBennet%26aufirst%3DA.%26aulast%3DClas%26aufirst%3DS.%2BD.%26aulast%3DDubost%26aufirst%3DD.%26aulast%3DEmbrey%26aufirst%3DM.%26aulast%3DGrobler%26aufirst%3DJ.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DHartingh%26aufirst%3DT.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DPajkovic%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRada%26aufirst%3DV.%26aulast%3DRearden%26aufirst%3DP.%26aulast%3DSchreier%26aufirst%3DJ.%2BD.%26aulast%3DSisko%26aufirst%3DJ.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DTruchon%26aufirst%3DJ.%2BF.%26aulast%3DWai%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25202-pyridinone%2520aminals%253A%2520A%2520prodrug%2520strategy%2520to%2520advance%2520a%2520second%2520generation%2520of%2520HIV-1%2520integrase%2520strand%2520transfer%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8154%26epage%3D8165%26doi%3D10.1021%2Facs.jmedchem.5b01037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJ8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJ8','PDB','4EJ8'); return false;">PDB: 4EJ8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EJK','PDB','4EJK'); return false;">PDB: 4EJK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4Q','PDB','4K4Q'); return false;">PDB: 4K4Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4K4R','PDB','4K4R'); return false;">PDB: 4K4R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFB','PDB','4KFB'); return false;">PDB: 4KFB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IG3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IG3','PDB','4IG3'); return false;">PDB: 4IG3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IFY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IFY','PDB','4IFY'); return false;">PDB: 4IFY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ICL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ICL','PDB','4ICL'); return false;">PDB: 4ICL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AO2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AO2','PDB','3AO2'); return false;">PDB: 3AO2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZT3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZT3','PDB','3ZT3'); return false;">PDB: 3ZT3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZSO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZSO','PDB','3ZSO'); return false;">PDB: 3ZSO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKO','PDB','1FKO'); return false;">PDB: 1FKO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EP4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EP4','PDB','1EP4'); return false;">PDB: 1EP4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JLE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JLE','PDB','2JLE'); return false;">PDB: 2JLE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OYF','PDB','3OYF'); return false;">PDB: 3OYF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS','PDB','4MBS'); return false;">PDB: 4MBS</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00497%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00497" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998711eae41929","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
